data_2v9h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2v9h _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -110.32 154.21 23.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.09 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.41 115.75 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.355 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.38 142.45 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.486 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -38.31 7.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.398 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -143.32 146.91 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.408 ' CD1' HD22 ' A' ' 43' ' ' LEU . 58.9 mt -111.23 130.49 64.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 173.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.8 156.44 34.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.467 ' HD2' HG11 ' A' ' 39' ' ' VAL . 5.9 m-85 -128.53 119.66 25.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.41 73.9 2.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.738 0.78 . . . . 0.0 110.599 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.691 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.023 179.467 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.301 0 CA-C-O 120.444 0.164 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.467 HG11 ' HD2' ' A' ' 31' ' ' PHE . 1.4 m -57.05 -29.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.65 71.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.949 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 -33.94 57.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 110.381 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.62 -31.45 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 29' ' ' ILE . 1.3 mt -56.66 -32.02 64.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.799 0.839 . . . . 0.0 112.788 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.1 -23.7 65.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.838 0.351 . . . . 0.0 111.633 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -7.49 53.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.403 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 56.7 mtp -100.39 132.64 22.19 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.9 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.547 ' HD2' HG21 ' A' ' 62' ' ' THR . 23.1 Cg_exo -66.33 -19.99 55.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.886 2.391 . . . . 0.0 112.665 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -104.06 155.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.404 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.3 176.21 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -68.91 121.52 16.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.983 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.98 -6.33 51.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.139 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 2.9 m-20 -81.16 156.49 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 111.263 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.03 125.98 35.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.27 128.43 72.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 111.907 -173.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -98.42 -178.27 3.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.082 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.19 -26.77 65.0 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.62 -37.12 86.13 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.548 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.68 -30.96 64.69 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.433 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.84 -46.86 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 123.303 0.377 . . . . 0.0 110.264 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.52 69.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.141 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 2.0 t-20 -68.22 -43.4 78.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.999 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.547 HG21 ' HD2' ' A' ' 47' ' ' PRO . 4.2 p -64.2 -40.78 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.774 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.719 HG13 HG22 ' A' ' 77' ' ' VAL . 39.7 mt -55.87 -52.7 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 123.427 0.455 . . . . 0.0 110.997 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.7 -29.64 67.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.56 -52.54 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.703 0.287 . . . . 0.0 110.414 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.22 -27.28 67.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.872 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -38.54 76.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.973 -0.454 . . . . 0.0 110.236 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.82 -14.79 59.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.538 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.0 p -79.71 -25.03 41.28 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.03 88.13 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.459 -0.791 . . . . 0.0 114.601 166.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.12 -29.18 38.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.578 0.689 . . . . 0.0 111.042 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -107.1 152.98 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.743 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 6.7 mm-40 -86.67 -26.93 24.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.342 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 6.8 t70 -148.75 146.89 28.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.457 HG13 ' HA ' ' A' ' 63' ' ' ILE . 62.1 t -129.89 119.8 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.112 0.257 . . . . 0.0 110.701 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.97 118.79 31.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.55 0.214 . . . . 0.0 110.928 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.719 HG22 HG13 ' A' ' 63' ' ' ILE . 27.5 t -107.91 123.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.89 157.85 44.79 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -102.7 148.21 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.398 0.618 . . . . 0.0 111.657 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -139.55 97.43 3.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.657 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.79 -118.47 8.3 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 15.83 24.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 110.003 174.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.71 128.58 52.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.33 115.69 31.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.79 129.53 56.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.681 0.753 . . . . 0.0 110.87 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 77' ' ' VAL . 13.1 t -113.98 105.78 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.413 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -90.91 133.92 34.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.86 154.89 33.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.038 0.447 . . . . 0.0 110.956 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 4.3 tptt . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.757 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 31.6 Cg_exo . . . . . 0 CA--C 1.53 0.316 0 CA-C-O 121.797 0.665 . . . . 0.0 113.648 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.548 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 29.3 m -96.12 146.48 24.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.877 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.621 HG23 ' HA ' ' A' ' 121' ' ' VAL . 6.0 mt -63.05 117.77 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 162' ' ' ARG . . . -104.08 -48.62 3.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.41 137.52 34.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.138 0.494 . . . . 0.0 111.323 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.41 HG22 HD13 ' A' ' 165' ' ' LEU . 1.0 OUTLIER -111.63 121.75 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.09 52.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.756 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.582 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 23.1 m-85 -114.92 138.05 51.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -173.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.548 ' OG ' ' HE3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -138.79 112.16 8.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.418 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.703 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 112.56 22.32 5.81 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.371 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.16 69.52 7.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.229 0.537 . . . . 0.0 110.383 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -85.16 -26.77 26.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.357 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.6 m -112.28 -60.77 1.82 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.082 0.467 . . . . 0.0 111.197 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -89.28 141.52 14.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.512 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 146.49 52.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.16 -35.29 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -64.13 -35.61 81.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.1 mtp -67.16 -45.17 77.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.267 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 107' ' ' ASP . 10.0 mt -62.72 -33.34 74.91 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.451 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.465 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -60.61 -48.9 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.303 0.377 . . . . 0.0 111.296 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -77.45 -27.98 52.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.285 -177.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -63.66 -44.28 94.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.281 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -42.85 97.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.535 ' HG2' ' HA ' ' A' ' 120' ' ' ARG . 8.6 mt-10 -61.25 -40.87 95.68 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.392 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.27 60.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.5 m -92.56 -16.36 25.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.235 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.32 -48.05 0.8 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.162 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 t -82.26 103.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.488 0.661 . . . . 0.0 109.685 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' HA ' ' HG2' ' A' ' 115' ' ' GLU . 2.2 ttp85 -128.6 149.49 50.61 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -174.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.621 ' HA ' HG23 ' A' ' 94' ' ' ILE . 43.1 t -68.03 123.61 21.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.155 0.502 . . . . 0.0 110.795 -175.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.79 70.05 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.713 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -102.95 156.13 17.88 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -177.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.743 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -56.55 133.62 53.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.858 0.463 . . . . 0.0 111.216 174.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.42 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.91 145.36 24.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.326 0.584 . . . . 0.0 111.626 -176.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.736 ' HB3' ' HG1' ' A' ' 129' ' ' THR . 12.8 t0 -117.44 121.64 41.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.049 173.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -17.47 61.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.912 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 p -88.64 -21.69 23.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.734 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.736 ' HG1' ' HB3' ' A' ' 126' ' ' ASP . 6.1 p -85.57 -7.68 58.72 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.405 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.5 ' HA ' HD11 ' A' ' 130' ' ' ILE . 9.2 mm -57.45 -46.38 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.116 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.82 -34.55 78.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.75 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.07 -35.19 77.79 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.288 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.2 mt -67.13 -43.61 88.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.208 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.467 ' HA ' HG13 ' A' ' 151' ' ' VAL . 91.9 mt-10 -57.28 -49.81 74.91 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.13 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -68.12 -35.48 78.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.477 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.32 -41.63 77.79 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.734 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.452 HD23 HD21 ' A' ' 110' ' ' LEU . 49.3 mt -71.94 -32.64 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 149' ' ' ALA . 18.0 mt-10 -63.6 -42.49 98.24 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.308 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.13 -37.94 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.916 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -62.82 -42.62 99.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.386 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -40.59 95.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.11 -30.65 68.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.322 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.1 m -73.91 -27.63 61.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.366 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.4 t -74.94 -85.09 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.87 19.3 23.43 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.32 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 49.9 1.76 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.394 0.677 . . . . 0.0 110.394 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -89.24 125.17 34.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.96 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.04 97.41 7.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.274 0.559 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -122.59 149.08 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.537 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.45 131.17 45.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.467 HG13 ' HA ' ' A' ' 134' ' ' GLU . 28.8 t -111.85 126.73 69.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.943 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 122.69 28.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.033 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.651 ' HB3' HD12 ' A' ' 167' ' ' LEU . . . -98.37 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.238 0.542 . . . . 0.0 110.902 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 28.0 t -98.27 120.61 47.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.61 118.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.619 . . . . 0.0 110.925 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.1 m -112.99 119.15 43.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.465 ' HA ' HG11 ' A' ' 163' ' ' VAL . 77.7 Cg_endo -77.86 137.59 15.99 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.767 2.311 . . . . 0.0 112.709 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -121.55 148.96 51.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.578 175.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 8.5 Cg_exo -73.33 58.59 3.7 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.712 2.941 . . . . 0.0 113.911 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.86 18.07 1.62 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 60.43 40.15 17.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.526 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.548 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -141.77 167.13 22.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.711 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -127.68 143.33 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 110.965 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -110.8 118.76 37.02 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.41 HD13 HG22 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -116.62 132.57 56.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.884 0.85 . . . . 0.0 111.371 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.548 ' HE3' ' OG ' ' A' ' 100' ' ' SER . 5.3 tttt -115.35 133.3 56.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.964 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' ' 153' ' ' ALA . 4.0 mm? -102.56 111.31 23.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.241 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.7 113.92 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.664 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.703 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 38.6 m-85 -105.07 118.09 35.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.452 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.822 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.655 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 26.4 p90 -104.52 153.03 21.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.88 116.65 29.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.91 113.82 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.63 0.729 . . . . 0.0 110.489 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 7.2 mmtm -79.17 -32.44 44.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.967 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.475 ' HB3' HG21 ' A' ' 83' ' ' THR . 24.0 t0 -149.32 139.91 22.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.079 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 43' ' ' LEU . 59.3 mt -112.1 122.49 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.15 140.71 50.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -114.71 148.61 38.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.497 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -142.86 75.62 1.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.36 177.161 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.358 0 CA-C-O 120.246 0.07 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -59.12 -35.8 59.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.27 -40.07 87.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.801 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.21 69.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 110.49 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.05 -40.74 71.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.475 HD13 HG23 ' A' ' 29' ' ' ILE . 4.1 mp -62.91 -32.19 73.42 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.536 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 49.0 mt -69.32 -22.85 63.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.334 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -85.44 -18.0 34.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.448 ' HG2' HG22 ' A' ' 62' ' ' THR . 42.0 mtp -82.4 148.44 59.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.839 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.52 12.51 2.85 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.779 2.32 . . . . 0.0 113.126 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.11 166.43 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.706 ' HD2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.89 176.94 7.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.137 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -66.4 126.78 29.88 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.689 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.44 -4.46 54.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.657 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.706 ' HB2' ' HD2' ' A' ' 49' ' ' ARG . 2.6 t0 -92.32 156.81 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.412 . . . . 0.0 111.359 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 m -88.34 134.09 33.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.884 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.13 128.91 65.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 111.411 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -98.57 -178.31 3.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.263 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -37.07 79.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.284 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.81 -37.88 80.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.157 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -74.29 -30.45 62.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -50.43 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 173.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.606 ' HA ' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -67.62 -32.71 73.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.59 0.233 . . . . 0.0 111.213 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.55 -41.65 88.32 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.684 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.448 HG22 ' HG2' ' A' ' 46' ' ' MET . 91.2 m -60.37 -43.51 96.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 172.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 60' ' ' SER . 59.7 mt -56.07 -54.54 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 123.274 0.359 . . . . 0.0 111.122 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -29.62 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.6 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.601 ' HA ' HG22 ' A' ' 69' ' ' THR . 80.3 mt -71.19 -30.09 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.814 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.85 -33.84 75.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.373 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.89 -13.27 61.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.196 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 66' ' ' LEU . 15.5 p -78.94 -24.43 43.99 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.758 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.02 10.16 84.03 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.291 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -91.41 -25.51 19.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.941 0.4 . . . . 0.0 110.876 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.7 148.43 42.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.343 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -91.8 -14.06 30.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.158 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 9.3 t70 -154.65 138.31 16.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 66' ' ' LEU . 49.0 t -126.34 118.79 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.4 118.16 31.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.373 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.625 HG21 HG12 ' A' ' 86' ' ' VAL . 90.8 t -107.62 122.18 61.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mt -131.14 140.1 49.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.655 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -99.79 140.03 34.59 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.536 0.684 . . . . 0.0 110.293 -178.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.65 95.08 4.31 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.54 -109.58 2.97 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.452 ' HB2' ' HG2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -112.67 13.69 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 175.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -103.48 135.12 45.67 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.46 ' HB2' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -103.48 111.63 24.16 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.059 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 tp -104.28 119.63 39.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.868 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.625 HG12 HG21 ' A' ' 77' ' ' VAL . 14.8 t -117.05 113.75 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.325 0.583 . . . . 0.0 111.265 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -102.24 140.62 36.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -137.38 157.31 34.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 120.978 0.418 . . . . 0.0 110.438 -174.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.416 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo . . . . . 0 N--CA 1.474 0.337 0 CA-C-O 121.523 0.551 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 4.3 m -110.42 140.22 44.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.897 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.559 HG23 ' HA ' ' A' ' 121' ' ' VAL . 13.7 mt -59.09 119.05 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 109.832 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.45 -32.12 9.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.501 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.11 138.38 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.701 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.4 HG23 ' CD1' ' A' ' 114' ' ' LEU . 1.5 mt -118.75 132.16 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.04 139.19 52.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.652 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.503 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.6 m-85 -112.68 139.33 48.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.58 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.69 123.02 17.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.132 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.62 17.61 25.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.839 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 99' ' ' PHE . 44.1 m-80 -96.94 77.24 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 111.033 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.26 -40.43 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.654 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -76.52 -57.88 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.353 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.57 143.95 10.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -71.02 145.95 49.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 0.0 112.091 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -39.89 84.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.098 171.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.13 -45.32 87.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.84 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -41.23 79.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -32.95 74.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.891 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -47.84 84.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 111.334 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -77.95 -27.12 49.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -63.88 -38.43 91.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.397 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.4 ' CD1' HG23 ' A' ' 97' ' ' ILE . 14.2 mt -68.14 -43.09 79.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.533 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -58.93 -43.53 91.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.194 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.3 61.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.629 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.4 m -91.17 -14.66 30.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 110.559 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.75 -26.55 7.55 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.971 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.16 104.0 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.187 0.517 . . . . 0.0 110.88 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.451 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 3.6 ptp85 -140.59 172.42 12.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.501 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 94' ' ' ILE . 50.9 t -69.97 128.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.35 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.12 61.78 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.337 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -120.85 146.31 46.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 35.2 t -65.69 151.73 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 111.227 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.756 HD22 ' HD2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -93.53 145.21 24.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.596 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.453 ' O ' HG12 ' A' ' 130' ' ' ILE . 5.3 t70 -104.62 99.01 8.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.296 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.756 ' HD2' HD22 ' A' ' 125' ' ' LEU . 1.1 mtp180 -72.2 -18.31 61.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.912 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -75.02 -31.59 61.4 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.33 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 p -95.39 -2.85 48.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.159 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.492 ' CG1' ' HA ' ' A' ' 127' ' ' ARG . 2.8 mm -55.59 -37.71 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.51 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -75.36 -27.13 59.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.872 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.436 ' O ' HD21 ' A' ' 137' ' ' LEU . 19.1 mt -66.29 -50.02 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.927 174.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.24 -49.09 78.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.638 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -40.32 93.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.573 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -34.86 65.08 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.197 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.436 HD21 ' O ' ' A' ' 133' ' ' ILE . 1.7 mm? -70.5 -40.26 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.927 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -58.77 -40.37 83.75 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.688 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.16 -38.78 91.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.824 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.412 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 2.1 m-30 -65.62 -38.07 88.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.505 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.69 -34.64 78.31 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 110.804 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.3 t80 -70.58 -30.75 67.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.96 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.27 -28.03 65.94 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.8 t -75.24 -88.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 110.574 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.416 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -112.68 18.61 22.25 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.716 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 20.7 mtmt 60.05 49.13 7.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 110.075 -173.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.248 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.22 97.12 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.335 1.022 . . . . 0.0 111.732 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.76 156.21 17.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.052 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 113.37 25.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.1 t -103.26 126.72 57.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -172.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -125.38 117.61 24.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.334 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.12 111.24 22.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.028 0.442 . . . . 0.0 110.092 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.1 t -94.08 123.27 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.245 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.4 m -109.89 117.62 55.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.6 m -109.55 117.42 52.75 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.121 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.68 142.49 16.14 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.667 2.245 . . . . 0.0 112.655 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -122.12 155.09 61.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 171.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.83 56.81 6.21 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.149 2.566 . . . . 0.0 113.76 -173.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.614 ' HB2' HD13 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -134.85 -89.53 0.35 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -167.75 36.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.542 ' HB2' HD12 ' A' ' 158' ' ' LEU . 10.9 mmt85 -131.42 162.2 30.73 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.442 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -135.2 148.01 28.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.858 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.27 127.45 53.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.82 122.16 46.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -120.48 132.7 55.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 110.559 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -102.07 110.79 22.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.201 -177.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.57 122.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.592 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 167' ' ' LEU . 23.7 m-85 -113.69 118.31 33.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.421 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.914 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.946 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -110.12 151.57 27.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.23 117.95 29.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -69.32 107.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.535 0.683 . . . . 0.0 110.228 178.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -20.53 31.6 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.578 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.709 ' HB3' HG21 ' A' ' 83' ' ' THR . 20.5 t70 -156.83 137.98 13.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.913 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.4 121.29 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.13 126.48 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.99 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.495 ' HD2' HG11 ' A' ' 39' ' ' VAL . 80.2 m-85 -104.24 122.23 44.95 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -117.97 -8.81 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.853 -172.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.767 ' HA2' ' H ' ' A' ' 88' ' ' VAL . . . . . . . . 0 N--CA 1.447 -0.606 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.985 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.381 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG11 ' HD2' ' A' ' 31' ' ' PHE . 1.8 m -54.3 -43.51 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 O-C-N 123.981 0.801 . . . . 0.0 112.222 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.32 -38.0 46.73 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.688 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.462 ' HA ' HD13 ' A' ' 44' ' ' LEU . . . -67.7 -37.72 82.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.18 -35.93 64.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.88 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -58.92 -31.12 68.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.315 0.646 . . . . 0.0 112.54 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 41' ' ' ALA . 69.0 mt -69.29 -19.47 63.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.701 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -92.73 -8.37 44.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.568 ' HE2' HG22 ' A' ' 62' ' ' THR . 87.8 mtp -90.16 141.61 27.93 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.577 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 26.3 Cg_exo -64.31 -37.04 42.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.773 2.315 . . . . 0.0 112.768 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.96 155.47 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.39 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -113.51 170.79 7.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.098 0.475 . . . . 0.0 110.983 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.465 ' HA ' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -67.24 138.72 57.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.2 177.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 -14.47 48.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.8 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.28 156.94 18.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 110.211 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.8 135.05 38.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.908 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.66 129.39 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.178 0.513 . . . . 0.0 110.889 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.482 ' O ' HD11 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -97.19 -177.56 3.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.386 0.613 . . . . 0.0 110.645 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -65.37 -29.83 70.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.339 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.77 62.83 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.664 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 43.0 m-20 -74.13 -29.56 61.88 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.63 HD12 ' HE ' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -63.13 -49.26 84.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -66.86 -35.94 81.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.577 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -62.39 -45.13 94.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.426 177.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.568 HG22 ' HE2' ' A' ' 46' ' ' MET . 63.1 m -58.24 -47.06 84.71 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.267 174.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.403 ' HA ' HG13 ' A' ' 75' ' ' VAL . 7.9 mt -56.92 -50.43 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.441 0.463 . . . . 0.0 111.142 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -69.81 -34.04 73.16 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -67.89 -46.7 70.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HA ' HG22 ' A' ' 69' ' ' THR . 60.7 mt -67.87 -30.9 70.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.914 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.56 99.23 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.11 -12.08 61.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.194 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 66' ' ' LEU . 32.7 p -78.42 -24.71 46.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.478 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.83 16.22 76.25 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.877 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -88.22 -32.48 18.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.303 0.573 . . . . 0.0 109.888 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.2 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 6.4 mm-40 -93.25 -27.1 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 14.8 t70 -141.78 137.07 31.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 63' ' ' ILE . 38.1 t -124.91 117.1 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.43 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.6 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.458 HG12 HG23 ' A' ' 62' ' ' THR . 16.0 m -104.67 144.11 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 110.405 174.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.11 155.99 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.63 ' HE ' HD12 ' A' ' 59' ' ' ILE . 1.4 mpp_? -116.07 127.14 54.63 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.291 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.86 95.27 4.76 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.99 -110.47 3.51 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.839 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.78 10.07 30.88 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -103.65 128.78 50.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.8 -176.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.06 113.2 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 0.0 110.328 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.9 112.66 24.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.216 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.56 106.85 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.301 0.572 . . . . 0.0 110.477 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -105.6 123.81 48.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.379 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.767 ' H ' ' HA2' ' A' ' 33' ' ' GLY . 4.2 m -124.51 147.47 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.445 0.641 . . . . 0.0 110.891 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.1 ttpt . . . . . 0 C--N 1.315 -0.932 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.135 -175.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.235 0.371 0 CA-C-O 121.555 0.564 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 86.6 m -94.6 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.842 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 125' ' ' LEU . 12.9 mt -73.21 118.73 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' ' HG2' ' A' ' 162' ' ' ARG . . . -97.44 -42.81 7.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.12 147.17 33.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.482 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -117.96 123.58 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 172.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.963 -175.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.721 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 21.6 m-85 -114.27 133.88 55.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.792 0.329 . . . . 0.0 110.791 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.9 m -126.39 144.39 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.801 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.76 -79.97 0.26 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 47.07 49.97 14.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.752 0.821 . . . . 0.0 112.611 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -76.17 -42.64 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 m -130.54 -25.73 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.76 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.446 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 13.6 t -111.4 132.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 155.46 39.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.378 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.27 77.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.291 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.156 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -45.44 73.65 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -32.61 71.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.074 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.721 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 9.9 mttt -58.14 -48.79 79.15 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.425 0.453 . . . . 0.0 111.584 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.81 48.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.735 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.3 -38.12 88.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.662 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.421 HD12 HG22 ' A' ' 133' ' ' ILE . 1.9 mm? -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.542 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 2.8 mt-10 -65.58 -37.83 87.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.417 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.72 -16.39 61.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.233 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.3 m -88.21 -16.02 34.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.965 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.06 -32.38 5.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.326 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.434 ' H ' HG21 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -90.73 113.0 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -174.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.542 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -141.06 176.72 8.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.642 -178.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.43 127.2 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.912 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.48 -27.81 18.82 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.553 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.97 162.41 19.41 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -79.03 164.86 24.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.49 ' HB2' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -112.04 143.63 42.72 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.057 -177.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 129' ' ' THR . 43.9 t0 -107.86 105.7 15.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.571 0.7 . . . . 0.0 110.097 174.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.432 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.3 -14.1 62.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.763 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.8 p -89.54 -23.47 22.01 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.071 0.939 . . . . 0.0 108.745 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.58 HG23 HD13 ' A' ' 133' ' ' ILE . 5.3 m -87.89 -13.57 41.63 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.715 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.536 HG22 ' HB1' ' A' ' 153' ' ' ALA . 4.3 mm -53.69 -39.95 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.097 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.54 94.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.2 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.492 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.58 HD13 HG23 ' A' ' 129' ' ' THR . 15.6 mt -63.09 -44.39 99.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.923 174.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.75 -44.66 96.48 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.726 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -41.32 93.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.634 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.42 -38.41 69.98 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.704 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.16 -33.06 71.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 111.492 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.29 -34.2 75.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.507 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.83 -32.46 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.519 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -62.51 -39.37 93.31 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.676 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.446 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -64.5 -34.53 78.44 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.099 0.476 . . . . 0.0 110.872 177.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -69.49 -30.79 68.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.156 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.6 m -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.797 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.5 t -76.18 -85.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.627 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.8 19.96 22.82 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.674 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mttp 66.7 42.21 2.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.429 0.692 . . . . 0.0 110.569 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -87.26 139.44 30.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.442 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -115.16 74.47 0.88 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.238 0.542 . . . . 0.0 110.127 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.482 ' HB3' ' HD1' ' A' ' 169' ' ' PHE . . . -95.4 142.04 28.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.369 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.597 ' H ' ' HB2' ' A' ' 170' ' ' GLN . 0.9 OUTLIER -99.41 126.42 45.3 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 11.4 p -113.4 138.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.176 0.512 . . . . 0.0 111.388 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.89 125.21 39.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.658 175.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.536 ' HB1' HG22 ' A' ' 130' ' ' ILE . . . -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.258 0.551 . . . . 0.0 110.919 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.57 128.77 56.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.329 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.74 123.36 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.433 0.635 . . . . 0.0 111.204 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.481 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 m -107.01 120.19 48.82 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.579 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 9.6 Cg_endo -89.64 130.4 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.408 2.739 . . . . 0.0 112.952 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -113.47 152.95 45.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 22.47 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.04 2.493 . . . . 0.0 113.876 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -115.72 19.98 14.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.992 0.425 . . . . 0.0 110.144 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 t30 67.51 26.62 8.14 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.999 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.526 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -129.75 167.03 18.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.288 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.21 153.53 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.0 0.429 . . . . 0.0 111.139 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -108.92 118.82 37.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 130' ' ' ILE . 59.4 tp -101.18 113.47 26.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.352 -175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -105.15 131.34 52.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 111.01 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.7 108.58 19.48 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.632 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 2.8 t -101.28 111.74 31.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.885 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -99.53 146.61 26.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.597 ' HB2' ' H ' ' A' ' 150' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.886 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.208 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.438 ' HE1' HD12 ' A' ' 59' ' ' ILE . 10.9 p90 -95.49 153.39 17.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.395 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.17 118.98 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -69.88 122.46 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -49.59 7.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.122 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.07 140.99 29.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.247 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.619 HG23 ' HE2' ' A' ' 46' ' ' MET . 7.1 mt -104.85 121.17 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 172.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 127.74 53.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.988 0.423 . . . . 0.0 110.121 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -102.79 125.84 49.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.024 -173.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.01 68.92 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.348 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.562 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -53.63 -40.25 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.118 0.886 . . . . 0.0 112.604 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.482 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.12 -33.45 57.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.489 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.25 -35.25 63.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.54 74.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.507 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.51 -32.35 57.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.032 0.933 . . . . 0.0 112.879 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.7 mt -69.45 -14.04 62.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -100.06 -7.45 24.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.744 176.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.619 ' HE2' HG23 ' A' ' 29' ' ' ILE . 14.4 mtm -102.24 136.34 19.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.394 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.37 12.67 2.78 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.7 2.267 . . . . 0.0 113.296 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.756 HG13 HG13 ' A' ' 54' ' ' VAL . 32.0 m -119.08 149.12 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 49' ' ' ARG . 6.0 mmm-85 -131.85 166.22 22.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.504 0.668 . . . . 0.0 111.598 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.511 HG21 HD13 ' A' ' 29' ' ' ILE . 6.2 p -68.12 121.28 15.82 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.611 174.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.26 62.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.222 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.19 150.78 25.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.082 0.468 . . . . 0.0 111.224 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 116.35 32.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.756 HG13 HG13 ' A' ' 48' ' ' VAL . 14.7 m -133.2 156.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.081 0.467 . . . . 0.0 112.001 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.444 ' O ' HD13 ' A' ' 59' ' ' ILE . 11.6 m-80 -99.3 179.16 4.67 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.312 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.84 -32.83 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.191 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.67 -31.73 72.9 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 12.2 m-20 -75.2 -33.72 61.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.075 177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 55' ' ' ASN . 1.3 mp -63.14 -46.63 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 171.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.733 ' HA ' HD11 ' A' ' 63' ' ' ILE . 19.0 m -65.35 -31.86 73.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.303 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -70.01 -38.87 76.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.407 178.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 m -58.29 -46.67 85.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 171.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.733 HD11 ' HA ' ' A' ' 60' ' ' SER . 68.8 mt -55.33 -55.0 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.385 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -29.55 68.19 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 45' ' ' SER . . . -67.7 -45.71 74.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.485 0.183 . . . . 0.0 110.614 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HA ' HG22 ' A' ' 69' ' ' THR . 93.7 mt -69.39 -30.89 68.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.58 -35.01 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.74 -12.75 61.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.445 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 66' ' ' LEU . 16.5 p -78.87 -25.1 43.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.497 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.5 8.04 83.53 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.609 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -82.99 -48.77 10.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.997 0.427 . . . . 0.0 110.829 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.85 150.16 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -53.75 17.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -135.49 140.7 45.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -121.47 118.65 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.07 118.79 31.51 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.021 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.06 122.74 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.25 158.6 42.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 150.84 31.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.999 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -125.49 95.03 4.31 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.33 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.11 -108.44 2.35 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.276 -171.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -104.36 5.54 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.643 0.377 . . . . 0.0 111.323 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.97 133.11 49.48 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.401 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 111.75 24.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.233 0.539 . . . . 0.0 110.127 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.0 tp -100.58 112.95 25.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.038 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.7 t -106.86 105.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.483 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -105.42 126.52 52.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.25 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.55 144.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.253 0.549 . . . . 0.0 109.867 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.33 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo . . . . . 0 C--O 1.234 0.304 0 CA-C-O 121.518 0.549 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -96.66 134.25 40.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.426 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.543 HG23 ' HA ' ' A' ' 121' ' ' VAL . 25.7 mt -65.06 118.63 7.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.6 -34.88 14.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.93 154.36 27.72 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 110.448 174.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.42 HG23 ' CD1' ' A' ' 114' ' ' LEU . 1.1 mt -112.67 122.96 67.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.127 172.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.496 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -103.38 130.74 50.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.049 -178.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.654 ' HB3' HD22 ' A' ' 102' ' ' ASN . 19.9 m-30 -112.96 134.77 54.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.862 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -142.35 137.17 30.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.435 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.26 76.98 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.636 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.654 HD22 ' HB3' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -89.97 72.35 7.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.644 0.735 . . . . 0.0 110.648 -177.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 12.9 mmmt -86.41 -19.91 28.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.865 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -53.0 6.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.92 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 106' ' ' LYS . 13.2 t -107.45 141.4 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.445 ' N ' HG11 ' A' ' 105' ' ' VAL . 7.9 mttm -68.98 158.11 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 112.608 -171.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.29 95.38 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.243 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.48 -34.76 72.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.721 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.4 82.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.176 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -32.87 74.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.818 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -59.64 -44.8 93.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.372 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.516 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 4.1 tm0? -77.72 -28.53 50.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.36 -45.74 91.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.046 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.42 ' CD1' HG23 ' A' ' 97' ' ' ILE . 18.0 mt -67.95 -36.59 80.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.831 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -59.88 -46.14 90.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.137 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -15.97 61.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.542 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.4 m -90.94 -12.11 37.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.749 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.03 -20.8 19.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.631 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.4 102.41 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.303 0.573 . . . . 0.0 110.762 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.24 173.56 11.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.543 -178.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.543 ' HA ' HG23 ' A' ' 94' ' ' ILE . 65.4 t -69.36 125.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 110.651 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.11 -5.62 61.38 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.405 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 4.3 mm-40 -107.14 160.3 15.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.34 138.79 40.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 145.99 24.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.752 -175.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -115.83 103.76 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.649 0.737 . . . . 0.0 110.425 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.53 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.47 -15.3 62.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.562 178.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p -84.11 -20.66 32.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.095 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 p -100.64 3.26 42.37 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.23 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.9 mm -57.5 -41.52 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.768 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.9 -38.01 87.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 111.51 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -33.84 73.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.677 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.92 -44.11 88.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.908 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 92.3 mt-10 -57.28 -51.3 69.91 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.488 175.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.417 ' HA ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -61.95 -34.2 75.68 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.756 0.66 . . . . 0.0 111.758 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.62 86.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.932 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.453 HD23 ' HZ ' ' A' ' 169' ' ' PHE . 9.9 mt -73.87 -36.61 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 134' ' ' GLU . 1.9 pt-20 -72.55 -28.86 63.09 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.4 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.22 -40.84 64.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.269 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -44.3 97.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.13 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.05 90.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.496 0.498 . . . . 0.0 111.278 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -67.08 -33.98 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.188 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.5 m -72.23 -28.75 63.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.899 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.55 -82.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.998 0.427 . . . . 0.0 110.913 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' A' ' 146' ' ' LYS . . . -112.7 20.9 19.74 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-O 118.88 -0.955 . . . . 0.0 113.21 -172.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER 70.02 16.72 7.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.759 1.224 . . . . 0.0 111.064 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -60.42 118.0 5.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.285 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.22 94.66 9.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.595 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.69 143.23 50.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.762 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.56 120.66 39.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 169' ' ' PHE . 17.6 t -98.53 124.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -174.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -129.39 120.31 25.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.301 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.31 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.201 0.524 . . . . 0.0 110.181 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.33 123.56 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.167 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 t -98.61 113.36 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.038 0.447 . . . . 0.0 110.19 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.0 m -106.0 123.54 38.82 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.12 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -88.23 146.11 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.892 2.394 . . . . 0.0 113.138 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -135.26 157.63 76.32 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.6 51.22 3.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.966 2.444 . . . . 0.0 113.932 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.491 ' HB2' HD13 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.33 17.02 2.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.97 176.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 41.7 t30 60.43 37.47 19.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.261 1.029 . . . . 0.0 109.933 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.08 161.39 32.16 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.527 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.4 147.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.64 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -108.92 119.05 38.41 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.476 HD21 HD12 ' A' ' 94' ' ' ILE . 41.2 tp -99.18 115.78 29.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.212 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.496 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -105.56 132.29 51.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.423 0.63 . . . . 0.0 111.194 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.454 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 1.8 mm? -108.84 109.93 21.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.163 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 t -101.34 114.19 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.268 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.453 ' HZ ' HD23 ' A' ' 137' ' ' LEU . 43.6 m-85 -105.51 118.32 36.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.246 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.317 -0.806 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -113.33 154.12 27.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.099 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.13 116.66 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 50' ' ' THR . 0.5 OUTLIER -65.22 114.29 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 121.359 0.6 . . . . 0.0 111.285 -177.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 2.1 mttm -76.99 -39.97 48.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.812 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -156.89 142.26 17.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.217 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.567 HG23 ' HE1' ' A' ' 46' ' ' MET . 91.9 mt -104.26 121.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -115.71 127.56 55.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.516 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.18 146.23 30.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.16 0.505 . . . . 0.0 111.163 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -133.41 156.62 47.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.484 178.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.716 -176.446 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.243 0 CA-C-O 120.42 0.153 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.402 ' H ' HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -58.84 -33.52 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.92 -36.95 60.92 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.255 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.591 ' HA ' HD11 ' A' ' 44' ' ' LEU . . . -73.2 -34.05 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.0 110.168 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.09 73.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.843 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.475 ' HA ' ' HE2' ' A' ' 46' ' ' MET . 3.8 mt -60.93 -32.72 72.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.074 0.55 . . . . 0.0 111.811 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.591 HD11 ' HA ' ' A' ' 41' ' ' ALA . 17.6 mt -71.85 -20.39 61.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.98 0.419 . . . . 0.0 111.249 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.578 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -91.73 -10.96 38.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.894 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.567 ' HE1' HG23 ' A' ' 29' ' ' ILE . 53.8 mtm -94.78 135.83 23.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.607 ' HD2' HG21 ' A' ' 62' ' ' THR . 55.2 Cg_endo -71.69 -17.6 29.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.642 2.228 . . . . 0.0 112.725 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 149.56 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.718 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -120.91 176.27 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.896 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.595 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -67.48 136.07 54.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.01 -8.72 59.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.529 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.16 156.23 17.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.93 125.12 34.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.525 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.22 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.308 0.575 . . . . 0.0 111.563 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.81 -177.78 3.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.618 ' HA ' HD11 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -69.55 -25.67 64.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 176.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -65.71 -35.8 81.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.396 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 53.0 m-20 -74.6 -28.9 61.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.908 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.618 HD11 ' HA ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -59.97 -47.0 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 172.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -30.3 68.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.5 m-20 -67.36 -46.53 73.07 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.778 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.607 HG21 ' HD2' ' A' ' 47' ' ' PRO . 2.2 p -62.88 -38.86 92.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.006 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.676 HG13 HG22 ' A' ' 77' ' ' VAL . 28.6 mt -55.81 -54.12 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 123.427 0.454 . . . . 0.0 110.626 176.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 64' ' ' ARG . 9.6 ptm85 -70.23 -31.19 68.48 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -69.48 -44.9 70.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.538 0.208 . . . . 0.0 110.713 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 45' ' ' SER . 58.9 mt -69.94 -30.79 68.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.731 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -37.87 88.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 110.647 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.1 -13.42 61.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 66' ' ' LEU . 19.0 p -79.26 -24.79 42.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.629 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.12 -1.76 73.54 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.432 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -76.34 -47.1 24.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.403 0.621 . . . . 0.0 109.887 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.6 136.3 54.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.29 -18.27 25.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.54 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 24.6 t70 -122.74 134.47 54.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 63' ' ' ILE . 87.4 t -132.7 118.46 34.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.61 116.82 27.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.731 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.676 HG22 HG13 ' A' ' 63' ' ' ILE . 78.9 t -103.9 122.51 56.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 175.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -125.69 148.78 48.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.71 136.91 53.03 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.501 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.22 95.99 4.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.364 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.75 -111.68 4.32 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 40.3 m-20 -106.16 7.01 31.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.976 0.417 . . . . 0.0 110.486 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.47 133.61 48.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.421 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 111.8 24.62 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 3.6 tp -104.32 116.43 32.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.056 0.455 . . . . 0.0 110.752 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.5 110.99 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 6.3 mt-30 -96.65 127.75 42.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.18 162.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 0.0 111.554 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.244 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo . . . . . 0 N--CA 1.454 -0.852 0 CA-C-O 121.105 0.377 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.461 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 59.8 m -125.19 137.79 54.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.72 HD13 ' HB2' ' A' ' 125' ' ' LEU . 21.7 mt -74.94 120.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.12 -38.59 10.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.063 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.52 143.0 25.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.537 HD13 HG21 ' A' ' 121' ' ' VAL . 2.4 mt -123.13 128.07 74.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 141.56 47.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.47 177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.45 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.9 m-85 -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.619 0.247 . . . . 0.0 111.021 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.0 140.42 42.12 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 169' ' ' PHE . . . 85.39 16.22 64.8 Favored Glycine 0 C--N 1.328 0.113 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.695 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 1.7 p30 -79.47 69.92 5.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.54 0.686 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -83.13 -47.62 11.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.184 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -27.96 24.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 2.2 t -126.66 141.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -68.84 156.72 37.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.139 0.495 . . . . 0.0 111.619 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -33.95 77.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 171.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.845 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -60.99 -39.42 89.57 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 175.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.9 mtp -73.33 -39.04 65.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.218 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -32.62 73.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.242 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.845 ' HE2' ' HA ' ' A' ' 108' ' ' ASP . 7.6 mtmm -57.14 -48.52 78.47 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.591 0.557 . . . . 0.0 111.138 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.1 45.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.415 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.416 ' ND2' HD22 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -63.46 -37.63 88.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.487 ' CD2' HG22 ' A' ' 97' ' ' ILE . 1.1 mp -72.31 -38.38 68.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.921 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.483 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 16.4 mt-10 -62.67 -39.45 93.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.901 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.48 -15.66 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.125 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.595 ' HB2' HG12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -95.0 -16.14 22.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 175.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.16 -37.01 2.37 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.608 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.453 ' H ' HG21 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -88.66 111.53 22.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.267 0.555 . . . . 0.0 111.715 -171.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.543 ' HG3' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.03 171.17 14.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.223 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 97' ' ' ILE . 48.2 t -69.25 127.82 31.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.233 0.54 . . . . 0.0 110.598 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.65 53.26 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.497 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.543 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 1.1 tp10 -89.02 156.72 18.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 122.71 0.404 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.99 134.48 43.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.72 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -114.89 142.85 46.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.227 -177.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.527 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 33.6 t0 -117.58 133.48 55.91 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 110.054 164.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -16.04 62.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.714 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 p -82.47 -26.59 32.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.461 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.527 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -86.52 -11.48 51.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.428 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.466 HD13 HD13 ' A' ' 125' ' ' LEU . 5.9 mm -55.15 -40.13 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.732 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.68 91.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.11 -35.21 76.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.13 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 117' ' ' SER . 3.2 mt -67.41 -40.2 84.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.213 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.421 ' HB3' HG22 ' A' ' 151' ' ' VAL . 41.4 mt-10 -61.1 -40.92 95.57 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.45 96.97 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.869 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.33 -37.23 92.65 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.528 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.444 HD21 ' HZ ' ' A' ' 169' ' ' PHE . 8.2 mt -66.83 -36.81 83.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.752 0.31 . . . . 0.0 110.943 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.718 ' HG3' HG23 ' A' ' 151' ' ' VAL . 2.9 mt-10 -67.2 -39.56 86.37 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.67 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -67.01 -43.35 83.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.07 -44.1 97.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.641 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -38.35 87.08 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.962 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -28.98 65.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m -70.94 -27.58 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.2 -83.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 111.187 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.85 19.77 22.93 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.525 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.87 44.26 13.96 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.734 0.778 . . . . 0.0 110.504 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -80.03 118.66 21.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.935 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 m -89.51 86.36 6.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.003 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.11 144.53 25.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.022 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.3 113.44 25.39 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.718 HG23 ' HG3' ' A' ' 138' ' ' GLU . 24.9 m -101.16 133.0 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.384 0.611 . . . . 0.0 111.519 -169.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 116.69 18.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.574 172.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.6 110.8 22.77 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.386 0.612 . . . . 0.0 109.909 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.65 113.47 36.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.108 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.456 ' H ' HG11 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -105.18 110.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.775 0.798 . . . . 0.0 109.205 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 7.3 m -112.41 116.46 48.54 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.842 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.522 ' HA ' HG13 ' A' ' 163' ' ' VAL . 59.0 Cg_endo -71.79 135.65 26.21 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.624 2.216 . . . . 0.0 112.429 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -100.54 159.03 30.78 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.261 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.33 80.07 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.18 2.586 . . . . 0.0 113.306 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.485 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 1.0 OUTLIER -174.51 -112.31 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.712 0.805 . . . . 0.0 109.188 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.485 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 3.0 t-20 -146.15 9.62 1.12 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.968 0.89 . . . . 0.0 109.842 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.532 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 1.1 mpt_? -117.92 167.36 11.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.868 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.608 HG23 HD23 ' A' ' 125' ' ' LEU . 18.5 m -130.95 159.76 42.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 111.466 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.43 119.13 38.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.444 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.7 tp -108.19 125.95 52.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -123.43 132.27 53.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 111.132 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.45 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 2.7 mm? -108.52 110.87 22.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.011 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.18 112.3 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.331 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.444 ' HZ ' HD21 ' A' ' 137' ' ' LEU . 11.4 m-30 -109.65 127.86 54.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.323 0.582 . . . . 0.0 111.398 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.16 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -104.99 153.18 21.79 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.8 t -87.06 113.84 25.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -72.07 125.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.6 0.714 . . . . 0.0 110.346 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -91.4 -29.66 16.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.974 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.45 137.12 14.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.056 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.4 mt -109.64 121.38 62.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -119.88 127.86 53.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.174 0.511 . . . . 0.0 109.851 -178.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.672 ' HD2' HG11 ' A' ' 39' ' ' VAL . 58.7 m-85 -101.34 149.22 24.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.066 -175.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.73 167.4 21.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.402 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.54 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.27 -178.556 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.672 HG11 ' HD2' ' A' ' 31' ' ' PHE . 1.6 m -56.67 -41.85 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 123.857 0.723 . . . . 0.0 112.151 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.417 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.27 -34.16 55.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.573 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.75 -34.43 64.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.135 0.493 . . . . 0.0 110.953 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . . . -76.32 -33.81 59.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.834 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.84 -31.04 58.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 112.695 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 78.4 mt -66.56 -18.95 65.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.595 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -93.77 -8.45 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.695 0.284 . . . . 0.0 110.823 176.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.473 ' SD ' ' HZ ' ' A' ' 31' ' ' PHE . 36.7 mtp -93.23 136.6 24.25 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.613 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.696 ' HD2' HG21 ' A' ' 62' ' ' THR . 3.0 Cg_exo -78.41 6.56 4.69 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.069 2.513 . . . . 0.0 112.597 174.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.8 156.64 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 20.2 mtp85 -132.47 176.6 8.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.423 0.63 . . . . 0.0 112.114 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.9 p -67.84 120.49 14.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.883 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.31 44.94 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.095 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.4 OUTLIER -77.72 156.27 30.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.147 0.499 . . . . 0.0 111.573 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.67 117.01 30.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.16 129.07 73.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 112.283 -168.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.447 ' O ' HD11 ' A' ' 59' ' ' ILE . 2.0 p30 -100.14 -175.96 3.09 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.72 172.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.46 -26.21 68.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.966 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.33 -34.02 70.17 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.52 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -74.33 -29.7 61.71 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.427 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.631 HG13 HG13 ' A' ' 77' ' ' VAL . 1.2 mp -67.27 -44.85 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.478 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 p -71.0 -29.62 65.63 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 110.568 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.9 -45.73 73.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.696 HG21 ' HD2' ' A' ' 47' ' ' PRO . 2.2 p -63.74 -39.49 94.4 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.673 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 77' ' ' VAL . 28.9 mt -56.04 -50.68 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 123.364 0.415 . . . . 0.0 110.326 174.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 mtt85 -65.04 -36.63 84.96 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.545 0.528 . . . . 0.0 111.985 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 45' ' ' SER . . . -65.67 -48.76 71.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.068 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.595 HD22 ' HB2' ' A' ' 45' ' ' SER . 29.3 mt -70.71 -30.78 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.46 -36.25 78.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 110.724 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.05 -13.59 61.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.208 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 66' ' ' LEU . 19.0 p -78.77 -25.06 44.37 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.435 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.38 21.04 72.07 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.639 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -85.56 -23.89 27.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.7 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.12 176.76 7.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.575 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 3.6 mm-40 -97.16 -23.42 16.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.664 0.268 . . . . 0.0 111.521 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.762 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 3.6 t70 -155.67 145.0 20.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.5 119.07 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.431 ' HG3' HD13 ' A' ' 78' ' ' LEU . 2.6 ptp180 -121.01 124.96 46.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.306 0.574 . . . . 0.0 110.997 172.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.634 HG21 HG12 ' A' ' 86' ' ' VAL . 90.5 t -101.3 123.35 54.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 175.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.431 HD13 ' HG3' ' A' ' 76' ' ' ARG . 1.1 mp -128.07 158.01 39.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 145.78 47.62 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.386 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -128.03 96.09 4.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.7 -110.14 3.31 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.54 13.77 23.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.38 132.18 50.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.802 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 111.58 24.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.035 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 4.2 tp -105.11 112.75 25.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.634 HG12 HG21 ' A' ' 77' ' ' VAL . 18.3 t -108.58 106.75 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.08 159.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.835 0.35 . . . . 0.0 110.381 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.762 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 3.3 tptm . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.501 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 16.8 Cg_exo . . . . . 0 C--O 1.233 0.237 0 CA-C-O 121.412 0.505 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.7 m -102.58 139.77 37.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.161 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.4 mt -62.15 118.86 5.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.01 -25.41 11.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.14 0.495 . . . . 0.0 110.554 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -147.96 138.56 23.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.655 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.89 120.51 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.646 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 2.3 m -118.85 143.12 47.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.985 0.421 . . . . 0.0 111.006 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.794 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -121.75 135.93 54.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.497 -172.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.3 m -147.24 119.78 8.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.66 -7.96 39.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.791 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.488 ' OD1' ' HB3' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -81.11 83.88 6.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 110.937 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -85.92 -29.52 23.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.841 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -66.35 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.518 -175.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.508 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 15.1 t -90.47 142.52 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -69.74 146.48 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.07 0.462 . . . . 0.0 111.814 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.532 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 4.5 p30 -63.86 -33.01 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.206 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.58 -40.02 95.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.5 mtp -67.96 -40.32 83.23 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.381 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.03 -36.07 82.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.841 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.794 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 15.6 mttt -58.92 -46.1 88.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.816 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 3.0 tp60 -76.66 -27.98 55.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.288 -177.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.36 -49.95 71.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.69 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.44 -34.96 79.1 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.977 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -60.46 -42.47 96.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.437 178.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.03 -15.56 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.686 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.9 m -88.08 -16.58 33.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.51 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.35 -15.21 22.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.112 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.513 ' H ' HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -94.46 103.73 15.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.241 0.543 . . . . 0.0 110.162 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HG2' ' HA ' ' A' ' 115' ' ' GLU . 12.3 mtm180 -134.34 172.15 13.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.203 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.87 123.64 28.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 110.206 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.25 71.2 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.004 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 159.77 15.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 120.895 0.378 . . . . 0.0 110.81 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -66.33 142.93 57.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.925 170.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.48 148.23 22.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.087 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.72 98.1 6.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.459 0.647 . . . . 0.0 110.516 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.53 ' HD3' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.49 -14.83 62.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.56 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.53 HG21 ' HD3' ' A' ' 127' ' ' ARG . 3.2 p -85.08 -23.02 28.7 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.299 -0.251 . . . . 0.0 111.172 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 p -100.24 5.53 44.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.47 ' HA ' HD11 ' A' ' 130' ' ' ILE . 7.0 mm -57.64 -42.78 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . . . -64.86 -38.09 89.81 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.803 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 -27.46 63.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.779 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 130' ' ' ILE . 11.2 mt -67.45 -44.99 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.416 ' OE2' ' HA ' ' A' ' 131' ' ' ALA . 35.5 mt-10 -61.37 -47.77 84.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.241 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.51 82.2 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.959 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.02 -30.43 63.25 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.891 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.5 mt -76.11 -32.61 59.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.689 0.244 . . . . 0.0 110.741 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.819 ' HG3' HG22 ' A' ' 151' ' ' VAL . 6.5 mt-10 -64.98 -39.52 93.6 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 173.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -66.47 -43.56 85.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.599 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -62.37 -33.4 74.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.17 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -71.34 -44.41 65.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.139 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -30.22 66.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -173.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -28.85 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.469 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.58 -84.77 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.48 19.62 23.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.98 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? 62.56 52.55 2.88 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.446 0.641 . . . . 0.0 109.65 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -88.8 105.41 17.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.048 -173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.08 121.57 32.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.308 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.49 162.69 40.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.06 114.47 27.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.819 HG22 ' HG3' ' A' ' 138' ' ' GLU . 23.3 t -96.67 123.1 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.036 0.446 . . . . 0.0 110.812 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -124.71 117.7 24.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 167' ' ' LEU . . . -97.78 111.62 23.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.37 133.05 61.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.03 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.446 ' H ' HG21 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -102.26 123.04 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.274 0.559 . . . . 0.0 110.43 178.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.3 m -104.37 119.83 52.66 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.158 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 131.05 11.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 112.583 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.553 HD13 ' HB2' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -123.1 155.67 64.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.388 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.96 56.26 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.831 2.354 . . . . 0.0 113.879 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.495 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -144.32 19.37 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 177.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 38.5 t30 60.21 38.55 20.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 122.185 0.993 . . . . 0.0 109.247 -173.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.553 ' HB2' HD13 ' A' ' 158' ' ' LEU . 7.3 mmt180 -130.28 160.62 33.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.143 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.74 148.64 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.986 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.25 122.26 46.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.91 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.3 tp -96.13 110.39 22.67 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.646 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -113.22 132.06 55.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.792 0.806 . . . . 0.0 111.426 -175.428 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -107.78 110.69 22.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.445 -176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.93 111.05 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.448 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.93 117.43 34.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.373 -174.78 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -110.4 153.11 25.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.973 -0.613 . . . . 0.0 109.972 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -79.68 113.32 18.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 84' ' ' LEU . 3.2 t -73.79 125.49 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.49 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -85.54 -31.5 22.68 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.671 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -157.63 147.01 19.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.245 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.435 HD11 ' HG ' ' A' ' 43' ' ' LEU . 56.8 mt -109.9 120.14 60.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -107.77 127.03 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.941 -176.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -105.11 120.13 40.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 52.8 mm-40 -103.64 66.18 0.85 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.665 0.745 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.733 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.945 179.057 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.151 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -40.49 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.16 -41.77 94.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.145 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.14 68.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.826 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.3 81.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.435 ' HG ' HD11 ' A' ' 29' ' ' ILE . 4.7 mp -63.85 -31.61 72.84 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.932 0.493 . . . . 0.0 111.186 175.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.4 mt -74.55 -13.21 60.64 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.585 ' HB2' HD22 ' A' ' 66' ' ' LEU . 1.2 m -96.01 -8.19 34.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.15 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.604 ' HE1' HG22 ' A' ' 62' ' ' THR . 62.9 mtp -91.5 148.96 38.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.419 175.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 7.2 Cg_exo -75.0 -10.85 21.39 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.671 2.247 . . . . 0.0 112.212 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.634 ' HB ' HG13 ' A' ' 54' ' ' VAL . 9.4 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.175 -175.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -133.76 177.96 7.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.2 p -66.27 131.29 45.78 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.221 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.68 -7.4 65.49 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.51 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -97.7 156.05 16.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 111.003 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.27 124.04 34.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.717 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.634 HG13 ' HB ' ' A' ' 48' ' ' VAL . 1.1 m -129.32 135.84 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.11 0.481 . . . . 0.0 110.864 -171.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -98.51 -178.75 4.11 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.13 -36.88 85.64 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.37 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.04 -29.2 68.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.067 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 17.7 m-20 -73.75 -29.81 62.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.077 0.151 . . . . 0.0 110.866 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.99 -50.71 78.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 171.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.582 ' HA ' HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -66.07 -29.26 69.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.623 176.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 0.6 OUTLIER -69.58 -41.03 76.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.989 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.604 HG22 ' HE1' ' A' ' 46' ' ' MET . 85.2 m -58.61 -46.92 86.0 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.941 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.713 ' HA ' HG13 ' A' ' 75' ' ' VAL . 66.6 mt -52.83 -55.38 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.682 0.614 . . . . 0.0 110.854 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.59 -29.41 66.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.434 -174.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 69' ' ' THR . . . -67.66 -54.82 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 45' ' ' SER . 30.2 mt -62.54 -30.81 71.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.343 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -46.2 83.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.69 60.1 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 45' ' ' SER . 82.2 p -79.91 -24.13 41.31 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.821 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.07 78.56 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.067 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -82.74 -36.33 25.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.102 0.477 . . . . 0.0 110.383 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.511 ' HE1' HD23 ' A' ' 66' ' ' LEU . 22.6 m-85 -129.72 164.36 24.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.516 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HG2' ' HD3' ' A' ' 89' ' ' LYS . 0.7 OUTLIER -77.72 -50.99 11.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.447 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -133.49 144.05 49.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.392 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.713 HG13 ' HA ' ' A' ' 63' ' ' ILE . 24.4 t -128.28 120.68 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -174.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -114.26 118.43 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.801 174.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.3 t -112.42 123.08 67.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.017 0.437 . . . . 0.0 109.934 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.75 159.03 43.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -96.06 141.85 28.96 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.075 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -136.65 93.66 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.96 -109.31 2.79 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.143 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 11.88 20.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.74 141.78 35.49 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.419 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.449 ' HB2' HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -102.1 111.28 23.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 30' ' ' HIS . 0.8 OUTLIER -93.02 111.63 23.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.51 -174.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 5.0 t -114.1 103.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.459 0.647 . . . . 0.0 109.905 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.591 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.83 127.13 44.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 150.41 30.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.512 ' HD3' ' HG2' ' A' ' 73' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.176 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 19.1 Cg_endo . . . . . 0 N--CA 1.461 -0.394 0 N-CA-C 111.007 -0.42 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.869 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 17.1 m -84.47 125.51 32.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.339 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.2 mt -66.08 116.58 5.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.7 -38.43 10.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.927 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.54 138.66 26.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.41 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.03 122.12 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.542 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -118.87 134.59 55.06 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.243 -173.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 24.0 m-85 -116.65 135.38 53.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -170.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.4 m -139.87 110.92 6.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.291 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.44 47.1 0.26 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.857 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -83.16 77.44 9.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.136 0.493 . . . . 0.0 110.553 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.35 -37.48 19.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.918 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.8 m -141.6 -58.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.886 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -75.05 126.01 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -74.31 159.75 32.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.432 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -34.68 78.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.554 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.0 -38.33 90.68 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.9 mtp -70.98 -39.14 72.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -37.76 88.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.38 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 31.1 mttt -60.75 -44.01 97.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 110.937 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 13.8 tt0 -77.66 -27.68 50.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.338 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -66.86 -43.52 83.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.223 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -34.0 76.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.802 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -63.36 -38.14 90.0 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -18.32 61.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.436 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.8 m -91.48 -13.87 31.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.546 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.37 -14.63 50.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.9 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.09 103.57 14.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.199 0.523 . . . . 0.0 110.242 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.04 174.92 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.747 -176.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.77 125.16 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.425 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.67 -28.22 16.4 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.786 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.492 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -86.02 163.88 17.69 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 122.683 0.393 . . . . 0.0 110.413 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.41 156.2 19.69 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.508 HD21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -113.79 138.75 49.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.018 0.437 . . . . 0.0 111.126 -176.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.636 ' HB3' ' HG1' ' A' ' 129' ' ' THR . 12.7 t0 -100.1 115.04 28.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.573 0.701 . . . . 0.0 110.529 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.457 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -72.31 -16.22 61.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.44 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.1 p -85.64 -24.0 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.082 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.636 ' HG1' ' HB3' ' A' ' 126' ' ' ASP . 20.3 p -90.75 2.76 55.73 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.603 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 mm -56.98 -37.54 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.398 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.19 99.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.815 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 -39.2 78.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.142 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.549 HG21 HD13 ' A' ' 137' ' ' LEU . 14.4 mt -64.2 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.227 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HB3' HG22 ' A' ' 151' ' ' VAL . 37.4 mt-10 -59.29 -45.55 90.98 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.024 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -37.16 86.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.49 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.59 -34.12 72.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.629 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.558 HD12 HD13 ' A' ' 167' ' ' LEU . 5.0 mt -69.91 -35.95 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.55 0.175 . . . . 0.0 111.352 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.477 ' HG3' HG23 ' A' ' 151' ' ' VAL . 8.5 mt-10 -64.04 -36.71 84.88 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 110.116 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.59 -37.13 79.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.016 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -45.0 94.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.396 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -39.1 92.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.012 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -29.44 66.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.199 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.4 m -70.35 -27.09 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.445 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.1 t -73.94 -88.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.445 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.23 18.79 25.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.104 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt 65.9 44.66 2.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.492 0.717 . . . . 0.0 110.321 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -78.55 113.72 16.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.775 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.46 99.98 11.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.483 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.39 147.5 44.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.338 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.01 136.01 39.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.6 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 134' ' ' GLU . 2.2 m -97.76 132.21 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.406 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 115.41 16.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.365 169.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.42 111.18 22.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.83 123.34 57.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.516 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.434 ' H ' HG21 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -99.71 114.61 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 110.17 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.47 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 6.9 m -113.62 119.35 41.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.12 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.5 Cg_endo -86.23 139.55 6.15 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.255 2.637 . . . . 0.0 112.615 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -114.88 142.03 27.77 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.08 93.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 114.348 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.41 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.3 OUTLIER 176.3 -92.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.603 1.161 . . . . 0.0 108.391 175.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.41 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 13.4 p-10 -165.3 28.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 109.137 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.869 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -123.02 164.2 19.02 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.64 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.508 HG12 HD21 ' A' ' 125' ' ' LEU . 9.4 p -137.3 147.74 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.395 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.28 123.07 48.67 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.1 tp -102.24 114.35 28.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.542 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -110.21 131.09 55.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.884 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.558 HD13 HD12 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -109.03 112.89 25.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.56 -176.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.848 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.57 117.64 34.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.303 0.573 . . . . 0.0 110.33 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 -177.148 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -111.14 153.86 25.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.67 113.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.29 121.42 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.438 0.637 . . . . 0.0 110.791 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -84.37 -26.13 28.62 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.154 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -158.44 154.01 26.15 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.432 ' CD1' HD22 ' A' ' 43' ' ' LEU . 86.9 mt -125.59 128.09 72.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.375 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.94 133.24 55.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.309 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -118.47 135.15 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -113.6 -58.49 2.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 -164.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.373 0 CA-C-O 120.349 0.118 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 m -62.1 -29.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 O-C-N 123.647 0.592 . . . . 0.0 112.361 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.65 -40.47 85.75 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.687 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.48 -36.22 63.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.34 0.591 . . . . 0.0 110.357 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.58 87.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.91 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' A' ' 29' ' ' ILE . 4.0 mt -58.74 -33.9 70.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.922 0.489 . . . . 0.0 112.207 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.4 mt -74.15 -15.14 61.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.008 0.432 . . . . 0.0 111.335 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.464 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -92.01 -20.92 20.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.245 176.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.539 ' HE2' HG22 ' A' ' 62' ' ' THR . 91.0 mtp -81.75 146.04 55.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.259 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.569 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 6.1 Cg_exo -80.25 9.09 3.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.011 2.474 . . . . 0.0 112.458 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 154.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.6 mtm105 -130.63 173.73 10.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 111.275 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.407 HG21 HD13 ' A' ' 29' ' ' ILE . 16.8 p -67.64 124.58 23.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.416 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -10.36 57.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.864 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.7 156.57 16.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 0.0 110.208 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.09 130.39 35.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.54 HG12 HG23 ' A' ' 26' ' ' VAL . 17.3 m -121.67 127.16 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.169 0.509 . . . . 0.0 110.912 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -97.31 179.38 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.399 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.528 ' HA ' HD11 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -68.87 -30.83 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.241 0.543 . . . . 0.0 109.65 175.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.58 -33.42 75.87 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.495 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.96 -31.04 61.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -61.6 -50.76 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.695 ' HA ' HD13 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -69.64 -29.99 67.6 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.637 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.569 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 1.2 m-80 -72.22 -36.71 69.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.618 177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.539 HG22 ' HE2' ' A' ' 46' ' ' MET . 74.5 m -60.48 -44.16 96.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.233 0.333 . . . . 0.0 110.273 171.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.763 ' HA ' HG13 ' A' ' 75' ' ' VAL . 32.1 mt -54.34 -53.02 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 123.351 0.407 . . . . 0.0 110.618 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 64' ' ' ARG . 1.2 tpt180 -65.72 -38.22 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -66.45 -48.14 70.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.632 HD11 HG12 ' A' ' 75' ' ' VAL . 86.4 mt -67.52 -29.92 69.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.15 99.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 110.081 172.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.12 -13.46 61.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.677 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 66' ' ' LEU . 30.2 p -78.93 -24.74 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.902 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.6 73.05 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.607 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -73.47 -44.13 58.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 109.99 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.443 ' HE1' ' HB3' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -124.03 154.83 39.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.692 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.685 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 5.3 mm-40 -72.1 -51.27 22.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.622 0.576 . . . . 0.0 111.956 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -129.61 146.42 51.41 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.77 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.763 HG13 ' HA ' ' A' ' 63' ' ' ILE . 38.4 t -127.86 120.64 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.19 116.9 27.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.564 HG22 HG13 ' A' ' 63' ' ' ILE . 60.0 t -104.81 130.78 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.49 158.61 39.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -117.99 129.52 55.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.421 0.629 . . . . 0.0 110.404 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.2 95.86 4.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.695 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.34 -109.9 3.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.507 -174.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.31 14.38 19.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.372 0.606 . . . . 0.0 109.933 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.83 139.69 40.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.735 ' HB2' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -106.08 114.13 28.09 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.001 177.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -106.87 123.43 48.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 110.518 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -118.66 118.38 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.34 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -109.62 132.8 53.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 m -125.56 162.46 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.218 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 tptp . . . . . 0 C--N 1.321 -0.638 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.516 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 68.3 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 CA-C-O 121.201 0.417 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 45.3 m -124.87 133.31 53.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.616 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.725 HD13 ' HB2' ' A' ' 125' ' ' LEU . 30.0 mt -68.61 117.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.2 -26.75 16.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.68 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.27 138.54 18.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.173 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 120' ' ' ARG . 0.6 OUTLIER -109.23 121.38 62.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.84 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.3 OUTLIER -113.14 133.46 55.02 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.412 -175.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.697 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.2 m-85 -112.11 135.07 53.23 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.838 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.68 118.07 8.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.223 -173.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.07 18.34 56.03 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.334 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.534 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -85.15 93.39 8.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.589 . . . . 0.0 110.843 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.677 ' H ' ' HD2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -85.52 -46.09 11.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.251 -179.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.2 -77.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.062 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.63 125.64 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -71.01 157.82 37.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.592 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -36.55 76.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.952 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 4.3 t0 -62.5 -38.47 90.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.481 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtt -73.34 -35.67 66.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -32.89 74.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.593 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.697 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -56.7 -44.84 81.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 176.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -28.3 53.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.388 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.66 -43.17 90.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.499 HD11 HG22 ' A' ' 119' ' ' VAL . 1.4 mm? -67.72 -35.83 79.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.781 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.85 -35.51 80.86 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.52 -23.09 58.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.874 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -17.82 31.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 0.0 110.199 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.05 -14.15 31.37 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.13 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.5 HG23 HD12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -100.62 102.54 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.4 0.619 . . . . 0.0 110.604 -174.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HA ' HD12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -143.74 176.45 9.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.128 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.29 127.42 28.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.374 0.607 . . . . 0.0 110.556 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.48 -10.28 62.96 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.925 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -111.45 166.09 11.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.685 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 1.4 m -75.72 162.34 28.3 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.266 177.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.725 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -132.18 145.15 51.16 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.512 0.196 . . . . 0.0 110.891 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -109.72 122.05 46.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.621 0.724 . . . . 0.0 111.319 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -73.02 -15.7 61.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.211 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.5 p -90.09 -17.25 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.1 m -84.32 -13.64 51.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.279 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HA ' HD11 ' A' ' 130' ' ' ILE . 6.5 mm -54.16 -40.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.065 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.71 99.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.012 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.93 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 119' ' ' VAL . 52.0 mt -62.22 -46.76 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.942 0.401 . . . . 0.0 110.12 174.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.93 -49.83 74.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.309 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -65.3 -33.3 75.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.587 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.455 ' N ' ' HG3' ' A' ' 135' ' ' LYS . . . -68.09 -41.79 86.12 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.309 -0.472 . . . . 0.0 111.987 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.28 -33.0 72.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.404 0.145 . . . . 0.0 111.278 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -36.72 80.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.063 0.458 . . . . 0.0 110.683 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.13 -44.84 78.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.324 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -38.27 90.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.415 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.534 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -60.39 -43.53 96.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.209 0.528 . . . . 0.0 110.766 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -29.38 65.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.648 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.8 m -66.13 -28.16 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.738 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.3 t -78.28 -96.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 110.312 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -103.95 19.84 42.7 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.266 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.7 56.67 1.51 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -87.28 96.47 10.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.987 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.67 101.68 5.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.749 173.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.59 156.3 43.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.376 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.12 113.69 25.66 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.3 p -106.71 127.14 62.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.959 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.97 117.81 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.054 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.99 110.16 21.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.56 126.63 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.79 -173.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.574 HG11 HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -106.05 112.33 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.191 175.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.5 m -104.82 117.57 58.48 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.855 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.04 141.26 20.83 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.258 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.79 154.81 48.16 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.474 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 22.2 Cg_exo -66.5 76.96 0.36 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.549 2.833 . . . . 0.0 113.523 -176.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -167.39 -115.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 15.6 p-10 -144.11 27.35 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.099 0.952 . . . . 0.0 108.512 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.432 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 11.9 mmt180 -122.59 155.1 37.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.641 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.559 HG22 HD23 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -134.18 157.59 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.6 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -109.93 122.95 48.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.317 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.574 HD11 HG11 ' A' ' 155' ' ' VAL . 55.0 tp -106.6 116.41 31.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.84 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 12.4 tttt -119.22 132.77 55.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.436 ' N ' HD21 ' A' ' 167' ' ' LEU . 4.2 mm? -103.06 110.58 22.56 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.216 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 15.2 t -99.78 116.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.656 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.66 118.28 36.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.974 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.661 178.688 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.594 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 6.5 p90 -107.49 153.27 23.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.876 -0.662 . . . . 0.0 110.219 -175.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.46 112.39 17.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.92 125.39 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.01 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -41.3 10.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.722 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.89 148.55 30.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.598 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.446 ' CD1' HD22 ' A' ' 43' ' ' LEU . 51.1 mt -116.51 124.59 72.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.39 127.55 47.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -101.92 115.8 31.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.09 65.14 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.803 0.811 . . . . 0.0 110.733 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.856 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.519 176.515 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' H ' HG21 ' A' ' 39' ' ' VAL . 1.5 m -58.91 -30.99 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 123.779 0.674 . . . . 0.0 112.205 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.94 -35.08 61.64 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.354 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HA ' HD13 ' A' ' 44' ' ' LEU . . . -76.25 -36.11 58.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.001 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.78 88.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.855 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -54.97 -32.33 61.48 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.091 0.957 . . . . 0.0 113.088 174.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 41' ' ' ALA . 51.1 mt -70.98 -15.78 62.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.477 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -100.23 -8.39 23.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.546 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.7 mtp -94.55 137.19 22.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.188 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.57 34.39 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.991 2.461 . . . . 0.0 112.255 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.687 ' HB ' HG12 ' A' ' 54' ' ' VAL . 1.5 p -155.39 146.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.24 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.455 ' N ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -133.37 176.68 8.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.3 p -67.11 121.2 15.08 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.84 0.352 . . . . 0.0 110.17 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.44 47.99 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.456 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -82.84 156.48 23.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.619 0.247 . . . . 0.0 110.987 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -112.78 112.03 23.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.18 178.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.687 HG12 ' HB ' ' A' ' 48' ' ' VAL . 2.6 m -126.24 132.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.184 0.516 . . . . 0.0 112.343 -171.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -86.14 -177.27 6.23 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.067 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -61.16 -35.42 77.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.984 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -62.93 -37.44 87.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.203 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.751 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 1.3 m-20 -75.85 -29.04 58.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.585 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -47.4 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 171.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.644 ' HA ' HD11 ' A' ' 63' ' ' ILE . 3.7 m -68.76 -30.05 68.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.389 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.751 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 8.9 m-20 -63.75 -45.32 90.38 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 109.825 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.7 m -58.48 -43.88 89.13 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.095 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 60' ' ' SER . 65.2 mt -55.81 -50.9 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 123.39 0.431 . . . . 0.0 110.872 176.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -66.28 -36.03 81.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.89 -45.33 74.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.795 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.599 ' HA ' HG22 ' A' ' 69' ' ' THR . 83.9 mt -71.01 -29.03 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -39.5 92.66 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.231 0.539 . . . . 0.0 110.538 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.88 -9.48 58.4 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.406 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 66' ' ' LEU . 71.0 p -76.68 -20.16 56.94 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -170.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.47 21.27 75.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.943 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -105.01 -89.28 0.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.07 135.1 34.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.418 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.783 ' HB3' ' HB2' ' A' ' 124' ' ' SER . 0.1 OUTLIER -77.63 -30.01 52.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.775 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 11.8 t70 -123.42 135.43 54.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.667 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 88' ' ' VAL . 64.2 t -132.51 118.46 35.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.567 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -120.37 120.61 36.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.389 0.614 . . . . 0.0 110.051 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.1 t -105.19 123.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.29 137.7 51.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -88.0 110.12 20.35 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.49 95.22 5.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.55 -120.89 20.85 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -104.42 12.94 32.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.255 0.55 . . . . 0.0 109.963 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.89 141.71 35.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.791 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD13 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.02 110.87 22.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.08 112.42 24.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.199 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.16 105.79 19.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.425 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.93 131.44 42.28 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 75' ' ' VAL . 3.5 m -125.73 149.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.775 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.936 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HB2' HG21 ' A' ' 163' ' ' VAL . 56.8 Cg_endo . . . . . 0 CA--C 1.534 0.489 0 N-CA-C 114.065 0.756 . . . . 0.0 114.065 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.9 m -91.29 135.81 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 125' ' ' LEU . 34.7 mt -65.58 118.31 7.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.63 -37.04 8.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.312 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.39 144.03 32.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.471 HG22 ' CD2' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -119.39 123.52 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.616 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -103.71 131.27 51.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.516 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' HB3' HD22 ' A' ' 102' ' ' ASN . 20.3 m-85 -109.96 134.92 51.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.161 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.9 123.8 12.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.87 13.19 47.53 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.773 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.474 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -94.59 77.93 3.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.997 -178.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -40.77 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.336 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.9 m -75.97 -61.6 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.266 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.2 140.13 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 4.0 mmtm -70.46 151.95 44.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 111.224 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.5 -35.53 79.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.459 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.89 -34.74 73.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.68 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -65.65 -39.44 91.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 173.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.403 HD23 ' CZ ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -67.28 -32.97 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.369 177.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -41.74 97.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.99 -30.06 55.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -66.62 -40.61 88.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.473 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.471 ' CD2' HG22 ' A' ' 97' ' ' ILE . 2.3 mp -69.72 -36.88 76.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.723 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.581 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 1.5 mt-10 -63.34 -37.39 87.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.445 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 m -93.5 -14.53 26.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.024 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.49 -22.09 22.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.924 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.407 ' H ' HG21 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -96.45 104.43 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.355 0.598 . . . . 0.0 111.156 -175.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.581 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.85 173.76 11.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.694 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.78 123.8 23.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.665 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.74 -6.26 58.71 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.888 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.4 158.42 17.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.939 0.399 . . . . 0.0 110.452 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.783 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -80.32 144.08 33.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.478 176.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.23 144.59 25.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.782 0.325 . . . . 0.0 111.585 -172.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.49 106.0 16.3 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.331 0.586 . . . . 0.0 109.729 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.427 ' HD3' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.72 -17.65 62.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.482 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.427 HG21 ' HD3' ' A' ' 127' ' ' ARG . 18.8 p -83.83 -23.25 31.46 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.425 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 p -98.41 2.28 47.7 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.338 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.412 ' HA ' HD11 ' A' ' 130' ' ' ILE . 6.1 mm -58.04 -40.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.844 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.66 83.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.689 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.17 -31.72 68.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.345 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.61 -44.85 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.718 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 138' ' ' GLU . 94.4 mt-10 -59.36 -47.65 84.62 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.651 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -35.68 81.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.147 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.29 -38.04 81.16 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.289 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.58 -39.91 88.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.368 . . . . 0.0 111.282 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 134' ' ' GLU . 84.0 mt-10 -56.14 -43.88 78.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.136 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -31.94 67.21 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -34.62 78.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.163 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.474 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -71.16 -36.0 71.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.752 177.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -71.25 -30.56 66.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.41 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -30.27 63.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.4 p -79.65 -73.27 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.437 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.452 ' HA2' ' CE2' ' A' ' 147' ' ' TYR . . . -113.73 17.72 20.3 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.964 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 61.11 44.5 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 110.559 -173.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.452 ' CE2' ' HA2' ' A' ' 145' ' ' GLY . 66.4 m-85 -88.83 136.14 33.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.243 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.81 128.96 41.92 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.06 143.79 48.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.783 0.325 . . . . 0.0 110.647 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.97 113.68 27.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.68 131.23 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.158 0.504 . . . . 0.0 111.753 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -128.49 117.29 21.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.961 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.525 ' HB3' HD23 ' A' ' 167' ' ' LEU . . . -98.55 112.02 24.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 0.0 110.69 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.82 118.5 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.653 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.63 114.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.7 m -116.11 120.76 34.78 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.646 ' HA ' HG11 ' A' ' 163' ' ' VAL . 74.4 Cg_endo -75.28 147.87 33.5 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.778 2.319 . . . . 0.0 113.155 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.446 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 1.3 pp -117.1 160.48 37.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 158' ' ' LEU . 52.6 Cg_endo -76.11 73.92 4.76 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.712 2.275 . . . . 0.0 114.105 -171.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.446 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.4 OUTLIER -166.73 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.648 173.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.446 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 2.5 t30 -136.43 25.39 3.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -131.05 161.03 32.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -171.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.646 HG11 ' HA ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -132.74 155.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.085 175.031 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.17 125.52 54.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.151 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.0 tp -108.39 131.51 54.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.59 0.233 . . . . 0.0 110.538 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.616 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 37.8 tttt -122.6 133.55 54.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 0.0 111.261 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 153' ' ' ALA . 0.3 OUTLIER -105.91 109.69 21.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.76 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.64 119.36 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.495 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 60.4 m-85 -109.21 117.8 35.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.807 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 C--N 1.318 -0.786 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.162 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 43.9 p90 -105.95 148.9 27.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.72 113.36 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 84' ' ' LEU . 3.0 p -73.98 133.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.443 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -88.08 -42.92 12.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.56 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -147.21 144.92 29.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.726 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CD1' HD22 ' A' ' 43' ' ' LEU . 63.6 mt -106.86 120.51 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.46 127.45 54.43 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.071 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.656 ' HD2' HG13 ' A' ' 39' ' ' VAL . 78.6 m-85 -107.77 130.5 54.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -42.66 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -172.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.19 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.198 -174.559 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.656 HG13 ' HD2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -51.76 -38.75 22.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.659 -177.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.497 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -73.02 -40.75 50.58 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.683 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.25 78.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.37 72.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.673 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.43 HD22 ' CD1' ' A' ' 29' ' ' ILE . 2.9 mt -57.64 -31.08 65.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.5 mt -62.79 -26.76 68.88 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 111.58 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.14 -13.53 43.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.893 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.537 ' HE2' HG23 ' A' ' 62' ' ' THR . 11.4 mtp -90.26 138.48 27.18 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.481 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.565 ' HD2' HG21 ' A' ' 62' ' ' THR . 94.3 Cg_endo -81.47 16.0 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.882 2.388 . . . . 0.0 113.257 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 52' ' ' ASP . 1.2 p -153.73 147.02 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.537 ' N ' HG21 ' A' ' 48' ' ' VAL . 57.0 mtt85 -123.28 177.7 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.922 0.489 . . . . 0.0 110.458 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 p -65.6 126.5 28.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.411 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.77 -6.66 35.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.452 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.541 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.6 t0 -96.28 158.47 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.459 . . . . 0.0 110.651 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 133.02 34.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.97 128.98 72.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 112.007 -173.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -97.67 -179.63 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.008 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.42 -32.62 74.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 109.838 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 7.5 tp10 -61.29 -37.77 84.37 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.434 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.37 -32.21 62.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.292 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.54 -46.13 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.046 0.451 . . . . 0.0 109.951 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -73.64 -26.88 60.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.254 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -70.76 -45.61 64.47 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.417 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.565 HG21 ' HD2' ' A' ' 47' ' ' PRO . 6.3 p -64.51 -38.58 91.51 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.031 175.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.561 ' HA ' HG13 ' A' ' 75' ' ' VAL . 23.6 mt -55.35 -54.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.486 0.491 . . . . 0.0 110.42 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -70.78 -30.31 66.75 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.27 -46.95 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.661 0.267 . . . . 0.0 110.567 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.663 ' HA ' HG22 ' A' ' 69' ' ' THR . 75.4 mt -71.66 -29.63 64.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -39.25 91.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.558 . . . . 0.0 110.48 173.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.41 -12.35 61.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.117 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 66' ' ' LEU . 21.9 p -78.17 -24.47 47.23 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.978 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.42 7.73 83.01 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.454 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -83.41 -20.61 33.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 165.97 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.702 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 3.4 tm-20 -83.91 -50.49 8.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -136.65 137.72 40.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.817 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.561 HG13 ' HA ' ' A' ' 63' ' ' ILE . 46.6 t -116.79 120.51 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.74 0.305 . . . . 0.0 110.427 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -118.26 118.96 33.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.044 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.477 HG21 HG12 ' A' ' 86' ' ' VAL . 76.5 t -107.9 123.46 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.802 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.99 158.34 41.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.53 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -111.39 141.1 45.37 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.642 178.365 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -126.92 95.8 4.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.85 -109.68 3.02 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 14.28 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.292 0.567 . . . . 0.0 110.048 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.678 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.675 ' HB2' HG22 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -103.46 111.86 24.5 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 tp -101.73 116.74 33.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.477 HG12 HG21 ' A' ' 77' ' ' VAL . 20.4 t -107.69 110.16 30.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.362 0.601 . . . . 0.0 110.491 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -106.16 134.37 49.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.45 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.22 155.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.377 0.608 . . . . 0.0 110.995 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.877 -179.062 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.586 ' HB2' HG23 ' A' ' 163' ' ' VAL . 46.0 Cg_endo . . . . . 0 C--O 1.235 0.344 0 CA-C-O 121.86 0.692 . . . . 0.0 113.396 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.6 m -97.92 144.48 27.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.742 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 mt -69.59 117.98 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.59 -35.18 8.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.883 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -149.14 143.56 26.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.432 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 ' CD1' ' A' ' 114' ' ' LEU . 3.1 mt -117.11 124.04 72.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 172.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -106.16 136.03 46.59 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 -176.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -114.85 135.29 54.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.9 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -142.69 128.35 19.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.739 178.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.68 15.02 62.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.728 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -105.23 63.13 0.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -88.1 -21.87 24.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -51.63 23.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.088 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t -109.38 141.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.89 145.98 53.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.859 0.361 . . . . 0.0 111.577 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.822 ' HA ' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -60.28 -35.59 75.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.76 177.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.1 -45.36 75.46 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.967 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -43.23 77.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.451 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 107' ' ' ASP . 4.2 mt -64.64 -33.28 75.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -44.72 96.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.971 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.491 HE21 ' HB3' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -78.67 -27.95 45.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.896 -178.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.5 -38.63 90.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.057 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.581 HD21 HG22 ' A' ' 119' ' ' VAL . 17.2 mt -66.4 -36.04 81.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.634 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -63.93 -39.45 94.19 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.772 178.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.96 -16.48 60.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.48 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -88.7 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.381 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.81 -25.05 9.79 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.256 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.699 HG23 HD12 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -94.51 104.2 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.877 -175.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.634 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -132.13 168.19 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.792 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -72.07 129.03 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.461 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.63 -6.3 74.08 Favored Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.835 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.98 145.2 40.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.702 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -66.33 143.13 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.328 178.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 146.33 23.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.156 0.503 . . . . 0.0 111.981 -170.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.476 ' CG ' ' HG1' ' A' ' 129' ' ' THR . 12.9 t0 -107.45 96.35 6.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.152 171.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.573 ' HD3' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -71.89 -14.28 61.9 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.472 -178.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.573 HG21 ' HD3' ' A' ' 127' ' ' ARG . 34.2 p -90.53 -28.19 18.67 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.786 0.803 . . . . 0.0 108.897 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.476 ' HG1' ' CG ' ' A' ' 126' ' ' ASP . 1.5 m -95.13 6.4 49.15 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.51 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.469 ' HA ' HD11 ' A' ' 130' ' ' ILE . 2.8 mm -58.35 -35.26 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.006 176.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.31 -35.91 78.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.686 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.22 -38.94 89.13 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.699 HD12 HG23 ' A' ' 119' ' ' VAL . 6.5 mt -67.0 -42.64 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.347 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.9 -48.47 79.78 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.0 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -34.82 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.01 -36.96 91.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.523 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.49 -32.65 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 110.988 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -66.78 -43.05 85.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.614 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -31.43 70.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.771 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.34 -46.51 89.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.624 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.79 -36.46 83.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.824 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.37 -34.41 77.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.87 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.8 m -71.59 -30.08 65.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.76 -86.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.786 0.326 . . . . 0.0 111.294 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.68 18.14 24.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.934 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.6 mttp 60.49 47.2 8.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.548 0.689 . . . . 0.0 109.667 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -74.8 123.47 25.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.731 -175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.64 131.87 35.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.706 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -153.33 143.65 22.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.255 0.55 . . . . 0.0 110.975 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.23 114.06 24.73 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 170.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.29 134.48 45.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.546 0.689 . . . . 0.0 112.108 -167.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -130.48 116.54 18.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.244 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.66 111.53 23.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.18 0.514 . . . . 0.0 109.963 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.21 121.7 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.35 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.421 ' H ' HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -99.93 128.0 52.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.505 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.7 m -120.0 121.27 29.72 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.433 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 1.1 Cg_endo -85.72 147.0 9.48 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.407 2.738 . . . . 0.0 113.325 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.07 159.99 27.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.927 172.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.47 65.64 2.21 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.432 2.754 . . . . 0.0 114.121 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.533 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.1 OUTLIER -164.83 -113.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 9.6 p-10 -144.72 53.12 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.565 0.698 . . . . 0.0 110.735 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -143.12 159.91 41.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.456 175.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 92' ' ' PRO . 0.5 OUTLIER -132.33 153.03 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.377 178.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.81 124.96 53.03 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 43.3 tp -104.58 117.45 34.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.555 -172.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.556 ' HD3' ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -104.53 131.52 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.325 0.584 . . . . 0.0 110.809 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.626 HD11 ' HE2' ' A' ' 169' ' ' PHE . 1.2 mm? -106.39 109.74 21.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.288 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.39 111.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.34 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.626 ' HE2' HD11 ' A' ' 167' ' ' LEU . 6.0 m-85 -104.98 118.28 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 19.8 mm-40 . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.425 ' HE2' HG11 ' A' ' 26' ' ' VAL . 51.4 p90 -110.41 154.58 23.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.501 . . . . 0.0 110.715 -174.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.17 117.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.426 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.651 HG13 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.37 122.33 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.51 0.672 . . . . 0.0 110.667 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -95.6 -22.77 17.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.158 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.512 ' HB3' HG21 ' A' ' 83' ' ' THR . 8.0 t70 -152.41 139.06 18.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.969 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.597 HD13 HG21 ' A' ' 50' ' ' THR . 20.8 mt -118.46 123.36 71.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.989 174.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.524 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -121.21 133.2 55.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.188 -177.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -104.95 136.9 43.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.037 0.446 . . . . 0.0 110.802 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 1.7 mt-10 -119.32 70.39 0.84 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.329 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.957 -179.613 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -32.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.707 0.63 . . . . 0.0 112.618 -174.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.29 -37.17 63.25 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.227 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.49 66.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.167 0.508 . . . . 0.0 110.428 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.73 72.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 46' ' ' MET . 0.7 OUTLIER -55.88 -32.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.664 0.786 . . . . 0.0 112.811 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.413 ' HA ' HD21 ' A' ' 44' ' ' LEU . 97.0 mt -72.06 -14.14 61.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -7.98 38.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.404 ' HG3' ' HA ' ' A' ' 43' ' ' LEU . 1.8 mtm -94.01 133.61 27.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD2' HG21 ' A' ' 62' ' ' THR . 30.6 Cg_endo -64.91 -28.56 58.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.849 2.366 . . . . 0.0 112.653 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.21 149.58 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.158 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.0 177.87 7.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.591 -174.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.597 HG21 HD13 ' A' ' 29' ' ' ILE . 11.4 p -68.22 121.08 15.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.539 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.54 -6.58 52.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.142 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.74 157.05 16.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.932 0.396 . . . . 0.0 110.887 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.06 136.9 32.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.163 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.55 130.23 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.284 0.564 . . . . 0.0 111.244 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -97.77 -177.07 3.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.964 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.445 ' HA ' HD11 ' A' ' 59' ' ' ILE . 8.9 p-10 -63.91 -27.37 69.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.04 -30.98 65.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.564 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.688 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 36.1 m-20 -75.94 -28.83 58.12 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.275 0.23 . . . . 0.0 111.08 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -62.6 -47.47 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 171.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -70.14 -27.63 64.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.688 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.2 m-20 -68.91 -45.26 71.33 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.463 HG21 ' HD2' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -63.32 -40.12 96.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.719 175.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.456 ' HA ' HG13 ' A' ' 75' ' ' VAL . 56.7 mt -55.21 -55.38 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 123.61 0.569 . . . . 0.0 111.128 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -69.26 -31.01 69.26 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.01 -50.38 49.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.44 0.162 . . . . 0.0 110.746 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.572 ' HA ' HG22 ' A' ' 69' ' ' THR . 50.8 mt -68.34 -30.44 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.049 0.452 . . . . 0.0 110.313 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.12 -12.52 61.75 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.122 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.572 HG22 ' HA ' ' A' ' 66' ' ' LEU . 22.3 p -78.89 -22.54 45.78 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.137 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 19.2 76.71 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.351 -0.452 . . . . 0.0 113.138 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -89.76 -28.7 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.606 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 162.34 28.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.816 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -84.73 -37.93 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -140.5 144.6 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.456 HG13 ' HA ' ' A' ' 63' ' ' ILE . 48.3 t -128.63 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 119.53 33.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.361 177.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.11 124.29 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.044 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.0 146.13 47.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -107.76 132.7 53.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.77 95.2 3.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.043 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.95 2.48 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.035 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -106.24 2.1 26.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.006 0.522 . . . . 0.0 110.901 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -106.66 132.91 52.11 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.75 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.651 ' HB2' HG13 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -104.0 113.09 26.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.814 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' A' ' 30' ' ' HIS . 3.5 tp -102.86 112.24 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.406 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.2 t -110.08 106.22 20.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.546 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 6.6 mt-30 -92.91 136.18 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.49 142.87 41.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.126 0.489 . . . . 0.0 110.243 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.915 -175.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.462 -0.368 0 CA-C-O 121.552 0.563 . . . . 0.0 113.482 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 5.1 m -97.69 133.51 42.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.2 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.5 mt -71.95 117.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.56 -33.17 11.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.036 0.446 . . . . 0.0 110.555 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -147.26 143.08 27.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.446 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.609 HG23 HD21 ' A' ' 114' ' ' LEU . 1.3 mt -115.65 123.0 70.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.575 ' HB ' ' HE3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -122.42 132.86 54.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.243 0.545 . . . . 0.0 110.773 -175.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.5 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 21.3 m-85 -111.23 135.25 52.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.376 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.73 120.25 18.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.37 29.73 9.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.116 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 1.1 p30 -107.98 63.93 0.62 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.562 0.696 . . . . 0.0 110.566 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -85.16 -17.34 37.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.091 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -93.04 -52.03 4.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 31.7 t -108.03 128.92 63.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 106' ' ' LYS . 11.1 mmmt -69.95 149.4 47.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -170.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -35.13 69.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.729 173.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.78 -43.94 90.56 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.0 mtp -69.1 -41.2 77.76 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.45 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.52 HD13 HG13 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -61.16 -36.72 80.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.861 178.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.413 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -61.59 -46.17 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.135 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -28.73 55.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.172 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.29 -46.87 86.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.261 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.609 HD21 HG23 ' A' ' 97' ' ' ILE . 1.9 mp -66.25 -40.63 90.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.014 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.673 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 7.6 mt-10 -60.32 -42.42 95.57 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.402 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.13 -22.15 60.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.703 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -87.93 -16.86 32.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.73 -24.97 6.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.805 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.441 ' H ' HG21 ' A' ' 119' ' ' VAL . 0.2 OUTLIER -93.99 104.7 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.185 0.517 . . . . 0.0 111.641 -174.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.673 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.66 176.47 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.553 178.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.7 t -68.34 125.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.251 0.548 . . . . 0.0 111.593 -176.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.82 61.93 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.127 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.28 155.26 21.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 110.699 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.21 133.82 42.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -92.22 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.281 0.562 . . . . 0.0 111.061 -173.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -110.01 102.48 11.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.858 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.16 -15.75 62.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.74 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -84.13 -18.37 37.02 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.549 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.51 -0.75 45.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.33 -35.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.499 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.58 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.559 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.21 -28.55 60.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.804 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.29 -43.36 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.957 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.63 -42.01 99.34 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.61 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -41.75 98.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.157 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.62 93.05 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.635 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 18.2 mt -74.09 -32.43 63.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.586 0.231 . . . . 0.0 111.112 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.6 ' HG3' HG23 ' A' ' 151' ' ' VAL . 2.7 mt-10 -65.01 -40.91 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.207 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.51 -39.87 88.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.552 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -43.18 99.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.43 ' CD1' ' HB1' ' A' ' 149' ' ' ALA . 0.2 OUTLIER -65.81 -41.66 91.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.362 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -32.31 66.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.5 m -71.35 -32.25 68.31 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.0 -77.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.647 -175.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.21 17.49 19.29 Favored Glycine 0 N--CA 1.454 -0.107 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.768 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 55.71 58.63 4.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.569 0.699 . . . . 0.0 110.816 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -92.86 111.54 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.5 98.7 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -107.63 145.27 33.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.048 0.451 . . . . 0.0 111.579 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.29 114.14 26.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 171.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 138' ' ' GLU . 34.0 m -102.92 124.58 57.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.15 0.5 . . . . 0.0 111.469 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -130.9 117.02 18.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.492 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.86 112.47 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.427 0.632 . . . . 0.0 110.117 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.26 119.71 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.077 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.424 HG12 HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -99.6 112.14 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 m -104.23 117.42 59.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.533 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.31 137.46 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.2 2.6 . . . . 0.0 113.406 -176.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 1.2 pp -104.82 143.67 27.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 169.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 22.2 Cg_exo -65.28 80.91 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.704 2.936 . . . . 0.0 115.018 -168.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -169.32 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.786 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -163.03 22.64 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.441 0.639 . . . . 0.0 109.944 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.48 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -128.23 155.8 43.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 -174.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.7 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.25 131.74 55.33 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.424 HD11 HG12 ' A' ' 155' ' ' VAL . 21.9 tp -99.55 114.15 26.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.831 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.575 ' HE3' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.524 0.678 . . . . 0.0 111.138 -177.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -110.43 109.54 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.129 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.15 111.76 31.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.115 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.766 -177.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.482 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.413 ' HZ ' ' HB2' ' A' ' 79' ' ' ARG . 48.3 p90 -112.55 154.39 26.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.967 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.2 t -77.44 113.52 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 84' ' ' LEU . 2.6 p -76.17 124.1 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.469 0.652 . . . . 0.0 109.952 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HD3' ' HB2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -88.95 -36.66 15.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.642 -176.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -144.31 143.46 31.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.154 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' CD1' HD22 ' A' ' 43' ' ' LEU . 85.2 mt -104.62 121.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -111.32 126.38 54.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -106.15 115.61 30.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.461 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 tt0 -102.68 68.4 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.405 0.622 . . . . 0.0 110.056 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.905 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.589 177.871 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.453 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.462 ' H ' HG21 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -60.83 -29.13 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.27 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.93 -35.72 57.91 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.265 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.81 -34.61 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.351 0.596 . . . . 0.0 110.27 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.09 73.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.592 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD22 ' CD1' ' A' ' 29' ' ' ILE . 3.2 mt -60.08 -31.73 70.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.211 0.604 . . . . 0.0 112.073 172.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.24 -21.74 63.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.21 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.486 ' HB2' HD13 ' A' ' 66' ' ' LEU . 1.4 m -88.28 -19.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.036 0.446 . . . . 0.0 110.285 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.457 ' HE2' HG22 ' A' ' 62' ' ' THR . 68.0 mtp -82.65 138.68 43.94 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.853 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 10.8 Cg_exo -73.5 -14.88 24.94 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.931 2.421 . . . . 0.0 112.586 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.3 m -114.93 167.77 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.117 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -129.12 174.24 9.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.918 0.389 . . . . 0.0 110.456 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.1 p -67.96 122.88 19.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.994 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -5.35 44.29 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.059 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.14 155.15 34.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -92.84 113.01 25.17 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.75 127.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.586 -165.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -98.85 -178.09 3.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.312 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -28.98 70.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.05 -44.27 92.97 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.006 175.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.01 -34.83 75.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.227 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.18 -50.96 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 123.153 0.283 . . . . 0.0 110.286 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -67.89 -35.27 78.2 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.436 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -63.79 -45.37 90.03 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.449 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 77' ' ' VAL . 90.5 m -59.01 -42.58 90.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.416 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.2 mt -55.55 -56.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 123.318 0.386 . . . . 0.0 111.223 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 -70.29 -28.46 65.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.05 -52.72 61.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HA ' HG22 ' A' ' 69' ' ' THR . 5.4 mp -67.06 -31.79 72.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.672 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -33.8 76.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.792 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.68 -12.77 61.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.541 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 66' ' ' LEU . 20.4 p -78.73 -24.95 44.59 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.763 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.48 65.43 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.82 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.04 4.68 15.78 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.18 0.49 . . . . 0.0 111.007 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.9 163.91 26.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 166.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HB2' ' CB ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -87.15 -46.01 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 110.192 177.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -129.54 136.82 50.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.423 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.9 117.99 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 119.51 32.83 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 174.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.648 HG21 HG12 ' A' ' 86' ' ' VAL . 54.9 t -111.78 121.08 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.05 136.99 42.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.413 ' HB2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -93.43 136.39 33.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.986 0.422 . . . . 0.0 110.029 178.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -126.61 95.38 4.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.99 -109.52 2.84 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.373 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 15.0 p-10 -106.21 10.96 31.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.164 0.507 . . . . 0.0 111.001 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.87 141.34 46.81 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.624 -177.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -103.74 114.85 29.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 176.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tp -107.54 112.81 25.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.48 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.648 HG12 HG21 ' A' ' 77' ' ' VAL . 7.3 t -112.79 111.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.291 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 5.3 mt-30 -104.74 128.72 52.93 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 m -125.4 141.8 44.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.661 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 44.6 tttt . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.732 -172.447 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.688 ' HB2' HG23 ' A' ' 163' ' ' VAL . 2.9 Cg_exo . . . . . 0 N--CA 1.464 -0.214 0 N-CA-C 113.891 0.689 . . . . 0.0 113.891 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 50.3 m -89.39 136.21 33.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.53 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.761 HD13 ' HB2' ' A' ' 125' ' ' LEU . 35.7 mt -62.46 117.48 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.54 -27.79 13.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.827 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.4 149.87 22.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.573 HG23 HD13 ' A' ' 114' ' ' LEU . 3.7 mt -123.79 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.86 148.06 52.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.881 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.616 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 25.6 m-85 -120.43 153.63 36.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.104 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.58 143.75 23.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.759 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.63 73.41 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.32 -0.467 . . . . 0.0 114.199 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.5 OUTLIER -101.42 81.51 2.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.393 0.616 . . . . 0.0 110.532 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -86.14 -34.68 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.931 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -56.38 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.993 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -92.62 159.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.987 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 106' ' ' LYS . 2.4 mmmm -88.23 145.52 25.84 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.259 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.616 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 15.6 p-10 -66.74 -34.71 78.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.761 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.586 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 16.6 t70 -58.92 -38.35 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.089 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -42.77 68.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.405 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.19 -32.48 68.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.02 0.528 . . . . 0.0 111.959 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.586 ' HD3' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -58.63 -47.96 82.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.226 178.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.9 -28.58 49.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -36.46 83.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.573 HD13 HG23 ' A' ' 97' ' ' ILE . 11.6 mt -74.19 -38.92 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.709 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -61.99 -31.89 72.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.409 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.71 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.605 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -16.72 34.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.875 0.369 . . . . 0.0 110.267 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.86 -21.76 8.87 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.47 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.452 HG23 HD12 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -84.68 108.12 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.282 0.563 . . . . 0.0 111.303 -176.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.709 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.28 172.15 13.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.509 ' HA ' HG23 ' A' ' 94' ' ' ILE . 48.4 t -71.62 127.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.062 0.458 . . . . 0.0 110.503 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.53 -20.96 48.25 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.059 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.545 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -82.51 163.8 21.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.257 0.551 . . . . 0.0 110.628 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 73' ' ' GLU . 63.3 m -85.21 151.17 24.29 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.761 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -104.8 143.83 32.59 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.695 0.76 . . . . 0.0 111.607 -172.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.605 ' HB3' HG23 ' A' ' 129' ' ' THR . 9.7 t0 -104.65 98.09 7.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.397 176.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.536 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.85 -15.59 62.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.648 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.0 p -83.32 -17.88 40.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.085 0.469 . . . . 0.0 110.363 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.645 HG21 HD13 ' A' ' 133' ' ' ILE . 0.8 OUTLIER -103.11 6.72 38.69 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 176.07 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.6 mm -61.45 -39.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.36 78.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.188 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -33.12 70.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.066 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.645 HD13 HG21 ' A' ' 129' ' ' THR . 10.5 mt -68.55 -47.19 78.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.112 176.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.428 ' HG2' HG23 ' A' ' 151' ' ' VAL . 96.8 mt-10 -63.59 -41.73 98.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.966 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -37.12 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.026 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.09 -37.8 87.63 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.529 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.489 ' HA ' HD21 ' A' ' 137' ' ' LEU . 44.4 mt -74.45 -32.0 62.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.675 0.274 . . . . 0.0 111.066 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -37.65 75.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 110.039 175.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.97 -33.22 75.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.559 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.78 -45.42 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.525 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.431 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 2.1 m-85 -63.02 -37.1 85.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.755 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.2 t80 -68.13 -35.59 78.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.254 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.03 -31.24 69.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.688 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.9 t -74.57 -91.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.77 0.319 . . . . 0.0 110.338 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.92 18.39 24.16 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.094 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 58.92 50.32 8.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.357 0.598 . . . . 0.0 110.045 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -80.19 119.64 23.23 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.403 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.94 99.11 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.82 43.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.439 0.637 . . . . 0.0 111.382 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.71 113.06 24.98 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.8 p -108.16 127.44 64.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.439 0.638 . . . . 0.0 110.519 -174.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.91 116.84 20.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.542 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.94 110.58 22.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.17 124.91 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.906 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.476 ' H ' HG21 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -99.58 113.97 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.318 174.358 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.0 m -104.41 115.27 63.19 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.799 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.65 127.42 9.57 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.919 2.412 . . . . 0.0 112.618 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.79 150.9 39.71 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 171.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.49 79.74 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.463 2.776 . . . . 0.0 113.967 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.498 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -171.21 -104.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.583 0.753 . . . . 0.0 109.348 177.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 16.5 p-10 -157.5 34.92 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -133.78 155.3 50.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.877 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -127.6 151.52 34.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.812 177.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.63 118.88 37.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.86 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 155' ' ' VAL . 45.1 tp -96.82 121.05 38.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -175.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.44 132.49 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.433 0.635 . . . . 0.0 111.044 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.0 mm? -105.61 111.48 24.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.834 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 21.6 t -99.54 120.41 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -116.06 118.94 34.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.47 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.959 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -97.39 152.5 18.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.3 t -85.66 122.65 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.67 124.28 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.588 0.709 . . . . 0.0 110.689 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -80.31 -26.93 38.57 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.387 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -162.51 149.45 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 43' ' ' LEU . 58.7 mt -112.99 121.54 65.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.559 ' HB3' HD11 ' A' ' 85' ' ' LEU . 5.9 t-160 -116.77 127.22 54.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' HD2' HG13 ' A' ' 39' ' ' VAL . 19.5 m-85 -106.68 136.72 46.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -131.32 167.7 18.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.63 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.348 -177.587 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 120.547 0.213 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' A' ' 31' ' ' PHE . 2.7 m -66.48 -27.57 40.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.914 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.69 -36.97 61.8 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.134 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.488 ' HA ' HD13 ' A' ' 44' ' ' LEU . . . -76.47 -34.42 58.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.547 0.689 . . . . 0.0 110.157 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.57 68.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.997 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.63 HD23 ' HD2' ' A' ' 49' ' ' ARG . 5.1 mt -57.14 -31.29 65.21 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.356 0.662 . . . . 0.0 112.532 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 41' ' ' ALA . 67.1 mt -66.48 -22.31 66.19 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.565 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.512 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -98.57 -8.3 26.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.628 ' HG2' HG22 ' A' ' 62' ' ' THR . 30.9 mtp -83.54 143.25 43.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.204 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.74 -3.56 13.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.512 2.142 . . . . 0.0 113.334 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.597 HG23 HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -139.58 163.79 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.63 ' HD2' HD23 ' A' ' 43' ' ' LEU . 9.6 mmm180 -120.31 176.06 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.936 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 p -66.94 132.92 48.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.61 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.37 -5.7 77.83 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.638 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 156.64 18.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.881 0.372 . . . . 0.0 111.081 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 125.1 30.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.322 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.597 HG13 HG23 ' A' ' 48' ' ' VAL . 20.9 m -123.14 137.22 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.705 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -97.49 178.54 5.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.026 0.441 . . . . 0.0 110.804 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -27.17 63.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.53 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -29.44 64.67 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.36 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.576 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 42.3 m-20 -73.91 -29.2 61.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.524 175.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.87 -49.34 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.75 -36.36 84.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -64.06 -42.33 97.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 178.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.628 HG22 ' HG2' ' A' ' 46' ' ' MET . 54.0 m -60.04 -42.55 94.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.646 ' HA ' HG13 ' A' ' 75' ' ' VAL . 55.3 mt -55.62 -49.3 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.53 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -36.43 82.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.027 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.11 66.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.661 ' HA ' HG23 ' A' ' 69' ' ' THR . 89.9 mt -71.08 -28.31 64.24 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.224 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -45.23 66.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.63 -15.79 59.73 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 66' ' ' LEU . 9.7 t -80.78 -24.29 38.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.35 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.5 1.65 90.17 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 164.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -85.12 -6.33 59.3 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.945 0.872 . . . . 0.0 111.698 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' HE1' HD21 ' A' ' 66' ' ' LEU . 14.2 m-85 -124.43 159.14 31.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -91.75 -36.95 13.28 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.887 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 26.7 t0 -137.73 140.97 41.0 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 63' ' ' ILE . 49.1 t -128.17 119.84 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.892 0.377 . . . . 0.0 110.5 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.7 118.13 30.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.877 173.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.607 HG21 HG12 ' A' ' 86' ' ' VAL . 61.4 t -106.95 122.34 60.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.445 HD13 HD22 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -138.81 137.97 37.12 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.8 137.15 36.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.407 0.622 . . . . 0.0 110.82 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -113.99 95.31 5.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.74 -109.37 2.87 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.483 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.29 11.02 21.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.239 0.542 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.86 139.57 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.724 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.719 ' HB2' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -104.8 114.89 29.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.487 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 30' ' ' HIS . 20.6 tp -109.23 115.11 29.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.233 0.54 . . . . 0.0 110.453 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.607 HG12 HG21 ' A' ' 77' ' ' VAL . 19.0 t -106.25 108.24 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.351 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.487 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 73.5 mt-30 -97.06 126.38 42.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.41 150.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.85 0.834 . . . . 0.0 111.159 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.441 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 16.4 tttm . . . . . 0 C--N 1.308 -1.199 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.149 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 9.6 Cg_endo . . . . . 0 N--CA 1.449 -1.107 0 CA-C-O 121.104 0.376 . . . . 0.0 111.344 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.9 m -96.36 147.72 23.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.194 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 125' ' ' LEU . 42.4 mt -58.12 118.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.444 ' HB3' ' HG2' ' A' ' 162' ' ' ARG . . . -105.82 -38.24 6.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.183 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.97 27.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.498 HG12 HD22 ' A' ' 165' ' ' LEU . 1.2 mt -114.83 123.69 70.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 168.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.88 135.4 54.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -176.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.541 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.1 m-85 -111.45 135.47 51.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -141.93 112.11 6.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.877 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.682 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 178.96 -60.12 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.911 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.466 ' HB2' ' OH ' ' A' ' 141' ' ' TYR . 0.7 OUTLIER -153.6 148.41 26.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.122 0.487 . . . . 0.0 111.957 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -86.52 -13.01 47.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.903 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.637 ' HB3' HG13 ' A' ' 144' ' ' VAL . 54.0 m -58.35 -50.85 72.18 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.706 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.458 HG23 HD22 ' A' ' 110' ' ' LEU . 9.3 p -87.31 137.68 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.541 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -78.63 143.33 36.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.234 -174.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -33.95 75.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.106 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -30.79 71.84 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.568 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.435 ' SD ' ' HB2' ' A' ' 106' ' ' LYS . 29.6 mtp -73.03 -46.07 54.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.413 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 106' ' ' LYS . 4.5 mt -63.22 -31.87 73.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -59.31 -43.4 92.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 111.019 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.97 -28.81 58.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.364 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.63 -43.98 91.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.245 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.34 -36.82 85.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.917 175.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -31.42 72.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.56 61.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.547 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.0 m -84.66 -16.83 40.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 110.178 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 106.07 1.28 38.83 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.269 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.01 117.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.183 0.516 . . . . 0.0 110.863 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.69 170.5 15.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.222 -177.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.586 ' HA ' HG23 ' A' ' 94' ' ' ILE . 40.8 t -71.73 126.3 31.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.982 0.42 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.84 -5.91 79.42 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.943 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.9 OUTLIER -106.47 154.59 20.62 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.51 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 1.5 m -57.12 139.34 52.75 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.537 0.523 . . . . 0.0 111.524 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.634 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.92 145.33 25.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.322 0.582 . . . . 0.0 111.183 -175.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.518 ' HA ' ' NH1' ' A' ' 127' ' ' ARG . 26.2 t0 -117.77 111.58 19.28 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.716 0.77 . . . . 0.0 111.243 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.518 ' NH1' ' HA ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -71.2 -15.23 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.051 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.4 p -89.72 -15.43 32.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.741 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -92.73 2.49 56.71 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.929 175.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.1 mm -59.8 -41.32 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.924 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.39 86.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.816 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.33 -41.63 96.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.115 0.483 . . . . 0.0 109.732 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.447 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 10.7 mt -63.55 -45.99 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.479 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -60.37 -49.45 77.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 2.9 tptp -61.95 -40.28 94.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.27 65.84 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.843 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.502 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 12.7 mt -74.01 -32.64 63.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.632 0.253 . . . . 0.0 110.985 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.488 ' HG3' HG13 ' A' ' 151' ' ' VAL . 52.9 mt-10 -67.04 -37.47 84.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 174.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -31.29 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.455 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -66.41 -36.93 84.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.466 ' OH ' ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -62.64 -35.72 80.52 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 177.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -69.35 -34.52 74.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.651 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.29 66.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 104' ' ' SER . 12.4 t -74.87 -86.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.76 18.77 24.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.576 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.6 56.8 3.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.685 0.755 . . . . 0.0 110.063 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -86.18 149.84 24.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.298 -174.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 89.21 3.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.665 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.4 ' HB1' ' CD1' ' A' ' 141' ' ' TYR . . . -140.12 156.52 46.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 0.0 112.036 -174.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 m -117.61 139.98 50.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.843 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.488 HG13 ' HG3' ' A' ' 138' ' ' GLU . 6.6 p -114.4 139.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.134 0.492 . . . . 0.0 110.682 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 127.69 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.228 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.727 ' HB3' HD12 ' A' ' 167' ' ' LEU . . . -92.64 116.92 29.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.46 0.648 . . . . 0.0 111.387 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.28 112.33 30.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.904 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.95 111.43 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 120.971 0.415 . . . . 0.0 110.042 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 22.2 m -118.96 125.15 27.85 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.036 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.501 ' HA ' HG11 ' A' ' 163' ' ' VAL . 3.1 Cg_exo -82.38 145.62 13.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.191 2.594 . . . . 0.0 112.563 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.601 HD13 ' HB2' ' A' ' 160' ' ' ARG . 0.3 OUTLIER -105.82 158.88 31.38 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.88 62.77 4.88 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.355 2.703 . . . . 0.0 113.483 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.601 ' HB2' HD13 ' A' ' 158' ' ' LEU . 8.6 mmt180 -146.84 -93.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 -168.69 32.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 174.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.456 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -136.87 166.61 23.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.083 -177.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 157' ' ' PRO . 0.5 OUTLIER -128.99 148.03 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.117 0.484 . . . . 0.0 111.163 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -112.07 122.18 47.04 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.498 HD22 HG12 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -119.14 132.58 56.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.713 0.768 . . . . 0.0 111.363 -176.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -120.91 133.34 55.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.975 -176.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 153' ' ' ALA . 4.5 mm? -103.56 110.32 22.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.747 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.1 116.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.682 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 75.7 m-85 -97.87 118.56 34.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.538 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -109.43 153.95 23.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.89 117.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.909 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.407 HG23 HD11 ' A' ' 84' ' ' LEU . 2.5 t -72.22 115.69 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -41.53 23.58 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.134 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.67 ' HB3' HG21 ' A' ' 83' ' ' THR . 25.0 t70 -144.11 143.77 31.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.043 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.425 HD11 HD13 ' A' ' 43' ' ' LEU . 35.5 mt -105.31 121.84 57.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.93 128.59 45.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.271 0.557 . . . . 0.0 111.125 -175.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -105.33 137.84 42.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.638 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.46 -42.91 2.96 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.311 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.071 -176.443 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.681 0 CA-C-O 120.447 0.165 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -61.31 -32.48 53.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.463 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.97 -37.61 83.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.9 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.19 63.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.082 0.468 . . . . 0.0 110.738 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.88 -40.05 55.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.479 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.425 HD13 HD11 ' A' ' 29' ' ' ILE . 4.5 mp -61.1 -29.92 70.04 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.289 0.635 . . . . 0.0 112.159 176.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 84.5 mt -62.45 -24.97 67.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.478 ' HB2' HD22 ' A' ' 66' ' ' LEU . 1.5 m -96.82 -7.82 32.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.521 ' HE1' HG22 ' A' ' 62' ' ' THR . 33.9 mtp -87.39 131.6 43.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.026 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 13.1 Cg_exo -70.82 -25.43 23.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.914 2.409 . . . . 0.0 112.667 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.457 HG13 HG11 ' A' ' 54' ' ' VAL . 1.4 m -112.9 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.24 0.543 . . . . 0.0 111.418 -176.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -118.21 -179.87 3.9 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.487 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.9 p -67.47 121.43 15.79 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.847 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -6.11 47.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.5 m-20 -86.0 153.72 21.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.545 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.27 139.01 33.04 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG11 HG13 ' A' ' 48' ' ' VAL . 2.8 m -128.07 127.24 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.869 -174.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.54 -177.36 3.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.108 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.513 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -68.07 -36.3 79.61 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.54 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.549 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 22.6 m-20 -74.14 -29.81 61.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.787 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -48.38 88.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -70.42 -32.49 70.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.549 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 2.0 m-20 -62.06 -49.76 74.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 110.476 177.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.521 HG22 ' HE1' ' A' ' 46' ' ' MET . 44.4 m -61.46 -44.34 97.27 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.48 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.621 HD13 HG21 ' A' ' 77' ' ' VAL . 2.4 mt -59.22 -48.2 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 123.39 0.431 . . . . 0.0 110.844 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -33.54 74.14 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.21 -51.59 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.585 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 45' ' ' SER . 79.8 mt -67.61 -30.08 69.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.28 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' HD1' HG21 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -65.05 -41.77 94.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 110.608 175.514 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.75 -13.51 62.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.92 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 66' ' ' LEU . 26.4 p -79.37 -25.0 42.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.594 0.235 . . . . 0.0 111.184 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.72 26.97 71.39 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.415 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -95.64 -20.05 19.25 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.117 0.484 . . . . 0.0 110.207 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.67 154.85 45.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 36.3 mt-10 -80.43 -43.66 20.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 111.6 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 12.6 t70 -132.91 136.34 46.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 t -124.98 117.88 51.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.507 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 76' ' ' ARG . 2.4 tpp85 -121.12 122.37 39.87 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.962 172.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 63' ' ' ILE . 27.1 m -96.64 137.54 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -128.34 154.15 46.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -107.57 115.16 29.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.786 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.79 95.62 5.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 -110.45 3.37 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.212 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -106.74 8.32 30.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.225 0.536 . . . . 0.0 110.743 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.67 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -111.08 141.52 44.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.546 -173.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.44 HD22 ' HB ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -102.96 115.55 30.81 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.02 179.087 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.32 112.43 24.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.123 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -102.4 109.87 27.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.502 0.668 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -103.95 126.42 51.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.599 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.18 158.3 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.908 0.385 . . . . 0.0 111.262 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.5 tptp . . . . . 0 C--O 1.239 0.547 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 72.6 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 N-CA-C 113.919 0.699 . . . . 0.0 113.919 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.1 m -99.54 138.12 37.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.6 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.805 HD13 ' HB2' ' A' ' 125' ' ' LEU . 20.7 mt -61.62 117.61 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.04 -22.92 13.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.117 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 138.66 13.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.891 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.42 HG23 ' CD2' ' A' ' 114' ' ' LEU . 2.2 mt -118.0 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.419 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -117.68 132.27 56.51 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.75 -175.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.639 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 22.2 m-85 -105.84 151.06 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.95 139.71 20.77 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.6 18.5 56.64 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.33 56.99 4.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.455 0.702 . . . . 0.0 110.807 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -86.57 -34.81 19.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 m -84.97 -51.06 6.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.64 137.3 44.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.69 147.86 50.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.619 -174.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.639 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -64.39 -33.09 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.855 176.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -38.01 74.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.024 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -44.08 55.24 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 106' ' ' LYS . 31.1 mt -61.21 -32.49 72.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.101 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.416 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 7.8 mttt -60.47 -46.21 90.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 111.227 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -77.89 -28.24 49.82 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.609 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.094 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.42 ' CD2' HG23 ' A' ' 97' ' ' ILE . 2.3 mp -68.07 -40.57 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.619 174.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.572 ' HG2' ' HB2' ' A' ' 120' ' ' ARG . 1.9 mt-10 -60.46 -42.35 96.0 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.86 -16.0 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.677 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.5 m -91.98 -13.27 31.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.49 -22.03 13.86 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.998 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.35 104.04 15.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.092 0.472 . . . . 0.0 110.079 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.572 ' HB2' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.0 170.16 16.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.241 -178.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.54 131.47 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.35 0.595 . . . . 0.0 111.283 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.17 -6.63 81.06 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.709 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.566 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -100.15 166.88 10.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.0 111.519 -174.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -61.99 148.08 44.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.433 173.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.805 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -112.3 135.08 53.42 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.716 0.769 . . . . 0.0 110.979 -177.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.707 ' HB3' HG23 ' A' ' 129' ' ' THR . 23.7 t0 -106.17 97.31 7.14 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 172.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.719 ' HD3' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.58 -15.24 62.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.758 -176.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.719 HG21 ' HD3' ' A' ' 127' ' ' ARG . 12.5 p -89.74 -23.62 21.75 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.698 0.285 . . . . 0.0 110.96 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.707 HG23 ' HB3' ' A' ' 126' ' ' ASP . 0.5 OUTLIER -87.99 -1.29 57.9 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.406 0.622 . . . . 0.0 110.517 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 153' ' ' ALA . 5.6 mm -57.51 -43.36 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.215 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.721 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.28 -36.53 84.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.149 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.513 HG21 HD13 ' A' ' 137' ' ' LEU . 16.3 mt -65.18 -45.23 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.353 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -61.12 -47.7 85.05 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 135' ' ' LYS . 17.2 mmtm -67.09 -34.58 77.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.646 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.94 -39.98 84.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.024 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.513 HD13 HG21 ' A' ' 133' ' ' ILE . 37.0 mt -69.66 -32.54 71.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.633 0.254 . . . . 0.0 111.032 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.658 ' HG3' HG22 ' A' ' 151' ' ' VAL . 20.1 mt-10 -63.09 -41.46 99.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 174.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.24 -43.48 94.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.688 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.29 -38.55 90.56 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.228 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -35.47 80.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.947 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -30.4 67.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.206 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -28.44 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.2 t -72.47 -83.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.233 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.53 18.62 22.59 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.584 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt 63.11 45.58 5.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.368 0.667 . . . . 0.0 110.184 -174.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -80.57 119.62 23.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.092 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.71 73.02 6.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.44 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 143.9 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.39 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.5 m -97.94 115.66 28.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.658 HG22 ' HG3' ' A' ' 138' ' ' GLU . 13.2 t -107.07 122.35 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.563 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 119.57 24.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.388 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 130' ' ' ILE . . . -95.9 111.97 23.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.258 0.552 . . . . 0.0 110.246 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.58 118.82 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.811 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.4 HG12 HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -101.09 116.75 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.331 177.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.481 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.1 m -120.77 122.13 28.63 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.791 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.3 Cg_endo -88.11 142.69 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.68 2.92 . . . . 0.0 113.003 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -120.56 159.39 48.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.033 178.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.06 -7.69 12.28 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 123.726 2.951 . . . . 0.0 115.0 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.51 12.42 8.57 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 122.488 -0.132 . . . . 0.0 111.193 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 1.3 m-20 62.22 42.35 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.0 0.905 . . . . 0.0 110.603 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.72 ' HB2' HD13 ' A' ' 158' ' ' LEU . 14.5 mmt85 -131.02 163.57 27.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.381 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -127.43 146.49 33.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.23 0.538 . . . . 0.0 110.537 176.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.08 123.41 49.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.494 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.4 HD11 HG12 ' A' ' 155' ' ' VAL . 21.1 tp -107.22 119.71 40.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.115 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -115.4 131.27 56.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.376 0.607 . . . . 0.0 110.58 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.54 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.6 mm? -104.3 109.93 21.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.462 -176.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.9 t -96.41 111.41 26.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.78 135.2 50.39 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.318 -0.801 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.326 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -107.9 152.76 23.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.686 -0.257 . . . . 0.0 110.428 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.57 113.3 23.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.26 118.42 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 111.256 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -76.69 -46.77 24.31 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 178.363 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.84 146.66 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.608 HD11 ' HG ' ' A' ' 43' ' ' LEU . 62.4 mt -105.39 119.99 55.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -109.65 127.55 54.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.89 137.48 41.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.012 0.434 . . . . 0.0 110.476 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.39 -30.58 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.468 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.796 -176.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.11 -37.54 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.71 -40.23 90.11 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.95 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.8 -34.84 69.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.909 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -32.46 70.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.31 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.608 ' HG ' HD11 ' A' ' 29' ' ' ILE . 4.8 mp -68.94 -30.99 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.0 mt -68.96 -23.38 64.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -80.61 -20.96 42.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.422 177.452 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.552 ' HB3' HG23 ' A' ' 62' ' ' THR . 24.7 mtt -82.53 139.39 44.32 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.95 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 31.4 Cg_exo -63.36 -36.2 57.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.656 2.237 . . . . 0.0 112.328 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.416 ' H ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -109.86 150.12 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.389 -178.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 14.6 mmm-85 -127.82 178.09 6.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 0.0 111.067 -175.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -64.65 122.58 17.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.95 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.39 -10.1 42.45 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.83 -174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 5.2 m-20 -89.32 152.77 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.531 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.91 127.7 36.49 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.74 131.15 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.421 0.629 . . . . 0.0 112.491 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.472 ' O ' HD11 ' A' ' 59' ' ' ILE . 14.3 m-80 -93.13 173.17 7.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.38 174.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.96 -31.6 71.96 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -61.21 -36.97 81.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.893 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.582 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 37.8 m-20 -75.05 -29.21 60.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.08 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.472 HD11 ' O ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -64.64 -45.31 95.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -32.18 73.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.921 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.582 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.4 m-80 -69.63 -43.55 72.45 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.203 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 46' ' ' MET . 1.3 p -63.29 -43.15 98.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.032 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mt -54.21 -49.63 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 123.519 0.512 . . . . 0.0 110.45 174.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -46.59 89.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.416 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.8 -48.45 81.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.467 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.605 ' HA ' HG22 ' A' ' 69' ' ' THR . 54.1 mt -69.89 -29.51 66.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -34.36 77.51 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 110.287 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.16 61.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.421 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.605 HG22 ' HA ' ' A' ' 66' ' ' LEU . 18.8 p -77.61 -25.64 49.98 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.222 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.57 -5.85 20.35 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 116.143 -0.48 . . . . 0.0 114.114 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.63 -23.87 22.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.167 0.483 . . . . 0.0 111.228 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.547 ' CD1' HG23 ' A' ' 88' ' ' VAL . 6.0 m-85 -101.47 157.19 16.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.581 ' HG2' ' HD2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -86.78 -41.66 13.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.151 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.708 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 8.4 t70 -145.88 139.19 26.12 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.73 120.77 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.84 118.53 31.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.751 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG21 HG12 ' A' ' 86' ' ' VAL . 54.3 t -106.6 126.48 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.011 0.434 . . . . 0.0 110.014 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -126.36 159.08 34.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 129.86 50.63 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.806 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.0 96.63 6.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.815 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.2 -109.85 3.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.616 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' HB3' ' HD2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -111.44 15.9 21.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.394 0.616 . . . . 0.0 110.375 177.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.06 141.41 38.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.085 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.401 HD22 HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -104.84 119.15 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -112.23 116.99 31.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.98 0.419 . . . . 0.0 110.17 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.505 HG12 HG21 ' A' ' 77' ' ' VAL . 5.0 t -106.72 111.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.253 0.549 . . . . 0.0 110.72 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.13 136.24 41.3 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.547 HG23 ' CD1' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -130.78 155.82 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.126 0.489 . . . . 0.0 110.326 -173.349 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.2 -175.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.6 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 3.5 Cg_exo . . . . . 0 N--CA 1.456 -0.714 0 CA-C-O 121.683 0.618 . . . . 0.0 112.559 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -104.34 136.83 43.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.336 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 125' ' ' LEU . 31.0 mt -64.83 118.25 6.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.15 -27.84 14.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.82 139.85 15.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.041 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.465 HG22 HD22 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -110.17 122.88 65.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 167.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -116.27 131.94 56.8 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.388 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.616 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -113.43 134.12 54.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.824 -175.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.3 125.75 16.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.66 -2.34 57.19 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.363 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.494 HD22 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -86.36 82.15 8.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.187 0.518 . . . . 0.0 110.709 -177.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.88 -35.77 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.043 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -70.32 -64.91 0.8 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.126 0.488 . . . . 0.0 110.626 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.65 130.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -69.41 158.38 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 0.0 112.087 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -61.47 -34.6 75.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.723 173.133 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -43.1 96.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.983 176.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 mmm -74.45 -35.35 63.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.753 0.311 . . . . 0.0 111.131 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -31.65 72.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.549 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.616 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.93 -43.42 86.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 110.763 176.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -78.29 -28.6 47.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.115 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -66.39 -42.64 87.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.19 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.44 ' HA ' HD11 ' A' ' 114' ' ' LEU . 1.4 mm? -68.08 -38.45 82.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.53 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -40.16 88.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.097 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.92 -19.38 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.915 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 m -89.23 -12.86 39.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 102.62 -11.86 56.5 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.629 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.3 t -100.5 101.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.486 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 26.8 ptt180 -142.93 175.32 9.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -176.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.545 ' HA ' HG23 ' A' ' 94' ' ' ILE . 14.6 p -68.89 135.09 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.216 176.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.33 18.02 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.37 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -84.91 160.5 20.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 110.994 177.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.98 150.58 27.57 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 170.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.802 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -119.02 130.72 55.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -174.052 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.584 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 20.0 t0 -90.13 112.87 24.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.629 0.728 . . . . 0.0 109.893 172.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.645 ' HG3' HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -71.63 -15.69 62.25 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.079 -179.146 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.3 p -83.45 -25.36 31.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.338 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.584 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -89.34 -1.1 57.94 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.952 177.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' HA ' HD11 ' A' ' 133' ' ' ILE . 4.4 mm -56.72 -41.53 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.473 ' HA ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.08 -38.36 90.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.86 -31.22 68.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.583 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 130' ' ' ILE . 7.7 mt -67.03 -43.62 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.54 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 131' ' ' ALA . 49.1 mt-10 -62.44 -44.4 96.5 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.591 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.34 93.57 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.748 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.37 -37.49 92.82 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.931 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.406 HD11 HG23 ' A' ' 151' ' ' VAL . 8.8 mt -68.27 -39.58 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.501 0.191 . . . . 0.0 111.368 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.4 -39.26 88.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.282 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.743 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -60.96 -45.06 96.29 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -61.78 -41.42 97.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.181 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -70.75 -34.37 71.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.096 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.2 m -66.51 -28.56 68.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.401 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 11.8 t -80.13 -88.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.975 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.25 18.06 26.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.5 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 1.0 OUTLIER 59.99 44.67 13.07 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.283 0.633 . . . . 0.0 110.697 -174.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -73.58 102.96 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.91 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.32 84.28 6.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 111.676 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -117.81 141.56 48.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 m -100.05 122.42 42.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.749 0.309 . . . . 0.0 110.459 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.447 ' H ' HG11 ' A' ' 151' ' ' VAL . 2.2 p -105.47 133.12 50.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.384 0.612 . . . . 0.0 111.657 -174.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -129.23 122.53 29.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.514 173.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.4 ' HB1' HG21 ' A' ' 130' ' ' ILE . . . -93.8 112.06 23.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.113 0.482 . . . . 0.0 110.762 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.19 116.88 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.731 HG13 HD23 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.39 118.31 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.433 178.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.5 m -124.12 117.48 26.96 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.629 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 46.7 Cg_endo -69.51 143.83 53.34 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.611 2.207 . . . . 0.0 112.614 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.64 160.35 26.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.79 71.05 0.24 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.616 2.878 . . . . 0.0 114.322 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.489 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -164.51 -117.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 18.7 p-10 -138.63 36.79 2.22 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -133.71 157.83 44.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 -172.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -128.18 148.17 32.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.244 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -109.32 126.66 53.62 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.723 HD11 HG12 ' A' ' 155' ' ' VAL . 58.3 tp -113.25 114.35 26.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.934 0.397 . . . . 0.0 110.66 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 1.3 ttpt -113.28 131.69 55.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 0.0 110.693 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.444 ' N ' HD21 ' A' ' 167' ' ' LEU . 4.2 mm? -98.83 110.18 22.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.142 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 25.4 t -94.52 111.08 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -103.26 129.29 50.18 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -106.93 153.56 22.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.202 -0.499 . . . . 0.0 110.072 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.1 p -80.6 124.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 110.103 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.55 127.75 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.558 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -97.57 -39.44 9.12 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.546 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HB3' HG21 ' A' ' 83' ' ' THR . 34.7 t70 -143.8 142.06 30.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.548 HD13 HG21 ' A' ' 50' ' ' THR . 49.3 mt -109.14 122.07 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -122.75 128.09 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.963 -179.03 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -102.16 138.1 39.56 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.005 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.508 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 5.3 mm-40 -119.6 67.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.064 0.935 . . . . 0.0 109.982 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' HA2' HG23 ' A' ' 88' ' ' VAL . . . . . . . . 0 N--CA 1.443 -0.86 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.745 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.271 0 N-CA-C 110.618 -0.141 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -36.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -172.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.96 -35.66 57.83 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.556 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.69 -35.57 60.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -31.25 68.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.384 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.401 HD21 ' HA ' ' A' ' 43' ' ' LEU . 3.9 mt -57.46 -31.05 65.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 112.608 171.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt -70.41 -23.07 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 111.282 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.98 -17.23 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.278 0.561 . . . . 0.0 110.143 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.545 ' HG2' HG22 ' A' ' 62' ' ' THR . 92.4 mtp -82.81 137.9 43.73 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.823 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HG3' ' HB3' ' A' ' 61' ' ' ASN . 39.6 Cg_endo -69.0 -22.58 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.32 2.013 . . . . 0.0 112.701 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.557 HG11 ' N ' ' A' ' 49' ' ' ARG . 2.0 t -125.5 149.77 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.262 0.554 . . . . 0.0 110.811 -175.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.557 ' N ' HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -124.92 177.9 5.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.673 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.548 HG21 HD13 ' A' ' 29' ' ' ILE . 3.3 p -66.16 120.27 12.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.57 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.28 -5.51 38.61 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.214 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.52 155.78 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.79 140.66 29.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.56 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG11 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -125.98 129.16 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.637 0.256 . . . . 0.0 111.652 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.451 ' O ' HD13 ' A' ' 59' ' ' ILE . 1.3 t-20 -95.11 -178.55 4.51 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.25 -30.38 69.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.226 0.536 . . . . 0.0 110.033 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -35.69 81.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.507 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 3.8 m-20 -76.63 -29.6 56.52 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -61.1 -48.14 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 171.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -66.79 -33.48 75.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.55 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.454 ' HB3' ' HG3' ' A' ' 47' ' ' PRO . 4.3 t-20 -63.25 -48.03 79.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.634 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.545 HG22 ' HG2' ' A' ' 46' ' ' MET . 25.5 m -58.9 -46.36 88.07 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.331 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.514 ' HA ' HG13 ' A' ' 75' ' ' VAL . 24.4 mt -55.26 -49.46 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.862 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -68.26 -40.42 81.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.204 -175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.0 -53.15 60.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.76 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.817 ' HB3' HG23 ' A' ' 75' ' ' VAL . 6.3 mp -66.5 -30.59 70.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.699 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.407 0.622 . . . . 0.0 110.797 174.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.46 -13.17 61.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.756 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 66' ' ' LEU . 19.6 p -78.63 -25.32 45.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.34 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.94 -7.35 59.73 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.886 176.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.236 0.541 . . . . 0.0 110.572 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 150.31 49.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.938 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.58 -45.14 60.6 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.369 0.418 . . . . 0.0 111.303 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' A' ' 89' ' ' LYS . 7.5 t70 -139.43 146.68 40.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.817 HG23 ' HB3' ' A' ' 66' ' ' LEU . 70.7 t -126.16 122.72 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.675 0.274 . . . . 0.0 110.304 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.44 118.57 32.1 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.784 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.44 HG21 HG13 ' A' ' 63' ' ' ILE . 43.6 t -103.83 123.19 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.113 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.17 159.06 37.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.65 144.53 43.27 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.277 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -139.23 97.5 3.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.054 171.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 -111.07 3.66 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -112.99 18.82 17.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.298 0.571 . . . . 0.0 109.97 174.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -107.52 134.54 50.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.029 -177.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.5 HD21 ' HA ' ' A' ' 84' ' ' LEU . 1.6 mt -102.65 118.54 37.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.708 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.2 tp -106.09 112.38 25.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.027 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.428 HG11 HG23 ' A' ' 77' ' ' VAL . 3.2 t -110.22 104.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.306 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.508 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.49 148.65 23.52 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.53 HG23 ' HA2' ' A' ' 33' ' ' GLY . 15.5 m -125.89 152.32 32.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.092 0.472 . . . . 0.0 110.662 -178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.447 ' HB2' HG23 ' A' ' 163' ' ' VAL . 3.1 Cg_exo . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.287 0.453 . . . . 0.0 112.827 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 m -97.67 134.74 40.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.456 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.683 HG23 ' HA ' ' A' ' 121' ' ' VAL . 32.4 mt -61.96 120.29 7.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.1 -31.17 11.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.593 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.01 138.82 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.191 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.459 HG23 HD21 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -117.75 123.42 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.74 131.55 53.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.662 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.591 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 17.5 m-85 -109.21 134.84 51.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.356 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.11 113.94 11.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.447 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.36 13.09 9.19 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.665 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.48 68.54 4.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.731 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -85.39 -31.33 22.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.56 26.35 10.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 111.446 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.43 HG12 HD12 ' A' ' 110' ' ' LEU . 6.8 p -167.89 155.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -83.94 145.67 28.44 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.664 0.745 . . . . 0.0 111.272 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -35.62 80.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.468 175.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -41.74 89.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.248 174.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.74 -42.2 70.83 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.409 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.469 ' HA ' HD11 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -59.47 -39.67 84.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.935 175.178 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -42.86 99.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.514 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.567 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 1.6 tm0? -77.71 -27.96 50.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.116 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.93 -43.47 95.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.954 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.459 HD21 HG23 ' A' ' 97' ' ' ILE . 3.0 mp -68.49 -41.09 80.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.435 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -57.24 -45.76 83.62 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.791 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.01 -21.82 59.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.733 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -83.62 -17.16 42.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 110.297 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.58 -19.85 8.98 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.271 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.86 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 111.051 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.56 175.11 9.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.674 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.683 ' HA ' HG23 ' A' ' 94' ' ' ILE . 50.9 t -67.81 123.59 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.077 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.02 29.67 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.31 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.27 160.14 17.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.118 0.485 . . . . 0.0 111.901 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 m -84.75 127.43 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 170.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.787 HD13 HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.48 143.18 27.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.656 -171.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -91.76 113.26 25.48 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.864 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.458 ' HD2' HD22 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -72.04 -27.7 62.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.375 179.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 p -79.24 -22.67 44.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.29 0.88 51.46 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.862 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.787 HD12 HD13 ' A' ' 125' ' ' LEU . 5.0 mm -55.0 -45.14 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.654 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.42 91.0 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.246 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.96 -34.69 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.496 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 130' ' ' ILE . 61.4 mt -64.87 -48.58 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.748 176.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 130' ' ' ILE . 19.7 mt-10 -59.39 -50.02 75.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.08 0.467 . . . . 0.0 111.358 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -33.17 74.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.6 -37.16 89.2 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.152 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.9 -32.02 68.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.653 0.263 . . . . 0.0 111.12 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.723 ' HG3' HG22 ' A' ' 151' ' ' VAL . 58.5 mt-10 -64.08 -41.44 97.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.095 0.474 . . . . 0.0 110.269 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.82 -39.45 90.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.557 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -58.8 -45.52 89.68 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.035 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -41.7 87.83 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.406 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.25 -29.68 65.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.621 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.4 m -70.04 -28.56 65.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -72.81 -87.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.974 0.416 . . . . 0.0 110.737 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.22 19.52 22.41 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.395 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 62.19 0.96 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.615 0.722 . . . . 0.0 111.105 -174.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -105.63 121.08 43.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.969 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.86 93.6 7.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 110.669 176.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -117.43 153.17 33.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.57 ' HB2' ' HG3' ' A' ' 170' ' ' GLN . 6.8 m -99.65 132.65 44.85 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.723 HG22 ' HG3' ' A' ' 138' ' ' GLU . 21.6 t -110.58 129.34 65.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 110.302 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.06 117.02 24.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.435 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.27 111.12 23.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.158 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.5 113.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.11 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.687 ' HB ' HD23 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -106.15 116.97 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 66.9 m -122.98 124.0 26.65 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.861 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.7 Cg_exo -77.41 141.96 20.63 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.101 2.534 . . . . 0.0 111.768 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.79 156.42 36.61 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.97 76.86 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.134 2.556 . . . . 0.0 113.548 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.53 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -170.14 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.786 0.803 . . . . 0.0 109.124 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -127.08 161.25 28.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.086 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -127.45 144.6 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.244 176.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.85 130.96 55.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.687 HD23 ' HB ' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -109.92 130.37 55.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.097 0.475 . . . . 0.0 111.179 -176.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 130.69 52.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.016 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.2 mm? -106.92 111.63 24.22 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.412 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.03 111.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.855 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -103.92 117.5 34.47 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.57 ' HG3' ' HB2' ' A' ' 150' ' ' SER . 1.8 mt-30 . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -101.51 153.22 19.9 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -87.02 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.419 HG11 ' H ' ' A' ' 51' ' ' GLY . 4.7 p -68.6 127.87 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.618 0.723 . . . . 0.0 110.633 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -94.49 -41.1 9.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.397 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.18 137.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.633 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.98 121.53 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -113.39 127.69 56.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -102.84 134.3 46.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.729 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -133.91 77.53 1.72 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.246 0.546 . . . . 0.0 111.101 -173.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.863 178.693 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -61.67 -32.3 53.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.076 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.35 -37.24 70.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.97 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.27 -36.28 63.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.44 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.26 -39.22 78.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.069 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HA ' ' SD ' ' A' ' 46' ' ' MET . 1.4 mt -59.79 -31.57 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.435 0.694 . . . . 0.0 112.318 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.61 -16.42 61.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -93.88 -7.87 41.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 175.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.498 ' HG2' HG21 ' A' ' 62' ' ' THR . 70.7 mtp -90.25 147.2 36.34 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.71 -18.51 22.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 112.192 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.71 165.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.972 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.478 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -132.38 174.36 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 p -67.45 121.82 16.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.298 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' H ' HG11 ' A' ' 26' ' ' VAL . . . 102.97 -4.73 49.55 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.313 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -87.31 155.1 20.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 0.0 111.047 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.54 133.42 35.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.845 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.8 128.04 62.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.071 0.462 . . . . 0.0 111.363 -175.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.61 179.74 5.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.062 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -30.31 70.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.361 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 17.9 tp10 -66.18 -34.3 77.73 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.36 0.413 . . . . 0.0 110.758 174.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.8 -32.52 69.63 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.37 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.745 HD12 ' HD3' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -62.68 -49.5 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 123.241 0.338 . . . . 0.0 110.319 173.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -35.03 77.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.58 0.229 . . . . 0.0 111.401 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -66.05 -39.92 90.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.486 177.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.498 HG21 ' HG2' ' A' ' 46' ' ' MET . 68.4 m -59.02 -45.81 89.77 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.032 172.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.596 HD13 HG12 ' A' ' 77' ' ' VAL . 1.2 mt -54.96 -48.44 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 123.445 0.466 . . . . 0.0 110.425 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -67.08 -35.57 80.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.218 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 45' ' ' SER . . . -68.35 -54.89 14.26 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.239 0.337 . . . . 0.0 110.507 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.683 HD23 ' HE2' ' A' ' 72' ' ' PHE . 37.4 mt -58.72 -29.71 66.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -52.67 33.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.969 0.414 . . . . 0.0 110.821 172.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.37 61.33 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 65' ' ' ALA . 30.0 p -79.49 -6.62 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.678 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.87 75.06 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.464 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -83.07 -59.27 2.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.517 . . . . 0.0 111.604 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.683 ' HE2' HD23 ' A' ' 66' ' ' LEU . 2.4 m-85 -124.82 169.96 11.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.524 0.202 . . . . 0.0 111.292 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -79.01 -42.54 26.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.09 0.471 . . . . 0.0 110.846 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 30.6 t70 -137.89 141.04 40.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.597 HG12 HD11 ' A' ' 66' ' ' LEU . 46.8 t -124.75 119.02 55.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.077 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -120.98 117.29 26.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.943 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.596 HG12 HD13 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -109.41 129.99 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.634 0.73 . . . . 0.0 109.695 172.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.14 156.83 34.24 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.745 ' HD3' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -129.16 126.16 38.63 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.513 0.673 . . . . 0.0 111.202 -176.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -115.46 97.12 5.98 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.851 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.06 -109.08 2.71 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.234 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.48 10.42 23.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.708 0.289 . . . . 0.0 110.778 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.33 132.52 50.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.83 116.77 31.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.96 117.1 32.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.22 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.257 0.551 . . . . 0.0 110.989 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.729 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 64.4 mt-30 -93.55 137.93 32.33 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.95 152.24 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 -175.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.554 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.824 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.536 ' HB2' HG23 ' A' ' 163' ' ' VAL . 17.2 Cg_exo . . . . . 0 CA--C 1.529 0.245 0 CA-C-O 121.58 0.575 . . . . 0.0 113.277 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 7.2 m -105.31 139.16 40.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.913 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.509 ' CD1' HG11 ' A' ' 119' ' ' VAL . 50.0 mt -62.88 118.16 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.73 -42.5 11.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.1 39.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 176.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.433 HG13 HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -115.84 122.39 69.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.598 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -117.11 141.11 48.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.682 -175.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.665 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 26.1 m-85 -121.73 134.96 54.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.154 -172.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.0 114.39 11.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.841 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 119.91 36.58 0.82 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.052 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.423 HD22 ' HB3' ' A' ' 99' ' ' PHE . 8.9 m120 -95.06 83.85 4.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.346 0.594 . . . . 0.0 110.149 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.06 -45.34 10.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.413 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.18 -41.61 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -173.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.481 HG13 ' HE2' ' A' ' 141' ' ' TYR . 14.0 p -117.53 148.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.68 145.33 53.96 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.665 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 18.2 p-10 -66.42 -32.07 73.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.551 170.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -43.72 76.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.073 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.71 65.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -58.44 -32.03 68.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.11 176.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.509 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 3.9 mtpp -56.95 -44.44 82.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.435 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.48 -28.37 52.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.43 -40.57 93.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.664 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.647 HD12 HG22 ' A' ' 133' ' ' ILE . 1.4 mm? -66.86 -38.85 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.747 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.77 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 2.0 mt-10 -63.91 -39.5 94.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.168 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.2 -17.14 60.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.597 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.6 m -87.0 -16.44 35.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.305 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.85 -21.55 22.84 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.935 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.727 HG22 HD12 ' A' ' 133' ' ' ILE . 1.3 t -102.8 101.13 11.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.77 ' HB3' ' HA ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -142.64 175.25 9.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -167.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.436 ' HA ' HG23 ' A' ' 94' ' ' ILE . 16.2 t -63.46 129.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.47 175.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.47 -6.34 71.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.548 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.78 138.1 51.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 12.5 m -65.75 138.96 58.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -91.21 143.42 26.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.638 0.732 . . . . 0.0 112.894 -163.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.543 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 6.8 t0 -97.08 105.23 17.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.452 170.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.618 ' H ' ' HD2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -70.41 -14.17 62.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.632 -177.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.1 p -81.29 -24.53 37.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.653 0.263 . . . . 0.0 110.82 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -92.58 3.39 55.63 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 111.131 179.019 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.672 ' HA ' HD13 ' A' ' 133' ' ' ILE . 6.4 mm -59.46 -40.78 82.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.55 -34.95 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.472 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.1 -34.36 77.46 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.309 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.727 HD12 HG22 ' A' ' 119' ' ' VAL . 21.2 mt -64.8 -49.09 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.43 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.35 -45.78 92.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.414 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -40.61 89.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.316 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.33 88.77 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.759 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.514 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 13.8 mt -67.65 -35.72 79.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.639 0.257 . . . . 0.0 111.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.29 -30.48 66.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.859 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.41 -34.24 76.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -75.22 -39.83 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.346 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.481 ' HE2' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -61.24 -39.85 91.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.158 0.504 . . . . 0.0 110.867 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -30.07 69.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.536 177.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.4 m -73.11 -28.34 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 t -73.66 -87.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.448 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.94 19.3 23.29 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.597 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.6 mttp 66.59 51.44 1.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.447 0.699 . . . . 0.0 110.852 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -90.39 139.08 31.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.581 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.37 88.85 2.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.043 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.28 163.91 12.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.958 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.2 112.52 24.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 3.4 p -118.25 126.91 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.401 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 127.18 38.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.624 ' HB2' HG21 ' A' ' 130' ' ' ILE . . . -91.16 111.12 22.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.274 0.559 . . . . 0.0 110.258 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.61 123.25 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.25 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.516 HG23 HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -98.72 127.03 51.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.147 0.498 . . . . 0.0 110.208 177.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -104.74 120.34 50.56 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.153 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.35 135.18 18.14 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 122.821 2.347 . . . . 0.0 112.984 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.11 151.46 75.32 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.071 175.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.98 66.53 7.68 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.53 2.82 . . . . 0.0 113.499 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -148.6 16.07 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.169 173.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 37.9 t30 58.0 43.41 21.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.275 -168.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 74.9 mmt-85 -135.89 157.81 45.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.35 -177.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.588 HG22 HD21 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -132.7 145.6 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.019 173.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.65 121.73 45.88 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.459 HD13 ' HB1' ' A' ' 153' ' ' ALA . 37.9 tp -95.59 120.36 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.312 -174.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.598 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.71 131.78 55.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.649 0.738 . . . . 0.0 111.223 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.56 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.9 mm? -102.29 110.63 22.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.255 -176.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.7 t -96.67 110.71 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.526 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 8.0 m-85 -105.88 118.83 37.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.296 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.886 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -107.65 151.46 25.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.911 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.8 t -81.8 119.02 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.315 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 t -70.52 124.63 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.01 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -44.32 12.33 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.779 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 145.97 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.839 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -109.82 122.73 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -119.6 147.75 44.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.966 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.459 ' HD2' HG13 ' A' ' 39' ' ' VAL . 46.0 m-85 -124.43 130.97 53.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 0.0 110.991 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.68 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 1.4 tm-20 -123.22 69.89 1.02 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.482 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.512 178.47 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 120.543 0.211 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.459 HG13 ' HD2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -51.96 -40.03 27.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 124.069 0.856 . . . . 0.0 112.751 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.43 90.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.199 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.53 -33.56 66.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.21 -33.63 59.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.689 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 mp -61.85 -31.31 71.56 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.174 0.59 . . . . 0.0 111.713 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.9 mt -67.28 -23.96 65.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.388 . . . . 0.0 111.652 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.806 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -89.79 -8.55 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.221 0.534 . . . . 0.0 110.209 177.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.463 ' HE1' HG22 ' A' ' 62' ' ' THR . 85.2 mtp -88.14 143.03 32.3 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.01 -16.18 40.49 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 122.359 2.039 . . . . 0.0 113.209 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 m -129.02 169.46 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.058 0.456 . . . . 0.0 111.642 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -127.88 177.2 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.691 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -66.4 125.11 24.64 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.53 -7.08 39.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.452 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.4 156.33 19.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 0.0 111.176 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.12 134.02 36.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.119 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.67 129.51 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 111.892 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -82.1 173.62 11.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.397 170.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HA ' HD11 ' A' ' 59' ' ' ILE . 6.4 p-10 -68.74 -26.27 65.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.346 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.48 -32.45 72.46 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.763 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -76.79 -28.7 55.74 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 122.302 0.241 . . . . 0.0 111.363 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.548 HD11 ' HA ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -61.66 -45.04 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -67.62 -31.2 71.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.32 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.763 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.6 m-20 -66.15 -41.38 90.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.284 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.463 HG22 ' HE1' ' A' ' 46' ' ' MET . 56.3 m -58.37 -46.65 85.92 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.017 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 65.0 mt -54.04 -50.9 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.545 0.528 . . . . 0.0 110.644 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -39.86 95.87 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.587 0.755 . . . . 0.0 111.747 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.67 -52.55 36.58 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.882 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.806 HD22 ' HB2' ' A' ' 45' ' ' SER . 41.1 mt -64.48 -30.61 71.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.429 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.2 -40.39 82.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.674 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 -12.9 61.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.803 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 45' ' ' SER . 34.6 p -78.14 -23.01 47.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.576 0.227 . . . . 0.0 110.708 -177.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.39 23.18 76.53 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.198 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -87.92 -28.76 21.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.15 . . . . 0.0 111.229 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.44 161.46 35.76 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.253 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 124' ' ' SER . 0.0 OUTLIER -79.84 -38.91 31.83 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.174 0.296 . . . . 0.0 111.185 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.83 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 7.9 t70 -139.16 137.76 36.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 66' ' ' LEU . 75.2 t -117.89 119.56 61.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.992 0.425 . . . . 0.0 109.902 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 118.67 32.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.174 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.535 HG23 HG23 ' A' ' 86' ' ' VAL . 67.2 t -114.82 128.99 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp -128.68 155.7 44.61 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -118.18 126.73 52.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.322 0.582 . . . . 0.0 109.803 174.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -125.63 97.08 5.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.772 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 -108.83 2.61 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.92 7.81 15.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.401 . . . . 0.0 110.407 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.91 129.21 53.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.215 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.49 115.89 31.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 32' ' ' GLU . 12.4 tp -108.05 121.38 44.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 -175.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.535 HG23 HG23 ' A' ' 77' ' ' VAL . 21.9 t -112.84 113.19 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.626 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.68 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 33.9 mt-30 -99.82 138.51 36.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.9 148.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.098 0.475 . . . . 0.0 110.679 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.83 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.828 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.86 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.714 ' HB2' HG23 ' A' ' 163' ' ' VAL . 16.7 Cg_exo . . . . . 0 CA--C 1.531 0.361 0 N-CA-C 114.468 0.911 . . . . 0.0 114.468 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -88.12 140.17 29.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.493 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.656 HD13 ' HB2' ' A' ' 125' ' ' LEU . 33.9 mt -65.19 118.24 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.45 -40.75 14.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.06 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.54 146.55 25.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.777 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -107.53 128.78 62.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.92 133.02 54.85 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.626 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 22.6 m-85 -113.52 135.49 53.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -136.91 127.37 26.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.412 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.61 46.38 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.29 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.87 79.99 1.26 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -33.45 21.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.553 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -46.94 76.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.725 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.428 HG11 ' N ' ' A' ' 106' ' ' LYS . 11.5 t -118.29 141.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.428 ' N ' HG11 ' A' ' 105' ' ' VAL . 15.0 mttp -69.71 151.48 45.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 111.483 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -35.26 79.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.172 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -28.87 65.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.724 0.297 . . . . 0.0 111.153 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.6 mtp -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.537 HD22 HD23 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -64.25 -34.73 78.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.963 175.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.626 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 2.4 mttt -59.42 -43.12 93.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.915 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.66 -28.76 56.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.622 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.39 -45.0 85.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.299 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -65.93 -37.16 85.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.21 176.006 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HG2' ' CG ' ' A' ' 120' ' ' ARG . 67.0 mt-10 -59.38 -46.58 88.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.26 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.81 61.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -85.04 -16.99 38.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.315 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.98 -19.85 15.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.408 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.691 HG22 HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -96.0 106.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.316 0.579 . . . . 0.0 110.811 -176.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.426 ' CG ' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -119.0 163.29 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.136 -173.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.418 ' HA ' HG23 ' A' ' 94' ' ' ILE . 38.1 t -69.35 123.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 109.963 174.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.56 -7.27 80.02 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.061 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 161.58 13.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -74.89 149.54 39.46 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.656 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -103.04 146.76 27.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.969 0.414 . . . . 0.0 111.716 -173.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -116.25 101.49 8.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.648 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.463 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.46 -20.14 62.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.233 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -27.09 65.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.548 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -0.01 43.06 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.805 177.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.463 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.9 mm -59.31 -37.87 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.451 0.301 . . . . 0.0 111.69 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.38 86.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.913 0.387 . . . . 0.0 111.3 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -30.07 64.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.474 HD12 HG23 ' A' ' 119' ' ' VAL . 7.9 mt -69.26 -42.51 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.272 175.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -64.38 -40.57 96.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -68.46 -38.06 80.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.626 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.68 -37.5 92.49 Favored Glycine 0 C--O 1.227 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.852 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.537 HD23 HD22 ' A' ' 110' ' ' LEU . 11.1 mt -73.01 -34.3 66.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.682 0.277 . . . . 0.0 111.202 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -38.84 87.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.153 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.41 -37.53 71.51 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.597 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -61.47 -41.96 98.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.809 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 147' ' ' TYR . 1.2 m-85 -62.21 -37.58 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.847 177.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 56.9 t80 -70.41 -35.44 73.44 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.335 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.8 m -67.69 -31.81 72.02 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 t -74.63 -91.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.806 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.43 18.58 22.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.412 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 7.8 mtmt 60.01 57.42 3.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.441 0.639 . . . . 0.0 110.205 -173.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.457 ' O ' ' HD1' ' A' ' 141' ' ' TYR . 51.2 m-85 -96.64 34.89 1.58 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.701 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.13 102.71 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.97 152.51 45.58 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.617 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 m -96.77 126.63 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 110.373 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.4 p -106.48 134.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.43 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -108.81 117.04 33.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.012 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.432 ' HB3' HD12 ' A' ' 167' ' ' LEU . . . -92.21 110.45 21.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.318 0.58 . . . . 0.0 110.1 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.69 117.0 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.386 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -99.67 112.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.185 0.516 . . . . 0.0 110.047 175.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 8.1 m -104.7 121.65 46.2 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 6.2 Cg_exo -79.9 143.78 16.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.109 2.539 . . . . 0.0 112.126 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -129.92 156.76 78.55 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.939 174.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.85 70.85 3.49 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.489 2.793 . . . . 0.0 113.266 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.538 ' HB2' HD13 ' A' ' 158' ' ' LEU . 6.0 ttm180 -163.35 15.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.36 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.9 t30 55.59 42.27 29.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.199 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -129.95 157.99 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.815 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -128.74 152.37 36.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.114 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.87 118.71 37.46 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.425 HD11 HG11 ' A' ' 155' ' ' VAL . 51.8 tp -99.17 112.18 24.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.128 -175.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HG2' HG21 ' A' ' 168' ' ' VAL . 8.2 ttmt -111.63 132.68 54.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.483 0.658 . . . . 0.0 111.145 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.5 mm? -108.63 109.41 20.6 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.408 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.419 HG21 ' HG2' ' A' ' 166' ' ' LYS . 1.5 t -107.19 113.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.807 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.475 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 3.2 m-85 -98.34 118.91 36.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.117 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.627 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.097 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p90 -150.47 152.23 33.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.878 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 53' ' ' THR . 54.7 t -85.86 118.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.1 119.04 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.354 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.65 -34.61 19.74 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.442 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 83' ' ' THR . 20.8 t70 -158.57 145.6 17.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.196 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.587 HD13 HG21 ' A' ' 50' ' ' THR . 4.6 mt -109.28 120.65 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -116.5 127.11 54.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.767 -178.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.41 136.52 40.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.406 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.2 58.22 0.69 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.955 0.883 . . . . 0.0 109.647 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.052 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.611 179.823 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.528 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -51.22 -43.23 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.83 -35.54 50.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.75 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.692 ' HA ' HD13 ' A' ' 44' ' ' LEU . . . -71.45 -29.2 64.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.215 0.531 . . . . 0.0 111.031 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.71 -34.65 60.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.409 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.827 HD23 ' HG2' ' A' ' 49' ' ' ARG . 2.3 mt -56.98 -30.26 63.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.384 0.673 . . . . 0.0 112.79 170.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 41' ' ' ALA . 69.9 mt -61.57 -29.31 69.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 111.445 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.777 ' HB3' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -91.33 -8.82 47.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.014 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.513 ' HG3' ' HA ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -86.28 132.55 42.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 6.7 Cg_exo -74.23 -8.61 21.1 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.784 2.323 . . . . 0.0 112.749 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.411 HG13 ' CG1' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -139.93 151.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.939 0.4 . . . . 0.0 110.418 -175.111 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.827 ' HG2' HD23 ' A' ' 43' ' ' LEU . 81.5 mtt-85 -131.57 179.41 6.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.576 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.587 HG21 HD13 ' A' ' 29' ' ' ILE . 7.4 p -63.08 123.43 18.56 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.256 -177.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.44 -6.83 39.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.8 m-20 -87.61 148.87 24.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.816 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -101.15 124.51 46.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.342 178.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' CG1' HG13 ' A' ' 48' ' ' VAL . 2.1 m -142.02 145.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -170.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -100.47 -177.76 3.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.38 -26.44 66.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.786 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.83 -31.64 68.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.642 0.258 . . . . 0.0 110.572 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.38 -29.38 59.83 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.202 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -44.84 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.672 ' HA ' HD13 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -68.28 -34.01 75.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.435 177.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -66.58 -40.87 89.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.006 0.431 . . . . 0.0 110.387 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.559 HG21 HD13 ' A' ' 66' ' ' LEU . 90.9 m -58.59 -43.8 89.65 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.154 172.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.672 HD13 ' HA ' ' A' ' 60' ' ' SER . 74.6 mt -55.97 -47.15 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.743 176.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmm-85 -62.76 -42.53 99.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.63 -53.39 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.559 HD13 HG21 ' A' ' 62' ' ' THR . 16.4 mt -63.6 -32.66 74.19 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.657 0.598 . . . . 0.0 111.624 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -39.66 91.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.0 110.888 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.67 60.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.222 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 45' ' ' SER . 42.3 p -79.78 -24.93 41.14 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -172.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.75 20.73 79.84 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.752 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -88.83 -26.34 21.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.292 0.568 . . . . 0.0 110.142 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.16 156.54 43.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.364 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.519 ' OE1' ' HE2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.64 -44.24 24.33 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.29 0.369 . . . . 0.0 111.275 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 31.5 t70 -130.73 139.28 50.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.285 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 t -123.51 120.16 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.238 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.49 117.29 29.96 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.575 HG21 HG11 ' A' ' 86' ' ' VAL . 84.4 t -113.87 122.66 68.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.3 137.84 46.16 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.437 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 6.5 ptm180 -95.31 140.56 30.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.356 0.598 . . . . 0.0 110.387 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -130.62 96.94 4.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.43 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.68 -109.08 2.72 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.166 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -108.2 1.7 22.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 0.0 110.759 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.482 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.71 137.41 41.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 -173.624 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.71 115.54 30.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.24 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.6 tp -102.52 119.25 38.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.575 HG11 HG21 ' A' ' 77' ' ' VAL . 17.7 t -117.88 108.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.759 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.92 136.49 44.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.06 153.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.262 0.553 . . . . 0.0 111.073 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.581 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.819 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo . . . . . 0 C--O 1.232 0.197 0 CA-C-O 121.499 0.541 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 66.9 m -127.75 133.35 49.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.319 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.761 HD13 ' HB2' ' A' ' 125' ' ' LEU . 56.9 mt -69.13 118.86 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.09 -34.67 12.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.565 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 138.3 24.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 120' ' ' ARG . 4.7 mt -110.75 123.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 131.74 56.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.064 0.459 . . . . 0.0 110.898 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.578 ' HE2' HD11 ' A' ' 167' ' ' LEU . 21.2 m-85 -110.13 135.75 50.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.989 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.98 122.72 11.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.18 -14.5 64.39 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.535 174.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.29 78.11 3.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 110.829 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -85.84 -19.35 30.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -78.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.526 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.496 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 54.4 t -84.21 139.17 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -69.92 152.19 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.053 0.454 . . . . 0.0 111.644 -172.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.26 76.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.546 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -38.01 89.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mtp -73.05 -39.33 66.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.359 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -32.74 74.31 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.417 177.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.441 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 10.3 mttt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.076 0.465 . . . . 0.0 110.954 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -28.76 55.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.622 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -67.84 -38.5 83.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.9 -38.46 83.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.467 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.47 -33.66 76.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.088 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.38 -16.11 60.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.079 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 m -91.83 -16.55 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.193 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 107.93 -25.65 19.95 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.921 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.555 HG23 HD12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -88.19 107.89 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.155 0.503 . . . . 0.0 111.451 -173.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.442 ' HA ' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -140.94 175.49 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.548 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.435 HG22 HG13 ' A' ' 97' ' ' ILE . 27.3 t -67.33 126.32 26.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 110.074 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.29 -6.77 66.18 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.34 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 160.4 14.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.234 0.54 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.91 117.97 23.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.802 174.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.761 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.89 137.42 33.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.093 0.473 . . . . 0.0 112.074 -172.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -101.9 105.98 16.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.878 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.414 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.02 -15.72 62.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.403 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.8 p -87.18 -20.45 26.96 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.56 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.3 p -98.69 6.83 46.73 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.927 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.523 ' HA ' HD11 ' A' ' 133' ' ' ILE . 4.6 mm -55.94 -37.58 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.05 85.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.18 -36.22 79.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 110.068 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.555 HD12 HG23 ' A' ' 119' ' ' VAL . 7.0 mt -66.33 -42.99 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.443 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.18 -45.0 96.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -34.15 77.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.325 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.53 -42.16 89.06 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.777 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.9 -38.62 91.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HG3' HG13 ' A' ' 151' ' ' VAL . 13.8 mt-10 -69.62 -34.54 74.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.254 0.346 . . . . 0.0 111.067 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.52 -41.83 75.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.435 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.49 -37.18 82.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.496 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.95 -41.18 91.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.163 0.506 . . . . 0.0 110.476 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -30.35 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.51 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.8 m -72.35 -28.58 63.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.856 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.4 t -77.54 -82.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.767 0.317 . . . . 0.0 111.092 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.5 19.46 21.85 Favored Glycine 0 N--CA 1.454 -0.101 0 C-N-CA 121.358 -0.449 . . . . 0.0 112.833 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm 66.05 34.35 7.0 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.341 0.656 . . . . 0.0 110.485 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -76.63 126.27 30.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.219 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.62 59.12 0.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.242 0.544 . . . . 0.0 110.565 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.95 148.21 22.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.642 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 m -97.86 118.82 35.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.942 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.7 p -98.8 137.35 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 116.95 19.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.077 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.49 111.53 23.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.424 0.631 . . . . 0.0 109.949 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.99 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.391 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.422 ' H ' HG21 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -99.67 109.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.483 0.658 . . . . 0.0 110.219 175.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.6 m -104.67 113.47 64.93 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.811 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.37 128.13 8.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.085 2.523 . . . . 0.0 113.004 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -109.46 143.59 28.09 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.38 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 16.5 Cg_exo -67.69 79.52 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.83 3.02 . . . . 0.0 114.008 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -157.44 -75.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.3 t30 177.79 13.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.802 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.551 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 26.4 mmt-85 -117.92 157.7 26.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.414 -170.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.511 HG13 HD23 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -127.93 152.61 36.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.319 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -108.3 118.89 37.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.4 tp -106.58 110.7 22.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.07 0.462 . . . . 0.0 110.339 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -112.55 132.53 55.07 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.258 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.578 HD11 ' HE2' ' A' ' 99' ' ' PHE . 1.5 mp -114.31 112.09 22.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.696 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.55 112.99 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.596 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.503 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 2.4 m-85 -99.6 118.68 36.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 . . . . . 0 C--N 1.322 -0.613 0 CA-C-O 120.82 0.343 . . . . 0.0 110.867 -178.853 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.55 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 2.7 p90 -93.8 153.38 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.631 0.253 . . . . 0.0 110.51 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.36 117.78 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.245 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 84' ' ' LEU . 2.8 t -69.16 137.91 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.233 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 -37.75 5.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.27 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -143.86 138.55 28.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.481 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.698 HG23 ' HE2' ' A' ' 46' ' ' MET . 86.7 mt -103.87 120.72 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 127.95 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.407 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -103.8 122.33 44.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.366 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.757 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 4.3 mt-10 -98.68 54.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.913 0.863 . . . . 0.0 109.907 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.851 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.32 177.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.149 0 CA-C-O 119.975 -0.059 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -58.88 -31.61 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.56 81.23 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.872 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.696 ' HA ' HD13 ' A' ' 44' ' ' LEU . . . -76.19 -35.94 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.136 0.493 . . . . 0.0 110.696 176.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.42 83.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.442 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.592 HD23 ' HD2' ' A' ' 49' ' ' ARG . 2.6 mt -57.8 -32.76 67.87 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 41' ' ' ALA . 2.0 mt -72.58 -21.15 61.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.612 0.244 . . . . 0.0 111.352 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.45 -21.98 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.018 0.437 . . . . 0.0 110.369 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.698 ' HE2' HG23 ' A' ' 29' ' ' ILE . 77.0 mtm -82.65 135.73 45.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.39 -2.75 12.77 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.56 2.173 . . . . 0.0 112.444 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.78 147.56 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.592 ' HD2' HD23 ' A' ' 43' ' ' LEU . 4.1 mmm180 -129.6 175.13 9.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.936 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.6 p -68.06 120.99 15.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.69 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.18 -5.27 52.56 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.424 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -80.02 155.89 27.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 0.0 111.594 -177.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -106.24 126.04 51.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.229 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.03 133.45 58.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 112.134 -168.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -98.77 -177.27 3.6 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.094 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.568 ' HA ' HD11 ' A' ' 59' ' ' ILE . 10.1 t70 -60.32 -32.75 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.568 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.7 -43.09 89.94 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.549 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 31.1 m-20 -75.09 -27.99 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.246 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -59.78 -52.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 172.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.47 -26.29 62.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.259 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 64' ' ' ARG . 1.8 t-20 -63.98 -47.14 81.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -60.78 -45.66 93.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 174.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.1 mt -53.72 -55.5 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 123.544 0.528 . . . . 0.0 110.886 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.91 -30.47 67.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.08 -175.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.32 -48.22 68.22 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.558 0.218 . . . . 0.0 110.592 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.494 ' HA ' HG22 ' A' ' 69' ' ' THR . 84.0 mt -69.27 -30.41 68.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -40.51 94.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 110.774 175.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.57 -13.43 62.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.601 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 66' ' ' LEU . 12.3 p -79.03 -24.92 43.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.547 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.46 ' HA2' ' HG3' ' A' ' 123' ' ' GLU . . . 80.83 -10.25 47.64 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.317 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -67.07 -31.72 72.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.4 144.46 46.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.848 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -73.4 -37.25 66.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.054 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -139.49 136.51 34.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 66' ' ' LEU . 39.3 t -127.59 118.15 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.085 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.09 55.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 68.1 t -125.52 118.38 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -133.14 159.14 41.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -172.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.459 ' HD3' ' CD1' ' A' ' 59' ' ' ILE . 15.5 mtm180 -113.49 147.59 37.6 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.655 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -135.27 96.83 3.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.736 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.8 -109.25 2.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.512 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.407 ' HA ' ' CD2' ' A' ' 24' ' ' PHE . 3.8 m-20 -112.85 14.22 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.227 0.537 . . . . 0.0 109.923 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.45 136.82 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.257 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.55 HD13 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.34 112.13 24.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 tp -106.4 112.46 25.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.624 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.3 t -114.51 117.12 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.757 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.0 mt-30 -106.97 124.94 50.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.99 145.01 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.196 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.175 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.474 ' O ' ' HA ' ' A' ' 124' ' ' SER . 18.9 Cg_endo . . . . . 0 N--CA 1.459 -0.55 0 N-CA-C 113.939 0.707 . . . . 0.0 113.939 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.721 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 94.0 m -111.93 124.8 53.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.421 176.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.728 HD13 ' HB2' ' A' ' 125' ' ' LEU . 19.0 mt -67.54 118.8 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.01 6.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.239 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.05 144.33 27.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.401 . . . . 0.0 110.856 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.451 HD13 HG22 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -106.9 123.87 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 171.304 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.99 141.35 49.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.381 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HE1' ' HB2' ' A' ' 111' ' ' LYS . 24.1 m-85 -117.59 152.33 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 112.018 -172.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.79 111.91 3.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.46 55.09 0.28 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.257 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.473 HD22 HD23 ' A' ' 110' ' ' LEU . 33.1 m120 -126.24 41.52 3.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.224 -0.488 . . . . 0.0 112.044 -172.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HD3' ' HA ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -86.03 -16.03 39.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.526 177.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.496 ' HB2' ' CE1' ' A' ' 141' ' ' TYR . 75.6 m -105.21 -45.19 4.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.639 0.257 . . . . 0.0 111.108 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.0 t -120.62 147.65 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.44 147.45 50.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.188 0.518 . . . . 0.0 111.939 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.74 -35.2 78.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.446 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -35.09 79.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.121 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -41.65 77.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.215 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.473 HD23 HD22 ' A' ' 102' ' ' ASN . 0.3 OUTLIER -62.87 -40.62 98.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.235 175.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.531 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -64.96 -43.27 93.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.224 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.11 -27.42 60.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -66.57 -43.65 84.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.417 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -43.24 99.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.652 173.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.783 ' HG2' ' HG3' ' A' ' 120' ' ' ARG . 91.9 mt-10 -59.9 -42.95 94.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.511 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.75 -18.68 60.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.858 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 m -87.4 -17.18 32.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.632 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.75 -21.22 8.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.282 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.625 HG13 HD11 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -89.14 103.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.372 0.606 . . . . 0.0 110.147 -177.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.783 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 12.2 ttp-105 -130.98 161.88 30.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.346 -172.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.471 ' HA ' HG23 ' A' ' 94' ' ' ILE . 24.2 t -69.9 124.43 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.956 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.68 -21.67 44.89 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.594 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.46 ' HG3' ' HA2' ' A' ' 70' ' ' GLY . 1.0 OUTLIER -95.79 166.22 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 110.758 -178.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -83.13 142.65 31.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.425 -176.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -116.22 138.64 51.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.451 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 25.6 t0 -94.8 121.07 36.01 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.195 0.998 . . . . 0.0 111.486 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -21.85 61.27 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.661 -1.608 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.9 p -89.6 -10.68 45.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.905 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 1.1 p -104.33 7.32 35.71 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.001 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 mm -55.31 -43.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.644 0.59 . . . . 0.0 111.854 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 135' ' ' LYS . . . -62.48 -42.71 99.68 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.492 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.46 -29.02 66.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.888 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.25 -42.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.762 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.433 ' HA ' HG13 ' A' ' 151' ' ' VAL . 54.6 mt-10 -60.91 -46.76 89.38 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 50.6 mmtt -67.88 -36.39 80.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -40.23 84.79 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.374 -0.441 . . . . 0.0 112.608 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.533 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 10.0 mt -69.62 -31.97 70.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.806 ' HG3' HG22 ' A' ' 151' ' ' VAL . 6.2 mt-10 -64.62 -41.37 96.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.418 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -68.56 -34.06 75.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.543 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.418 ' HE1' HD11 ' A' ' 110' ' ' LEU . 28.0 t80 -60.76 -44.28 96.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.536 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 104' ' ' SER . 0.2 OUTLIER -62.7 -38.95 92.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 177.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.55 -29.93 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.999 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 m -70.55 -30.33 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.4 t -73.9 -82.28 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 110.853 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.69 18.67 22.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.029 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 63.73 40.82 7.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 110.271 -173.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -81.55 120.99 25.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.627 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 101.01 9.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -114.84 156.42 24.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 170' ' ' GLN . 0.7 OUTLIER -120.16 120.7 36.95 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.806 HG22 ' HG3' ' A' ' 138' ' ' GLU . 49.0 t -102.57 124.28 56.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 0.0 111.812 -172.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.85 115.82 26.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.87 111.12 23.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.65 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.66 112.97 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.033 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 117.65 49.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 109.369 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.6 m -104.67 116.89 60.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.944 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.508 ' HA ' HG11 ' A' ' 163' ' ' VAL . 91.4 Cg_endo -86.84 136.73 4.42 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.096 2.531 . . . . 0.0 113.113 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -126.03 150.2 68.61 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 171.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 22.1 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.471 2.781 . . . . 0.0 114.108 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -113.67 26.37 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.208 -0.308 . . . . 0.0 110.81 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.5 t30 74.88 5.35 4.36 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 0.0 111.52 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.721 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 9.8 mmt-85 -113.56 160.29 18.69 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 111.176 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.569 HG22 HD21 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -136.73 145.26 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.486 175.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.23 131.02 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.67 117.44 33.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.773 0.321 . . . . 0.0 111.188 -173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 131.63 56.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 0.0 109.816 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.514 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.89 111.72 23.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.305 -175.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.4 t -94.94 111.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.785 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.533 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 8.7 m-85 -114.18 142.02 46.78 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.231 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.406 ' HB2' ' H ' ' A' ' 150' ' ' SER . 45.3 mm-40 . . . . . 0 C--N 1.317 -0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 167.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.554 0.693 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 55' ' ' ASN . 23.9 mp0 -127.19 177.14 6.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.617 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.01 48.16 10.3 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -173.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -110.32 154.21 23.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.09 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.41 115.75 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.355 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.38 142.45 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.486 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -38.31 7.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.398 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -143.32 146.91 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.408 ' CD1' HD22 ' A' ' 43' ' ' LEU . 58.9 mt -111.23 130.49 64.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 173.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.8 156.44 34.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.656 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 5.9 m-85 -128.53 119.66 25.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.41 73.9 2.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.738 0.78 . . . . 0.0 110.599 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 156.24 -20.62 0.48 Allowed Glycine 0 C--N 1.314 -0.691 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.023 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 5.4 mt -85.11 129.04 34.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.32 -0.44 . . . . 0.0 111.08 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.93 -35.09 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.362 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -79.9 -55.52 4.91 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 120.917 0.389 . . . . 0.0 110.048 175.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.565 ' HB ' HD12 ' A' ' 34' ' ' LEU . 4.1 t -78.68 128.2 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.04 158.27 16.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.048 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.467 HG11 ' HD2' ' A' ' 31' ' ' PHE . 1.4 m -57.05 -29.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.65 71.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.949 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 -33.94 57.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 110.381 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.62 -31.45 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 29' ' ' ILE . 1.3 mt -56.66 -32.02 64.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.799 0.839 . . . . 0.0 112.788 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.1 -23.7 65.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.838 0.351 . . . . 0.0 111.633 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -7.49 53.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.403 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 56.7 mtp -100.39 132.64 22.19 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.9 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.547 ' HD2' HG21 ' A' ' 62' ' ' THR . 23.1 Cg_exo -66.33 -19.99 55.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.886 2.391 . . . . 0.0 112.665 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -104.06 155.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.404 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.3 176.21 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -68.91 121.52 16.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.983 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.98 -6.33 51.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.139 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 2.9 m-20 -81.16 156.49 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 111.263 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.03 125.98 35.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.27 128.43 72.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 111.907 -173.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 22' ' ' GLU . 14.4 m-80 -98.42 -178.27 3.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.082 175.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.19 -26.77 65.0 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.62 -37.12 86.13 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.548 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.68 -30.96 64.69 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.433 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.84 -46.86 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 123.303 0.377 . . . . 0.0 110.264 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.52 69.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.141 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 2.0 t-20 -68.22 -43.4 78.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.999 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.547 HG21 ' HD2' ' A' ' 47' ' ' PRO . 4.2 p -64.2 -40.78 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.774 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.719 HG13 HG22 ' A' ' 77' ' ' VAL . 39.7 mt -55.87 -52.7 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 123.427 0.455 . . . . 0.0 110.997 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.7 -29.64 67.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.56 -52.54 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.703 0.287 . . . . 0.0 110.414 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.22 -27.28 67.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.872 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -38.54 76.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.973 -0.454 . . . . 0.0 110.236 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.82 -14.79 59.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.538 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.0 p -79.71 -25.03 41.28 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.03 88.13 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.459 -0.791 . . . . 0.0 114.601 166.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.12 -29.18 38.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.578 0.689 . . . . 0.0 111.042 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.532 ' HE2' HD22 ' A' ' 34' ' ' LEU . 1.5 m-85 -107.1 152.98 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.743 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 6.7 mm-40 -86.67 -26.93 24.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.342 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 6.8 t70 -148.75 146.89 28.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.457 HG13 ' HA ' ' A' ' 63' ' ' ILE . 62.1 t -129.89 119.8 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.112 0.257 . . . . 0.0 110.701 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.97 118.79 31.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.55 0.214 . . . . 0.0 110.928 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.719 HG22 HG13 ' A' ' 63' ' ' ILE . 27.5 t -107.91 123.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.89 157.85 44.79 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -102.7 148.21 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.398 0.618 . . . . 0.0 111.657 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -139.55 97.43 3.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.657 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.79 -118.47 8.3 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 15.83 24.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 110.003 174.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.71 128.58 52.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.33 115.69 31.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.79 129.53 56.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.681 0.753 . . . . 0.0 110.87 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 77' ' ' VAL . 13.1 t -113.98 105.78 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.413 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -90.91 133.92 34.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.86 154.89 33.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.038 0.447 . . . . 0.0 110.956 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 4.3 tptt -99.71 147.92 24.91 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.757 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.742 ' HG3' ' HD2' ' A' ' 92' ' ' PRO . 1.9 tp10 -40.04 131.99 1.91 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 125.831 1.957 . . . . 0.0 113.241 -174.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.586 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -58.63 -51.49 81.43 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.771 -176.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.742 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 31.6 Cg_exo -62.05 140.91 86.82 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 121.712 1.608 . . . . 0.0 113.648 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.548 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 29.3 m -96.12 146.48 24.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.877 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.621 HG23 ' HA ' ' A' ' 121' ' ' VAL . 6.0 mt -63.05 117.77 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 162' ' ' ARG . . . -104.08 -48.62 3.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.41 137.52 34.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.138 0.494 . . . . 0.0 111.323 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.41 HG22 HD13 ' A' ' 165' ' ' LEU . 1.0 OUTLIER -111.63 121.75 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.09 52.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.756 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.582 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 23.1 m-85 -114.92 138.05 51.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -173.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.548 ' OG ' ' HE3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -138.79 112.16 8.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.418 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.703 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 112.56 22.32 5.81 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.371 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.16 69.52 7.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.229 0.537 . . . . 0.0 110.383 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -85.16 -26.77 26.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.357 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.6 m -112.28 -60.77 1.82 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.082 0.467 . . . . 0.0 111.197 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -89.28 141.52 14.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.512 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 146.49 52.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.16 -35.29 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -64.13 -35.61 81.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.1 mtp -67.16 -45.17 77.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.267 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 107' ' ' ASP . 10.0 mt -62.72 -33.34 74.91 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.451 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.465 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -60.61 -48.9 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.303 0.377 . . . . 0.0 111.296 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -77.45 -27.98 52.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.285 -177.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -63.66 -44.28 94.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.281 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -42.85 97.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.535 ' HG2' ' HA ' ' A' ' 120' ' ' ARG . 8.6 mt-10 -61.25 -40.87 95.68 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.392 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.27 60.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.5 m -92.56 -16.36 25.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.235 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.32 -48.05 0.8 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.162 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 t -82.26 103.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.488 0.661 . . . . 0.0 109.685 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' HA ' ' HG2' ' A' ' 115' ' ' GLU . 2.2 ttp85 -128.6 149.49 50.61 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -174.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.621 ' HA ' HG23 ' A' ' 94' ' ' ILE . 43.1 t -68.03 123.61 21.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.155 0.502 . . . . 0.0 110.795 -175.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.79 70.05 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.713 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -102.95 156.13 17.88 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -177.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.743 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -56.55 133.62 53.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.858 0.463 . . . . 0.0 111.216 174.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.42 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.91 145.36 24.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.326 0.584 . . . . 0.0 111.626 -176.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.736 ' HB3' ' HG1' ' A' ' 129' ' ' THR . 12.8 t0 -117.44 121.64 41.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.049 173.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -17.47 61.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.912 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 p -88.64 -21.69 23.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.734 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.736 ' HG1' ' HB3' ' A' ' 126' ' ' ASP . 6.1 p -85.57 -7.68 58.72 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.405 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.5 ' HA ' HD11 ' A' ' 130' ' ' ILE . 9.2 mm -57.45 -46.38 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.116 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.82 -34.55 78.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.75 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.07 -35.19 77.79 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.288 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.2 mt -67.13 -43.61 88.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.208 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.467 ' HA ' HG13 ' A' ' 151' ' ' VAL . 91.9 mt-10 -57.28 -49.81 74.91 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.13 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -68.12 -35.48 78.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.477 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.32 -41.63 77.79 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.734 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.452 HD23 HD21 ' A' ' 110' ' ' LEU . 49.3 mt -71.94 -32.64 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 149' ' ' ALA . 18.0 mt-10 -63.6 -42.49 98.24 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.308 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.13 -37.94 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.916 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -62.82 -42.62 99.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.386 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -40.59 95.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.11 -30.65 68.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.322 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.1 m -73.91 -27.63 61.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.366 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.4 t -74.94 -85.09 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.87 19.3 23.43 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.32 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 49.9 1.76 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.394 0.677 . . . . 0.0 110.394 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -89.24 125.17 34.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.96 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.04 97.41 7.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.274 0.559 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -122.59 149.08 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.537 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.45 131.17 45.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.467 HG13 ' HA ' ' A' ' 134' ' ' GLU . 28.8 t -111.85 126.73 69.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.943 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 122.69 28.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.033 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.651 ' HB3' HD12 ' A' ' 167' ' ' LEU . . . -98.37 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.238 0.542 . . . . 0.0 110.902 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 28.0 t -98.27 120.61 47.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.61 118.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.619 . . . . 0.0 110.925 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.1 m -112.99 119.15 43.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.465 ' HA ' HG11 ' A' ' 163' ' ' VAL . 77.7 Cg_endo -77.86 137.59 15.99 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.767 2.311 . . . . 0.0 112.709 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -121.55 148.96 51.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.578 175.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 8.5 Cg_exo -73.33 58.59 3.7 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.712 2.941 . . . . 0.0 113.911 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.86 18.07 1.62 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 60.43 40.15 17.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.526 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.548 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -141.77 167.13 22.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.711 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -127.68 143.33 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 110.965 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -110.8 118.76 37.02 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.41 HD13 HG22 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -116.62 132.57 56.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.884 0.85 . . . . 0.0 111.371 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.548 ' HE3' ' OG ' ' A' ' 100' ' ' SER . 5.3 tttt -115.35 133.3 56.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.964 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' ' 153' ' ' ALA . 4.0 mm? -102.56 111.31 23.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.241 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.7 113.92 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.664 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.703 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 38.6 m-85 -105.07 118.09 35.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.452 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.74 115.66 24.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.0 106.61 15.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.982 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.09 67.3 1.26 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.596 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.8 m -96.46 -22.65 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.246 0.546 . . . . 0.0 109.76 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.425 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.318 0.58 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -132.04 161.58 32.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.293 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.69 44.93 4.41 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.655 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 26.4 p90 -104.52 153.03 21.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.88 116.65 29.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.91 113.82 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.63 0.729 . . . . 0.0 110.489 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 7.2 mmtm -79.17 -32.44 44.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.967 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.475 ' HB3' HG21 ' A' ' 83' ' ' THR . 24.0 t0 -149.32 139.91 22.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.079 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 43' ' ' LEU . 59.3 mt -112.1 122.49 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.15 140.71 50.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -114.71 148.61 38.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.497 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -142.86 75.62 1.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.07 -44.97 0.13 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.36 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -71.01 134.81 47.43 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.008 0.432 . . . . 0.0 111.716 -176.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.41 -28.72 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.07 -37.67 7.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.958 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.65 121.25 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.889 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.61 156.54 19.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.917 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -59.12 -35.8 59.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.27 -40.07 87.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.801 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.21 69.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 110.49 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.05 -40.74 71.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.475 HD13 HG23 ' A' ' 29' ' ' ILE . 4.1 mp -62.91 -32.19 73.42 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.536 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 49.0 mt -69.32 -22.85 63.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.334 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -85.44 -18.0 34.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.448 ' HG2' HG22 ' A' ' 62' ' ' THR . 42.0 mtp -82.4 148.44 59.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.839 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.52 12.51 2.85 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.779 2.32 . . . . 0.0 113.126 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.11 166.43 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.706 ' HD2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.89 176.94 7.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.137 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -66.4 126.78 29.88 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.689 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.44 -4.46 54.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.657 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.706 ' HB2' ' HD2' ' A' ' 49' ' ' ARG . 2.6 t0 -92.32 156.81 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.412 . . . . 0.0 111.359 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 m -88.34 134.09 33.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.884 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.13 128.91 65.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 111.411 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -98.57 -178.31 3.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.263 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -37.07 79.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.284 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.81 -37.88 80.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.157 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -74.29 -30.45 62.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -50.43 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 173.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.606 ' HA ' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -67.62 -32.71 73.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.59 0.233 . . . . 0.0 111.213 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.55 -41.65 88.32 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.684 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.448 HG22 ' HG2' ' A' ' 46' ' ' MET . 91.2 m -60.37 -43.51 96.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 172.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 60' ' ' SER . 59.7 mt -56.07 -54.54 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 123.274 0.359 . . . . 0.0 111.122 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -29.62 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.6 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.601 ' HA ' HG22 ' A' ' 69' ' ' THR . 80.3 mt -71.19 -30.09 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.814 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.85 -33.84 75.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.373 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.89 -13.27 61.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.196 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 66' ' ' LEU . 15.5 p -78.94 -24.43 43.99 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.758 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.02 10.16 84.03 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.291 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -91.41 -25.51 19.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.941 0.4 . . . . 0.0 110.876 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.7 148.43 42.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.343 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -91.8 -14.06 30.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.158 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 9.3 t70 -154.65 138.31 16.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 66' ' ' LEU . 49.0 t -126.34 118.79 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.4 118.16 31.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.373 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.625 HG21 HG12 ' A' ' 86' ' ' VAL . 90.8 t -107.62 122.18 61.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mt -131.14 140.1 49.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.655 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -99.79 140.03 34.59 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.536 0.684 . . . . 0.0 110.293 -178.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.65 95.08 4.31 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.54 -109.58 2.97 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.452 ' HB2' ' HG2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -112.67 13.69 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 175.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -103.48 135.12 45.67 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.46 ' HB2' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -103.48 111.63 24.16 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.059 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 tp -104.28 119.63 39.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.868 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.625 HG12 HG21 ' A' ' 77' ' ' VAL . 14.8 t -117.05 113.75 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.325 0.583 . . . . 0.0 111.265 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -102.24 140.62 36.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -137.38 157.31 34.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 120.978 0.418 . . . . 0.0 110.438 -174.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.1 OUTLIER -100.24 138.66 37.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.416 -177.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.609 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -65.15 161.58 18.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.506 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -44.06 71.75 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 47.7 Cg_exo -58.61 139.79 92.16 Favored 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.611 1.541 . . . . 0.0 113.382 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 4.3 m -110.42 140.22 44.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.897 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.559 HG23 ' HA ' ' A' ' 121' ' ' VAL . 13.7 mt -59.09 119.05 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 109.832 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.45 -32.12 9.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.501 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.11 138.38 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.701 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.4 HG23 ' CD1' ' A' ' 114' ' ' LEU . 1.5 mt -118.75 132.16 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.04 139.19 52.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.652 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.503 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.6 m-85 -112.68 139.33 48.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.58 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.69 123.02 17.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.132 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.62 17.61 25.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.839 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 99' ' ' PHE . 44.1 m-80 -96.94 77.24 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 111.033 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.26 -40.43 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.654 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -76.52 -57.88 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.353 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.57 143.95 10.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -71.02 145.95 49.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 0.0 112.091 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -39.89 84.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.098 171.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.13 -45.32 87.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.84 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -41.23 79.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -32.95 74.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.891 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -47.84 84.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 111.334 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -77.95 -27.12 49.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -63.88 -38.43 91.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.397 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.4 ' CD1' HG23 ' A' ' 97' ' ' ILE . 14.2 mt -68.14 -43.09 79.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.533 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -58.93 -43.53 91.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.194 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.3 61.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.629 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.4 m -91.17 -14.66 30.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 110.559 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.75 -26.55 7.55 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.971 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.16 104.0 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.187 0.517 . . . . 0.0 110.88 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.451 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 3.6 ptp85 -140.59 172.42 12.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.501 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 94' ' ' ILE . 50.9 t -69.97 128.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.35 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.12 61.78 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.337 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -120.85 146.31 46.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 35.2 t -65.69 151.73 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 111.227 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.756 HD22 ' HD2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -93.53 145.21 24.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.596 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.453 ' O ' HG12 ' A' ' 130' ' ' ILE . 5.3 t70 -104.62 99.01 8.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.296 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.756 ' HD2' HD22 ' A' ' 125' ' ' LEU . 1.1 mtp180 -72.2 -18.31 61.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.912 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -75.02 -31.59 61.4 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.33 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 p -95.39 -2.85 48.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.159 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.492 ' CG1' ' HA ' ' A' ' 127' ' ' ARG . 2.8 mm -55.59 -37.71 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.51 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -75.36 -27.13 59.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.872 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.436 ' O ' HD21 ' A' ' 137' ' ' LEU . 19.1 mt -66.29 -50.02 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.927 174.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.24 -49.09 78.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.638 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -40.32 93.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.573 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -34.86 65.08 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.197 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.436 HD21 ' O ' ' A' ' 133' ' ' ILE . 1.7 mm? -70.5 -40.26 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.927 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -58.77 -40.37 83.75 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.688 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.16 -38.78 91.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.824 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.412 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 2.1 m-30 -65.62 -38.07 88.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.505 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.69 -34.64 78.31 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 110.804 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.3 t80 -70.58 -30.75 67.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.96 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.27 -28.03 65.94 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.8 t -75.24 -88.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 110.574 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.416 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -112.68 18.61 22.25 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.716 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 20.7 mtmt 60.05 49.13 7.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 110.075 -173.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.248 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.22 97.12 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.335 1.022 . . . . 0.0 111.732 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.76 156.21 17.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.052 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 113.37 25.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.1 t -103.26 126.72 57.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -172.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -125.38 117.61 24.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.334 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.12 111.24 22.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.028 0.442 . . . . 0.0 110.092 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.1 t -94.08 123.27 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.245 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.4 m -109.89 117.62 55.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.6 m -109.55 117.42 52.75 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.121 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.68 142.49 16.14 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.667 2.245 . . . . 0.0 112.655 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -122.12 155.09 61.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 171.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.83 56.81 6.21 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.149 2.566 . . . . 0.0 113.76 -173.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.614 ' HB2' HD13 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -134.85 -89.53 0.35 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -167.75 36.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.542 ' HB2' HD12 ' A' ' 158' ' ' LEU . 10.9 mmt85 -131.42 162.2 30.73 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.442 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -135.2 148.01 28.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.858 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.27 127.45 53.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.82 122.16 46.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -120.48 132.7 55.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 110.559 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -102.07 110.79 22.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.201 -177.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.57 122.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.592 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 167' ' ' LEU . 23.7 m-85 -113.69 118.31 33.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.421 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.85 115.98 31.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.914 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -80.98 120.6 24.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.931 0.396 . . . . 0.0 110.573 -178.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 102.25 106.97 3.04 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.86 -33.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.146 0.498 . . . . 0.0 109.769 -168.445 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.663 0.268 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.19 129.41 56.52 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.04 47.8 4.04 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -110.12 151.57 27.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.23 117.95 29.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -69.32 107.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.535 0.683 . . . . 0.0 110.228 178.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -20.53 31.6 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.578 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.709 ' HB3' HG21 ' A' ' 83' ' ' THR . 20.5 t70 -156.83 137.98 13.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.913 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.4 121.29 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.13 126.48 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.99 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.495 ' HD2' HG11 ' A' ' 39' ' ' VAL . 80.2 m-85 -104.24 122.23 44.95 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -117.97 -8.81 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.853 -172.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.767 ' HA2' ' H ' ' A' ' 88' ' ' VAL . . . -103.62 -10.8 34.64 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.985 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 HD12 ' HB ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -125.54 136.0 52.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.95 0.405 . . . . 0.0 111.257 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -116.68 -36.98 3.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.142 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -77.97 -42.26 33.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.138 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' HD12 ' A' ' 34' ' ' LEU . 9.5 t -69.11 141.36 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.16 157.26 16.49 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG11 ' HD2' ' A' ' 31' ' ' PHE . 1.8 m -54.3 -43.51 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 O-C-N 123.981 0.801 . . . . 0.0 112.222 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.32 -38.0 46.73 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.688 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.462 ' HA ' HD13 ' A' ' 44' ' ' LEU . . . -67.7 -37.72 82.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.18 -35.93 64.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.88 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -58.92 -31.12 68.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.315 0.646 . . . . 0.0 112.54 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 41' ' ' ALA . 69.0 mt -69.29 -19.47 63.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.701 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -92.73 -8.37 44.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.568 ' HE2' HG22 ' A' ' 62' ' ' THR . 87.8 mtp -90.16 141.61 27.93 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.577 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 26.3 Cg_exo -64.31 -37.04 42.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.773 2.315 . . . . 0.0 112.768 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.96 155.47 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.39 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -113.51 170.79 7.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.098 0.475 . . . . 0.0 110.983 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.465 ' HA ' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -67.24 138.72 57.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.2 177.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 -14.47 48.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.8 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.28 156.94 18.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 110.211 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.8 135.05 38.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.908 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.66 129.39 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.178 0.513 . . . . 0.0 110.889 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.482 ' O ' HD11 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -97.19 -177.56 3.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.386 0.613 . . . . 0.0 110.645 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -65.37 -29.83 70.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.339 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.77 62.83 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.664 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 43.0 m-20 -74.13 -29.56 61.88 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.63 HD12 ' HE ' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -63.13 -49.26 84.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -66.86 -35.94 81.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.577 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -62.39 -45.13 94.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.426 177.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.568 HG22 ' HE2' ' A' ' 46' ' ' MET . 63.1 m -58.24 -47.06 84.71 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.267 174.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.403 ' HA ' HG13 ' A' ' 75' ' ' VAL . 7.9 mt -56.92 -50.43 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.441 0.463 . . . . 0.0 111.142 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -69.81 -34.04 73.16 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -67.89 -46.7 70.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HA ' HG22 ' A' ' 69' ' ' THR . 60.7 mt -67.87 -30.9 70.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.914 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.56 99.23 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.11 -12.08 61.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.194 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 66' ' ' LEU . 32.7 p -78.42 -24.71 46.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.478 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.83 16.22 76.25 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.877 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -88.22 -32.48 18.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.303 0.573 . . . . 0.0 109.888 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.2 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 6.4 mm-40 -93.25 -27.1 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 14.8 t70 -141.78 137.07 31.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 63' ' ' ILE . 38.1 t -124.91 117.1 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.43 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.6 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.458 HG12 HG23 ' A' ' 62' ' ' THR . 16.0 m -104.67 144.11 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 110.405 174.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.11 155.99 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.63 ' HE ' HD12 ' A' ' 59' ' ' ILE . 1.4 mpp_? -116.07 127.14 54.63 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.291 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.86 95.27 4.76 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.99 -110.47 3.51 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.839 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.78 10.07 30.88 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -103.65 128.78 50.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.8 -176.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.06 113.2 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 0.0 110.328 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.9 112.66 24.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.216 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.56 106.85 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.301 0.572 . . . . 0.0 110.477 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -105.6 123.81 48.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.379 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.767 ' H ' ' HA2' ' A' ' 33' ' ' GLY . 4.2 m -124.51 147.47 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.445 0.641 . . . . 0.0 110.891 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.1 ttpt -100.37 142.81 31.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.135 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 125' ' ' LEU . 3.2 mm-40 76.04 171.09 0.25 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 124.511 1.132 . . . . 0.0 112.143 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.555 ' H ' ' HD2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -159.79 -52.11 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.246 -170.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.555 ' HD2' ' H ' ' A' ' 91' ' ' ARG . 55.0 Cg_endo -69.57 141.99 47.53 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.462 1.441 . . . . 0.0 113.015 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 86.6 m -94.6 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.842 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 125' ' ' LEU . 12.9 mt -73.21 118.73 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' ' HG2' ' A' ' 162' ' ' ARG . . . -97.44 -42.81 7.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.12 147.17 33.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.482 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -117.96 123.58 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 172.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.963 -175.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.721 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 21.6 m-85 -114.27 133.88 55.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.792 0.329 . . . . 0.0 110.791 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.9 m -126.39 144.39 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.801 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.76 -79.97 0.26 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 47.07 49.97 14.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.752 0.821 . . . . 0.0 112.611 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 171' ' ' GLU . 59.8 mmtt -76.17 -42.64 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 m -130.54 -25.73 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.76 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.446 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 13.6 t -111.4 132.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 155.46 39.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.378 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.27 77.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.291 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.156 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -45.44 73.65 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -32.61 71.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.074 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.721 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 9.9 mttt -58.14 -48.79 79.15 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.425 0.453 . . . . 0.0 111.584 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.81 48.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.735 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.3 -38.12 88.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.662 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.421 HD12 HG22 ' A' ' 133' ' ' ILE . 1.9 mm? -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.542 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 2.8 mt-10 -65.58 -37.83 87.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.417 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.72 -16.39 61.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.233 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.3 m -88.21 -16.02 34.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.965 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.06 -32.38 5.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.326 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.434 ' H ' HG21 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -90.73 113.0 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -174.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.542 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -141.06 176.72 8.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.642 -178.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.43 127.2 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.912 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.48 -27.81 18.82 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.553 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.97 162.41 19.41 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -79.03 164.86 24.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.49 ' HB2' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -112.04 143.63 42.72 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.057 -177.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 129' ' ' THR . 43.9 t0 -107.86 105.7 15.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.571 0.7 . . . . 0.0 110.097 174.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.432 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.3 -14.1 62.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.763 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.8 p -89.54 -23.47 22.01 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.071 0.939 . . . . 0.0 108.745 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.58 HG23 HD13 ' A' ' 133' ' ' ILE . 5.3 m -87.89 -13.57 41.63 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.715 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.536 HG22 ' HB1' ' A' ' 153' ' ' ALA . 4.3 mm -53.69 -39.95 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.097 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.54 94.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.2 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.492 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.58 HD13 HG23 ' A' ' 129' ' ' THR . 15.6 mt -63.09 -44.39 99.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.923 174.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.75 -44.66 96.48 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.726 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -41.32 93.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.634 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.42 -38.41 69.98 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.704 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.16 -33.06 71.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 111.492 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.29 -34.2 75.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.507 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.83 -32.46 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.519 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -62.51 -39.37 93.31 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.676 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.446 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -64.5 -34.53 78.44 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.099 0.476 . . . . 0.0 110.872 177.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -69.49 -30.79 68.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.156 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.6 m -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.797 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.5 t -76.18 -85.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.627 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.8 19.96 22.82 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.674 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mttp 66.7 42.21 2.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.429 0.692 . . . . 0.0 110.569 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -87.26 139.44 30.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.442 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -115.16 74.47 0.88 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.238 0.542 . . . . 0.0 110.127 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.482 ' HB3' ' HD1' ' A' ' 169' ' ' PHE . . . -95.4 142.04 28.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.369 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.597 ' H ' ' HB2' ' A' ' 170' ' ' GLN . 0.9 OUTLIER -99.41 126.42 45.3 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 11.4 p -113.4 138.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.176 0.512 . . . . 0.0 111.388 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.89 125.21 39.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.658 175.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.536 ' HB1' HG22 ' A' ' 130' ' ' ILE . . . -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.258 0.551 . . . . 0.0 110.919 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.57 128.77 56.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.329 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.74 123.36 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.433 0.635 . . . . 0.0 111.204 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.481 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 m -107.01 120.19 48.82 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.579 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 9.6 Cg_endo -89.64 130.4 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.408 2.739 . . . . 0.0 112.952 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -113.47 152.95 45.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 22.47 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.04 2.493 . . . . 0.0 113.876 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -115.72 19.98 14.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.992 0.425 . . . . 0.0 110.144 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 t30 67.51 26.62 8.14 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.999 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.526 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -129.75 167.03 18.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.288 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.21 153.53 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.0 0.429 . . . . 0.0 111.139 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -108.92 118.82 37.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 130' ' ' ILE . 59.4 tp -101.18 113.47 26.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.352 -175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -105.15 131.34 52.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 111.01 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.7 108.58 19.48 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.632 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 2.8 t -101.28 111.74 31.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.885 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -99.53 146.61 26.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.597 ' HB2' ' H ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -74.46 144.15 44.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.886 178.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.601 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 2.1 tt0 -57.98 -27.36 63.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.964 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 121.12 116.03 2.44 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.378 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.537 ' HB ' ' H ' ' A' ' 174' ' ' SER . 0.0 OUTLIER -89.19 -136.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.519 0.199 . . . . 0.0 111.142 -177.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.537 ' H ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 111.499 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.934 0.397 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -145.66 157.13 43.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.631 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.56 58.78 3.21 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.438 ' HE1' HD12 ' A' ' 59' ' ' ILE . 10.9 p90 -95.49 153.39 17.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.395 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.17 118.98 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -69.88 122.46 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -49.59 7.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.122 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.07 140.99 29.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.247 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.619 HG23 ' HE2' ' A' ' 46' ' ' MET . 7.1 mt -104.85 121.17 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 172.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 127.74 53.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.988 0.423 . . . . 0.0 110.121 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -102.79 125.84 49.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.024 -173.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.01 68.92 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.348 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.34 -41.33 0.13 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.562 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.869 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.4 OUTLIER -93.08 162.48 14.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.738 0.304 . . . . 0.0 110.884 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -156.42 -58.21 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.458 -176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -39.23 90.8 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.468 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.545 ' H ' HG21 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -77.8 121.27 30.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 164.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.62 157.16 28.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -53.63 -40.25 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.118 0.886 . . . . 0.0 112.604 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.482 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.12 -33.45 57.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.489 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.25 -35.25 63.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.54 74.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.507 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.51 -32.35 57.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.032 0.933 . . . . 0.0 112.879 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.7 mt -69.45 -14.04 62.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -100.06 -7.45 24.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.744 176.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.619 ' HE2' HG23 ' A' ' 29' ' ' ILE . 14.4 mtm -102.24 136.34 19.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.394 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.37 12.67 2.78 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.7 2.267 . . . . 0.0 113.296 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.756 HG13 HG13 ' A' ' 54' ' ' VAL . 32.0 m -119.08 149.12 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 49' ' ' ARG . 6.0 mmm-85 -131.85 166.22 22.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.504 0.668 . . . . 0.0 111.598 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.511 HG21 HD13 ' A' ' 29' ' ' ILE . 6.2 p -68.12 121.28 15.82 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.611 174.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.26 62.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.222 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.19 150.78 25.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.082 0.468 . . . . 0.0 111.224 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 116.35 32.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.756 HG13 HG13 ' A' ' 48' ' ' VAL . 14.7 m -133.2 156.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.081 0.467 . . . . 0.0 112.001 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.444 ' O ' HD13 ' A' ' 59' ' ' ILE . 11.6 m-80 -99.3 179.16 4.67 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.312 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.84 -32.83 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.191 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.67 -31.73 72.9 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 12.2 m-20 -75.2 -33.72 61.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.075 177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 55' ' ' ASN . 1.3 mp -63.14 -46.63 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 171.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.733 ' HA ' HD11 ' A' ' 63' ' ' ILE . 19.0 m -65.35 -31.86 73.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.303 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -70.01 -38.87 76.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.407 178.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 m -58.29 -46.67 85.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 171.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.733 HD11 ' HA ' ' A' ' 60' ' ' SER . 68.8 mt -55.33 -55.0 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.385 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -29.55 68.19 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 45' ' ' SER . . . -67.7 -45.71 74.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.485 0.183 . . . . 0.0 110.614 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HA ' HG22 ' A' ' 69' ' ' THR . 93.7 mt -69.39 -30.89 68.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.58 -35.01 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.74 -12.75 61.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.445 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 66' ' ' LEU . 16.5 p -78.87 -25.1 43.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.497 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.5 8.04 83.53 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.609 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -82.99 -48.77 10.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.997 0.427 . . . . 0.0 110.829 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.85 150.16 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -53.75 17.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -135.49 140.7 45.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -121.47 118.65 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.07 118.79 31.51 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.021 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.06 122.74 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.25 158.6 42.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 150.84 31.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.999 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -125.49 95.03 4.31 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.33 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.11 -108.44 2.35 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.276 -171.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -104.36 5.54 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.643 0.377 . . . . 0.0 111.323 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.97 133.11 49.48 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.401 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 111.75 24.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.233 0.539 . . . . 0.0 110.127 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.0 tp -100.58 112.95 25.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.038 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.7 t -106.86 105.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.483 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -105.42 126.52 52.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.25 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.55 144.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.253 0.549 . . . . 0.0 109.867 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.73 125.86 44.18 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.33 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 43.55 88.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 125.086 1.491 . . . . 0.0 113.732 176.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.869 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -80.93 -26.06 0.42 Allowed Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.011 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -71.05 140.93 38.86 Favored 'Trans proline' 0 C--N 1.377 2.066 0 CA-C-N 122.391 1.89 . . . . 0.0 113.234 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -96.66 134.25 40.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.426 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.543 HG23 ' HA ' ' A' ' 121' ' ' VAL . 25.7 mt -65.06 118.63 7.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.6 -34.88 14.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.93 154.36 27.72 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 110.448 174.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.42 HG23 ' CD1' ' A' ' 114' ' ' LEU . 1.1 mt -112.67 122.96 67.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.127 172.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.496 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -103.38 130.74 50.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.049 -178.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.654 ' HB3' HD22 ' A' ' 102' ' ' ASN . 19.9 m-30 -112.96 134.77 54.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.862 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -142.35 137.17 30.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.435 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.26 76.98 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.636 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.654 HD22 ' HB3' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -89.97 72.35 7.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.644 0.735 . . . . 0.0 110.648 -177.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 12.9 mmmt -86.41 -19.91 28.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.865 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -53.0 6.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.92 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 106' ' ' LYS . 13.2 t -107.45 141.4 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.445 ' N ' HG11 ' A' ' 105' ' ' VAL . 7.9 mttm -68.98 158.11 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 112.608 -171.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.29 95.38 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.243 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.48 -34.76 72.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.721 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.4 82.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.176 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -32.87 74.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.818 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -59.64 -44.8 93.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.372 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.516 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 4.1 tm0? -77.72 -28.53 50.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.36 -45.74 91.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.046 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.42 ' CD1' HG23 ' A' ' 97' ' ' ILE . 18.0 mt -67.95 -36.59 80.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.831 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -59.88 -46.14 90.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.137 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -15.97 61.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.542 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.4 m -90.94 -12.11 37.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.749 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.03 -20.8 19.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.631 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.4 102.41 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.303 0.573 . . . . 0.0 110.762 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.24 173.56 11.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.543 -178.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.543 ' HA ' HG23 ' A' ' 94' ' ' ILE . 65.4 t -69.36 125.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 110.651 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.11 -5.62 61.38 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 4.3 mm-40 -107.14 160.3 15.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.34 138.79 40.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 145.99 24.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.752 -175.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -115.83 103.76 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.649 0.737 . . . . 0.0 110.425 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.53 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.47 -15.3 62.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.562 178.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p -84.11 -20.66 32.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.095 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 p -100.64 3.26 42.37 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.23 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.9 mm -57.5 -41.52 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.768 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.9 -38.01 87.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 111.51 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -33.84 73.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.677 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.92 -44.11 88.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.908 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 92.3 mt-10 -57.28 -51.3 69.91 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.488 175.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.417 ' HA ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -61.95 -34.2 75.68 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.756 0.66 . . . . 0.0 111.758 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.62 86.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.932 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.453 HD23 ' HZ ' ' A' ' 169' ' ' PHE . 9.9 mt -73.87 -36.61 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 134' ' ' GLU . 1.9 pt-20 -72.55 -28.86 63.09 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.4 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.22 -40.84 64.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.269 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -44.3 97.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.13 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.05 90.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.496 0.498 . . . . 0.0 111.278 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -67.08 -33.98 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.188 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.5 m -72.23 -28.75 63.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.899 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.55 -82.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.998 0.427 . . . . 0.0 110.913 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' A' ' 146' ' ' LYS . . . -112.7 20.9 19.74 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-O 118.88 -0.955 . . . . 0.0 113.21 -172.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER 70.02 16.72 7.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.759 1.224 . . . . 0.0 111.064 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -60.42 118.0 5.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.285 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.22 94.66 9.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.595 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.69 143.23 50.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.762 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.56 120.66 39.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 169' ' ' PHE . 17.6 t -98.53 124.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -174.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -129.39 120.31 25.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.301 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.31 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.201 0.524 . . . . 0.0 110.181 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.33 123.56 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.167 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 t -98.61 113.36 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.038 0.447 . . . . 0.0 110.19 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.0 m -106.0 123.54 38.82 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.12 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -88.23 146.11 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.892 2.394 . . . . 0.0 113.138 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -135.26 157.63 76.32 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.6 51.22 3.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.966 2.444 . . . . 0.0 113.932 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.491 ' HB2' HD13 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.33 17.02 2.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.97 176.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 41.7 t30 60.43 37.47 19.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.261 1.029 . . . . 0.0 109.933 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.08 161.39 32.16 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.527 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.4 147.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.64 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -108.92 119.05 38.41 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.476 HD21 HD12 ' A' ' 94' ' ' ILE . 41.2 tp -99.18 115.78 29.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.212 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.496 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -105.56 132.29 51.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.423 0.63 . . . . 0.0 111.194 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.454 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 1.8 mm? -108.84 109.93 21.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.163 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 t -101.34 114.19 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.268 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.453 ' HZ ' HD23 ' A' ' 137' ' ' LEU . 43.6 m-85 -105.51 118.32 36.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.246 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.2 140.18 36.42 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -77.99 -9.4 59.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.769 0.318 . . . . 0.0 110.848 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -169.32 -142.15 3.45 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 t 59.8 68.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.303 0.573 . . . . 0.0 110.836 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.536 0.43 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.946 178.139 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -70.53 140.31 51.79 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.37 47.52 2.78 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -171.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -113.33 154.12 27.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.099 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.13 116.66 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 50' ' ' THR . 0.5 OUTLIER -65.22 114.29 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 121.359 0.6 . . . . 0.0 111.285 -177.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 2.1 mttm -76.99 -39.97 48.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.812 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -156.89 142.26 17.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.217 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.567 HG23 ' HE1' ' A' ' 46' ' ' MET . 91.9 mt -104.26 121.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -115.71 127.56 55.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.516 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.18 146.23 30.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.16 0.505 . . . . 0.0 111.163 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -133.41 156.62 47.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.484 178.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.74 -2.99 57.58 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.716 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.521 HD21 ' HA ' ' A' ' 34' ' ' LEU . 6.2 mt -73.25 155.92 39.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.151 0.5 . . . . 0.0 112.071 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -157.28 -52.48 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.657 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -82.91 -56.63 3.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.874 -178.252 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.4 t -76.98 143.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.582 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.07 157.81 16.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' H ' HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -58.84 -33.52 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.92 -36.95 60.92 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.255 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.591 ' HA ' HD11 ' A' ' 44' ' ' LEU . . . -73.2 -34.05 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.0 110.168 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.09 73.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.843 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.475 ' HA ' ' HE2' ' A' ' 46' ' ' MET . 3.8 mt -60.93 -32.72 72.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.074 0.55 . . . . 0.0 111.811 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.591 HD11 ' HA ' ' A' ' 41' ' ' ALA . 17.6 mt -71.85 -20.39 61.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.98 0.419 . . . . 0.0 111.249 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.578 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -91.73 -10.96 38.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.894 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.567 ' HE1' HG23 ' A' ' 29' ' ' ILE . 53.8 mtm -94.78 135.83 23.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.607 ' HD2' HG21 ' A' ' 62' ' ' THR . 55.2 Cg_endo -71.69 -17.6 29.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.642 2.228 . . . . 0.0 112.725 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 149.56 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.718 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -120.91 176.27 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.896 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.595 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -67.48 136.07 54.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.01 -8.72 59.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.529 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.16 156.23 17.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.93 125.12 34.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.525 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.22 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.308 0.575 . . . . 0.0 111.563 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.81 -177.78 3.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.618 ' HA ' HD11 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -69.55 -25.67 64.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 176.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -65.71 -35.8 81.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.396 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 53.0 m-20 -74.6 -28.9 61.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.908 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.618 HD11 ' HA ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -59.97 -47.0 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 172.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -30.3 68.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.5 m-20 -67.36 -46.53 73.07 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.778 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.607 HG21 ' HD2' ' A' ' 47' ' ' PRO . 2.2 p -62.88 -38.86 92.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.006 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.676 HG13 HG22 ' A' ' 77' ' ' VAL . 28.6 mt -55.81 -54.12 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 123.427 0.454 . . . . 0.0 110.626 176.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 64' ' ' ARG . 9.6 ptm85 -70.23 -31.19 68.48 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -69.48 -44.9 70.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.538 0.208 . . . . 0.0 110.713 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 45' ' ' SER . 58.9 mt -69.94 -30.79 68.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.731 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -37.87 88.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 110.647 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.1 -13.42 61.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 66' ' ' LEU . 19.0 p -79.26 -24.79 42.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.629 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.12 -1.76 73.54 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.432 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -76.34 -47.1 24.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.403 0.621 . . . . 0.0 109.887 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.6 136.3 54.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.29 -18.27 25.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.54 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 24.6 t70 -122.74 134.47 54.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 63' ' ' ILE . 87.4 t -132.7 118.46 34.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.61 116.82 27.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.731 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.676 HG22 HG13 ' A' ' 63' ' ' ILE . 78.9 t -103.9 122.51 56.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 175.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -125.69 148.78 48.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.71 136.91 53.03 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.501 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.22 95.99 4.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.364 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.75 -111.68 4.32 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 40.3 m-20 -106.16 7.01 31.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.976 0.417 . . . . 0.0 110.486 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.47 133.61 48.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.421 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 111.8 24.62 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 3.6 tp -104.32 116.43 32.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.056 0.455 . . . . 0.0 110.752 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.5 110.99 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 6.3 mt-30 -96.65 127.75 42.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.18 162.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 0.0 111.554 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -117.78 106.52 13.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.244 176.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.14 27.29 3.85 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.979 0.895 . . . . 0.0 109.489 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.16 -64.03 0.25 Allowed Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.579 -170.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -89.43 140.82 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.756 1.637 . . . . 0.0 112.241 -173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.461 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 59.8 m -125.19 137.79 54.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.72 HD13 ' HB2' ' A' ' 125' ' ' LEU . 21.7 mt -74.94 120.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.12 -38.59 10.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.063 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.52 143.0 25.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.537 HD13 HG21 ' A' ' 121' ' ' VAL . 2.4 mt -123.13 128.07 74.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 141.56 47.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.47 177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.45 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.9 m-85 -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.619 0.247 . . . . 0.0 111.021 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.0 140.42 42.12 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 169' ' ' PHE . . . 85.39 16.22 64.8 Favored Glycine 0 C--N 1.328 0.113 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.695 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 1.7 p30 -79.47 69.92 5.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.54 0.686 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -83.13 -47.62 11.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.184 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -27.96 24.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 2.2 t -126.66 141.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -68.84 156.72 37.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.139 0.495 . . . . 0.0 111.619 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -33.95 77.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 171.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.845 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -60.99 -39.42 89.57 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 175.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.9 mtp -73.33 -39.04 65.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.218 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -32.62 73.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.242 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.845 ' HE2' ' HA ' ' A' ' 108' ' ' ASP . 7.6 mtmm -57.14 -48.52 78.47 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.591 0.557 . . . . 0.0 111.138 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.1 45.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.415 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.416 ' ND2' HD22 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -63.46 -37.63 88.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.487 ' CD2' HG22 ' A' ' 97' ' ' ILE . 1.1 mp -72.31 -38.38 68.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.921 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.483 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 16.4 mt-10 -62.67 -39.45 93.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.901 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.48 -15.66 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.125 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.595 ' HB2' HG12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -95.0 -16.14 22.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 175.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.16 -37.01 2.37 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.608 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.453 ' H ' HG21 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -88.66 111.53 22.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.267 0.555 . . . . 0.0 111.715 -171.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.543 ' HG3' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.03 171.17 14.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.223 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 97' ' ' ILE . 48.2 t -69.25 127.82 31.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.233 0.54 . . . . 0.0 110.598 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.65 53.26 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.497 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.543 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 1.1 tp10 -89.02 156.72 18.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 122.71 0.404 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.99 134.48 43.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.72 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -114.89 142.85 46.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.227 -177.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.527 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 33.6 t0 -117.58 133.48 55.91 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 110.054 164.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -16.04 62.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.714 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 p -82.47 -26.59 32.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.461 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.527 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -86.52 -11.48 51.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.428 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.466 HD13 HD13 ' A' ' 125' ' ' LEU . 5.9 mm -55.15 -40.13 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.732 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.68 91.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.11 -35.21 76.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.13 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 117' ' ' SER . 3.2 mt -67.41 -40.2 84.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.213 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.421 ' HB3' HG22 ' A' ' 151' ' ' VAL . 41.4 mt-10 -61.1 -40.92 95.57 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.45 96.97 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.869 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.33 -37.23 92.65 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.528 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.444 HD21 ' HZ ' ' A' ' 169' ' ' PHE . 8.2 mt -66.83 -36.81 83.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.752 0.31 . . . . 0.0 110.943 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.718 ' HG3' HG23 ' A' ' 151' ' ' VAL . 2.9 mt-10 -67.2 -39.56 86.37 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.67 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -67.01 -43.35 83.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.07 -44.1 97.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.641 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -38.35 87.08 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.962 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -28.98 65.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m -70.94 -27.58 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.2 -83.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 111.187 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.85 19.77 22.93 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.525 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.87 44.26 13.96 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.734 0.778 . . . . 0.0 110.504 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -80.03 118.66 21.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.935 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 m -89.51 86.36 6.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.003 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.11 144.53 25.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.022 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.3 113.44 25.39 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.718 HG23 ' HG3' ' A' ' 138' ' ' GLU . 24.9 m -101.16 133.0 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.384 0.611 . . . . 0.0 111.519 -169.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 116.69 18.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.574 172.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.6 110.8 22.77 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.386 0.612 . . . . 0.0 109.909 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.65 113.47 36.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.108 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.456 ' H ' HG11 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -105.18 110.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.775 0.798 . . . . 0.0 109.205 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 7.3 m -112.41 116.46 48.54 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.842 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.522 ' HA ' HG13 ' A' ' 163' ' ' VAL . 59.0 Cg_endo -71.79 135.65 26.21 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.624 2.216 . . . . 0.0 112.429 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -100.54 159.03 30.78 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.261 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.33 80.07 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.18 2.586 . . . . 0.0 113.306 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.485 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 1.0 OUTLIER -174.51 -112.31 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.712 0.805 . . . . 0.0 109.188 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.485 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 3.0 t-20 -146.15 9.62 1.12 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.968 0.89 . . . . 0.0 109.842 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.532 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 1.1 mpt_? -117.92 167.36 11.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.868 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.608 HG23 HD23 ' A' ' 125' ' ' LEU . 18.5 m -130.95 159.76 42.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 111.466 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.43 119.13 38.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.444 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.7 tp -108.19 125.95 52.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -123.43 132.27 53.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 111.132 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.45 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 2.7 mm? -108.52 110.87 22.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.011 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.18 112.3 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.331 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.444 ' HZ ' HD21 ' A' ' 137' ' ' LEU . 11.4 m-30 -109.65 127.86 54.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.323 0.582 . . . . 0.0 111.398 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -98.63 135.28 40.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -82.71 15.39 2.65 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.013 0.435 . . . . 0.0 111.668 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.81 14.7 78.17 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.878 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.4 m 39.1 39.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.488 1.515 . . . . 0.0 113.465 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.233 0.221 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.31 178.421 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 69.22 153.93 0.11 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.099 0.96 . . . . 0.0 112.793 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.27 50.06 10.98 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.456 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -104.99 153.18 21.79 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.8 t -87.06 113.84 25.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -72.07 125.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.6 0.714 . . . . 0.0 110.346 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -91.4 -29.66 16.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.974 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.45 137.12 14.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.056 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.4 mt -109.64 121.38 62.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -119.88 127.86 53.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.174 0.511 . . . . 0.0 109.851 -178.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.672 ' HD2' HG11 ' A' ' 39' ' ' VAL . 58.7 m-85 -101.34 149.22 24.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.066 -175.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.73 167.4 21.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.402 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.15 -44.47 3.34 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.27 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -74.92 159.48 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.626 -177.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -113.52 -65.37 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.877 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -0.82 50.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.801 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 t -84.02 126.47 40.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.73 157.16 16.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.682 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.672 HG11 ' HD2' ' A' ' 31' ' ' PHE . 1.6 m -56.67 -41.85 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 123.857 0.723 . . . . 0.0 112.151 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.417 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.27 -34.16 55.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.573 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.75 -34.43 64.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.135 0.493 . . . . 0.0 110.953 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . . . -76.32 -33.81 59.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.834 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.84 -31.04 58.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 112.695 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 78.4 mt -66.56 -18.95 65.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.595 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -93.77 -8.45 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.695 0.284 . . . . 0.0 110.823 176.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.473 ' SD ' ' HZ ' ' A' ' 31' ' ' PHE . 36.7 mtp -93.23 136.6 24.25 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.613 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.696 ' HD2' HG21 ' A' ' 62' ' ' THR . 3.0 Cg_exo -78.41 6.56 4.69 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.069 2.513 . . . . 0.0 112.597 174.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.8 156.64 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 20.2 mtp85 -132.47 176.6 8.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.423 0.63 . . . . 0.0 112.114 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.9 p -67.84 120.49 14.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.883 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.31 44.94 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.095 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.4 OUTLIER -77.72 156.27 30.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.147 0.499 . . . . 0.0 111.573 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.67 117.01 30.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.16 129.07 73.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 112.283 -168.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.447 ' O ' HD11 ' A' ' 59' ' ' ILE . 2.0 p30 -100.14 -175.96 3.09 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.72 172.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.46 -26.21 68.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.966 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.33 -34.02 70.17 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.52 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -74.33 -29.7 61.71 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.427 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.631 HG13 HG13 ' A' ' 77' ' ' VAL . 1.2 mp -67.27 -44.85 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.478 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 p -71.0 -29.62 65.63 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 110.568 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.9 -45.73 73.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.696 HG21 ' HD2' ' A' ' 47' ' ' PRO . 2.2 p -63.74 -39.49 94.4 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.673 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 77' ' ' VAL . 28.9 mt -56.04 -50.68 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 123.364 0.415 . . . . 0.0 110.326 174.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 mtt85 -65.04 -36.63 84.96 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.545 0.528 . . . . 0.0 111.985 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 45' ' ' SER . . . -65.67 -48.76 71.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.068 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.595 HD22 ' HB2' ' A' ' 45' ' ' SER . 29.3 mt -70.71 -30.78 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.46 -36.25 78.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 110.724 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.05 -13.59 61.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.208 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 66' ' ' LEU . 19.0 p -78.77 -25.06 44.37 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.435 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.38 21.04 72.07 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.639 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -85.56 -23.89 27.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.7 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.12 176.76 7.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.575 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 3.6 mm-40 -97.16 -23.42 16.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.664 0.268 . . . . 0.0 111.521 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.762 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 3.6 t70 -155.67 145.0 20.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.5 119.07 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.431 ' HG3' HD13 ' A' ' 78' ' ' LEU . 2.6 ptp180 -121.01 124.96 46.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.306 0.574 . . . . 0.0 110.997 172.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.634 HG21 HG12 ' A' ' 86' ' ' VAL . 90.5 t -101.3 123.35 54.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 175.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.431 HD13 ' HG3' ' A' ' 76' ' ' ARG . 1.1 mp -128.07 158.01 39.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 145.78 47.62 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.386 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -128.03 96.09 4.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.7 -110.14 3.31 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.54 13.77 23.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.38 132.18 50.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.802 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 111.58 24.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.035 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 4.2 tp -105.11 112.75 25.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.634 HG12 HG21 ' A' ' 77' ' ' VAL . 18.3 t -108.58 106.75 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.08 159.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.835 0.35 . . . . 0.0 110.381 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.762 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 3.3 tptm -102.86 151.66 22.18 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.501 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' CD ' ' HE ' ' A' ' 127' ' ' ARG . 0.5 OUTLIER -25.94 128.3 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 O-C-N 125.957 2.036 . . . . 0.0 114.778 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.596 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 51.4 mtp85 -61.71 -49.91 84.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.476 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 91' ' ' ARG . 16.8 Cg_exo -69.49 140.51 43.86 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 121.505 1.47 . . . . 0.0 112.347 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.7 m -102.58 139.77 37.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.161 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.4 mt -62.15 118.86 5.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.01 -25.41 11.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.14 0.495 . . . . 0.0 110.554 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -147.96 138.56 23.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.655 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.89 120.51 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.646 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 2.3 m -118.85 143.12 47.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.985 0.421 . . . . 0.0 111.006 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.794 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -121.75 135.93 54.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.497 -172.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.3 m -147.24 119.78 8.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.66 -7.96 39.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.791 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.488 ' OD1' ' HB3' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -81.11 83.88 6.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 110.937 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -85.92 -29.52 23.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.841 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -66.35 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.518 -175.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.508 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 15.1 t -90.47 142.52 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -69.74 146.48 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.07 0.462 . . . . 0.0 111.814 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.532 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 4.5 p30 -63.86 -33.01 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.206 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.58 -40.02 95.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.5 mtp -67.96 -40.32 83.23 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.381 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.03 -36.07 82.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.841 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.794 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 15.6 mttt -58.92 -46.1 88.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.816 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 3.0 tp60 -76.66 -27.98 55.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.288 -177.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.36 -49.95 71.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.69 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.44 -34.96 79.1 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.977 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -60.46 -42.47 96.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.437 178.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.03 -15.56 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.686 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.9 m -88.08 -16.58 33.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.51 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.35 -15.21 22.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.112 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.513 ' H ' HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -94.46 103.73 15.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.241 0.543 . . . . 0.0 110.162 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HG2' ' HA ' ' A' ' 115' ' ' GLU . 12.3 mtm180 -134.34 172.15 13.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.203 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.87 123.64 28.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 110.206 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.25 71.2 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.004 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 159.77 15.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 120.895 0.378 . . . . 0.0 110.81 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -66.33 142.93 57.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.925 170.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.48 148.23 22.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.087 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.72 98.1 6.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.459 0.647 . . . . 0.0 110.516 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.53 ' HD3' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.49 -14.83 62.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.56 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.53 HG21 ' HD3' ' A' ' 127' ' ' ARG . 3.2 p -85.08 -23.02 28.7 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.299 -0.251 . . . . 0.0 111.172 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 p -100.24 5.53 44.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.47 ' HA ' HD11 ' A' ' 130' ' ' ILE . 7.0 mm -57.64 -42.78 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . . . -64.86 -38.09 89.81 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.803 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 -27.46 63.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.779 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 130' ' ' ILE . 11.2 mt -67.45 -44.99 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.416 ' OE2' ' HA ' ' A' ' 131' ' ' ALA . 35.5 mt-10 -61.37 -47.77 84.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.241 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.51 82.2 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.959 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.02 -30.43 63.25 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.891 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.5 mt -76.11 -32.61 59.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.689 0.244 . . . . 0.0 110.741 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.819 ' HG3' HG22 ' A' ' 151' ' ' VAL . 6.5 mt-10 -64.98 -39.52 93.6 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 173.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -66.47 -43.56 85.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.599 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -62.37 -33.4 74.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.17 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -71.34 -44.41 65.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.139 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -30.22 66.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -173.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -28.85 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.469 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.58 -84.77 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.48 19.62 23.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.98 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? 62.56 52.55 2.88 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.446 0.641 . . . . 0.0 109.65 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -88.8 105.41 17.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.048 -173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.806 ' HB2' HG22 ' A' ' 173' ' ' VAL . 0.5 OUTLIER -91.08 121.57 32.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.308 175.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.49 162.69 40.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.06 114.47 27.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.819 HG22 ' HG3' ' A' ' 138' ' ' GLU . 23.3 t -96.67 123.1 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.036 0.446 . . . . 0.0 110.812 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -124.71 117.7 24.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 167' ' ' LEU . . . -97.78 111.62 23.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.37 133.05 61.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.03 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.446 ' H ' HG21 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -102.26 123.04 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.274 0.559 . . . . 0.0 110.43 178.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.3 m -104.37 119.83 52.66 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.158 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 131.05 11.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 112.583 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.553 HD13 ' HB2' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -123.1 155.67 64.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.388 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.96 56.26 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.831 2.354 . . . . 0.0 113.879 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.495 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -144.32 19.37 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 177.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 38.5 t30 60.21 38.55 20.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 122.185 0.993 . . . . 0.0 109.247 -173.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.553 ' HB2' HD13 ' A' ' 158' ' ' LEU . 7.3 mmt180 -130.28 160.62 33.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.143 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.74 148.64 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.986 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.25 122.26 46.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.91 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.3 tp -96.13 110.39 22.67 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.646 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -113.22 132.06 55.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.792 0.806 . . . . 0.0 111.426 -175.428 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -107.78 110.69 22.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.445 -176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.93 111.05 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.448 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.93 117.43 34.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -111.19 116.23 30.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.373 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.39 153.45 35.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.835 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 144.31 48.67 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.994 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 148' ' ' SER . 0.3 OUTLIER -127.88 161.87 35.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.915 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 60.68 93.79 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.152 0.977 . . . . 0.0 110.03 -173.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.95 41.39 4.08 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -166.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -110.4 153.11 25.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.973 -0.613 . . . . 0.0 109.972 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -79.68 113.32 18.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 84' ' ' LEU . 3.2 t -73.79 125.49 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.49 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -85.54 -31.5 22.68 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.671 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -157.63 147.01 19.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.245 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.435 HD11 ' HG ' ' A' ' 43' ' ' LEU . 56.8 mt -109.9 120.14 60.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -107.77 127.03 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.941 -176.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.66 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 1.8 m-85 -105.11 120.13 40.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -177.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 52.8 mm-40 -103.64 66.18 0.85 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.665 0.745 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.18 -75.37 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.945 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.66 ' HG ' ' HB3' ' A' ' 31' ' ' PHE . 38.2 mt 50.56 71.48 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.482 0.713 . . . . 0.0 112.659 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.666 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -91.31 91.47 8.18 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.723 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 36' ' ' ARG . 3.8 mmt85 75.12 -21.89 0.28 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.683 1.193 . . . . 0.0 112.942 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.407 ' O ' HD21 ' A' ' 34' ' ' LEU . 4.8 t -97.73 120.19 46.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.32 158.1 30.35 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.528 0.517 . . . . 0.0 111.6 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -40.49 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.16 -41.77 94.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.145 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.14 68.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.826 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.3 81.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.435 ' HG ' HD11 ' A' ' 29' ' ' ILE . 4.7 mp -63.85 -31.61 72.84 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.932 0.493 . . . . 0.0 111.186 175.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.4 mt -74.55 -13.21 60.64 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.585 ' HB2' HD22 ' A' ' 66' ' ' LEU . 1.2 m -96.01 -8.19 34.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.15 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.604 ' HE1' HG22 ' A' ' 62' ' ' THR . 62.9 mtp -91.5 148.96 38.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.419 175.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 7.2 Cg_exo -75.0 -10.85 21.39 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.671 2.247 . . . . 0.0 112.212 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.634 ' HB ' HG13 ' A' ' 54' ' ' VAL . 9.4 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.175 -175.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -133.76 177.96 7.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.2 p -66.27 131.29 45.78 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.221 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.68 -7.4 65.49 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.51 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -97.7 156.05 16.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 111.003 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.27 124.04 34.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.717 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.634 HG13 ' HB ' ' A' ' 48' ' ' VAL . 1.1 m -129.32 135.84 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.11 0.481 . . . . 0.0 110.864 -171.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -98.51 -178.75 4.11 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.13 -36.88 85.64 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.37 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.04 -29.2 68.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.067 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 17.7 m-20 -73.75 -29.81 62.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.077 0.151 . . . . 0.0 110.866 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.99 -50.71 78.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 171.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.582 ' HA ' HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -66.07 -29.26 69.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.623 176.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 0.6 OUTLIER -69.58 -41.03 76.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.989 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.604 HG22 ' HE1' ' A' ' 46' ' ' MET . 85.2 m -58.61 -46.92 86.0 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.941 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.713 ' HA ' HG13 ' A' ' 75' ' ' VAL . 66.6 mt -52.83 -55.38 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.682 0.614 . . . . 0.0 110.854 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.59 -29.41 66.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.434 -174.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 69' ' ' THR . . . -67.66 -54.82 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 45' ' ' SER . 30.2 mt -62.54 -30.81 71.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.343 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -46.2 83.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.69 60.1 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 45' ' ' SER . 82.2 p -79.91 -24.13 41.31 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.821 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.07 78.56 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.067 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -82.74 -36.33 25.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.102 0.477 . . . . 0.0 110.383 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.511 ' HE1' HD23 ' A' ' 66' ' ' LEU . 22.6 m-85 -129.72 164.36 24.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.516 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.726 ' HB2' ' HB3' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -77.72 -50.99 11.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.447 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -133.49 144.05 49.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.392 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.713 HG13 ' HA ' ' A' ' 63' ' ' ILE . 24.4 t -128.28 120.68 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -174.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -114.26 118.43 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.801 174.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.3 t -112.42 123.08 67.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.017 0.437 . . . . 0.0 109.934 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.75 159.03 43.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -96.06 141.85 28.96 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.075 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -136.65 93.66 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.96 -109.31 2.79 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.143 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 11.88 20.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.74 141.78 35.49 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.419 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.449 ' HB2' HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -102.1 111.28 23.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 30' ' ' HIS . 0.8 OUTLIER -93.02 111.63 23.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.51 -174.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 5.0 t -114.1 103.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.459 0.647 . . . . 0.0 109.905 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.591 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.83 127.13 44.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 150.41 30.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.512 ' HD3' ' HG2' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -99.39 139.0 35.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.176 -172.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.666 ' HA ' ' HG2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -54.18 141.06 30.44 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.633 173.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.726 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -128.61 69.46 79.47 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.403 178.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 19.1 Cg_endo -60.76 138.86 82.19 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.78 1.653 . . . . 0.0 111.007 172.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.869 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 17.1 m -84.47 125.51 32.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.339 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.2 mt -66.08 116.58 5.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.7 -38.43 10.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.927 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.54 138.66 26.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.41 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.03 122.12 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.542 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -118.87 134.59 55.06 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.243 -173.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 24.0 m-85 -116.65 135.38 53.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -170.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.4 m -139.87 110.92 6.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.291 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.44 47.1 0.26 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.857 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -83.16 77.44 9.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.136 0.493 . . . . 0.0 110.553 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.35 -37.48 19.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.918 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.8 m -141.6 -58.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.886 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -75.05 126.01 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -74.31 159.75 32.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.432 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -34.68 78.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.554 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.0 -38.33 90.68 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.9 mtp -70.98 -39.14 72.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -37.76 88.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.38 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 31.1 mttt -60.75 -44.01 97.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 110.937 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 13.8 tt0 -77.66 -27.68 50.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.338 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -66.86 -43.52 83.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.223 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -34.0 76.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.802 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -63.36 -38.14 90.0 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -18.32 61.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.436 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.8 m -91.48 -13.87 31.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.546 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.37 -14.63 50.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.9 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.09 103.57 14.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.199 0.523 . . . . 0.0 110.242 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.04 174.92 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.747 -176.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.77 125.16 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.425 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.67 -28.22 16.4 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.786 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.492 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -86.02 163.88 17.69 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 122.683 0.393 . . . . 0.0 110.413 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.41 156.2 19.69 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.508 HD21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -113.79 138.75 49.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.018 0.437 . . . . 0.0 111.126 -176.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.636 ' HB3' ' HG1' ' A' ' 129' ' ' THR . 12.7 t0 -100.1 115.04 28.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.573 0.701 . . . . 0.0 110.529 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.457 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -72.31 -16.22 61.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.44 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.1 p -85.64 -24.0 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.082 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.636 ' HG1' ' HB3' ' A' ' 126' ' ' ASP . 20.3 p -90.75 2.76 55.73 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.603 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 mm -56.98 -37.54 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.398 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.19 99.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.815 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 -39.2 78.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.142 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.549 HG21 HD13 ' A' ' 137' ' ' LEU . 14.4 mt -64.2 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.227 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HB3' HG22 ' A' ' 151' ' ' VAL . 37.4 mt-10 -59.29 -45.55 90.98 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.024 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -37.16 86.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.49 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.59 -34.12 72.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.629 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.558 HD12 HD13 ' A' ' 167' ' ' LEU . 5.0 mt -69.91 -35.95 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.55 0.175 . . . . 0.0 111.352 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.477 ' HG3' HG23 ' A' ' 151' ' ' VAL . 8.5 mt-10 -64.04 -36.71 84.88 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 110.116 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.59 -37.13 79.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.016 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -45.0 94.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.396 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -39.1 92.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.012 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -29.44 66.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.199 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.4 m -70.35 -27.09 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.445 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.1 t -73.94 -88.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.445 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.23 18.79 25.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.104 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt 65.9 44.66 2.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.492 0.717 . . . . 0.0 110.321 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -78.55 113.72 16.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.775 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.46 99.98 11.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.483 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.39 147.5 44.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.338 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.01 136.01 39.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.6 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 134' ' ' GLU . 2.2 m -97.76 132.21 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.406 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 115.41 16.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.365 169.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.42 111.18 22.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.83 123.34 57.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.516 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.434 ' H ' HG21 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -99.71 114.61 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 110.17 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.47 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 6.9 m -113.62 119.35 41.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.12 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.5 Cg_endo -86.23 139.55 6.15 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.255 2.637 . . . . 0.0 112.615 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -114.88 142.03 27.77 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.08 93.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 114.348 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.41 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.3 OUTLIER 176.3 -92.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.603 1.161 . . . . 0.0 108.391 175.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.41 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 13.4 p-10 -165.3 28.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 109.137 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.869 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -123.02 164.2 19.02 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.64 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.508 HG12 HD21 ' A' ' 125' ' ' LEU . 9.4 p -137.3 147.74 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.395 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.28 123.07 48.67 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.1 tp -102.24 114.35 28.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.542 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -110.21 131.09 55.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.884 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.558 HD13 HD12 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -109.03 112.89 25.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.56 -176.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.848 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.57 117.64 34.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.303 0.573 . . . . 0.0 110.33 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -98.38 140.82 32.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.53 48.46 0.94 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.057 0.456 . . . . 0.0 109.884 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.47 -70.21 1.35 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.683 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.46 145.03 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.711 0.291 . . . . 0.0 110.901 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.324 -0.532 0 CA-C-O 120.928 0.394 . . . . 0.0 111.488 -177.814 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.136 0.493 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.09 154.16 35.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.76 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.09 43.33 26.74 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -111.14 153.86 25.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.67 113.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.29 121.42 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.438 0.637 . . . . 0.0 110.791 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -84.37 -26.13 28.62 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.154 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -158.44 154.01 26.15 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.432 ' CD1' HD22 ' A' ' 43' ' ' LEU . 86.9 mt -125.59 128.09 72.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.375 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.94 133.24 55.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.309 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.408 ' CD1' HD22 ' A' ' 34' ' ' LEU . 10.5 m-85 -118.47 135.15 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -113.6 -58.49 2.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.28 -4.95 90.37 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 -164.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -75.26 156.49 35.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.804 0.811 . . . . 0.0 112.525 -177.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -135.35 122.29 21.25 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.375 -1.284 . . . . 0.0 107.627 174.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER 83.17 -28.23 0.1 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.877 1.271 . . . . 0.0 111.176 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 t -79.54 122.82 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.981 0.42 . . . . 0.0 110.172 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.99 157.35 15.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.099 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 m -62.1 -29.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 O-C-N 123.647 0.592 . . . . 0.0 112.361 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.65 -40.47 85.75 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.687 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.48 -36.22 63.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.34 0.591 . . . . 0.0 110.357 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.58 87.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.91 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' A' ' 29' ' ' ILE . 4.0 mt -58.74 -33.9 70.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.922 0.489 . . . . 0.0 112.207 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.4 mt -74.15 -15.14 61.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.008 0.432 . . . . 0.0 111.335 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.464 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -92.01 -20.92 20.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.245 176.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.539 ' HE2' HG22 ' A' ' 62' ' ' THR . 91.0 mtp -81.75 146.04 55.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.259 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.569 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 6.1 Cg_exo -80.25 9.09 3.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.011 2.474 . . . . 0.0 112.458 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 154.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.6 mtm105 -130.63 173.73 10.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 111.275 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.407 HG21 HD13 ' A' ' 29' ' ' ILE . 16.8 p -67.64 124.58 23.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.416 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -10.36 57.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.864 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.7 156.57 16.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 0.0 110.208 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.09 130.39 35.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG12 HG23 ' A' ' 26' ' ' VAL . 17.3 m -121.67 127.16 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.169 0.509 . . . . 0.0 110.912 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -97.31 179.38 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.399 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' HA ' HD11 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -68.87 -30.83 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.241 0.543 . . . . 0.0 109.65 175.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.58 -33.42 75.87 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.495 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.96 -31.04 61.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -61.6 -50.76 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.695 ' HA ' HD13 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -69.64 -29.99 67.6 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.637 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.569 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 1.2 m-80 -72.22 -36.71 69.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.618 177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.539 HG22 ' HE2' ' A' ' 46' ' ' MET . 74.5 m -60.48 -44.16 96.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.233 0.333 . . . . 0.0 110.273 171.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.763 ' HA ' HG13 ' A' ' 75' ' ' VAL . 32.1 mt -54.34 -53.02 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 123.351 0.407 . . . . 0.0 110.618 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 64' ' ' ARG . 1.2 tpt180 -65.72 -38.22 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -66.45 -48.14 70.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.632 HD11 HG12 ' A' ' 75' ' ' VAL . 86.4 mt -67.52 -29.92 69.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.15 99.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 110.081 172.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.12 -13.46 61.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.677 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 66' ' ' LEU . 30.2 p -78.93 -24.74 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.902 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.6 73.05 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.607 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -73.47 -44.13 58.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 109.99 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' HE1' ' HB3' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -124.03 154.83 39.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.692 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.685 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 5.3 mm-40 -72.1 -51.27 22.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.622 0.576 . . . . 0.0 111.956 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -129.61 146.42 51.41 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.77 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.763 HG13 ' HA ' ' A' ' 63' ' ' ILE . 38.4 t -127.86 120.64 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.19 116.9 27.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.564 HG22 HG13 ' A' ' 63' ' ' ILE . 60.0 t -104.81 130.78 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.49 158.61 39.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -117.99 129.52 55.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.421 0.629 . . . . 0.0 110.404 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.2 95.86 4.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.695 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.34 -109.9 3.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.507 -174.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.31 14.38 19.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.372 0.606 . . . . 0.0 109.933 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.83 139.69 40.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.735 ' HB2' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -106.08 114.13 28.09 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.001 177.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -106.87 123.43 48.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 110.518 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -118.66 118.38 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.34 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -109.62 132.8 53.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 m -125.56 162.46 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.218 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -98.37 110.52 23.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 0.3 OUTLIER -157.83 163.01 38.43 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.815 -173.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 43.6 mtp85 117.2 -57.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 126.476 2.36 . . . . 0.0 111.961 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 68.3 Cg_endo -73.41 139.41 28.75 Favored 'Trans proline' 0 C--N 1.362 1.265 0 CA-C-N 120.605 1.252 . . . . 0.0 112.308 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 45.3 m -124.87 133.31 53.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.616 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.725 HD13 ' HB2' ' A' ' 125' ' ' LEU . 30.0 mt -68.61 117.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.2 -26.75 16.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.68 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.27 138.54 18.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.173 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 120' ' ' ARG . 0.6 OUTLIER -109.23 121.38 62.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.84 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.3 OUTLIER -113.14 133.46 55.02 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.412 -175.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.697 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.2 m-85 -112.11 135.07 53.23 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.838 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.68 118.07 8.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.223 -173.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.07 18.34 56.03 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.334 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.534 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -85.15 93.39 8.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.589 . . . . 0.0 110.843 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.677 ' H ' ' HD2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -85.52 -46.09 11.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.251 -179.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.2 -77.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.062 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.63 125.64 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -71.01 157.82 37.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.592 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -36.55 76.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.952 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 4.3 t0 -62.5 -38.47 90.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.481 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtt -73.34 -35.67 66.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -32.89 74.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.593 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.697 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -56.7 -44.84 81.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 176.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -28.3 53.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.388 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.66 -43.17 90.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.499 HD11 HG22 ' A' ' 119' ' ' VAL . 1.4 mm? -67.72 -35.83 79.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.781 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.85 -35.51 80.86 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.52 -23.09 58.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.874 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -17.82 31.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 0.0 110.199 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.05 -14.15 31.37 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.13 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.5 HG23 HD12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -100.62 102.54 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.4 0.619 . . . . 0.0 110.604 -174.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HA ' HD12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -143.74 176.45 9.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.128 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.29 127.42 28.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.374 0.607 . . . . 0.0 110.556 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.48 -10.28 62.96 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.925 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -111.45 166.09 11.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.685 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 1.4 m -75.72 162.34 28.3 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.266 177.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.725 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -132.18 145.15 51.16 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.512 0.196 . . . . 0.0 110.891 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -109.72 122.05 46.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.621 0.724 . . . . 0.0 111.319 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -73.02 -15.7 61.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.211 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.5 p -90.09 -17.25 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.1 m -84.32 -13.64 51.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.279 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HA ' HD11 ' A' ' 130' ' ' ILE . 6.5 mm -54.16 -40.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.065 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.71 99.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.012 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.93 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 119' ' ' VAL . 52.0 mt -62.22 -46.76 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.942 0.401 . . . . 0.0 110.12 174.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.93 -49.83 74.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.309 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -65.3 -33.3 75.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.587 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.455 ' N ' ' HG3' ' A' ' 135' ' ' LYS . . . -68.09 -41.79 86.12 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.309 -0.472 . . . . 0.0 111.987 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.28 -33.0 72.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.404 0.145 . . . . 0.0 111.278 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -36.72 80.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.063 0.458 . . . . 0.0 110.683 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.13 -44.84 78.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.324 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -38.27 90.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.415 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.534 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -60.39 -43.53 96.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.209 0.528 . . . . 0.0 110.766 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -29.38 65.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.648 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.8 m -66.13 -28.16 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.738 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.3 t -78.28 -96.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 110.312 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -103.95 19.84 42.7 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.266 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.7 56.67 1.51 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -87.28 96.47 10.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.987 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.67 101.68 5.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.749 173.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.59 156.3 43.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.376 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.12 113.69 25.66 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.3 p -106.71 127.14 62.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.959 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.97 117.81 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.054 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.99 110.16 21.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.56 126.63 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.79 -173.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.574 HG11 HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -106.05 112.33 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.191 175.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.5 m -104.82 117.57 58.48 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.855 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.04 141.26 20.83 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.258 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.79 154.81 48.16 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.474 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 22.2 Cg_exo -66.5 76.96 0.36 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.549 2.833 . . . . 0.0 113.523 -176.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -167.39 -115.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 15.6 p-10 -144.11 27.35 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.099 0.952 . . . . 0.0 108.512 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.432 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 11.9 mmt180 -122.59 155.1 37.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.641 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.559 HG22 HD23 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -134.18 157.59 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.6 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -109.93 122.95 48.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.317 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.574 HD11 HG11 ' A' ' 155' ' ' VAL . 55.0 tp -106.6 116.41 31.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.84 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 12.4 tttt -119.22 132.77 55.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.436 ' N ' HD21 ' A' ' 167' ' ' LEU . 4.2 mm? -103.06 110.58 22.56 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.216 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 15.2 t -99.78 116.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.656 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.66 118.28 36.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.974 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -74.05 144.2 45.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.661 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.62 -44.67 26.9 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -172.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 154.79 -29.15 0.67 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.968 -1.111 . . . . 0.0 113.135 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 37.6 t 69.47 -78.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.691 0.796 . . . . 0.0 111.267 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.158 0.504 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -83.33 152.07 25.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.44 47.29 8.21 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -171.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.594 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 6.5 p90 -107.49 153.27 23.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.876 -0.662 . . . . 0.0 110.219 -175.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.46 112.39 17.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.92 125.39 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.01 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -41.3 10.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.722 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.89 148.55 30.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.598 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.446 ' CD1' HD22 ' A' ' 43' ' ' LEU . 51.1 mt -116.51 124.59 72.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.39 127.55 47.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.652 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 3.6 m-85 -101.92 115.8 31.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.09 65.14 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.803 0.811 . . . . 0.0 110.733 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.84 -87.49 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.519 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' A' ' 31' ' ' PHE . 18.6 mt 54.33 -165.47 0.09 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.898 0.879 . . . . 0.0 113.292 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.456 ' OE1' ' HD3' ' A' ' 92' ' ' PRO . 0.8 OUTLIER -175.13 -101.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.947 176.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.446 ' H ' ' HB3' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -98.14 -1.59 41.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.012 0.434 . . . . 0.0 110.603 176.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.21 132.55 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.41 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.16 157.44 15.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.472 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' H ' HG21 ' A' ' 39' ' ' VAL . 1.5 m -58.91 -30.99 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 123.779 0.674 . . . . 0.0 112.205 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.94 -35.08 61.64 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.354 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HA ' HD13 ' A' ' 44' ' ' LEU . . . -76.25 -36.11 58.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.001 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.78 88.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.855 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -54.97 -32.33 61.48 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.091 0.957 . . . . 0.0 113.088 174.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 41' ' ' ALA . 51.1 mt -70.98 -15.78 62.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.477 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -100.23 -8.39 23.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.546 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.7 mtp -94.55 137.19 22.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.188 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.57 34.39 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.991 2.461 . . . . 0.0 112.255 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.687 ' HB ' HG12 ' A' ' 54' ' ' VAL . 1.5 p -155.39 146.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.24 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.455 ' N ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -133.37 176.68 8.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.3 p -67.11 121.2 15.08 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.84 0.352 . . . . 0.0 110.17 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.44 47.99 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.456 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -82.84 156.48 23.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.619 0.247 . . . . 0.0 110.987 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -112.78 112.03 23.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.18 178.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.687 HG12 ' HB ' ' A' ' 48' ' ' VAL . 2.6 m -126.24 132.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.184 0.516 . . . . 0.0 112.343 -171.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -86.14 -177.27 6.23 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.067 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -61.16 -35.42 77.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.984 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -62.93 -37.44 87.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.203 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.751 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 1.3 m-20 -75.85 -29.04 58.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.585 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -47.4 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 171.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.644 ' HA ' HD11 ' A' ' 63' ' ' ILE . 3.7 m -68.76 -30.05 68.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.389 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.751 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 8.9 m-20 -63.75 -45.32 90.38 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 109.825 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.7 m -58.48 -43.88 89.13 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.095 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 60' ' ' SER . 65.2 mt -55.81 -50.9 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 123.39 0.431 . . . . 0.0 110.872 176.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -66.28 -36.03 81.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.89 -45.33 74.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.795 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.599 ' HA ' HG22 ' A' ' 69' ' ' THR . 83.9 mt -71.01 -29.03 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -39.5 92.66 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.231 0.539 . . . . 0.0 110.538 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.88 -9.48 58.4 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.406 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 66' ' ' LEU . 71.0 p -76.68 -20.16 56.94 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -170.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.47 21.27 75.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.943 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -105.01 -89.28 0.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.07 135.1 34.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.418 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.783 ' HB3' ' HB2' ' A' ' 124' ' ' SER . 0.1 OUTLIER -77.63 -30.01 52.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.775 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 11.8 t70 -123.42 135.43 54.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.667 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 88' ' ' VAL . 64.2 t -132.51 118.46 35.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.567 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -120.37 120.61 36.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.389 0.614 . . . . 0.0 110.051 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.1 t -105.19 123.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.29 137.7 51.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -88.0 110.12 20.35 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.49 95.22 5.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.55 -120.89 20.85 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -104.42 12.94 32.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.255 0.55 . . . . 0.0 109.963 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.89 141.71 35.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.791 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD13 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.02 110.87 22.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.08 112.42 24.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.199 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.16 105.79 19.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.425 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.93 131.44 42.28 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 75' ' ' VAL . 3.5 m -125.73 149.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.775 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -114.89 124.11 50.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.936 -176.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 47.7 90.6 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.722 1.264 . . . . 0.0 113.85 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.468 ' HD2' ' OD1' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -71.73 -34.38 3.05 Favored Pre-proline 0 CA--C 1.561 1.37 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 177.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HD3' ' OE1' ' A' ' 35' ' ' GLN . 56.8 Cg_endo -70.06 141.89 45.16 Favored 'Trans proline' 0 C--N 1.372 1.794 0 CA-C-N 121.747 1.66 . . . . 0.0 114.065 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.9 m -91.29 135.81 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 125' ' ' LEU . 34.7 mt -65.58 118.31 7.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.63 -37.04 8.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.312 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.39 144.03 32.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.471 HG22 ' CD2' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -119.39 123.52 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.616 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -103.71 131.27 51.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.516 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' HB3' HD22 ' A' ' 102' ' ' ASN . 20.3 m-85 -109.96 134.92 51.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.161 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.9 123.8 12.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.87 13.19 47.53 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.773 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.474 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -94.59 77.93 3.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.997 -178.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -40.77 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.336 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.9 m -75.97 -61.6 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.266 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.2 140.13 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 4.0 mmtm -70.46 151.95 44.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 111.224 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.5 -35.53 79.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.459 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.89 -34.74 73.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.68 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -65.65 -39.44 91.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 173.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.403 HD23 ' CZ ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -67.28 -32.97 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.369 177.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -41.74 97.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.99 -30.06 55.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -66.62 -40.61 88.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.473 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' CD2' HG22 ' A' ' 97' ' ' ILE . 2.3 mp -69.72 -36.88 76.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.723 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.581 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 1.5 mt-10 -63.34 -37.39 87.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.445 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 m -93.5 -14.53 26.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.024 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.49 -22.09 22.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.924 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.407 ' H ' HG21 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -96.45 104.43 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.355 0.598 . . . . 0.0 111.156 -175.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.581 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.85 173.76 11.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.694 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.78 123.8 23.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.665 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.74 -6.26 58.71 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.888 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.4 158.42 17.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.939 0.399 . . . . 0.0 110.452 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.783 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -80.32 144.08 33.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.478 176.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.23 144.59 25.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.782 0.325 . . . . 0.0 111.585 -172.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.49 106.0 16.3 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.331 0.586 . . . . 0.0 109.729 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.427 ' HD3' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.72 -17.65 62.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.482 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.427 HG21 ' HD3' ' A' ' 127' ' ' ARG . 18.8 p -83.83 -23.25 31.46 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.425 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 p -98.41 2.28 47.7 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.338 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.412 ' HA ' HD11 ' A' ' 130' ' ' ILE . 6.1 mm -58.04 -40.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.844 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.66 83.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.689 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.17 -31.72 68.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.345 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.61 -44.85 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.718 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 138' ' ' GLU . 94.4 mt-10 -59.36 -47.65 84.62 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.651 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -35.68 81.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.147 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.29 -38.04 81.16 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.289 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.58 -39.91 88.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.368 . . . . 0.0 111.282 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 134' ' ' GLU . 84.0 mt-10 -56.14 -43.88 78.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.136 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -31.94 67.21 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -34.62 78.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.163 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.474 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -71.16 -36.0 71.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.752 177.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -71.25 -30.56 66.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.41 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -30.27 63.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.4 p -79.65 -73.27 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.437 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.452 ' HA2' ' CE2' ' A' ' 147' ' ' TYR . . . -113.73 17.72 20.3 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.964 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 61.11 44.5 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 110.559 -173.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.452 ' CE2' ' HA2' ' A' ' 145' ' ' GLY . 66.4 m-85 -88.83 136.14 33.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.243 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.81 128.96 41.92 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.06 143.79 48.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.783 0.325 . . . . 0.0 110.647 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.97 113.68 27.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.68 131.23 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.158 0.504 . . . . 0.0 111.753 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -128.49 117.29 21.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.961 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.525 ' HB3' HD23 ' A' ' 167' ' ' LEU . . . -98.55 112.02 24.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 0.0 110.69 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.82 118.5 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.653 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.63 114.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.7 m -116.11 120.76 34.78 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.646 ' HA ' HG11 ' A' ' 163' ' ' VAL . 74.4 Cg_endo -75.28 147.87 33.5 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.778 2.319 . . . . 0.0 113.155 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.446 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 1.3 pp -117.1 160.48 37.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 158' ' ' LEU . 52.6 Cg_endo -76.11 73.92 4.76 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.712 2.275 . . . . 0.0 114.105 -171.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.446 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.4 OUTLIER -166.73 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.648 173.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.468 ' OD1' ' HD2' ' A' ' 91' ' ' ARG . 2.5 t30 -136.43 25.39 3.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -131.05 161.03 32.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -171.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.646 HG11 ' HA ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -132.74 155.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.085 175.031 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.17 125.52 54.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.151 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.0 tp -108.39 131.51 54.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.59 0.233 . . . . 0.0 110.538 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.616 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 37.8 tttt -122.6 133.55 54.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 0.0 111.261 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 153' ' ' ALA . 0.3 OUTLIER -105.91 109.69 21.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.76 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.64 119.36 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.495 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 60.4 m-85 -109.21 117.8 35.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.807 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -89.85 129.22 36.25 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.84 42.13 0.9 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -169.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.75 -14.81 34.69 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 114.07 172.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.466 HG11 ' N ' ' A' ' 174' ' ' SER . 0.4 OUTLIER 73.82 -40.6 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.679 1.192 . . . . 0.0 112.644 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.466 ' N ' HG11 ' A' ' 173' ' ' VAL . 5.9 m . . . . . 0 C--O 1.233 0.192 0 CA-C-N 117.825 0.284 . . . . 0.0 111.19 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.19 154.54 22.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.139 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.34 46.0 3.13 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.59 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 43.9 p90 -105.95 148.9 27.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.72 113.36 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 84' ' ' LEU . 3.0 p -73.98 133.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.443 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -88.08 -42.92 12.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.56 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -147.21 144.92 29.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.726 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CD1' HD22 ' A' ' 43' ' ' LEU . 63.6 mt -106.86 120.51 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.46 127.45 54.43 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.071 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.656 ' HD2' HG13 ' A' ' 39' ' ' VAL . 78.6 m-85 -107.77 130.5 54.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -42.66 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -172.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.54 -33.34 43.5 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.198 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -96.05 121.62 38.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.877 0.37 . . . . 0.0 110.513 -177.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -107.2 -47.38 3.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.609 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -35.83 73.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.688 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 34' ' ' LEU . 3.6 t -78.44 125.6 38.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.18 157.95 16.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.656 HG13 ' HD2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -51.76 -38.75 22.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.659 -177.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.497 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -73.02 -40.75 50.58 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.683 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.25 78.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.37 72.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.673 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.43 HD22 ' CD1' ' A' ' 29' ' ' ILE . 2.9 mt -57.64 -31.08 65.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.5 mt -62.79 -26.76 68.88 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 111.58 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.14 -13.53 43.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.893 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.537 ' HE2' HG23 ' A' ' 62' ' ' THR . 11.4 mtp -90.26 138.48 27.18 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.481 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.565 ' HD2' HG21 ' A' ' 62' ' ' THR . 94.3 Cg_endo -81.47 16.0 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.882 2.388 . . . . 0.0 113.257 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 52' ' ' ASP . 1.2 p -153.73 147.02 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.537 ' N ' HG21 ' A' ' 48' ' ' VAL . 57.0 mtt85 -123.28 177.7 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.922 0.489 . . . . 0.0 110.458 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 p -65.6 126.5 28.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.411 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.77 -6.66 35.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.452 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.541 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.6 t0 -96.28 158.47 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.459 . . . . 0.0 110.651 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 133.02 34.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.97 128.98 72.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 112.007 -173.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -97.67 -179.63 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.008 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.42 -32.62 74.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 109.838 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 7.5 tp10 -61.29 -37.77 84.37 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.434 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.37 -32.21 62.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.292 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.54 -46.13 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.046 0.451 . . . . 0.0 109.951 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -73.64 -26.88 60.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.254 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -70.76 -45.61 64.47 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.417 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.565 HG21 ' HD2' ' A' ' 47' ' ' PRO . 6.3 p -64.51 -38.58 91.51 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.031 175.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.561 ' HA ' HG13 ' A' ' 75' ' ' VAL . 23.6 mt -55.35 -54.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.486 0.491 . . . . 0.0 110.42 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -70.78 -30.31 66.75 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.27 -46.95 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.661 0.267 . . . . 0.0 110.567 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.663 ' HA ' HG22 ' A' ' 69' ' ' THR . 75.4 mt -71.66 -29.63 64.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -39.25 91.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.558 . . . . 0.0 110.48 173.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.41 -12.35 61.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.117 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 66' ' ' LEU . 21.9 p -78.17 -24.47 47.23 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.978 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.42 7.73 83.01 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.454 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -83.41 -20.61 33.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 165.97 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.702 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 3.4 tm-20 -83.91 -50.49 8.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -136.65 137.72 40.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.817 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.561 HG13 ' HA ' ' A' ' 63' ' ' ILE . 46.6 t -116.79 120.51 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.74 0.305 . . . . 0.0 110.427 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -118.26 118.96 33.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.044 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.477 HG21 HG12 ' A' ' 86' ' ' VAL . 76.5 t -107.9 123.46 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.802 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.99 158.34 41.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.53 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -111.39 141.1 45.37 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.642 178.365 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -126.92 95.8 4.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.85 -109.68 3.02 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 14.28 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.292 0.567 . . . . 0.0 110.048 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.678 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.675 ' HB2' HG22 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -103.46 111.86 24.5 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 tp -101.73 116.74 33.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.477 HG12 HG21 ' A' ' 77' ' ' VAL . 20.4 t -107.69 110.16 30.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.362 0.601 . . . . 0.0 110.491 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -106.16 134.37 49.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.45 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.22 155.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.377 0.608 . . . . 0.0 110.995 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -100.69 133.12 45.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.877 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER 61.97 -167.83 0.2 Allowed 'General case' 0 C--O 1.236 0.375 0 O-C-N 124.266 0.979 . . . . 0.0 113.165 176.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.499 ' H ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -174.54 -45.11 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.328 -175.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.586 ' HB2' HG23 ' A' ' 163' ' ' VAL . 46.0 Cg_endo -69.65 140.68 43.69 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 121.161 1.241 . . . . 0.0 113.396 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.6 m -97.92 144.48 27.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.742 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 mt -69.59 117.98 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.59 -35.18 8.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.883 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -149.14 143.56 26.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.432 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 ' CD1' ' A' ' 114' ' ' LEU . 3.1 mt -117.11 124.04 72.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 172.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -106.16 136.03 46.59 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 -176.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -114.85 135.29 54.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.9 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -142.69 128.35 19.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.739 178.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.68 15.02 62.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.728 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -105.23 63.13 0.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -88.1 -21.87 24.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -51.63 23.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.088 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t -109.38 141.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.89 145.98 53.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.859 0.361 . . . . 0.0 111.577 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.822 ' HA ' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -60.28 -35.59 75.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.76 177.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.1 -45.36 75.46 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.967 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -43.23 77.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.451 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 107' ' ' ASP . 4.2 mt -64.64 -33.28 75.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -44.72 96.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.971 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.491 HE21 ' HB3' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -78.67 -27.95 45.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.896 -178.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.5 -38.63 90.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.057 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.581 HD21 HG22 ' A' ' 119' ' ' VAL . 17.2 mt -66.4 -36.04 81.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.634 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -63.93 -39.45 94.19 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.772 178.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.96 -16.48 60.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.48 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -88.7 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.381 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.81 -25.05 9.79 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.256 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.699 HG23 HD12 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -94.51 104.2 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.877 -175.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.634 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -132.13 168.19 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.792 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -72.07 129.03 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.461 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.63 -6.3 74.08 Favored Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.835 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.98 145.2 40.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.702 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -66.33 143.13 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.328 178.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 146.33 23.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.156 0.503 . . . . 0.0 111.981 -170.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.476 ' CG ' ' HG1' ' A' ' 129' ' ' THR . 12.9 t0 -107.45 96.35 6.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.152 171.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.573 ' HD3' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -71.89 -14.28 61.9 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.472 -178.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.573 HG21 ' HD3' ' A' ' 127' ' ' ARG . 34.2 p -90.53 -28.19 18.67 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.786 0.803 . . . . 0.0 108.897 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.476 ' HG1' ' CG ' ' A' ' 126' ' ' ASP . 1.5 m -95.13 6.4 49.15 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.51 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.469 ' HA ' HD11 ' A' ' 130' ' ' ILE . 2.8 mm -58.35 -35.26 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.006 176.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.31 -35.91 78.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.686 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.22 -38.94 89.13 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.699 HD12 HG23 ' A' ' 119' ' ' VAL . 6.5 mt -67.0 -42.64 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.347 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.9 -48.47 79.78 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.0 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -34.82 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.01 -36.96 91.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.523 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.49 -32.65 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 110.988 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -66.78 -43.05 85.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.614 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -31.43 70.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.771 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.34 -46.51 89.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.624 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.79 -36.46 83.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.824 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.37 -34.41 77.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.87 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.8 m -71.59 -30.08 65.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.76 -86.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.786 0.326 . . . . 0.0 111.294 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.68 18.14 24.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.934 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.6 mttp 60.49 47.2 8.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.548 0.689 . . . . 0.0 109.667 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -74.8 123.47 25.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.731 -175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.72 ' HB2' ' HA3' ' A' ' 172' ' ' GLY . 0.9 OUTLIER -81.64 131.87 35.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.706 177.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -153.33 143.65 22.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.255 0.55 . . . . 0.0 110.975 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.23 114.06 24.73 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 170.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.29 134.48 45.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.546 0.689 . . . . 0.0 112.108 -167.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -130.48 116.54 18.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.244 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.66 111.53 23.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.18 0.514 . . . . 0.0 109.963 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.21 121.7 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.35 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.421 ' H ' HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -99.93 128.0 52.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.505 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.7 m -120.0 121.27 29.72 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.433 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 1.1 Cg_endo -85.72 147.0 9.48 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.407 2.738 . . . . 0.0 113.325 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.07 159.99 27.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.927 172.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.47 65.64 2.21 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.432 2.754 . . . . 0.0 114.121 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.533 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.1 OUTLIER -164.83 -113.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 9.6 p-10 -144.72 53.12 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.565 0.698 . . . . 0.0 110.735 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -143.12 159.91 41.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.456 175.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 92' ' ' PRO . 0.5 OUTLIER -132.33 153.03 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.377 178.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.81 124.96 53.03 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 43.3 tp -104.58 117.45 34.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.555 -172.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.556 ' HD3' ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -104.53 131.52 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.325 0.584 . . . . 0.0 110.809 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.626 HD11 ' HE2' ' A' ' 169' ' ' PHE . 1.2 mm? -106.39 109.74 21.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.288 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.39 111.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.34 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.626 ' HE2' HD11 ' A' ' 167' ' ' LEU . 6.0 m-85 -104.98 118.28 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 19.8 mm-40 -89.63 121.13 31.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -72.2 112.36 8.22 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.653 0.595 . . . . 0.0 110.908 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.72 ' HA3' ' HB2' ' A' ' 148' ' ' SER . . . 92.67 -136.67 13.3 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.644 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.6 t 60.8 -90.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.834 0.854 . . . . 0.0 111.662 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.346 0.594 . . . . 0.0 112.47 -172.591 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.347 0.594 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -140.58 146.9 38.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.789 . . . . 0.0 108.948 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.66 49.02 39.28 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -170.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.425 ' HE2' HG11 ' A' ' 26' ' ' VAL . 51.4 p90 -110.41 154.58 23.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.501 . . . . 0.0 110.715 -174.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.17 117.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.426 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.651 HG13 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.37 122.33 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.51 0.672 . . . . 0.0 110.667 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -95.6 -22.77 17.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.158 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.512 ' HB3' HG21 ' A' ' 83' ' ' THR . 8.0 t70 -152.41 139.06 18.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.969 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.597 HD13 HG21 ' A' ' 50' ' ' THR . 20.8 mt -118.46 123.36 71.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.989 174.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.524 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -121.21 133.2 55.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.188 -177.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -104.95 136.9 43.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.037 0.446 . . . . 0.0 110.802 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 1.7 mt-10 -119.32 70.39 0.84 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.92 -16.9 0.22 Allowed Glycine 0 C--N 1.32 -0.329 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.957 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.702 HD23 ' HB ' ' A' ' 37' ' ' VAL . 7.1 mt -59.59 125.2 22.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.634 0.254 . . . . 0.0 111.03 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.76 29.73 1.52 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.365 -175.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.43 -51.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.225 0.536 . . . . 0.0 109.634 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.702 ' HB ' HD23 ' A' ' 34' ' ' LEU . 3.5 t -79.56 141.22 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.398 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.67 157.91 16.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.692 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -32.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.707 0.63 . . . . 0.0 112.618 -174.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.29 -37.17 63.25 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.227 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.49 66.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.167 0.508 . . . . 0.0 110.428 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.73 72.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 46' ' ' MET . 0.7 OUTLIER -55.88 -32.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.664 0.786 . . . . 0.0 112.811 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' HA ' HD21 ' A' ' 44' ' ' LEU . 97.0 mt -72.06 -14.14 61.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -7.98 38.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.404 ' HG3' ' HA ' ' A' ' 43' ' ' LEU . 1.8 mtm -94.01 133.61 27.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD2' HG21 ' A' ' 62' ' ' THR . 30.6 Cg_endo -64.91 -28.56 58.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.849 2.366 . . . . 0.0 112.653 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.21 149.58 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.158 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.0 177.87 7.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.591 -174.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.597 HG21 HD13 ' A' ' 29' ' ' ILE . 11.4 p -68.22 121.08 15.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.539 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.54 -6.58 52.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.142 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.74 157.05 16.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.932 0.396 . . . . 0.0 110.887 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.06 136.9 32.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.163 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.55 130.23 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.284 0.564 . . . . 0.0 111.244 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -97.77 -177.07 3.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.964 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.445 ' HA ' HD11 ' A' ' 59' ' ' ILE . 8.9 p-10 -63.91 -27.37 69.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.04 -30.98 65.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.564 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.688 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 36.1 m-20 -75.94 -28.83 58.12 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.275 0.23 . . . . 0.0 111.08 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -62.6 -47.47 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 171.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -70.14 -27.63 64.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.688 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.2 m-20 -68.91 -45.26 71.33 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.463 HG21 ' HD2' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -63.32 -40.12 96.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.719 175.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.456 ' HA ' HG13 ' A' ' 75' ' ' VAL . 56.7 mt -55.21 -55.38 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 123.61 0.569 . . . . 0.0 111.128 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -69.26 -31.01 69.26 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.01 -50.38 49.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.44 0.162 . . . . 0.0 110.746 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.572 ' HA ' HG22 ' A' ' 69' ' ' THR . 50.8 mt -68.34 -30.44 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.049 0.452 . . . . 0.0 110.313 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.12 -12.52 61.75 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.122 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.572 HG22 ' HA ' ' A' ' 66' ' ' LEU . 22.3 p -78.89 -22.54 45.78 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.137 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 19.2 76.71 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.351 -0.452 . . . . 0.0 113.138 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -89.76 -28.7 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.606 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 162.34 28.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.816 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -84.73 -37.93 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -140.5 144.6 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.456 HG13 ' HA ' ' A' ' 63' ' ' ILE . 48.3 t -128.63 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 119.53 33.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.361 177.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.11 124.29 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.044 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.0 146.13 47.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -107.76 132.7 53.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.77 95.2 3.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.043 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.95 2.48 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.035 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -106.24 2.1 26.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.006 0.522 . . . . 0.0 110.901 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -106.66 132.91 52.11 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.75 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.651 ' HB2' HG13 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -104.0 113.09 26.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.814 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' A' ' 30' ' ' HIS . 3.5 tp -102.86 112.24 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.406 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.2 t -110.08 106.22 20.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.546 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 6.6 mt-30 -92.91 136.18 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.49 142.87 41.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.126 0.489 . . . . 0.0 110.243 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.676 ' HD3' ' HG2' ' A' ' 90' ' ' GLU . 0.3 OUTLIER -100.26 143.32 30.6 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.915 -175.041 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.676 ' HG2' ' HD3' ' A' ' 89' ' ' LYS . 3.1 mm-40 73.19 -174.03 0.15 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 124.846 1.342 . . . . 0.0 112.261 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.554 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 6.0 ttt180 -171.34 -56.38 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.258 -170.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 91' ' ' ARG . 1.9 Cg_endo -81.29 141.7 12.93 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.815 1.676 . . . . 0.0 113.482 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 5.1 m -97.69 133.51 42.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.2 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.5 mt -71.95 117.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.56 -33.17 11.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.036 0.446 . . . . 0.0 110.555 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -147.26 143.08 27.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.446 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.609 HG23 HD21 ' A' ' 114' ' ' LEU . 1.3 mt -115.65 123.0 70.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.575 ' HB ' ' HE3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -122.42 132.86 54.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.243 0.545 . . . . 0.0 110.773 -175.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.5 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 21.3 m-85 -111.23 135.25 52.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.376 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.73 120.25 18.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.37 29.73 9.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.116 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 1.1 p30 -107.98 63.93 0.62 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.562 0.696 . . . . 0.0 110.566 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -85.16 -17.34 37.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.091 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -93.04 -52.03 4.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 31.7 t -108.03 128.92 63.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 106' ' ' LYS . 11.1 mmmt -69.95 149.4 47.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -170.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -35.13 69.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.729 173.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.78 -43.94 90.56 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.0 mtp -69.1 -41.2 77.76 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.45 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.52 HD13 HG13 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -61.16 -36.72 80.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.861 178.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.413 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -61.59 -46.17 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.135 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -28.73 55.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.172 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.29 -46.87 86.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.261 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.609 HD21 HG23 ' A' ' 97' ' ' ILE . 1.9 mp -66.25 -40.63 90.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.014 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.673 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 7.6 mt-10 -60.32 -42.42 95.57 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.402 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.13 -22.15 60.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.703 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -87.93 -16.86 32.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.73 -24.97 6.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.805 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.441 ' H ' HG21 ' A' ' 119' ' ' VAL . 0.2 OUTLIER -93.99 104.7 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.185 0.517 . . . . 0.0 111.641 -174.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.673 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.66 176.47 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.553 178.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.7 t -68.34 125.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.251 0.548 . . . . 0.0 111.593 -176.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.82 61.93 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.127 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.28 155.26 21.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 110.699 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.21 133.82 42.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -92.22 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.281 0.562 . . . . 0.0 111.061 -173.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -110.01 102.48 11.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.858 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.16 -15.75 62.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.74 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -84.13 -18.37 37.02 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.549 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.51 -0.75 45.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.33 -35.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.499 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.58 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.559 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.21 -28.55 60.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.804 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.29 -43.36 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.957 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.63 -42.01 99.34 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.61 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -41.75 98.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.157 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.62 93.05 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.635 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 18.2 mt -74.09 -32.43 63.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.586 0.231 . . . . 0.0 111.112 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.6 ' HG3' HG23 ' A' ' 151' ' ' VAL . 2.7 mt-10 -65.01 -40.91 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.207 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.51 -39.87 88.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.552 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -43.18 99.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.43 ' CD1' ' HB1' ' A' ' 149' ' ' ALA . 0.2 OUTLIER -65.81 -41.66 91.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.362 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -32.31 66.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.5 m -71.35 -32.25 68.31 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.0 -77.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.647 -175.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.21 17.49 19.29 Favored Glycine 0 N--CA 1.454 -0.107 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.768 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 55.71 58.63 4.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.569 0.699 . . . . 0.0 110.816 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -92.86 111.54 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.5 98.7 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -107.63 145.27 33.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.048 0.451 . . . . 0.0 111.579 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.29 114.14 26.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 171.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 138' ' ' GLU . 34.0 m -102.92 124.58 57.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.15 0.5 . . . . 0.0 111.469 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -130.9 117.02 18.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.492 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.86 112.47 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.427 0.632 . . . . 0.0 110.117 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.26 119.71 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.077 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.424 HG12 HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -99.6 112.14 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 m -104.23 117.42 59.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.533 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.31 137.46 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.2 2.6 . . . . 0.0 113.406 -176.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 1.2 pp -104.82 143.67 27.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 169.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 22.2 Cg_exo -65.28 80.91 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.704 2.936 . . . . 0.0 115.018 -168.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -169.32 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.786 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -163.03 22.64 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.441 0.639 . . . . 0.0 109.944 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.48 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -128.23 155.8 43.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 -174.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.7 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.25 131.74 55.33 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.424 HD11 HG12 ' A' ' 155' ' ' VAL . 21.9 tp -99.55 114.15 26.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.831 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.575 ' HE3' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.524 0.678 . . . . 0.0 111.138 -177.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -110.43 109.54 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.129 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.15 111.76 31.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.115 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.766 -177.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -105.33 114.42 28.59 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.448 ' H ' ' HG3' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -90.15 102.53 15.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.066 0.46 . . . . 0.0 111.909 -170.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.83 -84.03 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.519 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.551 HG21 ' N ' ' A' ' 174' ' ' SER . 1.9 m 62.15 -51.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.203 1.801 . . . . 0.0 113.815 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.551 ' N ' HG21 ' A' ' 173' ' ' VAL . 31.6 m . . . . . 0 N--CA 1.455 -0.203 0 CA-C-N 118.514 0.597 . . . . 0.0 111.32 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.79 0.329 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.31 171.83 7.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.126 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.26 46.72 7.36 Favored Glycine 0 CA--C 1.506 -0.482 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.413 ' HZ ' ' HB2' ' A' ' 79' ' ' ARG . 48.3 p90 -112.55 154.39 26.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.967 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.2 t -77.44 113.52 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 84' ' ' LEU . 2.6 p -76.17 124.1 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.469 0.652 . . . . 0.0 109.952 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HD3' ' HB2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -88.95 -36.66 15.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.642 -176.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -144.31 143.46 31.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.154 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' CD1' HD22 ' A' ' 43' ' ' LEU . 85.2 mt -104.62 121.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -111.32 126.38 54.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -106.15 115.61 30.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.461 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 tt0 -102.68 68.4 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.405 0.622 . . . . 0.0 110.056 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.62 -109.82 0.34 Allowed Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.589 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.657 ' H ' HG21 ' A' ' 88' ' ' VAL . 94.2 mt 56.62 -156.86 0.28 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.495 0.718 . . . . 0.0 112.033 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.98 -82.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.712 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.4 ttm-85 -118.76 11.54 12.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.406 0.622 . . . . 0.0 109.983 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.84 124.2 47.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.699 173.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.12 157.66 19.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.716 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.462 ' H ' HG21 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -60.83 -29.13 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.27 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.93 -35.72 57.91 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.265 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.81 -34.61 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.351 0.596 . . . . 0.0 110.27 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.09 73.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.592 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD22 ' CD1' ' A' ' 29' ' ' ILE . 3.2 mt -60.08 -31.73 70.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.211 0.604 . . . . 0.0 112.073 172.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.24 -21.74 63.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.21 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.486 ' HB2' HD13 ' A' ' 66' ' ' LEU . 1.4 m -88.28 -19.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.036 0.446 . . . . 0.0 110.285 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.457 ' HE2' HG22 ' A' ' 62' ' ' THR . 68.0 mtp -82.65 138.68 43.94 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.853 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 10.8 Cg_exo -73.5 -14.88 24.94 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.931 2.421 . . . . 0.0 112.586 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.3 m -114.93 167.77 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.117 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -129.12 174.24 9.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.918 0.389 . . . . 0.0 110.456 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.1 p -67.96 122.88 19.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.994 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -5.35 44.29 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.059 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.14 155.15 34.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -92.84 113.01 25.17 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.75 127.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.586 -165.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -98.85 -178.09 3.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.312 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -28.98 70.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.05 -44.27 92.97 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.006 175.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.01 -34.83 75.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.227 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.18 -50.96 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 123.153 0.283 . . . . 0.0 110.286 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -67.89 -35.27 78.2 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.436 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -63.79 -45.37 90.03 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.449 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 77' ' ' VAL . 90.5 m -59.01 -42.58 90.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.416 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.2 mt -55.55 -56.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 123.318 0.386 . . . . 0.0 111.223 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 -70.29 -28.46 65.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.05 -52.72 61.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HA ' HG22 ' A' ' 69' ' ' THR . 5.4 mp -67.06 -31.79 72.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.672 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -33.8 76.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.792 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.68 -12.77 61.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.541 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 66' ' ' LEU . 20.4 p -78.73 -24.95 44.59 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.763 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.48 65.43 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.82 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.04 4.68 15.78 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.18 0.49 . . . . 0.0 111.007 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.9 163.91 26.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 166.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HB2' ' CB ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -87.15 -46.01 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 110.192 177.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -129.54 136.82 50.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.423 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.9 117.99 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 119.51 32.83 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 174.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.648 HG21 HG12 ' A' ' 86' ' ' VAL . 54.9 t -111.78 121.08 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.05 136.99 42.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.413 ' HB2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -93.43 136.39 33.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.986 0.422 . . . . 0.0 110.029 178.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -126.61 95.38 4.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.99 -109.52 2.84 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.373 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 15.0 p-10 -106.21 10.96 31.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.164 0.507 . . . . 0.0 111.001 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.87 141.34 46.81 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.624 -177.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -103.74 114.85 29.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 176.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tp -107.54 112.81 25.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.48 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.648 HG12 HG21 ' A' ' 77' ' ' VAL . 7.3 t -112.79 111.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.291 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 5.3 mt-30 -104.74 128.72 52.93 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.657 HG21 ' H ' ' A' ' 34' ' ' LEU . 1.8 m -125.4 141.8 44.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.661 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -100.67 112.88 25.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.732 -172.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.27 174.59 0.26 Allowed 'General case' 0 CA--C 1.549 0.926 0 O-C-N 124.542 1.151 . . . . 0.0 112.051 172.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.494 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -143.34 -60.19 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -175.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.688 ' HB2' HG23 ' A' ' 163' ' ' VAL . 2.9 Cg_exo -76.08 139.1 21.24 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 121.523 1.482 . . . . 0.0 113.891 -174.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 50.3 m -89.39 136.21 33.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.53 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.761 HD13 ' HB2' ' A' ' 125' ' ' LEU . 35.7 mt -62.46 117.48 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.54 -27.79 13.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.827 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.4 149.87 22.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.573 HG23 HD13 ' A' ' 114' ' ' LEU . 3.7 mt -123.79 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.86 148.06 52.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.881 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.616 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 25.6 m-85 -120.43 153.63 36.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.104 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.58 143.75 23.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.759 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.63 73.41 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.32 -0.467 . . . . 0.0 114.199 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.5 OUTLIER -101.42 81.51 2.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.393 0.616 . . . . 0.0 110.532 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -86.14 -34.68 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.931 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -56.38 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.993 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -92.62 159.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.987 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 106' ' ' LYS . 2.4 mmmm -88.23 145.52 25.84 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.259 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.616 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 15.6 p-10 -66.74 -34.71 78.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.761 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.586 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 16.6 t70 -58.92 -38.35 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.089 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -42.77 68.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.405 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.19 -32.48 68.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.02 0.528 . . . . 0.0 111.959 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.586 ' HD3' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -58.63 -47.96 82.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.226 178.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.9 -28.58 49.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -36.46 83.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.573 HD13 HG23 ' A' ' 97' ' ' ILE . 11.6 mt -74.19 -38.92 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.709 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -61.99 -31.89 72.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.409 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.71 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.605 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -16.72 34.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.875 0.369 . . . . 0.0 110.267 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.86 -21.76 8.87 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.47 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.452 HG23 HD12 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -84.68 108.12 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.282 0.563 . . . . 0.0 111.303 -176.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.709 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.28 172.15 13.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.509 ' HA ' HG23 ' A' ' 94' ' ' ILE . 48.4 t -71.62 127.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.062 0.458 . . . . 0.0 110.503 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.53 -20.96 48.25 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.059 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.545 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -82.51 163.8 21.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.257 0.551 . . . . 0.0 110.628 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 73' ' ' GLU . 63.3 m -85.21 151.17 24.29 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.761 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -104.8 143.83 32.59 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.695 0.76 . . . . 0.0 111.607 -172.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.605 ' HB3' HG23 ' A' ' 129' ' ' THR . 9.7 t0 -104.65 98.09 7.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.397 176.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.536 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.85 -15.59 62.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.648 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.0 p -83.32 -17.88 40.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.085 0.469 . . . . 0.0 110.363 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.645 HG21 HD13 ' A' ' 133' ' ' ILE . 0.8 OUTLIER -103.11 6.72 38.69 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 176.07 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.6 mm -61.45 -39.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.36 78.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.188 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -33.12 70.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.066 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.645 HD13 HG21 ' A' ' 129' ' ' THR . 10.5 mt -68.55 -47.19 78.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.112 176.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.428 ' HG2' HG23 ' A' ' 151' ' ' VAL . 96.8 mt-10 -63.59 -41.73 98.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.966 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -37.12 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.026 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.09 -37.8 87.63 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.529 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.489 ' HA ' HD21 ' A' ' 137' ' ' LEU . 44.4 mt -74.45 -32.0 62.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.675 0.274 . . . . 0.0 111.066 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -37.65 75.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 110.039 175.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.97 -33.22 75.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.559 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.78 -45.42 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.525 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.431 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 2.1 m-85 -63.02 -37.1 85.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.755 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.2 t80 -68.13 -35.59 78.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.254 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.03 -31.24 69.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.688 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.9 t -74.57 -91.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.77 0.319 . . . . 0.0 110.338 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.92 18.39 24.16 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.094 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 58.92 50.32 8.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.357 0.598 . . . . 0.0 110.045 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -80.19 119.64 23.23 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.403 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.94 99.11 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.82 43.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.439 0.637 . . . . 0.0 111.382 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.71 113.06 24.98 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.8 p -108.16 127.44 64.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.439 0.638 . . . . 0.0 110.519 -174.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.91 116.84 20.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.542 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.94 110.58 22.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.17 124.91 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.906 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.476 ' H ' HG21 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -99.58 113.97 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.318 174.358 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.0 m -104.41 115.27 63.19 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.799 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.65 127.42 9.57 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.919 2.412 . . . . 0.0 112.618 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.79 150.9 39.71 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 171.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.49 79.74 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.463 2.776 . . . . 0.0 113.967 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.498 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -171.21 -104.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.583 0.753 . . . . 0.0 109.348 177.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 16.5 p-10 -157.5 34.92 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -133.78 155.3 50.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.877 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -127.6 151.52 34.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.812 177.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.63 118.88 37.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.86 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 155' ' ' VAL . 45.1 tp -96.82 121.05 38.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -175.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.44 132.49 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.433 0.635 . . . . 0.0 111.044 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.0 mm? -105.61 111.48 24.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.834 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 21.6 t -99.54 120.41 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -116.06 118.94 34.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.75 120.3 29.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.47 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.54 134.45 54.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.667 0.27 . . . . 0.0 110.446 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.416 ' O ' HG11 ' A' ' 173' ' ' VAL . . . 140.87 -78.67 0.29 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.533 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.478 ' CG1' ' H ' ' A' ' 174' ' ' SER . 10.2 p 41.19 -103.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 125.164 1.386 . . . . 0.0 112.865 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.478 ' H ' ' CG1' ' A' ' 173' ' ' VAL . 60.3 m . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 119.096 0.862 . . . . 0.0 110.99 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -96.8 21.83 9.02 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.07 77.37 1.93 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -97.39 152.5 18.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.3 t -85.66 122.65 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.67 124.28 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.588 0.709 . . . . 0.0 110.689 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -80.31 -26.93 38.57 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.387 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -162.51 149.45 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 43' ' ' LEU . 58.7 mt -112.99 121.54 65.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.559 ' HB3' HD11 ' A' ' 85' ' ' LEU . 5.9 t-160 -116.77 127.22 54.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.572 ' HB3' HD22 ' A' ' 34' ' ' LEU . 19.5 m-85 -106.68 136.72 46.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -131.32 167.7 18.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.63 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.95 -33.19 2.89 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.348 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -84.07 150.21 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -101.16 -63.76 1.11 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.776 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -109.66 31.62 5.67 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 111.772 -174.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.481 ' HB ' HD23 ' A' ' 34' ' ' LEU . 3.7 t -108.72 112.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.66 156.15 27.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.125 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' A' ' 31' ' ' PHE . 2.7 m -66.48 -27.57 40.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.914 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.69 -36.97 61.8 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.134 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.488 ' HA ' HD13 ' A' ' 44' ' ' LEU . . . -76.47 -34.42 58.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.547 0.689 . . . . 0.0 110.157 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.57 68.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.997 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.63 HD23 ' HD2' ' A' ' 49' ' ' ARG . 5.1 mt -57.14 -31.29 65.21 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.356 0.662 . . . . 0.0 112.532 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 41' ' ' ALA . 67.1 mt -66.48 -22.31 66.19 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.565 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.512 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -98.57 -8.3 26.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.628 ' HG2' HG22 ' A' ' 62' ' ' THR . 30.9 mtp -83.54 143.25 43.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.204 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.74 -3.56 13.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.512 2.142 . . . . 0.0 113.334 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.597 HG23 HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -139.58 163.79 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.63 ' HD2' HD23 ' A' ' 43' ' ' LEU . 9.6 mmm180 -120.31 176.06 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.936 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 p -66.94 132.92 48.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.61 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.37 -5.7 77.83 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.638 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 156.64 18.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.881 0.372 . . . . 0.0 111.081 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 125.1 30.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.322 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.597 HG13 HG23 ' A' ' 48' ' ' VAL . 20.9 m -123.14 137.22 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.705 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -97.49 178.54 5.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.026 0.441 . . . . 0.0 110.804 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -27.17 63.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.53 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -29.44 64.67 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.36 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.576 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 42.3 m-20 -73.91 -29.2 61.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.524 175.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.87 -49.34 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.75 -36.36 84.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -64.06 -42.33 97.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 178.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.628 HG22 ' HG2' ' A' ' 46' ' ' MET . 54.0 m -60.04 -42.55 94.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.646 ' HA ' HG13 ' A' ' 75' ' ' VAL . 55.3 mt -55.62 -49.3 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.53 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -36.43 82.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.027 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.11 66.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.661 ' HA ' HG23 ' A' ' 69' ' ' THR . 89.9 mt -71.08 -28.31 64.24 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.224 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -45.23 66.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.63 -15.79 59.73 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 66' ' ' LEU . 9.7 t -80.78 -24.29 38.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.35 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.5 1.65 90.17 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 164.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -85.12 -6.33 59.3 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.945 0.872 . . . . 0.0 111.698 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' HE1' HD21 ' A' ' 66' ' ' LEU . 14.2 m-85 -124.43 159.14 31.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.51 ' HG2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -91.75 -36.95 13.28 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.887 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 26.7 t0 -137.73 140.97 41.0 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 63' ' ' ILE . 49.1 t -128.17 119.84 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.892 0.377 . . . . 0.0 110.5 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.7 118.13 30.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.877 173.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.607 HG21 HG12 ' A' ' 86' ' ' VAL . 61.4 t -106.95 122.34 60.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.445 HD13 HD22 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -138.81 137.97 37.12 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.8 137.15 36.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.407 0.622 . . . . 0.0 110.82 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -113.99 95.31 5.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.74 -109.37 2.87 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.483 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.29 11.02 21.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.239 0.542 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.86 139.57 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.724 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.719 ' HB2' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -104.8 114.89 29.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.487 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 30' ' ' HIS . 20.6 tp -109.23 115.11 29.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.233 0.54 . . . . 0.0 110.453 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.607 HG12 HG21 ' A' ' 77' ' ' VAL . 19.0 t -106.25 108.24 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.351 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.487 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 73.5 mt-30 -97.06 126.38 42.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.41 150.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.85 0.834 . . . . 0.0 111.159 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.441 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 16.4 tttm -108.38 130.76 55.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.149 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 2.4 tp10 73.33 151.12 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.475 1.109 . . . . 0.0 111.956 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.67 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 5.8 tpt180 -155.22 -53.87 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.703 175.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 91' ' ' ARG . 9.6 Cg_endo -90.63 137.24 2.34 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.246 1.298 . . . . 0.0 111.344 171.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.9 m -96.36 147.72 23.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.194 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 125' ' ' LEU . 42.4 mt -58.12 118.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.444 ' HB3' ' HG2' ' A' ' 162' ' ' ARG . . . -105.82 -38.24 6.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.183 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.97 27.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.498 HG12 HD22 ' A' ' 165' ' ' LEU . 1.2 mt -114.83 123.69 70.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 168.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.88 135.4 54.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -176.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.541 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.1 m-85 -111.45 135.47 51.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -141.93 112.11 6.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.877 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.682 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 178.96 -60.12 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.911 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.466 ' HB2' ' OH ' ' A' ' 141' ' ' TYR . 0.7 OUTLIER -153.6 148.41 26.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.122 0.487 . . . . 0.0 111.957 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -86.52 -13.01 47.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.903 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.637 ' HB3' HG13 ' A' ' 144' ' ' VAL . 54.0 m -58.35 -50.85 72.18 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.706 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.458 HG23 HD22 ' A' ' 110' ' ' LEU . 9.3 p -87.31 137.68 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -78.63 143.33 36.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.234 -174.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -33.95 75.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.106 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -30.79 71.84 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.568 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.435 ' SD ' ' HB2' ' A' ' 106' ' ' LYS . 29.6 mtp -73.03 -46.07 54.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.413 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 106' ' ' LYS . 4.5 mt -63.22 -31.87 73.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -59.31 -43.4 92.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 111.019 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.97 -28.81 58.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.364 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.63 -43.98 91.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.245 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.34 -36.82 85.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.917 175.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -31.42 72.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.56 61.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.547 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.0 m -84.66 -16.83 40.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 110.178 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 106.07 1.28 38.83 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.269 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.01 117.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.183 0.516 . . . . 0.0 110.863 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.69 170.5 15.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.222 -177.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.586 ' HA ' HG23 ' A' ' 94' ' ' ILE . 40.8 t -71.73 126.3 31.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.982 0.42 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.84 -5.91 79.42 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.943 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.9 OUTLIER -106.47 154.59 20.62 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.51 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 1.5 m -57.12 139.34 52.75 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.537 0.523 . . . . 0.0 111.524 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.634 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.92 145.33 25.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.322 0.582 . . . . 0.0 111.183 -175.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.518 ' HA ' ' NH1' ' A' ' 127' ' ' ARG . 26.2 t0 -117.77 111.58 19.28 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.716 0.77 . . . . 0.0 111.243 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.518 ' NH1' ' HA ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -71.2 -15.23 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.051 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.4 p -89.72 -15.43 32.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.741 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -92.73 2.49 56.71 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.929 175.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.1 mm -59.8 -41.32 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.924 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.39 86.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.816 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.33 -41.63 96.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.115 0.483 . . . . 0.0 109.732 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.447 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 10.7 mt -63.55 -45.99 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.479 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -60.37 -49.45 77.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 2.9 tptp -61.95 -40.28 94.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.27 65.84 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.843 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.502 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 12.7 mt -74.01 -32.64 63.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.632 0.253 . . . . 0.0 110.985 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.488 ' HG3' HG13 ' A' ' 151' ' ' VAL . 52.9 mt-10 -67.04 -37.47 84.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 174.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -31.29 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.455 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -66.41 -36.93 84.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.466 ' OH ' ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -62.64 -35.72 80.52 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 177.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -69.35 -34.52 74.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.651 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.29 66.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 104' ' ' SER . 12.4 t -74.87 -86.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.76 18.77 24.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.576 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.6 56.8 3.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.685 0.755 . . . . 0.0 110.063 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -86.18 149.84 24.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.298 -174.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 89.21 3.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.665 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 171' ' ' GLU . . . -140.12 156.52 46.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 0.0 112.036 -174.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 m -117.61 139.98 50.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.843 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.488 HG13 ' HG3' ' A' ' 138' ' ' GLU . 6.6 p -114.4 139.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.134 0.492 . . . . 0.0 110.682 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 127.69 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.228 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.727 ' HB3' HD12 ' A' ' 167' ' ' LEU . . . -92.64 116.92 29.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.46 0.648 . . . . 0.0 111.387 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.28 112.33 30.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.904 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.95 111.43 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 120.971 0.415 . . . . 0.0 110.042 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 22.2 m -118.96 125.15 27.85 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.036 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.501 ' HA ' HG11 ' A' ' 163' ' ' VAL . 3.1 Cg_exo -82.38 145.62 13.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.191 2.594 . . . . 0.0 112.563 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.601 HD13 ' HB2' ' A' ' 160' ' ' ARG . 0.3 OUTLIER -105.82 158.88 31.38 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.88 62.77 4.88 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.355 2.703 . . . . 0.0 113.483 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.601 ' HB2' HD13 ' A' ' 158' ' ' LEU . 8.6 mmt180 -146.84 -93.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 -168.69 32.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 174.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.456 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -136.87 166.61 23.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.083 -177.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 157' ' ' PRO . 0.5 OUTLIER -128.99 148.03 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.117 0.484 . . . . 0.0 111.163 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -112.07 122.18 47.04 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.498 HD22 HG12 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -119.14 132.58 56.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.713 0.768 . . . . 0.0 111.363 -176.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -120.91 133.34 55.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.975 -176.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 153' ' ' ALA . 4.5 mm? -103.56 110.32 22.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.747 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.1 116.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.682 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 75.7 m-85 -97.87 118.56 34.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.13 115.59 25.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.538 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.546 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 0.1 OUTLIER -75.68 89.41 2.8 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.378 0.608 . . . . 0.0 110.464 178.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 170.99 -169.75 42.7 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 174' ' ' SER . 41.0 t 69.62 153.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.068 0.547 . . . . 0.0 110.955 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.414 ' N ' HG11 ' A' ' 173' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.23 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 120.946 0.403 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.47 165.78 22.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.696 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.59 43.57 6.09 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -109.43 153.95 23.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.89 117.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.909 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.407 HG23 HD11 ' A' ' 84' ' ' LEU . 2.5 t -72.22 115.69 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -41.53 23.58 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.134 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.67 ' HB3' HG21 ' A' ' 83' ' ' THR . 25.0 t70 -144.11 143.77 31.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.043 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.425 HD11 HD13 ' A' ' 43' ' ' LEU . 35.5 mt -105.31 121.84 57.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.93 128.59 45.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.271 0.557 . . . . 0.0 111.125 -175.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 41.3 m-85 -105.33 137.84 42.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.638 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.46 -42.91 2.96 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.64 4.45 85.74 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.071 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.541 HD22 HG23 ' A' ' 88' ' ' VAL . 4.5 mt -69.39 132.53 46.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.904 0.383 . . . . 0.0 111.471 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -82.27 -84.9 0.11 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.473 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -126.67 27.2 6.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 111.096 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HB ' HD12 ' A' ' 34' ' ' LEU . 3.0 t -85.97 132.61 31.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.95 154.97 21.1 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -61.31 -32.48 53.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.463 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.97 -37.61 83.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.9 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.19 63.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.082 0.468 . . . . 0.0 110.738 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.88 -40.05 55.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.479 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.425 HD13 HD11 ' A' ' 29' ' ' ILE . 4.5 mp -61.1 -29.92 70.04 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.289 0.635 . . . . 0.0 112.159 176.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 84.5 mt -62.45 -24.97 67.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.478 ' HB2' HD22 ' A' ' 66' ' ' LEU . 1.5 m -96.82 -7.82 32.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.521 ' HE1' HG22 ' A' ' 62' ' ' THR . 33.9 mtp -87.39 131.6 43.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.026 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 13.1 Cg_exo -70.82 -25.43 23.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.914 2.409 . . . . 0.0 112.667 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.457 HG13 HG11 ' A' ' 54' ' ' VAL . 1.4 m -112.9 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.24 0.543 . . . . 0.0 111.418 -176.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -118.21 -179.87 3.9 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.487 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.9 p -67.47 121.43 15.79 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.847 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -6.11 47.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.5 m-20 -86.0 153.72 21.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.545 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.27 139.01 33.04 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG11 HG13 ' A' ' 48' ' ' VAL . 2.8 m -128.07 127.24 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.869 -174.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.54 -177.36 3.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.108 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.513 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -68.07 -36.3 79.61 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.54 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.549 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 22.6 m-20 -74.14 -29.81 61.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.787 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -48.38 88.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -70.42 -32.49 70.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.549 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 2.0 m-20 -62.06 -49.76 74.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 110.476 177.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.521 HG22 ' HE1' ' A' ' 46' ' ' MET . 44.4 m -61.46 -44.34 97.27 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.48 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.621 HD13 HG21 ' A' ' 77' ' ' VAL . 2.4 mt -59.22 -48.2 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 123.39 0.431 . . . . 0.0 110.844 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -33.54 74.14 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.21 -51.59 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.585 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 45' ' ' SER . 79.8 mt -67.61 -30.08 69.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.28 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' HD1' HG21 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -65.05 -41.77 94.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 110.608 175.514 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.75 -13.51 62.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.92 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 66' ' ' LEU . 26.4 p -79.37 -25.0 42.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.594 0.235 . . . . 0.0 111.184 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.72 26.97 71.39 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.415 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -95.64 -20.05 19.25 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.117 0.484 . . . . 0.0 110.207 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.67 154.85 45.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 36.3 mt-10 -80.43 -43.66 20.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 111.6 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 12.6 t70 -132.91 136.34 46.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 t -124.98 117.88 51.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.507 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 76' ' ' ARG . 2.4 tpp85 -121.12 122.37 39.87 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.962 172.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 63' ' ' ILE . 27.1 m -96.64 137.54 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -128.34 154.15 46.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -107.57 115.16 29.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.786 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.79 95.62 5.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 -110.45 3.37 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.212 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -106.74 8.32 30.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.225 0.536 . . . . 0.0 110.743 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.67 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -111.08 141.52 44.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.546 -173.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.44 HD22 ' HB ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -102.96 115.55 30.81 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.02 179.087 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.32 112.43 24.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.123 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -102.4 109.87 27.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.502 0.668 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -103.95 126.42 51.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.599 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.541 HG23 HD22 ' A' ' 34' ' ' LEU . 28.5 m -125.18 158.3 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.908 0.385 . . . . 0.0 111.262 -177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.5 tptp -100.74 121.0 40.93 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -177.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' HB3' ' H ' ' A' ' 91' ' ' ARG . 0.6 OUTLIER 50.7 -118.61 1.25 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.816 1.322 . . . . 0.0 112.666 173.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -168.08 -55.8 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.698 -172.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 72.6 Cg_endo -84.96 138.59 6.91 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 120.863 1.042 . . . . 0.0 113.919 -169.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.1 m -99.54 138.12 37.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.6 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.805 HD13 ' HB2' ' A' ' 125' ' ' LEU . 20.7 mt -61.62 117.61 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.04 -22.92 13.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.117 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 138.66 13.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.891 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.42 HG23 ' CD2' ' A' ' 114' ' ' LEU . 2.2 mt -118.0 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.419 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -117.68 132.27 56.51 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.75 -175.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.639 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 22.2 m-85 -105.84 151.06 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.95 139.71 20.77 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.6 18.5 56.64 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.33 56.99 4.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.455 0.702 . . . . 0.0 110.807 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -86.57 -34.81 19.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 m -84.97 -51.06 6.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.64 137.3 44.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.69 147.86 50.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.619 -174.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.639 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -64.39 -33.09 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.855 176.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -38.01 74.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.024 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -44.08 55.24 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 106' ' ' LYS . 31.1 mt -61.21 -32.49 72.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.101 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.416 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 7.8 mttt -60.47 -46.21 90.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 111.227 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -77.89 -28.24 49.82 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.609 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.094 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.42 ' CD2' HG23 ' A' ' 97' ' ' ILE . 2.3 mp -68.07 -40.57 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.619 174.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.572 ' HG2' ' HB2' ' A' ' 120' ' ' ARG . 1.9 mt-10 -60.46 -42.35 96.0 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.86 -16.0 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.677 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.5 m -91.98 -13.27 31.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.49 -22.03 13.86 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.998 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.35 104.04 15.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.092 0.472 . . . . 0.0 110.079 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.572 ' HB2' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.0 170.16 16.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.241 -178.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.54 131.47 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.35 0.595 . . . . 0.0 111.283 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.17 -6.63 81.06 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.709 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.566 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -100.15 166.88 10.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.0 111.519 -174.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -61.99 148.08 44.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.433 173.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.805 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -112.3 135.08 53.42 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.716 0.769 . . . . 0.0 110.979 -177.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.707 ' HB3' HG23 ' A' ' 129' ' ' THR . 23.7 t0 -106.17 97.31 7.14 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 172.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.719 ' HD3' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.58 -15.24 62.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.758 -176.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.719 HG21 ' HD3' ' A' ' 127' ' ' ARG . 12.5 p -89.74 -23.62 21.75 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.698 0.285 . . . . 0.0 110.96 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.707 HG23 ' HB3' ' A' ' 126' ' ' ASP . 0.5 OUTLIER -87.99 -1.29 57.9 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.406 0.622 . . . . 0.0 110.517 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 153' ' ' ALA . 5.6 mm -57.51 -43.36 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.215 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.721 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.28 -36.53 84.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.149 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.513 HG21 HD13 ' A' ' 137' ' ' LEU . 16.3 mt -65.18 -45.23 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.353 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -61.12 -47.7 85.05 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 135' ' ' LYS . 17.2 mmtm -67.09 -34.58 77.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.646 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.94 -39.98 84.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.024 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.513 HD13 HG21 ' A' ' 133' ' ' ILE . 37.0 mt -69.66 -32.54 71.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.633 0.254 . . . . 0.0 111.032 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.658 ' HG3' HG22 ' A' ' 151' ' ' VAL . 20.1 mt-10 -63.09 -41.46 99.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 174.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.24 -43.48 94.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.688 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.29 -38.55 90.56 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.228 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -35.47 80.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.947 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -30.4 67.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.206 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -28.44 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.2 t -72.47 -83.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.233 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.53 18.62 22.59 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.584 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt 63.11 45.58 5.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.368 0.667 . . . . 0.0 110.184 -174.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -80.57 119.62 23.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.092 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.447 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -90.71 73.02 6.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.44 176.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 143.9 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.39 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.5 m -97.94 115.66 28.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.658 HG22 ' HG3' ' A' ' 138' ' ' GLU . 13.2 t -107.07 122.35 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.563 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 119.57 24.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.388 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 130' ' ' ILE . . . -95.9 111.97 23.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.258 0.552 . . . . 0.0 110.246 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.58 118.82 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.811 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.4 HG12 HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -101.09 116.75 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.331 177.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.481 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.1 m -120.77 122.13 28.63 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.791 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.3 Cg_endo -88.11 142.69 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.68 2.92 . . . . 0.0 113.003 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -120.56 159.39 48.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.033 178.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.06 -7.69 12.28 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 123.726 2.951 . . . . 0.0 115.0 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.51 12.42 8.57 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 122.488 -0.132 . . . . 0.0 111.193 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 1.3 m-20 62.22 42.35 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.0 0.905 . . . . 0.0 110.603 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.72 ' HB2' HD13 ' A' ' 158' ' ' LEU . 14.5 mmt85 -131.02 163.57 27.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.381 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -127.43 146.49 33.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.23 0.538 . . . . 0.0 110.537 176.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.08 123.41 49.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.494 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.4 HD11 HG12 ' A' ' 155' ' ' VAL . 21.1 tp -107.22 119.71 40.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.115 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -115.4 131.27 56.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.376 0.607 . . . . 0.0 110.58 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.54 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.6 mm? -104.3 109.93 21.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.462 -176.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.9 t -96.41 111.41 26.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.78 135.2 50.39 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -112.89 111.93 23.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -96.03 23.4 6.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.763 0.792 . . . . 0.0 110.799 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -133.45 20.09 4.2 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.464 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 148' ' ' SER . 11.2 t -98.59 123.37 51.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.422 0 O-C-N 124.103 0.877 . . . . 0.0 110.514 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 120.765 0.317 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.51 143.13 39.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.518 176.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.44 47.27 80.43 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -107.9 152.76 23.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.686 -0.257 . . . . 0.0 110.428 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.57 113.3 23.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.26 118.42 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 111.256 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -76.69 -46.77 24.31 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 178.363 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.84 146.66 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.608 HD11 ' HG ' ' A' ' 43' ' ' LEU . 62.4 mt -105.39 119.99 55.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -109.65 127.55 54.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.89 137.48 41.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.012 0.434 . . . . 0.0 110.476 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.39 -30.58 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.468 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.99 -73.81 1.19 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.796 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 37' ' ' VAL . 32.6 mt 61.88 -164.68 0.24 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.443 0.697 . . . . 0.0 112.126 -176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.49 HE21 ' HB2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -165.47 -89.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.744 -177.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' H ' ' HB3' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -128.02 11.2 6.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.445 0.64 . . . . 0.0 109.838 177.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.511 ' O ' HD23 ' A' ' 34' ' ' LEU . 42.3 t -108.42 140.66 26.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.311 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.54 158.11 18.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.11 -37.54 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.71 -40.23 90.11 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.95 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HB3' HG11 ' A' ' 37' ' ' VAL . . . -71.8 -34.84 69.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.909 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -32.46 70.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.31 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.608 ' HG ' HD11 ' A' ' 29' ' ' ILE . 4.8 mp -68.94 -30.99 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.0 mt -68.96 -23.38 64.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -80.61 -20.96 42.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.422 177.452 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.552 ' HB3' HG23 ' A' ' 62' ' ' THR . 24.7 mtt -82.53 139.39 44.32 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.95 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 31.4 Cg_exo -63.36 -36.2 57.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.656 2.237 . . . . 0.0 112.328 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' H ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -109.86 150.12 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.389 -178.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 14.6 mmm-85 -127.82 178.09 6.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 0.0 111.067 -175.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -64.65 122.58 17.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.95 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.39 -10.1 42.45 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.83 -174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 5.2 m-20 -89.32 152.77 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.531 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.91 127.7 36.49 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.74 131.15 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.421 0.629 . . . . 0.0 112.491 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.472 ' O ' HD11 ' A' ' 59' ' ' ILE . 14.3 m-80 -93.13 173.17 7.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.38 174.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.96 -31.6 71.96 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -61.21 -36.97 81.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.893 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.582 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 37.8 m-20 -75.05 -29.21 60.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.08 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.472 HD11 ' O ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -64.64 -45.31 95.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -32.18 73.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.921 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.582 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.4 m-80 -69.63 -43.55 72.45 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.203 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 46' ' ' MET . 1.3 p -63.29 -43.15 98.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.032 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mt -54.21 -49.63 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 123.519 0.512 . . . . 0.0 110.45 174.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -46.59 89.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.416 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.8 -48.45 81.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.467 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.605 ' HA ' HG22 ' A' ' 69' ' ' THR . 54.1 mt -69.89 -29.51 66.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -34.36 77.51 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 110.287 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.16 61.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.421 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.605 HG22 ' HA ' ' A' ' 66' ' ' LEU . 18.8 p -77.61 -25.64 49.98 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.222 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.57 -5.85 20.35 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 116.143 -0.48 . . . . 0.0 114.114 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.63 -23.87 22.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.167 0.483 . . . . 0.0 111.228 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.547 ' CD1' HG23 ' A' ' 88' ' ' VAL . 6.0 m-85 -101.47 157.19 16.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.581 ' HG2' ' HD2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -86.78 -41.66 13.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.151 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.708 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 8.4 t70 -145.88 139.19 26.12 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.73 120.77 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.84 118.53 31.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.751 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG21 HG12 ' A' ' 86' ' ' VAL . 54.3 t -106.6 126.48 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.011 0.434 . . . . 0.0 110.014 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -126.36 159.08 34.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 129.86 50.63 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.806 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.0 96.63 6.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.815 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.2 -109.85 3.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.616 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' HB3' ' HD2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -111.44 15.9 21.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.394 0.616 . . . . 0.0 110.375 177.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.06 141.41 38.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.085 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.401 HD22 HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -104.84 119.15 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -112.23 116.99 31.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.98 0.419 . . . . 0.0 110.17 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.505 HG12 HG21 ' A' ' 77' ' ' VAL . 5.0 t -106.72 111.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.253 0.549 . . . . 0.0 110.72 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.13 136.24 41.3 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.547 HG23 ' CD1' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -130.78 155.82 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.126 0.489 . . . . 0.0 110.326 -173.349 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -98.6 140.45 32.81 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.2 -175.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.479 ' HB3' ' H ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 79.35 -154.09 0.02 OUTLIER 'General case' 0 C--O 1.238 0.475 0 O-C-N 125.974 2.047 . . . . 0.0 111.407 -176.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.479 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 0.6 OUTLIER 159.62 -46.93 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 124.773 1.229 . . . . 0.0 109.555 -164.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.6 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 3.5 Cg_exo -79.31 140.42 15.4 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.266 1.311 . . . . 0.0 112.559 172.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -104.34 136.83 43.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.336 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 125' ' ' LEU . 31.0 mt -64.83 118.25 6.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.15 -27.84 14.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.82 139.85 15.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.041 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.465 HG22 HD22 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -110.17 122.88 65.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 167.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -116.27 131.94 56.8 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.388 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.616 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -113.43 134.12 54.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.824 -175.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.3 125.75 16.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.66 -2.34 57.19 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.363 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.494 HD22 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -86.36 82.15 8.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.187 0.518 . . . . 0.0 110.709 -177.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 171' ' ' GLU . 0.2 OUTLIER -85.88 -35.77 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.043 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -70.32 -64.91 0.8 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.126 0.488 . . . . 0.0 110.626 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.65 130.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -69.41 158.38 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 0.0 112.087 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -61.47 -34.6 75.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.723 173.133 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -43.1 96.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.983 176.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 mmm -74.45 -35.35 63.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.753 0.311 . . . . 0.0 111.131 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -31.65 72.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.549 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.616 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.93 -43.42 86.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 110.763 176.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -78.29 -28.6 47.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.115 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -66.39 -42.64 87.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.19 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.44 ' HA ' HD11 ' A' ' 114' ' ' LEU . 1.4 mm? -68.08 -38.45 82.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.53 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -40.16 88.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.097 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.92 -19.38 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.915 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 m -89.23 -12.86 39.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 102.62 -11.86 56.5 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.629 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.3 t -100.5 101.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.486 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 26.8 ptt180 -142.93 175.32 9.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -176.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.545 ' HA ' HG23 ' A' ' 94' ' ' ILE . 14.6 p -68.89 135.09 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.216 176.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.33 18.02 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.37 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -84.91 160.5 20.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 110.994 177.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.98 150.58 27.57 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 170.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.802 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -119.02 130.72 55.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -174.052 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.584 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 20.0 t0 -90.13 112.87 24.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.629 0.728 . . . . 0.0 109.893 172.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.645 ' HG3' HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -71.63 -15.69 62.25 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.079 -179.146 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.3 p -83.45 -25.36 31.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.338 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.584 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -89.34 -1.1 57.94 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.952 177.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' HA ' HD11 ' A' ' 133' ' ' ILE . 4.4 mm -56.72 -41.53 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.473 ' HA ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.08 -38.36 90.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.86 -31.22 68.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.583 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 130' ' ' ILE . 7.7 mt -67.03 -43.62 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.54 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 131' ' ' ALA . 49.1 mt-10 -62.44 -44.4 96.5 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.591 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.34 93.57 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.748 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.37 -37.49 92.82 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.931 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.406 HD11 HG23 ' A' ' 151' ' ' VAL . 8.8 mt -68.27 -39.58 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.501 0.191 . . . . 0.0 111.368 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.4 -39.26 88.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.282 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.743 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -60.96 -45.06 96.29 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -61.78 -41.42 97.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.181 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -70.75 -34.37 71.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.096 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.2 m -66.51 -28.56 68.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.401 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 11.8 t -80.13 -88.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.975 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.25 18.06 26.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.5 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 1.0 OUTLIER 59.99 44.67 13.07 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.283 0.633 . . . . 0.0 110.697 -174.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -73.58 102.96 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.91 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.421 ' O ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -88.32 84.28 6.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 111.676 -175.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -117.81 141.56 48.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 m -100.05 122.42 42.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.749 0.309 . . . . 0.0 110.459 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.447 ' H ' HG11 ' A' ' 151' ' ' VAL . 2.2 p -105.47 133.12 50.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.384 0.612 . . . . 0.0 111.657 -174.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -129.23 122.53 29.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.514 173.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.4 ' HB1' HG21 ' A' ' 130' ' ' ILE . . . -93.8 112.06 23.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.113 0.482 . . . . 0.0 110.762 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.19 116.88 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.731 HG13 HD23 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.39 118.31 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.433 178.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.5 m -124.12 117.48 26.96 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.629 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 46.7 Cg_endo -69.51 143.83 53.34 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.611 2.207 . . . . 0.0 112.614 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.64 160.35 26.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.79 71.05 0.24 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.616 2.878 . . . . 0.0 114.322 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.489 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -164.51 -117.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 18.7 p-10 -138.63 36.79 2.22 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -133.71 157.83 44.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 -172.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -128.18 148.17 32.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.244 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -109.32 126.66 53.62 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.723 HD11 HG12 ' A' ' 155' ' ' VAL . 58.3 tp -113.25 114.35 26.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.934 0.397 . . . . 0.0 110.66 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 1.3 ttpt -113.28 131.69 55.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 0.0 110.693 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.444 ' N ' HD21 ' A' ' 167' ' ' LEU . 4.2 mm? -98.83 110.18 22.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.142 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 25.4 t -94.52 111.08 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -103.26 129.29 50.18 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.4 113.61 11.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -105.0 72.33 1.0 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.283 -176.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 155.86 81.89 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.846 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 148' ' ' SER . 1.3 p -123.7 169.57 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.134 0.493 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -128.72 124.69 36.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.0 44.95 12.51 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -171.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -106.93 153.56 22.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.202 -0.499 . . . . 0.0 110.072 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.1 p -80.6 124.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 110.103 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.55 127.75 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.558 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -97.57 -39.44 9.12 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.546 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HB3' HG21 ' A' ' 83' ' ' THR . 34.7 t70 -143.8 142.06 30.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.548 HD13 HG21 ' A' ' 50' ' ' THR . 49.3 mt -109.14 122.07 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -122.75 128.09 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.963 -179.03 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 2.4 m-85 -102.16 138.1 39.56 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.005 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.508 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 5.3 mm-40 -119.6 67.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.064 0.935 . . . . 0.0 109.982 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' HA2' HG23 ' A' ' 88' ' ' VAL . . . 172.0 -83.0 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.745 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 31' ' ' PHE . 49.5 mt 65.23 120.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.075 0.941 . . . . 0.0 113.361 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HG3' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -131.49 91.05 2.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.238 176.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.73 -35.15 0.23 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.384 1.074 . . . . 0.0 112.585 173.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' A' ' 41' ' ' ALA . 1.4 t -88.38 113.11 24.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.32 158.08 35.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.618 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -36.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -172.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.96 -35.66 57.83 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.556 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.45 ' HB3' HG11 ' A' ' 37' ' ' VAL . . . -75.69 -35.57 60.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -31.25 68.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.384 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.401 HD21 ' HA ' ' A' ' 43' ' ' LEU . 3.9 mt -57.46 -31.05 65.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 112.608 171.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt -70.41 -23.07 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 111.282 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.98 -17.23 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.278 0.561 . . . . 0.0 110.143 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.545 ' HG2' HG22 ' A' ' 62' ' ' THR . 92.4 mtp -82.81 137.9 43.73 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.823 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HG3' ' HB3' ' A' ' 61' ' ' ASN . 39.6 Cg_endo -69.0 -22.58 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.32 2.013 . . . . 0.0 112.701 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.557 HG11 ' N ' ' A' ' 49' ' ' ARG . 2.0 t -125.5 149.77 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.262 0.554 . . . . 0.0 110.811 -175.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.557 ' N ' HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -124.92 177.9 5.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.673 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.548 HG21 HD13 ' A' ' 29' ' ' ILE . 3.3 p -66.16 120.27 12.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.57 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.28 -5.51 38.61 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.214 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.52 155.78 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.79 140.66 29.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.56 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG11 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -125.98 129.16 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.637 0.256 . . . . 0.0 111.652 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.451 ' O ' HD13 ' A' ' 59' ' ' ILE . 1.3 t-20 -95.11 -178.55 4.51 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.25 -30.38 69.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.226 0.536 . . . . 0.0 110.033 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -35.69 81.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.507 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 3.8 m-20 -76.63 -29.6 56.52 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -61.1 -48.14 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 171.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -66.79 -33.48 75.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.55 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.454 ' HB3' ' HG3' ' A' ' 47' ' ' PRO . 4.3 t-20 -63.25 -48.03 79.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.634 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.545 HG22 ' HG2' ' A' ' 46' ' ' MET . 25.5 m -58.9 -46.36 88.07 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.331 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.514 ' HA ' HG13 ' A' ' 75' ' ' VAL . 24.4 mt -55.26 -49.46 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.862 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -68.26 -40.42 81.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.204 -175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.0 -53.15 60.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.76 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.817 ' HB3' HG23 ' A' ' 75' ' ' VAL . 6.3 mp -66.5 -30.59 70.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.699 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.407 0.622 . . . . 0.0 110.797 174.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.46 -13.17 61.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.756 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 66' ' ' LEU . 19.6 p -78.63 -25.32 45.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.34 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.94 -7.35 59.73 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.886 176.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.236 0.541 . . . . 0.0 110.572 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 150.31 49.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.938 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.58 -45.14 60.6 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.369 0.418 . . . . 0.0 111.303 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' A' ' 89' ' ' LYS . 7.5 t70 -139.43 146.68 40.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.817 HG23 ' HB3' ' A' ' 66' ' ' LEU . 70.7 t -126.16 122.72 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.675 0.274 . . . . 0.0 110.304 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.44 118.57 32.1 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.784 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.44 HG21 HG13 ' A' ' 63' ' ' ILE . 43.6 t -103.83 123.19 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.113 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.17 159.06 37.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.65 144.53 43.27 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.277 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -139.23 97.5 3.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.054 171.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 -111.07 3.66 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -112.99 18.82 17.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.298 0.571 . . . . 0.0 109.97 174.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -107.52 134.54 50.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.029 -177.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.5 HD21 ' HA ' ' A' ' 84' ' ' LEU . 1.6 mt -102.65 118.54 37.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.708 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.2 tp -106.09 112.38 25.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.027 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.428 HG11 HG23 ' A' ' 77' ' ' VAL . 3.2 t -110.22 104.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.306 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.508 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.49 148.65 23.52 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.53 HG23 ' HA2' ' A' ' 33' ' ' GLY . 15.5 m -125.89 152.32 32.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.092 0.472 . . . . 0.0 110.662 -178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.879 ' HD3' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.19 139.43 36.88 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.879 ' HG2' ' HD3' ' A' ' 89' ' ' LYS . 25.1 mm-40 66.17 -169.59 0.2 Allowed 'General case' 0 C--O 1.236 0.344 0 O-C-N 124.407 1.067 . . . . 0.0 112.006 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.409 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -174.4 -54.91 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.307 -168.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.447 ' HB2' HG23 ' A' ' 163' ' ' VAL . 3.1 Cg_exo -75.18 142.03 26.84 Favored 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 121.642 1.561 . . . . 0.0 112.827 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 m -97.67 134.74 40.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.456 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.683 HG23 ' HA ' ' A' ' 121' ' ' VAL . 32.4 mt -61.96 120.29 7.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.1 -31.17 11.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.593 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.01 138.82 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.191 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.459 HG23 HD21 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -117.75 123.42 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.74 131.55 53.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.662 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.591 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 17.5 m-85 -109.21 134.84 51.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.356 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.11 113.94 11.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.447 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.36 13.09 9.19 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.665 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.48 68.54 4.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.731 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -85.39 -31.33 22.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.56 26.35 10.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 111.446 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.43 HG12 HD12 ' A' ' 110' ' ' LEU . 6.8 p -167.89 155.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -83.94 145.67 28.44 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.664 0.745 . . . . 0.0 111.272 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -35.62 80.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.468 175.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -41.74 89.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.248 174.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.74 -42.2 70.83 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.409 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.469 ' HA ' HD11 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -59.47 -39.67 84.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.935 175.178 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -42.86 99.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.514 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.567 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 1.6 tm0? -77.71 -27.96 50.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.116 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.93 -43.47 95.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.954 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.459 HD21 HG23 ' A' ' 97' ' ' ILE . 3.0 mp -68.49 -41.09 80.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.435 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -57.24 -45.76 83.62 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.791 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.01 -21.82 59.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.733 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -83.62 -17.16 42.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 110.297 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.58 -19.85 8.98 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.271 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.86 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 111.051 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.56 175.11 9.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.674 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.683 ' HA ' HG23 ' A' ' 94' ' ' ILE . 50.9 t -67.81 123.59 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.077 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.02 29.67 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.31 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.27 160.14 17.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.118 0.485 . . . . 0.0 111.901 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 m -84.75 127.43 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 170.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.787 HD13 HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.48 143.18 27.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.656 -171.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -91.76 113.26 25.48 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.864 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.458 ' HD2' HD22 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -72.04 -27.7 62.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.375 179.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 p -79.24 -22.67 44.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.29 0.88 51.46 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.862 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.787 HD12 HD13 ' A' ' 125' ' ' LEU . 5.0 mm -55.0 -45.14 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.654 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.42 91.0 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.246 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.96 -34.69 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.496 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 130' ' ' ILE . 61.4 mt -64.87 -48.58 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.748 176.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 130' ' ' ILE . 19.7 mt-10 -59.39 -50.02 75.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.08 0.467 . . . . 0.0 111.358 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -33.17 74.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.6 -37.16 89.2 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.152 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.9 -32.02 68.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.653 0.263 . . . . 0.0 111.12 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.723 ' HG3' HG22 ' A' ' 151' ' ' VAL . 58.5 mt-10 -64.08 -41.44 97.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.095 0.474 . . . . 0.0 110.269 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.82 -39.45 90.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.557 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -58.8 -45.52 89.68 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.035 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -41.7 87.83 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.406 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.25 -29.68 65.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.621 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.4 m -70.04 -28.56 65.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -72.81 -87.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.974 0.416 . . . . 0.0 110.737 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.22 19.52 22.41 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.395 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 62.19 0.96 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.615 0.722 . . . . 0.0 111.105 -174.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -105.63 121.08 43.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.969 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.86 93.6 7.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 110.669 176.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -117.43 153.17 33.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.57 ' HB2' ' HG3' ' A' ' 170' ' ' GLN . 6.8 m -99.65 132.65 44.85 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.723 HG22 ' HG3' ' A' ' 138' ' ' GLU . 21.6 t -110.58 129.34 65.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 110.302 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.06 117.02 24.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.435 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.27 111.12 23.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.158 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.5 113.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.11 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.687 ' HB ' HD23 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -106.15 116.97 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 66.9 m -122.98 124.0 26.65 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.861 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.7 Cg_exo -77.41 141.96 20.63 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.101 2.534 . . . . 0.0 111.768 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.79 156.42 36.61 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.97 76.86 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.134 2.556 . . . . 0.0 113.548 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.53 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -170.14 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.786 0.803 . . . . 0.0 109.124 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -127.08 161.25 28.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.086 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -127.45 144.6 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.244 176.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.85 130.96 55.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.687 HD23 ' HB ' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -109.92 130.37 55.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.097 0.475 . . . . 0.0 111.179 -176.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 130.69 52.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.016 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.2 mm? -106.92 111.63 24.22 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.412 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.03 111.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.855 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -103.92 117.5 34.47 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.57 ' HG3' ' HB2' ' A' ' 150' ' ' SER . 1.8 mt-30 -78.15 114.99 17.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.09 103.93 12.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.321 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 94.14 56.46 1.38 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.147 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.1 t -81.81 -65.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.13 178.602 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -125.94 131.48 52.28 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.027 0.442 . . . . 0.0 110.215 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.52 42.1 10.6 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.646 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -101.51 153.22 19.9 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -87.02 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.419 HG11 ' H ' ' A' ' 51' ' ' GLY . 4.7 p -68.6 127.87 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.618 0.723 . . . . 0.0 110.633 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -94.49 -41.1 9.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.397 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.18 137.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.633 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.98 121.53 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -113.39 127.69 56.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CD1' HD22 ' A' ' 34' ' ' LEU . 29.4 m-85 -102.84 134.3 46.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.729 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -133.91 77.53 1.72 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.246 0.546 . . . . 0.0 111.101 -173.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.54 -28.63 0.18 Allowed Glycine 0 C--N 1.316 -0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.863 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.507 HD22 ' CD1' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -88.49 146.75 25.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.535 0.683 . . . . 0.0 111.787 178.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -142.31 142.27 32.5 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 170.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 78.62 -32.06 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.631 1.207 . . . . 0.0 110.506 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.9 t -82.75 118.72 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.34 156.2 19.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -61.67 -32.3 53.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.076 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.35 -37.24 70.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.97 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.27 -36.28 63.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.44 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.26 -39.22 78.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.069 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HA ' ' SD ' ' A' ' 46' ' ' MET . 1.4 mt -59.79 -31.57 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.435 0.694 . . . . 0.0 112.318 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.61 -16.42 61.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -93.88 -7.87 41.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 175.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.498 ' HG2' HG21 ' A' ' 62' ' ' THR . 70.7 mtp -90.25 147.2 36.34 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.71 -18.51 22.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 112.192 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.71 165.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.972 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.478 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -132.38 174.36 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 p -67.45 121.82 16.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.298 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' H ' HG11 ' A' ' 26' ' ' VAL . . . 102.97 -4.73 49.55 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.313 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -87.31 155.1 20.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 0.0 111.047 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.54 133.42 35.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.845 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.8 128.04 62.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.071 0.462 . . . . 0.0 111.363 -175.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.61 179.74 5.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.062 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -30.31 70.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.361 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 17.9 tp10 -66.18 -34.3 77.73 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.36 0.413 . . . . 0.0 110.758 174.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.8 -32.52 69.63 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.37 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.745 HD12 ' HD3' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -62.68 -49.5 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 123.241 0.338 . . . . 0.0 110.319 173.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -35.03 77.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.58 0.229 . . . . 0.0 111.401 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -66.05 -39.92 90.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.486 177.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.498 HG21 ' HG2' ' A' ' 46' ' ' MET . 68.4 m -59.02 -45.81 89.77 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.032 172.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.596 HD13 HG12 ' A' ' 77' ' ' VAL . 1.2 mt -54.96 -48.44 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 123.445 0.466 . . . . 0.0 110.425 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -67.08 -35.57 80.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.218 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 45' ' ' SER . . . -68.35 -54.89 14.26 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.239 0.337 . . . . 0.0 110.507 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.683 HD23 ' HE2' ' A' ' 72' ' ' PHE . 37.4 mt -58.72 -29.71 66.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -52.67 33.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.969 0.414 . . . . 0.0 110.821 172.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.37 61.33 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 65' ' ' ALA . 30.0 p -79.49 -6.62 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.678 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.87 75.06 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.464 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -83.07 -59.27 2.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.517 . . . . 0.0 111.604 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.683 ' HE2' HD23 ' A' ' 66' ' ' LEU . 2.4 m-85 -124.82 169.96 11.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.524 0.202 . . . . 0.0 111.292 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -79.01 -42.54 26.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.09 0.471 . . . . 0.0 110.846 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 30.6 t70 -137.89 141.04 40.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.597 HG12 HD11 ' A' ' 66' ' ' LEU . 46.8 t -124.75 119.02 55.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.077 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -120.98 117.29 26.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.943 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.596 HG12 HD13 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -109.41 129.99 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.634 0.73 . . . . 0.0 109.695 172.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.14 156.83 34.24 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.745 ' HD3' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -129.16 126.16 38.63 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.513 0.673 . . . . 0.0 111.202 -176.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -115.46 97.12 5.98 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.851 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.06 -109.08 2.71 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.234 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.48 10.42 23.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.708 0.289 . . . . 0.0 110.778 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.33 132.52 50.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.83 116.77 31.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.96 117.1 32.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.22 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.257 0.551 . . . . 0.0 110.989 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.729 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 64.4 mt-30 -93.55 137.93 32.33 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.95 152.24 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 -175.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -98.71 150.16 22.09 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.824 -178.23 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.51 144.13 6.09 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 124.752 1.282 . . . . 0.0 113.788 -167.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 4.6 mtm180 -71.32 -51.91 9.49 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.776 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.536 ' HB2' HG23 ' A' ' 163' ' ' VAL . 17.2 Cg_exo -68.1 139.92 48.05 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.55 1.5 . . . . 0.0 113.277 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 7.2 m -105.31 139.16 40.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.913 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.509 ' CD1' HG11 ' A' ' 119' ' ' VAL . 50.0 mt -62.88 118.16 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.73 -42.5 11.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.1 39.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 176.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.433 HG13 HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -115.84 122.39 69.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.598 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -117.11 141.11 48.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.682 -175.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.665 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 26.1 m-85 -121.73 134.96 54.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.154 -172.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.0 114.39 11.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.841 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 169' ' ' PHE . . . 119.91 36.58 0.82 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.052 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.423 HD22 ' HB3' ' A' ' 99' ' ' PHE . 8.9 m120 -95.06 83.85 4.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.346 0.594 . . . . 0.0 110.149 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.06 -45.34 10.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.413 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.18 -41.61 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -173.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.481 HG13 ' HE2' ' A' ' 141' ' ' TYR . 14.0 p -117.53 148.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.68 145.33 53.96 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.665 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 18.2 p-10 -66.42 -32.07 73.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.551 170.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -43.72 76.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.073 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.71 65.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -58.44 -32.03 68.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.11 176.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.509 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 3.9 mtpp -56.95 -44.44 82.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.435 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.48 -28.37 52.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.43 -40.57 93.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.664 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.647 HD12 HG22 ' A' ' 133' ' ' ILE . 1.4 mm? -66.86 -38.85 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.747 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.77 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 2.0 mt-10 -63.91 -39.5 94.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.168 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.2 -17.14 60.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.597 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.6 m -87.0 -16.44 35.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.305 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.85 -21.55 22.84 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.935 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.727 HG22 HD12 ' A' ' 133' ' ' ILE . 1.3 t -102.8 101.13 11.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.77 ' HB3' ' HA ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -142.64 175.25 9.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -167.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.436 ' HA ' HG23 ' A' ' 94' ' ' ILE . 16.2 t -63.46 129.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.47 175.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.47 -6.34 71.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.548 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.78 138.1 51.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 12.5 m -65.75 138.96 58.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -91.21 143.42 26.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.638 0.732 . . . . 0.0 112.894 -163.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.543 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 6.8 t0 -97.08 105.23 17.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.452 170.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.618 ' H ' ' HD2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -70.41 -14.17 62.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.632 -177.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.1 p -81.29 -24.53 37.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.653 0.263 . . . . 0.0 110.82 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -92.58 3.39 55.63 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 111.131 179.019 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.672 ' HA ' HD13 ' A' ' 133' ' ' ILE . 6.4 mm -59.46 -40.78 82.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.55 -34.95 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.472 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.1 -34.36 77.46 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.309 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.727 HD12 HG22 ' A' ' 119' ' ' VAL . 21.2 mt -64.8 -49.09 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.43 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.35 -45.78 92.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.414 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -40.61 89.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.316 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.33 88.77 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.759 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.514 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 13.8 mt -67.65 -35.72 79.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.639 0.257 . . . . 0.0 111.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.29 -30.48 66.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.859 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.41 -34.24 76.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -75.22 -39.83 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.346 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.481 ' HE2' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -61.24 -39.85 91.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.158 0.504 . . . . 0.0 110.867 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -30.07 69.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.536 177.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.4 m -73.11 -28.34 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 t -73.66 -87.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.448 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.94 19.3 23.29 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.597 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.6 mttp 66.59 51.44 1.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.447 0.699 . . . . 0.0 110.852 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -90.39 139.08 31.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.581 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.37 88.85 2.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.043 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.28 163.91 12.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.958 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.2 112.52 24.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 3.4 p -118.25 126.91 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.401 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 127.18 38.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.624 ' HB2' HG21 ' A' ' 130' ' ' ILE . . . -91.16 111.12 22.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.274 0.559 . . . . 0.0 110.258 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.61 123.25 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.25 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.516 HG23 HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -98.72 127.03 51.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.147 0.498 . . . . 0.0 110.208 177.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -104.74 120.34 50.56 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.153 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.35 135.18 18.14 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 122.821 2.347 . . . . 0.0 112.984 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.11 151.46 75.32 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.071 175.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.98 66.53 7.68 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.53 2.82 . . . . 0.0 113.499 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -148.6 16.07 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.169 173.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 37.9 t30 58.0 43.41 21.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.275 -168.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 74.9 mmt-85 -135.89 157.81 45.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.35 -177.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.588 HG22 HD21 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -132.7 145.6 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.019 173.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.65 121.73 45.88 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.459 HD13 ' HB1' ' A' ' 153' ' ' ALA . 37.9 tp -95.59 120.36 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.312 -174.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.598 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.71 131.78 55.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.649 0.738 . . . . 0.0 111.223 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.56 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.9 mm? -102.29 110.63 22.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.255 -176.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.7 t -96.67 110.71 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.526 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 8.0 m-85 -105.88 118.83 37.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.296 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.72 115.23 15.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.32 87.45 6.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.356 0.598 . . . . 0.0 110.658 -176.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 134.42 -131.64 6.01 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.385 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.5 t 69.04 -74.18 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.598 0.759 . . . . 0.0 110.597 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.349 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.548 0.213 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -81.5 152.74 27.17 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.938 0.399 . . . . 0.0 110.351 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.13 46.64 4.08 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -172.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -107.65 151.46 25.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.911 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.8 t -81.8 119.02 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.315 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 t -70.52 124.63 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.01 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -44.32 12.33 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.779 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 145.97 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.839 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -109.82 122.73 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -119.6 147.75 44.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.966 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.479 ' CD1' HD22 ' A' ' 34' ' ' LEU . 46.0 m-85 -124.43 130.97 53.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 0.0 110.991 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.68 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 1.4 tm-20 -123.22 69.89 1.02 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.482 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.11 -44.54 0.13 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.512 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.635 HD21 HG23 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -91.41 133.62 35.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.763 0.316 . . . . 0.0 111.149 -178.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.56 -36.12 2.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.869 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -44.21 83.75 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.158 175.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.2 t -81.74 130.34 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.76 156.97 17.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.543 0.211 . . . . 0.0 111.078 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.459 HG13 ' HD2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -51.96 -40.03 27.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 124.069 0.856 . . . . 0.0 112.751 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.43 90.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.199 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.53 -33.56 66.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.21 -33.63 59.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.689 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 mp -61.85 -31.31 71.56 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.174 0.59 . . . . 0.0 111.713 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.9 mt -67.28 -23.96 65.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.388 . . . . 0.0 111.652 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.806 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -89.79 -8.55 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.221 0.534 . . . . 0.0 110.209 177.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.463 ' HE1' HG22 ' A' ' 62' ' ' THR . 85.2 mtp -88.14 143.03 32.3 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.01 -16.18 40.49 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 122.359 2.039 . . . . 0.0 113.209 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 m -129.02 169.46 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.058 0.456 . . . . 0.0 111.642 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -127.88 177.2 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.691 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -66.4 125.11 24.64 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.53 -7.08 39.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.452 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.4 156.33 19.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 0.0 111.176 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.12 134.02 36.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.119 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.67 129.51 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 111.892 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -82.1 173.62 11.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.397 170.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HA ' HD11 ' A' ' 59' ' ' ILE . 6.4 p-10 -68.74 -26.27 65.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.346 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.48 -32.45 72.46 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.763 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -76.79 -28.7 55.74 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 122.302 0.241 . . . . 0.0 111.363 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.548 HD11 ' HA ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -61.66 -45.04 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -67.62 -31.2 71.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.32 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.763 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.6 m-20 -66.15 -41.38 90.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.284 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.463 HG22 ' HE1' ' A' ' 46' ' ' MET . 56.3 m -58.37 -46.65 85.92 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.017 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 65.0 mt -54.04 -50.9 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.545 0.528 . . . . 0.0 110.644 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -39.86 95.87 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.587 0.755 . . . . 0.0 111.747 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.67 -52.55 36.58 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.882 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.806 HD22 ' HB2' ' A' ' 45' ' ' SER . 41.1 mt -64.48 -30.61 71.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.429 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.2 -40.39 82.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.674 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 -12.9 61.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.803 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 45' ' ' SER . 34.6 p -78.14 -23.01 47.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.576 0.227 . . . . 0.0 110.708 -177.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.39 23.18 76.53 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.198 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -87.92 -28.76 21.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.15 . . . . 0.0 111.229 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.637 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -136.44 161.46 35.76 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.253 -177.026 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -79.84 -38.91 31.83 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.174 0.296 . . . . 0.0 111.185 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.83 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 7.9 t70 -139.16 137.76 36.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 66' ' ' LEU . 75.2 t -117.89 119.56 61.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.992 0.425 . . . . 0.0 109.902 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 118.67 32.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.174 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.535 HG23 HG23 ' A' ' 86' ' ' VAL . 67.2 t -114.82 128.99 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp -128.68 155.7 44.61 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -118.18 126.73 52.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.322 0.582 . . . . 0.0 109.803 174.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -125.63 97.08 5.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.772 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 -108.83 2.61 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.92 7.81 15.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.401 . . . . 0.0 110.407 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.91 129.21 53.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.215 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.49 115.89 31.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 32' ' ' GLU . 12.4 tp -108.05 121.38 44.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 -175.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.535 HG23 HG23 ' A' ' 77' ' ' VAL . 21.9 t -112.84 113.19 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.626 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.68 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 33.9 mt-30 -99.82 138.51 36.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.635 HG23 HD21 ' A' ' 34' ' ' LEU . 22.7 m -125.9 148.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.098 0.475 . . . . 0.0 110.679 -178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.83 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -100.17 150.84 22.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.86 -178.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.542 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -6.22 101.91 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 126.422 2.326 . . . . 0.0 114.274 178.353 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.637 ' HA ' ' HA ' ' A' ' 72' ' ' PHE . 31.3 mtp-105 -64.87 -55.1 30.19 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -170.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.714 ' HB2' HG23 ' A' ' 163' ' ' VAL . 16.7 Cg_exo -68.52 142.28 53.31 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.025 1.817 . . . . 0.0 114.468 -170.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -88.12 140.17 29.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.493 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.656 HD13 ' HB2' ' A' ' 125' ' ' LEU . 33.9 mt -65.19 118.24 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.45 -40.75 14.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.06 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.54 146.55 25.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.777 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -107.53 128.78 62.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.92 133.02 54.85 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.626 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 22.6 m-85 -113.52 135.49 53.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -136.91 127.37 26.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.412 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.61 46.38 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.29 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.87 79.99 1.26 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -33.45 21.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.553 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -46.94 76.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.725 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.428 HG11 ' N ' ' A' ' 106' ' ' LYS . 11.5 t -118.29 141.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.428 ' N ' HG11 ' A' ' 105' ' ' VAL . 15.0 mttp -69.71 151.48 45.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 111.483 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -35.26 79.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.172 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -28.87 65.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.724 0.297 . . . . 0.0 111.153 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.6 mtp -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.537 HD22 HD23 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -64.25 -34.73 78.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.963 175.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.626 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 2.4 mttt -59.42 -43.12 93.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.915 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.66 -28.76 56.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.622 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.39 -45.0 85.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.299 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -65.93 -37.16 85.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.21 176.006 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HG2' ' CG ' ' A' ' 120' ' ' ARG . 67.0 mt-10 -59.38 -46.58 88.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.26 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.81 61.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -85.04 -16.99 38.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.315 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.98 -19.85 15.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.408 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.691 HG22 HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -96.0 106.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.316 0.579 . . . . 0.0 110.811 -176.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.426 ' CG ' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -119.0 163.29 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.136 -173.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.418 ' HA ' HG23 ' A' ' 94' ' ' ILE . 38.1 t -69.35 123.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 109.963 174.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.56 -7.27 80.02 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.061 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 161.58 13.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -74.89 149.54 39.46 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.656 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -103.04 146.76 27.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.969 0.414 . . . . 0.0 111.716 -173.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.517 ' HA ' ' HG3' ' A' ' 90' ' ' GLU . 34.6 t0 -116.25 101.49 8.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.648 174.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.463 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.46 -20.14 62.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.233 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -27.09 65.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.548 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -0.01 43.06 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.805 177.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.463 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.9 mm -59.31 -37.87 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.451 0.301 . . . . 0.0 111.69 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.38 86.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.913 0.387 . . . . 0.0 111.3 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -30.07 64.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.474 HD12 HG23 ' A' ' 119' ' ' VAL . 7.9 mt -69.26 -42.51 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.272 175.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -64.38 -40.57 96.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -68.46 -38.06 80.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.626 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.68 -37.5 92.49 Favored Glycine 0 C--O 1.227 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.852 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.537 HD23 HD22 ' A' ' 110' ' ' LEU . 11.1 mt -73.01 -34.3 66.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.682 0.277 . . . . 0.0 111.202 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -38.84 87.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.153 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.41 -37.53 71.51 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.597 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -61.47 -41.96 98.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.809 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 147' ' ' TYR . 1.2 m-85 -62.21 -37.58 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.847 177.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 56.9 t80 -70.41 -35.44 73.44 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.335 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.8 m -67.69 -31.81 72.02 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 t -74.63 -91.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.806 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.43 18.58 22.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.412 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 7.8 mtmt 60.01 57.42 3.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.441 0.639 . . . . 0.0 110.205 -173.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.457 ' O ' ' HD1' ' A' ' 141' ' ' TYR . 51.2 m-85 -96.64 34.89 1.58 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.701 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.13 102.71 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.97 152.51 45.58 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.617 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 m -96.77 126.63 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 110.373 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.4 p -106.48 134.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.43 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -108.81 117.04 33.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.012 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.432 ' HB3' HD12 ' A' ' 167' ' ' LEU . . . -92.21 110.45 21.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.318 0.58 . . . . 0.0 110.1 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.69 117.0 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.386 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -99.67 112.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.185 0.516 . . . . 0.0 110.047 175.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 8.1 m -104.7 121.65 46.2 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 6.2 Cg_exo -79.9 143.78 16.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.109 2.539 . . . . 0.0 112.126 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -129.92 156.76 78.55 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.939 174.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.85 70.85 3.49 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.489 2.793 . . . . 0.0 113.266 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.538 ' HB2' HD13 ' A' ' 158' ' ' LEU . 6.0 ttm180 -163.35 15.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.36 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.9 t30 55.59 42.27 29.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.199 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -129.95 157.99 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.815 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -128.74 152.37 36.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.114 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.87 118.71 37.46 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.425 HD11 HG11 ' A' ' 155' ' ' VAL . 51.8 tp -99.17 112.18 24.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.128 -175.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HG2' HG21 ' A' ' 168' ' ' VAL . 8.2 ttmt -111.63 132.68 54.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.483 0.658 . . . . 0.0 111.145 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.5 mm? -108.63 109.41 20.6 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.408 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.419 HG21 ' HG2' ' A' ' 166' ' ' LYS . 1.5 t -107.19 113.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.807 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.475 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 3.2 m-85 -98.34 118.91 36.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.117 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.4 114.68 19.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.627 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -80.49 99.99 8.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.538 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 99.63 98.9 2.21 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.701 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.2 p -138.69 -62.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.383 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.327 -0.413 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.576 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.897 ' HA ' ' HB ' ' A' ' 53' ' ' THR . 1.8 mm-40 57.33 62.3 2.22 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 124.289 0.993 . . . . 0.0 112.578 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.84 -53.17 0.98 Allowed Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.323 171.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p90 -150.47 152.23 33.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.878 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 53' ' ' THR . 54.7 t -85.86 118.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.1 119.04 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.354 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.65 -34.61 19.74 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.442 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 83' ' ' THR . 20.8 t70 -158.57 145.6 17.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.196 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.587 HD13 HG21 ' A' ' 50' ' ' THR . 4.6 mt -109.28 120.65 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -116.5 127.11 54.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.767 -178.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.41 136.52 40.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.406 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.2 58.22 0.69 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.955 0.883 . . . . 0.0 109.647 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.95 -121.57 0.93 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.611 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.3 mt 62.18 138.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.27 1.028 . . . . 0.0 113.755 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.33 -56.64 0.32 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.008 -0.432 . . . . 0.0 110.658 174.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -36.78 65.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.132 0.491 . . . . 0.0 110.334 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 141.59 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.721 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.35 159.53 15.07 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.99 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -51.22 -43.23 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.83 -35.54 50.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.75 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.692 ' HA ' HD13 ' A' ' 44' ' ' LEU . . . -71.45 -29.2 64.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.215 0.531 . . . . 0.0 111.031 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.71 -34.65 60.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.409 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.827 HD23 ' HG2' ' A' ' 49' ' ' ARG . 2.3 mt -56.98 -30.26 63.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.384 0.673 . . . . 0.0 112.79 170.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 41' ' ' ALA . 69.9 mt -61.57 -29.31 69.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 111.445 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.777 ' HB3' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -91.33 -8.82 47.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.014 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.513 ' HG3' ' HA ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -86.28 132.55 42.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 6.7 Cg_exo -74.23 -8.61 21.1 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.784 2.323 . . . . 0.0 112.749 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.411 HG13 ' CG1' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -139.93 151.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.939 0.4 . . . . 0.0 110.418 -175.111 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.827 ' HG2' HD23 ' A' ' 43' ' ' LEU . 81.5 mtt-85 -131.57 179.41 6.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.576 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.587 HG21 HD13 ' A' ' 29' ' ' ILE . 7.4 p -63.08 123.43 18.56 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.256 -177.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.44 -6.83 39.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.8 m-20 -87.61 148.87 24.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.816 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.897 ' HB ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -101.15 124.51 46.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.342 178.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' CG1' HG13 ' A' ' 48' ' ' VAL . 2.1 m -142.02 145.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -170.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -100.47 -177.76 3.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.38 -26.44 66.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.786 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.83 -31.64 68.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.642 0.258 . . . . 0.0 110.572 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.38 -29.38 59.83 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.202 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -44.84 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.672 ' HA ' HD13 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -68.28 -34.01 75.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.435 177.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -66.58 -40.87 89.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.006 0.431 . . . . 0.0 110.387 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.559 HG21 HD13 ' A' ' 66' ' ' LEU . 90.9 m -58.59 -43.8 89.65 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.154 172.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.672 HD13 ' HA ' ' A' ' 60' ' ' SER . 74.6 mt -55.97 -47.15 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.743 176.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmm-85 -62.76 -42.53 99.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.63 -53.39 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.559 HD13 HG21 ' A' ' 62' ' ' THR . 16.4 mt -63.6 -32.66 74.19 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.657 0.598 . . . . 0.0 111.624 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -39.66 91.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.0 110.888 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.67 60.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.222 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 45' ' ' SER . 42.3 p -79.78 -24.93 41.14 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -172.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.75 20.73 79.84 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.752 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -88.83 -26.34 21.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.292 0.568 . . . . 0.0 110.142 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.16 156.54 43.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.364 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.519 ' OE1' ' HE2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.64 -44.24 24.33 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.29 0.369 . . . . 0.0 111.275 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 31.5 t70 -130.73 139.28 50.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.285 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 t -123.51 120.16 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.238 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.49 117.29 29.96 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.575 HG21 HG11 ' A' ' 86' ' ' VAL . 84.4 t -113.87 122.66 68.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.3 137.84 46.16 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.437 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 6.5 ptm180 -95.31 140.56 30.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.356 0.598 . . . . 0.0 110.387 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -130.62 96.94 4.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.43 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.68 -109.08 2.72 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.166 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -108.2 1.7 22.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 0.0 110.759 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.482 HG21 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.71 137.41 41.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 -173.624 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.71 115.54 30.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.24 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.6 tp -102.52 119.25 38.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.575 HG11 HG21 ' A' ' 77' ' ' VAL . 17.7 t -117.88 108.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.759 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.92 136.49 44.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.06 153.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.262 0.553 . . . . 0.0 111.073 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.581 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -98.91 122.27 41.94 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.614 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -147.98 167.08 25.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.74 -168.049 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.8 OUTLIER 110.59 -63.7 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 126.525 1.93 . . . . 0.0 113.243 172.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.16 139.61 56.12 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 121.414 1.409 . . . . 0.0 112.917 -173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 66.9 m -127.75 133.35 49.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.319 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.761 HD13 ' HB2' ' A' ' 125' ' ' LEU . 56.9 mt -69.13 118.86 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.09 -34.67 12.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.565 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 138.3 24.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 120' ' ' ARG . 4.7 mt -110.75 123.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 131.74 56.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.064 0.459 . . . . 0.0 110.898 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.578 ' HE2' HD11 ' A' ' 167' ' ' LEU . 21.2 m-85 -110.13 135.75 50.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.989 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.98 122.72 11.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.18 -14.5 64.39 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.535 174.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.29 78.11 3.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 110.829 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -85.84 -19.35 30.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -78.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.526 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.496 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 54.4 t -84.21 139.17 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -69.92 152.19 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.053 0.454 . . . . 0.0 111.644 -172.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.26 76.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.546 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -38.01 89.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mtp -73.05 -39.33 66.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.359 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -32.74 74.31 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.417 177.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.441 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 10.3 mttt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.076 0.465 . . . . 0.0 110.954 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -28.76 55.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.622 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -67.84 -38.5 83.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.9 -38.46 83.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.467 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.47 -33.66 76.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.088 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.38 -16.11 60.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.079 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 m -91.83 -16.55 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.193 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 107.93 -25.65 19.95 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.921 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.555 HG23 HD12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -88.19 107.89 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.155 0.503 . . . . 0.0 111.451 -173.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.442 ' HA ' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -140.94 175.49 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.548 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.435 HG22 HG13 ' A' ' 97' ' ' ILE . 27.3 t -67.33 126.32 26.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 110.074 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.29 -6.77 66.18 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.34 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 160.4 14.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.234 0.54 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.91 117.97 23.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.802 174.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.761 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.89 137.42 33.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.093 0.473 . . . . 0.0 112.074 -172.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -101.9 105.98 16.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.878 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.414 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.02 -15.72 62.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.403 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.8 p -87.18 -20.45 26.96 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.56 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.3 p -98.69 6.83 46.73 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.927 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.523 ' HA ' HD11 ' A' ' 133' ' ' ILE . 4.6 mm -55.94 -37.58 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.05 85.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.18 -36.22 79.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 110.068 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.555 HD12 HG23 ' A' ' 119' ' ' VAL . 7.0 mt -66.33 -42.99 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.443 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.18 -45.0 96.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -34.15 77.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.325 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.53 -42.16 89.06 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.777 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.9 -38.62 91.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HG3' HG13 ' A' ' 151' ' ' VAL . 13.8 mt-10 -69.62 -34.54 74.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.254 0.346 . . . . 0.0 111.067 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.52 -41.83 75.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.435 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.49 -37.18 82.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.496 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.95 -41.18 91.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.163 0.506 . . . . 0.0 110.476 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -30.35 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.51 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.8 m -72.35 -28.58 63.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.856 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.4 t -77.54 -82.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.767 0.317 . . . . 0.0 111.092 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.5 19.46 21.85 Favored Glycine 0 N--CA 1.454 -0.101 0 C-N-CA 121.358 -0.449 . . . . 0.0 112.833 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm 66.05 34.35 7.0 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.341 0.656 . . . . 0.0 110.485 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -76.63 126.27 30.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.219 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.62 59.12 0.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.242 0.544 . . . . 0.0 110.565 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.95 148.21 22.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.642 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 m -97.86 118.82 35.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.942 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.7 p -98.8 137.35 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 116.95 19.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.077 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.49 111.53 23.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.424 0.631 . . . . 0.0 109.949 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.99 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.391 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.422 ' H ' HG21 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -99.67 109.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.483 0.658 . . . . 0.0 110.219 175.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.6 m -104.67 113.47 64.93 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.811 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.37 128.13 8.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.085 2.523 . . . . 0.0 113.004 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -109.46 143.59 28.09 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.38 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 16.5 Cg_exo -67.69 79.52 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.83 3.02 . . . . 0.0 114.008 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -157.44 -75.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.3 t30 177.79 13.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.802 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.551 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 26.4 mmt-85 -117.92 157.7 26.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.414 -170.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.511 HG13 HD23 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -127.93 152.61 36.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.319 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -108.3 118.89 37.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.4 tp -106.58 110.7 22.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.07 0.462 . . . . 0.0 110.339 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -112.55 132.53 55.07 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.258 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.578 HD11 ' HE2' ' A' ' 99' ' ' PHE . 1.5 mp -114.31 112.09 22.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.696 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.55 112.99 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.596 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.503 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 2.4 m-85 -99.6 118.68 36.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.93 113.53 20.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.82 0.343 . . . . 0.0 110.867 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.38 61.51 1.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.668 0.747 . . . . 0.0 109.515 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.94 50.48 0.72 Allowed Glycine 0 CA--C 1.504 -0.595 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.895 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.492 ' HB ' ' H ' ' A' ' 174' ' ' SER . 0.1 OUTLIER -125.97 -145.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.892 -174.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.492 ' H ' ' HB ' ' A' ' 173' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.378 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.29 118.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.693 1.246 . . . . 0.0 111.602 177.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.09 44.83 64.79 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.487 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.55 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 2.7 p90 -93.8 153.38 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.631 0.253 . . . . 0.0 110.51 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.36 117.78 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.245 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 84' ' ' LEU . 2.8 t -69.16 137.91 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.233 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 -37.75 5.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.27 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -143.86 138.55 28.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.481 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.698 HG23 ' HE2' ' A' ' 46' ' ' MET . 86.7 mt -103.87 120.72 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 127.95 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.407 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -103.8 122.33 44.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.366 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.757 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 4.3 mt-10 -98.68 54.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.913 0.863 . . . . 0.0 109.907 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.87 -100.77 0.14 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.32 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' A' ' 34' ' ' LEU . 7.1 mt 45.64 84.77 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.079 0.952 . . . . 0.0 112.946 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -96.95 -29.33 13.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.654 -176.265 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -118.16 -42.51 2.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.62 144.53 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.725 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.58 157.96 16.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.991 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -58.88 -31.61 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.56 81.23 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.872 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.696 ' HA ' HD13 ' A' ' 44' ' ' LEU . . . -76.19 -35.94 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.136 0.493 . . . . 0.0 110.696 176.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.42 83.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.442 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.592 HD23 ' HD2' ' A' ' 49' ' ' ARG . 2.6 mt -57.8 -32.76 67.87 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 41' ' ' ALA . 2.0 mt -72.58 -21.15 61.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.612 0.244 . . . . 0.0 111.352 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.45 -21.98 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.018 0.437 . . . . 0.0 110.369 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.698 ' HE2' HG23 ' A' ' 29' ' ' ILE . 77.0 mtm -82.65 135.73 45.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.39 -2.75 12.77 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.56 2.173 . . . . 0.0 112.444 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.78 147.56 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.592 ' HD2' HD23 ' A' ' 43' ' ' LEU . 4.1 mmm180 -129.6 175.13 9.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.936 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.6 p -68.06 120.99 15.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.69 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.18 -5.27 52.56 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.424 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -80.02 155.89 27.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 0.0 111.594 -177.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -106.24 126.04 51.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.229 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.03 133.45 58.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 112.134 -168.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -98.77 -177.27 3.6 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.094 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.568 ' HA ' HD11 ' A' ' 59' ' ' ILE . 10.1 t70 -60.32 -32.75 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.568 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.7 -43.09 89.94 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.549 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 31.1 m-20 -75.09 -27.99 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.246 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -59.78 -52.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 172.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.47 -26.29 62.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.259 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 64' ' ' ARG . 1.8 t-20 -63.98 -47.14 81.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -60.78 -45.66 93.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 174.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.1 mt -53.72 -55.5 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 123.544 0.528 . . . . 0.0 110.886 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.91 -30.47 67.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.08 -175.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.32 -48.22 68.22 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.558 0.218 . . . . 0.0 110.592 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.494 ' HA ' HG22 ' A' ' 69' ' ' THR . 84.0 mt -69.27 -30.41 68.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -40.51 94.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 110.774 175.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.57 -13.43 62.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.601 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 66' ' ' LEU . 12.3 p -79.03 -24.92 43.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.547 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.46 ' HA2' ' HG3' ' A' ' 123' ' ' GLU . . . 80.83 -10.25 47.64 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.317 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -67.07 -31.72 72.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.4 144.46 46.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.848 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -73.4 -37.25 66.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.054 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -139.49 136.51 34.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 66' ' ' LEU . 39.3 t -127.59 118.15 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.085 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.09 55.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 68.1 t -125.52 118.38 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -133.14 159.14 41.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -172.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.459 ' HD3' ' CD1' ' A' ' 59' ' ' ILE . 15.5 mtm180 -113.49 147.59 37.6 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.655 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -135.27 96.83 3.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.736 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.8 -109.25 2.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.512 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.407 ' HA ' ' CD2' ' A' ' 24' ' ' PHE . 3.8 m-20 -112.85 14.22 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.227 0.537 . . . . 0.0 109.923 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.45 136.82 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.257 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.55 HD13 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.34 112.13 24.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 tp -106.4 112.46 25.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.624 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.3 t -114.51 117.12 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.757 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.0 mt-30 -106.97 124.94 50.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.99 145.01 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.196 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.16 111.7 24.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.175 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 35' ' ' GLN . 3.6 mt-10 -119.6 95.48 4.8 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.078 -0.388 . . . . 0.0 110.438 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.73 -69.71 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.86 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.474 ' O ' ' HA ' ' A' ' 124' ' ' SER . 18.9 Cg_endo -88.29 141.08 4.83 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.641 1.561 . . . . 0.0 113.939 -167.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.721 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 94.0 m -111.93 124.8 53.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.421 176.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.728 HD13 ' HB2' ' A' ' 125' ' ' LEU . 19.0 mt -67.54 118.8 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.01 6.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.239 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.05 144.33 27.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.401 . . . . 0.0 110.856 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.451 HD13 HG22 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -106.9 123.87 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 171.304 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.99 141.35 49.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.381 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HE1' ' HB2' ' A' ' 111' ' ' LYS . 24.1 m-85 -117.59 152.33 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 112.018 -172.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.79 111.91 3.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.544 ' HA3' ' HG2' ' A' ' 171' ' ' GLU . . . 118.46 55.09 0.28 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.257 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.473 HD22 HD23 ' A' ' 110' ' ' LEU . 33.1 m120 -126.24 41.52 3.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.224 -0.488 . . . . 0.0 112.044 -172.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HD3' ' HA ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -86.03 -16.03 39.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.526 177.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.496 ' HB2' ' CE1' ' A' ' 141' ' ' TYR . 75.6 m -105.21 -45.19 4.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.639 0.257 . . . . 0.0 111.108 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.0 t -120.62 147.65 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.44 147.45 50.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.188 0.518 . . . . 0.0 111.939 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.74 -35.2 78.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.446 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -35.09 79.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.121 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -41.65 77.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.215 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.473 HD23 HD22 ' A' ' 102' ' ' ASN . 0.3 OUTLIER -62.87 -40.62 98.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.235 175.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.531 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -64.96 -43.27 93.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.224 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.11 -27.42 60.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -66.57 -43.65 84.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.417 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -43.24 99.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.652 173.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.783 ' HG2' ' HG3' ' A' ' 120' ' ' ARG . 91.9 mt-10 -59.9 -42.95 94.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.511 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.75 -18.68 60.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.858 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 m -87.4 -17.18 32.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.632 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.75 -21.22 8.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.282 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.625 HG13 HD11 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -89.14 103.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.372 0.606 . . . . 0.0 110.147 -177.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.783 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 12.2 ttp-105 -130.98 161.88 30.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.346 -172.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.471 ' HA ' HG23 ' A' ' 94' ' ' ILE . 24.2 t -69.9 124.43 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.956 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.68 -21.67 44.89 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.594 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.46 ' HG3' ' HA2' ' A' ' 70' ' ' GLY . 1.0 OUTLIER -95.79 166.22 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 110.758 -178.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -83.13 142.65 31.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.425 -176.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -116.22 138.64 51.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.451 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 25.6 t0 -94.8 121.07 36.01 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.195 0.998 . . . . 0.0 111.486 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -21.85 61.27 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.661 -1.608 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.9 p -89.6 -10.68 45.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.905 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 1.1 p -104.33 7.32 35.71 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.001 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 mm -55.31 -43.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.644 0.59 . . . . 0.0 111.854 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 135' ' ' LYS . . . -62.48 -42.71 99.68 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.492 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.46 -29.02 66.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.888 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.25 -42.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.762 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' HA ' HG13 ' A' ' 151' ' ' VAL . 54.6 mt-10 -60.91 -46.76 89.38 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 50.6 mmtt -67.88 -36.39 80.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -40.23 84.79 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.374 -0.441 . . . . 0.0 112.608 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.533 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 10.0 mt -69.62 -31.97 70.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.806 ' HG3' HG22 ' A' ' 151' ' ' VAL . 6.2 mt-10 -64.62 -41.37 96.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.418 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -68.56 -34.06 75.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.543 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.418 ' HE1' HD11 ' A' ' 110' ' ' LEU . 28.0 t80 -60.76 -44.28 96.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.536 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 104' ' ' SER . 0.2 OUTLIER -62.7 -38.95 92.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 177.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.55 -29.93 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.999 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 m -70.55 -30.33 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.4 t -73.9 -82.28 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 110.853 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.69 18.67 22.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.029 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 63.73 40.82 7.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 110.271 -173.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -81.55 120.99 25.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.627 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 101.01 9.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -114.84 156.42 24.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 170' ' ' GLN . 0.7 OUTLIER -120.16 120.7 36.95 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.806 HG22 ' HG3' ' A' ' 138' ' ' GLU . 49.0 t -102.57 124.28 56.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 0.0 111.812 -172.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.85 115.82 26.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.87 111.12 23.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.65 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.66 112.97 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.033 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 117.65 49.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 109.369 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.6 m -104.67 116.89 60.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.944 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.508 ' HA ' HG11 ' A' ' 163' ' ' VAL . 91.4 Cg_endo -86.84 136.73 4.42 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.096 2.531 . . . . 0.0 113.113 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -126.03 150.2 68.61 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 171.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 22.1 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.471 2.781 . . . . 0.0 114.108 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -113.67 26.37 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.208 -0.308 . . . . 0.0 110.81 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.5 t30 74.88 5.35 4.36 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 0.0 111.52 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.721 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 9.8 mmt-85 -113.56 160.29 18.69 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 111.176 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.569 HG22 HD21 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -136.73 145.26 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.486 175.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.23 131.02 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.67 117.44 33.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.773 0.321 . . . . 0.0 111.188 -173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 131.63 56.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 0.0 109.816 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.514 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.89 111.72 23.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.305 -175.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.4 t -94.94 111.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.785 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.533 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 8.7 m-85 -114.18 142.02 46.78 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.231 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.406 ' HB2' ' H ' ' A' ' 150' ' ' SER . 45.3 mm-40 -82.18 125.06 30.47 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 167.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.544 ' HG2' ' HA3' ' A' ' 101' ' ' GLY . 1.3 mt-10 -81.61 32.2 0.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -170.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.43 129.96 5.43 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.5 ' HB ' ' H ' ' A' ' 174' ' ' SER . 0.0 OUTLIER -81.08 -136.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.587 0.232 . . . . 0.0 110.395 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.5 ' H ' ' HB ' ' A' ' 173' ' ' VAL . 2.5 m . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.129 0.49 . . . . 0.0 109.732 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -110.32 154.21 23.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.09 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.41 115.75 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.355 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.38 142.45 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.486 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -38.31 7.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.398 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -143.32 146.91 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.9 mt -111.23 130.49 64.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.8 156.44 34.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.479 ' HD2' HG12 ' A' ' 39' ' ' VAL . 5.9 m-85 -128.53 119.66 25.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.41 73.9 2.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.738 0.78 . . . . 0.0 110.599 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.691 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.023 179.467 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.301 0 CA-C-O 120.444 0.164 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.479 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.4 m -57.05 -29.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.65 71.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.949 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 -33.94 57.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 110.381 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.62 -31.45 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.66 -32.02 64.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.799 0.839 . . . . 0.0 112.788 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.1 -23.7 65.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.838 0.351 . . . . 0.0 111.633 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.525 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -90.34 -7.49 53.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 178.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.466 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 56.7 mtp -100.39 132.64 22.19 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.9 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 23.1 Cg_exo -66.33 -19.99 55.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.886 2.391 . . . . 0.0 112.665 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -104.06 155.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.404 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.528 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.3 176.21 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -68.91 121.52 16.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.983 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.98 -6.33 51.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.139 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 2.9 m-20 -81.16 156.49 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 111.263 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.03 125.98 35.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.27 128.43 72.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 111.907 -173.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -98.42 -178.27 3.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.082 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.19 -26.77 65.0 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.62 -37.12 86.13 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.548 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.68 -30.96 64.69 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.433 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.84 -46.86 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 123.303 0.377 . . . . 0.0 110.264 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.52 69.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.141 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 2.0 t-20 -68.22 -43.4 78.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.999 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 p -64.2 -40.78 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.774 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.47 HG13 HG23 ' A' ' 77' ' ' VAL . 39.7 mt -55.87 -52.7 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 123.427 0.455 . . . . 0.0 110.997 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.7 -29.64 67.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.34 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.56 -52.54 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.703 0.287 . . . . 0.0 110.414 176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 45' ' ' SER . 66.9 mt -66.22 -27.28 67.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.872 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -38.54 76.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.973 -0.454 . . . . 0.0 110.236 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.82 -14.79 59.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.538 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 65' ' ' ALA . 69.0 p -79.71 -25.03 41.28 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.03 88.13 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.459 -0.791 . . . . 0.0 114.601 166.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.12 -29.18 38.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.578 0.689 . . . . 0.0 111.042 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.492 ' HE1' HD22 ' A' ' 66' ' ' LEU . 1.5 m-85 -107.1 152.98 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 6.7 mm-40 -86.67 -26.93 24.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.342 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 6.8 t70 -148.75 146.89 28.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 66' ' ' LEU . 62.1 t -129.89 119.8 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.112 0.257 . . . . 0.0 110.701 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.97 118.79 31.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.55 0.214 . . . . 0.0 110.928 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.47 HG23 HG13 ' A' ' 63' ' ' ILE . 27.5 t -107.91 123.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.89 157.85 44.79 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -102.7 148.21 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.398 0.618 . . . . 0.0 111.657 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -139.55 97.43 3.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.657 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.79 -118.47 8.3 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 15.83 24.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 110.003 174.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.71 128.58 52.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -102.33 115.69 31.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -113.79 129.53 56.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.681 0.753 . . . . 0.0 110.87 -175.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG13 HG22 ' A' ' 77' ' ' VAL . 13.1 t -113.98 105.78 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.413 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -90.91 133.92 34.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.86 154.89 33.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.038 0.447 . . . . 0.0 110.956 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.641 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 4.3 tptt . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.757 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 31.6 Cg_exo . . . . . 0 CA--C 1.53 0.316 0 CA-C-O 121.797 0.665 . . . . 0.0 113.648 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.589 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 29.3 m -96.12 146.48 24.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.877 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.451 HG13 ' HB2' ' A' ' 125' ' ' LEU . 6.0 mt -63.05 117.77 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.08 -48.62 3.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.41 137.52 34.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.138 0.494 . . . . 0.0 111.323 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.782 HG21 HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -111.63 121.75 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.09 52.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.756 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.595 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 23.1 m-85 -114.92 138.05 51.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -173.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.557 ' OG ' ' HE3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -138.79 112.16 8.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.418 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.726 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 112.56 22.32 5.81 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.371 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.16 69.52 7.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.229 0.537 . . . . 0.0 110.383 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -85.16 -26.77 26.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.357 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.6 m -112.28 -60.77 1.82 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.082 0.467 . . . . 0.0 111.197 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -89.28 141.52 14.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.512 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 146.49 52.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.709 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.16 -35.29 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -64.13 -35.61 81.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.1 mtp -67.16 -45.17 77.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.267 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.709 HD12 ' HA ' ' A' ' 107' ' ' ASP . 10.0 mt -62.72 -33.34 74.91 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.451 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -60.61 -48.9 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.303 0.377 . . . . 0.0 111.296 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.45 -27.98 52.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.285 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -63.66 -44.28 94.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.281 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.782 HD22 HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -63.88 -42.85 97.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 175.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' A' ' 120' ' ' ARG . 8.6 mt-10 -61.25 -40.87 95.68 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.392 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.27 60.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.5 m -92.56 -16.36 25.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.235 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.32 -48.05 0.8 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.162 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 t -82.26 103.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.488 0.661 . . . . 0.0 109.685 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' HA ' ' HG2' ' A' ' 115' ' ' GLU . 2.2 ttp85 -128.6 149.49 50.61 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -174.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.03 123.61 21.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.155 0.502 . . . . 0.0 110.795 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.79 70.05 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.713 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -102.95 156.13 17.88 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -177.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.745 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -56.55 133.62 53.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.858 0.463 . . . . 0.0 111.216 174.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.91 145.36 24.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.326 0.584 . . . . 0.0 111.626 -176.369 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.556 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 12.8 t0 -117.44 121.64 41.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.049 173.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -17.47 61.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.912 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 p -88.64 -21.69 23.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.734 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 6.1 p -85.57 -7.68 58.72 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.405 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 153' ' ' ALA . 9.2 mm -57.45 -46.38 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.116 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.82 -34.55 78.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.75 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.07 -35.19 77.79 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.288 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.2 mt -67.13 -43.61 88.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.208 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -57.28 -49.81 74.91 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.13 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -68.12 -35.48 78.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.477 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.32 -41.63 77.79 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.734 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.444 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 49.3 mt -71.94 -32.64 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.675 ' HG3' HG23 ' A' ' 151' ' ' VAL . 18.0 mt-10 -63.6 -42.49 98.24 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.308 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.13 -37.94 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.916 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.2 m-85 -62.82 -42.62 99.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.386 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -40.59 95.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.11 -30.65 68.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.322 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.1 m -73.91 -27.63 61.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.366 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 140' ' ' PHE . 24.4 t -74.94 -85.09 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.87 19.3 23.43 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.32 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 49.9 1.76 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.394 0.677 . . . . 0.0 110.394 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -89.24 125.17 34.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.96 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.04 97.41 7.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.274 0.559 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -122.59 149.08 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.537 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.45 131.17 45.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.675 HG23 ' HG3' ' A' ' 138' ' ' GLU . 28.8 t -111.85 126.73 69.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.943 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 122.69 28.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.033 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.695 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -98.37 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.238 0.542 . . . . 0.0 110.902 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 28.0 t -98.27 120.61 47.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.61 118.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.619 . . . . 0.0 110.925 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.1 m -112.99 119.15 43.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.86 137.59 15.99 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.767 2.311 . . . . 0.0 112.709 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -121.55 148.96 51.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.578 175.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 8.5 Cg_exo -73.33 58.59 3.7 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.712 2.941 . . . . 0.0 113.911 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.578 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -144.86 18.07 1.62 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 60.43 40.15 17.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.526 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.589 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -141.77 167.13 22.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.711 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -127.68 143.33 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 110.965 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -110.8 118.76 37.02 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.487 ' HG ' HG23 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -116.62 132.57 56.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.884 0.85 . . . . 0.0 111.371 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.557 ' HE3' ' OG ' ' A' ' 100' ' ' SER . 5.3 tttt -115.35 133.3 56.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.964 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.595 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.0 mm? -102.56 111.31 23.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.241 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.7 113.92 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.664 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.726 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 38.6 m-85 -105.07 118.09 35.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.452 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.822 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.666 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 26.4 p90 -104.52 153.03 21.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.88 116.65 29.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.91 113.82 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.63 0.729 . . . . 0.0 110.489 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 7.2 mmtm -79.17 -32.44 44.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.967 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HB3' HG23 ' A' ' 83' ' ' THR . 24.0 t0 -149.32 139.91 22.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.079 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.3 mt -112.1 122.49 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.15 140.71 50.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -114.71 148.61 38.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.497 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -142.86 75.62 1.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.36 177.161 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.358 0 CA-C-O 120.246 0.07 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -59.12 -35.8 59.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.27 -40.07 87.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.801 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.21 69.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 110.49 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.05 -40.74 71.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HA ' ' SD ' ' A' ' 46' ' ' MET . 4.1 mp -62.91 -32.19 73.42 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.536 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 49.0 mt -69.32 -22.85 63.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.334 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -85.44 -18.0 34.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.662 ' HG2' HG23 ' A' ' 62' ' ' THR . 42.0 mtp -82.4 148.44 59.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.839 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.52 12.51 2.85 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.779 2.32 . . . . 0.0 113.126 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.11 166.43 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.722 ' HD2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.89 176.94 7.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.137 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -66.4 126.78 29.88 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.689 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.44 -4.46 54.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.657 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.722 ' HB2' ' HD2' ' A' ' 49' ' ' ARG . 2.6 t0 -92.32 156.81 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.412 . . . . 0.0 111.359 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 m -88.34 134.09 33.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.884 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.13 128.91 65.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 111.411 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -98.57 -178.31 3.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.263 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -37.07 79.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.284 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.81 -37.88 80.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.157 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -74.29 -30.45 62.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -50.43 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 173.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -67.62 -32.71 73.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.59 0.233 . . . . 0.0 111.213 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.55 -41.65 88.32 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.684 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.662 HG23 ' HG2' ' A' ' 46' ' ' MET . 91.2 m -60.37 -43.51 96.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 172.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 60' ' ' SER . 59.7 mt -56.07 -54.54 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 123.274 0.359 . . . . 0.0 111.122 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -69.33 -29.62 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.6 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HB2' HG11 ' A' ' 75' ' ' VAL . 80.3 mt -71.19 -30.09 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.814 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.85 -33.84 75.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.373 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.89 -13.27 61.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.196 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.5 p -78.94 -24.43 43.99 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.758 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.02 10.16 84.03 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.291 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -91.41 -25.51 19.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.941 0.4 . . . . 0.0 110.876 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.7 148.43 42.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.343 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -91.8 -14.06 30.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.158 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 9.3 t70 -154.65 138.31 16.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 66' ' ' LEU . 49.0 t -126.34 118.79 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.4 118.16 31.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.373 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.62 122.18 61.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mt -131.14 140.1 49.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.666 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -99.79 140.03 34.59 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.536 0.684 . . . . 0.0 110.293 -178.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.65 95.08 4.31 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.54 -109.58 2.97 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.484 ' HB2' ' HG2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -112.67 13.69 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 175.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.476 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -103.48 135.12 45.67 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.449 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -103.48 111.63 24.16 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.059 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 tp -104.28 119.63 39.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.868 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -117.05 113.75 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.325 0.583 . . . . 0.0 111.265 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -102.24 140.62 36.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.38 157.31 34.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 120.978 0.418 . . . . 0.0 110.438 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.416 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo . . . . . 0 N--CA 1.474 0.337 0 CA-C-O 121.523 0.551 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 4.3 m -110.42 140.22 44.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.897 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 121' ' ' VAL . 13.7 mt -59.09 119.05 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 109.832 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.45 -32.12 9.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.501 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.11 138.38 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.701 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.426 HG21 ' CD1' ' A' ' 114' ' ' LEU . 1.5 mt -118.75 132.16 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.04 139.19 52.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.652 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.524 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.6 m-85 -112.68 139.33 48.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.58 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.69 123.02 17.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.132 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.62 17.61 25.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.839 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -96.94 77.24 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 111.033 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.26 -40.43 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.654 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -76.52 -57.88 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.353 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.57 143.95 10.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -71.02 145.95 49.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 0.0 112.091 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -39.89 84.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.098 171.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.13 -45.32 87.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.84 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -41.23 79.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -32.95 74.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.891 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -47.84 84.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 111.334 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -77.95 -27.12 49.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -63.88 -38.43 91.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.397 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.426 ' CD1' HG21 ' A' ' 97' ' ' ILE . 14.2 mt -68.14 -43.09 79.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.533 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -58.93 -43.53 91.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.194 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.3 61.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.629 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.4 m -91.17 -14.66 30.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 110.559 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.75 -26.55 7.55 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.971 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -89.16 104.0 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.187 0.517 . . . . 0.0 110.88 -176.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 3.6 ptp85 -140.59 172.42 12.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.501 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.554 ' HA ' HG22 ' A' ' 94' ' ' ILE . 50.9 t -69.97 128.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.35 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.12 61.78 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.337 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -120.85 146.31 46.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.07 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 35.2 t -65.69 151.73 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 111.227 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.53 145.21 24.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.596 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 130' ' ' ILE . 5.3 t70 -104.62 99.01 8.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.296 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.503 ' HA ' ' CG1' ' A' ' 130' ' ' ILE . 1.1 mtp180 -72.2 -18.31 61.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.912 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -75.02 -31.59 61.4 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.33 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 p -95.39 -2.85 48.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.159 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CG1' ' HA ' ' A' ' 127' ' ' ARG . 2.8 mm -55.59 -37.71 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.51 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -75.36 -27.13 59.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.872 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 19.1 mt -66.29 -50.02 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.927 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HG2' HG12 ' A' ' 151' ' ' VAL . 88.0 mt-10 -58.24 -49.09 78.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.638 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -40.32 93.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.573 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -34.86 65.08 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.197 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 137' ' ' LEU . 1.7 mm? -70.5 -40.26 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.927 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -58.77 -40.37 83.75 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.688 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.16 -38.78 91.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.824 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.41 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 2.1 m-30 -65.62 -38.07 88.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.505 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.69 -34.64 78.31 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 110.804 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.3 t80 -70.58 -30.75 67.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.96 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.27 -28.03 65.94 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.8 t -75.24 -88.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 110.574 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.464 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -112.68 18.61 22.25 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.716 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 20.7 mtmt 60.05 49.13 7.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 110.075 -173.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.248 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.22 97.12 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.335 1.022 . . . . 0.0 111.732 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.76 156.21 17.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.052 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 113.37 25.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.406 HG12 ' HG2' ' A' ' 134' ' ' GLU . 93.1 t -103.26 126.72 57.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -172.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -125.38 117.61 24.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.334 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.12 111.24 22.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.028 0.442 . . . . 0.0 110.092 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.1 t -94.08 123.27 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.245 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.4 m -109.89 117.62 55.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.6 m -109.55 117.42 52.75 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.121 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.68 142.49 16.14 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.667 2.245 . . . . 0.0 112.655 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -122.12 155.09 61.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 171.534 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.83 56.81 6.21 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.149 2.566 . . . . 0.0 113.76 -173.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.549 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -134.85 -89.53 0.35 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -167.75 36.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.666 ' HB2' HD11 ' A' ' 158' ' ' LEU . 10.9 mmt85 -131.42 162.2 30.73 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.442 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -135.2 148.01 28.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.858 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.27 127.45 53.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.82 122.16 46.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -120.48 132.7 55.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 110.559 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.524 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -102.07 110.79 22.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.201 -177.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.57 122.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.592 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.436 ' HE2' ' HB3' ' A' ' 167' ' ' LEU . 23.7 m-85 -113.69 118.31 33.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.421 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.914 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.946 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -110.12 151.57 27.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.23 117.95 29.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.32 107.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.535 0.683 . . . . 0.0 110.228 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -20.53 31.6 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.578 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.754 ' HB3' HG23 ' A' ' 83' ' ' THR . 20.5 t70 -156.83 137.98 13.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.913 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.4 121.29 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.13 126.48 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.99 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' HD2' HG12 ' A' ' 39' ' ' VAL . 80.2 m-85 -104.24 122.23 44.95 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.661 ' HG3' HD11 ' A' ' 85' ' ' LEU . 1.4 mm-40 -117.97 -8.81 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.853 -172.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.812 ' HA3' ' H ' ' A' ' 88' ' ' VAL . . . . . . . . 0 N--CA 1.447 -0.606 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.985 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.381 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.8 m -54.3 -43.51 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 O-C-N 123.981 0.801 . . . . 0.0 112.222 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.32 -38.0 46.73 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.688 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -67.7 -37.72 82.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.18 -35.93 64.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.88 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -58.92 -31.12 68.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.315 0.646 . . . . 0.0 112.54 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 41' ' ' ALA . 69.0 mt -69.29 -19.47 63.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.701 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.516 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -92.73 -8.37 44.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.785 ' HG2' HG23 ' A' ' 62' ' ' THR . 87.8 mtp -90.16 141.61 27.93 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.602 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 26.3 Cg_exo -64.31 -37.04 42.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.773 2.315 . . . . 0.0 112.768 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -121.96 155.47 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.39 -177.532 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -113.51 170.79 7.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.098 0.475 . . . . 0.0 110.983 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -67.24 138.72 57.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.2 177.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 -14.47 48.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.8 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.28 156.94 18.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 110.211 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.8 135.05 38.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.908 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.433 HG12 HG21 ' A' ' 48' ' ' VAL . 6.0 m -128.66 129.39 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.178 0.513 . . . . 0.0 110.889 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.19 -177.56 3.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.386 0.613 . . . . 0.0 110.645 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -65.37 -29.83 70.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.339 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.77 62.83 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.664 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 43.0 m-20 -74.13 -29.56 61.88 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.13 -49.26 84.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -66.86 -35.94 81.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.602 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -62.39 -45.13 94.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.426 177.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.785 HG23 ' HG2' ' A' ' 46' ' ' MET . 63.1 m -58.24 -47.06 84.71 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.267 174.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 77' ' ' VAL . 7.9 mt -56.92 -50.43 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.441 0.463 . . . . 0.0 111.142 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -69.81 -34.04 73.16 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.89 -46.7 70.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 45' ' ' SER . 60.7 mt -67.87 -30.9 70.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.914 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.56 99.23 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.11 -12.08 61.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.194 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 65' ' ' ALA . 32.7 p -78.42 -24.71 46.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.478 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.83 16.22 76.25 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.877 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -88.22 -32.48 18.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.303 0.573 . . . . 0.0 109.888 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.2 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 6.4 mm-40 -93.25 -27.1 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 14.8 t70 -141.78 137.07 31.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 88' ' ' VAL . 38.1 t -124.91 117.1 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.43 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.6 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.507 HG22 HD11 ' A' ' 63' ' ' ILE . 16.0 m -104.67 144.11 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 110.405 174.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.11 155.99 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -116.07 127.14 54.63 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.291 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.86 95.27 4.76 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.99 -110.47 3.51 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.839 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.78 10.07 30.88 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.754 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -103.65 128.78 50.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.8 -176.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.06 113.2 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 0.0 110.328 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.661 HD11 ' HG3' ' A' ' 32' ' ' GLU . 3.1 tp -93.9 112.66 24.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.216 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.56 106.85 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.301 0.572 . . . . 0.0 110.477 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -105.6 123.81 48.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.379 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.812 ' H ' ' HA3' ' A' ' 33' ' ' GLY . 4.2 m -124.51 147.47 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.445 0.641 . . . . 0.0 110.891 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.1 ttpt . . . . . 0 C--N 1.315 -0.932 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.135 -175.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.235 0.371 0 CA-C-O 121.555 0.564 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.504 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 86.6 m -94.6 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.842 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 125' ' ' LEU . 12.9 mt -73.21 118.73 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HB2' ' HG2' ' A' ' 162' ' ' ARG . . . -97.44 -42.81 7.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.12 147.17 33.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.482 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -117.96 123.58 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 172.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.963 -175.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.727 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 21.6 m-85 -114.27 133.88 55.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.792 0.329 . . . . 0.0 110.791 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.9 m -126.39 144.39 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.801 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.76 -79.97 0.26 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 47.07 49.97 14.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.752 0.821 . . . . 0.0 112.611 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -76.17 -42.64 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 m -130.54 -25.73 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.76 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 13.6 t -111.4 132.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 155.46 39.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.378 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.27 77.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.291 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.156 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -45.44 73.65 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -32.61 71.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.074 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.727 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 9.9 mttt -58.14 -48.79 79.15 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.425 0.453 . . . . 0.0 111.584 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.81 48.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.735 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.3 -38.12 88.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.662 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.9 mm? -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 2.8 mt-10 -65.58 -37.83 87.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.417 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.72 -16.39 61.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.233 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.3 m -88.21 -16.02 34.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.965 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.06 -32.38 5.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.326 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 125' ' ' LEU . 0.3 OUTLIER -90.73 113.0 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -174.065 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.569 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -141.06 176.72 8.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.642 -178.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 94' ' ' ILE . 53.1 t -67.43 127.2 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.912 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.48 -27.81 18.82 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.553 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.97 162.41 19.41 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.534 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -79.03 164.86 24.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -112.04 143.63 42.72 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.057 -177.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.444 ' HB3' ' HB ' ' A' ' 129' ' ' THR . 43.9 t0 -107.86 105.7 15.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.571 0.7 . . . . 0.0 110.097 174.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.468 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.3 -14.1 62.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.763 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.8 p -89.54 -23.47 22.01 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.071 0.939 . . . . 0.0 108.745 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 126' ' ' ASP . 5.3 m -87.89 -13.57 41.63 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.715 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.3 mm -53.69 -39.95 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.097 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.54 94.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.2 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.492 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 130' ' ' ILE . 15.6 mt -63.09 -44.39 99.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.923 174.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.75 -44.66 96.48 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.726 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -41.32 93.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.634 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.42 -38.41 69.98 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.704 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.16 -33.06 71.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 111.492 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.29 -34.2 75.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.507 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.83 -32.46 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.519 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -62.51 -39.37 93.31 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.676 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.434 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -64.5 -34.53 78.44 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.099 0.476 . . . . 0.0 110.872 177.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -69.49 -30.79 68.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.156 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.6 m -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.797 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 9.5 t -76.18 -85.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.627 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.8 19.96 22.82 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.674 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mttp 66.7 42.21 2.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.429 0.692 . . . . 0.0 110.569 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -87.26 139.44 30.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.442 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -115.16 74.47 0.88 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.238 0.542 . . . . 0.0 110.127 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.4 142.04 28.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.369 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.688 ' H ' ' HB2' ' A' ' 170' ' ' GLN . 0.9 OUTLIER -99.41 126.42 45.3 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 11.4 p -113.4 138.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.176 0.512 . . . . 0.0 111.388 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.89 125.21 39.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.658 175.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.616 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.258 0.551 . . . . 0.0 110.919 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.57 128.77 56.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.329 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.74 123.36 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.433 0.635 . . . . 0.0 111.204 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 m -107.01 120.19 48.82 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.579 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 9.6 Cg_endo -89.64 130.4 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.408 2.739 . . . . 0.0 112.952 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -113.47 152.95 45.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.226 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 22.47 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.04 2.493 . . . . 0.0 113.876 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -115.72 19.98 14.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.992 0.425 . . . . 0.0 110.144 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 t30 67.51 26.62 8.14 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.999 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.531 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -129.75 167.03 18.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.288 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.497 HG21 HD22 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -133.21 153.53 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.0 0.429 . . . . 0.0 111.139 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -108.92 118.82 37.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.494 HD11 ' HB1' ' A' ' 153' ' ' ALA . 59.4 tp -101.18 113.47 26.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.352 -175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -105.15 131.34 52.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 111.01 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.7 108.58 19.48 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.632 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 2.8 t -101.28 111.74 31.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.885 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -99.53 146.61 26.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.688 ' HB2' ' H ' ' A' ' 150' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.886 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.208 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' HE1' HD11 ' A' ' 59' ' ' ILE . 10.9 p90 -95.49 153.39 17.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.395 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.17 118.98 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -69.88 122.46 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -49.59 7.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.122 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.07 140.99 29.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.247 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.527 HG21 ' HE1' ' A' ' 46' ' ' MET . 7.1 mt -104.85 121.17 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 172.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 127.74 53.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.988 0.423 . . . . 0.0 110.121 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD2' HG12 ' A' ' 39' ' ' VAL . 75.7 m-85 -102.79 125.84 49.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.024 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.01 68.92 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.348 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.562 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 31' ' ' PHE . 5.6 m -53.63 -40.25 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.118 0.886 . . . . 0.0 112.604 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.12 -33.45 57.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.489 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.25 -35.25 63.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.54 74.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.507 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.51 -32.35 57.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.032 0.933 . . . . 0.0 112.879 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.7 mt -69.45 -14.04 62.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.499 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -100.06 -7.45 24.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.744 176.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.527 ' HE1' HG21 ' A' ' 29' ' ' ILE . 14.4 mtm -102.24 136.34 19.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.394 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.37 12.67 2.78 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.7 2.267 . . . . 0.0 113.296 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.73 HG12 HG11 ' A' ' 54' ' ' VAL . 32.0 m -119.08 149.12 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 49' ' ' ARG . 6.0 mmm-85 -131.85 166.22 22.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.504 0.668 . . . . 0.0 111.598 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 p -68.12 121.28 15.82 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.611 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.26 62.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.222 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.19 150.78 25.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.082 0.468 . . . . 0.0 111.224 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 116.35 32.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.73 HG11 HG12 ' A' ' 48' ' ' VAL . 14.7 m -133.2 156.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.081 0.467 . . . . 0.0 112.001 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 11.6 m-80 -99.3 179.16 4.67 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.312 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.84 -32.83 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.191 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.67 -31.73 72.9 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 12.2 m-20 -75.2 -33.72 61.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.075 177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 55' ' ' ASN . 1.3 mp -63.14 -46.63 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 171.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.76 ' HA ' HD12 ' A' ' 63' ' ' ILE . 19.0 m -65.35 -31.86 73.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.303 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -70.01 -38.87 76.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.407 178.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 m -58.29 -46.67 85.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 171.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 60' ' ' SER . 68.8 mt -55.33 -55.0 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.385 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -29.55 68.19 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.7 -45.71 74.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.485 0.183 . . . . 0.0 110.614 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 45' ' ' SER . 93.7 mt -69.39 -30.89 68.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.58 -35.01 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.74 -12.75 61.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.445 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.5 p -78.87 -25.1 43.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.497 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.5 8.04 83.53 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.609 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -82.99 -48.77 10.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.997 0.427 . . . . 0.0 110.829 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.85 150.16 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -53.75 17.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -135.49 140.7 45.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -121.47 118.65 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.404 ' HG2' HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -120.07 118.79 31.51 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.021 175.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 HG13 ' A' ' 86' ' ' VAL . 98.3 t -118.06 122.74 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.404 HD11 ' HG2' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -133.25 158.6 42.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 150.84 31.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.999 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -125.49 95.03 4.31 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.33 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.11 -108.44 2.35 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.276 -171.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -104.36 5.54 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.643 0.377 . . . . 0.0 111.323 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.97 133.11 49.48 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.401 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 111.75 24.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.233 0.539 . . . . 0.0 110.127 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.0 tp -100.58 112.95 25.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.038 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.41 HG13 HG22 ' A' ' 77' ' ' VAL . 36.7 t -106.86 105.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.483 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -105.42 126.52 52.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.25 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.55 144.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.253 0.549 . . . . 0.0 109.867 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.33 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 13.9 Cg_exo . . . . . 0 C--O 1.234 0.304 0 CA-C-O 121.518 0.549 . . . . 0.0 113.234 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -96.66 134.25 40.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.426 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 125' ' ' LEU . 25.7 mt -65.06 118.63 7.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.6 -34.88 14.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -157.93 154.36 27.72 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 110.448 174.168 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 114' ' ' LEU . 1.1 mt -112.67 122.96 67.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.127 172.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.511 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -103.38 130.74 50.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.049 -178.09 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.472 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 19.9 m-30 -112.96 134.77 54.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.862 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -142.35 137.17 30.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.435 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.26 76.98 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.636 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.97 72.35 7.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.644 0.735 . . . . 0.0 110.648 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 12.9 mmmt -86.41 -19.91 28.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.865 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -53.0 6.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.92 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.2 t -107.45 141.4 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -68.98 158.11 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 112.608 -171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.29 95.38 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.243 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.48 -34.76 72.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.721 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.4 82.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.176 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -32.87 74.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.818 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -59.64 -44.8 93.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.372 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.529 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 4.1 tm0? -77.72 -28.53 50.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.36 -45.74 91.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.046 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.485 ' CD1' HG21 ' A' ' 97' ' ' ILE . 18.0 mt -67.95 -36.59 80.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.831 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -59.88 -46.14 90.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.137 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -15.97 61.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.542 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.4 m -90.94 -12.11 37.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.749 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.03 -20.8 19.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.631 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.4 102.41 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.303 0.573 . . . . 0.0 110.762 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.24 173.56 11.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.543 -178.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HA ' HG22 ' A' ' 94' ' ' ILE . 65.4 t -69.36 125.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 110.651 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.11 -5.62 61.38 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 4.3 mm-40 -107.14 160.3 15.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.34 138.79 40.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.754 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.67 145.99 24.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.752 -175.542 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -115.83 103.76 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.649 0.737 . . . . 0.0 110.425 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.566 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.47 -15.3 62.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.562 178.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p -84.11 -20.66 32.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.095 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 p -100.64 3.26 42.37 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.23 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.9 mm -57.5 -41.52 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.768 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.9 -38.01 87.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 111.51 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -33.84 73.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.677 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.92 -44.11 88.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.908 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 92.3 mt-10 -57.28 -51.3 69.91 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.488 175.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -61.95 -34.2 75.68 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.756 0.66 . . . . 0.0 111.758 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.62 86.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.932 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.42 HD22 ' HZ ' ' A' ' 169' ' ' PHE . 9.9 mt -73.87 -36.61 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 134' ' ' GLU . 1.9 pt-20 -72.55 -28.86 63.09 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.4 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.22 -40.84 64.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.269 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.538 ' O ' HG23 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -61.9 -44.3 97.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.13 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.05 90.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.496 0.498 . . . . 0.0 111.278 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -67.08 -33.98 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.188 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.5 m -72.23 -28.75 63.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.899 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 140' ' ' PHE . 41.2 t -78.55 -82.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.998 0.427 . . . . 0.0 110.913 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.558 ' O ' ' HG2' ' A' ' 146' ' ' LYS . . . -112.7 20.9 19.74 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-O 118.88 -0.955 . . . . 0.0 113.21 -172.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER 70.02 16.72 7.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.759 1.224 . . . . 0.0 111.064 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -60.42 118.0 5.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.285 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.22 94.66 9.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.595 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.69 143.23 50.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.762 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.56 120.66 39.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.53 124.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -129.39 120.31 25.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.301 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.644 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -98.31 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.201 0.524 . . . . 0.0 110.181 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.33 123.56 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.167 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 t -98.61 113.36 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.038 0.447 . . . . 0.0 110.19 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.0 m -106.0 123.54 38.82 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.12 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -88.23 146.11 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.892 2.394 . . . . 0.0 113.138 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -135.26 157.63 76.32 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.6 51.22 3.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.966 2.444 . . . . 0.0 113.932 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.47 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.33 17.02 2.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.97 176.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 41.7 t30 60.43 37.47 19.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.261 1.029 . . . . 0.0 109.933 -173.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.511 ' HB2' HD11 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -131.08 161.39 32.16 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.527 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.754 HG21 HD22 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -133.4 147.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.64 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -108.92 119.05 38.41 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.2 tp -99.18 115.78 29.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.212 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.511 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -105.56 132.29 51.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.423 0.63 . . . . 0.0 111.194 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 1.8 mm? -108.84 109.93 21.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.163 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 t -101.34 114.19 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.268 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.42 ' HZ ' HD22 ' A' ' 137' ' ' LEU . 43.6 m-85 -105.51 118.32 36.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.246 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.317 -0.806 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -113.33 154.12 27.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.099 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.13 116.66 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.622 ' HB ' ' HA ' ' A' ' 50' ' ' THR . 0.5 OUTLIER -65.22 114.29 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 121.359 0.6 . . . . 0.0 111.285 -177.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 2.1 mttm -76.99 -39.97 48.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.812 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -156.89 142.26 17.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.217 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.586 HD12 HD21 ' A' ' 43' ' ' LEU . 91.9 mt -104.26 121.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.565 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -115.71 127.56 55.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.516 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.56 ' HE2' ' HE1' ' A' ' 46' ' ' MET . 0.7 OUTLIER -106.18 146.23 30.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.16 0.505 . . . . 0.0 111.163 -176.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -133.41 156.62 47.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.484 178.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.716 -176.446 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.243 0 CA-C-O 120.42 0.153 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.84 -33.52 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.92 -36.95 60.92 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.255 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.742 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -73.2 -34.05 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.0 110.168 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.09 73.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.843 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 29' ' ' ILE . 3.8 mt -60.93 -32.72 72.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.074 0.55 . . . . 0.0 111.811 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 41' ' ' ALA . 17.6 mt -71.85 -20.39 61.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.98 0.419 . . . . 0.0 111.249 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.524 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -91.73 -10.96 38.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.894 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.56 ' HE1' ' HE2' ' A' ' 31' ' ' PHE . 53.8 mtm -94.78 135.83 23.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.69 -17.6 29.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.642 2.228 . . . . 0.0 112.725 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 149.56 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.718 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -120.91 176.27 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.896 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.622 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -67.48 136.07 54.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.01 -8.72 59.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.529 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.16 156.23 17.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.93 125.12 34.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.525 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.22 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.308 0.575 . . . . 0.0 111.563 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.81 -177.78 3.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -25.67 64.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -65.71 -35.8 81.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.396 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.647 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 53.0 m-20 -74.6 -28.9 61.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.908 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.97 -47.0 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 172.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -30.3 68.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.5 m-20 -67.36 -46.53 73.07 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.778 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 p -62.88 -38.86 92.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.006 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.6 mt -55.81 -54.12 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 123.427 0.454 . . . . 0.0 110.626 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 64' ' ' ARG . 9.6 ptm85 -70.23 -31.19 68.48 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.9 70.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.538 0.208 . . . . 0.0 110.713 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 45' ' ' SER . 58.9 mt -69.94 -30.79 68.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.731 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -37.87 88.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 110.647 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.1 -13.42 61.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 45' ' ' SER . 19.0 p -79.26 -24.79 42.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.629 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.12 -1.76 73.54 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.432 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -76.34 -47.1 24.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.403 0.621 . . . . 0.0 109.887 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.6 136.3 54.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.29 -18.27 25.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.54 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 24.6 t70 -122.74 134.47 54.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.4 t -132.7 118.46 34.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.61 116.82 27.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.731 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.9 t -103.9 122.51 56.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -125.69 148.78 48.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.71 136.91 53.03 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.501 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.22 95.99 4.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.364 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.75 -111.68 4.32 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 40.3 m-20 -106.16 7.01 31.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.976 0.417 . . . . 0.0 110.486 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.47 133.61 48.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.421 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 111.8 24.62 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 3.6 tp -104.32 116.43 32.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.056 0.455 . . . . 0.0 110.752 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.5 110.99 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 6.3 mt-30 -96.65 127.75 42.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.18 162.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 0.0 111.554 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.244 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 5.7 Cg_endo . . . . . 0 N--CA 1.454 -0.852 0 CA-C-O 121.105 0.377 . . . . 0.0 112.241 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 59.8 m -125.19 137.79 54.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 125' ' ' LEU . 21.7 mt -74.94 120.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.12 -38.59 10.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.063 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.52 143.0 25.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.485 HG21 HD22 ' A' ' 114' ' ' LEU . 2.4 mt -123.13 128.07 74.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 141.56 47.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.47 177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.466 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.9 m-85 -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.619 0.247 . . . . 0.0 111.021 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.0 140.42 42.12 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 169' ' ' PHE . . . 85.39 16.22 64.8 Favored Glycine 0 C--N 1.328 0.113 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.695 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 1.7 p30 -79.47 69.92 5.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.54 0.686 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -83.13 -47.62 11.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.184 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -27.96 24.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 2.2 t -126.66 141.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -68.84 156.72 37.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.139 0.495 . . . . 0.0 111.619 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -33.95 77.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 171.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.853 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -60.99 -39.42 89.57 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 175.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.9 mtp -73.33 -39.04 65.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.218 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -62.8 -32.62 73.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.242 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' A' ' 108' ' ' ASP . 7.6 mtmm -57.14 -48.52 78.47 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.591 0.557 . . . . 0.0 111.138 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.1 45.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.415 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -63.46 -37.63 88.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.485 HD22 HG21 ' A' ' 97' ' ' ILE . 1.1 mp -72.31 -38.38 68.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.921 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 16.4 mt-10 -62.67 -39.45 93.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.901 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.48 -15.66 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.125 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.631 ' HB2' HG12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -95.0 -16.14 22.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 175.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.16 -37.01 2.37 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.608 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.66 111.53 22.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.267 0.555 . . . . 0.0 111.715 -171.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.03 171.17 14.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.223 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.25 127.82 31.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.233 0.54 . . . . 0.0 110.598 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.65 53.26 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.497 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.576 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 1.1 tp10 -89.02 156.72 18.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 122.71 0.404 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.99 134.48 43.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.728 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -114.89 142.85 46.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.227 -177.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.542 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 33.6 t0 -117.58 133.48 55.91 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 110.054 164.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.408 ' CD ' ' H ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -71.29 -16.04 62.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.714 178.164 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 p -82.47 -26.59 32.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.461 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -86.52 -11.48 51.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.428 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 130' ' ' ILE . 5.9 mm -55.15 -40.13 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.732 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.68 91.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.11 -35.21 76.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.13 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.631 HG12 ' HB2' ' A' ' 117' ' ' SER . 3.2 mt -67.41 -40.2 84.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.213 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -61.1 -40.92 95.57 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.45 96.97 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.869 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.33 -37.23 92.65 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.528 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.667 HD22 ' HZ ' ' A' ' 169' ' ' PHE . 8.2 mt -66.83 -36.81 83.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.752 0.31 . . . . 0.0 110.943 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.2 -39.56 86.37 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.67 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -67.01 -43.35 83.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.07 -44.1 97.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.641 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -38.35 87.08 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.962 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -28.98 65.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m -70.94 -27.58 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.409 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 4.1 t -75.2 -83.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 111.187 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.409 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.85 19.77 22.93 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.525 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.87 44.26 13.96 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.734 0.778 . . . . 0.0 110.504 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -80.03 118.66 21.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.935 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 m -89.51 86.36 6.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.003 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.11 144.53 25.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.022 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.3 113.44 25.39 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.9 m -101.16 133.0 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.384 0.611 . . . . 0.0 111.519 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 116.69 18.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.574 172.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.6 110.8 22.77 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.386 0.612 . . . . 0.0 109.909 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.65 113.47 36.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.108 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.18 110.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.775 0.798 . . . . 0.0 109.205 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 7.3 m -112.41 116.46 48.54 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.842 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.502 ' HA ' HG12 ' A' ' 163' ' ' VAL . 59.0 Cg_endo -71.79 135.65 26.21 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.624 2.216 . . . . 0.0 112.429 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -100.54 159.03 30.78 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.261 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.33 80.07 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.18 2.586 . . . . 0.0 113.306 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 1.0 OUTLIER -174.51 -112.31 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.712 0.805 . . . . 0.0 109.188 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 3.0 t-20 -146.15 9.62 1.12 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.968 0.89 . . . . 0.0 109.842 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.538 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 1.1 mpt_? -117.92 167.36 11.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.868 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 125' ' ' LEU . 18.5 m -130.95 159.76 42.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 111.466 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.43 119.13 38.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.444 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.7 tp -108.19 125.95 52.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.459 ' HB3' ' HE2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -123.43 132.27 53.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 111.132 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 2.7 mm? -108.52 110.87 22.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.011 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.18 112.3 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.331 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.667 ' HZ ' HD22 ' A' ' 137' ' ' LEU . 11.4 m-30 -109.65 127.86 54.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.323 0.582 . . . . 0.0 111.398 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.16 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -104.99 153.18 21.79 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.8 t -87.06 113.84 25.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -72.07 125.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.6 0.714 . . . . 0.0 110.346 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -91.4 -29.66 16.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.974 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.45 137.12 14.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.056 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.4 mt -109.64 121.38 62.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -119.88 127.86 53.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.174 0.511 . . . . 0.0 109.851 -178.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.68 ' HD2' HG12 ' A' ' 39' ' ' VAL . 58.7 m-85 -101.34 149.22 24.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.066 -175.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -137.73 167.4 21.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.402 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.54 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.27 -178.556 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.68 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.6 m -56.67 -41.85 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 123.857 0.723 . . . . 0.0 112.151 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.27 -34.16 55.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.573 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.75 -34.43 64.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.135 0.493 . . . . 0.0 110.953 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.32 -33.81 59.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.834 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.84 -31.04 58.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 112.695 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 78.4 mt -66.56 -18.95 65.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.77 -8.45 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.695 0.284 . . . . 0.0 110.823 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.474 ' SD ' ' HZ ' ' A' ' 31' ' ' PHE . 36.7 mtp -93.23 136.6 24.25 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.613 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 3.0 Cg_exo -78.41 6.56 4.69 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.069 2.513 . . . . 0.0 112.597 174.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.8 156.64 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 20.2 mtp85 -132.47 176.6 8.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.423 0.63 . . . . 0.0 112.114 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.9 p -67.84 120.49 14.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.883 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.31 44.94 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.095 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.4 OUTLIER -77.72 156.27 30.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.147 0.499 . . . . 0.0 111.573 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.67 117.01 30.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.16 129.07 73.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 112.283 -168.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -100.14 -175.96 3.09 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.72 172.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.46 -26.21 68.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.966 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.33 -34.02 70.17 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.52 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -74.33 -29.7 61.71 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.427 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.27 -44.85 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.478 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 p -71.0 -29.62 65.63 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 110.568 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.9 -45.73 73.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 p -63.74 -39.49 94.4 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.673 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 28.9 mt -56.04 -50.68 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 123.364 0.415 . . . . 0.0 110.326 174.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 mtt85 -65.04 -36.63 84.96 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.545 0.528 . . . . 0.0 111.985 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.67 -48.76 71.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.068 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.471 HD22 ' HE1' ' A' ' 72' ' ' PHE . 29.3 mt -70.71 -30.78 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.46 -36.25 78.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 110.724 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.05 -13.59 61.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.208 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 65' ' ' ALA . 19.0 p -78.77 -25.06 44.37 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.435 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.38 21.04 72.07 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.639 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -85.56 -23.89 27.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.7 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HE1' HD22 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -127.12 176.76 7.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.575 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 3.6 mm-40 -97.16 -23.42 16.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.664 0.268 . . . . 0.0 111.521 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.784 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 3.6 t70 -155.67 145.0 20.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.5 119.07 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -121.01 124.96 46.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.306 0.574 . . . . 0.0 110.997 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.5 t -101.3 123.35 54.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.07 158.01 39.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 145.78 47.62 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.386 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -128.03 96.09 4.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.7 -110.14 3.31 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.54 13.77 23.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.38 132.18 50.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.802 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 111.58 24.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.035 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 4.2 tp -105.11 112.75 25.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.407 ' HB ' ' CD1' ' A' ' 31' ' ' PHE . 18.3 t -108.58 106.75 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 54.1 mt-30 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.08 159.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.835 0.35 . . . . 0.0 110.381 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 3.3 tptm . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.501 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 16.8 Cg_exo . . . . . 0 C--O 1.233 0.237 0 CA-C-O 121.412 0.505 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.7 m -102.58 139.77 37.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.161 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.4 mt -62.15 118.86 5.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.01 -25.41 11.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.14 0.495 . . . . 0.0 110.554 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -147.96 138.56 23.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.655 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.89 120.51 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.689 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 2.3 m -118.85 143.12 47.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.985 0.421 . . . . 0.0 111.006 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.808 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -121.75 135.93 54.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.497 -172.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.3 m -147.24 119.78 8.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.66 -7.96 39.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.791 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -81.11 83.88 6.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 110.937 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -85.92 -29.52 23.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.841 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -66.35 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.518 -175.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.497 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 15.1 t -90.47 142.52 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -69.74 146.48 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.07 0.462 . . . . 0.0 111.814 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.549 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 4.5 p30 -63.86 -33.01 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.206 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.58 -40.02 95.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.5 mtp -67.96 -40.32 83.23 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.381 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.03 -36.07 82.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.841 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.808 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 15.6 mttt -58.92 -46.1 88.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.816 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 3.0 tp60 -76.66 -27.98 55.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.288 -177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.36 -49.95 71.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.69 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.44 -34.96 79.1 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.977 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -60.46 -42.47 96.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.437 178.441 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.03 -15.56 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.686 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.9 m -88.08 -16.58 33.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.51 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.35 -15.21 22.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.112 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.46 103.73 15.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.241 0.543 . . . . 0.0 110.162 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 115' ' ' GLU . 12.3 mtm180 -134.34 172.15 13.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.203 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.87 123.64 28.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 110.206 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.25 71.2 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.004 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 159.77 15.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 120.895 0.378 . . . . 0.0 110.81 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -66.33 142.93 57.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.925 170.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.565 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.48 148.23 22.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.087 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.72 98.1 6.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.459 0.647 . . . . 0.0 110.516 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.466 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -70.49 -14.83 62.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.56 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 p -85.08 -23.02 28.7 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.299 -0.251 . . . . 0.0 111.172 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 p -100.24 5.53 44.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.466 HG12 ' HA ' ' A' ' 127' ' ' ARG . 7.0 mm -57.64 -42.78 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.427 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . . . -64.86 -38.09 89.81 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.803 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 -27.46 63.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.779 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.2 mt -67.45 -44.99 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 131' ' ' ALA . 35.5 mt-10 -61.37 -47.77 84.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.241 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.51 82.2 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.959 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.02 -30.43 63.25 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.891 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.5 mt -76.11 -32.61 59.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.689 0.244 . . . . 0.0 110.741 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.595 ' HG3' HG23 ' A' ' 151' ' ' VAL . 6.5 mt-10 -64.98 -39.52 93.6 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 173.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -66.47 -43.56 85.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.599 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -62.37 -33.4 74.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.17 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.497 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -71.34 -44.41 65.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.139 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -30.22 66.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -173.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -28.85 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.469 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.58 -84.77 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.48 19.62 23.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.98 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? 62.56 52.55 2.88 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.446 0.641 . . . . 0.0 109.65 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -88.8 105.41 17.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.048 -173.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.08 121.57 32.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.308 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.49 162.69 40.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.06 114.47 27.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.595 HG23 ' HG3' ' A' ' 138' ' ' GLU . 23.3 t -96.67 123.1 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.036 0.446 . . . . 0.0 110.812 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -124.71 117.7 24.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.78 111.62 23.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.37 133.05 61.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.03 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.26 123.04 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.274 0.559 . . . . 0.0 110.43 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.3 m -104.37 119.83 52.66 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.158 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 131.05 11.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 112.583 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -123.1 155.67 64.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.388 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.96 56.26 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.831 2.354 . . . . 0.0 113.879 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.501 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -144.32 19.37 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 177.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 38.5 t30 60.21 38.55 20.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 122.185 0.993 . . . . 0.0 109.247 -173.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.454 ' HB2' HD11 ' A' ' 158' ' ' LEU . 7.3 mmt180 -130.28 160.62 33.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.143 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -130.74 148.64 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.986 178.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.25 122.26 46.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.91 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.3 tp -96.13 110.39 22.67 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.689 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -113.22 132.06 55.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.792 0.806 . . . . 0.0 111.426 -175.428 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -107.78 110.69 22.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.445 -176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.93 111.05 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.448 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.93 117.43 34.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.373 -174.78 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -110.4 153.11 25.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.973 -0.613 . . . . 0.0 109.972 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -79.68 113.32 18.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.79 125.49 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.49 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -85.54 -31.5 22.68 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.671 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB3' HG23 ' A' ' 83' ' ' THR . 29.5 t70 -157.63 147.01 19.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.245 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.8 mt -109.9 120.14 60.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.77 127.03 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.941 -176.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -105.11 120.13 40.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.578 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 52.8 mm-40 -103.64 66.18 0.85 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.665 0.745 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.733 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.945 179.057 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.151 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -51.86 -40.49 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.16 -41.77 94.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.145 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.14 68.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.826 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.3 81.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.85 -31.61 72.84 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.932 0.493 . . . . 0.0 111.186 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.4 mt -74.55 -13.21 60.64 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.819 ' HB3' HG21 ' A' ' 69' ' ' THR . 1.2 m -96.01 -8.19 34.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.15 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.695 ' HG2' HG23 ' A' ' 62' ' ' THR . 62.9 mtp -91.5 148.96 38.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.419 175.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 7.2 Cg_exo -75.0 -10.85 21.39 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.671 2.247 . . . . 0.0 112.212 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.4 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.175 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -133.76 177.96 7.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.2 p -66.27 131.29 45.78 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.221 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.68 -7.4 65.49 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.51 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -97.7 156.05 16.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 111.003 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.27 124.04 34.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.717 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.32 135.84 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.11 0.481 . . . . 0.0 110.864 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.401 ' O ' HD12 ' A' ' 59' ' ' ILE . 36.5 m-80 -98.51 -178.75 4.11 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.13 -36.88 85.64 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.37 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.04 -29.2 68.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.067 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 17.7 m-20 -73.75 -29.81 62.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.077 0.151 . . . . 0.0 110.866 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -61.99 -50.71 78.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 171.128 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.759 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -66.07 -29.26 69.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.623 176.721 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.539 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -69.58 -41.03 76.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.989 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.695 HG23 ' HG2' ' A' ' 46' ' ' MET . 85.2 m -58.61 -46.92 86.0 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.941 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 60' ' ' SER . 66.6 mt -52.83 -55.38 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.682 0.614 . . . . 0.0 110.854 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.59 -29.41 66.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.434 -174.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.66 -54.82 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 66' ' ' LEU . 30.2 mt -62.54 -30.81 71.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.343 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -46.2 83.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.69 60.1 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.819 HG21 ' HB3' ' A' ' 45' ' ' SER . 82.2 p -79.91 -24.13 41.31 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.821 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.07 78.56 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.067 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -82.74 -36.33 25.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.102 0.477 . . . . 0.0 110.383 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -129.72 164.36 24.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.516 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.528 ' HG2' ' HD3' ' A' ' 89' ' ' LYS . 0.7 OUTLIER -77.72 -50.99 11.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.447 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -133.49 144.05 49.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.392 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.28 120.68 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -114.26 118.43 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.801 174.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.451 HG22 HG13 ' A' ' 86' ' ' VAL . 51.3 t -112.42 123.08 67.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.017 0.437 . . . . 0.0 109.934 173.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.75 159.03 43.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -96.06 141.85 28.96 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.075 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -136.65 93.66 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.96 -109.31 2.79 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.143 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 11.88 20.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.74 141.78 35.49 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.419 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.1 111.28 23.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.02 111.63 23.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.51 -174.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.451 HG13 HG22 ' A' ' 77' ' ' VAL . 5.0 t -114.1 103.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.459 0.647 . . . . 0.0 109.905 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.578 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.83 127.13 44.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 150.41 30.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.528 ' HD3' ' HG2' ' A' ' 73' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.176 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 19.1 Cg_endo . . . . . 0 N--CA 1.461 -0.394 0 N-CA-C 111.007 -0.42 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.884 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 17.1 m -84.47 125.51 32.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.339 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.523 HD11 ' HB2' ' A' ' 125' ' ' LEU . 11.2 mt -66.08 116.58 5.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.7 -38.43 10.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.927 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.54 138.66 26.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.41 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.717 HG21 HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -106.03 122.12 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -118.87 134.59 55.06 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.243 -173.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 24.0 m-85 -116.65 135.38 53.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -170.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.4 m -139.87 110.92 6.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.291 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.44 47.1 0.26 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.857 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -83.16 77.44 9.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.136 0.493 . . . . 0.0 110.553 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.35 -37.48 19.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.918 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.8 m -141.6 -58.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.886 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -75.05 126.01 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -74.31 159.75 32.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.432 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -34.68 78.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.554 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.0 -38.33 90.68 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.9 mtp -70.98 -39.14 72.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -37.76 88.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.38 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 31.1 mttt -60.75 -44.01 97.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 110.937 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 13.8 tt0 -77.66 -27.68 50.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.338 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -66.86 -43.52 83.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.223 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -66.38 -34.0 76.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.802 174.503 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -63.36 -38.14 90.0 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -18.32 61.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.436 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.8 m -91.48 -13.87 31.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.546 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.37 -14.63 50.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.9 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.09 103.57 14.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.199 0.523 . . . . 0.0 110.242 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.521 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.04 174.92 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.747 -176.173 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 94' ' ' ILE . 45.5 t -68.77 125.16 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.425 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.67 -28.22 16.4 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.786 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.521 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -86.02 163.88 17.69 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 122.683 0.393 . . . . 0.0 110.413 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.41 156.2 19.69 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.675 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -113.79 138.75 49.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.018 0.437 . . . . 0.0 111.126 -176.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.51 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 12.7 t0 -100.1 115.04 28.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.573 0.701 . . . . 0.0 110.529 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.458 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -72.31 -16.22 61.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.44 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.1 p -85.64 -24.0 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.082 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.51 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 20.3 p -90.75 2.76 55.73 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.603 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.1 mm -56.98 -37.54 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.398 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.19 99.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.815 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 -39.2 78.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.142 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.2 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.227 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -59.29 -45.55 90.98 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.024 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -37.16 86.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.49 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.59 -34.12 72.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.629 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 167' ' ' LEU . 5.0 mt -69.91 -35.95 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.55 0.175 . . . . 0.0 111.352 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -64.04 -36.71 84.88 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 110.116 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.59 -37.13 79.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.016 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -45.0 94.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.396 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -39.1 92.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.012 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -29.44 66.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.199 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.4 m -70.35 -27.09 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.467 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.1 t -73.94 -88.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.467 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.23 18.79 25.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.104 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt 65.9 44.66 2.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.492 0.717 . . . . 0.0 110.321 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -78.55 113.72 16.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.775 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.46 99.98 11.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.483 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.39 147.5 44.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.338 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.01 136.01 39.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.6 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.2 m -97.76 132.21 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.406 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 115.41 16.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.365 169.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.42 111.18 22.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.83 123.34 57.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.516 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.71 114.61 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 110.17 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.53 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 6.9 m -113.62 119.35 41.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.12 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.5 Cg_endo -86.23 139.55 6.15 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.255 2.637 . . . . 0.0 112.615 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 0.3 OUTLIER -114.88 142.03 27.77 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.225 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 36.3 Cg_exo -59.08 93.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 114.348 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.492 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.3 OUTLIER 176.3 -92.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.603 1.161 . . . . 0.0 108.391 175.192 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.492 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 13.4 p-10 -165.3 28.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 109.137 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.884 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -123.02 164.2 19.02 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.64 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.675 HG11 HD22 ' A' ' 125' ' ' LEU . 9.4 p -137.3 147.74 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.395 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.28 123.07 48.67 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.426 ' HB3' HG23 ' A' ' 97' ' ' ILE . 28.1 tp -102.24 114.35 28.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.581 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -110.21 131.09 55.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.884 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.524 HD11 HD13 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -109.03 112.89 25.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.56 -176.325 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.848 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.57 117.64 34.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.303 0.573 . . . . 0.0 110.33 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 -177.148 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -111.14 153.86 25.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.67 113.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.29 121.42 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.438 0.637 . . . . 0.0 110.791 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -84.37 -26.13 28.62 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.154 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.443 ' HB3' HG23 ' A' ' 83' ' ' THR . 27.0 t0 -158.44 154.01 26.15 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.509 HD12 HD21 ' A' ' 43' ' ' LEU . 86.9 mt -125.59 128.09 72.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.375 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.94 133.24 55.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.309 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.454 ' HD2' HG12 ' A' ' 39' ' ' VAL . 10.5 m-85 -118.47 135.15 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -113.6 -58.49 2.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 -164.888 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.373 0 CA-C-O 120.349 0.118 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.454 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.9 m -62.1 -29.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 O-C-N 123.647 0.592 . . . . 0.0 112.361 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.65 -40.47 85.75 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.687 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -74.48 -36.22 63.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.34 0.591 . . . . 0.0 110.357 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.58 87.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.91 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 29' ' ' ILE . 4.0 mt -58.74 -33.9 70.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.922 0.489 . . . . 0.0 112.207 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 41' ' ' ALA . 53.4 mt -74.15 -15.14 61.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.008 0.432 . . . . 0.0 111.335 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.01 -20.92 20.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.245 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.688 ' HG2' HG23 ' A' ' 62' ' ' THR . 91.0 mtp -81.75 146.04 55.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.259 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.59 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 6.1 Cg_exo -80.25 9.09 3.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.011 2.474 . . . . 0.0 112.458 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 154.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 16.6 mtm105 -130.63 173.73 10.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 111.275 -174.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 p -67.64 124.58 23.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.416 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -10.36 57.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.864 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -93.7 156.57 16.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 0.0 110.208 178.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.09 130.39 35.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.67 127.16 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.169 0.509 . . . . 0.0 110.912 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.446 ' O ' HD12 ' A' ' 59' ' ' ILE . 49.3 m-80 -97.31 179.38 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.399 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -30.83 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.241 0.543 . . . . 0.0 109.65 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.58 -33.42 75.87 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.495 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.96 -31.04 61.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.6 -50.76 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.72 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -69.64 -29.99 67.6 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.637 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 1.2 m-80 -72.22 -36.71 69.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.618 177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 46' ' ' MET . 74.5 m -60.48 -44.16 96.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.233 0.333 . . . . 0.0 110.273 171.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 60' ' ' SER . 32.1 mt -54.34 -53.02 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 123.351 0.407 . . . . 0.0 110.618 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 64' ' ' ARG . 1.2 tpt180 -65.72 -38.22 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 69' ' ' THR . . . -66.45 -48.14 70.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.442 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 86.4 mt -67.52 -29.92 69.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.15 99.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 110.081 172.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.12 -13.46 61.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.677 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 65' ' ' ALA . 30.2 p -78.93 -24.74 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.902 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.6 73.05 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.607 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -73.47 -44.13 58.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 109.99 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.442 ' HE1' ' HB3' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -124.03 154.83 39.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.692 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.724 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 5.3 mm-40 -72.1 -51.27 22.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.622 0.576 . . . . 0.0 111.956 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -129.61 146.42 51.41 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.77 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 88' ' ' VAL . 38.4 t -127.86 120.64 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.19 116.9 27.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.418 ' HB ' HG23 ' A' ' 59' ' ' ILE . 60.0 t -104.81 130.78 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.49 158.61 39.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -117.99 129.52 55.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.421 0.629 . . . . 0.0 110.404 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.2 95.86 4.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.695 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.34 -109.9 3.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.507 -174.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.31 14.38 19.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.372 0.606 . . . . 0.0 109.933 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -106.83 139.69 40.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -106.08 114.13 28.09 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.001 177.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -106.87 123.43 48.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 110.518 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -118.66 118.38 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.34 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -109.62 132.8 53.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 75' ' ' VAL . 4.5 m -125.56 162.46 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.218 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 tptp . . . . . 0 C--N 1.321 -0.638 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.516 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 68.3 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 CA-C-O 121.201 0.417 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 45.3 m -124.87 133.31 53.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.616 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 125' ' ' LEU . 30.0 mt -68.61 117.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.2 -26.75 16.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.68 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.27 138.54 18.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.173 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.501 HG13 HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -109.23 121.38 62.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.853 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.3 OUTLIER -113.14 133.46 55.02 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.412 -175.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.696 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.2 m-85 -112.11 135.07 53.23 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.838 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.68 118.07 8.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.223 -173.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.07 18.34 56.03 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.334 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.545 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -85.15 93.39 8.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.589 . . . . 0.0 110.843 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.732 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -85.52 -46.09 11.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.251 -179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.2 -77.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.062 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.63 125.64 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -71.01 157.82 37.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.592 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -36.55 76.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.952 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.575 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 4.3 t0 -62.5 -38.47 90.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.481 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtt -73.34 -35.67 66.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -32.89 74.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.593 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.696 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -56.7 -44.84 81.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 176.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -28.3 53.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.388 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.66 -43.17 90.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.4 mm? -67.72 -35.83 79.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.781 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.85 -35.51 80.86 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.52 -23.09 58.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.874 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -17.82 31.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 0.0 110.199 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.05 -14.15 31.37 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.13 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.62 102.54 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.4 0.619 . . . . 0.0 110.604 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.74 176.45 9.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.128 -175.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 97' ' ' ILE . 70.7 t -67.29 127.42 28.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.374 0.607 . . . . 0.0 110.556 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.48 -10.28 62.96 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.925 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -111.45 166.09 11.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.724 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 1.4 m -75.72 162.34 28.3 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.266 177.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -132.18 145.15 51.16 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.512 0.196 . . . . 0.0 110.891 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -109.72 122.05 46.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.621 0.724 . . . . 0.0 111.319 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.444 ' HA ' HG12 ' A' ' 130' ' ' ILE . 6.9 mtp180 -73.02 -15.7 61.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.211 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.5 p -90.09 -17.25 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.1 m -84.32 -13.64 51.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.279 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 153' ' ' ALA . 6.5 mm -54.16 -40.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.065 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.71 99.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.012 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.424 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 0.6 OUTLIER -71.93 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 178.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 130' ' ' ILE . 52.0 mt -62.22 -46.76 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.942 0.401 . . . . 0.0 110.12 174.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.93 -49.83 74.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.309 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -65.3 -33.3 75.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.587 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 135' ' ' LYS . . . -68.09 -41.79 86.12 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.309 -0.472 . . . . 0.0 111.987 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.28 -33.0 72.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.404 0.145 . . . . 0.0 111.278 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -36.72 80.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.063 0.458 . . . . 0.0 110.683 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.13 -44.84 78.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.324 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -38.27 90.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.415 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.545 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -60.39 -43.53 96.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.209 0.528 . . . . 0.0 110.766 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -29.38 65.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.648 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.8 m -66.13 -28.16 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.738 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 4.3 t -78.28 -96.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 110.312 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -103.95 19.84 42.7 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.266 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.7 56.67 1.51 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -87.28 96.47 10.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.987 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.67 101.68 5.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.749 173.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.59 156.3 43.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.376 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.12 113.69 25.66 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.3 p -106.71 127.14 62.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.959 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.97 117.81 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.054 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -93.99 110.16 21.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.56 126.63 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.79 -173.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.05 112.33 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.191 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.5 m -104.82 117.57 58.48 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.855 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.04 141.26 20.83 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.258 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -115.79 154.81 48.16 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.478 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 22.2 Cg_exo -66.5 76.96 0.36 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.549 2.833 . . . . 0.0 113.523 -176.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.51 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -167.39 -115.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 15.6 p-10 -144.11 27.35 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.099 0.952 . . . . 0.0 108.512 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.458 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 11.9 mmt180 -122.59 155.1 37.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.641 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.409 HG21 HD22 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -134.18 157.59 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.6 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -109.93 122.95 48.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.317 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.0 tp -106.6 116.41 31.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.853 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 12.4 tttt -119.22 132.77 55.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.06 110.58 22.56 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.216 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 15.2 t -99.78 116.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.656 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.66 118.28 36.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.974 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.661 178.688 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' HZ ' HD12 ' A' ' 84' ' ' LEU . 6.5 p90 -107.49 153.27 23.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.876 -0.662 . . . . 0.0 110.219 -175.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.46 112.39 17.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.92 125.39 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.01 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -41.3 10.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.722 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HB3' HG23 ' A' ' 83' ' ' THR . 38.7 t70 -147.89 148.55 30.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.598 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -116.51 124.59 72.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.39 127.55 47.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -101.92 115.8 31.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HG3' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -94.09 65.14 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.803 0.811 . . . . 0.0 110.733 -176.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.856 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.519 176.515 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m -58.91 -30.99 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 123.779 0.674 . . . . 0.0 112.205 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.94 -35.08 61.64 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.354 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -76.25 -36.11 58.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.001 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.78 88.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.855 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -32.33 61.48 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.091 0.957 . . . . 0.0 113.088 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 41' ' ' ALA . 51.1 mt -70.98 -15.78 62.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -8.39 23.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.546 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.7 mtp -94.55 137.19 22.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.188 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.57 34.39 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.991 2.461 . . . . 0.0 112.255 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HB ' HG11 ' A' ' 54' ' ' VAL . 1.5 p -155.39 146.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.24 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' H ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -133.37 176.68 8.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.183 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.3 p -67.11 121.2 15.08 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.84 0.352 . . . . 0.0 110.17 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.44 47.99 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.456 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.6 t0 -82.84 156.48 23.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.619 0.247 . . . . 0.0 110.987 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -112.78 112.03 23.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.18 178.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.653 HG11 ' HB ' ' A' ' 48' ' ' VAL . 2.6 m -126.24 132.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.184 0.516 . . . . 0.0 112.343 -171.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' O ' HD12 ' A' ' 59' ' ' ILE . 10.2 m-20 -86.14 -177.27 6.23 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.067 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -61.16 -35.42 77.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.984 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -62.93 -37.44 87.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.203 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.757 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 1.3 m-20 -75.85 -29.04 58.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.585 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.78 -47.4 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 171.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.686 ' HA ' HD12 ' A' ' 63' ' ' ILE . 3.7 m -68.76 -30.05 68.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.389 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.757 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 8.9 m-20 -63.75 -45.32 90.38 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 109.825 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.7 m -58.48 -43.88 89.13 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.095 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' A' ' 60' ' ' SER . 65.2 mt -55.81 -50.9 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 123.39 0.431 . . . . 0.0 110.872 176.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -66.28 -36.03 81.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.89 -45.33 74.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.795 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HB2' HG11 ' A' ' 75' ' ' VAL . 83.9 mt -71.01 -29.03 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -39.5 92.66 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.231 0.539 . . . . 0.0 110.538 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.88 -9.48 58.4 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.406 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.0 p -76.68 -20.16 56.94 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -170.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.47 21.27 75.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.943 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -105.01 -89.28 0.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.07 135.1 34.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.418 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.771 ' HB3' ' HB2' ' A' ' 124' ' ' SER . 0.1 OUTLIER -77.63 -30.01 52.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.8 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 11.8 t70 -123.42 135.43 54.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.667 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 88' ' ' VAL . 64.2 t -132.51 118.46 35.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.567 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -120.37 120.61 36.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.389 0.614 . . . . 0.0 110.051 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.441 HG22 HG13 ' A' ' 86' ' ' VAL . 70.1 t -105.19 123.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.29 137.7 51.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -88.0 110.12 20.35 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.49 95.22 5.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.55 -120.89 20.85 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -104.42 12.94 32.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.255 0.55 . . . . 0.0 109.963 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.89 141.71 35.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.791 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.533 HD12 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.02 110.87 22.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.429 HD11 ' HG3' ' A' ' 32' ' ' GLU . 13.6 tp -100.08 112.42 24.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.199 -175.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.441 HG13 HG22 ' A' ' 77' ' ' VAL . 6.1 t -116.16 105.79 19.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.425 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.93 131.44 42.28 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 75' ' ' VAL . 3.5 m -125.73 149.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.936 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HB2' HG22 ' A' ' 163' ' ' VAL . 56.8 Cg_endo . . . . . 0 CA--C 1.534 0.489 0 N-CA-C 114.065 0.756 . . . . 0.0 114.065 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 17.9 m -91.29 135.81 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 125' ' ' LEU . 34.7 mt -65.58 118.31 7.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.63 -37.04 8.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.312 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.39 144.03 32.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.474 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -119.39 123.52 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.315 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.62 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -103.71 131.27 51.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.516 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -109.96 134.92 51.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.161 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.9 123.8 12.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.87 13.19 47.53 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.773 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -94.59 77.93 3.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.997 -178.159 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -40.77 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.336 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.9 m -75.97 -61.6 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.266 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.2 140.13 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 4.0 mmtm -70.46 151.95 44.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 111.224 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.5 -35.53 79.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.459 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -69.89 -34.74 73.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.68 177.205 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.493 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -65.65 -39.44 91.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 173.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -32.97 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.369 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -61.53 -41.74 97.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 176.541 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.99 -30.06 55.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -66.62 -40.61 88.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.473 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.474 ' CD2' HG21 ' A' ' 97' ' ' ILE . 2.3 mp -69.72 -36.88 76.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.723 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.601 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 1.5 mt-10 -63.34 -37.39 87.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.445 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 m -93.5 -14.53 26.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.024 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.49 -22.09 22.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.924 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.45 104.43 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.355 0.598 . . . . 0.0 111.156 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.601 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.85 173.76 11.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.694 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.78 123.8 23.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.665 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.74 -6.26 58.71 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.888 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.4 158.42 17.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.939 0.399 . . . . 0.0 110.452 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.771 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -80.32 144.08 33.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.478 176.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.591 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.23 144.59 25.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.782 0.325 . . . . 0.0 111.585 -172.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.49 106.0 16.3 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.331 0.586 . . . . 0.0 109.729 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -17.65 62.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.482 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.8 p -83.83 -23.25 31.46 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.425 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 p -98.41 2.28 47.7 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.338 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 130' ' ' ILE . 6.1 mm -58.04 -40.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.844 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.66 83.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.689 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.17 -31.72 68.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.345 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.61 -44.85 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.718 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 138' ' ' GLU . 94.4 mt-10 -59.36 -47.65 84.62 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.651 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -35.68 81.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.147 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.29 -38.04 81.16 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.289 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 137' ' ' LEU . 1.2 mm? -66.58 -39.91 88.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.368 . . . . 0.0 111.282 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 134' ' ' GLU . 84.0 mt-10 -56.14 -43.88 78.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.136 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -31.94 67.21 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -34.62 78.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.163 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.478 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -71.16 -36.0 71.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.752 177.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -71.25 -30.56 66.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.41 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -30.27 63.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 145' ' ' GLY . 1.4 p -79.65 -73.27 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.437 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.494 ' H ' HG13 ' A' ' 144' ' ' VAL . . . -113.73 17.72 20.3 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.964 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 61.11 44.5 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 110.559 -173.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.448 ' CE2' ' HA3' ' A' ' 145' ' ' GLY . 66.4 m-85 -88.83 136.14 33.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.243 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.81 128.96 41.92 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.06 143.79 48.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.783 0.325 . . . . 0.0 110.647 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.97 113.68 27.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.68 131.23 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.158 0.504 . . . . 0.0 111.753 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -128.49 117.29 21.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.961 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.55 112.02 24.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 0.0 110.69 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.82 118.5 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.653 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.63 114.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.7 m -116.11 120.76 34.78 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.596 ' HA ' HG12 ' A' ' 163' ' ' VAL . 74.4 Cg_endo -75.28 147.87 33.5 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.778 2.319 . . . . 0.0 113.155 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 1.3 pp -117.1 160.48 37.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 158' ' ' LEU . 52.6 Cg_endo -76.11 73.92 4.76 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.712 2.275 . . . . 0.0 114.105 -171.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.4 OUTLIER -166.73 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.648 173.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.421 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 2.5 t30 -136.43 25.39 3.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 12.1 mmt180 -131.05 161.03 32.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -171.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -132.74 155.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.085 175.031 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.17 125.52 54.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.151 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.0 tp -108.39 131.51 54.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.59 0.233 . . . . 0.0 110.538 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.62 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 37.8 tttt -122.6 133.55 54.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 0.0 111.261 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.91 109.69 21.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.76 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.64 119.36 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.495 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -109.21 117.8 35.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.807 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 C--N 1.318 -0.786 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.162 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.548 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 43.9 p90 -105.95 148.9 27.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.72 113.36 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 p -73.98 133.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.443 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -88.08 -42.92 12.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.56 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -147.21 144.92 29.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.726 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.492 HD12 HD21 ' A' ' 43' ' ' LEU . 63.6 mt -106.86 120.51 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.46 127.45 54.43 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.071 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.782 ' HD2' HG12 ' A' ' 39' ' ' VAL . 78.6 m-85 -107.77 130.5 54.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG3' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -109.36 -42.66 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -172.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.19 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.198 -174.559 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.782 HG12 ' HD2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -51.76 -38.75 22.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.659 -177.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -73.02 -40.75 50.58 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.683 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.25 78.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.37 72.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.673 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 29' ' ' ILE . 2.9 mt -57.64 -31.08 65.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.5 mt -62.79 -26.76 68.88 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 111.58 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.14 -13.53 43.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.893 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.4 mtp -90.26 138.48 27.18 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.481 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.47 16.0 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.882 2.388 . . . . 0.0 113.257 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 52' ' ' ASP . 1.2 p -153.73 147.02 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.406 ' HG2' HD22 ' A' ' 43' ' ' LEU . 57.0 mtt85 -123.28 177.7 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.922 0.489 . . . . 0.0 110.458 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 p -65.6 126.5 28.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.411 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.77 -6.66 35.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.452 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.6 t0 -96.28 158.47 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.459 . . . . 0.0 110.651 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 133.02 34.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.442 HG13 HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -125.97 128.98 72.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 112.007 -173.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 87.7 m-20 -97.67 -179.63 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.008 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.42 -32.62 74.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 109.838 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 7.5 tp10 -61.29 -37.77 84.37 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.434 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.37 -32.21 62.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.292 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -63.54 -46.13 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.046 0.451 . . . . 0.0 109.951 173.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -73.64 -26.88 60.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.254 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -70.76 -45.61 64.47 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.417 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.3 p -64.51 -38.58 91.51 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.031 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -55.35 -54.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.486 0.491 . . . . 0.0 110.42 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -70.78 -30.31 66.75 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.27 -46.95 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.661 0.267 . . . . 0.0 110.567 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' HG23 ' A' ' 69' ' ' THR . 75.4 mt -71.66 -29.63 64.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -39.25 91.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.558 . . . . 0.0 110.48 173.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.41 -12.35 61.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.117 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 66' ' ' LEU . 21.9 p -78.17 -24.47 47.23 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.978 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.42 7.73 83.01 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.454 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -83.41 -20.61 33.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 165.97 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.725 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 3.4 tm-20 -83.91 -50.49 8.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -136.65 137.72 40.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.817 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.79 120.51 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.74 0.305 . . . . 0.0 110.427 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -118.26 118.96 33.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.044 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.5 t -107.9 123.46 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.802 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.99 158.34 41.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -111.39 141.1 45.37 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.642 178.365 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -126.92 95.8 4.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.85 -109.68 3.02 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 14.28 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.292 0.567 . . . . 0.0 110.048 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.678 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.46 111.86 24.5 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.45 HD11 ' HG3' ' A' ' 32' ' ' GLU . 16.6 tp -101.73 116.74 33.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.4 t -107.69 110.16 30.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.362 0.601 . . . . 0.0 110.491 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 27.3 mt-30 -106.16 134.37 49.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.45 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.22 155.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.377 0.608 . . . . 0.0 110.995 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.877 -179.062 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 46.0 Cg_endo . . . . . 0 C--O 1.235 0.344 0 CA-C-O 121.86 0.692 . . . . 0.0 113.396 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 80.6 m -97.92 144.48 27.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.742 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 125' ' ' LEU . 35.8 mt -69.59 117.98 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.59 -35.18 8.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.883 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -149.14 143.56 26.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.432 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.529 HG21 ' CD1' ' A' ' 114' ' ' LEU . 3.1 mt -117.11 124.04 72.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 172.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.558 ' HB ' ' HD3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -106.16 136.03 46.59 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 -176.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -114.85 135.29 54.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.9 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.465 ' OG ' ' HD2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -142.69 128.35 19.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.739 178.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.68 15.02 62.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.728 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -105.23 63.13 0.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -88.1 -21.87 24.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -51.63 23.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.088 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t -109.38 141.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.89 145.98 53.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.859 0.361 . . . . 0.0 111.577 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.853 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -60.28 -35.59 75.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.76 177.094 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.1 -45.36 75.46 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.967 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -43.23 77.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.451 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.853 HD12 ' HA ' ' A' ' 107' ' ' ASP . 4.2 mt -64.64 -33.28 75.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -44.72 96.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.971 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -27.95 45.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.896 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.5 -38.63 90.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.057 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.529 ' CD1' HG21 ' A' ' 97' ' ' ILE . 17.2 mt -66.4 -36.04 81.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.641 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -63.93 -39.45 94.19 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.772 178.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.96 -16.48 60.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.48 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -88.7 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.381 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.81 -25.05 9.79 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.256 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.51 104.2 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.877 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.641 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -132.13 168.19 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.792 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -72.07 129.03 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.461 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.63 -6.3 74.08 Favored Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.835 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.98 145.2 40.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.725 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -66.33 143.13 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.328 178.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.551 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.76 146.33 23.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.156 0.503 . . . . 0.0 111.981 -170.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -107.45 96.35 6.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.152 171.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.431 ' HD3' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -71.89 -14.28 61.9 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.472 -178.397 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.431 HG23 ' HD3' ' A' ' 127' ' ' ARG . 34.2 p -90.53 -28.19 18.67 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.786 0.803 . . . . 0.0 108.897 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 m -95.13 6.4 49.15 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.51 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 130' ' ' ILE . 2.8 mm -58.35 -35.26 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.006 176.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.31 -35.91 78.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.686 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.22 -38.94 89.13 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.0 -42.64 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.347 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.9 -48.47 79.78 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.0 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -34.82 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.01 -36.96 91.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.523 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.49 -32.65 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 110.988 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -66.78 -43.05 85.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.614 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -31.43 70.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.771 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.1 t80 -60.34 -46.51 89.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.624 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.79 -36.46 83.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.824 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.37 -34.41 77.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.87 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.8 m -71.59 -30.08 65.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 140' ' ' PHE . 19.3 t -78.76 -86.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.786 0.326 . . . . 0.0 111.294 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.68 18.14 24.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.934 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.6 mttp 60.49 47.2 8.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.548 0.689 . . . . 0.0 109.667 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -74.8 123.47 25.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.731 -175.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.64 131.87 35.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.706 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -153.33 143.65 22.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.255 0.55 . . . . 0.0 110.975 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.23 114.06 24.73 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 170.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.29 134.48 45.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.546 0.689 . . . . 0.0 112.108 -167.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -130.48 116.54 18.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.244 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.66 111.53 23.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.18 0.514 . . . . 0.0 109.963 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.21 121.7 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.35 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.93 128.0 52.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.7 m -120.0 121.27 29.72 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.433 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 1.1 Cg_endo -85.72 147.0 9.48 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.407 2.738 . . . . 0.0 113.325 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.657 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -105.07 159.99 27.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.927 172.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.47 65.64 2.21 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.432 2.754 . . . . 0.0 114.121 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.54 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -164.83 -113.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 9.6 p-10 -144.72 53.12 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.565 0.698 . . . . 0.0 110.735 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.657 ' HB2' HD11 ' A' ' 158' ' ' LEU . 1.6 mpp_? -143.12 159.91 41.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.456 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -132.33 153.03 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.377 178.502 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.81 124.96 53.03 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 43.3 tp -104.58 117.45 34.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.555 -172.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.558 ' HD3' ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -104.53 131.52 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.325 0.584 . . . . 0.0 110.809 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.556 HD12 ' HE2' ' A' ' 169' ' ' PHE . 1.2 mm? -106.39 109.74 21.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.288 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.39 111.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.34 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.556 ' HE2' HD12 ' A' ' 167' ' ' LEU . 6.0 m-85 -104.98 118.28 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 19.8 mm-40 . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -110.41 154.58 23.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.501 . . . . 0.0 110.715 -174.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.17 117.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.426 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.37 122.33 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.51 0.672 . . . . 0.0 110.667 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -95.6 -22.77 17.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.158 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HB3' HG23 ' A' ' 83' ' ' THR . 8.0 t70 -152.41 139.06 18.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.969 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 mt -118.46 123.36 71.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.989 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.472 ' HB3' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -121.21 133.2 55.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.188 -177.134 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -104.95 136.9 43.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.037 0.446 . . . . 0.0 110.802 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 1.7 mt-10 -119.32 70.39 0.84 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.329 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.957 -179.613 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -32.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.707 0.63 . . . . 0.0 112.618 -174.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.29 -37.17 63.25 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.227 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.49 66.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.167 0.508 . . . . 0.0 110.428 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.73 72.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 46' ' ' MET . 0.7 OUTLIER -55.88 -32.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.664 0.786 . . . . 0.0 112.811 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.06 -14.14 61.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -7.98 38.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.5 ' HB3' HG22 ' A' ' 62' ' ' THR . 1.8 mtm -94.01 133.61 27.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HG3' ' HB3' ' A' ' 61' ' ' ASN . 30.6 Cg_endo -64.91 -28.56 58.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.849 2.366 . . . . 0.0 112.653 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.21 149.58 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.158 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.0 177.87 7.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.591 -174.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.4 p -68.22 121.08 15.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.539 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.54 -6.58 52.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.142 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.74 157.05 16.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.932 0.396 . . . . 0.0 110.887 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.06 136.9 32.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.163 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.55 130.23 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.284 0.564 . . . . 0.0 111.244 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -97.77 -177.07 3.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.964 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -63.91 -27.37 69.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.04 -30.98 65.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.564 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 36.1 m-20 -75.94 -28.83 58.12 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.275 0.23 . . . . 0.0 111.08 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -47.47 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 171.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.419 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.0 m -70.14 -27.63 64.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.708 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.2 m-20 -68.91 -45.26 71.33 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.5 HG22 ' HB3' ' A' ' 46' ' ' MET . 0.9 OUTLIER -63.32 -40.12 96.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.719 175.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 60' ' ' SER . 56.7 mt -55.21 -55.38 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 123.61 0.569 . . . . 0.0 111.128 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -69.26 -31.01 69.26 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 69' ' ' THR . . . -69.01 -50.38 49.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.44 0.162 . . . . 0.0 110.746 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 75' ' ' VAL . 50.8 mt -68.34 -30.44 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.049 0.452 . . . . 0.0 110.313 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.12 -12.52 61.75 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.122 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 65' ' ' ALA . 22.3 p -78.89 -22.54 45.78 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.137 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 19.2 76.71 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.351 -0.452 . . . . 0.0 113.138 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -89.76 -28.7 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.606 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 162.34 28.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.816 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -84.73 -37.93 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -140.5 144.6 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 66' ' ' LEU . 48.3 t -128.63 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 119.53 33.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.361 177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 86' ' ' VAL . 84.1 t -106.11 124.29 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.044 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.0 146.13 47.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -107.76 132.7 53.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.77 95.2 3.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.043 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.95 2.48 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.035 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -106.24 2.1 26.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.006 0.522 . . . . 0.0 110.901 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.492 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -106.66 132.91 52.11 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.75 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.0 113.09 26.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.814 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 30' ' ' HIS . 3.5 tp -102.86 112.24 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.406 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.509 HG13 HG22 ' A' ' 77' ' ' VAL . 15.2 t -110.08 106.22 20.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.546 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 6.6 mt-30 -92.91 136.18 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.49 142.87 41.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.126 0.489 . . . . 0.0 110.243 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.915 -175.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.462 -0.368 0 CA-C-O 121.552 0.563 . . . . 0.0 113.482 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 5.1 m -97.69 133.51 42.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.2 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.5 mt -71.95 117.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.56 -33.17 11.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.036 0.446 . . . . 0.0 110.555 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -147.26 143.08 27.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.446 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.699 HG21 HD22 ' A' ' 114' ' ' LEU . 1.3 mt -115.65 123.0 70.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.605 ' HB ' ' HE3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -122.42 132.86 54.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.243 0.545 . . . . 0.0 110.773 -175.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.515 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 21.3 m-85 -111.23 135.25 52.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.376 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.73 120.25 18.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.37 29.73 9.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.116 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 2.8 p-10 -107.98 63.93 0.62 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.562 0.696 . . . . 0.0 110.566 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -85.16 -17.34 37.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.091 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -93.04 -52.03 4.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 31.7 t -108.03 128.92 63.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 11.1 mmmt -69.95 149.4 47.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -170.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -35.13 69.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.729 173.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.78 -43.94 90.56 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.0 mtp -69.1 -41.2 77.76 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.45 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -36.72 80.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.861 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -46.17 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.135 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -28.73 55.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.172 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.29 -46.87 86.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.261 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.699 HD22 HG21 ' A' ' 97' ' ' ILE . 1.9 mp -66.25 -40.63 90.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.014 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.695 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 7.6 mt-10 -60.32 -42.42 95.57 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.402 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.13 -22.15 60.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.703 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -87.93 -16.86 32.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.73 -24.97 6.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.805 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.99 104.7 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.185 0.517 . . . . 0.0 111.641 -174.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.695 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.66 176.47 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.553 178.116 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 94' ' ' ILE . 44.7 t -68.34 125.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.251 0.548 . . . . 0.0 111.593 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.82 61.93 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.127 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.28 155.26 21.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 110.699 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.21 133.82 42.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.507 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -92.22 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.281 0.562 . . . . 0.0 111.061 -173.447 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -110.01 102.48 11.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.858 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.406 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -71.16 -15.75 62.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.74 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -84.13 -18.37 37.02 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.549 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.51 -0.75 45.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 130' ' ' ILE . 4.9 mm -59.33 -35.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.499 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.58 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.559 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.21 -28.55 60.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.804 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.29 -43.36 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.957 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.63 -42.01 99.34 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.61 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -41.75 98.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.157 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.62 93.05 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.635 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.595 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 18.2 mt -74.09 -32.43 63.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.586 0.231 . . . . 0.0 111.112 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.01 -40.91 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.207 175.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.51 -39.87 88.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.552 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -43.18 99.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -41.66 91.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.362 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -32.31 66.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.5 m -71.35 -32.25 68.31 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.619 HG13 ' H ' ' A' ' 145' ' ' GLY . 1.9 p -76.0 -77.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.647 -175.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.619 ' H ' HG13 ' A' ' 144' ' ' VAL . . . -114.21 17.49 19.29 Favored Glycine 0 N--CA 1.454 -0.107 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.768 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 55.71 58.63 4.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.569 0.699 . . . . 0.0 110.816 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -92.86 111.54 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.5 98.7 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -107.63 145.27 33.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.048 0.451 . . . . 0.0 111.579 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.29 114.14 26.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 171.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.92 124.58 57.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.15 0.5 . . . . 0.0 111.469 -171.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -130.9 117.02 18.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.492 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.86 112.47 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.427 0.632 . . . . 0.0 110.117 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.26 119.71 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.077 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -99.6 112.14 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 m -104.23 117.42 59.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.533 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 163' ' ' VAL . 88.5 Cg_endo -80.31 137.46 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.2 2.6 . . . . 0.0 113.406 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 1.2 pp -104.82 143.67 27.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 169.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 22.2 Cg_exo -65.28 80.91 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.704 2.936 . . . . 0.0 115.018 -168.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -169.32 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.786 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -163.03 22.64 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.441 0.639 . . . . 0.0 109.944 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.498 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -128.23 155.8 43.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 -174.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 157' ' ' PRO . 3.7 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.683 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.25 131.74 55.33 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.435 ' HB3' HG23 ' A' ' 97' ' ' ILE . 21.9 tp -99.55 114.15 26.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.831 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.605 ' HE3' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.524 0.678 . . . . 0.0 111.138 -177.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.515 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -110.43 109.54 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.129 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.15 111.76 31.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.115 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.595 ' HZ ' HD13 ' A' ' 137' ' ' LEU . 15.2 m-30 -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.766 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.482 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HZ ' ' HB2' ' A' ' 79' ' ' ARG . 48.3 p90 -112.55 154.39 26.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.967 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.2 t -77.44 113.52 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -76.17 124.1 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.469 0.652 . . . . 0.0 109.952 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -88.95 -36.66 15.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.642 -176.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -144.31 143.46 31.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.154 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 85.2 mt -104.62 121.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -111.32 126.38 54.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -106.15 115.61 30.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.477 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 tt0 -102.68 68.4 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.405 0.622 . . . . 0.0 110.056 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.905 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.589 177.871 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.453 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -60.83 -29.13 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.27 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.93 -35.72 57.91 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.265 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -75.81 -34.61 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.351 0.596 . . . . 0.0 110.27 177.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.09 73.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.592 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mt -60.08 -31.73 70.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.211 0.604 . . . . 0.0 112.073 172.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 41' ' ' ALA . 90.4 mt -69.24 -21.74 63.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.21 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 m -88.28 -19.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.036 0.446 . . . . 0.0 110.285 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.521 ' HG2' HG23 ' A' ' 62' ' ' THR . 68.0 mtp -82.65 138.68 43.94 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.853 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 10.8 Cg_exo -73.5 -14.88 24.94 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.931 2.421 . . . . 0.0 112.586 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.506 HG11 HG12 ' A' ' 54' ' ' VAL . 29.3 m -114.93 167.77 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.117 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 4.9 mmt85 -129.12 174.24 9.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.918 0.389 . . . . 0.0 110.456 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.1 p -67.96 122.88 19.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.994 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -5.35 44.29 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.059 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -76.14 155.15 34.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -92.84 113.01 25.17 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.506 HG12 HG11 ' A' ' 48' ' ' VAL . 5.7 m -116.75 127.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.586 -165.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.42 ' O ' HD12 ' A' ' 59' ' ' ILE . 16.2 m-80 -98.85 -178.09 3.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.312 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -28.98 70.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 10.9 tt0 -64.05 -44.27 92.97 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.006 175.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.01 -34.83 75.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.227 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -62.18 -50.96 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 123.153 0.283 . . . . 0.0 110.286 175.222 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.622 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.1 m -67.89 -35.27 78.2 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.436 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 6.9 t-20 -63.79 -45.37 90.03 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.449 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.521 HG23 ' HG2' ' A' ' 46' ' ' MET . 90.5 m -59.01 -42.58 90.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.416 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 60' ' ' SER . 71.2 mt -55.55 -56.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 123.318 0.386 . . . . 0.0 111.223 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 -70.29 -28.46 65.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.05 -52.72 61.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.06 -31.79 72.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.672 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -33.8 76.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.792 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.68 -12.77 61.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.541 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 p -78.73 -24.95 44.59 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.763 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.48 65.43 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.82 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.04 4.68 15.78 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.18 0.49 . . . . 0.0 111.007 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.9 163.91 26.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 166.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -87.15 -46.01 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 110.192 177.467 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 33.9 t70 -129.54 136.82 50.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.423 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.9 117.99 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 119.51 32.83 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 174.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.653 HG22 HG13 ' A' ' 86' ' ' VAL . 54.9 t -111.78 121.08 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.05 136.99 42.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -93.43 136.39 33.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.986 0.422 . . . . 0.0 110.029 178.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -126.61 95.38 4.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.99 -109.52 2.84 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.373 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.425 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 15.0 p-10 -106.21 10.96 31.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.164 0.507 . . . . 0.0 111.001 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.87 141.34 46.81 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.624 -177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -103.74 114.85 29.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 176.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tp -107.54 112.81 25.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.48 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.653 HG13 HG22 ' A' ' 77' ' ' VAL . 7.3 t -112.79 111.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.291 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.477 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 5.3 mt-30 -104.74 128.72 52.93 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 m -125.4 141.8 44.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.661 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 44.6 tttt . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.732 -172.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 2.9 Cg_exo . . . . . 0 N--CA 1.464 -0.214 0 N-CA-C 113.891 0.689 . . . . 0.0 113.891 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 50.3 m -89.39 136.21 33.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.53 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 125' ' ' LEU . 35.7 mt -62.46 117.48 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.54 -27.79 13.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.827 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.4 149.87 22.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 114' ' ' LEU . 3.7 mt -123.79 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.86 148.06 52.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.881 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.616 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 25.6 m-85 -120.43 153.63 36.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.104 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.58 143.75 23.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.759 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.63 73.41 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.32 -0.467 . . . . 0.0 114.199 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.5 OUTLIER -101.42 81.51 2.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.393 0.616 . . . . 0.0 110.532 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -86.14 -34.68 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.931 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -56.38 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.993 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -92.62 159.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.987 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' A' ' 106' ' ' LYS . 2.4 mmmm -88.23 145.52 25.84 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.259 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.616 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 15.6 p-10 -66.74 -34.71 78.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.761 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.606 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 16.6 t70 -58.92 -38.35 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.089 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -42.77 68.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.405 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.19 -32.48 68.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.02 0.528 . . . . 0.0 111.959 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.606 ' HD3' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -58.63 -47.96 82.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.226 178.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.9 -28.58 49.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -36.46 83.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.551 HD12 HG21 ' A' ' 97' ' ' ILE . 11.6 mt -74.19 -38.92 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.723 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -61.99 -31.89 72.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.409 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.71 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.605 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -16.72 34.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.875 0.369 . . . . 0.0 110.267 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.86 -21.76 8.87 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.47 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.68 108.12 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.282 0.563 . . . . 0.0 111.303 -176.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.723 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.28 172.15 13.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' A' ' 94' ' ' ILE . 48.4 t -71.62 127.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.062 0.458 . . . . 0.0 110.503 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.53 -20.96 48.25 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.059 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -82.51 163.8 21.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.257 0.551 . . . . 0.0 110.628 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 73' ' ' GLU . 63.3 m -85.21 151.17 24.29 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.535 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -104.8 143.83 32.59 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.695 0.76 . . . . 0.0 111.607 -172.333 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.588 ' HB3' HG22 ' A' ' 129' ' ' THR . 9.7 t0 -104.65 98.09 7.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.397 176.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.572 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.85 -15.59 62.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.648 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.0 p -83.32 -17.88 40.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.085 0.469 . . . . 0.0 110.363 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 126' ' ' ASP . 0.8 OUTLIER -103.11 6.72 38.69 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 176.07 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.572 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.6 mm -61.45 -39.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.36 78.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.188 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -33.12 70.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.066 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 mt -68.55 -47.19 78.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.112 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.59 -41.73 98.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.966 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -37.12 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.026 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.09 -37.8 87.63 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.529 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 44.4 mt -74.45 -32.0 62.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.675 0.274 . . . . 0.0 111.066 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -37.65 75.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 110.039 175.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.97 -33.22 75.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.559 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.476 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.6 t80 -64.78 -45.42 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.525 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 2.1 m-85 -63.02 -37.1 85.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.2 t80 -68.13 -35.59 78.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.254 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.03 -31.24 69.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.688 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 140' ' ' PHE . 7.9 t -74.57 -91.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.77 0.319 . . . . 0.0 110.338 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.92 18.39 24.16 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.094 -177.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.767 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 58.92 50.32 8.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.357 0.598 . . . . 0.0 110.045 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -80.19 119.64 23.23 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.403 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.94 99.11 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.82 43.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.439 0.637 . . . . 0.0 111.382 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.71 113.06 24.98 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.8 p -108.16 127.44 64.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.439 0.638 . . . . 0.0 110.519 -174.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.91 116.84 20.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.542 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.94 110.58 22.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.17 124.91 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.906 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.58 113.97 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.318 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.0 m -104.41 115.27 63.19 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.799 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.65 127.42 9.57 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.919 2.412 . . . . 0.0 112.618 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -105.79 150.9 39.71 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 171.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.49 79.74 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.463 2.776 . . . . 0.0 113.967 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.432 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -171.21 -104.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.583 0.753 . . . . 0.0 109.348 177.643 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 16.5 p-10 -157.5 34.92 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HB2' HD11 ' A' ' 158' ' ' LEU . 1.5 mmt85 -133.78 155.3 50.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.877 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -127.6 151.52 34.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.812 177.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.63 118.88 37.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.86 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.1 tp -96.82 121.05 38.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.44 132.49 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.433 0.635 . . . . 0.0 111.044 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.609 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.0 mm? -105.61 111.48 24.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.834 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 21.6 t -99.54 120.41 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -116.06 118.94 34.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.47 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.959 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -97.39 152.5 18.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.3 t -85.66 122.65 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.67 124.28 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.588 0.709 . . . . 0.0 110.689 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -80.31 -26.93 38.57 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.387 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -162.51 149.45 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.453 HD12 HD21 ' A' ' 43' ' ' LEU . 58.7 mt -112.99 121.54 65.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.9 t-160 -116.77 127.22 54.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' HD2' HG12 ' A' ' 39' ' ' VAL . 19.5 m-85 -106.68 136.72 46.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -131.32 167.7 18.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.63 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.348 -177.587 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 120.547 0.213 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.567 HG12 ' HD2' ' A' ' 31' ' ' PHE . 2.7 m -66.48 -27.57 40.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.914 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.69 -36.97 61.8 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.134 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -76.47 -34.42 58.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.547 0.689 . . . . 0.0 110.157 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.57 68.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.997 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.684 HD22 ' HD2' ' A' ' 49' ' ' ARG . 5.1 mt -57.14 -31.29 65.21 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.356 0.662 . . . . 0.0 112.532 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 41' ' ' ALA . 67.1 mt -66.48 -22.31 66.19 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.565 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.57 -8.3 26.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.562 ' HG2' HG23 ' A' ' 62' ' ' THR . 30.9 mtp -83.54 143.25 43.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.204 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.74 -3.56 13.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.512 2.142 . . . . 0.0 113.334 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -139.58 163.79 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.684 ' HD2' HD22 ' A' ' 43' ' ' LEU . 9.6 mmm180 -120.31 176.06 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.936 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 p -66.94 132.92 48.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.61 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.37 -5.7 77.83 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.638 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 156.64 18.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.881 0.372 . . . . 0.0 111.081 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 125.1 30.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.322 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 HG11 ' A' ' 48' ' ' VAL . 20.9 m -123.14 137.22 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.705 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -97.49 178.54 5.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.026 0.441 . . . . 0.0 110.804 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -27.17 63.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.53 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -29.44 64.67 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.36 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 42.3 m-20 -73.91 -29.2 61.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.524 175.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.87 -49.34 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.719 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -64.75 -36.36 84.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 176.469 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -64.06 -42.33 97.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 178.252 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.562 HG23 ' HG2' ' A' ' 46' ' ' MET . 54.0 m -60.04 -42.55 94.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 60' ' ' SER . 55.3 mt -55.62 -49.3 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.53 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -36.43 82.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.027 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.11 66.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.623 HD22 ' HE1' ' A' ' 72' ' ' PHE . 89.9 mt -71.08 -28.31 64.24 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.224 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -45.23 66.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.63 -15.79 59.73 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 66' ' ' LEU . 9.7 t -80.78 -24.29 38.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.35 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.5 1.65 90.17 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 164.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.12 -6.33 59.3 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.945 0.872 . . . . 0.0 111.698 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.623 ' HE1' HD22 ' A' ' 66' ' ' LEU . 14.2 m-85 -124.43 159.14 31.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -91.75 -36.95 13.28 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.887 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 26.7 t0 -137.73 140.97 41.0 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 66' ' ' LEU . 49.1 t -128.17 119.84 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.892 0.377 . . . . 0.0 110.5 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.7 118.13 30.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.877 173.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.578 HG22 HG13 ' A' ' 86' ' ' VAL . 61.4 t -106.95 122.34 60.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.81 137.97 37.12 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.8 137.15 36.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.407 0.622 . . . . 0.0 110.82 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -113.99 95.31 5.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.74 -109.37 2.87 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.483 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.29 11.02 21.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.239 0.542 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.86 139.57 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.724 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -104.8 114.89 29.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.487 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 20.6 tp -109.23 115.11 29.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.233 0.54 . . . . 0.0 110.453 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.578 HG13 HG22 ' A' ' 77' ' ' VAL . 19.0 t -106.25 108.24 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.351 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.505 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 73.5 mt-30 -97.06 126.38 42.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.41 150.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.85 0.834 . . . . 0.0 111.159 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.463 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 16.4 tttm . . . . . 0 C--N 1.308 -1.199 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.149 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.502 ' HB2' HG13 ' A' ' 163' ' ' VAL . 9.6 Cg_endo . . . . . 0 N--CA 1.449 -1.107 0 CA-C-O 121.104 0.376 . . . . 0.0 111.344 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.9 m -96.36 147.72 23.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.194 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.649 HG13 ' HB2' ' A' ' 125' ' ' LEU . 42.4 mt -58.12 118.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 162' ' ' ARG . . . -105.82 -38.24 6.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.183 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.97 27.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.487 HG12 HD21 ' A' ' 165' ' ' LEU . 1.2 mt -114.83 123.69 70.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 168.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.88 135.4 54.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -176.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.1 m-85 -111.45 135.47 51.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -141.93 112.11 6.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.877 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.695 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 178.96 -60.12 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.911 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.467 ' HB2' ' OH ' ' A' ' 141' ' ' TYR . 0.7 OUTLIER -153.6 148.41 26.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.122 0.487 . . . . 0.0 111.957 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -86.52 -13.01 47.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.903 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.586 ' HB3' HG11 ' A' ' 144' ' ' VAL . 54.0 m -58.35 -50.85 72.18 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.706 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p -87.31 137.68 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.547 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -78.63 143.33 36.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.234 -174.052 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -67.68 -33.95 75.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.106 177.058 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -30.79 71.84 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.568 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 106' ' ' LYS . 29.6 mtp -73.03 -46.07 54.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.413 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.55 HD22 HD22 ' A' ' 137' ' ' LEU . 4.5 mt -63.22 -31.87 73.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -59.31 -43.4 92.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 111.019 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.97 -28.81 58.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.364 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.63 -43.98 91.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.245 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.421 HD22 HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -65.34 -36.82 85.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.917 175.071 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -31.42 72.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.56 61.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.547 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.0 m -84.66 -16.83 40.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 110.178 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 106.07 1.28 38.83 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.269 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -103.01 117.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.183 0.516 . . . . 0.0 110.863 -177.103 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.69 170.5 15.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.222 -177.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.8 t -71.73 126.3 31.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.982 0.42 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.84 -5.91 79.42 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.943 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.9 OUTLIER -106.47 154.59 20.62 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.508 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 1.5 m -57.12 139.34 52.75 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.537 0.523 . . . . 0.0 111.524 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.649 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.92 145.33 25.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.322 0.582 . . . . 0.0 111.183 -175.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.534 ' HA ' ' NH1' ' A' ' 127' ' ' ARG . 26.2 t0 -117.77 111.58 19.28 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.716 0.77 . . . . 0.0 111.243 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.534 ' NH1' ' HA ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -71.2 -15.23 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.051 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.4 p -89.72 -15.43 32.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.741 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -92.73 2.49 56.71 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.929 175.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 130' ' ' ILE . 7.1 mm -59.8 -41.32 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.924 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.39 86.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.816 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.33 -41.63 96.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.115 0.483 . . . . 0.0 109.732 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 10.7 mt -63.55 -45.99 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.479 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -60.37 -49.45 77.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 2.9 tptp -61.95 -40.28 94.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.27 65.84 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.843 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.55 HD22 HD22 ' A' ' 110' ' ' LEU . 12.7 mt -74.01 -32.64 63.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.632 0.253 . . . . 0.0 110.985 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.744 ' HG3' HG12 ' A' ' 151' ' ' VAL . 52.9 mt-10 -67.04 -37.47 84.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 174.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -31.29 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.456 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -66.41 -36.93 84.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.467 ' OH ' ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -62.64 -35.72 80.52 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 177.322 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -69.35 -34.52 74.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.651 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.29 66.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 104' ' ' SER . 12.4 t -74.87 -86.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.76 18.77 24.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.576 -176.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.6 56.8 3.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.685 0.755 . . . . 0.0 110.063 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -86.18 149.84 24.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.298 -174.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 89.21 3.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.665 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.12 156.52 46.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 0.0 112.036 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 m -117.61 139.98 50.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.843 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.744 HG12 ' HG3' ' A' ' 138' ' ' GLU . 6.6 p -114.4 139.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.134 0.492 . . . . 0.0 110.682 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 127.69 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.228 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.64 116.92 29.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.46 0.648 . . . . 0.0 111.387 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.28 112.33 30.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.904 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.95 111.43 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 120.971 0.415 . . . . 0.0 110.042 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.517 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 22.2 m -118.96 125.15 27.85 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.036 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.1 Cg_exo -82.38 145.62 13.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.191 2.594 . . . . 0.0 112.563 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.3 OUTLIER -105.82 158.88 31.38 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.88 62.77 4.88 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.355 2.703 . . . . 0.0 113.483 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.64 ' HB2' HD12 ' A' ' 158' ' ' LEU . 8.6 mmt180 -146.84 -93.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 -168.69 32.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 174.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.462 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -136.87 166.61 23.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.083 -177.286 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.528 HG21 HD22 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -128.99 148.03 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.117 0.484 . . . . 0.0 111.163 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -112.07 122.18 47.04 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.487 HD21 HG12 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -119.14 132.58 56.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.713 0.768 . . . . 0.0 111.363 -176.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -120.91 133.34 55.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.975 -176.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.5 mm? -103.56 110.32 22.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.747 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.1 116.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.695 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 75.7 m-85 -97.87 118.56 34.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.538 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -109.43 153.95 23.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.89 117.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.909 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.22 115.69 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -41.53 23.58 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.134 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.699 ' HB3' HG23 ' A' ' 83' ' ' THR . 25.0 t70 -144.11 143.77 31.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.043 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.5 mt -105.31 121.84 57.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.93 128.59 45.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.271 0.557 . . . . 0.0 111.125 -175.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -105.33 137.84 42.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.638 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.46 -42.91 2.96 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.311 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.071 -176.443 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.681 0 CA-C-O 120.447 0.165 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -61.31 -32.48 53.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.463 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.97 -37.61 83.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.9 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.19 63.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.082 0.468 . . . . 0.0 110.738 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.88 -40.05 55.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.479 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.1 -29.92 70.04 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.289 0.635 . . . . 0.0 112.159 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 84.5 mt -62.45 -24.97 67.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.515 ' HB2' HD23 ' A' ' 66' ' ' LEU . 1.5 m -96.82 -7.82 32.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.48 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 33.9 mtp -87.39 131.6 43.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.026 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 13.1 Cg_exo -70.82 -25.43 23.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.914 2.409 . . . . 0.0 112.667 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 m -112.9 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.24 0.543 . . . . 0.0 111.418 -176.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -118.21 -179.87 3.9 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.487 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.9 p -67.47 121.43 15.79 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.847 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -6.11 47.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.5 m-20 -86.0 153.72 21.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.545 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.27 139.01 33.04 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 127.24 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.869 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.54 -177.36 3.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.108 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.513 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -68.07 -36.3 79.61 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.54 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 22.6 m-20 -74.14 -29.81 61.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.787 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -48.38 88.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -70.42 -32.49 70.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.562 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 2.0 m-20 -62.06 -49.76 74.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 110.476 177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 46' ' ' MET . 44.4 m -61.46 -44.34 97.27 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.48 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CD1' HG22 ' A' ' 77' ' ' VAL . 2.4 mt -59.22 -48.2 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 123.39 0.431 . . . . 0.0 110.844 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -33.54 74.14 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.21 -51.59 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.585 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 45' ' ' SER . 79.8 mt -67.61 -30.08 69.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.28 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -41.77 94.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 110.608 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.75 -13.51 62.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.92 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 65' ' ' ALA . 26.4 p -79.37 -25.0 42.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.594 0.235 . . . . 0.0 111.184 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.72 26.97 71.39 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.415 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -95.64 -20.05 19.25 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.117 0.484 . . . . 0.0 110.207 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.67 154.85 45.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 36.3 mt-10 -80.43 -43.66 20.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 111.6 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 12.6 t70 -132.91 136.34 46.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 66' ' ' LEU . 25.9 t -124.98 117.88 51.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.507 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 76' ' ' ARG . 2.4 tpp85 -121.12 122.37 39.87 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.962 172.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 63' ' ' ILE . 27.1 m -96.64 137.54 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -128.34 154.15 46.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -107.57 115.16 29.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.786 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.79 95.62 5.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 -110.45 3.37 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.212 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -106.74 8.32 30.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.225 0.536 . . . . 0.0 110.743 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.699 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -111.08 141.52 44.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.546 -173.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.96 115.55 30.81 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.02 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.32 112.43 24.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.123 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -102.4 109.87 27.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.502 0.668 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -103.95 126.42 51.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.599 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.18 158.3 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.908 0.385 . . . . 0.0 111.262 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.5 tptp . . . . . 0 C--O 1.239 0.547 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 72.6 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 N-CA-C 113.919 0.699 . . . . 0.0 113.919 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.1 m -99.54 138.12 37.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.6 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 20.7 mt -61.62 117.61 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.04 -22.92 13.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.117 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 138.66 13.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.891 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.433 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.2 mt -118.0 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.431 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -117.68 132.27 56.51 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.75 -175.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.64 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 22.2 m-85 -105.84 151.06 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.95 139.71 20.77 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.6 18.5 56.64 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.33 56.99 4.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.455 0.702 . . . . 0.0 110.807 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -86.57 -34.81 19.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 m -84.97 -51.06 6.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.64 137.3 44.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.69 147.86 50.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.619 -174.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.64 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -64.39 -33.09 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.855 176.153 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -38.01 74.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.024 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -44.08 55.24 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 106' ' ' LYS . 31.1 mt -61.21 -32.49 72.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.101 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.407 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 7.8 mttt -60.47 -46.21 90.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 111.227 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 5.3 tp60 -77.89 -28.24 49.82 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.609 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.094 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.433 ' CD2' HG21 ' A' ' 97' ' ' ILE . 2.3 mp -68.07 -40.57 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.619 174.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.607 ' HG2' ' HB2' ' A' ' 120' ' ' ARG . 1.9 mt-10 -60.46 -42.35 96.0 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.86 -16.0 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.677 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.5 m -91.98 -13.27 31.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.49 -22.03 13.86 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.998 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 94' ' ' ILE . 41.0 t -92.35 104.04 15.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.092 0.472 . . . . 0.0 110.079 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.607 ' HB2' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.0 170.16 16.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.241 -178.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.54 131.47 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.35 0.595 . . . . 0.0 111.283 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.17 -6.63 81.06 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.709 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.58 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -100.15 166.88 10.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.0 111.519 -174.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -61.99 148.08 44.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.433 173.555 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -112.3 135.08 53.42 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.716 0.769 . . . . 0.0 110.979 -177.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' HG22 ' A' ' 129' ' ' THR . 23.7 t0 -106.17 97.31 7.14 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 172.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.616 ' HD3' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.58 -15.24 62.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.758 -176.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.616 HG23 ' HD3' ' A' ' 127' ' ' ARG . 12.5 p -89.74 -23.62 21.75 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.698 0.285 . . . . 0.0 110.96 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 126' ' ' ASP . 0.5 OUTLIER -87.99 -1.29 57.9 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.406 0.622 . . . . 0.0 110.517 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.703 HG23 ' HB3' ' A' ' 153' ' ' ALA . 5.6 mm -57.51 -43.36 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.215 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.721 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.28 -36.53 84.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.149 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.3 mt -65.18 -45.23 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.353 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -61.12 -47.7 85.05 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 17.2 mmtm -67.09 -34.58 77.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.646 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.94 -39.98 84.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.024 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.587 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 37.0 mt -69.66 -32.54 71.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.633 0.254 . . . . 0.0 111.032 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -63.09 -41.46 99.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.24 -43.48 94.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.688 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.403 ' O ' HG23 ' A' ' 144' ' ' VAL . 14.6 m-85 -65.29 -38.55 90.56 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.228 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -35.47 80.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.947 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -30.4 67.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.206 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -28.44 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 140' ' ' PHE . 12.2 t -72.47 -83.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.233 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.53 18.62 22.59 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.584 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt 63.11 45.58 5.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.368 0.667 . . . . 0.0 110.184 -174.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -80.57 119.62 23.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.092 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.71 73.02 6.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.44 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 143.9 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.39 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.5 m -97.94 115.66 28.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 13.2 t -107.07 122.35 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.563 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 119.57 24.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.388 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.703 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -95.9 111.97 23.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.258 0.552 . . . . 0.0 110.246 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.58 118.82 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.811 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.09 116.75 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.331 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.474 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.1 m -120.77 122.13 28.63 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.791 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.3 Cg_endo -88.11 142.69 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.68 2.92 . . . . 0.0 113.003 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -120.56 159.39 48.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.033 178.056 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.06 -7.69 12.28 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 123.726 2.951 . . . . 0.0 115.0 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.51 12.42 8.57 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 122.488 -0.132 . . . . 0.0 111.193 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 1.3 m-20 62.22 42.35 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.0 0.905 . . . . 0.0 110.603 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HB2' HD11 ' A' ' 158' ' ' LEU . 14.5 mmt85 -131.02 163.57 27.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.381 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.547 HG21 HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -127.43 146.49 33.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.23 0.538 . . . . 0.0 110.537 176.318 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.08 123.41 49.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.494 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.1 tp -107.22 119.71 40.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.115 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.431 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -115.4 131.27 56.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.376 0.607 . . . . 0.0 110.58 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.6 mm? -104.3 109.93 21.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.462 -176.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.9 t -96.41 111.41 26.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.587 ' HZ ' HD13 ' A' ' 137' ' ' LEU . 48.6 m-85 -108.78 135.2 50.39 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.318 -0.801 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.326 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -107.9 152.76 23.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.686 -0.257 . . . . 0.0 110.428 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.57 113.3 23.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.26 118.42 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 111.256 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -76.69 -46.77 24.31 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 178.363 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.84 146.66 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.427 ' HB ' HD11 ' A' ' 43' ' ' LEU . 62.4 mt -105.39 119.99 55.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -109.65 127.55 54.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.89 137.48 41.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.012 0.434 . . . . 0.0 110.476 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.39 -30.58 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.468 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.796 -176.993 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.11 -37.54 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.71 -40.23 90.11 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.95 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -71.8 -34.84 69.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.909 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -32.46 70.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.31 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' A' ' 29' ' ' ILE . 4.8 mp -68.94 -30.99 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 41' ' ' ALA . 53.0 mt -68.96 -23.38 64.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.411 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -80.61 -20.96 42.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.422 177.452 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.547 ' HB3' HG22 ' A' ' 62' ' ' THR . 24.7 mtt -82.53 139.39 44.32 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.95 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 31.4 Cg_exo -63.36 -36.2 57.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.656 2.237 . . . . 0.0 112.328 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.86 150.12 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.389 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 14.6 mmm-85 -127.82 178.09 6.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 0.0 111.067 -175.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -64.65 122.58 17.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.95 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.39 -10.1 42.45 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.83 -174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 5.2 m-20 -89.32 152.77 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.531 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.91 127.7 36.49 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.74 131.15 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.421 0.629 . . . . 0.0 112.491 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -93.13 173.17 7.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.38 174.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.96 -31.6 71.96 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -61.21 -36.97 81.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.893 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 37.8 m-20 -75.05 -29.21 60.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.08 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -45.31 95.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -32.18 73.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.921 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.598 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.4 m-80 -69.63 -43.55 72.45 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.203 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 46' ' ' MET . 1.3 p -63.29 -43.15 98.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.032 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mt -54.21 -49.63 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 123.519 0.512 . . . . 0.0 110.45 174.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -46.59 89.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.416 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 45' ' ' SER . . . -60.8 -48.45 81.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.467 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 75' ' ' VAL . 54.1 mt -69.89 -29.51 66.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -34.36 77.51 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 110.287 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.16 61.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.421 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.8 p -77.61 -25.64 49.98 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.222 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.57 -5.85 20.35 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 116.143 -0.48 . . . . 0.0 114.114 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.63 -23.87 22.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.167 0.483 . . . . 0.0 111.228 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.562 ' CD1' HG21 ' A' ' 88' ' ' VAL . 6.0 m-85 -101.47 157.19 16.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.62 ' HG2' ' HD2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -86.78 -41.66 13.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.151 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.724 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 8.4 t70 -145.88 139.19 26.12 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 66' ' ' LEU . 22.6 t -116.73 120.77 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -174.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.84 118.53 31.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.751 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.6 126.48 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.011 0.434 . . . . 0.0 110.014 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -126.36 159.08 34.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 129.86 50.63 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.806 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.0 96.63 6.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.815 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.2 -109.85 3.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.616 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -111.44 15.9 21.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.394 0.616 . . . . 0.0 110.375 177.618 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.06 141.41 38.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.085 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.84 119.15 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -112.23 116.99 31.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.98 0.419 . . . . 0.0 110.17 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -106.72 111.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.253 0.549 . . . . 0.0 110.72 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.13 136.24 41.3 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.562 HG21 ' CD1' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -130.78 155.82 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.126 0.489 . . . . 0.0 110.326 -173.349 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.724 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.2 -175.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 3.5 Cg_exo . . . . . 0 N--CA 1.456 -0.714 0 CA-C-O 121.683 0.618 . . . . 0.0 112.559 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -104.34 136.83 43.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.336 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 125' ' ' LEU . 31.0 mt -64.83 118.25 6.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.15 -27.84 14.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.82 139.85 15.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.041 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.17 122.88 65.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 167.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.493 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -116.27 131.94 56.8 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.388 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.607 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -113.43 134.12 54.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.824 -175.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.3 125.75 16.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.66 -2.34 57.19 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.363 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.488 HD21 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -86.36 82.15 8.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.187 0.518 . . . . 0.0 110.709 -177.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.88 -35.77 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.043 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -70.32 -64.91 0.8 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.126 0.488 . . . . 0.0 110.626 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.65 130.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -69.41 158.38 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 0.0 112.087 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -61.47 -34.6 75.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.723 173.133 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -43.1 96.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.983 176.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 mmm -74.45 -35.35 63.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.753 0.311 . . . . 0.0 111.131 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -31.65 72.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.549 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.607 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.93 -43.42 86.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 110.763 176.071 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -78.29 -28.6 47.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.115 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -66.39 -42.64 87.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.19 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -68.08 -38.45 82.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.53 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -40.16 88.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.097 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.92 -19.38 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.915 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 m -89.23 -12.86 39.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 102.62 -11.86 56.5 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.629 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.3 t -100.5 101.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.519 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 26.8 ptt180 -142.93 175.32 9.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -176.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 94' ' ' ILE . 14.6 p -68.89 135.09 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.216 176.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.33 18.02 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.37 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -84.91 160.5 20.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 110.994 177.351 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.98 150.58 27.57 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 170.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.634 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -119.02 130.72 55.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -174.052 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.584 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 20.0 t0 -90.13 112.87 24.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.629 0.728 . . . . 0.0 109.893 172.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -15.69 62.25 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.079 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.3 p -83.45 -25.36 31.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.338 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.584 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -89.34 -1.1 57.94 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.952 177.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.559 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.4 mm -56.72 -41.53 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.481 ' HA ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.08 -38.36 90.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.86 -31.22 68.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.583 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.7 mt -67.03 -43.62 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.54 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 131' ' ' ALA . 49.1 mt-10 -62.44 -44.4 96.5 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.591 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.34 93.57 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.748 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.37 -37.49 92.82 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.931 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 mt -68.27 -39.58 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.501 0.191 . . . . 0.0 111.368 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.4 -39.26 88.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.282 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.743 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -60.96 -45.06 96.29 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 147' ' ' TYR . 1.2 m-85 -61.78 -41.42 97.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.181 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -70.75 -34.37 71.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.096 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.2 m -66.51 -28.56 68.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.8 t -80.13 -88.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.975 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.25 18.06 26.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.5 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 1.0 OUTLIER 59.99 44.67 13.07 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.283 0.633 . . . . 0.0 110.697 -174.078 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HB3' ' A' ' 141' ' ' TYR . 69.3 m-85 -73.58 102.96 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.91 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.32 84.28 6.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 111.676 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -117.81 141.56 48.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 m -100.05 122.42 42.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.749 0.309 . . . . 0.0 110.459 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.2 p -105.47 133.12 50.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.384 0.612 . . . . 0.0 111.657 -174.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -129.23 122.53 29.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.514 173.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -93.8 112.06 23.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.113 0.482 . . . . 0.0 110.762 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.19 116.88 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.471 HG13 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -105.39 118.31 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.433 178.192 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.5 m -124.12 117.48 26.96 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.629 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 46.7 Cg_endo -69.51 143.83 53.34 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.611 2.207 . . . . 0.0 112.614 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.64 160.35 26.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.79 71.05 0.24 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.616 2.878 . . . . 0.0 114.322 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -164.51 -117.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 18.7 p-10 -138.63 36.79 2.22 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -133.71 157.83 44.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 -172.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -128.18 148.17 32.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.244 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -109.32 126.66 53.62 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.471 HD13 HG13 ' A' ' 155' ' ' VAL . 58.3 tp -113.25 114.35 26.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.934 0.397 . . . . 0.0 110.66 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.493 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 1.3 ttpt -113.28 131.69 55.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 0.0 110.693 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.2 mm? -98.83 110.18 22.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.142 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.483 HG22 ' HE2' ' A' ' 166' ' ' LYS . 25.4 t -94.52 111.08 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -103.26 129.29 50.18 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -106.93 153.56 22.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.202 -0.499 . . . . 0.0 110.072 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.523 HG13 ' HE2' ' A' ' 27' ' ' LYS . 2.1 p -80.6 124.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 110.103 175.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.55 127.75 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.558 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' HG13 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -97.57 -39.44 9.12 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.546 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.611 ' HB3' HG23 ' A' ' 83' ' ' THR . 34.7 t70 -143.8 142.06 30.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.3 mt -109.14 122.07 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -122.75 128.09 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.963 -179.03 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -102.16 138.1 39.56 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.005 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 5.3 mm-40 -119.6 67.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.064 0.935 . . . . 0.0 109.982 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.745 ' HA3' HG22 ' A' ' 88' ' ' VAL . . . . . . . . 0 N--CA 1.443 -0.86 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.745 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.271 0 N-CA-C 110.618 -0.141 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -54.37 -36.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -172.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.96 -35.66 57.83 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.556 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.69 -35.57 60.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -31.25 68.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.384 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.46 -31.05 65.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 112.608 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt -70.41 -23.07 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 111.282 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.98 -17.23 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.278 0.561 . . . . 0.0 110.143 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.665 ' HG2' HG23 ' A' ' 62' ' ' THR . 92.4 mtp -82.81 137.9 43.73 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.823 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HG3' ' HB3' ' A' ' 61' ' ' ASN . 39.6 Cg_endo -69.0 -22.58 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.32 2.013 . . . . 0.0 112.701 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.702 HG11 HG13 ' A' ' 54' ' ' VAL . 2.0 t -125.5 149.77 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.262 0.554 . . . . 0.0 110.811 -175.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 177.9 5.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.673 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -66.16 120.27 12.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.57 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.28 -5.51 38.61 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.214 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' CB ' HG13 ' A' ' 48' ' ' VAL . 1.1 m-20 -98.52 155.78 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.79 140.66 29.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.56 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.702 HG13 HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -125.98 129.16 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.637 0.256 . . . . 0.0 111.652 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.467 ' O ' HD12 ' A' ' 59' ' ' ILE . 1.3 t-20 -95.11 -178.55 4.51 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.25 -30.38 69.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.226 0.536 . . . . 0.0 110.033 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -35.69 81.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.507 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.574 ' HB3' HG12 ' A' ' 54' ' ' VAL . 3.8 m-20 -76.63 -29.6 56.52 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -61.1 -48.14 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 171.621 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -66.79 -33.48 75.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.55 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.481 ' HB3' ' HG3' ' A' ' 47' ' ' PRO . 4.3 t-20 -63.25 -48.03 79.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.634 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.665 HG23 ' HG2' ' A' ' 46' ' ' MET . 25.5 m -58.9 -46.36 88.07 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.331 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 77' ' ' VAL . 24.4 mt -55.26 -49.46 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.862 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -68.26 -40.42 81.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.204 -175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.0 -53.15 60.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.76 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.722 ' HB3' HG21 ' A' ' 75' ' ' VAL . 6.3 mp -66.5 -30.59 70.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.699 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.407 0.622 . . . . 0.0 110.797 174.791 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.46 -13.17 61.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.756 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 p -78.63 -25.32 45.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.34 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.94 -7.35 59.73 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.886 176.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.236 0.541 . . . . 0.0 110.572 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 150.31 49.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.938 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.58 -45.14 60.6 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.369 0.418 . . . . 0.0 111.303 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 7.5 t70 -139.43 146.68 40.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 66' ' ' LEU . 70.7 t -126.16 122.72 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.675 0.274 . . . . 0.0 110.304 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.44 118.57 32.1 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.784 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.5 HG22 HG13 ' A' ' 86' ' ' VAL . 43.6 t -103.83 123.19 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.113 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.17 159.06 37.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.65 144.53 43.27 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.277 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -139.23 97.5 3.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.054 171.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 -111.07 3.66 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -112.99 18.82 17.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.298 0.571 . . . . 0.0 109.97 174.574 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.611 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -107.52 134.54 50.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.029 -177.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 84' ' ' LEU . 1.6 mt -102.65 118.54 37.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.708 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.2 tp -106.09 112.38 25.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.027 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.5 HG13 HG22 ' A' ' 77' ' ' VAL . 3.2 t -110.22 104.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.306 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.49 148.65 23.52 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.745 HG22 ' HA3' ' A' ' 33' ' ' GLY . 15.5 m -125.89 152.32 32.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.092 0.472 . . . . 0.0 110.662 -178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.287 0.453 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 m -97.67 134.74 40.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.456 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 125' ' ' LEU . 32.4 mt -61.96 120.29 7.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.1 -31.17 11.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.593 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.01 138.82 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.191 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -117.75 123.42 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.074 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.74 131.55 53.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.662 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.604 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 17.5 m-85 -109.21 134.84 51.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.356 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.11 113.94 11.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.447 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 115.36 13.09 9.19 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.665 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.48 68.54 4.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.731 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -85.39 -31.33 22.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.56 26.35 10.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 111.446 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.8 p -167.89 155.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -83.94 145.67 28.44 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.664 0.745 . . . . 0.0 111.272 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -35.62 80.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.468 175.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -41.74 89.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.248 174.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.74 -42.2 70.83 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.409 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -39.67 84.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.935 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -42.86 99.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.514 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.579 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 1.6 tm0? -77.71 -27.96 50.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.116 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.93 -43.47 95.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.954 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 HG21 ' A' ' 97' ' ' ILE . 3.0 mp -68.49 -41.09 80.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.435 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -57.24 -45.76 83.62 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.791 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.01 -21.82 59.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.733 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -83.62 -17.16 42.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 110.297 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.58 -19.85 8.98 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.271 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.86 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 111.051 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.49 ' HA ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -141.56 175.11 9.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.674 -178.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 94' ' ' ILE . 50.9 t -67.81 123.59 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.077 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.02 29.67 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.31 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.27 160.14 17.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.118 0.485 . . . . 0.0 111.901 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 m -84.75 127.43 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 170.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.48 143.18 27.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.656 -171.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -91.76 113.26 25.48 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.864 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.04 -27.7 62.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.375 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 p -79.24 -22.67 44.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.29 0.88 51.46 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.862 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 125' ' ' LEU . 5.0 mm -55.0 -45.14 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.654 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.42 91.0 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.246 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.96 -34.69 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.496 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 130' ' ' ILE . 61.4 mt -64.87 -48.58 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.748 176.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 130' ' ' ILE . 19.7 mt-10 -59.39 -50.02 75.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.08 0.467 . . . . 0.0 111.358 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -33.17 74.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.6 -37.16 89.2 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.152 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.9 -32.02 68.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.653 0.263 . . . . 0.0 111.12 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.615 ' HG3' HG23 ' A' ' 151' ' ' VAL . 58.5 mt-10 -64.08 -41.44 97.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.095 0.474 . . . . 0.0 110.269 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.82 -39.45 90.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.557 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 144' ' ' VAL . 2.5 t80 -58.8 -45.52 89.68 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.035 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -41.7 87.83 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.406 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.404 ' HE1' ' HG ' ' A' ' 148' ' ' SER . 1.9 t80 -71.25 -29.68 65.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.621 178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.4 m -70.04 -28.56 65.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 140' ' ' PHE . 21.4 t -72.81 -87.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.974 0.416 . . . . 0.0 110.737 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.22 19.52 22.41 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.395 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 62.19 0.96 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.615 0.722 . . . . 0.0 111.105 -174.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -105.63 121.08 43.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.969 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.404 ' HG ' ' HE1' ' A' ' 142' ' ' TYR . 1.0 OUTLIER -94.86 93.6 7.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 110.669 176.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -117.43 153.17 33.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.58 ' HB2' ' HG3' ' A' ' 170' ' ' GLN . 6.8 m -99.65 132.65 44.85 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.615 HG23 ' HG3' ' A' ' 138' ' ' GLU . 21.6 t -110.58 129.34 65.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 110.302 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 168' ' ' VAL . 0.2 OUTLIER -123.06 117.02 24.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.435 176.144 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -95.27 111.12 23.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.158 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.5 113.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.11 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.15 116.97 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.497 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 66.9 m -122.98 124.0 26.65 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.861 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.7 Cg_exo -77.41 141.96 20.63 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.101 2.534 . . . . 0.0 111.768 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.79 156.42 36.61 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.97 76.86 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.134 2.556 . . . . 0.0 113.548 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.494 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -164.53 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.494 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 2.3 t30 -170.14 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.786 0.803 . . . . 0.0 109.124 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -127.08 161.25 28.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.086 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.45 144.6 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.244 176.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.85 130.96 55.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.92 130.37 55.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.097 0.475 . . . . 0.0 111.179 -176.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 130.69 52.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.016 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.2 mm? -106.92 111.63 24.22 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.412 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 152' ' ' LYS . 25.8 t -95.03 111.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.855 -176.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.401 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 81.8 m-85 -103.92 117.5 34.47 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 150' ' ' SER . 1.8 mt-30 . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -101.51 153.22 19.9 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -87.02 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.6 127.87 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.618 0.723 . . . . 0.0 110.633 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -94.49 -41.1 9.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.397 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.18 137.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.633 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.98 121.53 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 7.0 t60 -113.39 127.69 56.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.549 ' HD2' HG12 ' A' ' 39' ' ' VAL . 29.4 m-85 -102.84 134.3 46.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.754 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -133.91 77.53 1.72 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.246 0.546 . . . . 0.0 111.101 -173.369 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.863 178.693 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.549 HG12 ' HD2' ' A' ' 31' ' ' PHE . 2.3 m -61.67 -32.3 53.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.076 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.35 -37.24 70.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.97 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.27 -36.28 63.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.44 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.26 -39.22 78.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.069 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HA ' ' SD ' ' A' ' 46' ' ' MET . 1.4 mt -59.79 -31.57 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.435 0.694 . . . . 0.0 112.318 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.61 -16.42 61.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.757 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.8 OUTLIER -93.88 -7.87 41.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 175.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.516 ' HG2' HG23 ' A' ' 62' ' ' THR . 70.7 mtp -90.25 147.2 36.34 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.71 -18.51 22.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 112.192 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.459 HG11 HG12 ' A' ' 54' ' ' VAL . 4.3 m -116.71 165.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.972 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -132.38 174.36 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 p -67.45 121.82 16.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.298 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.97 -4.73 49.55 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.313 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -87.31 155.1 20.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 0.0 111.047 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.54 133.42 35.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.845 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.459 HG12 HG11 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -130.8 128.04 62.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.071 0.462 . . . . 0.0 111.363 -175.445 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.61 179.74 5.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.062 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -30.31 70.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.361 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 17.9 tp10 -66.18 -34.3 77.73 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.36 0.413 . . . . 0.0 110.758 174.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.8 -32.52 69.63 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.37 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -62.68 -49.5 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 123.241 0.338 . . . . 0.0 110.319 173.78 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -35.03 77.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.58 0.229 . . . . 0.0 111.401 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -66.05 -39.92 90.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.486 177.766 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.516 HG23 ' HG2' ' A' ' 46' ' ' MET . 68.4 m -59.02 -45.81 89.77 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.032 172.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.416 HG13 HG13 ' A' ' 77' ' ' VAL . 1.2 mt -54.96 -48.44 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 123.445 0.466 . . . . 0.0 110.425 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -67.08 -35.57 80.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.218 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 69' ' ' THR . . . -68.35 -54.89 14.26 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.239 0.337 . . . . 0.0 110.507 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.78 HD22 ' HE2' ' A' ' 72' ' ' PHE . 37.4 mt -58.72 -29.71 66.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -52.67 33.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.969 0.414 . . . . 0.0 110.821 172.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.37 61.33 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.757 HG21 ' HB3' ' A' ' 45' ' ' SER . 30.0 p -79.49 -6.62 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.678 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.87 75.06 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.478 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -83.07 -59.27 2.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.517 . . . . 0.0 111.604 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.78 ' HE2' HD22 ' A' ' 66' ' ' LEU . 2.4 m-85 -124.82 169.96 11.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.524 0.202 . . . . 0.0 111.292 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 1.9 tm-20 -79.01 -42.54 26.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.09 0.471 . . . . 0.0 110.846 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 30.6 t70 -137.89 141.04 40.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.75 119.02 55.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.077 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -120.98 117.29 26.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.943 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.709 ' HB ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -109.41 129.99 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.634 0.73 . . . . 0.0 109.695 172.312 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.14 156.83 34.24 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -129.16 126.16 38.63 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.513 0.673 . . . . 0.0 111.202 -176.195 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -115.46 97.12 5.98 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.851 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.06 -109.08 2.71 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.234 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.48 10.42 23.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.708 0.289 . . . . 0.0 110.778 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.33 132.52 50.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.83 116.77 31.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 0.8 OUTLIER -109.96 117.1 32.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.709 HG22 ' HB ' ' A' ' 77' ' ' VAL . 4.8 t -111.22 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.257 0.551 . . . . 0.0 110.989 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.754 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 64.4 mt-30 -93.55 137.93 32.33 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.95 152.24 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 -175.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.554 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.824 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 17.2 Cg_exo . . . . . 0 CA--C 1.529 0.245 0 CA-C-O 121.58 0.575 . . . . 0.0 113.277 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 7.2 m -105.31 139.16 40.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.913 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.635 HD11 ' HB2' ' A' ' 125' ' ' LEU . 50.0 mt -62.88 118.16 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.73 -42.5 11.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.1 39.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 176.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 165' ' ' LEU . 0.7 OUTLIER -115.84 122.39 69.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.538 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.63 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -117.11 141.11 48.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.682 -175.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.667 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 26.1 m-85 -121.73 134.96 54.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.154 -172.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.0 114.39 11.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.841 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.554 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 119.91 36.58 0.82 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.052 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.433 ' ND2' ' HB3' ' A' ' 107' ' ' ASP . 10.1 m-80 -95.06 83.85 4.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.346 0.594 . . . . 0.0 110.149 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.06 -45.34 10.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.413 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.18 -41.61 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -173.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.495 HG12 ' HE2' ' A' ' 141' ' ' TYR . 14.0 p -117.53 148.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.68 145.33 53.96 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.667 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 18.2 p-10 -66.42 -32.07 73.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.551 170.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -43.72 76.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.073 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.71 65.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -58.44 -32.03 68.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.11 176.532 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.505 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 3.9 mtpp -56.95 -44.44 82.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.435 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.48 -28.37 52.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.43 -40.57 93.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.664 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 97' ' ' ILE . 1.4 mm? -66.86 -38.85 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.747 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.779 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 2.0 mt-10 -63.91 -39.5 94.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.168 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.2 -17.14 60.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.597 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.6 m -87.0 -16.44 35.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.305 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.85 -21.55 22.84 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.935 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.59 HG21 HD11 ' A' ' 133' ' ' ILE . 1.3 t -102.8 101.13 11.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.779 ' HB3' ' HA ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -142.64 175.25 9.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -167.273 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.441 HG23 HG13 ' A' ' 97' ' ' ILE . 16.2 t -63.46 129.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.47 175.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.47 -6.34 71.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.548 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.78 138.1 51.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 12.5 m -65.75 138.96 58.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.635 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -91.21 143.42 26.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.638 0.732 . . . . 0.0 112.894 -163.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.545 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 6.8 t0 -97.08 105.23 17.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.452 170.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.701 ' H ' ' HD2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -70.41 -14.17 62.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.632 -177.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.1 p -81.29 -24.53 37.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.653 0.263 . . . . 0.0 110.82 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.545 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -92.58 3.39 55.63 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 111.131 179.019 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 153' ' ' ALA . 6.4 mm -59.46 -40.78 82.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.55 -34.95 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.472 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.1 -34.36 77.46 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.309 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 130' ' ' ILE . 21.2 mt -64.8 -49.09 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.43 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.35 -45.78 92.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.414 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -40.61 89.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.316 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.33 88.77 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.759 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.528 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 13.8 mt -67.65 -35.72 79.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.639 0.257 . . . . 0.0 111.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.29 -30.48 66.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.859 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.41 -34.24 76.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.455 ' O ' HG23 ' A' ' 144' ' ' VAL . 22.2 m-85 -75.22 -39.83 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.346 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.495 ' HE2' HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -61.24 -39.85 91.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.158 0.504 . . . . 0.0 110.867 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -30.07 69.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.536 177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.4 m -73.11 -28.34 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 140' ' ' PHE . 16.0 t -73.66 -87.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.448 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.94 19.3 23.29 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.597 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.6 mttp 66.59 51.44 1.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.447 0.699 . . . . 0.0 110.852 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -90.39 139.08 31.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.581 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.37 88.85 2.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.043 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.28 163.91 12.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.958 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.2 112.52 24.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 3.4 p -118.25 126.91 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.401 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 127.18 38.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.726 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -91.16 111.12 22.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.274 0.559 . . . . 0.0 110.258 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.61 123.25 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.25 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.5 HG12 ' HB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -98.72 127.03 51.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.147 0.498 . . . . 0.0 110.208 177.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -104.74 120.34 50.56 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.153 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.35 135.18 18.14 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 122.821 2.347 . . . . 0.0 112.984 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 0.7 OUTLIER -135.11 151.46 75.32 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.071 175.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 4.1 Cg_exo -76.98 66.53 7.68 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.53 2.82 . . . . 0.0 113.499 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -148.6 16.07 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.169 173.537 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 37.9 t30 58.0 43.41 21.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.275 -168.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HD3' ' HB ' ' A' ' 93' ' ' THR . 74.9 mmt-85 -135.89 157.81 45.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.35 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.5 ' HB ' HG12 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -132.7 145.6 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.019 173.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.65 121.73 45.88 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 97' ' ' ILE . 37.9 tp -95.59 120.36 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.312 -174.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.63 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.71 131.78 55.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.649 0.738 . . . . 0.0 111.223 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.575 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.9 mm? -102.29 110.63 22.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.255 -176.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.7 t -96.67 110.71 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.554 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 8.0 m-85 -105.88 118.83 37.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.296 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.886 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -107.65 151.46 25.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.911 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.8 t -81.8 119.02 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.315 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 t -70.52 124.63 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.01 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -44.32 12.33 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.779 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 145.97 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.839 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -109.82 122.73 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -119.6 147.75 44.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.966 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.478 ' HD2' HG12 ' A' ' 39' ' ' VAL . 46.0 m-85 -124.43 130.97 53.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 0.0 110.991 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 1.4 tm-20 -123.22 69.89 1.02 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.482 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.512 178.47 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 120.543 0.211 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.478 HG12 ' HD2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -51.96 -40.03 27.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 124.069 0.856 . . . . 0.0 112.751 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.43 90.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.199 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -72.53 -33.56 66.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.21 -33.63 59.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.689 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 mp -61.85 -31.31 71.56 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.174 0.59 . . . . 0.0 111.713 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 41' ' ' ALA . 45.9 mt -67.28 -23.96 65.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.388 . . . . 0.0 111.652 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.516 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -89.79 -8.55 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.221 0.534 . . . . 0.0 110.209 177.528 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.49 ' HG2' HG23 ' A' ' 62' ' ' THR . 85.2 mtp -88.14 143.03 32.3 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.01 -16.18 40.49 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 122.359 2.039 . . . . 0.0 113.209 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 54' ' ' VAL . 2.5 m -129.02 169.46 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.058 0.456 . . . . 0.0 111.642 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -127.88 177.2 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.691 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -66.4 125.11 24.64 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.53 -7.08 39.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.452 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.4 156.33 19.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 0.0 111.176 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.12 134.02 36.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.119 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 48' ' ' VAL . 3.1 m -131.67 129.51 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 111.892 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.42 ' O ' HD12 ' A' ' 59' ' ' ILE . 4.6 m-20 -82.1 173.62 11.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.397 170.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.74 -26.27 65.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.346 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.48 -32.45 72.46 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.774 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -76.79 -28.7 55.74 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 122.302 0.241 . . . . 0.0 111.363 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.66 -45.04 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.31 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.79 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.2 m -67.62 -31.2 71.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.32 175.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.774 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.6 m-20 -66.15 -41.38 90.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.284 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.49 HG23 ' HG2' ' A' ' 46' ' ' MET . 56.3 m -58.37 -46.65 85.92 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.017 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 60' ' ' SER . 65.0 mt -54.04 -50.9 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.545 0.528 . . . . 0.0 110.644 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -39.86 95.87 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.587 0.755 . . . . 0.0 111.747 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.67 -52.55 36.58 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.882 -176.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 45' ' ' SER . 41.1 mt -64.48 -30.61 71.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.429 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.2 -40.39 82.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.674 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 -12.9 61.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.803 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 65' ' ' ALA . 34.6 p -78.14 -23.01 47.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.576 0.227 . . . . 0.0 110.708 -177.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.39 23.18 76.53 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.198 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -87.92 -28.76 21.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.15 . . . . 0.0 111.229 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.44 161.46 35.76 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.253 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 124' ' ' SER . 0.0 OUTLIER -79.84 -38.91 31.83 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.174 0.296 . . . . 0.0 111.185 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.843 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 7.9 t70 -139.16 137.76 36.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 66' ' ' LEU . 75.2 t -117.89 119.56 61.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.992 0.425 . . . . 0.0 109.902 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 118.67 32.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.174 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 67.2 t -114.82 128.99 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp -128.68 155.7 44.61 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -118.18 126.73 52.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.322 0.582 . . . . 0.0 109.803 174.084 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -125.63 97.08 5.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.772 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 -108.83 2.61 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.92 7.81 15.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.401 . . . . 0.0 110.407 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.91 129.21 53.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.215 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.49 115.89 31.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.4 tp -108.05 121.38 44.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 -175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' A' ' 31' ' ' PHE . 21.9 t -112.84 113.19 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.626 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.701 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 33.9 mt-30 -99.82 138.51 36.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.9 148.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.098 0.475 . . . . 0.0 110.679 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.843 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.828 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.86 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.557 ' HB2' HG22 ' A' ' 163' ' ' VAL . 16.7 Cg_exo . . . . . 0 CA--C 1.531 0.361 0 N-CA-C 114.468 0.911 . . . . 0.0 114.468 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -88.12 140.17 29.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.493 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 125' ' ' LEU . 33.9 mt -65.19 118.24 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.45 -40.75 14.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.06 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.54 146.55 25.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.777 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -107.53 128.78 62.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.92 133.02 54.85 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.632 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 22.6 m-85 -113.52 135.49 53.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -136.91 127.37 26.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.412 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.61 46.38 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.29 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.87 79.99 1.26 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -33.45 21.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.553 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -46.94 76.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.725 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.5 t -118.29 141.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -69.71 151.48 45.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 111.483 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -35.26 79.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.172 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -28.87 65.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.724 0.297 . . . . 0.0 111.153 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.6 mtp -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -34.73 78.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.963 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.632 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 2.4 mttt -59.42 -43.12 93.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.915 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.66 -28.76 56.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.622 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.39 -45.0 85.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.299 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.482 HD12 HG23 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -65.93 -37.16 85.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.21 176.006 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.445 ' HG2' ' CG ' ' A' ' 120' ' ' ARG . 67.0 mt-10 -59.38 -46.58 88.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.26 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.81 61.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -85.04 -16.99 38.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.315 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.98 -19.85 15.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.408 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.482 HG23 HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -96.0 106.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.316 0.579 . . . . 0.0 110.811 -176.045 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.445 ' CG ' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -119.0 163.29 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.136 -173.579 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.1 t -69.35 123.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 109.963 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.56 -7.27 80.02 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.061 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 161.58 13.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -74.89 149.54 39.46 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.294 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.789 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -103.04 146.76 27.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.969 0.414 . . . . 0.0 111.716 -173.081 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -116.25 101.49 8.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.648 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.496 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.46 -20.14 62.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.233 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -27.09 65.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.548 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -0.01 43.06 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.805 177.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.9 mm -59.31 -37.87 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.451 0.301 . . . . 0.0 111.69 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.38 86.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.913 0.387 . . . . 0.0 111.3 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -30.07 64.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.26 -42.51 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.272 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -64.38 -40.57 96.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -68.46 -38.06 80.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.626 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.68 -37.5 92.49 Favored Glycine 0 C--O 1.227 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.852 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.487 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 11.1 mt -73.01 -34.3 66.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.682 0.277 . . . . 0.0 111.202 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -38.84 87.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.153 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.41 -37.53 71.51 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.597 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 144' ' ' VAL . 11.1 t80 -61.47 -41.96 98.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.809 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.453 ' HD1' ' O ' ' A' ' 147' ' ' TYR . 1.2 m-85 -62.21 -37.58 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.847 177.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 56.9 t80 -70.41 -35.44 73.44 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.335 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.8 m -67.69 -31.81 72.02 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 140' ' ' PHE . 11.0 t -74.63 -91.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.806 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.43 18.58 22.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.412 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 7.8 mtmt 60.01 57.42 3.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.441 0.639 . . . . 0.0 110.205 -173.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.453 ' O ' ' HD1' ' A' ' 141' ' ' TYR . 51.2 m-85 -96.64 34.89 1.58 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.701 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.13 102.71 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.97 152.51 45.58 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.617 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 m -96.77 126.63 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 110.373 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.4 p -106.48 134.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.43 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -108.81 117.04 33.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.012 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.21 110.45 21.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.318 0.58 . . . . 0.0 110.1 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.69 117.0 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.386 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.67 112.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.185 0.516 . . . . 0.0 110.047 175.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 8.1 m -104.7 121.65 46.2 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 6.2 Cg_exo -79.9 143.78 16.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.109 2.539 . . . . 0.0 112.126 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -129.92 156.76 78.55 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.939 174.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.85 70.85 3.49 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.489 2.793 . . . . 0.0 113.266 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 158' ' ' LEU . 6.0 ttm180 -163.35 15.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.36 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.9 t30 55.59 42.27 29.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.199 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -129.95 157.99 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.815 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.789 HG21 HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.74 152.37 36.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.114 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.87 118.71 37.46 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.8 tp -99.17 112.18 24.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.128 -175.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HG2' HG22 ' A' ' 168' ' ' VAL . 8.2 ttmt -111.63 132.68 54.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.483 0.658 . . . . 0.0 111.145 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.511 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.5 mm? -108.63 109.41 20.6 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.408 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 166' ' ' LYS . 1.5 t -107.19 113.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.807 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 3.2 m-85 -98.34 118.91 36.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.117 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.627 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.097 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p90 -150.47 152.23 33.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.878 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -85.86 118.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.1 119.04 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.354 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.65 -34.61 19.74 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.442 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.481 ' HB3' HG23 ' A' ' 83' ' ' THR . 20.8 t70 -158.57 145.6 17.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.196 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.645 HD13 HD21 ' A' ' 43' ' ' LEU . 4.6 mt -109.28 120.65 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -116.5 127.11 54.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.767 -178.736 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.41 136.52 40.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.406 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.2 58.22 0.69 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.955 0.883 . . . . 0.0 109.647 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.052 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.611 179.823 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.528 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -51.22 -43.23 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.83 -35.54 50.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.75 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.45 -29.2 64.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.215 0.531 . . . . 0.0 111.031 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.71 -34.65 60.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.409 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.772 HD22 ' HG2' ' A' ' 49' ' ' ARG . 2.3 mt -56.98 -30.26 63.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.384 0.673 . . . . 0.0 112.79 170.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.57 -29.31 69.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 111.445 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.745 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -91.33 -8.82 47.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.014 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.542 ' HG3' ' HA ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -86.28 132.55 42.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 6.7 Cg_exo -74.23 -8.61 21.1 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.784 2.323 . . . . 0.0 112.749 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.424 HG11 ' CG1' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -139.93 151.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.939 0.4 . . . . 0.0 110.418 -175.111 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.772 ' HG2' HD22 ' A' ' 43' ' ' LEU . 81.5 mtt-85 -131.57 179.41 6.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.576 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.4 p -63.08 123.43 18.56 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.256 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.44 -6.83 39.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.8 m-20 -87.61 148.87 24.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.816 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -101.15 124.51 46.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.342 178.758 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.424 ' CG1' HG11 ' A' ' 48' ' ' VAL . 2.1 m -142.02 145.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -170.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -100.47 -177.76 3.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.38 -26.44 66.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.786 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.83 -31.64 68.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.642 0.258 . . . . 0.0 110.572 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.38 -29.38 59.83 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.202 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -44.84 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.72 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -68.28 -34.01 75.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.435 177.371 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -66.58 -40.87 89.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.006 0.431 . . . . 0.0 110.387 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.9 m -58.59 -43.8 89.65 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.154 172.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 60' ' ' SER . 74.6 mt -55.97 -47.15 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.743 176.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmm-85 -62.76 -42.53 99.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 69' ' ' THR . . . -59.63 -53.39 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 45' ' ' SER . 16.4 mt -63.6 -32.66 74.19 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.657 0.598 . . . . 0.0 111.624 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -39.66 91.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.0 110.888 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.67 60.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.222 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 45' ' ' SER . 42.3 p -79.78 -24.93 41.14 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -172.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.75 20.73 79.84 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.752 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -88.83 -26.34 21.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.292 0.568 . . . . 0.0 110.142 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.16 156.54 43.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.364 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.527 ' OE1' ' HE2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.64 -44.24 24.33 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.29 0.369 . . . . 0.0 111.275 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 31.5 t70 -130.73 139.28 50.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.285 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 66' ' ' LEU . 25.2 t -123.51 120.16 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.238 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.49 117.29 29.96 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.473 HG22 HG13 ' A' ' 86' ' ' VAL . 84.4 t -113.87 122.66 68.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.3 137.84 46.16 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.439 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 6.5 ptm180 -95.31 140.56 30.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.356 0.598 . . . . 0.0 110.387 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -130.62 96.94 4.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.43 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.68 -109.08 2.72 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.166 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -108.2 1.7 22.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 0.0 110.759 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.71 137.41 41.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 -173.624 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.71 115.54 30.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.24 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.6 tp -102.52 119.25 38.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.473 HG13 HG22 ' A' ' 77' ' ' VAL . 17.7 t -117.88 108.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.759 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.92 136.49 44.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.06 153.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.262 0.553 . . . . 0.0 111.073 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.819 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 20.0 Cg_exo . . . . . 0 C--O 1.232 0.197 0 CA-C-O 121.499 0.541 . . . . 0.0 112.917 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 66.9 m -127.75 133.35 49.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.319 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 125' ' ' LEU . 56.9 mt -69.13 118.86 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.09 -34.67 12.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.565 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 138.3 24.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 121' ' ' VAL . 4.7 mt -110.75 123.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 131.74 56.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.064 0.459 . . . . 0.0 110.898 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.657 ' HE2' HD13 ' A' ' 167' ' ' LEU . 21.2 m-85 -110.13 135.75 50.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.989 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.98 122.72 11.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.18 -14.5 64.39 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.535 174.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.29 78.11 3.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 110.829 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -85.84 -19.35 30.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -78.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.526 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.49 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 54.4 t -84.21 139.17 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -69.92 152.19 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.053 0.454 . . . . 0.0 111.644 -172.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.26 76.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.546 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -38.01 89.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mtp -73.05 -39.33 66.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.359 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.485 HD21 ' HE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -63.64 -32.74 74.31 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.417 177.375 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.439 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 10.3 mttt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.076 0.465 . . . . 0.0 110.954 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -28.76 55.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.622 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -67.84 -38.5 83.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.5 mm? -67.9 -38.46 83.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.467 175.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.47 -33.66 76.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.088 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.38 -16.11 60.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.079 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 m -91.83 -16.55 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.193 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 107.93 -25.65 19.95 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.921 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.19 107.89 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.155 0.503 . . . . 0.0 111.451 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.468 ' HA ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -140.94 175.49 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.548 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 97' ' ' ILE . 27.3 t -67.33 126.32 26.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 110.074 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.29 -6.77 66.18 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.34 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 160.4 14.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.234 0.54 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.91 117.97 23.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.802 174.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.835 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.89 137.42 33.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.093 0.473 . . . . 0.0 112.074 -172.224 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -101.9 105.98 16.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.878 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.446 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.02 -15.72 62.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.403 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.8 p -87.18 -20.45 26.96 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.56 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.3 p -98.69 6.83 46.73 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.927 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.6 mm -55.94 -37.58 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.05 85.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.18 -36.22 79.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 110.068 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.0 mt -66.33 -42.99 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.443 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.18 -45.0 96.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -34.15 77.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.325 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.53 -42.16 89.06 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.777 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.9 -38.62 91.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.452 ' HG3' HG12 ' A' ' 151' ' ' VAL . 13.8 mt-10 -69.62 -34.54 74.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.254 0.346 . . . . 0.0 111.067 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.52 -41.83 75.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.435 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 144' ' ' VAL . 5.4 m-85 -67.49 -37.18 82.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.49 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.95 -41.18 91.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.163 0.506 . . . . 0.0 110.476 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -30.35 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.51 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.8 m -72.35 -28.58 63.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.856 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 140' ' ' PHE . 31.4 t -77.54 -82.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.767 0.317 . . . . 0.0 111.092 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.5 19.46 21.85 Favored Glycine 0 N--CA 1.454 -0.101 0 C-N-CA 121.358 -0.449 . . . . 0.0 112.833 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm 66.05 34.35 7.0 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.341 0.656 . . . . 0.0 110.485 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -76.63 126.27 30.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.219 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.62 59.12 0.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.242 0.544 . . . . 0.0 110.565 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.95 148.21 22.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.642 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 m -97.86 118.82 35.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.942 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.7 p -98.8 137.35 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 116.95 19.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.077 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.49 111.53 23.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.424 0.631 . . . . 0.0 109.949 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.99 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.391 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.67 109.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.483 0.658 . . . . 0.0 110.219 175.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.6 m -104.67 113.47 64.93 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.811 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.37 128.13 8.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.085 2.523 . . . . 0.0 113.004 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -109.46 143.59 28.09 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.38 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 16.5 Cg_exo -67.69 79.52 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.83 3.02 . . . . 0.0 114.008 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -157.44 -75.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 6.3 t30 177.79 13.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.802 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.587 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 26.4 mmt-85 -117.92 157.7 26.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.414 -170.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.835 HG11 HD22 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -127.93 152.61 36.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.319 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -108.3 118.89 37.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.4 tp -106.58 110.7 22.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.07 0.462 . . . . 0.0 110.339 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -112.55 132.53 55.07 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.258 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.657 HD13 ' HE2' ' A' ' 99' ' ' PHE . 1.5 mp -114.31 112.09 22.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.696 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.55 112.99 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.596 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.51 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 2.4 m-85 -99.6 118.68 36.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 . . . . . 0 C--N 1.322 -0.613 0 CA-C-O 120.82 0.343 . . . . 0.0 110.867 -178.853 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.606 ' HZ ' HD12 ' A' ' 84' ' ' LEU . 2.7 p90 -93.8 153.38 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.631 0.253 . . . . 0.0 110.51 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.36 117.78 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.245 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.16 137.91 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.233 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 -37.75 5.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.27 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -143.86 138.55 28.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.481 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.664 HG21 ' HE1' ' A' ' 46' ' ' MET . 86.7 mt -103.87 120.72 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 127.95 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.407 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -103.8 122.33 44.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.366 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.774 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 4.3 mt-10 -98.68 54.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.913 0.863 . . . . 0.0 109.907 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.851 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.32 177.925 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.149 0 CA-C-O 119.975 -0.059 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -58.88 -31.61 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.56 81.23 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.872 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.19 -35.94 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.136 0.493 . . . . 0.0 110.696 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.42 83.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.442 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.626 HD22 ' HD2' ' A' ' 49' ' ' ARG . 2.6 mt -57.8 -32.76 67.87 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.58 -21.15 61.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.612 0.244 . . . . 0.0 111.352 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -93.45 -21.98 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.018 0.437 . . . . 0.0 110.369 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.664 ' HE1' HG21 ' A' ' 29' ' ' ILE . 77.0 mtm -82.65 135.73 45.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.39 -2.75 12.77 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.56 2.173 . . . . 0.0 112.444 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.78 147.56 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HD2' HD22 ' A' ' 43' ' ' LEU . 4.1 mmm180 -129.6 175.13 9.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.936 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.6 p -68.06 120.99 15.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.69 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.18 -5.27 52.56 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.424 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -80.02 155.89 27.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 0.0 111.594 -177.673 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -106.24 126.04 51.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.229 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 58' ' ' ASP . 0.3 OUTLIER -133.03 133.45 58.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 112.134 -168.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.449 ' O ' HD12 ' A' ' 59' ' ' ILE . 2.7 m120 -98.77 -177.27 3.6 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.094 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.32 -32.75 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.568 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.7 -43.09 89.94 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.549 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' A' ' 54' ' ' VAL . 31.1 m-20 -75.09 -27.99 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.246 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.915 HD11 ' HD3' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -59.78 -52.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 172.031 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -71.47 -26.29 62.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.259 178.563 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.439 ' HA ' ' HD2' ' A' ' 64' ' ' ARG . 1.8 t-20 -63.98 -47.14 81.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -60.78 -45.66 93.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 174.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 60' ' ' SER . 67.1 mt -53.72 -55.5 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 123.544 0.528 . . . . 0.0 110.886 177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.91 -30.47 67.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.08 -175.013 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.32 -48.22 68.22 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.558 0.218 . . . . 0.0 110.592 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB2' HG11 ' A' ' 75' ' ' VAL . 84.0 mt -69.27 -30.41 68.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -40.51 94.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 110.774 175.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.57 -13.43 62.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.601 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.3 p -79.03 -24.92 43.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.547 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.475 ' HA3' ' HG3' ' A' ' 123' ' ' GLU . . . 80.83 -10.25 47.64 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.317 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -67.07 -31.72 72.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.4 144.46 46.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.848 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -73.4 -37.25 66.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.054 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -139.49 136.51 34.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 66' ' ' LEU . 39.3 t -127.59 118.15 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.085 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.09 55.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.659 HG22 HG13 ' A' ' 86' ' ' VAL . 68.1 t -125.52 118.38 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 77' ' ' VAL . 2.2 mm? -133.14 159.14 41.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -172.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.915 ' HD3' HD11 ' A' ' 59' ' ' ILE . 15.5 mtm180 -113.49 147.59 37.6 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.655 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -135.27 96.83 3.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.736 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.8 -109.25 2.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.512 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 24' ' ' PHE . 3.8 m-20 -112.85 14.22 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.227 0.537 . . . . 0.0 109.923 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.45 136.82 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.257 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.606 HD12 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.34 112.13 24.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 tp -106.4 112.46 25.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.624 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 77' ' ' VAL . 8.3 t -114.51 117.12 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.774 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.0 mt-30 -106.97 124.94 50.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.99 145.01 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.196 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.175 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 124' ' ' SER . 18.9 Cg_endo . . . . . 0 N--CA 1.459 -0.55 0 N-CA-C 113.939 0.707 . . . . 0.0 113.939 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.754 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 94.0 m -111.93 124.8 53.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.421 176.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 125' ' ' LEU . 19.0 mt -67.54 118.8 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.01 6.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.239 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.05 144.33 27.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.401 . . . . 0.0 110.856 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -106.9 123.87 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 171.304 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.99 141.35 49.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.381 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.547 ' HE1' ' HB2' ' A' ' 111' ' ' LYS . 24.1 m-85 -117.59 152.33 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 112.018 -172.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.79 111.91 3.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.46 55.09 0.28 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.257 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.534 HD21 HD22 ' A' ' 110' ' ' LEU . 33.1 m120 -126.24 41.52 3.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.224 -0.488 . . . . 0.0 112.044 -172.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -86.03 -16.03 39.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.526 177.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 141' ' ' TYR . 75.6 m -105.21 -45.19 4.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.639 0.257 . . . . 0.0 111.108 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.0 t -120.62 147.65 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.44 147.45 50.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.188 0.518 . . . . 0.0 111.939 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.74 -35.2 78.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.446 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -35.09 79.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.121 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -41.65 77.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.215 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.534 HD22 HD21 ' A' ' 102' ' ' ASN . 0.3 OUTLIER -62.87 -40.62 98.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.235 175.157 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.547 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -64.96 -43.27 93.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.224 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.11 -27.42 60.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -66.57 -43.65 84.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.417 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -61.63 -43.24 99.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.652 173.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.817 ' HG2' ' HG3' ' A' ' 120' ' ' ARG . 91.9 mt-10 -59.9 -42.95 94.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.511 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.75 -18.68 60.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.858 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 m -87.4 -17.18 32.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.632 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.75 -21.22 8.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.282 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.14 103.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.372 0.606 . . . . 0.0 110.147 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.817 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 12.2 ttp-105 -130.98 161.88 30.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.346 -172.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.419 ' HA ' HG22 ' A' ' 94' ' ' ILE . 24.2 t -69.9 124.43 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.956 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.68 -21.67 44.89 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.594 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.475 ' HG3' ' HA3' ' A' ' 70' ' ' GLY . 1.0 OUTLIER -95.79 166.22 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 110.758 -178.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -83.13 142.65 31.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.425 -176.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -116.22 138.64 51.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.451 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 25.6 t0 -94.8 121.07 36.01 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.195 0.998 . . . . 0.0 111.486 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -21.85 61.27 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.661 -1.608 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.9 p -89.6 -10.68 45.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.905 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 1.1 p -104.33 7.32 35.71 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.001 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.518 HD11 HD11 ' A' ' 125' ' ' LEU . 5.5 mm -55.31 -43.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.644 0.59 . . . . 0.0 111.854 -177.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 135' ' ' LYS . . . -62.48 -42.71 99.68 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.492 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.46 -29.02 66.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.888 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.25 -42.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.762 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.91 -46.76 89.38 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 50.6 mmtt -67.88 -36.39 80.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -40.23 84.79 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.374 -0.441 . . . . 0.0 112.608 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.531 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 10.0 mt -69.62 -31.97 70.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.881 ' HG3' HG23 ' A' ' 151' ' ' VAL . 6.2 mt-10 -64.62 -41.37 96.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.418 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -68.56 -34.06 75.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.543 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.463 ' HE1' HD12 ' A' ' 110' ' ' LEU . 28.0 t80 -60.76 -44.28 96.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.536 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.512 ' CE1' ' HB2' ' A' ' 104' ' ' SER . 0.2 OUTLIER -62.7 -38.95 92.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 177.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.55 -29.93 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.999 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 m -70.55 -30.33 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 140' ' ' PHE . 19.4 t -73.9 -82.28 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 110.853 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.69 18.67 22.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.029 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 63.73 40.82 7.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 110.271 -173.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -81.55 120.99 25.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.627 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 101.01 9.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -114.84 156.42 24.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.16 120.7 36.95 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.881 HG23 ' HG3' ' A' ' 138' ' ' GLU . 49.0 t -102.57 124.28 56.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 0.0 111.812 -172.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.85 115.82 26.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.87 111.12 23.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.65 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.66 112.97 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.033 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 117.65 49.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 109.369 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.6 m -104.67 116.89 60.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.944 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 163' ' ' VAL . 91.4 Cg_endo -86.84 136.73 4.42 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.096 2.531 . . . . 0.0 113.113 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.702 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -126.03 150.2 68.61 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 171.715 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 22.1 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.471 2.781 . . . . 0.0 114.108 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -113.67 26.37 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.208 -0.308 . . . . 0.0 110.81 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.5 t30 74.88 5.35 4.36 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 0.0 111.52 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.754 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 9.8 mmt-85 -113.56 160.29 18.69 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 111.176 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 157' ' ' PRO . 0.7 OUTLIER -136.73 145.26 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.486 175.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.23 131.02 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.67 117.44 33.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.773 0.321 . . . . 0.0 111.188 -173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 131.63 56.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 0.0 109.816 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.89 111.72 23.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.305 -175.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.4 t -94.94 111.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.785 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.531 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 8.7 m-85 -114.18 142.02 46.78 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.231 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 . . . . . 0 C--N 1.317 -0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 167.187 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.554 0.693 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 55' ' ' ASN . 23.9 mp0 -127.19 177.14 6.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.617 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.01 48.16 10.3 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -173.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -110.32 154.21 23.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.09 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.41 115.75 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.355 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.38 142.45 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.486 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -38.31 7.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.398 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -143.32 146.91 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.9 mt -111.23 130.49 64.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.8 156.44 34.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.678 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 5.9 m-85 -128.53 119.66 25.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.41 73.9 2.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.738 0.78 . . . . 0.0 110.599 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 156.24 -20.62 0.48 Allowed Glycine 0 C--N 1.314 -0.691 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.023 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 5.4 mt -85.11 129.04 34.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.32 -0.44 . . . . 0.0 111.08 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.93 -35.09 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.362 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -79.9 -55.52 4.91 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 120.917 0.389 . . . . 0.0 110.048 175.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.408 ' HB ' HD13 ' A' ' 34' ' ' LEU . 4.1 t -78.68 128.2 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.04 158.27 16.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.048 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.479 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.4 m -57.05 -29.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.65 71.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.949 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 -33.94 57.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 110.381 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.62 -31.45 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.66 -32.02 64.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.799 0.839 . . . . 0.0 112.788 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.1 -23.7 65.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.838 0.351 . . . . 0.0 111.633 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.525 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -90.34 -7.49 53.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 178.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 56.7 mtp -100.39 132.64 22.19 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.9 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 23.1 Cg_exo -66.33 -19.99 55.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.886 2.391 . . . . 0.0 112.665 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -104.06 155.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.404 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.528 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.3 176.21 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -68.91 121.52 16.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.983 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.98 -6.33 51.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.139 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 2.9 m-20 -81.16 156.49 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 111.263 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.03 125.98 35.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.27 128.43 72.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 111.907 -173.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 22' ' ' GLU . 14.4 m-80 -98.42 -178.27 3.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.082 175.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.19 -26.77 65.0 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.62 -37.12 86.13 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.548 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.68 -30.96 64.69 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.433 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.84 -46.86 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 123.303 0.377 . . . . 0.0 110.264 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.52 69.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.141 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 2.0 t-20 -68.22 -43.4 78.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.999 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 p -64.2 -40.78 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.774 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.47 HG13 HG23 ' A' ' 77' ' ' VAL . 39.7 mt -55.87 -52.7 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 123.427 0.455 . . . . 0.0 110.997 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.7 -29.64 67.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.56 -52.54 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.703 0.287 . . . . 0.0 110.414 176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 45' ' ' SER . 66.9 mt -66.22 -27.28 67.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.872 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -38.54 76.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.973 -0.454 . . . . 0.0 110.236 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.82 -14.79 59.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.538 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 65' ' ' ALA . 69.0 p -79.71 -25.03 41.28 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.03 88.13 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.459 -0.791 . . . . 0.0 114.601 166.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.12 -29.18 38.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.578 0.689 . . . . 0.0 111.042 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.583 ' HE2' HD21 ' A' ' 34' ' ' LEU . 1.5 m-85 -107.1 152.98 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 6.7 mm-40 -86.67 -26.93 24.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.342 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 6.8 t70 -148.75 146.89 28.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 66' ' ' LEU . 62.1 t -129.89 119.8 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.112 0.257 . . . . 0.0 110.701 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.97 118.79 31.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.55 0.214 . . . . 0.0 110.928 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.47 HG23 HG13 ' A' ' 63' ' ' ILE . 27.5 t -107.91 123.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.89 157.85 44.79 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -102.7 148.21 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.398 0.618 . . . . 0.0 111.657 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -139.55 97.43 3.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.657 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.79 -118.47 8.3 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 15.83 24.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 110.003 174.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.71 128.58 52.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -102.33 115.69 31.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -113.79 129.53 56.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.681 0.753 . . . . 0.0 110.87 -175.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG13 HG22 ' A' ' 77' ' ' VAL . 13.1 t -113.98 105.78 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.413 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -90.91 133.92 34.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.86 154.89 33.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.038 0.447 . . . . 0.0 110.956 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.641 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 4.3 tptt -99.71 147.92 24.91 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.757 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.751 ' HG3' ' HD2' ' A' ' 92' ' ' PRO . 1.9 tp10 -40.04 131.99 1.91 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 125.831 1.957 . . . . 0.0 113.241 -174.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.586 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -58.63 -51.49 81.43 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.771 -176.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.751 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 31.6 Cg_exo -62.05 140.91 86.82 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 121.712 1.608 . . . . 0.0 113.648 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.589 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 29.3 m -96.12 146.48 24.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.877 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.451 HG13 ' HB2' ' A' ' 125' ' ' LEU . 6.0 mt -63.05 117.77 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.08 -48.62 3.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.41 137.52 34.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.138 0.494 . . . . 0.0 111.323 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.782 HG21 HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -111.63 121.75 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.09 52.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.756 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.595 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 23.1 m-85 -114.92 138.05 51.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -173.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.557 ' OG ' ' HE3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -138.79 112.16 8.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.418 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.726 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 112.56 22.32 5.81 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.371 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.16 69.52 7.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.229 0.537 . . . . 0.0 110.383 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -85.16 -26.77 26.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.357 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.6 m -112.28 -60.77 1.82 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.082 0.467 . . . . 0.0 111.197 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -89.28 141.52 14.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.512 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 146.49 52.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.709 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.16 -35.29 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -64.13 -35.61 81.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.1 mtp -67.16 -45.17 77.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.267 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.709 HD12 ' HA ' ' A' ' 107' ' ' ASP . 10.0 mt -62.72 -33.34 74.91 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.451 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -60.61 -48.9 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.303 0.377 . . . . 0.0 111.296 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.45 -27.98 52.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.285 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -63.66 -44.28 94.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.281 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.782 HD22 HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -63.88 -42.85 97.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 175.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' A' ' 120' ' ' ARG . 8.6 mt-10 -61.25 -40.87 95.68 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.392 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.27 60.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.5 m -92.56 -16.36 25.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.235 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.32 -48.05 0.8 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.162 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 t -82.26 103.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.488 0.661 . . . . 0.0 109.685 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' HA ' ' HG2' ' A' ' 115' ' ' GLU . 2.2 ttp85 -128.6 149.49 50.61 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -174.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.03 123.61 21.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.155 0.502 . . . . 0.0 110.795 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.79 70.05 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.713 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -102.95 156.13 17.88 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -177.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.745 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -56.55 133.62 53.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.858 0.463 . . . . 0.0 111.216 174.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.91 145.36 24.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.326 0.584 . . . . 0.0 111.626 -176.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.556 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 12.8 t0 -117.44 121.64 41.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.049 173.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -17.47 61.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.912 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 p -88.64 -21.69 23.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.734 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 6.1 p -85.57 -7.68 58.72 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.405 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 153' ' ' ALA . 9.2 mm -57.45 -46.38 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.116 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.82 -34.55 78.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.75 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.07 -35.19 77.79 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.288 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.2 mt -67.13 -43.61 88.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.208 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -57.28 -49.81 74.91 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.13 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -68.12 -35.48 78.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.477 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.32 -41.63 77.79 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.734 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.444 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 49.3 mt -71.94 -32.64 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.675 ' HG3' HG23 ' A' ' 151' ' ' VAL . 18.0 mt-10 -63.6 -42.49 98.24 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.308 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.13 -37.94 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.916 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.2 m-85 -62.82 -42.62 99.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.386 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -40.59 95.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.11 -30.65 68.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.322 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.1 m -73.91 -27.63 61.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.366 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 140' ' ' PHE . 24.4 t -74.94 -85.09 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.87 19.3 23.43 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.32 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 49.9 1.76 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.394 0.677 . . . . 0.0 110.394 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -89.24 125.17 34.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.96 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.04 97.41 7.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.274 0.559 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -122.59 149.08 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.537 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.45 131.17 45.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.675 HG23 ' HG3' ' A' ' 138' ' ' GLU . 28.8 t -111.85 126.73 69.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.943 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 122.69 28.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.033 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.695 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -98.37 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.238 0.542 . . . . 0.0 110.902 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 28.0 t -98.27 120.61 47.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.61 118.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.619 . . . . 0.0 110.925 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.1 m -112.99 119.15 43.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.86 137.59 15.99 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.767 2.311 . . . . 0.0 112.709 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -121.55 148.96 51.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.578 175.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 8.5 Cg_exo -73.33 58.59 3.7 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.712 2.941 . . . . 0.0 113.911 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.578 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -144.86 18.07 1.62 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 60.43 40.15 17.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.526 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.589 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -141.77 167.13 22.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.711 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -127.68 143.33 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 110.965 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -110.8 118.76 37.02 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.487 ' HG ' HG23 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -116.62 132.57 56.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.884 0.85 . . . . 0.0 111.371 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.557 ' HE3' ' OG ' ' A' ' 100' ' ' SER . 5.3 tttt -115.35 133.3 56.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.964 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.595 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.0 mm? -102.56 111.31 23.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.241 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.7 113.92 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.664 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.726 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 38.6 m-85 -105.07 118.09 35.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.452 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.74 115.66 24.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.0 106.61 15.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.982 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.09 67.3 1.26 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.596 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.8 m -96.46 -22.65 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.246 0.546 . . . . 0.0 109.76 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.425 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.318 0.58 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -132.04 161.58 32.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.293 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.69 44.93 4.41 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.666 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 26.4 p90 -104.52 153.03 21.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.88 116.65 29.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.91 113.82 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.63 0.729 . . . . 0.0 110.489 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 7.2 mmtm -79.17 -32.44 44.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.967 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HB3' HG23 ' A' ' 83' ' ' THR . 24.0 t0 -149.32 139.91 22.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.079 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.3 mt -112.1 122.49 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.15 140.71 50.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' CD1' HD21 ' A' ' 34' ' ' LEU . 48.6 m-85 -114.71 148.61 38.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.497 -173.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -142.86 75.62 1.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.07 -44.97 0.13 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.36 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -71.01 134.81 47.43 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.008 0.432 . . . . 0.0 111.716 -176.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.42 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 1.0 OUTLIER -110.41 -28.72 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 178.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.07 -37.67 7.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.958 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.65 121.25 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.889 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.61 156.54 19.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.917 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -59.12 -35.8 59.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.27 -40.07 87.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.801 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.21 69.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 110.49 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.05 -40.74 71.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HA ' ' SD ' ' A' ' 46' ' ' MET . 4.1 mp -62.91 -32.19 73.42 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.536 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 49.0 mt -69.32 -22.85 63.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.334 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -85.44 -18.0 34.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.662 ' HG2' HG23 ' A' ' 62' ' ' THR . 42.0 mtp -82.4 148.44 59.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.839 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.52 12.51 2.85 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.779 2.32 . . . . 0.0 113.126 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.11 166.43 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.722 ' HD2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.89 176.94 7.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.137 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -66.4 126.78 29.88 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.689 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.44 -4.46 54.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.657 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.722 ' HB2' ' HD2' ' A' ' 49' ' ' ARG . 2.6 t0 -92.32 156.81 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.412 . . . . 0.0 111.359 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 m -88.34 134.09 33.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.884 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.13 128.91 65.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 111.411 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -98.57 -178.31 3.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.263 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -37.07 79.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.284 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.81 -37.88 80.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.157 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -74.29 -30.45 62.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -50.43 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 173.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -67.62 -32.71 73.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.59 0.233 . . . . 0.0 111.213 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.55 -41.65 88.32 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.684 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.662 HG23 ' HG2' ' A' ' 46' ' ' MET . 91.2 m -60.37 -43.51 96.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 172.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 60' ' ' SER . 59.7 mt -56.07 -54.54 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 123.274 0.359 . . . . 0.0 111.122 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -69.33 -29.62 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.6 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HB2' HG11 ' A' ' 75' ' ' VAL . 80.3 mt -71.19 -30.09 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.814 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.85 -33.84 75.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.373 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.89 -13.27 61.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.196 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.5 p -78.94 -24.43 43.99 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.758 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.02 10.16 84.03 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.291 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -91.41 -25.51 19.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.941 0.4 . . . . 0.0 110.876 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.7 148.43 42.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.343 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -91.8 -14.06 30.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.158 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 9.3 t70 -154.65 138.31 16.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 66' ' ' LEU . 49.0 t -126.34 118.79 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.4 118.16 31.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.373 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.62 122.18 61.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mt -131.14 140.1 49.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.666 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -99.79 140.03 34.59 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.536 0.684 . . . . 0.0 110.293 -178.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.65 95.08 4.31 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.54 -109.58 2.97 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.484 ' HB2' ' HG2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -112.67 13.69 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 175.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.476 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -103.48 135.12 45.67 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.449 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -103.48 111.63 24.16 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.059 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 tp -104.28 119.63 39.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.868 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -117.05 113.75 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.325 0.583 . . . . 0.0 111.265 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -102.24 140.62 36.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.38 157.31 34.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 120.978 0.418 . . . . 0.0 110.438 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.1 OUTLIER -100.24 138.66 37.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.416 -177.114 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.637 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -65.15 161.58 18.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.506 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -44.06 71.75 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 47.7 Cg_exo -58.61 139.79 92.16 Favored 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.611 1.541 . . . . 0.0 113.382 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 4.3 m -110.42 140.22 44.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.897 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 121' ' ' VAL . 13.7 mt -59.09 119.05 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 109.832 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.45 -32.12 9.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.501 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.11 138.38 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.701 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.426 HG21 ' CD1' ' A' ' 114' ' ' LEU . 1.5 mt -118.75 132.16 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.04 139.19 52.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.652 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.524 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.6 m-85 -112.68 139.33 48.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.58 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.69 123.02 17.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.132 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.62 17.61 25.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.839 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -96.94 77.24 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 111.033 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.26 -40.43 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.654 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -76.52 -57.88 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.353 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.57 143.95 10.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -71.02 145.95 49.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 0.0 112.091 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -39.89 84.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.098 171.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.13 -45.32 87.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.84 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -41.23 79.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -32.95 74.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.891 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -47.84 84.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 111.334 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -77.95 -27.12 49.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -63.88 -38.43 91.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.397 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.426 ' CD1' HG21 ' A' ' 97' ' ' ILE . 14.2 mt -68.14 -43.09 79.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.533 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -58.93 -43.53 91.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.194 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.3 61.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.629 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.4 m -91.17 -14.66 30.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 110.559 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.75 -26.55 7.55 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.971 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -89.16 104.0 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.187 0.517 . . . . 0.0 110.88 -176.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 3.6 ptp85 -140.59 172.42 12.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.501 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.554 ' HA ' HG22 ' A' ' 94' ' ' ILE . 50.9 t -69.97 128.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.35 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.12 61.78 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.337 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -120.85 146.31 46.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.07 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 35.2 t -65.69 151.73 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 111.227 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.53 145.21 24.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.596 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 130' ' ' ILE . 5.3 t70 -104.62 99.01 8.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.296 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.503 ' HA ' ' CG1' ' A' ' 130' ' ' ILE . 1.1 mtp180 -72.2 -18.31 61.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.912 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -75.02 -31.59 61.4 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.33 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 p -95.39 -2.85 48.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.159 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CG1' ' HA ' ' A' ' 127' ' ' ARG . 2.8 mm -55.59 -37.71 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.51 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -75.36 -27.13 59.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.872 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 19.1 mt -66.29 -50.02 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.927 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HG2' HG12 ' A' ' 151' ' ' VAL . 88.0 mt-10 -58.24 -49.09 78.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.638 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -40.32 93.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.573 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -34.86 65.08 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.197 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 137' ' ' LEU . 1.7 mm? -70.5 -40.26 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.927 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -58.77 -40.37 83.75 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.688 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.16 -38.78 91.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.824 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.41 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 2.1 m-30 -65.62 -38.07 88.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.505 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.69 -34.64 78.31 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 110.804 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.3 t80 -70.58 -30.75 67.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.96 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.27 -28.03 65.94 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.8 t -75.24 -88.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 110.574 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.464 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -112.68 18.61 22.25 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.716 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 20.7 mtmt 60.05 49.13 7.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 110.075 -173.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.248 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.22 97.12 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.335 1.022 . . . . 0.0 111.732 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.76 156.21 17.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.052 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 113.37 25.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.406 HG12 ' HG2' ' A' ' 134' ' ' GLU . 93.1 t -103.26 126.72 57.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -172.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -125.38 117.61 24.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.334 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.12 111.24 22.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.028 0.442 . . . . 0.0 110.092 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.1 t -94.08 123.27 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.245 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.4 m -109.89 117.62 55.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.6 m -109.55 117.42 52.75 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.121 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.68 142.49 16.14 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.667 2.245 . . . . 0.0 112.655 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -122.12 155.09 61.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 171.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.83 56.81 6.21 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.149 2.566 . . . . 0.0 113.76 -173.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.549 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -134.85 -89.53 0.35 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -167.75 36.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.666 ' HB2' HD11 ' A' ' 158' ' ' LEU . 10.9 mmt85 -131.42 162.2 30.73 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.442 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -135.2 148.01 28.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.858 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.27 127.45 53.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.82 122.16 46.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -120.48 132.7 55.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 110.559 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.524 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -102.07 110.79 22.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.201 -177.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.57 122.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.592 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.436 ' HE2' ' HB3' ' A' ' 167' ' ' LEU . 23.7 m-85 -113.69 118.31 33.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.421 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.85 115.98 31.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.914 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -80.98 120.6 24.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.931 0.396 . . . . 0.0 110.573 -178.186 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 102.25 106.97 3.04 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.86 -33.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.146 0.498 . . . . 0.0 109.769 -168.445 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.663 0.268 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.19 129.41 56.52 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.04 47.8 4.04 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -110.12 151.57 27.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.23 117.95 29.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.32 107.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.535 0.683 . . . . 0.0 110.228 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -20.53 31.6 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.578 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.754 ' HB3' HG23 ' A' ' 83' ' ' THR . 20.5 t70 -156.83 137.98 13.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.913 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.4 121.29 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.13 126.48 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.99 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' HD2' HG12 ' A' ' 39' ' ' VAL . 80.2 m-85 -104.24 122.23 44.95 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.661 ' HG3' HD11 ' A' ' 85' ' ' LEU . 1.4 mm-40 -117.97 -8.81 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.853 -172.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.812 ' HA3' ' H ' ' A' ' 88' ' ' VAL . . . -103.62 -10.8 34.64 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.985 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.589 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -125.54 136.0 52.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.95 0.405 . . . . 0.0 111.257 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -116.68 -36.98 3.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.142 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -77.97 -42.26 33.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.138 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.589 ' HB ' HD13 ' A' ' 34' ' ' LEU . 9.5 t -69.11 141.36 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.16 157.26 16.49 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.8 m -54.3 -43.51 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 O-C-N 123.981 0.801 . . . . 0.0 112.222 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.32 -38.0 46.73 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.688 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -67.7 -37.72 82.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.18 -35.93 64.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.88 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -58.92 -31.12 68.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.315 0.646 . . . . 0.0 112.54 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 41' ' ' ALA . 69.0 mt -69.29 -19.47 63.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.701 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.516 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -92.73 -8.37 44.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.785 ' HG2' HG23 ' A' ' 62' ' ' THR . 87.8 mtp -90.16 141.61 27.93 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.602 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 26.3 Cg_exo -64.31 -37.04 42.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.773 2.315 . . . . 0.0 112.768 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -121.96 155.47 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.39 -177.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -113.51 170.79 7.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.098 0.475 . . . . 0.0 110.983 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -67.24 138.72 57.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.2 177.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 -14.47 48.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.8 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.28 156.94 18.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 110.211 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.8 135.05 38.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.908 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.433 HG12 HG21 ' A' ' 48' ' ' VAL . 6.0 m -128.66 129.39 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.178 0.513 . . . . 0.0 110.889 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.19 -177.56 3.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.386 0.613 . . . . 0.0 110.645 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -65.37 -29.83 70.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.339 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.77 62.83 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.664 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 43.0 m-20 -74.13 -29.56 61.88 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.13 -49.26 84.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -66.86 -35.94 81.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.602 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -62.39 -45.13 94.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.426 177.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.785 HG23 ' HG2' ' A' ' 46' ' ' MET . 63.1 m -58.24 -47.06 84.71 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.267 174.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 77' ' ' VAL . 7.9 mt -56.92 -50.43 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.441 0.463 . . . . 0.0 111.142 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -69.81 -34.04 73.16 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.89 -46.7 70.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 45' ' ' SER . 60.7 mt -67.87 -30.9 70.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.914 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.56 99.23 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.11 -12.08 61.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.194 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 65' ' ' ALA . 32.7 p -78.42 -24.71 46.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.478 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.83 16.22 76.25 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.877 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -88.22 -32.48 18.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.303 0.573 . . . . 0.0 109.888 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.2 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 6.4 mm-40 -93.25 -27.1 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 14.8 t70 -141.78 137.07 31.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 88' ' ' VAL . 38.1 t -124.91 117.1 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.43 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.6 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.507 HG22 HD11 ' A' ' 63' ' ' ILE . 16.0 m -104.67 144.11 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 110.405 174.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.11 155.99 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -116.07 127.14 54.63 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.291 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.86 95.27 4.76 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.99 -110.47 3.51 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.839 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.78 10.07 30.88 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.754 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -103.65 128.78 50.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.8 -176.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.06 113.2 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 0.0 110.328 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.661 HD11 ' HG3' ' A' ' 32' ' ' GLU . 3.1 tp -93.9 112.66 24.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.216 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.56 106.85 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.301 0.572 . . . . 0.0 110.477 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -105.6 123.81 48.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.379 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.812 ' H ' ' HA3' ' A' ' 33' ' ' GLY . 4.2 m -124.51 147.47 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.445 0.641 . . . . 0.0 110.891 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.1 ttpt -100.37 142.81 31.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.135 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 125' ' ' LEU . 3.2 mm-40 76.04 171.09 0.25 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 124.511 1.132 . . . . 0.0 112.143 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.642 ' H ' ' HD2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -159.79 -52.11 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.246 -170.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.642 ' HD2' ' H ' ' A' ' 91' ' ' ARG . 55.0 Cg_endo -69.57 141.99 47.53 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.462 1.441 . . . . 0.0 113.015 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.504 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 86.6 m -94.6 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.842 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 125' ' ' LEU . 12.9 mt -73.21 118.73 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HB2' ' HG2' ' A' ' 162' ' ' ARG . . . -97.44 -42.81 7.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.12 147.17 33.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.482 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -117.96 123.58 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 172.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.963 -175.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.727 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 21.6 m-85 -114.27 133.88 55.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.792 0.329 . . . . 0.0 110.791 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.9 m -126.39 144.39 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.801 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.76 -79.97 0.26 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 47.07 49.97 14.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.752 0.821 . . . . 0.0 112.611 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 171' ' ' GLU . 59.8 mmtt -76.17 -42.64 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 m -130.54 -25.73 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.76 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 13.6 t -111.4 132.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 155.46 39.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.378 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.27 77.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.291 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.156 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -45.44 73.65 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -32.61 71.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.074 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.727 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 9.9 mttt -58.14 -48.79 79.15 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.425 0.453 . . . . 0.0 111.584 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.81 48.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.735 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.3 -38.12 88.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.662 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.9 mm? -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 2.8 mt-10 -65.58 -37.83 87.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.417 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.72 -16.39 61.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.233 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.3 m -88.21 -16.02 34.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.965 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.06 -32.38 5.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.326 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 125' ' ' LEU . 0.3 OUTLIER -90.73 113.0 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -174.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.569 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -141.06 176.72 8.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.642 -178.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 94' ' ' ILE . 53.1 t -67.43 127.2 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.912 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.48 -27.81 18.82 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.553 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.97 162.41 19.41 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.534 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -79.03 164.86 24.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -112.04 143.63 42.72 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.057 -177.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.444 ' HB3' ' HB ' ' A' ' 129' ' ' THR . 43.9 t0 -107.86 105.7 15.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.571 0.7 . . . . 0.0 110.097 174.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.468 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.3 -14.1 62.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.763 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.8 p -89.54 -23.47 22.01 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.071 0.939 . . . . 0.0 108.745 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 126' ' ' ASP . 5.3 m -87.89 -13.57 41.63 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.715 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.3 mm -53.69 -39.95 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.097 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.54 94.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.2 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.492 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 130' ' ' ILE . 15.6 mt -63.09 -44.39 99.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.923 174.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.75 -44.66 96.48 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.726 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -41.32 93.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.634 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.42 -38.41 69.98 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.704 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.16 -33.06 71.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 111.492 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.29 -34.2 75.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.507 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.83 -32.46 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.519 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -62.51 -39.37 93.31 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.676 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.434 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -64.5 -34.53 78.44 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.099 0.476 . . . . 0.0 110.872 177.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -69.49 -30.79 68.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.156 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.6 m -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.797 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 9.5 t -76.18 -85.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.627 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.8 19.96 22.82 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.674 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mttp 66.7 42.21 2.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.429 0.692 . . . . 0.0 110.569 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -87.26 139.44 30.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.442 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -115.16 74.47 0.88 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.238 0.542 . . . . 0.0 110.127 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.4 142.04 28.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.369 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.688 ' H ' ' HB2' ' A' ' 170' ' ' GLN . 0.9 OUTLIER -99.41 126.42 45.3 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 11.4 p -113.4 138.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.176 0.512 . . . . 0.0 111.388 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.89 125.21 39.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.658 175.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.616 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.258 0.551 . . . . 0.0 110.919 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.57 128.77 56.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.329 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.74 123.36 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.433 0.635 . . . . 0.0 111.204 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 m -107.01 120.19 48.82 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.579 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 9.6 Cg_endo -89.64 130.4 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.408 2.739 . . . . 0.0 112.952 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -113.47 152.95 45.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.226 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 22.47 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.04 2.493 . . . . 0.0 113.876 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -115.72 19.98 14.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.992 0.425 . . . . 0.0 110.144 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 t30 67.51 26.62 8.14 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.999 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.531 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -129.75 167.03 18.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.288 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.497 HG21 HD22 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -133.21 153.53 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.0 0.429 . . . . 0.0 111.139 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -108.92 118.82 37.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.494 HD11 ' HB1' ' A' ' 153' ' ' ALA . 59.4 tp -101.18 113.47 26.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.352 -175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -105.15 131.34 52.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 111.01 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.7 108.58 19.48 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.632 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 2.8 t -101.28 111.74 31.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.885 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -99.53 146.61 26.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.688 ' HB2' ' H ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -74.46 144.15 44.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.886 178.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.59 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 2.1 tt0 -57.98 -27.36 63.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.964 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 121.12 116.03 2.44 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.378 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.476 ' HB ' ' H ' ' A' ' 174' ' ' SER . 0.0 OUTLIER -89.19 -136.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.519 0.199 . . . . 0.0 111.142 -177.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.476 ' H ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 111.499 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.934 0.397 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -145.66 157.13 43.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.631 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.56 58.78 3.21 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' HE1' HD11 ' A' ' 59' ' ' ILE . 10.9 p90 -95.49 153.39 17.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.395 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.17 118.98 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -69.88 122.46 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -49.59 7.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.122 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.07 140.99 29.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.247 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.527 HG21 ' HE1' ' A' ' 46' ' ' MET . 7.1 mt -104.85 121.17 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 172.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 127.74 53.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.988 0.423 . . . . 0.0 110.121 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 34' ' ' LEU . 75.7 m-85 -102.79 125.84 49.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.024 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.01 68.92 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.348 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.34 -41.33 0.13 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.562 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.9 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.4 OUTLIER -93.08 162.48 14.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.738 0.304 . . . . 0.0 110.884 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -156.42 -58.21 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.458 -176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -39.23 90.8 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.468 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -77.8 121.27 30.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 164.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.62 157.16 28.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 31' ' ' PHE . 5.6 m -53.63 -40.25 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.118 0.886 . . . . 0.0 112.604 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.12 -33.45 57.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.489 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.25 -35.25 63.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.54 74.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.507 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.51 -32.35 57.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.032 0.933 . . . . 0.0 112.879 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.7 mt -69.45 -14.04 62.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.499 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -100.06 -7.45 24.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.744 176.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.527 ' HE1' HG21 ' A' ' 29' ' ' ILE . 14.4 mtm -102.24 136.34 19.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.394 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.37 12.67 2.78 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.7 2.267 . . . . 0.0 113.296 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.73 HG12 HG11 ' A' ' 54' ' ' VAL . 32.0 m -119.08 149.12 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 49' ' ' ARG . 6.0 mmm-85 -131.85 166.22 22.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.504 0.668 . . . . 0.0 111.598 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 p -68.12 121.28 15.82 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.611 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.26 62.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.222 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.19 150.78 25.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.082 0.468 . . . . 0.0 111.224 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 116.35 32.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.73 HG11 HG12 ' A' ' 48' ' ' VAL . 14.7 m -133.2 156.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.081 0.467 . . . . 0.0 112.001 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 11.6 m-80 -99.3 179.16 4.67 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.312 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.84 -32.83 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.191 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.67 -31.73 72.9 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 12.2 m-20 -75.2 -33.72 61.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.075 177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 55' ' ' ASN . 1.3 mp -63.14 -46.63 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 171.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.76 ' HA ' HD12 ' A' ' 63' ' ' ILE . 19.0 m -65.35 -31.86 73.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.303 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -70.01 -38.87 76.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.407 178.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 m -58.29 -46.67 85.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 171.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 60' ' ' SER . 68.8 mt -55.33 -55.0 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.385 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -29.55 68.19 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.7 -45.71 74.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.485 0.183 . . . . 0.0 110.614 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 45' ' ' SER . 93.7 mt -69.39 -30.89 68.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.58 -35.01 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.74 -12.75 61.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.445 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.5 p -78.87 -25.1 43.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.497 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.5 8.04 83.53 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.609 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -82.99 -48.77 10.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.997 0.427 . . . . 0.0 110.829 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.85 150.16 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -53.75 17.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -135.49 140.7 45.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -121.47 118.65 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.404 ' HG2' HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -120.07 118.79 31.51 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.021 175.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 HG13 ' A' ' 86' ' ' VAL . 98.3 t -118.06 122.74 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.404 HD11 ' HG2' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -133.25 158.6 42.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 150.84 31.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.999 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -125.49 95.03 4.31 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.33 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.11 -108.44 2.35 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.276 -171.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -104.36 5.54 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.643 0.377 . . . . 0.0 111.323 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.97 133.11 49.48 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.401 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 111.75 24.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.233 0.539 . . . . 0.0 110.127 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.0 tp -100.58 112.95 25.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.038 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.41 HG13 HG22 ' A' ' 77' ' ' VAL . 36.7 t -106.86 105.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.483 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -105.42 126.52 52.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.25 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG21 HD23 ' A' ' 34' ' ' LEU . 2.7 m -125.55 144.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.253 0.549 . . . . 0.0 109.867 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.73 125.86 44.18 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.33 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 43.55 88.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 125.086 1.491 . . . . 0.0 113.732 176.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.9 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -80.93 -26.06 0.42 Allowed Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.011 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 13.9 Cg_exo -71.05 140.93 38.86 Favored 'Trans proline' 0 C--N 1.377 2.066 0 CA-C-N 122.391 1.89 . . . . 0.0 113.234 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -96.66 134.25 40.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.426 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 125' ' ' LEU . 25.7 mt -65.06 118.63 7.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.6 -34.88 14.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -157.93 154.36 27.72 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 110.448 174.168 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 114' ' ' LEU . 1.1 mt -112.67 122.96 67.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.127 172.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.511 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -103.38 130.74 50.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.049 -178.09 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.472 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 19.9 m-30 -112.96 134.77 54.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.862 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -142.35 137.17 30.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.435 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.26 76.98 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.636 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.97 72.35 7.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.644 0.735 . . . . 0.0 110.648 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 12.9 mmmt -86.41 -19.91 28.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.865 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -53.0 6.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.92 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.2 t -107.45 141.4 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -68.98 158.11 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 112.608 -171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.29 95.38 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.243 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.48 -34.76 72.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.721 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.4 82.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.176 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -32.87 74.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.818 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -59.64 -44.8 93.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.372 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.529 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 4.1 tm0? -77.72 -28.53 50.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.36 -45.74 91.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.046 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.485 ' CD1' HG21 ' A' ' 97' ' ' ILE . 18.0 mt -67.95 -36.59 80.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.831 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -59.88 -46.14 90.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.137 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -15.97 61.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.542 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.4 m -90.94 -12.11 37.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.749 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.03 -20.8 19.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.631 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.4 102.41 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.303 0.573 . . . . 0.0 110.762 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.24 173.56 11.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.543 -178.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HA ' HG22 ' A' ' 94' ' ' ILE . 65.4 t -69.36 125.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 110.651 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.11 -5.62 61.38 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 4.3 mm-40 -107.14 160.3 15.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.34 138.79 40.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.754 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.67 145.99 24.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.752 -175.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -115.83 103.76 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.649 0.737 . . . . 0.0 110.425 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.566 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.47 -15.3 62.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.562 178.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p -84.11 -20.66 32.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.095 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 p -100.64 3.26 42.37 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.23 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.9 mm -57.5 -41.52 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.768 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.9 -38.01 87.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 111.51 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -33.84 73.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.677 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.92 -44.11 88.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.908 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 92.3 mt-10 -57.28 -51.3 69.91 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.488 175.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -61.95 -34.2 75.68 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.756 0.66 . . . . 0.0 111.758 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.62 86.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.932 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.42 HD22 ' HZ ' ' A' ' 169' ' ' PHE . 9.9 mt -73.87 -36.61 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 134' ' ' GLU . 1.9 pt-20 -72.55 -28.86 63.09 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.4 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.22 -40.84 64.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.269 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.538 ' O ' HG23 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -61.9 -44.3 97.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.13 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.05 90.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.496 0.498 . . . . 0.0 111.278 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -67.08 -33.98 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.188 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.5 m -72.23 -28.75 63.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.899 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 140' ' ' PHE . 41.2 t -78.55 -82.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.998 0.427 . . . . 0.0 110.913 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.558 ' O ' ' HG2' ' A' ' 146' ' ' LYS . . . -112.7 20.9 19.74 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-O 118.88 -0.955 . . . . 0.0 113.21 -172.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER 70.02 16.72 7.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.759 1.224 . . . . 0.0 111.064 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -60.42 118.0 5.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.285 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.22 94.66 9.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.595 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.69 143.23 50.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.762 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.56 120.66 39.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.53 124.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -129.39 120.31 25.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.301 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.644 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -98.31 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.201 0.524 . . . . 0.0 110.181 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.33 123.56 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.167 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 t -98.61 113.36 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.038 0.447 . . . . 0.0 110.19 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.0 m -106.0 123.54 38.82 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.12 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -88.23 146.11 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.892 2.394 . . . . 0.0 113.138 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -135.26 157.63 76.32 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.6 51.22 3.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.966 2.444 . . . . 0.0 113.932 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.47 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.33 17.02 2.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.97 176.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 41.7 t30 60.43 37.47 19.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.261 1.029 . . . . 0.0 109.933 -173.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.511 ' HB2' HD11 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -131.08 161.39 32.16 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.527 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.754 HG21 HD22 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -133.4 147.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.64 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -108.92 119.05 38.41 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.2 tp -99.18 115.78 29.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.212 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.511 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -105.56 132.29 51.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.423 0.63 . . . . 0.0 111.194 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 1.8 mm? -108.84 109.93 21.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.163 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 t -101.34 114.19 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.268 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.42 ' HZ ' HD22 ' A' ' 137' ' ' LEU . 43.6 m-85 -105.51 118.32 36.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.246 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.2 140.18 36.42 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -77.99 -9.4 59.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.769 0.318 . . . . 0.0 110.848 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -169.32 -142.15 3.45 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 t 59.8 68.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.303 0.573 . . . . 0.0 110.836 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.536 0.43 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.946 178.139 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -70.53 140.31 51.79 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.37 47.52 2.78 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -171.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -113.33 154.12 27.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.099 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.13 116.66 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.622 ' HB ' ' HA ' ' A' ' 50' ' ' THR . 0.5 OUTLIER -65.22 114.29 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 121.359 0.6 . . . . 0.0 111.285 -177.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 2.1 mttm -76.99 -39.97 48.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.812 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -156.89 142.26 17.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.217 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.586 HD12 HD21 ' A' ' 43' ' ' LEU . 91.9 mt -104.26 121.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.565 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -115.71 127.56 55.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.516 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.56 ' HE2' ' HE1' ' A' ' 46' ' ' MET . 0.7 OUTLIER -106.18 146.23 30.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.16 0.505 . . . . 0.0 111.163 -176.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -133.41 156.62 47.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.484 178.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.74 -2.99 57.58 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.716 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 34' ' ' LEU . 6.2 mt -73.25 155.92 39.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.151 0.5 . . . . 0.0 112.071 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -157.28 -52.48 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.657 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -82.91 -56.63 3.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.874 -178.252 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.414 ' O ' HD13 ' A' ' 34' ' ' LEU . 3.4 t -76.98 143.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.582 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.07 157.81 16.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.84 -33.52 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.92 -36.95 60.92 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.255 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.742 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -73.2 -34.05 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.0 110.168 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.09 73.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.843 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 29' ' ' ILE . 3.8 mt -60.93 -32.72 72.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.074 0.55 . . . . 0.0 111.811 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 41' ' ' ALA . 17.6 mt -71.85 -20.39 61.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.98 0.419 . . . . 0.0 111.249 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.524 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -91.73 -10.96 38.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.894 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.56 ' HE1' ' HE2' ' A' ' 31' ' ' PHE . 53.8 mtm -94.78 135.83 23.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.69 -17.6 29.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.642 2.228 . . . . 0.0 112.725 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 149.56 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.718 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -120.91 176.27 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.896 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.622 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -67.48 136.07 54.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.01 -8.72 59.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.529 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.16 156.23 17.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.93 125.12 34.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.525 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.22 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.308 0.575 . . . . 0.0 111.563 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.81 -177.78 3.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -25.67 64.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -65.71 -35.8 81.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.396 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.647 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 53.0 m-20 -74.6 -28.9 61.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.908 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.97 -47.0 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 172.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -30.3 68.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.5 m-20 -67.36 -46.53 73.07 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.778 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 p -62.88 -38.86 92.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.006 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.6 mt -55.81 -54.12 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 123.427 0.454 . . . . 0.0 110.626 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 64' ' ' ARG . 9.6 ptm85 -70.23 -31.19 68.48 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.9 70.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.538 0.208 . . . . 0.0 110.713 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 45' ' ' SER . 58.9 mt -69.94 -30.79 68.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.731 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -37.87 88.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 110.647 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.1 -13.42 61.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 45' ' ' SER . 19.0 p -79.26 -24.79 42.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.629 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.12 -1.76 73.54 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.432 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -76.34 -47.1 24.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.403 0.621 . . . . 0.0 109.887 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.6 136.3 54.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.29 -18.27 25.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.54 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 24.6 t70 -122.74 134.47 54.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.4 t -132.7 118.46 34.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.61 116.82 27.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.731 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.9 t -103.9 122.51 56.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -125.69 148.78 48.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.71 136.91 53.03 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.501 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.22 95.99 4.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.364 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.75 -111.68 4.32 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 40.3 m-20 -106.16 7.01 31.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.976 0.417 . . . . 0.0 110.486 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.47 133.61 48.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.421 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 111.8 24.62 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 3.6 tp -104.32 116.43 32.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.056 0.455 . . . . 0.0 110.752 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.5 110.99 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 6.3 mt-30 -96.65 127.75 42.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.18 162.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 0.0 111.554 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -117.78 106.52 13.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.244 176.114 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.14 27.29 3.85 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.979 0.895 . . . . 0.0 109.489 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.16 -64.03 0.25 Allowed Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.579 -170.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 5.7 Cg_endo -89.43 140.82 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.756 1.637 . . . . 0.0 112.241 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 59.8 m -125.19 137.79 54.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 125' ' ' LEU . 21.7 mt -74.94 120.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.12 -38.59 10.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.063 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.52 143.0 25.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.485 HG21 HD22 ' A' ' 114' ' ' LEU . 2.4 mt -123.13 128.07 74.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 141.56 47.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.47 177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.466 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.9 m-85 -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.619 0.247 . . . . 0.0 111.021 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.0 140.42 42.12 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 169' ' ' PHE . . . 85.39 16.22 64.8 Favored Glycine 0 C--N 1.328 0.113 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.695 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 1.7 p30 -79.47 69.92 5.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.54 0.686 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -83.13 -47.62 11.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.184 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -27.96 24.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 2.2 t -126.66 141.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -68.84 156.72 37.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.139 0.495 . . . . 0.0 111.619 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -33.95 77.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 171.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.853 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -60.99 -39.42 89.57 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 175.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.9 mtp -73.33 -39.04 65.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.218 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -62.8 -32.62 73.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.242 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' A' ' 108' ' ' ASP . 7.6 mtmm -57.14 -48.52 78.47 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.591 0.557 . . . . 0.0 111.138 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.1 45.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.415 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -63.46 -37.63 88.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.485 HD22 HG21 ' A' ' 97' ' ' ILE . 1.1 mp -72.31 -38.38 68.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.921 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 16.4 mt-10 -62.67 -39.45 93.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.901 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.48 -15.66 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.125 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.631 ' HB2' HG12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -95.0 -16.14 22.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 175.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.16 -37.01 2.37 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.608 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.66 111.53 22.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.267 0.555 . . . . 0.0 111.715 -171.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.03 171.17 14.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.223 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.25 127.82 31.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.233 0.54 . . . . 0.0 110.598 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.65 53.26 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.497 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.576 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 1.1 tp10 -89.02 156.72 18.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 122.71 0.404 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.99 134.48 43.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.728 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -114.89 142.85 46.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.227 -177.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.542 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 33.6 t0 -117.58 133.48 55.91 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 110.054 164.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.408 ' CD ' ' H ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -71.29 -16.04 62.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.714 178.164 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 p -82.47 -26.59 32.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.461 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -86.52 -11.48 51.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.428 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 130' ' ' ILE . 5.9 mm -55.15 -40.13 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.732 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.68 91.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.11 -35.21 76.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.13 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.631 HG12 ' HB2' ' A' ' 117' ' ' SER . 3.2 mt -67.41 -40.2 84.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.213 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -61.1 -40.92 95.57 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.45 96.97 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.869 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.33 -37.23 92.65 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.528 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.667 HD22 ' HZ ' ' A' ' 169' ' ' PHE . 8.2 mt -66.83 -36.81 83.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.752 0.31 . . . . 0.0 110.943 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.2 -39.56 86.37 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.67 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -67.01 -43.35 83.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.07 -44.1 97.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.641 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -38.35 87.08 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.962 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -28.98 65.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m -70.94 -27.58 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.409 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 4.1 t -75.2 -83.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 111.187 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.409 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.85 19.77 22.93 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.525 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.87 44.26 13.96 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.734 0.778 . . . . 0.0 110.504 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -80.03 118.66 21.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.935 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 m -89.51 86.36 6.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.003 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.11 144.53 25.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.022 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.3 113.44 25.39 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.9 m -101.16 133.0 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.384 0.611 . . . . 0.0 111.519 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 116.69 18.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.574 172.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.6 110.8 22.77 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.386 0.612 . . . . 0.0 109.909 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.65 113.47 36.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.108 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.18 110.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.775 0.798 . . . . 0.0 109.205 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 7.3 m -112.41 116.46 48.54 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.842 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.502 ' HA ' HG12 ' A' ' 163' ' ' VAL . 59.0 Cg_endo -71.79 135.65 26.21 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.624 2.216 . . . . 0.0 112.429 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -100.54 159.03 30.78 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.261 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.33 80.07 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.18 2.586 . . . . 0.0 113.306 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 1.0 OUTLIER -174.51 -112.31 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.712 0.805 . . . . 0.0 109.188 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 3.0 t-20 -146.15 9.62 1.12 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.968 0.89 . . . . 0.0 109.842 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.538 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 1.1 mpt_? -117.92 167.36 11.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.868 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 125' ' ' LEU . 18.5 m -130.95 159.76 42.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 111.466 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.43 119.13 38.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.444 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.7 tp -108.19 125.95 52.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.459 ' HB3' ' HE2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -123.43 132.27 53.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 111.132 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 2.7 mm? -108.52 110.87 22.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.011 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.18 112.3 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.331 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.667 ' HZ ' HD22 ' A' ' 137' ' ' LEU . 11.4 m-30 -109.65 127.86 54.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.323 0.582 . . . . 0.0 111.398 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -98.63 135.28 40.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -82.71 15.39 2.65 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.013 0.435 . . . . 0.0 111.668 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.81 14.7 78.17 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.878 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.4 m 39.1 39.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.488 1.515 . . . . 0.0 113.465 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.233 0.221 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.31 178.421 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 69.22 153.93 0.11 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.099 0.96 . . . . 0.0 112.793 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.27 50.06 10.98 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.456 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -104.99 153.18 21.79 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.8 t -87.06 113.84 25.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -72.07 125.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.6 0.714 . . . . 0.0 110.346 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -91.4 -29.66 16.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.974 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.45 137.12 14.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.056 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.4 mt -109.64 121.38 62.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -119.88 127.86 53.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.174 0.511 . . . . 0.0 109.851 -178.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.68 ' HD2' HG12 ' A' ' 39' ' ' VAL . 58.7 m-85 -101.34 149.22 24.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.066 -175.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -137.73 167.4 21.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.402 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.15 -44.47 3.34 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.27 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.5 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -74.92 159.48 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.626 -177.005 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -113.52 -65.37 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.877 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -0.82 50.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.801 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 t -84.02 126.47 40.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.73 157.16 16.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.682 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.68 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.6 m -56.67 -41.85 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 123.857 0.723 . . . . 0.0 112.151 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.27 -34.16 55.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.573 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.75 -34.43 64.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.135 0.493 . . . . 0.0 110.953 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.32 -33.81 59.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.834 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.84 -31.04 58.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 112.695 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 78.4 mt -66.56 -18.95 65.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.77 -8.45 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.695 0.284 . . . . 0.0 110.823 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.474 ' SD ' ' HZ ' ' A' ' 31' ' ' PHE . 36.7 mtp -93.23 136.6 24.25 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.613 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 3.0 Cg_exo -78.41 6.56 4.69 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.069 2.513 . . . . 0.0 112.597 174.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.8 156.64 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 20.2 mtp85 -132.47 176.6 8.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.423 0.63 . . . . 0.0 112.114 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.9 p -67.84 120.49 14.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.883 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.31 44.94 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.095 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.4 OUTLIER -77.72 156.27 30.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.147 0.499 . . . . 0.0 111.573 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.67 117.01 30.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.16 129.07 73.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 112.283 -168.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -100.14 -175.96 3.09 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.72 172.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.46 -26.21 68.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.966 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.33 -34.02 70.17 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.52 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -74.33 -29.7 61.71 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.427 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.27 -44.85 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.478 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 p -71.0 -29.62 65.63 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 110.568 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.9 -45.73 73.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 p -63.74 -39.49 94.4 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.673 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 28.9 mt -56.04 -50.68 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 123.364 0.415 . . . . 0.0 110.326 174.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 mtt85 -65.04 -36.63 84.96 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.545 0.528 . . . . 0.0 111.985 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.67 -48.76 71.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.068 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.471 HD22 ' HE1' ' A' ' 72' ' ' PHE . 29.3 mt -70.71 -30.78 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.46 -36.25 78.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 110.724 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.05 -13.59 61.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.208 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 65' ' ' ALA . 19.0 p -78.77 -25.06 44.37 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.435 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.38 21.04 72.07 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.639 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -85.56 -23.89 27.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.7 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HE1' HD22 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -127.12 176.76 7.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.575 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 3.6 mm-40 -97.16 -23.42 16.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.664 0.268 . . . . 0.0 111.521 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.784 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 3.6 t70 -155.67 145.0 20.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.5 119.07 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -121.01 124.96 46.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.306 0.574 . . . . 0.0 110.997 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.5 t -101.3 123.35 54.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.07 158.01 39.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 145.78 47.62 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.386 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -128.03 96.09 4.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.7 -110.14 3.31 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.54 13.77 23.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.38 132.18 50.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.802 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 111.58 24.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.035 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 4.2 tp -105.11 112.75 25.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.407 ' HB ' ' CD1' ' A' ' 31' ' ' PHE . 18.3 t -108.58 106.75 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 54.1 mt-30 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.08 159.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.835 0.35 . . . . 0.0 110.381 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 3.3 tptm -102.86 151.66 22.18 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.501 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' CD ' ' HE ' ' A' ' 127' ' ' ARG . 0.5 OUTLIER -25.94 128.3 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 O-C-N 125.957 2.036 . . . . 0.0 114.778 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.6 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 51.4 mtp85 -61.71 -49.91 84.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.476 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 91' ' ' ARG . 16.8 Cg_exo -69.49 140.51 43.86 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 121.505 1.47 . . . . 0.0 112.347 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.7 m -102.58 139.77 37.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.161 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.4 mt -62.15 118.86 5.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.01 -25.41 11.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.14 0.495 . . . . 0.0 110.554 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -147.96 138.56 23.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.655 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.89 120.51 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.689 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 2.3 m -118.85 143.12 47.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.985 0.421 . . . . 0.0 111.006 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.808 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -121.75 135.93 54.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.497 -172.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.3 m -147.24 119.78 8.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.66 -7.96 39.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.791 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -81.11 83.88 6.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 110.937 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -85.92 -29.52 23.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.841 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -66.35 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.518 -175.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.497 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 15.1 t -90.47 142.52 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -69.74 146.48 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.07 0.462 . . . . 0.0 111.814 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.549 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 4.5 p30 -63.86 -33.01 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.206 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.58 -40.02 95.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.5 mtp -67.96 -40.32 83.23 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.381 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.03 -36.07 82.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.841 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.808 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 15.6 mttt -58.92 -46.1 88.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.816 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 3.0 tp60 -76.66 -27.98 55.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.288 -177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.36 -49.95 71.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.69 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.44 -34.96 79.1 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.977 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -60.46 -42.47 96.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.437 178.441 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.03 -15.56 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.686 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.9 m -88.08 -16.58 33.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.51 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.35 -15.21 22.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.112 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.46 103.73 15.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.241 0.543 . . . . 0.0 110.162 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 115' ' ' GLU . 12.3 mtm180 -134.34 172.15 13.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.203 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.87 123.64 28.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 110.206 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.25 71.2 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.004 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 159.77 15.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 120.895 0.378 . . . . 0.0 110.81 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -66.33 142.93 57.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.925 170.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.565 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.48 148.23 22.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.087 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.72 98.1 6.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.459 0.647 . . . . 0.0 110.516 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.518 ' HE ' ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -70.49 -14.83 62.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.56 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 p -85.08 -23.02 28.7 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.299 -0.251 . . . . 0.0 111.172 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 p -100.24 5.53 44.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.466 HG12 ' HA ' ' A' ' 127' ' ' ARG . 7.0 mm -57.64 -42.78 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.427 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . . . -64.86 -38.09 89.81 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.803 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 -27.46 63.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.779 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.2 mt -67.45 -44.99 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 131' ' ' ALA . 35.5 mt-10 -61.37 -47.77 84.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.241 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.51 82.2 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.959 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.02 -30.43 63.25 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.891 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.5 mt -76.11 -32.61 59.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.689 0.244 . . . . 0.0 110.741 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.595 ' HG3' HG23 ' A' ' 151' ' ' VAL . 6.5 mt-10 -64.98 -39.52 93.6 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 173.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -66.47 -43.56 85.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.599 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -62.37 -33.4 74.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.17 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.497 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -71.34 -44.41 65.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.139 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -30.22 66.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -173.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -28.85 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.469 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.58 -84.77 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.48 19.62 23.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.98 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? 62.56 52.55 2.88 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.446 0.641 . . . . 0.0 109.65 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -88.8 105.41 17.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.048 -173.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.791 ' HB2' HG21 ' A' ' 173' ' ' VAL . 0.5 OUTLIER -91.08 121.57 32.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.308 175.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.49 162.69 40.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.06 114.47 27.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.595 HG23 ' HG3' ' A' ' 138' ' ' GLU . 23.3 t -96.67 123.1 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.036 0.446 . . . . 0.0 110.812 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -124.71 117.7 24.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.78 111.62 23.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.37 133.05 61.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.03 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.26 123.04 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.274 0.559 . . . . 0.0 110.43 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.3 m -104.37 119.83 52.66 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.158 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 131.05 11.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 112.583 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -123.1 155.67 64.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.388 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.96 56.26 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.831 2.354 . . . . 0.0 113.879 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.501 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -144.32 19.37 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 177.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 38.5 t30 60.21 38.55 20.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 122.185 0.993 . . . . 0.0 109.247 -173.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.454 ' HB2' HD11 ' A' ' 158' ' ' LEU . 7.3 mmt180 -130.28 160.62 33.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.143 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -130.74 148.64 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.986 178.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.25 122.26 46.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.91 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.3 tp -96.13 110.39 22.67 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.689 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -113.22 132.06 55.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.792 0.806 . . . . 0.0 111.426 -175.428 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -107.78 110.69 22.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.445 -176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.93 111.05 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.448 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.93 117.43 34.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -111.19 116.23 30.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.373 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.39 153.45 35.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.835 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 144.31 48.67 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.994 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.791 HG21 ' HB2' ' A' ' 148' ' ' SER . 0.3 OUTLIER -127.88 161.87 35.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.103 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.915 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 60.68 93.79 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.152 0.977 . . . . 0.0 110.03 -173.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.95 41.39 4.08 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -166.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -110.4 153.11 25.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.973 -0.613 . . . . 0.0 109.972 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -79.68 113.32 18.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.79 125.49 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.49 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -85.54 -31.5 22.68 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.671 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB3' HG23 ' A' ' 83' ' ' THR . 29.5 t70 -157.63 147.01 19.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.245 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.8 mt -109.9 120.14 60.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.77 127.03 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.941 -176.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.678 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 1.8 m-85 -105.11 120.13 40.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -177.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.578 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 52.8 mm-40 -103.64 66.18 0.85 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.665 0.745 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.18 -75.37 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.945 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.678 ' HG ' ' HB3' ' A' ' 31' ' ' PHE . 38.2 mt 50.56 71.48 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.482 0.713 . . . . 0.0 112.659 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.665 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -91.31 91.47 8.18 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.723 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' A' ' 36' ' ' ARG . 3.8 mmt85 75.12 -21.89 0.28 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.683 1.193 . . . . 0.0 112.942 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 t -97.73 120.19 46.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.32 158.1 30.35 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.528 0.517 . . . . 0.0 111.6 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -51.86 -40.49 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.16 -41.77 94.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.145 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.14 68.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.826 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.3 81.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.85 -31.61 72.84 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.932 0.493 . . . . 0.0 111.186 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.4 mt -74.55 -13.21 60.64 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.819 ' HB3' HG21 ' A' ' 69' ' ' THR . 1.2 m -96.01 -8.19 34.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.15 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.695 ' HG2' HG23 ' A' ' 62' ' ' THR . 62.9 mtp -91.5 148.96 38.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.419 175.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 7.2 Cg_exo -75.0 -10.85 21.39 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.671 2.247 . . . . 0.0 112.212 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.4 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.175 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -133.76 177.96 7.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.2 p -66.27 131.29 45.78 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.221 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.68 -7.4 65.49 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.51 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -97.7 156.05 16.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 111.003 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.27 124.04 34.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.717 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.32 135.84 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.11 0.481 . . . . 0.0 110.864 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.401 ' O ' HD12 ' A' ' 59' ' ' ILE . 36.5 m-80 -98.51 -178.75 4.11 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.13 -36.88 85.64 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.37 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.04 -29.2 68.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.067 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 17.7 m-20 -73.75 -29.81 62.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.077 0.151 . . . . 0.0 110.866 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -61.99 -50.71 78.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 171.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.759 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -66.07 -29.26 69.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.623 176.721 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.539 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -69.58 -41.03 76.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.989 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.695 HG23 ' HG2' ' A' ' 46' ' ' MET . 85.2 m -58.61 -46.92 86.0 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.941 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 60' ' ' SER . 66.6 mt -52.83 -55.38 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.682 0.614 . . . . 0.0 110.854 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.59 -29.41 66.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.434 -174.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.66 -54.82 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 66' ' ' LEU . 30.2 mt -62.54 -30.81 71.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.343 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -46.2 83.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.69 60.1 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.819 HG21 ' HB3' ' A' ' 45' ' ' SER . 82.2 p -79.91 -24.13 41.31 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.821 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.07 78.56 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.067 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -82.74 -36.33 25.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.102 0.477 . . . . 0.0 110.383 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -129.72 164.36 24.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.516 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.745 ' HB2' ' HB3' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -77.72 -50.99 11.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.447 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -133.49 144.05 49.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.392 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.28 120.68 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -114.26 118.43 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.801 174.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.451 HG22 HG13 ' A' ' 86' ' ' VAL . 51.3 t -112.42 123.08 67.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.017 0.437 . . . . 0.0 109.934 173.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.75 159.03 43.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -96.06 141.85 28.96 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.075 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -136.65 93.66 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.96 -109.31 2.79 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.143 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 11.88 20.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.74 141.78 35.49 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.419 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.1 111.28 23.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.02 111.63 23.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.51 -174.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.451 HG13 HG22 ' A' ' 77' ' ' VAL . 5.0 t -114.1 103.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.459 0.647 . . . . 0.0 109.905 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.578 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.83 127.13 44.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 150.41 30.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.528 ' HD3' ' HG2' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -99.39 139.0 35.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.176 -172.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.665 ' HA ' ' HG2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -54.18 141.06 30.44 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.633 173.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.745 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -128.61 69.46 79.47 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.403 178.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 19.1 Cg_endo -60.76 138.86 82.19 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.78 1.653 . . . . 0.0 111.007 172.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.884 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 17.1 m -84.47 125.51 32.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.339 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.523 HD11 ' HB2' ' A' ' 125' ' ' LEU . 11.2 mt -66.08 116.58 5.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.7 -38.43 10.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.927 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.54 138.66 26.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.41 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.717 HG21 HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -106.03 122.12 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -118.87 134.59 55.06 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.243 -173.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 24.0 m-85 -116.65 135.38 53.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -170.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.4 m -139.87 110.92 6.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.291 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.44 47.1 0.26 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.857 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -83.16 77.44 9.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.136 0.493 . . . . 0.0 110.553 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.35 -37.48 19.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.918 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.8 m -141.6 -58.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.886 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -75.05 126.01 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -74.31 159.75 32.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.432 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -34.68 78.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.554 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.0 -38.33 90.68 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.9 mtp -70.98 -39.14 72.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -37.76 88.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.38 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 31.1 mttt -60.75 -44.01 97.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 110.937 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 13.8 tt0 -77.66 -27.68 50.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.338 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -66.86 -43.52 83.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.223 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -66.38 -34.0 76.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.802 174.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -63.36 -38.14 90.0 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -18.32 61.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.436 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.8 m -91.48 -13.87 31.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.546 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.37 -14.63 50.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.9 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.09 103.57 14.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.199 0.523 . . . . 0.0 110.242 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.521 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.04 174.92 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.747 -176.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 94' ' ' ILE . 45.5 t -68.77 125.16 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.425 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.67 -28.22 16.4 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.786 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.521 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -86.02 163.88 17.69 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 122.683 0.393 . . . . 0.0 110.413 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.403 ' CB ' ' HB2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -87.41 156.2 19.69 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.675 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -113.79 138.75 49.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.018 0.437 . . . . 0.0 111.126 -176.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.51 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 12.7 t0 -100.1 115.04 28.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.573 0.701 . . . . 0.0 110.529 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.458 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -72.31 -16.22 61.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.44 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.1 p -85.64 -24.0 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.082 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.51 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 20.3 p -90.75 2.76 55.73 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.603 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.1 mm -56.98 -37.54 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.398 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.19 99.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.815 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 -39.2 78.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.142 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.2 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.227 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -59.29 -45.55 90.98 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.024 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -37.16 86.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.49 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.59 -34.12 72.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.629 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 167' ' ' LEU . 5.0 mt -69.91 -35.95 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.55 0.175 . . . . 0.0 111.352 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -64.04 -36.71 84.88 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 110.116 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.59 -37.13 79.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.016 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -45.0 94.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.396 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -39.1 92.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.012 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -29.44 66.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.199 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.4 m -70.35 -27.09 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.467 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.1 t -73.94 -88.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.467 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.23 18.79 25.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.104 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt 65.9 44.66 2.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.492 0.717 . . . . 0.0 110.321 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -78.55 113.72 16.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.775 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.46 99.98 11.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.483 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.39 147.5 44.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.338 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.01 136.01 39.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.6 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.2 m -97.76 132.21 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.406 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 115.41 16.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.365 169.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.42 111.18 22.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.83 123.34 57.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.516 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.71 114.61 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 110.17 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.53 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 6.9 m -113.62 119.35 41.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.12 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.5 Cg_endo -86.23 139.55 6.15 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.255 2.637 . . . . 0.0 112.615 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 0.3 OUTLIER -114.88 142.03 27.77 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.225 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 36.3 Cg_exo -59.08 93.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 114.348 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.492 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.3 OUTLIER 176.3 -92.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.603 1.161 . . . . 0.0 108.391 175.192 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.492 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 13.4 p-10 -165.3 28.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 109.137 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.884 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -123.02 164.2 19.02 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.64 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.675 HG11 HD22 ' A' ' 125' ' ' LEU . 9.4 p -137.3 147.74 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.395 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.28 123.07 48.67 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.426 ' HB3' HG23 ' A' ' 97' ' ' ILE . 28.1 tp -102.24 114.35 28.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.581 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -110.21 131.09 55.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.884 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.524 HD11 HD13 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -109.03 112.89 25.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.56 -176.325 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.848 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.57 117.64 34.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.303 0.573 . . . . 0.0 110.33 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -98.38 140.82 32.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.53 48.46 0.94 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.057 0.456 . . . . 0.0 109.884 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.47 -70.21 1.35 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.683 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.46 145.03 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.711 0.291 . . . . 0.0 110.901 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.324 -0.532 0 CA-C-O 120.928 0.394 . . . . 0.0 111.488 -177.814 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.136 0.493 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.09 154.16 35.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.76 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.09 43.33 26.74 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -111.14 153.86 25.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.67 113.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.29 121.42 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.438 0.637 . . . . 0.0 110.791 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -84.37 -26.13 28.62 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.154 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' HB3' HG23 ' A' ' 83' ' ' THR . 27.0 t0 -158.44 154.01 26.15 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.509 HD12 HD21 ' A' ' 43' ' ' LEU . 86.9 mt -125.59 128.09 72.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.375 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.94 133.24 55.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.309 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.454 ' HD2' HG12 ' A' ' 39' ' ' VAL . 10.5 m-85 -118.47 135.15 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -113.6 -58.49 2.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.28 -4.95 90.37 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 -164.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.26 156.49 35.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.804 0.811 . . . . 0.0 112.525 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 1.4 tt0 -135.35 122.29 21.25 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.375 -1.284 . . . . 0.0 107.627 174.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER 83.17 -28.23 0.1 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.877 1.271 . . . . 0.0 111.176 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 t -79.54 122.82 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.981 0.42 . . . . 0.0 110.172 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.99 157.35 15.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.099 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.454 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.9 m -62.1 -29.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 O-C-N 123.647 0.592 . . . . 0.0 112.361 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.65 -40.47 85.75 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.687 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -74.48 -36.22 63.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.34 0.591 . . . . 0.0 110.357 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.58 87.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.91 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 29' ' ' ILE . 4.0 mt -58.74 -33.9 70.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.922 0.489 . . . . 0.0 112.207 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 41' ' ' ALA . 53.4 mt -74.15 -15.14 61.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.008 0.432 . . . . 0.0 111.335 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.01 -20.92 20.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.245 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.688 ' HG2' HG23 ' A' ' 62' ' ' THR . 91.0 mtp -81.75 146.04 55.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.259 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.59 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 6.1 Cg_exo -80.25 9.09 3.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.011 2.474 . . . . 0.0 112.458 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 154.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 16.6 mtm105 -130.63 173.73 10.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 111.275 -174.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 p -67.64 124.58 23.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.416 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -10.36 57.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.864 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -93.7 156.57 16.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 0.0 110.208 178.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.09 130.39 35.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.67 127.16 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.169 0.509 . . . . 0.0 110.912 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.446 ' O ' HD12 ' A' ' 59' ' ' ILE . 49.3 m-80 -97.31 179.38 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.399 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -30.83 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.241 0.543 . . . . 0.0 109.65 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.58 -33.42 75.87 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.495 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.96 -31.04 61.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.6 -50.76 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.72 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -69.64 -29.99 67.6 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.637 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 1.2 m-80 -72.22 -36.71 69.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.618 177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 46' ' ' MET . 74.5 m -60.48 -44.16 96.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.233 0.333 . . . . 0.0 110.273 171.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 60' ' ' SER . 32.1 mt -54.34 -53.02 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 123.351 0.407 . . . . 0.0 110.618 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 64' ' ' ARG . 1.2 tpt180 -65.72 -38.22 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 69' ' ' THR . . . -66.45 -48.14 70.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.442 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 86.4 mt -67.52 -29.92 69.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.15 99.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 110.081 172.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.12 -13.46 61.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.677 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 65' ' ' ALA . 30.2 p -78.93 -24.74 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.902 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.6 73.05 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.607 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -73.47 -44.13 58.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 109.99 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.442 ' HE1' ' HB3' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -124.03 154.83 39.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.692 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.724 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 5.3 mm-40 -72.1 -51.27 22.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.622 0.576 . . . . 0.0 111.956 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -129.61 146.42 51.41 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.77 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 88' ' ' VAL . 38.4 t -127.86 120.64 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.19 116.9 27.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.418 ' HB ' HG23 ' A' ' 59' ' ' ILE . 60.0 t -104.81 130.78 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.49 158.61 39.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -117.99 129.52 55.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.421 0.629 . . . . 0.0 110.404 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.2 95.86 4.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.695 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.34 -109.9 3.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.507 -174.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.31 14.38 19.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.372 0.606 . . . . 0.0 109.933 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -106.83 139.69 40.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -106.08 114.13 28.09 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.001 177.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -106.87 123.43 48.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 110.518 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -118.66 118.38 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.34 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -109.62 132.8 53.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 75' ' ' VAL . 4.5 m -125.56 162.46 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.218 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -98.37 110.52 23.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 0.3 OUTLIER -157.83 163.01 38.43 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.815 -173.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 43.6 mtp85 117.2 -57.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 126.476 2.36 . . . . 0.0 111.961 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 68.3 Cg_endo -73.41 139.41 28.75 Favored 'Trans proline' 0 C--N 1.362 1.265 0 CA-C-N 120.605 1.252 . . . . 0.0 112.308 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 45.3 m -124.87 133.31 53.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.616 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 125' ' ' LEU . 30.0 mt -68.61 117.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.2 -26.75 16.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.68 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.27 138.54 18.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.173 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.501 HG13 HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -109.23 121.38 62.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.853 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.3 OUTLIER -113.14 133.46 55.02 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.412 -175.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.696 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.2 m-85 -112.11 135.07 53.23 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.838 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.68 118.07 8.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.223 -173.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.07 18.34 56.03 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.334 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.545 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -85.15 93.39 8.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.589 . . . . 0.0 110.843 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.732 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -85.52 -46.09 11.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.251 -179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.2 -77.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.062 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.63 125.64 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -71.01 157.82 37.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.592 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -36.55 76.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.952 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.575 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 4.3 t0 -62.5 -38.47 90.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.481 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtt -73.34 -35.67 66.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -32.89 74.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.593 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.696 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -56.7 -44.84 81.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 176.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -28.3 53.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.388 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.66 -43.17 90.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.4 mm? -67.72 -35.83 79.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.781 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.85 -35.51 80.86 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.52 -23.09 58.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.874 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -17.82 31.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 0.0 110.199 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.05 -14.15 31.37 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.13 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.62 102.54 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.4 0.619 . . . . 0.0 110.604 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.74 176.45 9.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.128 -175.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 97' ' ' ILE . 70.7 t -67.29 127.42 28.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.374 0.607 . . . . 0.0 110.556 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.48 -10.28 62.96 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.925 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -111.45 166.09 11.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.724 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 1.4 m -75.72 162.34 28.3 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.266 177.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -132.18 145.15 51.16 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.512 0.196 . . . . 0.0 110.891 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -109.72 122.05 46.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.621 0.724 . . . . 0.0 111.319 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.444 ' HA ' HG12 ' A' ' 130' ' ' ILE . 6.9 mtp180 -73.02 -15.7 61.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.211 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.5 p -90.09 -17.25 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.1 m -84.32 -13.64 51.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.279 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 153' ' ' ALA . 6.5 mm -54.16 -40.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.065 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.71 99.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.012 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.424 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 0.6 OUTLIER -71.93 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 178.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 130' ' ' ILE . 52.0 mt -62.22 -46.76 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.942 0.401 . . . . 0.0 110.12 174.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.93 -49.83 74.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.309 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -65.3 -33.3 75.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.587 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 135' ' ' LYS . . . -68.09 -41.79 86.12 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.309 -0.472 . . . . 0.0 111.987 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.28 -33.0 72.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.404 0.145 . . . . 0.0 111.278 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -36.72 80.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.063 0.458 . . . . 0.0 110.683 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.13 -44.84 78.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.324 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -38.27 90.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.415 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.545 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -60.39 -43.53 96.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.209 0.528 . . . . 0.0 110.766 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -29.38 65.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.648 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.8 m -66.13 -28.16 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.738 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 4.3 t -78.28 -96.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 110.312 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -103.95 19.84 42.7 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.266 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.7 56.67 1.51 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -87.28 96.47 10.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.987 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.67 101.68 5.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.749 173.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.59 156.3 43.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.376 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.12 113.69 25.66 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.3 p -106.71 127.14 62.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.959 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.97 117.81 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.054 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -93.99 110.16 21.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.56 126.63 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.79 -173.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.05 112.33 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.191 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.5 m -104.82 117.57 58.48 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.855 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.04 141.26 20.83 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.258 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -115.79 154.81 48.16 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.478 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 22.2 Cg_exo -66.5 76.96 0.36 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.549 2.833 . . . . 0.0 113.523 -176.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.51 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -167.39 -115.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 15.6 p-10 -144.11 27.35 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.099 0.952 . . . . 0.0 108.512 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.458 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 11.9 mmt180 -122.59 155.1 37.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.641 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.409 HG21 HD22 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -134.18 157.59 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.6 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -109.93 122.95 48.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.317 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.0 tp -106.6 116.41 31.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.853 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 12.4 tttt -119.22 132.77 55.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.06 110.58 22.56 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.216 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 15.2 t -99.78 116.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.656 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.66 118.28 36.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.974 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -74.05 144.2 45.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.661 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.62 -44.67 26.9 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -172.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 154.79 -29.15 0.67 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.968 -1.111 . . . . 0.0 113.135 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 37.6 t 69.47 -78.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.691 0.796 . . . . 0.0 111.267 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.158 0.504 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -83.33 152.07 25.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.44 47.29 8.21 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -171.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' HZ ' HD12 ' A' ' 84' ' ' LEU . 6.5 p90 -107.49 153.27 23.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.876 -0.662 . . . . 0.0 110.219 -175.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.46 112.39 17.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.92 125.39 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.01 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -41.3 10.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.722 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HB3' HG23 ' A' ' 83' ' ' THR . 38.7 t70 -147.89 148.55 30.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.598 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -116.51 124.59 72.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.39 127.55 47.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.666 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 3.6 m-85 -101.92 115.8 31.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HG3' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -94.09 65.14 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.803 0.811 . . . . 0.0 110.733 -176.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.84 -87.49 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.519 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.666 ' HG ' ' HB3' ' A' ' 31' ' ' PHE . 18.6 mt 54.33 -165.47 0.09 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.898 0.879 . . . . 0.0 113.292 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.482 ' OE1' ' HD3' ' A' ' 92' ' ' PRO . 0.8 OUTLIER -175.13 -101.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.947 176.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -98.14 -1.59 41.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.012 0.434 . . . . 0.0 110.603 176.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.462 HG22 ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -90.21 132.55 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.41 175.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.16 157.44 15.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.472 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m -58.91 -30.99 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 123.779 0.674 . . . . 0.0 112.205 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.94 -35.08 61.64 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.354 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -76.25 -36.11 58.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.001 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.78 88.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.855 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -32.33 61.48 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.091 0.957 . . . . 0.0 113.088 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 41' ' ' ALA . 51.1 mt -70.98 -15.78 62.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -8.39 23.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.546 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.7 mtp -94.55 137.19 22.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.188 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.57 34.39 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.991 2.461 . . . . 0.0 112.255 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HB ' HG11 ' A' ' 54' ' ' VAL . 1.5 p -155.39 146.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.24 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' H ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -133.37 176.68 8.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.183 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.3 p -67.11 121.2 15.08 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.84 0.352 . . . . 0.0 110.17 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.44 47.99 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.456 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.6 t0 -82.84 156.48 23.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.619 0.247 . . . . 0.0 110.987 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -112.78 112.03 23.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.18 178.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.653 HG11 ' HB ' ' A' ' 48' ' ' VAL . 2.6 m -126.24 132.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.184 0.516 . . . . 0.0 112.343 -171.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.405 ' O ' HD12 ' A' ' 59' ' ' ILE . 10.2 m-20 -86.14 -177.27 6.23 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.067 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -61.16 -35.42 77.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.984 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -62.93 -37.44 87.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.203 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.757 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 1.3 m-20 -75.85 -29.04 58.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.585 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.78 -47.4 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 171.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.686 ' HA ' HD12 ' A' ' 63' ' ' ILE . 3.7 m -68.76 -30.05 68.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.389 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.757 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 8.9 m-20 -63.75 -45.32 90.38 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 109.825 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.7 m -58.48 -43.88 89.13 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.095 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' A' ' 60' ' ' SER . 65.2 mt -55.81 -50.9 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 123.39 0.431 . . . . 0.0 110.872 176.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -66.28 -36.03 81.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.89 -45.33 74.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.795 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HB2' HG11 ' A' ' 75' ' ' VAL . 83.9 mt -71.01 -29.03 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -39.5 92.66 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.231 0.539 . . . . 0.0 110.538 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.88 -9.48 58.4 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.406 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.0 p -76.68 -20.16 56.94 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -170.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.47 21.27 75.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.943 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -105.01 -89.28 0.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.07 135.1 34.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.418 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.771 ' HB3' ' HB2' ' A' ' 124' ' ' SER . 0.1 OUTLIER -77.63 -30.01 52.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.8 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 11.8 t70 -123.42 135.43 54.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.667 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 88' ' ' VAL . 64.2 t -132.51 118.46 35.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.567 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -120.37 120.61 36.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.389 0.614 . . . . 0.0 110.051 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.441 HG22 HG13 ' A' ' 86' ' ' VAL . 70.1 t -105.19 123.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.29 137.7 51.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -88.0 110.12 20.35 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.49 95.22 5.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.55 -120.89 20.85 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -104.42 12.94 32.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.255 0.55 . . . . 0.0 109.963 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.89 141.71 35.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.791 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.533 HD12 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.02 110.87 22.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD11 ' HG3' ' A' ' 32' ' ' GLU . 13.6 tp -100.08 112.42 24.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.199 -175.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.441 HG13 HG22 ' A' ' 77' ' ' VAL . 6.1 t -116.16 105.79 19.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.425 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.93 131.44 42.28 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 75' ' ' VAL . 3.5 m -125.73 149.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -114.89 124.11 50.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.936 -176.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 47.7 90.6 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.722 1.264 . . . . 0.0 113.85 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.479 ' HD2' ' OD1' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -71.73 -34.38 3.05 Favored Pre-proline 0 CA--C 1.561 1.37 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 177.207 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HD3' ' OE1' ' A' ' 35' ' ' GLN . 56.8 Cg_endo -70.06 141.89 45.16 Favored 'Trans proline' 0 C--N 1.372 1.794 0 CA-C-N 121.747 1.66 . . . . 0.0 114.065 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 17.9 m -91.29 135.81 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 125' ' ' LEU . 34.7 mt -65.58 118.31 7.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.63 -37.04 8.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.312 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.39 144.03 32.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.474 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -119.39 123.52 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.315 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.62 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -103.71 131.27 51.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.516 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -109.96 134.92 51.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.161 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.9 123.8 12.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.87 13.19 47.53 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.773 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -94.59 77.93 3.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.997 -178.159 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -40.77 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.336 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.9 m -75.97 -61.6 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.266 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.2 140.13 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 4.0 mmtm -70.46 151.95 44.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 111.224 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.5 -35.53 79.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.459 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -69.89 -34.74 73.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.68 177.205 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.493 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -65.65 -39.44 91.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 173.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -32.97 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.369 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -61.53 -41.74 97.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 176.541 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.99 -30.06 55.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -66.62 -40.61 88.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.473 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.474 ' CD2' HG21 ' A' ' 97' ' ' ILE . 2.3 mp -69.72 -36.88 76.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.723 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.601 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 1.5 mt-10 -63.34 -37.39 87.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.445 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 m -93.5 -14.53 26.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.024 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.49 -22.09 22.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.924 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.45 104.43 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.355 0.598 . . . . 0.0 111.156 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.601 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.85 173.76 11.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.694 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.78 123.8 23.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.665 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.74 -6.26 58.71 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.888 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.4 158.42 17.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.939 0.399 . . . . 0.0 110.452 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.771 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -80.32 144.08 33.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.478 176.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.591 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.23 144.59 25.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.782 0.325 . . . . 0.0 111.585 -172.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.49 106.0 16.3 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.331 0.586 . . . . 0.0 109.729 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -17.65 62.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.482 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.8 p -83.83 -23.25 31.46 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.425 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 p -98.41 2.28 47.7 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.338 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 130' ' ' ILE . 6.1 mm -58.04 -40.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.844 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.66 83.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.689 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.17 -31.72 68.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.345 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.61 -44.85 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.718 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 138' ' ' GLU . 94.4 mt-10 -59.36 -47.65 84.62 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.651 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -35.68 81.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.147 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.29 -38.04 81.16 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.289 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 137' ' ' LEU . 1.2 mm? -66.58 -39.91 88.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.368 . . . . 0.0 111.282 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 134' ' ' GLU . 84.0 mt-10 -56.14 -43.88 78.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.136 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -31.94 67.21 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -34.62 78.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.163 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.478 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -71.16 -36.0 71.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.752 177.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -71.25 -30.56 66.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.41 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -30.27 63.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 145' ' ' GLY . 1.4 p -79.65 -73.27 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.437 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.494 ' H ' HG13 ' A' ' 144' ' ' VAL . . . -113.73 17.72 20.3 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.964 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 61.11 44.5 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 110.559 -173.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.448 ' CE2' ' HA3' ' A' ' 145' ' ' GLY . 66.4 m-85 -88.83 136.14 33.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.243 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.81 128.96 41.92 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.06 143.79 48.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.783 0.325 . . . . 0.0 110.647 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.97 113.68 27.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.68 131.23 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.158 0.504 . . . . 0.0 111.753 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -128.49 117.29 21.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.961 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.55 112.02 24.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 0.0 110.69 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.82 118.5 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.653 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.63 114.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.7 m -116.11 120.76 34.78 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.596 ' HA ' HG12 ' A' ' 163' ' ' VAL . 74.4 Cg_endo -75.28 147.87 33.5 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.778 2.319 . . . . 0.0 113.155 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 1.3 pp -117.1 160.48 37.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 158' ' ' LEU . 52.6 Cg_endo -76.11 73.92 4.76 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.712 2.275 . . . . 0.0 114.105 -171.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.4 OUTLIER -166.73 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.648 173.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.479 ' OD1' ' HD2' ' A' ' 91' ' ' ARG . 2.5 t30 -136.43 25.39 3.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 12.1 mmt180 -131.05 161.03 32.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -171.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -132.74 155.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.085 175.031 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.17 125.52 54.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.151 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.0 tp -108.39 131.51 54.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.59 0.233 . . . . 0.0 110.538 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.62 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 37.8 tttt -122.6 133.55 54.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 0.0 111.261 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.91 109.69 21.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.76 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.64 119.36 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.495 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -109.21 117.8 35.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.807 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -89.85 129.22 36.25 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.84 42.13 0.9 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -169.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.75 -14.81 34.69 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 114.07 172.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.82 -40.6 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.679 1.192 . . . . 0.0 112.644 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.233 0.192 0 CA-C-N 117.825 0.284 . . . . 0.0 111.19 178.559 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.19 154.54 22.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.139 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.34 46.0 3.13 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.59 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 43.9 p90 -105.95 148.9 27.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.72 113.36 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 p -73.98 133.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.443 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -88.08 -42.92 12.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.56 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -147.21 144.92 29.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.726 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.492 HD12 HD21 ' A' ' 43' ' ' LEU . 63.6 mt -106.86 120.51 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.46 127.45 54.43 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.071 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.782 ' HD2' HG12 ' A' ' 39' ' ' VAL . 78.6 m-85 -107.77 130.5 54.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG3' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -109.36 -42.66 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -172.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.54 -33.34 43.5 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.198 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.604 HD21 ' HD1' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -96.05 121.62 38.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.877 0.37 . . . . 0.0 110.513 -177.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -107.2 -47.38 3.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.609 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -35.83 73.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.688 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 34' ' ' LEU . 3.6 t -78.44 125.6 38.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.18 157.95 16.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.782 HG12 ' HD2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -51.76 -38.75 22.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.659 -177.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -73.02 -40.75 50.58 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.683 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.25 78.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.37 72.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.673 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 29' ' ' ILE . 2.9 mt -57.64 -31.08 65.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.5 mt -62.79 -26.76 68.88 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 111.58 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.14 -13.53 43.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.893 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.4 mtp -90.26 138.48 27.18 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.481 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.47 16.0 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.882 2.388 . . . . 0.0 113.257 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 52' ' ' ASP . 1.2 p -153.73 147.02 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.406 ' HG2' HD22 ' A' ' 43' ' ' LEU . 57.0 mtt85 -123.28 177.7 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.922 0.489 . . . . 0.0 110.458 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 p -65.6 126.5 28.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.411 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.77 -6.66 35.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.452 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.6 t0 -96.28 158.47 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.459 . . . . 0.0 110.651 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 133.02 34.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.442 HG13 HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -125.97 128.98 72.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 112.007 -173.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 87.7 m-20 -97.67 -179.63 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.008 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.42 -32.62 74.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 109.838 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 7.5 tp10 -61.29 -37.77 84.37 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.434 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.37 -32.21 62.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.292 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -63.54 -46.13 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.046 0.451 . . . . 0.0 109.951 173.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -73.64 -26.88 60.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.254 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -70.76 -45.61 64.47 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.417 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.3 p -64.51 -38.58 91.51 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.031 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -55.35 -54.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.486 0.491 . . . . 0.0 110.42 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -70.78 -30.31 66.75 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.27 -46.95 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.661 0.267 . . . . 0.0 110.567 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' HG23 ' A' ' 69' ' ' THR . 75.4 mt -71.66 -29.63 64.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -39.25 91.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.558 . . . . 0.0 110.48 173.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.41 -12.35 61.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.117 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 66' ' ' LEU . 21.9 p -78.17 -24.47 47.23 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.978 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.42 7.73 83.01 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.454 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -83.41 -20.61 33.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 165.97 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.725 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 3.4 tm-20 -83.91 -50.49 8.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -136.65 137.72 40.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.817 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.79 120.51 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.74 0.305 . . . . 0.0 110.427 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -118.26 118.96 33.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.044 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.5 t -107.9 123.46 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.802 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.99 158.34 41.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -111.39 141.1 45.37 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.642 178.365 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -126.92 95.8 4.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.85 -109.68 3.02 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 14.28 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.292 0.567 . . . . 0.0 110.048 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.678 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.46 111.86 24.5 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.45 HD11 ' HG3' ' A' ' 32' ' ' GLU . 16.6 tp -101.73 116.74 33.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.4 t -107.69 110.16 30.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.362 0.601 . . . . 0.0 110.491 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 27.3 mt-30 -106.16 134.37 49.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.45 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.22 155.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.377 0.608 . . . . 0.0 110.995 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -100.69 133.12 45.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.877 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER 61.97 -167.83 0.2 Allowed 'General case' 0 C--O 1.236 0.375 0 O-C-N 124.266 0.979 . . . . 0.0 113.165 176.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.528 ' H ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -174.54 -45.11 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.328 -175.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 46.0 Cg_endo -69.65 140.68 43.69 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 121.161 1.241 . . . . 0.0 113.396 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 80.6 m -97.92 144.48 27.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.742 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 125' ' ' LEU . 35.8 mt -69.59 117.98 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.59 -35.18 8.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.883 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -149.14 143.56 26.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.432 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.529 HG21 ' CD1' ' A' ' 114' ' ' LEU . 3.1 mt -117.11 124.04 72.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 172.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.558 ' HB ' ' HD3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -106.16 136.03 46.59 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 -176.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -114.85 135.29 54.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.9 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.465 ' OG ' ' HD2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -142.69 128.35 19.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.739 178.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.68 15.02 62.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.728 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -105.23 63.13 0.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -88.1 -21.87 24.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -51.63 23.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.088 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t -109.38 141.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.89 145.98 53.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.859 0.361 . . . . 0.0 111.577 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.853 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -60.28 -35.59 75.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.76 177.094 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.1 -45.36 75.46 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.967 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -43.23 77.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.451 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.853 HD12 ' HA ' ' A' ' 107' ' ' ASP . 4.2 mt -64.64 -33.28 75.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -44.72 96.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.971 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -27.95 45.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.896 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.5 -38.63 90.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.057 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.529 ' CD1' HG21 ' A' ' 97' ' ' ILE . 17.2 mt -66.4 -36.04 81.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.641 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -63.93 -39.45 94.19 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.772 178.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.96 -16.48 60.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.48 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -88.7 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.381 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.81 -25.05 9.79 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.256 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.51 104.2 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.877 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.641 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -132.13 168.19 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.792 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -72.07 129.03 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.461 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.63 -6.3 74.08 Favored Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.835 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.98 145.2 40.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.725 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -66.33 143.13 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.328 178.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.551 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.76 146.33 23.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.156 0.503 . . . . 0.0 111.981 -170.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -107.45 96.35 6.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.152 171.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.431 ' HD3' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -71.89 -14.28 61.9 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.472 -178.397 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.431 HG23 ' HD3' ' A' ' 127' ' ' ARG . 34.2 p -90.53 -28.19 18.67 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.786 0.803 . . . . 0.0 108.897 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 m -95.13 6.4 49.15 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.51 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 130' ' ' ILE . 2.8 mm -58.35 -35.26 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.006 176.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.31 -35.91 78.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.686 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.22 -38.94 89.13 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.0 -42.64 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.347 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.9 -48.47 79.78 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.0 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -34.82 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.01 -36.96 91.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.523 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.49 -32.65 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 110.988 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -66.78 -43.05 85.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.614 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -31.43 70.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.771 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.1 t80 -60.34 -46.51 89.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.624 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.79 -36.46 83.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.824 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.37 -34.41 77.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.87 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.8 m -71.59 -30.08 65.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 140' ' ' PHE . 19.3 t -78.76 -86.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.786 0.326 . . . . 0.0 111.294 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.68 18.14 24.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.934 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.6 mttp 60.49 47.2 8.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.548 0.689 . . . . 0.0 109.667 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -74.8 123.47 25.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.731 -175.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.728 ' HB2' ' HA2' ' A' ' 172' ' ' GLY . 0.9 OUTLIER -81.64 131.87 35.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.706 177.298 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -153.33 143.65 22.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.255 0.55 . . . . 0.0 110.975 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.23 114.06 24.73 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 170.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.29 134.48 45.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.546 0.689 . . . . 0.0 112.108 -167.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -130.48 116.54 18.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.244 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.66 111.53 23.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.18 0.514 . . . . 0.0 109.963 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.21 121.7 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.35 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.93 128.0 52.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.7 m -120.0 121.27 29.72 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.433 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 1.1 Cg_endo -85.72 147.0 9.48 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.407 2.738 . . . . 0.0 113.325 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.657 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -105.07 159.99 27.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.927 172.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.47 65.64 2.21 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.432 2.754 . . . . 0.0 114.121 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.54 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -164.83 -113.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 9.6 p-10 -144.72 53.12 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.565 0.698 . . . . 0.0 110.735 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.657 ' HB2' HD11 ' A' ' 158' ' ' LEU . 1.6 mpp_? -143.12 159.91 41.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.456 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -132.33 153.03 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.377 178.502 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.81 124.96 53.03 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 43.3 tp -104.58 117.45 34.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.555 -172.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.558 ' HD3' ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -104.53 131.52 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.325 0.584 . . . . 0.0 110.809 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.556 HD12 ' HE2' ' A' ' 169' ' ' PHE . 1.2 mm? -106.39 109.74 21.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.288 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.39 111.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.34 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.556 ' HE2' HD12 ' A' ' 167' ' ' LEU . 6.0 m-85 -104.98 118.28 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 19.8 mm-40 -89.63 121.13 31.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -72.2 112.36 8.22 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.653 0.595 . . . . 0.0 110.908 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.728 ' HA2' ' HB2' ' A' ' 148' ' ' SER . . . 92.67 -136.67 13.3 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.644 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.6 t 60.8 -90.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.834 0.854 . . . . 0.0 111.662 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.346 0.594 . . . . 0.0 112.47 -172.591 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.347 0.594 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -140.58 146.9 38.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.789 . . . . 0.0 108.948 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.66 49.02 39.28 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -170.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -110.41 154.58 23.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.501 . . . . 0.0 110.715 -174.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.17 117.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.426 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.37 122.33 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.51 0.672 . . . . 0.0 110.667 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -95.6 -22.77 17.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.158 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HB3' HG23 ' A' ' 83' ' ' THR . 8.0 t70 -152.41 139.06 18.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.969 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 mt -118.46 123.36 71.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.989 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.472 ' HB3' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -121.21 133.2 55.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.188 -177.134 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -104.95 136.9 43.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.037 0.446 . . . . 0.0 110.802 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 1.7 mt-10 -119.32 70.39 0.84 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.92 -16.9 0.22 Allowed Glycine 0 C--N 1.32 -0.329 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.957 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 34' ' ' LEU . 7.1 mt -59.59 125.2 22.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.634 0.254 . . . . 0.0 111.03 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.76 29.73 1.52 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.365 -175.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.43 -51.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.225 0.536 . . . . 0.0 109.634 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HB ' HD22 ' A' ' 34' ' ' LEU . 3.5 t -79.56 141.22 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.398 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.67 157.91 16.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.692 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -32.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.707 0.63 . . . . 0.0 112.618 -174.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.29 -37.17 63.25 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.227 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.49 66.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.167 0.508 . . . . 0.0 110.428 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.73 72.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 46' ' ' MET . 0.7 OUTLIER -55.88 -32.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.664 0.786 . . . . 0.0 112.811 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.06 -14.14 61.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -7.98 38.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.5 ' HB3' HG22 ' A' ' 62' ' ' THR . 1.8 mtm -94.01 133.61 27.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HG3' ' HB3' ' A' ' 61' ' ' ASN . 30.6 Cg_endo -64.91 -28.56 58.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.849 2.366 . . . . 0.0 112.653 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.21 149.58 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.158 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.0 177.87 7.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.591 -174.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.4 p -68.22 121.08 15.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.539 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.54 -6.58 52.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.142 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.74 157.05 16.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.932 0.396 . . . . 0.0 110.887 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.06 136.9 32.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.163 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.55 130.23 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.284 0.564 . . . . 0.0 111.244 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -97.77 -177.07 3.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.964 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -63.91 -27.37 69.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.04 -30.98 65.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.564 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 36.1 m-20 -75.94 -28.83 58.12 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.275 0.23 . . . . 0.0 111.08 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -47.47 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 171.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.419 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.0 m -70.14 -27.63 64.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.708 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.2 m-20 -68.91 -45.26 71.33 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.5 HG22 ' HB3' ' A' ' 46' ' ' MET . 0.9 OUTLIER -63.32 -40.12 96.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.719 175.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 60' ' ' SER . 56.7 mt -55.21 -55.38 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 123.61 0.569 . . . . 0.0 111.128 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -69.26 -31.01 69.26 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 69' ' ' THR . . . -69.01 -50.38 49.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.44 0.162 . . . . 0.0 110.746 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 75' ' ' VAL . 50.8 mt -68.34 -30.44 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.049 0.452 . . . . 0.0 110.313 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.12 -12.52 61.75 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.122 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 65' ' ' ALA . 22.3 p -78.89 -22.54 45.78 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.137 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 19.2 76.71 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.351 -0.452 . . . . 0.0 113.138 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -89.76 -28.7 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.606 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 162.34 28.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.816 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -84.73 -37.93 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -140.5 144.6 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 66' ' ' LEU . 48.3 t -128.63 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 119.53 33.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.361 177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 86' ' ' VAL . 84.1 t -106.11 124.29 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.044 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.0 146.13 47.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -107.76 132.7 53.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.77 95.2 3.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.043 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.95 2.48 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.035 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -106.24 2.1 26.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.006 0.522 . . . . 0.0 110.901 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.492 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -106.66 132.91 52.11 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.75 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.0 113.09 26.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.814 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 30' ' ' HIS . 3.5 tp -102.86 112.24 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.406 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.509 HG13 HG22 ' A' ' 77' ' ' VAL . 15.2 t -110.08 106.22 20.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.546 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 6.6 mt-30 -92.91 136.18 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.49 142.87 41.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.126 0.489 . . . . 0.0 110.243 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.686 ' HD3' ' HG2' ' A' ' 90' ' ' GLU . 0.3 OUTLIER -100.26 143.32 30.6 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.915 -175.041 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.686 ' HG2' ' HD3' ' A' ' 89' ' ' LYS . 3.1 mm-40 73.19 -174.03 0.15 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 124.846 1.342 . . . . 0.0 112.261 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.543 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 6.0 ttt180 -171.34 -56.38 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.258 -170.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 91' ' ' ARG . 1.9 Cg_endo -81.29 141.7 12.93 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.815 1.676 . . . . 0.0 113.482 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 5.1 m -97.69 133.51 42.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.2 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.5 mt -71.95 117.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.56 -33.17 11.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.036 0.446 . . . . 0.0 110.555 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -147.26 143.08 27.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.446 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.699 HG21 HD22 ' A' ' 114' ' ' LEU . 1.3 mt -115.65 123.0 70.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.605 ' HB ' ' HE3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -122.42 132.86 54.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.243 0.545 . . . . 0.0 110.773 -175.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.515 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 21.3 m-85 -111.23 135.25 52.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.376 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.73 120.25 18.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.37 29.73 9.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.116 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 2.8 p-10 -107.98 63.93 0.62 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.562 0.696 . . . . 0.0 110.566 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -85.16 -17.34 37.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.091 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -93.04 -52.03 4.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 31.7 t -108.03 128.92 63.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 11.1 mmmt -69.95 149.4 47.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -170.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -35.13 69.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.729 173.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.78 -43.94 90.56 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.0 mtp -69.1 -41.2 77.76 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.45 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -36.72 80.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.861 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -46.17 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.135 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -28.73 55.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.172 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.29 -46.87 86.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.261 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.699 HD22 HG21 ' A' ' 97' ' ' ILE . 1.9 mp -66.25 -40.63 90.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.014 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.695 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 7.6 mt-10 -60.32 -42.42 95.57 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.402 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.13 -22.15 60.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.703 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -87.93 -16.86 32.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.73 -24.97 6.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.805 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.99 104.7 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.185 0.517 . . . . 0.0 111.641 -174.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.695 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.66 176.47 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.553 178.116 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 94' ' ' ILE . 44.7 t -68.34 125.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.251 0.548 . . . . 0.0 111.593 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.82 61.93 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.127 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.28 155.26 21.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 110.699 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.21 133.82 42.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.507 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -92.22 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.281 0.562 . . . . 0.0 111.061 -173.447 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -110.01 102.48 11.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.858 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.406 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -71.16 -15.75 62.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.74 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -84.13 -18.37 37.02 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.549 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.51 -0.75 45.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 130' ' ' ILE . 4.9 mm -59.33 -35.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.499 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.58 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.559 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.21 -28.55 60.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.804 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.29 -43.36 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.957 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.63 -42.01 99.34 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.61 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -41.75 98.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.157 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.62 93.05 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.635 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.595 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 18.2 mt -74.09 -32.43 63.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.586 0.231 . . . . 0.0 111.112 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.01 -40.91 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.207 175.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.51 -39.87 88.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.552 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -43.18 99.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -41.66 91.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.362 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -32.31 66.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.5 m -71.35 -32.25 68.31 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.619 HG13 ' H ' ' A' ' 145' ' ' GLY . 1.9 p -76.0 -77.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.647 -175.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.619 ' H ' HG13 ' A' ' 144' ' ' VAL . . . -114.21 17.49 19.29 Favored Glycine 0 N--CA 1.454 -0.107 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.768 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 55.71 58.63 4.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.569 0.699 . . . . 0.0 110.816 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -92.86 111.54 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.5 98.7 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -107.63 145.27 33.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.048 0.451 . . . . 0.0 111.579 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.29 114.14 26.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 171.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.92 124.58 57.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.15 0.5 . . . . 0.0 111.469 -171.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -130.9 117.02 18.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.492 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.86 112.47 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.427 0.632 . . . . 0.0 110.117 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.26 119.71 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.077 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -99.6 112.14 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 m -104.23 117.42 59.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.533 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 163' ' ' VAL . 88.5 Cg_endo -80.31 137.46 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.2 2.6 . . . . 0.0 113.406 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 1.2 pp -104.82 143.67 27.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 169.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 22.2 Cg_exo -65.28 80.91 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.704 2.936 . . . . 0.0 115.018 -168.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -169.32 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.786 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -163.03 22.64 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.441 0.639 . . . . 0.0 109.944 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.498 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -128.23 155.8 43.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 -174.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 157' ' ' PRO . 3.7 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.683 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.25 131.74 55.33 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.435 ' HB3' HG23 ' A' ' 97' ' ' ILE . 21.9 tp -99.55 114.15 26.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.831 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.605 ' HE3' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.524 0.678 . . . . 0.0 111.138 -177.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.515 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -110.43 109.54 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.129 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.15 111.76 31.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.115 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.595 ' HZ ' HD13 ' A' ' 137' ' ' LEU . 15.2 m-30 -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.766 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -105.33 114.42 28.59 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.15 102.53 15.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.066 0.46 . . . . 0.0 111.909 -170.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 173' ' ' VAL . . . 81.83 -84.03 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.519 175.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 172' ' ' GLY . 1.9 m 62.15 -51.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.203 1.801 . . . . 0.0 113.815 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.455 -0.203 0 CA-C-N 118.514 0.597 . . . . 0.0 111.32 -178.612 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.79 0.329 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.31 171.83 7.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.126 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.26 46.72 7.36 Favored Glycine 0 CA--C 1.506 -0.482 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HZ ' ' HB2' ' A' ' 79' ' ' ARG . 48.3 p90 -112.55 154.39 26.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.967 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.2 t -77.44 113.52 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -76.17 124.1 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.469 0.652 . . . . 0.0 109.952 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -88.95 -36.66 15.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.642 -176.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -144.31 143.46 31.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.154 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 85.2 mt -104.62 121.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -111.32 126.38 54.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -106.15 115.61 30.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.477 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 tt0 -102.68 68.4 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.405 0.622 . . . . 0.0 110.056 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.62 -109.82 0.34 Allowed Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.589 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.684 ' H ' HG23 ' A' ' 88' ' ' VAL . 94.2 mt 56.62 -156.86 0.28 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.495 0.718 . . . . 0.0 112.033 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.43 ' H ' ' HB3' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -169.98 -82.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.712 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 35' ' ' GLN . 7.4 ttm-85 -118.76 11.54 12.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.406 0.622 . . . . 0.0 109.983 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.84 124.2 47.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.699 173.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.12 157.66 19.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.716 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -60.83 -29.13 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.27 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.93 -35.72 57.91 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.265 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -75.81 -34.61 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.351 0.596 . . . . 0.0 110.27 177.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.09 73.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.592 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mt -60.08 -31.73 70.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.211 0.604 . . . . 0.0 112.073 172.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 41' ' ' ALA . 90.4 mt -69.24 -21.74 63.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.21 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 m -88.28 -19.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.036 0.446 . . . . 0.0 110.285 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.521 ' HG2' HG23 ' A' ' 62' ' ' THR . 68.0 mtp -82.65 138.68 43.94 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.853 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 10.8 Cg_exo -73.5 -14.88 24.94 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.931 2.421 . . . . 0.0 112.586 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.506 HG11 HG12 ' A' ' 54' ' ' VAL . 29.3 m -114.93 167.77 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.117 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 4.9 mmt85 -129.12 174.24 9.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.918 0.389 . . . . 0.0 110.456 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.1 p -67.96 122.88 19.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.994 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -5.35 44.29 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.059 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -76.14 155.15 34.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -92.84 113.01 25.17 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.506 HG12 HG11 ' A' ' 48' ' ' VAL . 5.7 m -116.75 127.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.586 -165.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.42 ' O ' HD12 ' A' ' 59' ' ' ILE . 16.2 m-80 -98.85 -178.09 3.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.312 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -28.98 70.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 10.9 tt0 -64.05 -44.27 92.97 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.006 175.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.01 -34.83 75.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.227 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -62.18 -50.96 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 123.153 0.283 . . . . 0.0 110.286 175.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.622 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.1 m -67.89 -35.27 78.2 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.436 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 6.9 t-20 -63.79 -45.37 90.03 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.449 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.521 HG23 ' HG2' ' A' ' 46' ' ' MET . 90.5 m -59.01 -42.58 90.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.416 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 60' ' ' SER . 71.2 mt -55.55 -56.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 123.318 0.386 . . . . 0.0 111.223 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 -70.29 -28.46 65.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.05 -52.72 61.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.06 -31.79 72.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.672 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -33.8 76.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.792 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.68 -12.77 61.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.541 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 p -78.73 -24.95 44.59 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.763 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.48 65.43 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.82 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.04 4.68 15.78 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.18 0.49 . . . . 0.0 111.007 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.9 163.91 26.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 166.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -87.15 -46.01 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 110.192 177.467 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 33.9 t70 -129.54 136.82 50.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.423 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.9 117.99 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 119.51 32.83 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 174.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.653 HG22 HG13 ' A' ' 86' ' ' VAL . 54.9 t -111.78 121.08 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.05 136.99 42.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -93.43 136.39 33.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.986 0.422 . . . . 0.0 110.029 178.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -126.61 95.38 4.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.99 -109.52 2.84 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.373 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.425 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 15.0 p-10 -106.21 10.96 31.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.164 0.507 . . . . 0.0 111.001 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.87 141.34 46.81 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.624 -177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -103.74 114.85 29.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 176.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tp -107.54 112.81 25.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.48 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.653 HG13 HG22 ' A' ' 77' ' ' VAL . 7.3 t -112.79 111.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.291 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.477 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 5.3 mt-30 -104.74 128.72 52.93 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.684 HG23 ' H ' ' A' ' 34' ' ' LEU . 1.8 m -125.4 141.8 44.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.661 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 44.6 tttt -100.67 112.88 25.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.732 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.27 174.59 0.26 Allowed 'General case' 0 CA--C 1.549 0.926 0 O-C-N 124.542 1.151 . . . . 0.0 112.051 172.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.491 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -143.34 -60.19 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -175.442 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 2.9 Cg_exo -76.08 139.1 21.24 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 121.523 1.482 . . . . 0.0 113.891 -174.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 50.3 m -89.39 136.21 33.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.53 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 125' ' ' LEU . 35.7 mt -62.46 117.48 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.54 -27.79 13.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.827 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.4 149.87 22.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 114' ' ' LEU . 3.7 mt -123.79 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.86 148.06 52.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.881 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.616 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 25.6 m-85 -120.43 153.63 36.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.104 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.58 143.75 23.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.759 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.63 73.41 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.32 -0.467 . . . . 0.0 114.199 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.5 OUTLIER -101.42 81.51 2.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.393 0.616 . . . . 0.0 110.532 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -86.14 -34.68 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.931 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -56.38 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.993 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -92.62 159.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.987 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' A' ' 106' ' ' LYS . 2.4 mmmm -88.23 145.52 25.84 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.259 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.616 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 15.6 p-10 -66.74 -34.71 78.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.761 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.606 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 16.6 t70 -58.92 -38.35 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.089 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -42.77 68.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.405 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.19 -32.48 68.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.02 0.528 . . . . 0.0 111.959 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.606 ' HD3' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -58.63 -47.96 82.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.226 178.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.9 -28.58 49.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -36.46 83.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.551 HD12 HG21 ' A' ' 97' ' ' ILE . 11.6 mt -74.19 -38.92 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.723 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -61.99 -31.89 72.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.409 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.71 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.605 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -16.72 34.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.875 0.369 . . . . 0.0 110.267 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.86 -21.76 8.87 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.47 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.68 108.12 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.282 0.563 . . . . 0.0 111.303 -176.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.723 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.28 172.15 13.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' A' ' 94' ' ' ILE . 48.4 t -71.62 127.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.062 0.458 . . . . 0.0 110.503 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.53 -20.96 48.25 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.059 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -82.51 163.8 21.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.257 0.551 . . . . 0.0 110.628 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 73' ' ' GLU . 63.3 m -85.21 151.17 24.29 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.535 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -104.8 143.83 32.59 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.695 0.76 . . . . 0.0 111.607 -172.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.588 ' HB3' HG22 ' A' ' 129' ' ' THR . 9.7 t0 -104.65 98.09 7.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.397 176.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.572 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.85 -15.59 62.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.648 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.0 p -83.32 -17.88 40.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.085 0.469 . . . . 0.0 110.363 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 126' ' ' ASP . 0.8 OUTLIER -103.11 6.72 38.69 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 176.07 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.572 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.6 mm -61.45 -39.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.36 78.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.188 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -33.12 70.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.066 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 mt -68.55 -47.19 78.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.112 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.59 -41.73 98.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.966 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -37.12 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.026 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.09 -37.8 87.63 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.529 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 44.4 mt -74.45 -32.0 62.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.675 0.274 . . . . 0.0 111.066 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -37.65 75.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 110.039 175.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.97 -33.22 75.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.559 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.476 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.6 t80 -64.78 -45.42 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.525 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 2.1 m-85 -63.02 -37.1 85.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.2 t80 -68.13 -35.59 78.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.254 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.03 -31.24 69.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.688 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 140' ' ' PHE . 7.9 t -74.57 -91.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.77 0.319 . . . . 0.0 110.338 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.92 18.39 24.16 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.094 -177.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.767 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 58.92 50.32 8.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.357 0.598 . . . . 0.0 110.045 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -80.19 119.64 23.23 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.403 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.94 99.11 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.82 43.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.439 0.637 . . . . 0.0 111.382 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.71 113.06 24.98 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.8 p -108.16 127.44 64.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.439 0.638 . . . . 0.0 110.519 -174.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.91 116.84 20.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.542 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.94 110.58 22.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.17 124.91 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.906 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.58 113.97 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.318 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.0 m -104.41 115.27 63.19 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.799 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.65 127.42 9.57 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.919 2.412 . . . . 0.0 112.618 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -105.79 150.9 39.71 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 171.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.49 79.74 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.463 2.776 . . . . 0.0 113.967 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.432 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -171.21 -104.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.583 0.753 . . . . 0.0 109.348 177.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 16.5 p-10 -157.5 34.92 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HB2' HD11 ' A' ' 158' ' ' LEU . 1.5 mmt85 -133.78 155.3 50.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.877 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -127.6 151.52 34.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.812 177.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.63 118.88 37.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.86 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.1 tp -96.82 121.05 38.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.44 132.49 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.433 0.635 . . . . 0.0 111.044 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.609 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.0 mm? -105.61 111.48 24.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.834 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 21.6 t -99.54 120.41 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -116.06 118.94 34.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.75 120.3 29.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.47 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.54 134.45 54.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.667 0.27 . . . . 0.0 110.446 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 140.87 -78.67 0.29 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.533 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.808 HG13 ' H ' ' A' ' 174' ' ' SER . 10.2 p 41.19 -103.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 125.164 1.386 . . . . 0.0 112.865 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.808 ' H ' HG13 ' A' ' 173' ' ' VAL . 60.3 m . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 119.096 0.862 . . . . 0.0 110.99 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -96.8 21.83 9.02 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.07 77.37 1.93 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -97.39 152.5 18.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.3 t -85.66 122.65 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.67 124.28 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.588 0.709 . . . . 0.0 110.689 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -80.31 -26.93 38.57 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.387 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -162.51 149.45 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.453 HD12 HD21 ' A' ' 43' ' ' LEU . 58.7 mt -112.99 121.54 65.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.9 t-160 -116.77 127.22 54.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.644 ' HB3' HD21 ' A' ' 34' ' ' LEU . 19.5 m-85 -106.68 136.72 46.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -131.32 167.7 18.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.63 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.95 -33.19 2.89 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.348 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.644 HD21 ' HB3' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -84.07 150.21 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -101.16 -63.76 1.11 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.776 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -109.66 31.62 5.67 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 111.772 -174.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' HB ' HD22 ' A' ' 34' ' ' LEU . 3.7 t -108.72 112.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.66 156.15 27.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.125 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.567 HG12 ' HD2' ' A' ' 31' ' ' PHE . 2.7 m -66.48 -27.57 40.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.914 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.69 -36.97 61.8 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.134 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -76.47 -34.42 58.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.547 0.689 . . . . 0.0 110.157 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.57 68.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.997 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.684 HD22 ' HD2' ' A' ' 49' ' ' ARG . 5.1 mt -57.14 -31.29 65.21 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.356 0.662 . . . . 0.0 112.532 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 41' ' ' ALA . 67.1 mt -66.48 -22.31 66.19 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.565 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.57 -8.3 26.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.562 ' HG2' HG23 ' A' ' 62' ' ' THR . 30.9 mtp -83.54 143.25 43.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.204 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.74 -3.56 13.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.512 2.142 . . . . 0.0 113.334 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -139.58 163.79 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.684 ' HD2' HD22 ' A' ' 43' ' ' LEU . 9.6 mmm180 -120.31 176.06 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.936 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 p -66.94 132.92 48.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.61 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.37 -5.7 77.83 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.638 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 156.64 18.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.881 0.372 . . . . 0.0 111.081 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 125.1 30.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.322 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 HG11 ' A' ' 48' ' ' VAL . 20.9 m -123.14 137.22 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.705 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -97.49 178.54 5.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.026 0.441 . . . . 0.0 110.804 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -27.17 63.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.53 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -29.44 64.67 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.36 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 42.3 m-20 -73.91 -29.2 61.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.524 175.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.87 -49.34 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.719 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -64.75 -36.36 84.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 176.469 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -64.06 -42.33 97.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 178.252 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.562 HG23 ' HG2' ' A' ' 46' ' ' MET . 54.0 m -60.04 -42.55 94.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 60' ' ' SER . 55.3 mt -55.62 -49.3 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.53 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -36.43 82.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.027 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.11 66.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.623 HD22 ' HE1' ' A' ' 72' ' ' PHE . 89.9 mt -71.08 -28.31 64.24 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.224 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -45.23 66.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.63 -15.79 59.73 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 66' ' ' LEU . 9.7 t -80.78 -24.29 38.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.35 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.5 1.65 90.17 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 164.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.12 -6.33 59.3 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.945 0.872 . . . . 0.0 111.698 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.623 ' HE1' HD22 ' A' ' 66' ' ' LEU . 14.2 m-85 -124.43 159.14 31.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HG2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -91.75 -36.95 13.28 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.887 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 26.7 t0 -137.73 140.97 41.0 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 66' ' ' LEU . 49.1 t -128.17 119.84 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.892 0.377 . . . . 0.0 110.5 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.7 118.13 30.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.877 173.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.578 HG22 HG13 ' A' ' 86' ' ' VAL . 61.4 t -106.95 122.34 60.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.81 137.97 37.12 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.8 137.15 36.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.407 0.622 . . . . 0.0 110.82 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -113.99 95.31 5.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.74 -109.37 2.87 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.483 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.29 11.02 21.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.239 0.542 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.86 139.57 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.724 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -104.8 114.89 29.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.487 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 20.6 tp -109.23 115.11 29.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.233 0.54 . . . . 0.0 110.453 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.578 HG13 HG22 ' A' ' 77' ' ' VAL . 19.0 t -106.25 108.24 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.351 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.505 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 73.5 mt-30 -97.06 126.38 42.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.41 150.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.85 0.834 . . . . 0.0 111.159 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.463 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 16.4 tttm -108.38 130.76 55.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.149 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.541 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 2.4 tp10 73.33 151.12 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.475 1.109 . . . . 0.0 111.956 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.67 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 5.8 tpt180 -155.22 -53.87 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.703 175.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 91' ' ' ARG . 9.6 Cg_endo -90.63 137.24 2.34 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.246 1.298 . . . . 0.0 111.344 171.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.9 m -96.36 147.72 23.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.194 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.649 HG13 ' HB2' ' A' ' 125' ' ' LEU . 42.4 mt -58.12 118.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 162' ' ' ARG . . . -105.82 -38.24 6.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.183 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.97 27.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.487 HG12 HD21 ' A' ' 165' ' ' LEU . 1.2 mt -114.83 123.69 70.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 168.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.88 135.4 54.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -176.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.1 m-85 -111.45 135.47 51.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -141.93 112.11 6.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.877 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.695 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 178.96 -60.12 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.911 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.467 ' HB2' ' OH ' ' A' ' 141' ' ' TYR . 0.7 OUTLIER -153.6 148.41 26.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.122 0.487 . . . . 0.0 111.957 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -86.52 -13.01 47.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.903 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.586 ' HB3' HG11 ' A' ' 144' ' ' VAL . 54.0 m -58.35 -50.85 72.18 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.706 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p -87.31 137.68 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -78.63 143.33 36.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.234 -174.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.445 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -67.68 -33.95 75.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.106 177.058 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -30.79 71.84 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.568 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 106' ' ' LYS . 29.6 mtp -73.03 -46.07 54.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.413 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.55 HD22 HD22 ' A' ' 137' ' ' LEU . 4.5 mt -63.22 -31.87 73.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -59.31 -43.4 92.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 111.019 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.97 -28.81 58.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.364 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.63 -43.98 91.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.245 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.421 HD22 HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -65.34 -36.82 85.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.917 175.071 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -31.42 72.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.56 61.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.547 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.0 m -84.66 -16.83 40.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 110.178 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 106.07 1.28 38.83 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.269 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -103.01 117.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.183 0.516 . . . . 0.0 110.863 -177.103 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.69 170.5 15.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.222 -177.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.8 t -71.73 126.3 31.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.982 0.42 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.84 -5.91 79.42 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.943 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.9 OUTLIER -106.47 154.59 20.62 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.508 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 1.5 m -57.12 139.34 52.75 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.537 0.523 . . . . 0.0 111.524 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.649 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.92 145.33 25.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.322 0.582 . . . . 0.0 111.183 -175.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.534 ' HA ' ' NH1' ' A' ' 127' ' ' ARG . 26.2 t0 -117.77 111.58 19.28 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.716 0.77 . . . . 0.0 111.243 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.534 ' NH1' ' HA ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -71.2 -15.23 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.051 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.4 p -89.72 -15.43 32.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.741 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -92.73 2.49 56.71 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.929 175.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 130' ' ' ILE . 7.1 mm -59.8 -41.32 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.924 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.39 86.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.816 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.33 -41.63 96.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.115 0.483 . . . . 0.0 109.732 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 10.7 mt -63.55 -45.99 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.479 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -60.37 -49.45 77.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 2.9 tptp -61.95 -40.28 94.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.27 65.84 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.843 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.55 HD22 HD22 ' A' ' 110' ' ' LEU . 12.7 mt -74.01 -32.64 63.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.632 0.253 . . . . 0.0 110.985 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.744 ' HG3' HG12 ' A' ' 151' ' ' VAL . 52.9 mt-10 -67.04 -37.47 84.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 174.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -31.29 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.456 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -66.41 -36.93 84.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.467 ' OH ' ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -62.64 -35.72 80.52 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 177.322 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -69.35 -34.52 74.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.651 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.29 66.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 104' ' ' SER . 12.4 t -74.87 -86.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.76 18.77 24.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.576 -176.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.6 56.8 3.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.685 0.755 . . . . 0.0 110.063 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -86.18 149.84 24.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.298 -174.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 89.21 3.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.665 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.12 156.52 46.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 0.0 112.036 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 m -117.61 139.98 50.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.843 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.744 HG12 ' HG3' ' A' ' 138' ' ' GLU . 6.6 p -114.4 139.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.134 0.492 . . . . 0.0 110.682 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 127.69 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.228 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.64 116.92 29.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.46 0.648 . . . . 0.0 111.387 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.28 112.33 30.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.904 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.95 111.43 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 120.971 0.415 . . . . 0.0 110.042 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.517 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 22.2 m -118.96 125.15 27.85 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.036 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.1 Cg_exo -82.38 145.62 13.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.191 2.594 . . . . 0.0 112.563 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.3 OUTLIER -105.82 158.88 31.38 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.88 62.77 4.88 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.355 2.703 . . . . 0.0 113.483 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.64 ' HB2' HD12 ' A' ' 158' ' ' LEU . 8.6 mmt180 -146.84 -93.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 -168.69 32.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 174.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.462 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -136.87 166.61 23.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.083 -177.286 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.528 HG21 HD22 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -128.99 148.03 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.117 0.484 . . . . 0.0 111.163 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -112.07 122.18 47.04 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.487 HD21 HG12 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -119.14 132.58 56.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.713 0.768 . . . . 0.0 111.363 -176.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -120.91 133.34 55.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.975 -176.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.5 mm? -103.56 110.32 22.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.747 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.1 116.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.695 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 75.7 m-85 -97.87 118.56 34.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.13 115.59 25.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.538 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.68 89.41 2.8 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.378 0.608 . . . . 0.0 110.464 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 170.99 -169.75 42.7 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 41.0 t 69.62 153.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.068 0.547 . . . . 0.0 110.955 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.23 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 120.946 0.403 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.47 165.78 22.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.696 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.59 43.57 6.09 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -109.43 153.95 23.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.89 117.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.909 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.22 115.69 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -41.53 23.58 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.134 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.699 ' HB3' HG23 ' A' ' 83' ' ' THR . 25.0 t70 -144.11 143.77 31.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.043 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.5 mt -105.31 121.84 57.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.93 128.59 45.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.271 0.557 . . . . 0.0 111.125 -175.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.456 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 41.3 m-85 -105.33 137.84 42.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.638 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.46 -42.91 2.96 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.64 4.45 85.74 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.071 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.496 HD13 ' HB ' ' A' ' 37' ' ' VAL . 4.5 mt -69.39 132.53 46.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.904 0.383 . . . . 0.0 111.471 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -82.27 -84.9 0.11 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.473 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -126.67 27.2 6.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 111.096 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' A' ' 34' ' ' LEU . 3.0 t -85.97 132.61 31.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.95 154.97 21.1 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -61.31 -32.48 53.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.463 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.97 -37.61 83.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.9 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.19 63.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.082 0.468 . . . . 0.0 110.738 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.88 -40.05 55.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.479 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.1 -29.92 70.04 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.289 0.635 . . . . 0.0 112.159 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 84.5 mt -62.45 -24.97 67.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.515 ' HB2' HD23 ' A' ' 66' ' ' LEU . 1.5 m -96.82 -7.82 32.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.48 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 33.9 mtp -87.39 131.6 43.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.026 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 13.1 Cg_exo -70.82 -25.43 23.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.914 2.409 . . . . 0.0 112.667 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 m -112.9 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.24 0.543 . . . . 0.0 111.418 -176.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -118.21 -179.87 3.9 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.487 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.9 p -67.47 121.43 15.79 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.847 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -6.11 47.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.5 m-20 -86.0 153.72 21.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.545 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.27 139.01 33.04 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 127.24 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.869 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.54 -177.36 3.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.108 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.513 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -68.07 -36.3 79.61 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.54 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 22.6 m-20 -74.14 -29.81 61.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.787 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -48.38 88.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -70.42 -32.49 70.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.562 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 2.0 m-20 -62.06 -49.76 74.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 110.476 177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 46' ' ' MET . 44.4 m -61.46 -44.34 97.27 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.48 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CD1' HG22 ' A' ' 77' ' ' VAL . 2.4 mt -59.22 -48.2 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 123.39 0.431 . . . . 0.0 110.844 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -33.54 74.14 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.21 -51.59 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.585 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 45' ' ' SER . 79.8 mt -67.61 -30.08 69.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.28 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -41.77 94.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 110.608 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.75 -13.51 62.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.92 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 65' ' ' ALA . 26.4 p -79.37 -25.0 42.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.594 0.235 . . . . 0.0 111.184 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.72 26.97 71.39 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.415 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -95.64 -20.05 19.25 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.117 0.484 . . . . 0.0 110.207 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.67 154.85 45.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 36.3 mt-10 -80.43 -43.66 20.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 111.6 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 12.6 t70 -132.91 136.34 46.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 66' ' ' LEU . 25.9 t -124.98 117.88 51.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.507 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 76' ' ' ARG . 2.4 tpp85 -121.12 122.37 39.87 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.962 172.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 63' ' ' ILE . 27.1 m -96.64 137.54 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -128.34 154.15 46.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -107.57 115.16 29.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.786 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.79 95.62 5.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 -110.45 3.37 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.212 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -106.74 8.32 30.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.225 0.536 . . . . 0.0 110.743 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.699 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -111.08 141.52 44.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.546 -173.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.96 115.55 30.81 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.02 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.32 112.43 24.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.123 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -102.4 109.87 27.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.502 0.668 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -103.95 126.42 51.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.599 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.18 158.3 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.908 0.385 . . . . 0.0 111.262 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.5 tptp -100.74 121.0 40.93 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -177.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' HB3' ' H ' ' A' ' 91' ' ' ARG . 0.6 OUTLIER 50.7 -118.61 1.25 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.816 1.322 . . . . 0.0 112.666 173.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.508 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -168.08 -55.8 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.698 -172.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 72.6 Cg_endo -84.96 138.59 6.91 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 120.863 1.042 . . . . 0.0 113.919 -169.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.1 m -99.54 138.12 37.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.6 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 20.7 mt -61.62 117.61 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.04 -22.92 13.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.117 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 138.66 13.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.891 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.433 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.2 mt -118.0 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.431 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -117.68 132.27 56.51 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.75 -175.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.64 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 22.2 m-85 -105.84 151.06 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.95 139.71 20.77 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.6 18.5 56.64 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.33 56.99 4.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.455 0.702 . . . . 0.0 110.807 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -86.57 -34.81 19.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 m -84.97 -51.06 6.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.64 137.3 44.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.69 147.86 50.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.619 -174.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.64 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -64.39 -33.09 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.855 176.153 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -38.01 74.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.024 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -44.08 55.24 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 106' ' ' LYS . 31.1 mt -61.21 -32.49 72.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.101 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.407 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 7.8 mttt -60.47 -46.21 90.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 111.227 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 5.3 tp60 -77.89 -28.24 49.82 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.609 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.094 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.433 ' CD2' HG21 ' A' ' 97' ' ' ILE . 2.3 mp -68.07 -40.57 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.619 174.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.607 ' HG2' ' HB2' ' A' ' 120' ' ' ARG . 1.9 mt-10 -60.46 -42.35 96.0 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.86 -16.0 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.677 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.5 m -91.98 -13.27 31.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.49 -22.03 13.86 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.998 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 94' ' ' ILE . 41.0 t -92.35 104.04 15.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.092 0.472 . . . . 0.0 110.079 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.607 ' HB2' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.0 170.16 16.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.241 -178.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.54 131.47 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.35 0.595 . . . . 0.0 111.283 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.17 -6.63 81.06 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.709 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.58 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -100.15 166.88 10.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.0 111.519 -174.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -61.99 148.08 44.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.433 173.555 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -112.3 135.08 53.42 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.716 0.769 . . . . 0.0 110.979 -177.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' HG22 ' A' ' 129' ' ' THR . 23.7 t0 -106.17 97.31 7.14 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 172.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.616 ' HD3' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.58 -15.24 62.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.758 -176.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.616 HG23 ' HD3' ' A' ' 127' ' ' ARG . 12.5 p -89.74 -23.62 21.75 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.698 0.285 . . . . 0.0 110.96 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 126' ' ' ASP . 0.5 OUTLIER -87.99 -1.29 57.9 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.406 0.622 . . . . 0.0 110.517 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.703 HG23 ' HB3' ' A' ' 153' ' ' ALA . 5.6 mm -57.51 -43.36 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.215 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.721 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.28 -36.53 84.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.149 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.3 mt -65.18 -45.23 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.353 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -61.12 -47.7 85.05 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 17.2 mmtm -67.09 -34.58 77.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.646 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.94 -39.98 84.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.024 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.587 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 37.0 mt -69.66 -32.54 71.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.633 0.254 . . . . 0.0 111.032 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -63.09 -41.46 99.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.24 -43.48 94.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.688 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.403 ' O ' HG23 ' A' ' 144' ' ' VAL . 14.6 m-85 -65.29 -38.55 90.56 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.228 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -35.47 80.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.947 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -30.4 67.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.206 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -28.44 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 140' ' ' PHE . 12.2 t -72.47 -83.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.233 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.53 18.62 22.59 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.584 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt 63.11 45.58 5.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.368 0.667 . . . . 0.0 110.184 -174.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -80.57 119.62 23.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.092 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.456 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -90.71 73.02 6.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.44 176.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 143.9 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.39 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.5 m -97.94 115.66 28.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 13.2 t -107.07 122.35 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.563 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 119.57 24.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.388 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.703 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -95.9 111.97 23.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.258 0.552 . . . . 0.0 110.246 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.58 118.82 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.811 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.09 116.75 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.331 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.474 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.1 m -120.77 122.13 28.63 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.791 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.3 Cg_endo -88.11 142.69 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.68 2.92 . . . . 0.0 113.003 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -120.56 159.39 48.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.033 178.056 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.06 -7.69 12.28 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 123.726 2.951 . . . . 0.0 115.0 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.51 12.42 8.57 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 122.488 -0.132 . . . . 0.0 111.193 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 1.3 m-20 62.22 42.35 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.0 0.905 . . . . 0.0 110.603 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HB2' HD11 ' A' ' 158' ' ' LEU . 14.5 mmt85 -131.02 163.57 27.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.381 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.547 HG21 HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -127.43 146.49 33.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.23 0.538 . . . . 0.0 110.537 176.318 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.08 123.41 49.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.494 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.1 tp -107.22 119.71 40.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.115 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.431 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -115.4 131.27 56.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.376 0.607 . . . . 0.0 110.58 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.6 mm? -104.3 109.93 21.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.462 -176.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.9 t -96.41 111.41 26.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.587 ' HZ ' HD13 ' A' ' 137' ' ' LEU . 48.6 m-85 -108.78 135.2 50.39 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.436 ' HB3' HG23 ' A' ' 173' ' ' VAL . 1.6 mp0 -112.89 111.93 23.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -96.03 23.4 6.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.763 0.792 . . . . 0.0 110.799 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -133.45 20.09 4.2 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.464 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 148' ' ' SER . 11.2 t -98.59 123.37 51.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.422 0 O-C-N 124.103 0.877 . . . . 0.0 110.514 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 120.765 0.317 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.51 143.13 39.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.518 176.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.44 47.27 80.43 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -107.9 152.76 23.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.686 -0.257 . . . . 0.0 110.428 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.57 113.3 23.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.26 118.42 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 111.256 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -76.69 -46.77 24.31 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 178.363 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.84 146.66 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.427 ' HB ' HD11 ' A' ' 43' ' ' LEU . 62.4 mt -105.39 119.99 55.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -109.65 127.55 54.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.89 137.48 41.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.012 0.434 . . . . 0.0 110.476 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.39 -30.58 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.468 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.99 -73.81 1.19 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.796 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 37' ' ' VAL . 32.6 mt 61.88 -164.68 0.24 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.443 0.697 . . . . 0.0 112.126 -176.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.469 HE21 ' HB2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -165.47 -89.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.744 -177.305 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.02 11.2 6.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.445 0.64 . . . . 0.0 109.838 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.494 ' O ' HD22 ' A' ' 34' ' ' LEU . 42.3 t -108.42 140.66 26.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.311 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.54 158.11 18.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.11 -37.54 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.71 -40.23 90.11 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.95 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -71.8 -34.84 69.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.909 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -32.46 70.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.31 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' A' ' 29' ' ' ILE . 4.8 mp -68.94 -30.99 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 41' ' ' ALA . 53.0 mt -68.96 -23.38 64.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.411 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -80.61 -20.96 42.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.422 177.452 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.547 ' HB3' HG22 ' A' ' 62' ' ' THR . 24.7 mtt -82.53 139.39 44.32 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.95 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 31.4 Cg_exo -63.36 -36.2 57.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.656 2.237 . . . . 0.0 112.328 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.86 150.12 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.389 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 14.6 mmm-85 -127.82 178.09 6.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 0.0 111.067 -175.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -64.65 122.58 17.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.95 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.39 -10.1 42.45 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.83 -174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 5.2 m-20 -89.32 152.77 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.531 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.91 127.7 36.49 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.74 131.15 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.421 0.629 . . . . 0.0 112.491 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -93.13 173.17 7.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.38 174.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.96 -31.6 71.96 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -61.21 -36.97 81.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.893 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 37.8 m-20 -75.05 -29.21 60.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.08 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -45.31 95.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -32.18 73.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.921 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.598 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.4 m-80 -69.63 -43.55 72.45 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.203 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 46' ' ' MET . 1.3 p -63.29 -43.15 98.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.032 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mt -54.21 -49.63 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 123.519 0.512 . . . . 0.0 110.45 174.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -46.59 89.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.416 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 45' ' ' SER . . . -60.8 -48.45 81.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.467 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 75' ' ' VAL . 54.1 mt -69.89 -29.51 66.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -34.36 77.51 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 110.287 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.16 61.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.421 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.8 p -77.61 -25.64 49.98 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.222 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.57 -5.85 20.35 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 116.143 -0.48 . . . . 0.0 114.114 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.63 -23.87 22.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.167 0.483 . . . . 0.0 111.228 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.562 ' CD1' HG21 ' A' ' 88' ' ' VAL . 6.0 m-85 -101.47 157.19 16.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.62 ' HG2' ' HD2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -86.78 -41.66 13.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.151 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.724 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 8.4 t70 -145.88 139.19 26.12 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 66' ' ' LEU . 22.6 t -116.73 120.77 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -174.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.84 118.53 31.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.751 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.6 126.48 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.011 0.434 . . . . 0.0 110.014 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -126.36 159.08 34.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 129.86 50.63 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.806 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.0 96.63 6.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.815 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.2 -109.85 3.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.616 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -111.44 15.9 21.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.394 0.616 . . . . 0.0 110.375 177.618 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.06 141.41 38.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.085 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.84 119.15 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -112.23 116.99 31.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.98 0.419 . . . . 0.0 110.17 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -106.72 111.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.253 0.549 . . . . 0.0 110.72 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.13 136.24 41.3 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG21 ' CD1' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -130.78 155.82 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.126 0.489 . . . . 0.0 110.326 -173.349 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.724 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -98.6 140.45 32.81 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.2 -175.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 79.35 -154.09 0.02 OUTLIER 'General case' 0 C--O 1.238 0.475 0 O-C-N 125.974 2.047 . . . . 0.0 111.407 -176.218 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.427 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 0.6 OUTLIER 159.62 -46.93 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 124.773 1.229 . . . . 0.0 109.555 -164.375 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 3.5 Cg_exo -79.31 140.42 15.4 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.266 1.311 . . . . 0.0 112.559 172.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -104.34 136.83 43.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.336 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 125' ' ' LEU . 31.0 mt -64.83 118.25 6.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.15 -27.84 14.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.82 139.85 15.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.041 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.17 122.88 65.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 167.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.493 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -116.27 131.94 56.8 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.388 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.607 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -113.43 134.12 54.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.824 -175.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.3 125.75 16.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.66 -2.34 57.19 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.363 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.488 HD21 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -86.36 82.15 8.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.187 0.518 . . . . 0.0 110.709 -177.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 171' ' ' GLU . 0.2 OUTLIER -85.88 -35.77 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.043 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -70.32 -64.91 0.8 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.126 0.488 . . . . 0.0 110.626 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.65 130.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -69.41 158.38 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 0.0 112.087 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -61.47 -34.6 75.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.723 173.133 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -43.1 96.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.983 176.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 mmm -74.45 -35.35 63.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.753 0.311 . . . . 0.0 111.131 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -31.65 72.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.549 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.607 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.93 -43.42 86.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 110.763 176.071 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -78.29 -28.6 47.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.115 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -66.39 -42.64 87.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.19 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -68.08 -38.45 82.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.53 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -40.16 88.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.097 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.92 -19.38 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.915 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 m -89.23 -12.86 39.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 102.62 -11.86 56.5 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.629 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.3 t -100.5 101.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.519 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 26.8 ptt180 -142.93 175.32 9.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -176.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 94' ' ' ILE . 14.6 p -68.89 135.09 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.216 176.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.33 18.02 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.37 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -84.91 160.5 20.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 110.994 177.351 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.98 150.58 27.57 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 170.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.634 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -119.02 130.72 55.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -174.052 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.584 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 20.0 t0 -90.13 112.87 24.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.629 0.728 . . . . 0.0 109.893 172.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -15.69 62.25 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.079 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.3 p -83.45 -25.36 31.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.338 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.584 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -89.34 -1.1 57.94 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.952 177.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.559 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.4 mm -56.72 -41.53 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.481 ' HA ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.08 -38.36 90.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.86 -31.22 68.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.583 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.7 mt -67.03 -43.62 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.54 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 131' ' ' ALA . 49.1 mt-10 -62.44 -44.4 96.5 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.591 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.34 93.57 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.748 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.37 -37.49 92.82 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.931 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 mt -68.27 -39.58 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.501 0.191 . . . . 0.0 111.368 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.4 -39.26 88.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.282 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.743 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -60.96 -45.06 96.29 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 147' ' ' TYR . 1.2 m-85 -61.78 -41.42 97.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.181 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -70.75 -34.37 71.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.096 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.2 m -66.51 -28.56 68.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.8 t -80.13 -88.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.975 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.25 18.06 26.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.5 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 1.0 OUTLIER 59.99 44.67 13.07 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.283 0.633 . . . . 0.0 110.697 -174.078 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HB3' ' A' ' 141' ' ' TYR . 69.3 m-85 -73.58 102.96 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.91 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.32 84.28 6.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 111.676 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -117.81 141.56 48.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 m -100.05 122.42 42.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.749 0.309 . . . . 0.0 110.459 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.2 p -105.47 133.12 50.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.384 0.612 . . . . 0.0 111.657 -174.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -129.23 122.53 29.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.514 173.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -93.8 112.06 23.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.113 0.482 . . . . 0.0 110.762 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.19 116.88 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.471 HG13 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -105.39 118.31 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.433 178.192 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.5 m -124.12 117.48 26.96 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.629 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 46.7 Cg_endo -69.51 143.83 53.34 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.611 2.207 . . . . 0.0 112.614 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.64 160.35 26.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.79 71.05 0.24 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.616 2.878 . . . . 0.0 114.322 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -164.51 -117.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 18.7 p-10 -138.63 36.79 2.22 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -133.71 157.83 44.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 -172.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -128.18 148.17 32.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.244 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -109.32 126.66 53.62 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.471 HD13 HG13 ' A' ' 155' ' ' VAL . 58.3 tp -113.25 114.35 26.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.934 0.397 . . . . 0.0 110.66 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.493 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 1.3 ttpt -113.28 131.69 55.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 0.0 110.693 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.2 mm? -98.83 110.18 22.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.142 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.483 HG22 ' HE2' ' A' ' 166' ' ' LYS . 25.4 t -94.52 111.08 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -103.26 129.29 50.18 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.4 113.61 11.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.502 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -105.0 72.33 1.0 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.283 -176.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 155.86 81.89 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.846 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 1.3 p -123.7 169.57 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.134 0.493 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -128.72 124.69 36.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.0 44.95 12.51 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -171.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -106.93 153.56 22.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.202 -0.499 . . . . 0.0 110.072 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.523 HG13 ' HE2' ' A' ' 27' ' ' LYS . 2.1 p -80.6 124.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 110.103 175.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.55 127.75 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.558 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' HG13 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -97.57 -39.44 9.12 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.546 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.611 ' HB3' HG23 ' A' ' 83' ' ' THR . 34.7 t70 -143.8 142.06 30.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.3 mt -109.14 122.07 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -122.75 128.09 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.963 -179.03 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 2.4 m-85 -102.16 138.1 39.56 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.005 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 5.3 mm-40 -119.6 67.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.064 0.935 . . . . 0.0 109.982 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.745 ' HA3' HG22 ' A' ' 88' ' ' VAL . . . 172.0 -83.0 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.745 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' A' ' 31' ' ' PHE . 49.5 mt 65.23 120.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.075 0.941 . . . . 0.0 113.361 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.432 ' HG3' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -131.49 91.05 2.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.238 176.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.73 -35.15 0.23 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.384 1.074 . . . . 0.0 112.585 173.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.38 113.11 24.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.32 158.08 35.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.618 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -54.37 -36.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -172.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.96 -35.66 57.83 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.556 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.69 -35.57 60.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -31.25 68.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.384 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.46 -31.05 65.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 112.608 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt -70.41 -23.07 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 111.282 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.98 -17.23 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.278 0.561 . . . . 0.0 110.143 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.665 ' HG2' HG23 ' A' ' 62' ' ' THR . 92.4 mtp -82.81 137.9 43.73 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.823 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HG3' ' HB3' ' A' ' 61' ' ' ASN . 39.6 Cg_endo -69.0 -22.58 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.32 2.013 . . . . 0.0 112.701 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.702 HG11 HG13 ' A' ' 54' ' ' VAL . 2.0 t -125.5 149.77 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.262 0.554 . . . . 0.0 110.811 -175.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 177.9 5.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.673 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -66.16 120.27 12.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.57 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.28 -5.51 38.61 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.214 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' CB ' HG13 ' A' ' 48' ' ' VAL . 1.1 m-20 -98.52 155.78 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.79 140.66 29.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.56 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.702 HG13 HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -125.98 129.16 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.637 0.256 . . . . 0.0 111.652 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.467 ' O ' HD12 ' A' ' 59' ' ' ILE . 1.3 t-20 -95.11 -178.55 4.51 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.25 -30.38 69.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.226 0.536 . . . . 0.0 110.033 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -35.69 81.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.507 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.574 ' HB3' HG12 ' A' ' 54' ' ' VAL . 3.8 m-20 -76.63 -29.6 56.52 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -61.1 -48.14 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 171.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -66.79 -33.48 75.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.55 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.481 ' HB3' ' HG3' ' A' ' 47' ' ' PRO . 4.3 t-20 -63.25 -48.03 79.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.634 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.665 HG23 ' HG2' ' A' ' 46' ' ' MET . 25.5 m -58.9 -46.36 88.07 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.331 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 77' ' ' VAL . 24.4 mt -55.26 -49.46 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.862 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -68.26 -40.42 81.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.204 -175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.0 -53.15 60.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.76 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.722 ' HB3' HG21 ' A' ' 75' ' ' VAL . 6.3 mp -66.5 -30.59 70.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.699 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.407 0.622 . . . . 0.0 110.797 174.791 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.46 -13.17 61.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.756 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 p -78.63 -25.32 45.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.34 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.94 -7.35 59.73 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.886 176.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.236 0.541 . . . . 0.0 110.572 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 150.31 49.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.938 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.58 -45.14 60.6 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.369 0.418 . . . . 0.0 111.303 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 7.5 t70 -139.43 146.68 40.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 66' ' ' LEU . 70.7 t -126.16 122.72 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.675 0.274 . . . . 0.0 110.304 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.44 118.57 32.1 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.784 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.5 HG22 HG13 ' A' ' 86' ' ' VAL . 43.6 t -103.83 123.19 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.113 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.17 159.06 37.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.65 144.53 43.27 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.277 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -139.23 97.5 3.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.054 171.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 -111.07 3.66 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -112.99 18.82 17.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.298 0.571 . . . . 0.0 109.97 174.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.611 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -107.52 134.54 50.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.029 -177.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 84' ' ' LEU . 1.6 mt -102.65 118.54 37.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.708 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.2 tp -106.09 112.38 25.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.027 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.5 HG13 HG22 ' A' ' 77' ' ' VAL . 3.2 t -110.22 104.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.306 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.49 148.65 23.52 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.745 HG22 ' HA3' ' A' ' 33' ' ' GLY . 15.5 m -125.89 152.32 32.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.092 0.472 . . . . 0.0 110.662 -178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.895 ' HD3' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.19 139.43 36.88 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.895 ' HG2' ' HD3' ' A' ' 89' ' ' LYS . 25.1 mm-40 66.17 -169.59 0.2 Allowed 'General case' 0 C--O 1.236 0.344 0 O-C-N 124.407 1.067 . . . . 0.0 112.006 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.432 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -174.4 -54.91 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.307 -168.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.18 142.03 26.84 Favored 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 121.642 1.561 . . . . 0.0 112.827 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 m -97.67 134.74 40.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.456 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 125' ' ' LEU . 32.4 mt -61.96 120.29 7.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.1 -31.17 11.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.593 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.01 138.82 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.191 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -117.75 123.42 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.074 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.74 131.55 53.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.662 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.604 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 17.5 m-85 -109.21 134.84 51.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.356 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.11 113.94 11.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.447 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 115.36 13.09 9.19 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.665 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.48 68.54 4.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.731 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -85.39 -31.33 22.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.56 26.35 10.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 111.446 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.8 p -167.89 155.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -83.94 145.67 28.44 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.664 0.745 . . . . 0.0 111.272 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -35.62 80.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.468 175.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -41.74 89.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.248 174.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.74 -42.2 70.83 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.409 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -39.67 84.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.935 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -42.86 99.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.514 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.579 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 1.6 tm0? -77.71 -27.96 50.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.116 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.93 -43.47 95.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.954 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 HG21 ' A' ' 97' ' ' ILE . 3.0 mp -68.49 -41.09 80.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.435 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -57.24 -45.76 83.62 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.791 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.01 -21.82 59.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.733 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -83.62 -17.16 42.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 110.297 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.58 -19.85 8.98 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.271 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.86 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 111.051 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.49 ' HA ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -141.56 175.11 9.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.674 -178.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 94' ' ' ILE . 50.9 t -67.81 123.59 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.077 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.02 29.67 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.31 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.27 160.14 17.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.118 0.485 . . . . 0.0 111.901 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 m -84.75 127.43 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 170.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.48 143.18 27.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.656 -171.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -91.76 113.26 25.48 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.864 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.04 -27.7 62.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.375 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 p -79.24 -22.67 44.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.29 0.88 51.46 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.862 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 125' ' ' LEU . 5.0 mm -55.0 -45.14 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.654 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.42 91.0 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.246 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.96 -34.69 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.496 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 130' ' ' ILE . 61.4 mt -64.87 -48.58 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.748 176.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 130' ' ' ILE . 19.7 mt-10 -59.39 -50.02 75.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.08 0.467 . . . . 0.0 111.358 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -33.17 74.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.6 -37.16 89.2 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.152 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.9 -32.02 68.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.653 0.263 . . . . 0.0 111.12 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.615 ' HG3' HG23 ' A' ' 151' ' ' VAL . 58.5 mt-10 -64.08 -41.44 97.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.095 0.474 . . . . 0.0 110.269 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.82 -39.45 90.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.557 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 144' ' ' VAL . 2.5 t80 -58.8 -45.52 89.68 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.035 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -41.7 87.83 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.406 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' HE1' ' HG ' ' A' ' 148' ' ' SER . 1.9 t80 -71.25 -29.68 65.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.621 178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.4 m -70.04 -28.56 65.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 140' ' ' PHE . 21.4 t -72.81 -87.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.974 0.416 . . . . 0.0 110.737 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.22 19.52 22.41 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.395 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 62.19 0.96 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.615 0.722 . . . . 0.0 111.105 -174.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -105.63 121.08 43.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.969 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.404 ' HG ' ' HE1' ' A' ' 142' ' ' TYR . 1.0 OUTLIER -94.86 93.6 7.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 110.669 176.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -117.43 153.17 33.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.58 ' HB2' ' HG3' ' A' ' 170' ' ' GLN . 6.8 m -99.65 132.65 44.85 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.615 HG23 ' HG3' ' A' ' 138' ' ' GLU . 21.6 t -110.58 129.34 65.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 110.302 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 168' ' ' VAL . 0.2 OUTLIER -123.06 117.02 24.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.435 176.144 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -95.27 111.12 23.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.158 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.5 113.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.11 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.15 116.97 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.497 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 66.9 m -122.98 124.0 26.65 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.861 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.7 Cg_exo -77.41 141.96 20.63 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.101 2.534 . . . . 0.0 111.768 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.79 156.42 36.61 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.97 76.86 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.134 2.556 . . . . 0.0 113.548 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.494 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -164.53 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.494 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 2.3 t30 -170.14 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.786 0.803 . . . . 0.0 109.124 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -127.08 161.25 28.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.086 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.45 144.6 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.244 176.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.85 130.96 55.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.92 130.37 55.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.097 0.475 . . . . 0.0 111.179 -176.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 130.69 52.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.016 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.2 mm? -106.92 111.63 24.22 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.412 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 152' ' ' LYS . 25.8 t -95.03 111.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.855 -176.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.401 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 81.8 m-85 -103.92 117.5 34.47 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 150' ' ' SER . 1.8 mt-30 -78.15 114.99 17.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.09 103.93 12.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.321 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 94.14 56.46 1.38 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.147 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.1 t -81.81 -65.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.13 178.602 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -125.94 131.48 52.28 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.027 0.442 . . . . 0.0 110.215 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.52 42.1 10.6 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.646 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -101.51 153.22 19.9 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -87.02 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.6 127.87 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.618 0.723 . . . . 0.0 110.633 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -94.49 -41.1 9.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.397 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.18 137.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.633 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.98 121.53 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 7.0 t60 -113.39 127.69 56.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.549 ' HD2' HG12 ' A' ' 39' ' ' VAL . 29.4 m-85 -102.84 134.3 46.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.754 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -133.91 77.53 1.72 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.246 0.546 . . . . 0.0 111.101 -173.369 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.54 -28.63 0.18 Allowed Glycine 0 C--N 1.316 -0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.863 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -88.49 146.75 25.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.535 0.683 . . . . 0.0 111.787 178.071 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -142.31 142.27 32.5 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 170.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 78.62 -32.06 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.631 1.207 . . . . 0.0 110.506 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.418 ' O ' HD13 ' A' ' 34' ' ' LEU . 10.9 t -82.75 118.72 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 169.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.34 156.2 19.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.549 HG12 ' HD2' ' A' ' 31' ' ' PHE . 2.3 m -61.67 -32.3 53.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.076 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.35 -37.24 70.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.97 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.27 -36.28 63.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.44 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.26 -39.22 78.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.069 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HA ' ' SD ' ' A' ' 46' ' ' MET . 1.4 mt -59.79 -31.57 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.435 0.694 . . . . 0.0 112.318 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.61 -16.42 61.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.757 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.8 OUTLIER -93.88 -7.87 41.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 175.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.516 ' HG2' HG23 ' A' ' 62' ' ' THR . 70.7 mtp -90.25 147.2 36.34 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.71 -18.51 22.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 112.192 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.459 HG11 HG12 ' A' ' 54' ' ' VAL . 4.3 m -116.71 165.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.972 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -132.38 174.36 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 p -67.45 121.82 16.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.298 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.97 -4.73 49.55 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.313 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -87.31 155.1 20.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 0.0 111.047 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.54 133.42 35.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.845 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.459 HG12 HG11 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -130.8 128.04 62.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.071 0.462 . . . . 0.0 111.363 -175.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.61 179.74 5.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.062 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -30.31 70.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.361 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 17.9 tp10 -66.18 -34.3 77.73 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.36 0.413 . . . . 0.0 110.758 174.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.8 -32.52 69.63 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.37 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -62.68 -49.5 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 123.241 0.338 . . . . 0.0 110.319 173.78 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -35.03 77.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.58 0.229 . . . . 0.0 111.401 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -66.05 -39.92 90.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.486 177.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.516 HG23 ' HG2' ' A' ' 46' ' ' MET . 68.4 m -59.02 -45.81 89.77 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.032 172.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.416 HG13 HG13 ' A' ' 77' ' ' VAL . 1.2 mt -54.96 -48.44 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 123.445 0.466 . . . . 0.0 110.425 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -67.08 -35.57 80.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.218 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 69' ' ' THR . . . -68.35 -54.89 14.26 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.239 0.337 . . . . 0.0 110.507 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.78 HD22 ' HE2' ' A' ' 72' ' ' PHE . 37.4 mt -58.72 -29.71 66.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -52.67 33.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.969 0.414 . . . . 0.0 110.821 172.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.37 61.33 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.757 HG21 ' HB3' ' A' ' 45' ' ' SER . 30.0 p -79.49 -6.62 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.678 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.87 75.06 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.478 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -83.07 -59.27 2.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.517 . . . . 0.0 111.604 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.78 ' HE2' HD22 ' A' ' 66' ' ' LEU . 2.4 m-85 -124.82 169.96 11.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.524 0.202 . . . . 0.0 111.292 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 1.9 tm-20 -79.01 -42.54 26.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.09 0.471 . . . . 0.0 110.846 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 30.6 t70 -137.89 141.04 40.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.75 119.02 55.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.077 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -120.98 117.29 26.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.943 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.709 ' HB ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -109.41 129.99 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.634 0.73 . . . . 0.0 109.695 172.312 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.14 156.83 34.24 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -129.16 126.16 38.63 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.513 0.673 . . . . 0.0 111.202 -176.195 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -115.46 97.12 5.98 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.851 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.06 -109.08 2.71 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.234 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.48 10.42 23.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.708 0.289 . . . . 0.0 110.778 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.33 132.52 50.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.83 116.77 31.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 0.8 OUTLIER -109.96 117.1 32.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.709 HG22 ' HB ' ' A' ' 77' ' ' VAL . 4.8 t -111.22 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.257 0.551 . . . . 0.0 110.989 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.754 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 64.4 mt-30 -93.55 137.93 32.33 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.95 152.24 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 -175.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -98.71 150.16 22.09 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.824 -178.23 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.51 144.13 6.09 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 124.752 1.282 . . . . 0.0 113.788 -167.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.463 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 4.6 mtm180 -71.32 -51.91 9.49 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.776 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 17.2 Cg_exo -68.1 139.92 48.05 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.55 1.5 . . . . 0.0 113.277 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 7.2 m -105.31 139.16 40.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.913 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.635 HD11 ' HB2' ' A' ' 125' ' ' LEU . 50.0 mt -62.88 118.16 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.73 -42.5 11.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.1 39.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 176.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 165' ' ' LEU . 0.7 OUTLIER -115.84 122.39 69.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.538 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.63 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -117.11 141.11 48.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.682 -175.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.667 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 26.1 m-85 -121.73 134.96 54.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.154 -172.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.0 114.39 11.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.841 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.554 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 119.91 36.58 0.82 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.052 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.433 ' ND2' ' HB3' ' A' ' 107' ' ' ASP . 10.1 m-80 -95.06 83.85 4.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.346 0.594 . . . . 0.0 110.149 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.06 -45.34 10.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.413 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.18 -41.61 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -173.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.495 HG12 ' HE2' ' A' ' 141' ' ' TYR . 14.0 p -117.53 148.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.68 145.33 53.96 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.667 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 18.2 p-10 -66.42 -32.07 73.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.551 170.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -43.72 76.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.073 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.71 65.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -58.44 -32.03 68.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.11 176.532 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.505 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 3.9 mtpp -56.95 -44.44 82.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.435 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.48 -28.37 52.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.43 -40.57 93.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.664 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 97' ' ' ILE . 1.4 mm? -66.86 -38.85 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.747 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.779 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 2.0 mt-10 -63.91 -39.5 94.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.168 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.2 -17.14 60.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.597 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.6 m -87.0 -16.44 35.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.305 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.85 -21.55 22.84 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.935 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.59 HG21 HD11 ' A' ' 133' ' ' ILE . 1.3 t -102.8 101.13 11.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.779 ' HB3' ' HA ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -142.64 175.25 9.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -167.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.441 HG23 HG13 ' A' ' 97' ' ' ILE . 16.2 t -63.46 129.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.47 175.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.47 -6.34 71.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.548 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.78 138.1 51.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 12.5 m -65.75 138.96 58.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.635 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -91.21 143.42 26.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.638 0.732 . . . . 0.0 112.894 -163.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.545 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 6.8 t0 -97.08 105.23 17.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.452 170.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.701 ' H ' ' HD2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -70.41 -14.17 62.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.632 -177.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.1 p -81.29 -24.53 37.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.653 0.263 . . . . 0.0 110.82 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.545 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -92.58 3.39 55.63 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 111.131 179.019 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 153' ' ' ALA . 6.4 mm -59.46 -40.78 82.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.55 -34.95 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.472 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.1 -34.36 77.46 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.309 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 130' ' ' ILE . 21.2 mt -64.8 -49.09 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.43 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.35 -45.78 92.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.414 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -40.61 89.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.316 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.33 88.77 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.759 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.528 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 13.8 mt -67.65 -35.72 79.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.639 0.257 . . . . 0.0 111.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.29 -30.48 66.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.859 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.41 -34.24 76.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.455 ' O ' HG23 ' A' ' 144' ' ' VAL . 22.2 m-85 -75.22 -39.83 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.346 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.495 ' HE2' HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -61.24 -39.85 91.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.158 0.504 . . . . 0.0 110.867 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -30.07 69.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.536 177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.4 m -73.11 -28.34 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 140' ' ' PHE . 16.0 t -73.66 -87.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.448 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.94 19.3 23.29 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.597 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.6 mttp 66.59 51.44 1.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.447 0.699 . . . . 0.0 110.852 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -90.39 139.08 31.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.581 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.37 88.85 2.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.043 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.28 163.91 12.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.958 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.2 112.52 24.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 3.4 p -118.25 126.91 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.401 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 127.18 38.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.726 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -91.16 111.12 22.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.274 0.559 . . . . 0.0 110.258 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.61 123.25 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.25 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.5 HG12 ' HB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -98.72 127.03 51.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.147 0.498 . . . . 0.0 110.208 177.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -104.74 120.34 50.56 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.153 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.35 135.18 18.14 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 122.821 2.347 . . . . 0.0 112.984 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 0.7 OUTLIER -135.11 151.46 75.32 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.071 175.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 4.1 Cg_exo -76.98 66.53 7.68 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.53 2.82 . . . . 0.0 113.499 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -148.6 16.07 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.169 173.537 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 37.9 t30 58.0 43.41 21.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.275 -168.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HD3' ' HB ' ' A' ' 93' ' ' THR . 74.9 mmt-85 -135.89 157.81 45.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.35 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.5 ' HB ' HG12 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -132.7 145.6 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.019 173.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.65 121.73 45.88 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 97' ' ' ILE . 37.9 tp -95.59 120.36 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.312 -174.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.63 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.71 131.78 55.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.649 0.738 . . . . 0.0 111.223 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.575 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.9 mm? -102.29 110.63 22.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.255 -176.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.7 t -96.67 110.71 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.554 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 8.0 m-85 -105.88 118.83 37.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.296 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.72 115.23 15.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -82.32 87.45 6.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.356 0.598 . . . . 0.0 110.658 -176.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 134.42 -131.64 6.01 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.385 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.5 t 69.04 -74.18 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.598 0.759 . . . . 0.0 110.597 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.349 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.548 0.213 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -81.5 152.74 27.17 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.938 0.399 . . . . 0.0 110.351 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.13 46.64 4.08 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -172.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -107.65 151.46 25.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.911 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.8 t -81.8 119.02 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.315 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 t -70.52 124.63 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.01 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -44.32 12.33 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.779 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 145.97 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.839 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -109.82 122.73 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -119.6 147.75 44.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.966 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.5 ' CD1' HD21 ' A' ' 34' ' ' LEU . 46.0 m-85 -124.43 130.97 53.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 0.0 110.991 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 1.4 tm-20 -123.22 69.89 1.02 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.482 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.11 -44.54 0.13 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.512 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD21 ' CD1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -91.41 133.62 35.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.763 0.316 . . . . 0.0 111.149 -178.298 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.56 -36.12 2.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.869 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -44.21 83.75 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.158 175.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.2 t -81.74 130.34 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.76 156.97 17.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.543 0.211 . . . . 0.0 111.078 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.478 HG12 ' HD2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -51.96 -40.03 27.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 124.069 0.856 . . . . 0.0 112.751 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.43 90.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.199 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -72.53 -33.56 66.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.21 -33.63 59.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.689 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 mp -61.85 -31.31 71.56 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.174 0.59 . . . . 0.0 111.713 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 41' ' ' ALA . 45.9 mt -67.28 -23.96 65.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.388 . . . . 0.0 111.652 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.516 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -89.79 -8.55 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.221 0.534 . . . . 0.0 110.209 177.528 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.49 ' HG2' HG23 ' A' ' 62' ' ' THR . 85.2 mtp -88.14 143.03 32.3 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.01 -16.18 40.49 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 122.359 2.039 . . . . 0.0 113.209 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 54' ' ' VAL . 2.5 m -129.02 169.46 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.058 0.456 . . . . 0.0 111.642 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -127.88 177.2 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.691 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -66.4 125.11 24.64 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.53 -7.08 39.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.452 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.4 156.33 19.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 0.0 111.176 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.12 134.02 36.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.119 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 48' ' ' VAL . 3.1 m -131.67 129.51 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 111.892 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.42 ' O ' HD12 ' A' ' 59' ' ' ILE . 4.6 m-20 -82.1 173.62 11.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.397 170.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.74 -26.27 65.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.346 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.48 -32.45 72.46 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.774 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -76.79 -28.7 55.74 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 122.302 0.241 . . . . 0.0 111.363 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.66 -45.04 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.31 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.79 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.2 m -67.62 -31.2 71.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.32 175.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.774 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.6 m-20 -66.15 -41.38 90.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.284 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.49 HG23 ' HG2' ' A' ' 46' ' ' MET . 56.3 m -58.37 -46.65 85.92 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.017 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 60' ' ' SER . 65.0 mt -54.04 -50.9 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.545 0.528 . . . . 0.0 110.644 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -39.86 95.87 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.587 0.755 . . . . 0.0 111.747 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.67 -52.55 36.58 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.882 -176.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 45' ' ' SER . 41.1 mt -64.48 -30.61 71.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.429 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.2 -40.39 82.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.674 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 -12.9 61.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.803 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 65' ' ' ALA . 34.6 p -78.14 -23.01 47.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.576 0.227 . . . . 0.0 110.708 -177.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.39 23.18 76.53 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.198 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -87.92 -28.76 21.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.15 . . . . 0.0 111.229 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -136.44 161.46 35.76 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.253 -177.026 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -79.84 -38.91 31.83 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.174 0.296 . . . . 0.0 111.185 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.843 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 7.9 t70 -139.16 137.76 36.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 66' ' ' LEU . 75.2 t -117.89 119.56 61.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.992 0.425 . . . . 0.0 109.902 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 118.67 32.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.174 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 67.2 t -114.82 128.99 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp -128.68 155.7 44.61 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -118.18 126.73 52.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.322 0.582 . . . . 0.0 109.803 174.084 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -125.63 97.08 5.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.772 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 -108.83 2.61 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.92 7.81 15.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.401 . . . . 0.0 110.407 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.91 129.21 53.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.215 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.49 115.89 31.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.4 tp -108.05 121.38 44.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 -175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' A' ' 31' ' ' PHE . 21.9 t -112.84 113.19 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.626 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.701 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 33.9 mt-30 -99.82 138.51 36.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.9 148.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.098 0.475 . . . . 0.0 110.679 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.843 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -100.17 150.84 22.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.86 -178.397 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -6.22 101.91 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 126.422 2.326 . . . . 0.0 114.274 178.353 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.644 ' HA ' ' HA ' ' A' ' 72' ' ' PHE . 31.3 mtp-105 -64.87 -55.1 30.19 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -170.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.557 ' HB2' HG22 ' A' ' 163' ' ' VAL . 16.7 Cg_exo -68.52 142.28 53.31 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.025 1.817 . . . . 0.0 114.468 -170.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -88.12 140.17 29.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.493 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 125' ' ' LEU . 33.9 mt -65.19 118.24 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.45 -40.75 14.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.06 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.54 146.55 25.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.777 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -107.53 128.78 62.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.92 133.02 54.85 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.632 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 22.6 m-85 -113.52 135.49 53.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -136.91 127.37 26.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.412 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.61 46.38 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.29 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.87 79.99 1.26 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -33.45 21.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.553 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -46.94 76.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.725 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.5 t -118.29 141.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -69.71 151.48 45.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 111.483 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -35.26 79.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.172 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -28.87 65.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.724 0.297 . . . . 0.0 111.153 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.6 mtp -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -34.73 78.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.963 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.632 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 2.4 mttt -59.42 -43.12 93.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.915 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.66 -28.76 56.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.622 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.39 -45.0 85.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.299 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.482 HD12 HG23 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -65.93 -37.16 85.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.21 176.006 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.445 ' HG2' ' CG ' ' A' ' 120' ' ' ARG . 67.0 mt-10 -59.38 -46.58 88.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.26 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.81 61.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -85.04 -16.99 38.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.315 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.98 -19.85 15.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.408 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.482 HG23 HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -96.0 106.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.316 0.579 . . . . 0.0 110.811 -176.045 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.445 ' CG ' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -119.0 163.29 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.136 -173.579 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.1 t -69.35 123.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 109.963 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.56 -7.27 80.02 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.061 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 161.58 13.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -74.89 149.54 39.46 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.294 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.789 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -103.04 146.76 27.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.969 0.414 . . . . 0.0 111.716 -173.081 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.535 ' HA ' ' HG3' ' A' ' 90' ' ' GLU . 34.6 t0 -116.25 101.49 8.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.648 174.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.496 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.46 -20.14 62.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.233 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -27.09 65.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.548 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -0.01 43.06 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.805 177.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.9 mm -59.31 -37.87 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.451 0.301 . . . . 0.0 111.69 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.38 86.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.913 0.387 . . . . 0.0 111.3 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -30.07 64.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.26 -42.51 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.272 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -64.38 -40.57 96.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -68.46 -38.06 80.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.626 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.68 -37.5 92.49 Favored Glycine 0 C--O 1.227 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.852 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.487 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 11.1 mt -73.01 -34.3 66.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.682 0.277 . . . . 0.0 111.202 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -38.84 87.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.153 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.41 -37.53 71.51 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.597 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 144' ' ' VAL . 11.1 t80 -61.47 -41.96 98.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.809 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.453 ' HD1' ' O ' ' A' ' 147' ' ' TYR . 1.2 m-85 -62.21 -37.58 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.847 177.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 56.9 t80 -70.41 -35.44 73.44 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.335 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.8 m -67.69 -31.81 72.02 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 140' ' ' PHE . 11.0 t -74.63 -91.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.806 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.43 18.58 22.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.412 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 7.8 mtmt 60.01 57.42 3.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.441 0.639 . . . . 0.0 110.205 -173.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.453 ' O ' ' HD1' ' A' ' 141' ' ' TYR . 51.2 m-85 -96.64 34.89 1.58 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.701 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.13 102.71 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.97 152.51 45.58 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.617 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 m -96.77 126.63 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 110.373 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.4 p -106.48 134.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.43 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -108.81 117.04 33.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.012 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.21 110.45 21.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.318 0.58 . . . . 0.0 110.1 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.69 117.0 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.386 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.67 112.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.185 0.516 . . . . 0.0 110.047 175.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 8.1 m -104.7 121.65 46.2 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 6.2 Cg_exo -79.9 143.78 16.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.109 2.539 . . . . 0.0 112.126 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -129.92 156.76 78.55 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.939 174.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.85 70.85 3.49 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.489 2.793 . . . . 0.0 113.266 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 158' ' ' LEU . 6.0 ttm180 -163.35 15.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.36 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.9 t30 55.59 42.27 29.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.199 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -129.95 157.99 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.815 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.789 HG21 HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.74 152.37 36.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.114 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.87 118.71 37.46 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.8 tp -99.17 112.18 24.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.128 -175.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HG2' HG22 ' A' ' 168' ' ' VAL . 8.2 ttmt -111.63 132.68 54.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.483 0.658 . . . . 0.0 111.145 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.511 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.5 mm? -108.63 109.41 20.6 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.408 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 166' ' ' LYS . 1.5 t -107.19 113.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.807 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 3.2 m-85 -98.34 118.91 36.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.117 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.4 114.68 19.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.627 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -80.49 99.99 8.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.538 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 99.63 98.9 2.21 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.701 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.485 HG13 ' H ' ' A' ' 174' ' ' SER . 2.2 p -138.69 -62.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.383 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 173' ' ' VAL . 1.7 m . . . . . 0 C--N 1.327 -0.413 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.917 ' HA ' ' HB ' ' A' ' 53' ' ' THR . 1.8 mm-40 57.33 62.3 2.22 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 124.289 0.993 . . . . 0.0 112.578 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.84 -53.17 0.98 Allowed Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.323 171.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p90 -150.47 152.23 33.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.878 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -85.86 118.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.1 119.04 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.354 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.65 -34.61 19.74 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.442 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.481 ' HB3' HG23 ' A' ' 83' ' ' THR . 20.8 t70 -158.57 145.6 17.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.196 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.645 HD13 HD21 ' A' ' 43' ' ' LEU . 4.6 mt -109.28 120.65 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -116.5 127.11 54.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.767 -178.736 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.41 136.52 40.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.406 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.2 58.22 0.69 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.955 0.883 . . . . 0.0 109.647 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.95 -121.57 0.93 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.611 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD22 ' HB ' ' A' ' 37' ' ' VAL . 20.3 mt 62.18 138.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.27 1.028 . . . . 0.0 113.755 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.33 -56.64 0.32 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.008 -0.432 . . . . 0.0 110.658 174.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -36.78 65.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.132 0.491 . . . . 0.0 110.334 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -101.7 141.59 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.721 -179.059 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.35 159.53 15.07 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.99 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -51.22 -43.23 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.83 -35.54 50.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.75 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.45 -29.2 64.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.215 0.531 . . . . 0.0 111.031 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.71 -34.65 60.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.409 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.772 HD22 ' HG2' ' A' ' 49' ' ' ARG . 2.3 mt -56.98 -30.26 63.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.384 0.673 . . . . 0.0 112.79 170.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.57 -29.31 69.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 111.445 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.745 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -91.33 -8.82 47.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.014 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.542 ' HG3' ' HA ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -86.28 132.55 42.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 6.7 Cg_exo -74.23 -8.61 21.1 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.784 2.323 . . . . 0.0 112.749 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.424 HG11 ' CG1' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -139.93 151.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.939 0.4 . . . . 0.0 110.418 -175.111 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.772 ' HG2' HD22 ' A' ' 43' ' ' LEU . 81.5 mtt-85 -131.57 179.41 6.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.576 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.4 p -63.08 123.43 18.56 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.256 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.44 -6.83 39.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.8 m-20 -87.61 148.87 24.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.816 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.917 ' HB ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -101.15 124.51 46.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.342 178.758 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.424 ' CG1' HG11 ' A' ' 48' ' ' VAL . 2.1 m -142.02 145.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -170.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -100.47 -177.76 3.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.38 -26.44 66.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.786 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.83 -31.64 68.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.642 0.258 . . . . 0.0 110.572 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.38 -29.38 59.83 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.202 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -44.84 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.72 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -68.28 -34.01 75.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.435 177.371 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -66.58 -40.87 89.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.006 0.431 . . . . 0.0 110.387 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.9 m -58.59 -43.8 89.65 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.154 172.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 60' ' ' SER . 74.6 mt -55.97 -47.15 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.743 176.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmm-85 -62.76 -42.53 99.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 69' ' ' THR . . . -59.63 -53.39 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 45' ' ' SER . 16.4 mt -63.6 -32.66 74.19 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.657 0.598 . . . . 0.0 111.624 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -39.66 91.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.0 110.888 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.67 60.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.222 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 45' ' ' SER . 42.3 p -79.78 -24.93 41.14 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -172.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.75 20.73 79.84 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.752 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -88.83 -26.34 21.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.292 0.568 . . . . 0.0 110.142 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.16 156.54 43.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.364 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.527 ' OE1' ' HE2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.64 -44.24 24.33 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.29 0.369 . . . . 0.0 111.275 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 31.5 t70 -130.73 139.28 50.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.285 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 66' ' ' LEU . 25.2 t -123.51 120.16 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.238 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.49 117.29 29.96 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.473 HG22 HG13 ' A' ' 86' ' ' VAL . 84.4 t -113.87 122.66 68.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.3 137.84 46.16 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.439 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 6.5 ptm180 -95.31 140.56 30.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.356 0.598 . . . . 0.0 110.387 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -130.62 96.94 4.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.43 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.68 -109.08 2.72 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.166 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -108.2 1.7 22.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 0.0 110.759 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.71 137.41 41.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 -173.624 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.71 115.54 30.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.24 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.6 tp -102.52 119.25 38.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.473 HG13 HG22 ' A' ' 77' ' ' VAL . 17.7 t -117.88 108.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.759 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.92 136.49 44.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.06 153.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.262 0.553 . . . . 0.0 111.073 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -98.91 122.27 41.94 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -147.98 167.08 25.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.74 -168.049 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.8 OUTLIER 110.59 -63.7 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 126.525 1.93 . . . . 0.0 113.243 172.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 20.0 Cg_exo -66.16 139.61 56.12 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 121.414 1.409 . . . . 0.0 112.917 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 66.9 m -127.75 133.35 49.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.319 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 125' ' ' LEU . 56.9 mt -69.13 118.86 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.09 -34.67 12.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.565 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 138.3 24.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 121' ' ' VAL . 4.7 mt -110.75 123.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 131.74 56.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.064 0.459 . . . . 0.0 110.898 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.657 ' HE2' HD13 ' A' ' 167' ' ' LEU . 21.2 m-85 -110.13 135.75 50.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.989 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.98 122.72 11.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.18 -14.5 64.39 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.535 174.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.29 78.11 3.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 110.829 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -85.84 -19.35 30.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -78.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.526 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.49 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 54.4 t -84.21 139.17 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -69.92 152.19 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.053 0.454 . . . . 0.0 111.644 -172.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.26 76.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.546 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -38.01 89.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mtp -73.05 -39.33 66.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.359 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.485 HD21 ' HE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -63.64 -32.74 74.31 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.417 177.375 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.439 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 10.3 mttt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.076 0.465 . . . . 0.0 110.954 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -28.76 55.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.622 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -67.84 -38.5 83.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.5 mm? -67.9 -38.46 83.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.467 175.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.47 -33.66 76.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.088 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.38 -16.11 60.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.079 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 m -91.83 -16.55 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.193 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 107.93 -25.65 19.95 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.921 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.19 107.89 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.155 0.503 . . . . 0.0 111.451 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.468 ' HA ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -140.94 175.49 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.548 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 97' ' ' ILE . 27.3 t -67.33 126.32 26.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 110.074 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.29 -6.77 66.18 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.34 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 160.4 14.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.234 0.54 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.91 117.97 23.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.802 174.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.835 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.89 137.42 33.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.093 0.473 . . . . 0.0 112.074 -172.224 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -101.9 105.98 16.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.878 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.446 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.02 -15.72 62.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.403 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.8 p -87.18 -20.45 26.96 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.56 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.3 p -98.69 6.83 46.73 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.927 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.6 mm -55.94 -37.58 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.05 85.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.18 -36.22 79.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 110.068 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.0 mt -66.33 -42.99 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.443 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.18 -45.0 96.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -34.15 77.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.325 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.53 -42.16 89.06 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.777 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.9 -38.62 91.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.452 ' HG3' HG12 ' A' ' 151' ' ' VAL . 13.8 mt-10 -69.62 -34.54 74.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.254 0.346 . . . . 0.0 111.067 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.52 -41.83 75.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.435 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 144' ' ' VAL . 5.4 m-85 -67.49 -37.18 82.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.49 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.95 -41.18 91.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.163 0.506 . . . . 0.0 110.476 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -30.35 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.51 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.8 m -72.35 -28.58 63.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.856 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 140' ' ' PHE . 31.4 t -77.54 -82.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.767 0.317 . . . . 0.0 111.092 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.5 19.46 21.85 Favored Glycine 0 N--CA 1.454 -0.101 0 C-N-CA 121.358 -0.449 . . . . 0.0 112.833 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm 66.05 34.35 7.0 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.341 0.656 . . . . 0.0 110.485 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -76.63 126.27 30.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.219 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.62 59.12 0.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.242 0.544 . . . . 0.0 110.565 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.95 148.21 22.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.642 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 m -97.86 118.82 35.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.942 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.7 p -98.8 137.35 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 116.95 19.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.077 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.49 111.53 23.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.424 0.631 . . . . 0.0 109.949 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.99 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.391 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.67 109.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.483 0.658 . . . . 0.0 110.219 175.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.6 m -104.67 113.47 64.93 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.811 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.37 128.13 8.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.085 2.523 . . . . 0.0 113.004 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -109.46 143.59 28.09 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.38 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 16.5 Cg_exo -67.69 79.52 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.83 3.02 . . . . 0.0 114.008 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -157.44 -75.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 6.3 t30 177.79 13.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.802 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.587 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 26.4 mmt-85 -117.92 157.7 26.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.414 -170.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.835 HG11 HD22 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -127.93 152.61 36.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.319 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -108.3 118.89 37.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.4 tp -106.58 110.7 22.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.07 0.462 . . . . 0.0 110.339 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -112.55 132.53 55.07 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.258 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.657 HD13 ' HE2' ' A' ' 99' ' ' PHE . 1.5 mp -114.31 112.09 22.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.696 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.55 112.99 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.596 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.51 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 2.4 m-85 -99.6 118.68 36.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.93 113.53 20.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.82 0.343 . . . . 0.0 110.867 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.38 61.51 1.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.668 0.747 . . . . 0.0 109.515 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.94 50.48 0.72 Allowed Glycine 0 CA--C 1.504 -0.595 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.895 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.511 ' HB ' ' H ' ' A' ' 174' ' ' SER . 0.1 OUTLIER -125.97 -145.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.892 -174.401 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.511 ' H ' ' HB ' ' A' ' 173' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.378 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.29 118.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.693 1.246 . . . . 0.0 111.602 177.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.09 44.83 64.79 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.487 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.606 ' HZ ' HD12 ' A' ' 84' ' ' LEU . 2.7 p90 -93.8 153.38 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.631 0.253 . . . . 0.0 110.51 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.36 117.78 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.245 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.16 137.91 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.233 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 -37.75 5.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.27 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -143.86 138.55 28.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.481 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.664 HG21 ' HE1' ' A' ' 46' ' ' MET . 86.7 mt -103.87 120.72 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 127.95 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.407 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -103.8 122.33 44.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.366 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.774 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 4.3 mt-10 -98.68 54.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.913 0.863 . . . . 0.0 109.907 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.87 -100.77 0.14 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.32 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' H ' HG23 ' A' ' 88' ' ' VAL . 7.1 mt 45.64 84.77 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.079 0.952 . . . . 0.0 112.946 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.543 ' HB2' ' HB2' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -96.95 -29.33 13.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.654 -176.265 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -118.16 -42.51 2.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.47 ' HB ' HD22 ' A' ' 34' ' ' LEU . 46.8 t -87.62 144.53 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.725 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.58 157.96 16.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.991 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -58.88 -31.61 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.56 81.23 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.872 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.19 -35.94 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.136 0.493 . . . . 0.0 110.696 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.42 83.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.442 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.626 HD22 ' HD2' ' A' ' 49' ' ' ARG . 2.6 mt -57.8 -32.76 67.87 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.58 -21.15 61.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.612 0.244 . . . . 0.0 111.352 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -93.45 -21.98 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.018 0.437 . . . . 0.0 110.369 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.664 ' HE1' HG21 ' A' ' 29' ' ' ILE . 77.0 mtm -82.65 135.73 45.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.39 -2.75 12.77 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.56 2.173 . . . . 0.0 112.444 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.78 147.56 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HD2' HD22 ' A' ' 43' ' ' LEU . 4.1 mmm180 -129.6 175.13 9.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.936 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.6 p -68.06 120.99 15.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.69 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.18 -5.27 52.56 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.424 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -80.02 155.89 27.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 0.0 111.594 -177.673 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -106.24 126.04 51.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.229 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 58' ' ' ASP . 0.3 OUTLIER -133.03 133.45 58.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 112.134 -168.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.449 ' O ' HD12 ' A' ' 59' ' ' ILE . 2.7 m120 -98.77 -177.27 3.6 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.094 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.32 -32.75 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.568 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.7 -43.09 89.94 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.549 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' A' ' 54' ' ' VAL . 31.1 m-20 -75.09 -27.99 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.246 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.915 HD11 ' HD3' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -59.78 -52.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 172.031 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -71.47 -26.29 62.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.259 178.563 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.439 ' HA ' ' HD2' ' A' ' 64' ' ' ARG . 1.8 t-20 -63.98 -47.14 81.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -60.78 -45.66 93.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 174.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 60' ' ' SER . 67.1 mt -53.72 -55.5 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 123.544 0.528 . . . . 0.0 110.886 177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.91 -30.47 67.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.08 -175.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.32 -48.22 68.22 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.558 0.218 . . . . 0.0 110.592 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB2' HG11 ' A' ' 75' ' ' VAL . 84.0 mt -69.27 -30.41 68.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -40.51 94.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 110.774 175.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.57 -13.43 62.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.601 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.3 p -79.03 -24.92 43.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.547 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.475 ' HA3' ' HG3' ' A' ' 123' ' ' GLU . . . 80.83 -10.25 47.64 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.317 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -67.07 -31.72 72.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.4 144.46 46.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.848 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -73.4 -37.25 66.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.054 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -139.49 136.51 34.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 66' ' ' LEU . 39.3 t -127.59 118.15 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.085 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.09 55.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.659 HG22 HG13 ' A' ' 86' ' ' VAL . 68.1 t -125.52 118.38 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 77' ' ' VAL . 2.2 mm? -133.14 159.14 41.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -172.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.915 ' HD3' HD11 ' A' ' 59' ' ' ILE . 15.5 mtm180 -113.49 147.59 37.6 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.655 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -135.27 96.83 3.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.736 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.8 -109.25 2.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.512 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 24' ' ' PHE . 3.8 m-20 -112.85 14.22 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.227 0.537 . . . . 0.0 109.923 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.45 136.82 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.257 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.606 HD12 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.34 112.13 24.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 tp -106.4 112.46 25.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.624 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 77' ' ' VAL . 8.3 t -114.51 117.12 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.774 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.0 mt-30 -106.97 124.94 50.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 34' ' ' LEU . 2.0 m -125.99 145.01 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.196 -174.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.16 111.7 24.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.175 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 35' ' ' GLN . 3.6 mt-10 -119.6 95.48 4.8 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.078 -0.388 . . . . 0.0 110.438 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.73 -69.71 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.86 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 124' ' ' SER . 18.9 Cg_endo -88.29 141.08 4.83 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.641 1.561 . . . . 0.0 113.939 -167.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.754 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 94.0 m -111.93 124.8 53.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.421 176.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 125' ' ' LEU . 19.0 mt -67.54 118.8 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.01 6.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.239 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.05 144.33 27.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.401 . . . . 0.0 110.856 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -106.9 123.87 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 171.304 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.99 141.35 49.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.381 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.547 ' HE1' ' HB2' ' A' ' 111' ' ' LYS . 24.1 m-85 -117.59 152.33 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 112.018 -172.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.79 111.91 3.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.556 ' HA2' ' HG2' ' A' ' 171' ' ' GLU . . . 118.46 55.09 0.28 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.257 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.534 HD21 HD22 ' A' ' 110' ' ' LEU . 33.1 m120 -126.24 41.52 3.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.224 -0.488 . . . . 0.0 112.044 -172.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -86.03 -16.03 39.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.526 177.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 141' ' ' TYR . 75.6 m -105.21 -45.19 4.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.639 0.257 . . . . 0.0 111.108 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.0 t -120.62 147.65 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.44 147.45 50.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.188 0.518 . . . . 0.0 111.939 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.74 -35.2 78.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.446 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -35.09 79.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.121 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -41.65 77.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.215 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.534 HD22 HD21 ' A' ' 102' ' ' ASN . 0.3 OUTLIER -62.87 -40.62 98.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.235 175.157 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.547 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -64.96 -43.27 93.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.224 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.11 -27.42 60.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -66.57 -43.65 84.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.417 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -61.63 -43.24 99.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.652 173.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.817 ' HG2' ' HG3' ' A' ' 120' ' ' ARG . 91.9 mt-10 -59.9 -42.95 94.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.511 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.75 -18.68 60.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.858 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 m -87.4 -17.18 32.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.632 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.75 -21.22 8.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.282 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.14 103.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.372 0.606 . . . . 0.0 110.147 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.817 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 12.2 ttp-105 -130.98 161.88 30.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.346 -172.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.419 ' HA ' HG22 ' A' ' 94' ' ' ILE . 24.2 t -69.9 124.43 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.956 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.68 -21.67 44.89 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.594 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.475 ' HG3' ' HA3' ' A' ' 70' ' ' GLY . 1.0 OUTLIER -95.79 166.22 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 110.758 -178.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -83.13 142.65 31.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.425 -176.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -116.22 138.64 51.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.451 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 25.6 t0 -94.8 121.07 36.01 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.195 0.998 . . . . 0.0 111.486 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -21.85 61.27 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.661 -1.608 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.9 p -89.6 -10.68 45.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.905 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 1.1 p -104.33 7.32 35.71 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.001 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.518 HD11 HD11 ' A' ' 125' ' ' LEU . 5.5 mm -55.31 -43.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.644 0.59 . . . . 0.0 111.854 -177.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 135' ' ' LYS . . . -62.48 -42.71 99.68 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.492 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.46 -29.02 66.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.888 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.25 -42.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.762 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.91 -46.76 89.38 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 50.6 mmtt -67.88 -36.39 80.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -40.23 84.79 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.374 -0.441 . . . . 0.0 112.608 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.531 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 10.0 mt -69.62 -31.97 70.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.881 ' HG3' HG23 ' A' ' 151' ' ' VAL . 6.2 mt-10 -64.62 -41.37 96.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.418 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -68.56 -34.06 75.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.543 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.463 ' HE1' HD12 ' A' ' 110' ' ' LEU . 28.0 t80 -60.76 -44.28 96.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.536 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.512 ' CE1' ' HB2' ' A' ' 104' ' ' SER . 0.2 OUTLIER -62.7 -38.95 92.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 177.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.55 -29.93 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.999 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 m -70.55 -30.33 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 140' ' ' PHE . 19.4 t -73.9 -82.28 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 110.853 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.69 18.67 22.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.029 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 63.73 40.82 7.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 110.271 -173.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -81.55 120.99 25.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.627 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 101.01 9.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -114.84 156.42 24.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.16 120.7 36.95 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.881 HG23 ' HG3' ' A' ' 138' ' ' GLU . 49.0 t -102.57 124.28 56.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 0.0 111.812 -172.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.85 115.82 26.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.87 111.12 23.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.65 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.66 112.97 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.033 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 117.65 49.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 109.369 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.6 m -104.67 116.89 60.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.944 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 163' ' ' VAL . 91.4 Cg_endo -86.84 136.73 4.42 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.096 2.531 . . . . 0.0 113.113 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.702 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -126.03 150.2 68.61 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 171.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 22.1 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.471 2.781 . . . . 0.0 114.108 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -113.67 26.37 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.208 -0.308 . . . . 0.0 110.81 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.5 t30 74.88 5.35 4.36 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 0.0 111.52 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.754 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 9.8 mmt-85 -113.56 160.29 18.69 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 111.176 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 157' ' ' PRO . 0.7 OUTLIER -136.73 145.26 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.486 175.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.23 131.02 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.67 117.44 33.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.773 0.321 . . . . 0.0 111.188 -173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 131.63 56.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 0.0 109.816 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.89 111.72 23.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.305 -175.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.4 t -94.94 111.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.785 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.531 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 8.7 m-85 -114.18 142.02 46.78 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.231 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -82.18 125.06 30.47 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 167.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.556 ' HG2' ' HA2' ' A' ' 101' ' ' GLY . 1.3 mt-10 -81.61 32.2 0.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -170.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.43 129.96 5.43 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.473 ' HB ' ' H ' ' A' ' 174' ' ' SER . 0.0 OUTLIER -81.08 -136.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.587 0.232 . . . . 0.0 110.395 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.473 ' H ' ' HB ' ' A' ' 173' ' ' VAL . 2.5 m . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.129 0.49 . . . . 0.0 109.732 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -110.32 154.21 23.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.09 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.41 115.75 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.355 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.38 142.45 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.486 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -38.31 7.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.398 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -143.32 146.91 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.9 mt -111.23 130.49 64.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.8 156.44 34.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.479 ' HD2' HG12 ' A' ' 39' ' ' VAL . 5.9 m-85 -128.53 119.66 25.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.41 73.9 2.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.738 0.78 . . . . 0.0 110.599 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.691 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.023 179.467 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.301 0 CA-C-O 120.444 0.164 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.479 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.4 m -57.05 -29.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.65 71.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.949 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 -33.94 57.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 110.381 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.62 -31.45 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.66 -32.02 64.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.799 0.839 . . . . 0.0 112.788 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.1 -23.7 65.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.838 0.351 . . . . 0.0 111.633 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.525 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -90.34 -7.49 53.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 178.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.466 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 56.7 mtp -100.39 132.64 22.19 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.9 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 23.1 Cg_exo -66.33 -19.99 55.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.886 2.391 . . . . 0.0 112.665 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -104.06 155.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.404 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.528 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.3 176.21 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -68.91 121.52 16.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.983 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.98 -6.33 51.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.139 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 2.9 m-20 -81.16 156.49 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 111.263 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.03 125.98 35.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.27 128.43 72.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 111.907 -173.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -98.42 -178.27 3.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.082 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.19 -26.77 65.0 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.62 -37.12 86.13 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.548 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.68 -30.96 64.69 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.433 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.84 -46.86 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 123.303 0.377 . . . . 0.0 110.264 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.52 69.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.141 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 2.0 t-20 -68.22 -43.4 78.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.999 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 p -64.2 -40.78 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.774 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.47 HG13 HG23 ' A' ' 77' ' ' VAL . 39.7 mt -55.87 -52.7 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 123.427 0.455 . . . . 0.0 110.997 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.7 -29.64 67.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.56 -52.54 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.703 0.287 . . . . 0.0 110.414 176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 45' ' ' SER . 66.9 mt -66.22 -27.28 67.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.872 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -38.54 76.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.973 -0.454 . . . . 0.0 110.236 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.82 -14.79 59.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.538 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 65' ' ' ALA . 69.0 p -79.71 -25.03 41.28 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.03 88.13 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.459 -0.791 . . . . 0.0 114.601 166.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.12 -29.18 38.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.578 0.689 . . . . 0.0 111.042 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.492 ' HE1' HD22 ' A' ' 66' ' ' LEU . 1.5 m-85 -107.1 152.98 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 6.7 mm-40 -86.67 -26.93 24.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.342 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 6.8 t70 -148.75 146.89 28.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 66' ' ' LEU . 62.1 t -129.89 119.8 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.112 0.257 . . . . 0.0 110.701 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.97 118.79 31.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.55 0.214 . . . . 0.0 110.928 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.47 HG23 HG13 ' A' ' 63' ' ' ILE . 27.5 t -107.91 123.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.89 157.85 44.79 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -102.7 148.21 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.398 0.618 . . . . 0.0 111.657 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -139.55 97.43 3.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.657 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.79 -118.47 8.3 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 15.83 24.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 110.003 174.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.71 128.58 52.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -102.33 115.69 31.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -113.79 129.53 56.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.681 0.753 . . . . 0.0 110.87 -175.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG13 HG22 ' A' ' 77' ' ' VAL . 13.1 t -113.98 105.78 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.413 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -90.91 133.92 34.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.86 154.89 33.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.038 0.447 . . . . 0.0 110.956 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.641 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 4.3 tptt . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.757 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 31.6 Cg_exo . . . . . 0 CA--C 1.53 0.316 0 CA-C-O 121.797 0.665 . . . . 0.0 113.648 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.589 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 29.3 m -96.12 146.48 24.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.877 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.451 HG13 ' HB2' ' A' ' 125' ' ' LEU . 6.0 mt -63.05 117.77 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.08 -48.62 3.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.41 137.52 34.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.138 0.494 . . . . 0.0 111.323 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.782 HG21 HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -111.63 121.75 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.09 52.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.756 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.595 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 23.1 m-85 -114.92 138.05 51.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -173.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.557 ' OG ' ' HE3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -138.79 112.16 8.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.418 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.726 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 112.56 22.32 5.81 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.371 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.16 69.52 7.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.229 0.537 . . . . 0.0 110.383 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -85.16 -26.77 26.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.357 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.6 m -112.28 -60.77 1.82 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.082 0.467 . . . . 0.0 111.197 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -89.28 141.52 14.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.512 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 146.49 52.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.709 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.16 -35.29 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -64.13 -35.61 81.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.1 mtp -67.16 -45.17 77.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.267 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.709 HD12 ' HA ' ' A' ' 107' ' ' ASP . 10.0 mt -62.72 -33.34 74.91 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.451 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -60.61 -48.9 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.303 0.377 . . . . 0.0 111.296 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -27.98 52.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.285 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -63.66 -44.28 94.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.281 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.782 HD22 HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -63.88 -42.85 97.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 175.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' A' ' 120' ' ' ARG . 8.6 mt-10 -61.25 -40.87 95.68 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.392 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.27 60.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.5 m -92.56 -16.36 25.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.235 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.32 -48.05 0.8 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.162 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 t -82.26 103.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.488 0.661 . . . . 0.0 109.685 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' HA ' ' HG2' ' A' ' 115' ' ' GLU . 2.2 ttp85 -128.6 149.49 50.61 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -174.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.03 123.61 21.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.155 0.502 . . . . 0.0 110.795 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.79 70.05 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.713 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -102.95 156.13 17.88 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -177.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.745 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -56.55 133.62 53.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.858 0.463 . . . . 0.0 111.216 174.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.91 145.36 24.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.326 0.584 . . . . 0.0 111.626 -176.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.556 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 12.8 t0 -117.44 121.64 41.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.049 173.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -17.47 61.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.912 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 p -88.64 -21.69 23.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.734 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 6.1 p -85.57 -7.68 58.72 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.405 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 153' ' ' ALA . 9.2 mm -57.45 -46.38 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.116 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.82 -34.55 78.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.75 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.07 -35.19 77.79 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.288 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.2 mt -67.13 -43.61 88.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.208 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -57.28 -49.81 74.91 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.13 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -68.12 -35.48 78.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.477 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.32 -41.63 77.79 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.734 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.444 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 49.3 mt -71.94 -32.64 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.675 ' HG3' HG23 ' A' ' 151' ' ' VAL . 18.0 mt-10 -63.6 -42.49 98.24 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.308 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.13 -37.94 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.916 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.2 m-85 -62.82 -42.62 99.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.386 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -40.59 95.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.11 -30.65 68.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.322 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.1 m -73.91 -27.63 61.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.366 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 140' ' ' PHE . 24.4 t -74.94 -85.09 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.87 19.3 23.43 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.32 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 49.9 1.76 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.394 0.677 . . . . 0.0 110.394 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -89.24 125.17 34.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.96 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.04 97.41 7.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.274 0.559 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -122.59 149.08 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.537 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.45 131.17 45.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.675 HG23 ' HG3' ' A' ' 138' ' ' GLU . 28.8 t -111.85 126.73 69.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.943 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 122.69 28.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.033 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.695 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -98.37 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.238 0.542 . . . . 0.0 110.902 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 28.0 t -98.27 120.61 47.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.61 118.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.619 . . . . 0.0 110.925 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.1 m -112.99 119.15 43.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.86 137.59 15.99 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.767 2.311 . . . . 0.0 112.709 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -121.55 148.96 51.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.578 175.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 8.5 Cg_exo -73.33 58.59 3.7 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.712 2.941 . . . . 0.0 113.911 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.578 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -144.86 18.07 1.62 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 60.43 40.15 17.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.526 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.589 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -141.77 167.13 22.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.711 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -127.68 143.33 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 110.965 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -110.8 118.76 37.02 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.487 ' HG ' HG23 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -116.62 132.57 56.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.884 0.85 . . . . 0.0 111.371 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.557 ' HE3' ' OG ' ' A' ' 100' ' ' SER . 5.3 tttt -115.35 133.3 56.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.964 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.595 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.0 mm? -102.56 111.31 23.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.241 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.7 113.92 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.664 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.726 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 38.6 m-85 -105.07 118.09 35.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.452 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.822 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.666 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 26.4 p90 -104.52 153.03 21.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.88 116.65 29.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.91 113.82 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.63 0.729 . . . . 0.0 110.489 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 7.2 mmtm -79.17 -32.44 44.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.967 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HB3' HG23 ' A' ' 83' ' ' THR . 24.0 t0 -149.32 139.91 22.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.079 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.3 mt -112.1 122.49 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.15 140.71 50.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -114.71 148.61 38.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.497 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -142.86 75.62 1.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.36 177.161 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.358 0 CA-C-O 120.246 0.07 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -59.12 -35.8 59.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.27 -40.07 87.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.801 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.21 69.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 110.49 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.05 -40.74 71.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HA ' ' SD ' ' A' ' 46' ' ' MET . 4.1 mp -62.91 -32.19 73.42 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.536 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 49.0 mt -69.32 -22.85 63.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.334 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -85.44 -18.0 34.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.662 ' HG2' HG23 ' A' ' 62' ' ' THR . 42.0 mtp -82.4 148.44 59.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.839 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.52 12.51 2.85 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.779 2.32 . . . . 0.0 113.126 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.11 166.43 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.722 ' HD2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.89 176.94 7.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.137 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -66.4 126.78 29.88 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.689 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.44 -4.46 54.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.657 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.722 ' HB2' ' HD2' ' A' ' 49' ' ' ARG . 2.6 t0 -92.32 156.81 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.412 . . . . 0.0 111.359 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 m -88.34 134.09 33.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.884 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.13 128.91 65.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 111.411 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -98.57 -178.31 3.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.263 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -37.07 79.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.284 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.81 -37.88 80.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.157 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -74.29 -30.45 62.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -50.43 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 173.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -67.62 -32.71 73.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.59 0.233 . . . . 0.0 111.213 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.55 -41.65 88.32 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.684 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.662 HG23 ' HG2' ' A' ' 46' ' ' MET . 91.2 m -60.37 -43.51 96.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 172.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 60' ' ' SER . 59.7 mt -56.07 -54.54 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 123.274 0.359 . . . . 0.0 111.122 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -69.33 -29.62 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.6 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HB2' HG11 ' A' ' 75' ' ' VAL . 80.3 mt -71.19 -30.09 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.814 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.85 -33.84 75.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.373 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.89 -13.27 61.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.196 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.5 p -78.94 -24.43 43.99 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.758 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.02 10.16 84.03 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.291 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -91.41 -25.51 19.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.941 0.4 . . . . 0.0 110.876 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.7 148.43 42.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.343 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -91.8 -14.06 30.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.158 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 9.3 t70 -154.65 138.31 16.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 66' ' ' LEU . 49.0 t -126.34 118.79 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.4 118.16 31.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.373 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.62 122.18 61.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mt -131.14 140.1 49.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.666 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -99.79 140.03 34.59 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.536 0.684 . . . . 0.0 110.293 -178.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.65 95.08 4.31 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.54 -109.58 2.97 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.484 ' HB2' ' HG2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -112.67 13.69 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 175.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.476 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -103.48 135.12 45.67 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.449 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -103.48 111.63 24.16 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.059 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 tp -104.28 119.63 39.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.868 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -117.05 113.75 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.325 0.583 . . . . 0.0 111.265 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -102.24 140.62 36.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.38 157.31 34.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 120.978 0.418 . . . . 0.0 110.438 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.416 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo . . . . . 0 N--CA 1.474 0.337 0 CA-C-O 121.523 0.551 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 4.3 m -110.42 140.22 44.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.897 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 121' ' ' VAL . 13.7 mt -59.09 119.05 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 109.832 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.45 -32.12 9.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.501 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.11 138.38 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.701 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.426 HG21 ' CD1' ' A' ' 114' ' ' LEU . 1.5 mt -118.75 132.16 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.04 139.19 52.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.652 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.524 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.6 m-85 -112.68 139.33 48.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.58 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.69 123.02 17.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.132 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.62 17.61 25.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.839 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.492 ' ND2' ' HB3' ' A' ' 99' ' ' PHE . 44.1 m-80 -96.94 77.24 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 111.033 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.26 -40.43 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.654 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -76.52 -57.88 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.353 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.57 143.95 10.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -71.02 145.95 49.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 0.0 112.091 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -39.89 84.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.098 171.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.13 -45.32 87.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.84 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -41.23 79.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -32.95 74.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.891 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -47.84 84.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 111.334 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -77.95 -27.12 49.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -63.88 -38.43 91.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.397 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.426 ' CD1' HG21 ' A' ' 97' ' ' ILE . 14.2 mt -68.14 -43.09 79.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.533 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -58.93 -43.53 91.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.194 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.3 61.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.629 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.4 m -91.17 -14.66 30.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 110.559 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.75 -26.55 7.55 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.971 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -89.16 104.0 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.187 0.517 . . . . 0.0 110.88 -176.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 3.6 ptp85 -140.59 172.42 12.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.501 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.554 ' HA ' HG22 ' A' ' 94' ' ' ILE . 50.9 t -69.97 128.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.35 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.12 61.78 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.337 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -120.85 146.31 46.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 35.2 t -65.69 151.73 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 111.227 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.53 145.21 24.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.596 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 130' ' ' ILE . 5.3 t70 -104.62 99.01 8.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.296 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.503 ' HA ' ' CG1' ' A' ' 130' ' ' ILE . 1.1 mtp180 -72.2 -18.31 61.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.912 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -75.02 -31.59 61.4 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.33 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 p -95.39 -2.85 48.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.159 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CG1' ' HA ' ' A' ' 127' ' ' ARG . 2.8 mm -55.59 -37.71 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.51 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -75.36 -27.13 59.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.872 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 19.1 mt -66.29 -50.02 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.927 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HG2' HG12 ' A' ' 151' ' ' VAL . 88.0 mt-10 -58.24 -49.09 78.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.638 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -40.32 93.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.573 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -34.86 65.08 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.197 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 137' ' ' LEU . 1.7 mm? -70.5 -40.26 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.927 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -58.77 -40.37 83.75 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.688 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.16 -38.78 91.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.824 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.41 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 2.1 m-30 -65.62 -38.07 88.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.505 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.69 -34.64 78.31 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 110.804 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.3 t80 -70.58 -30.75 67.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.96 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.27 -28.03 65.94 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.8 t -75.24 -88.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 110.574 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.464 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -112.68 18.61 22.25 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.716 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 20.7 mtmt 60.05 49.13 7.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 110.075 -173.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.248 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.22 97.12 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.335 1.022 . . . . 0.0 111.732 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.76 156.21 17.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.052 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 113.37 25.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.406 HG12 ' HG2' ' A' ' 134' ' ' GLU . 93.1 t -103.26 126.72 57.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -172.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -125.38 117.61 24.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.334 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.12 111.24 22.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.028 0.442 . . . . 0.0 110.092 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.1 t -94.08 123.27 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.245 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.4 m -109.89 117.62 55.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.6 m -109.55 117.42 52.75 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.121 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.68 142.49 16.14 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.667 2.245 . . . . 0.0 112.655 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -122.12 155.09 61.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 171.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.83 56.81 6.21 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.149 2.566 . . . . 0.0 113.76 -173.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.549 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -134.85 -89.53 0.35 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -167.75 36.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.666 ' HB2' HD11 ' A' ' 158' ' ' LEU . 10.9 mmt85 -131.42 162.2 30.73 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.442 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -135.2 148.01 28.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.858 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.27 127.45 53.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.82 122.16 46.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -120.48 132.7 55.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 110.559 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.524 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -102.07 110.79 22.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.201 -177.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.57 122.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.592 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.436 ' HE2' ' HB3' ' A' ' 167' ' ' LEU . 23.7 m-85 -113.69 118.31 33.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.421 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.914 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.946 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -110.12 151.57 27.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.23 117.95 29.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.32 107.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.535 0.683 . . . . 0.0 110.228 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -20.53 31.6 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.578 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.754 ' HB3' HG23 ' A' ' 83' ' ' THR . 20.5 t70 -156.83 137.98 13.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.913 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.4 121.29 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.13 126.48 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.99 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' HD2' HG12 ' A' ' 39' ' ' VAL . 80.2 m-85 -104.24 122.23 44.95 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.661 ' HG3' HD11 ' A' ' 85' ' ' LEU . 1.4 mm-40 -117.97 -8.81 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.853 -172.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.812 ' HA3' ' H ' ' A' ' 88' ' ' VAL . . . . . . . . 0 N--CA 1.447 -0.606 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.985 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.381 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.8 m -54.3 -43.51 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 O-C-N 123.981 0.801 . . . . 0.0 112.222 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.32 -38.0 46.73 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.688 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -67.7 -37.72 82.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.18 -35.93 64.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.88 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -58.92 -31.12 68.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.315 0.646 . . . . 0.0 112.54 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 41' ' ' ALA . 69.0 mt -69.29 -19.47 63.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.701 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.516 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -92.73 -8.37 44.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.785 ' HG2' HG23 ' A' ' 62' ' ' THR . 87.8 mtp -90.16 141.61 27.93 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.602 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 26.3 Cg_exo -64.31 -37.04 42.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.773 2.315 . . . . 0.0 112.768 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -121.96 155.47 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.39 -177.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -113.51 170.79 7.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.098 0.475 . . . . 0.0 110.983 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -67.24 138.72 57.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.2 177.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 -14.47 48.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.8 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.28 156.94 18.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 110.211 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.8 135.05 38.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.908 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.433 HG12 HG21 ' A' ' 48' ' ' VAL . 6.0 m -128.66 129.39 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.178 0.513 . . . . 0.0 110.889 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.19 -177.56 3.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.386 0.613 . . . . 0.0 110.645 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -65.37 -29.83 70.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.339 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.77 62.83 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.664 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 43.0 m-20 -74.13 -29.56 61.88 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.13 -49.26 84.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -66.86 -35.94 81.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.602 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -62.39 -45.13 94.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.426 177.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.785 HG23 ' HG2' ' A' ' 46' ' ' MET . 63.1 m -58.24 -47.06 84.71 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.267 174.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 77' ' ' VAL . 7.9 mt -56.92 -50.43 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.441 0.463 . . . . 0.0 111.142 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -69.81 -34.04 73.16 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.89 -46.7 70.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 45' ' ' SER . 60.7 mt -67.87 -30.9 70.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.914 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.56 99.23 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.11 -12.08 61.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.194 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 65' ' ' ALA . 32.7 p -78.42 -24.71 46.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.478 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.83 16.22 76.25 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.877 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -88.22 -32.48 18.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.303 0.573 . . . . 0.0 109.888 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.2 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 6.4 mm-40 -93.25 -27.1 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 14.8 t70 -141.78 137.07 31.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 88' ' ' VAL . 38.1 t -124.91 117.1 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.43 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.6 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.507 HG22 HD11 ' A' ' 63' ' ' ILE . 16.0 m -104.67 144.11 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 110.405 174.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.11 155.99 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -116.07 127.14 54.63 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.291 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.86 95.27 4.76 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.99 -110.47 3.51 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.839 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.78 10.07 30.88 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.754 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -103.65 128.78 50.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.8 -176.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.06 113.2 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 0.0 110.328 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.661 HD11 ' HG3' ' A' ' 32' ' ' GLU . 3.1 tp -93.9 112.66 24.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.216 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.56 106.85 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.301 0.572 . . . . 0.0 110.477 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -105.6 123.81 48.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.379 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.812 ' H ' ' HA3' ' A' ' 33' ' ' GLY . 4.2 m -124.51 147.47 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.445 0.641 . . . . 0.0 110.891 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.1 ttpt . . . . . 0 C--N 1.315 -0.932 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.135 -175.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.235 0.371 0 CA-C-O 121.555 0.564 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.504 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 86.6 m -94.6 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.842 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 125' ' ' LEU . 12.9 mt -73.21 118.73 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HB2' ' HG2' ' A' ' 162' ' ' ARG . . . -97.44 -42.81 7.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.12 147.17 33.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.482 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -117.96 123.58 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 172.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.963 -175.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.727 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 21.6 m-85 -114.27 133.88 55.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.792 0.329 . . . . 0.0 110.791 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.9 m -126.39 144.39 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.801 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.76 -79.97 0.26 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 47.07 49.97 14.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.752 0.821 . . . . 0.0 112.611 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -76.17 -42.64 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 m -130.54 -25.73 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.76 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 13.6 t -111.4 132.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 155.46 39.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.378 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.27 77.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.291 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.156 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -45.44 73.65 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -32.61 71.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.074 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.727 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 9.9 mttt -58.14 -48.79 79.15 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.425 0.453 . . . . 0.0 111.584 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.81 48.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.735 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.3 -38.12 88.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.662 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.9 mm? -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 2.8 mt-10 -65.58 -37.83 87.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.417 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.72 -16.39 61.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.233 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.3 m -88.21 -16.02 34.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.965 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.06 -32.38 5.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.326 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 125' ' ' LEU . 0.3 OUTLIER -90.73 113.0 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -174.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.569 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -141.06 176.72 8.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.642 -178.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 94' ' ' ILE . 53.1 t -67.43 127.2 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.912 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.48 -27.81 18.82 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.553 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.97 162.41 19.41 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.534 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -79.03 164.86 24.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -112.04 143.63 42.72 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.057 -177.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.444 ' HB3' ' HB ' ' A' ' 129' ' ' THR . 43.9 t0 -107.86 105.7 15.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.571 0.7 . . . . 0.0 110.097 174.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.468 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.3 -14.1 62.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.763 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.8 p -89.54 -23.47 22.01 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.071 0.939 . . . . 0.0 108.745 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 126' ' ' ASP . 5.3 m -87.89 -13.57 41.63 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.715 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.3 mm -53.69 -39.95 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.097 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.54 94.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.2 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.492 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 130' ' ' ILE . 15.6 mt -63.09 -44.39 99.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.923 174.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.75 -44.66 96.48 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.726 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -41.32 93.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.634 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.42 -38.41 69.98 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.704 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.16 -33.06 71.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 111.492 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.29 -34.2 75.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.507 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.83 -32.46 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.519 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -62.51 -39.37 93.31 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.676 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.434 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -64.5 -34.53 78.44 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.099 0.476 . . . . 0.0 110.872 177.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -69.49 -30.79 68.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.156 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.6 m -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.797 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 9.5 t -76.18 -85.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.627 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.8 19.96 22.82 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.674 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mttp 66.7 42.21 2.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.429 0.692 . . . . 0.0 110.569 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -87.26 139.44 30.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.442 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -115.16 74.47 0.88 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.238 0.542 . . . . 0.0 110.127 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.4 142.04 28.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.369 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.688 ' H ' ' HB2' ' A' ' 170' ' ' GLN . 0.9 OUTLIER -99.41 126.42 45.3 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 11.4 p -113.4 138.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.176 0.512 . . . . 0.0 111.388 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.89 125.21 39.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.658 175.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.616 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.258 0.551 . . . . 0.0 110.919 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.57 128.77 56.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.329 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.74 123.36 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.433 0.635 . . . . 0.0 111.204 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 m -107.01 120.19 48.82 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.579 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 9.6 Cg_endo -89.64 130.4 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.408 2.739 . . . . 0.0 112.952 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -113.47 152.95 45.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 22.47 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.04 2.493 . . . . 0.0 113.876 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -115.72 19.98 14.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.992 0.425 . . . . 0.0 110.144 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 t30 67.51 26.62 8.14 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.999 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.531 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -129.75 167.03 18.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.288 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.497 HG21 HD22 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -133.21 153.53 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.0 0.429 . . . . 0.0 111.139 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -108.92 118.82 37.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.494 HD11 ' HB1' ' A' ' 153' ' ' ALA . 59.4 tp -101.18 113.47 26.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.352 -175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -105.15 131.34 52.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 111.01 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.7 108.58 19.48 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.632 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 2.8 t -101.28 111.74 31.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.885 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -99.53 146.61 26.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.688 ' HB2' ' H ' ' A' ' 150' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.886 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.208 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' HE1' HD11 ' A' ' 59' ' ' ILE . 10.9 p90 -95.49 153.39 17.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.395 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.17 118.98 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -69.88 122.46 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -49.59 7.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.122 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.07 140.99 29.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.247 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.527 HG21 ' HE1' ' A' ' 46' ' ' MET . 7.1 mt -104.85 121.17 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 172.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 127.74 53.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.988 0.423 . . . . 0.0 110.121 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD2' HG12 ' A' ' 39' ' ' VAL . 75.7 m-85 -102.79 125.84 49.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.024 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.01 68.92 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.348 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.562 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 31' ' ' PHE . 5.6 m -53.63 -40.25 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.118 0.886 . . . . 0.0 112.604 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.12 -33.45 57.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.489 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.25 -35.25 63.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.54 74.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.507 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.51 -32.35 57.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.032 0.933 . . . . 0.0 112.879 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.7 mt -69.45 -14.04 62.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.499 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -100.06 -7.45 24.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.744 176.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.527 ' HE1' HG21 ' A' ' 29' ' ' ILE . 14.4 mtm -102.24 136.34 19.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.394 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.37 12.67 2.78 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.7 2.267 . . . . 0.0 113.296 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.73 HG12 HG11 ' A' ' 54' ' ' VAL . 32.0 m -119.08 149.12 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 49' ' ' ARG . 6.0 mmm-85 -131.85 166.22 22.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.504 0.668 . . . . 0.0 111.598 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 p -68.12 121.28 15.82 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.611 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.26 62.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.222 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.19 150.78 25.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.082 0.468 . . . . 0.0 111.224 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 116.35 32.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.73 HG11 HG12 ' A' ' 48' ' ' VAL . 14.7 m -133.2 156.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.081 0.467 . . . . 0.0 112.001 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 11.6 m-80 -99.3 179.16 4.67 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.312 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.84 -32.83 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.191 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.67 -31.73 72.9 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 12.2 m-20 -75.2 -33.72 61.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.075 177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 55' ' ' ASN . 1.3 mp -63.14 -46.63 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 171.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.76 ' HA ' HD12 ' A' ' 63' ' ' ILE . 19.0 m -65.35 -31.86 73.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.303 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -70.01 -38.87 76.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.407 178.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 m -58.29 -46.67 85.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 171.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 60' ' ' SER . 68.8 mt -55.33 -55.0 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.385 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -29.55 68.19 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.7 -45.71 74.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.485 0.183 . . . . 0.0 110.614 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 45' ' ' SER . 93.7 mt -69.39 -30.89 68.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.58 -35.01 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.74 -12.75 61.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.445 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.5 p -78.87 -25.1 43.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.497 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.5 8.04 83.53 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.609 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -82.99 -48.77 10.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.997 0.427 . . . . 0.0 110.829 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.85 150.16 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -53.75 17.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -135.49 140.7 45.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -121.47 118.65 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.404 ' HG2' HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -120.07 118.79 31.51 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.021 175.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 HG13 ' A' ' 86' ' ' VAL . 98.3 t -118.06 122.74 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.404 HD11 ' HG2' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -133.25 158.6 42.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 150.84 31.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.999 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -125.49 95.03 4.31 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.33 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.11 -108.44 2.35 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.276 -171.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -104.36 5.54 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.643 0.377 . . . . 0.0 111.323 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.97 133.11 49.48 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.401 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 111.75 24.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.233 0.539 . . . . 0.0 110.127 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.0 tp -100.58 112.95 25.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.038 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.41 HG13 HG22 ' A' ' 77' ' ' VAL . 36.7 t -106.86 105.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.483 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -105.42 126.52 52.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.25 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.55 144.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.253 0.549 . . . . 0.0 109.867 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.33 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 13.9 Cg_exo . . . . . 0 C--O 1.234 0.304 0 CA-C-O 121.518 0.549 . . . . 0.0 113.234 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -96.66 134.25 40.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.426 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 125' ' ' LEU . 25.7 mt -65.06 118.63 7.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.6 -34.88 14.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -157.93 154.36 27.72 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 110.448 174.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 114' ' ' LEU . 1.1 mt -112.67 122.96 67.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.127 172.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.511 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -103.38 130.74 50.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.049 -178.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.659 ' HB3' HD21 ' A' ' 102' ' ' ASN . 19.9 m-30 -112.96 134.77 54.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.862 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -142.35 137.17 30.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.435 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.26 76.98 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.636 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.659 HD21 ' HB3' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -89.97 72.35 7.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.644 0.735 . . . . 0.0 110.648 -177.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 12.9 mmmt -86.41 -19.91 28.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.865 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -53.0 6.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.92 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.2 t -107.45 141.4 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -68.98 158.11 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 112.608 -171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.29 95.38 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.243 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.48 -34.76 72.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.721 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.4 82.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.176 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -32.87 74.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.818 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -59.64 -44.8 93.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.372 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.529 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 4.1 tm0? -77.72 -28.53 50.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.36 -45.74 91.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.046 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.485 ' CD1' HG21 ' A' ' 97' ' ' ILE . 18.0 mt -67.95 -36.59 80.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.831 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -59.88 -46.14 90.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.137 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -15.97 61.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.542 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.4 m -90.94 -12.11 37.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.749 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.03 -20.8 19.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.631 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.4 102.41 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.303 0.573 . . . . 0.0 110.762 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.24 173.56 11.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.543 -178.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HA ' HG22 ' A' ' 94' ' ' ILE . 65.4 t -69.36 125.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 110.651 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.11 -5.62 61.38 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 4.3 mm-40 -107.14 160.3 15.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.34 138.79 40.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.754 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.67 145.99 24.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.752 -175.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -115.83 103.76 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.649 0.737 . . . . 0.0 110.425 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.566 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.47 -15.3 62.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.562 178.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p -84.11 -20.66 32.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.095 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 p -100.64 3.26 42.37 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.23 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.9 mm -57.5 -41.52 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.768 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.9 -38.01 87.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 111.51 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -33.84 73.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.677 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.92 -44.11 88.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.908 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 92.3 mt-10 -57.28 -51.3 69.91 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.488 175.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -61.95 -34.2 75.68 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.756 0.66 . . . . 0.0 111.758 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.62 86.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.932 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.42 HD22 ' HZ ' ' A' ' 169' ' ' PHE . 9.9 mt -73.87 -36.61 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 134' ' ' GLU . 1.9 pt-20 -72.55 -28.86 63.09 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.4 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.22 -40.84 64.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.269 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.538 ' O ' HG23 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -61.9 -44.3 97.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.13 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.05 90.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.496 0.498 . . . . 0.0 111.278 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -67.08 -33.98 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.188 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.5 m -72.23 -28.75 63.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.899 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 140' ' ' PHE . 41.2 t -78.55 -82.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.998 0.427 . . . . 0.0 110.913 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.558 ' O ' ' HG2' ' A' ' 146' ' ' LYS . . . -112.7 20.9 19.74 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-O 118.88 -0.955 . . . . 0.0 113.21 -172.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER 70.02 16.72 7.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.759 1.224 . . . . 0.0 111.064 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -60.42 118.0 5.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.285 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.22 94.66 9.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.595 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.69 143.23 50.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.762 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.56 120.66 39.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.53 124.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -129.39 120.31 25.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.301 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.644 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -98.31 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.201 0.524 . . . . 0.0 110.181 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.33 123.56 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.167 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 t -98.61 113.36 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.038 0.447 . . . . 0.0 110.19 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.0 m -106.0 123.54 38.82 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.12 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -88.23 146.11 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.892 2.394 . . . . 0.0 113.138 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -135.26 157.63 76.32 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.6 51.22 3.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.966 2.444 . . . . 0.0 113.932 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.47 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.33 17.02 2.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.97 176.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 41.7 t30 60.43 37.47 19.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.261 1.029 . . . . 0.0 109.933 -173.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.511 ' HB2' HD11 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -131.08 161.39 32.16 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.527 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.754 HG21 HD22 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -133.4 147.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.64 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -108.92 119.05 38.41 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.2 tp -99.18 115.78 29.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.212 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.511 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -105.56 132.29 51.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.423 0.63 . . . . 0.0 111.194 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 1.8 mm? -108.84 109.93 21.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.163 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 t -101.34 114.19 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.268 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.42 ' HZ ' HD22 ' A' ' 137' ' ' LEU . 43.6 m-85 -105.51 118.32 36.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.246 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.317 -0.806 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -113.33 154.12 27.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.099 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.13 116.66 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.622 ' HB ' ' HA ' ' A' ' 50' ' ' THR . 0.5 OUTLIER -65.22 114.29 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 121.359 0.6 . . . . 0.0 111.285 -177.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 2.1 mttm -76.99 -39.97 48.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.812 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -156.89 142.26 17.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.217 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.586 HD12 HD21 ' A' ' 43' ' ' LEU . 91.9 mt -104.26 121.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.565 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -115.71 127.56 55.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.516 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.56 ' HE2' ' HE1' ' A' ' 46' ' ' MET . 0.7 OUTLIER -106.18 146.23 30.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.16 0.505 . . . . 0.0 111.163 -176.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -133.41 156.62 47.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.484 178.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.716 -176.446 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.243 0 CA-C-O 120.42 0.153 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.84 -33.52 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.92 -36.95 60.92 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.255 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.742 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -73.2 -34.05 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.0 110.168 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.09 73.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.843 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 29' ' ' ILE . 3.8 mt -60.93 -32.72 72.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.074 0.55 . . . . 0.0 111.811 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 41' ' ' ALA . 17.6 mt -71.85 -20.39 61.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.98 0.419 . . . . 0.0 111.249 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.524 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -91.73 -10.96 38.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.894 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.56 ' HE1' ' HE2' ' A' ' 31' ' ' PHE . 53.8 mtm -94.78 135.83 23.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.69 -17.6 29.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.642 2.228 . . . . 0.0 112.725 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 149.56 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.718 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -120.91 176.27 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.896 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.622 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -67.48 136.07 54.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.01 -8.72 59.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.529 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.16 156.23 17.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.93 125.12 34.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.525 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.22 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.308 0.575 . . . . 0.0 111.563 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.81 -177.78 3.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -25.67 64.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -65.71 -35.8 81.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.396 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.647 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 53.0 m-20 -74.6 -28.9 61.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.908 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.97 -47.0 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 172.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -30.3 68.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.5 m-20 -67.36 -46.53 73.07 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.778 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 p -62.88 -38.86 92.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.006 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.6 mt -55.81 -54.12 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 123.427 0.454 . . . . 0.0 110.626 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 64' ' ' ARG . 9.6 ptm85 -70.23 -31.19 68.48 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.9 70.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.538 0.208 . . . . 0.0 110.713 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 45' ' ' SER . 58.9 mt -69.94 -30.79 68.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.731 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -37.87 88.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 110.647 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.1 -13.42 61.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 45' ' ' SER . 19.0 p -79.26 -24.79 42.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.629 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.12 -1.76 73.54 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.432 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -76.34 -47.1 24.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.403 0.621 . . . . 0.0 109.887 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.6 136.3 54.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.29 -18.27 25.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.54 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 24.6 t70 -122.74 134.47 54.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.4 t -132.7 118.46 34.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.61 116.82 27.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.731 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.9 t -103.9 122.51 56.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -125.69 148.78 48.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.71 136.91 53.03 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.501 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.22 95.99 4.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.364 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.75 -111.68 4.32 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 40.3 m-20 -106.16 7.01 31.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.976 0.417 . . . . 0.0 110.486 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.47 133.61 48.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.421 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 111.8 24.62 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 3.6 tp -104.32 116.43 32.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.056 0.455 . . . . 0.0 110.752 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.5 110.99 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 6.3 mt-30 -96.65 127.75 42.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.18 162.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 0.0 111.554 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.244 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 5.7 Cg_endo . . . . . 0 N--CA 1.454 -0.852 0 CA-C-O 121.105 0.377 . . . . 0.0 112.241 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 59.8 m -125.19 137.79 54.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 125' ' ' LEU . 21.7 mt -74.94 120.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.12 -38.59 10.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.063 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.52 143.0 25.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.485 HG21 HD22 ' A' ' 114' ' ' LEU . 2.4 mt -123.13 128.07 74.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 141.56 47.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.47 177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.466 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.9 m-85 -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.619 0.247 . . . . 0.0 111.021 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.0 140.42 42.12 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 169' ' ' PHE . . . 85.39 16.22 64.8 Favored Glycine 0 C--N 1.328 0.113 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.695 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 1.7 p30 -79.47 69.92 5.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.54 0.686 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -83.13 -47.62 11.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.184 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -27.96 24.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 2.2 t -126.66 141.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -68.84 156.72 37.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.139 0.495 . . . . 0.0 111.619 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -33.95 77.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 171.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.853 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -60.99 -39.42 89.57 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 175.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.9 mtp -73.33 -39.04 65.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.218 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -62.8 -32.62 73.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.242 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' A' ' 108' ' ' ASP . 7.6 mtmm -57.14 -48.52 78.47 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.591 0.557 . . . . 0.0 111.138 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.1 45.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.415 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -37.63 88.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.485 HD22 HG21 ' A' ' 97' ' ' ILE . 1.1 mp -72.31 -38.38 68.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.921 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 16.4 mt-10 -62.67 -39.45 93.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.901 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.48 -15.66 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.125 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.631 ' HB2' HG12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -95.0 -16.14 22.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 175.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.16 -37.01 2.37 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.608 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.66 111.53 22.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.267 0.555 . . . . 0.0 111.715 -171.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.03 171.17 14.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.223 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.25 127.82 31.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.233 0.54 . . . . 0.0 110.598 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.65 53.26 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.497 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.576 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 1.1 tp10 -89.02 156.72 18.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 122.71 0.404 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.99 134.48 43.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.728 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -114.89 142.85 46.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.227 -177.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.542 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 33.6 t0 -117.58 133.48 55.91 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 110.054 164.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.408 ' CD ' ' H ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -71.29 -16.04 62.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.714 178.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 p -82.47 -26.59 32.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.461 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -86.52 -11.48 51.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.428 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 130' ' ' ILE . 5.9 mm -55.15 -40.13 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.732 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.68 91.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.11 -35.21 76.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.13 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.631 HG12 ' HB2' ' A' ' 117' ' ' SER . 3.2 mt -67.41 -40.2 84.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.213 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -61.1 -40.92 95.57 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.45 96.97 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.869 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.33 -37.23 92.65 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.528 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.667 HD22 ' HZ ' ' A' ' 169' ' ' PHE . 8.2 mt -66.83 -36.81 83.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.752 0.31 . . . . 0.0 110.943 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.2 -39.56 86.37 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.67 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -67.01 -43.35 83.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.07 -44.1 97.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.641 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -38.35 87.08 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.962 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -28.98 65.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m -70.94 -27.58 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.409 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 4.1 t -75.2 -83.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 111.187 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.409 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.85 19.77 22.93 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.525 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.87 44.26 13.96 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.734 0.778 . . . . 0.0 110.504 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -80.03 118.66 21.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.935 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 m -89.51 86.36 6.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.003 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.11 144.53 25.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.022 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.3 113.44 25.39 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.9 m -101.16 133.0 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.384 0.611 . . . . 0.0 111.519 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 116.69 18.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.574 172.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.6 110.8 22.77 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.386 0.612 . . . . 0.0 109.909 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.65 113.47 36.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.108 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.18 110.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.775 0.798 . . . . 0.0 109.205 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 7.3 m -112.41 116.46 48.54 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.842 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.502 ' HA ' HG12 ' A' ' 163' ' ' VAL . 59.0 Cg_endo -71.79 135.65 26.21 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.624 2.216 . . . . 0.0 112.429 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -100.54 159.03 30.78 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.261 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.33 80.07 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.18 2.586 . . . . 0.0 113.306 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 1.0 OUTLIER -174.51 -112.31 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.712 0.805 . . . . 0.0 109.188 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 3.0 t-20 -146.15 9.62 1.12 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.968 0.89 . . . . 0.0 109.842 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.538 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 1.1 mpt_? -117.92 167.36 11.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.868 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 125' ' ' LEU . 18.5 m -130.95 159.76 42.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 111.466 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.43 119.13 38.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.444 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.7 tp -108.19 125.95 52.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.459 ' HB3' ' HE2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -123.43 132.27 53.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 111.132 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 2.7 mm? -108.52 110.87 22.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.011 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.18 112.3 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.331 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.667 ' HZ ' HD22 ' A' ' 137' ' ' LEU . 11.4 m-30 -109.65 127.86 54.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.323 0.582 . . . . 0.0 111.398 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.16 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -104.99 153.18 21.79 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.8 t -87.06 113.84 25.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -72.07 125.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.6 0.714 . . . . 0.0 110.346 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -91.4 -29.66 16.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.974 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.45 137.12 14.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.056 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.4 mt -109.64 121.38 62.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -119.88 127.86 53.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.174 0.511 . . . . 0.0 109.851 -178.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.68 ' HD2' HG12 ' A' ' 39' ' ' VAL . 58.7 m-85 -101.34 149.22 24.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.066 -175.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -137.73 167.4 21.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.402 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.54 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.27 -178.556 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.68 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.6 m -56.67 -41.85 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 123.857 0.723 . . . . 0.0 112.151 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.27 -34.16 55.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.573 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.75 -34.43 64.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.135 0.493 . . . . 0.0 110.953 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.32 -33.81 59.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.834 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.84 -31.04 58.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 112.695 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 78.4 mt -66.56 -18.95 65.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.77 -8.45 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.695 0.284 . . . . 0.0 110.823 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.474 ' SD ' ' HZ ' ' A' ' 31' ' ' PHE . 36.7 mtp -93.23 136.6 24.25 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.613 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 3.0 Cg_exo -78.41 6.56 4.69 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.069 2.513 . . . . 0.0 112.597 174.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.8 156.64 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 20.2 mtp85 -132.47 176.6 8.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.423 0.63 . . . . 0.0 112.114 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.9 p -67.84 120.49 14.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.883 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.31 44.94 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.095 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.4 OUTLIER -77.72 156.27 30.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.147 0.499 . . . . 0.0 111.573 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.67 117.01 30.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.16 129.07 73.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 112.283 -168.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -100.14 -175.96 3.09 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.72 172.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.46 -26.21 68.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.966 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.33 -34.02 70.17 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.52 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -74.33 -29.7 61.71 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.427 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.27 -44.85 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.478 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 p -71.0 -29.62 65.63 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 110.568 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.9 -45.73 73.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 p -63.74 -39.49 94.4 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.673 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 28.9 mt -56.04 -50.68 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 123.364 0.415 . . . . 0.0 110.326 174.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 mtt85 -65.04 -36.63 84.96 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.545 0.528 . . . . 0.0 111.985 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.67 -48.76 71.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.068 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.471 HD22 ' HE1' ' A' ' 72' ' ' PHE . 29.3 mt -70.71 -30.78 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.46 -36.25 78.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 110.724 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.05 -13.59 61.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.208 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 65' ' ' ALA . 19.0 p -78.77 -25.06 44.37 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.435 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.38 21.04 72.07 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.639 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -85.56 -23.89 27.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.7 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HE1' HD22 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -127.12 176.76 7.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.575 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 3.6 mm-40 -97.16 -23.42 16.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.664 0.268 . . . . 0.0 111.521 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.784 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 3.6 t70 -155.67 145.0 20.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.5 119.07 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -121.01 124.96 46.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.306 0.574 . . . . 0.0 110.997 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.5 t -101.3 123.35 54.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.07 158.01 39.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 145.78 47.62 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.386 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -128.03 96.09 4.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.7 -110.14 3.31 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.54 13.77 23.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.38 132.18 50.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.802 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 111.58 24.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.035 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 4.2 tp -105.11 112.75 25.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.407 ' HB ' ' CD1' ' A' ' 31' ' ' PHE . 18.3 t -108.58 106.75 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 54.1 mt-30 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.08 159.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.835 0.35 . . . . 0.0 110.381 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 3.3 tptm . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.501 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 16.8 Cg_exo . . . . . 0 C--O 1.233 0.237 0 CA-C-O 121.412 0.505 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.7 m -102.58 139.77 37.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.161 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.4 mt -62.15 118.86 5.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.01 -25.41 11.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.14 0.495 . . . . 0.0 110.554 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -147.96 138.56 23.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.655 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.89 120.51 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.689 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 2.3 m -118.85 143.12 47.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.985 0.421 . . . . 0.0 111.006 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.808 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -121.75 135.93 54.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.497 -172.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.3 m -147.24 119.78 8.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.66 -7.96 39.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.791 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -81.11 83.88 6.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 110.937 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -85.92 -29.52 23.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.841 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -66.35 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.518 -175.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.497 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 15.1 t -90.47 142.52 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -69.74 146.48 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.07 0.462 . . . . 0.0 111.814 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.549 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 4.5 p30 -63.86 -33.01 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.206 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.58 -40.02 95.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.5 mtp -67.96 -40.32 83.23 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.381 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.03 -36.07 82.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.841 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.808 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 15.6 mttt -58.92 -46.1 88.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.816 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 3.0 tp60 -76.66 -27.98 55.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.288 -177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.36 -49.95 71.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.69 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.44 -34.96 79.1 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.977 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -60.46 -42.47 96.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.437 178.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.03 -15.56 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.686 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.9 m -88.08 -16.58 33.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.51 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.35 -15.21 22.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.112 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.46 103.73 15.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.241 0.543 . . . . 0.0 110.162 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 115' ' ' GLU . 12.3 mtm180 -134.34 172.15 13.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.203 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.87 123.64 28.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 110.206 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.25 71.2 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.004 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 159.77 15.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 120.895 0.378 . . . . 0.0 110.81 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -66.33 142.93 57.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.925 170.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.565 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.48 148.23 22.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.087 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.72 98.1 6.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.459 0.647 . . . . 0.0 110.516 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.466 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -70.49 -14.83 62.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.56 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 p -85.08 -23.02 28.7 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.299 -0.251 . . . . 0.0 111.172 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 p -100.24 5.53 44.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.466 HG12 ' HA ' ' A' ' 127' ' ' ARG . 7.0 mm -57.64 -42.78 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.427 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . . . -64.86 -38.09 89.81 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.803 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 -27.46 63.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.779 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.2 mt -67.45 -44.99 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 131' ' ' ALA . 35.5 mt-10 -61.37 -47.77 84.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.241 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.51 82.2 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.959 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.02 -30.43 63.25 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.891 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.5 mt -76.11 -32.61 59.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.689 0.244 . . . . 0.0 110.741 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.595 ' HG3' HG23 ' A' ' 151' ' ' VAL . 6.5 mt-10 -64.98 -39.52 93.6 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 173.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -66.47 -43.56 85.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.599 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -62.37 -33.4 74.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.17 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.497 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -71.34 -44.41 65.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.139 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -30.22 66.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -173.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -28.85 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.469 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.58 -84.77 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.48 19.62 23.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.98 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? 62.56 52.55 2.88 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.446 0.641 . . . . 0.0 109.65 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -88.8 105.41 17.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.048 -173.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.08 121.57 32.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.308 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.49 162.69 40.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.06 114.47 27.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.595 HG23 ' HG3' ' A' ' 138' ' ' GLU . 23.3 t -96.67 123.1 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.036 0.446 . . . . 0.0 110.812 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -124.71 117.7 24.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.78 111.62 23.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.37 133.05 61.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.03 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.26 123.04 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.274 0.559 . . . . 0.0 110.43 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.3 m -104.37 119.83 52.66 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.158 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 131.05 11.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 112.583 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -123.1 155.67 64.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.96 56.26 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.831 2.354 . . . . 0.0 113.879 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.501 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -144.32 19.37 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 177.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 38.5 t30 60.21 38.55 20.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 122.185 0.993 . . . . 0.0 109.247 -173.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.454 ' HB2' HD11 ' A' ' 158' ' ' LEU . 7.3 mmt180 -130.28 160.62 33.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.143 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -130.74 148.64 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.986 178.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.25 122.26 46.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.91 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.3 tp -96.13 110.39 22.67 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.689 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -113.22 132.06 55.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.792 0.806 . . . . 0.0 111.426 -175.428 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -107.78 110.69 22.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.445 -176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.93 111.05 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.448 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.93 117.43 34.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.373 -174.78 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -110.4 153.11 25.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.973 -0.613 . . . . 0.0 109.972 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -79.68 113.32 18.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.79 125.49 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.49 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -85.54 -31.5 22.68 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.671 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB3' HG23 ' A' ' 83' ' ' THR . 29.5 t70 -157.63 147.01 19.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.245 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.8 mt -109.9 120.14 60.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.77 127.03 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.941 -176.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -105.11 120.13 40.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.578 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 52.8 mm-40 -103.64 66.18 0.85 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.665 0.745 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.733 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.945 179.057 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.151 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -51.86 -40.49 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.16 -41.77 94.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.145 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.14 68.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.826 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.3 81.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.85 -31.61 72.84 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.932 0.493 . . . . 0.0 111.186 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.4 mt -74.55 -13.21 60.64 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.819 ' HB3' HG21 ' A' ' 69' ' ' THR . 1.2 m -96.01 -8.19 34.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.15 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.695 ' HG2' HG23 ' A' ' 62' ' ' THR . 62.9 mtp -91.5 148.96 38.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.419 175.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 7.2 Cg_exo -75.0 -10.85 21.39 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.671 2.247 . . . . 0.0 112.212 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.4 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.175 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -133.76 177.96 7.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.2 p -66.27 131.29 45.78 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.221 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.68 -7.4 65.49 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.51 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -97.7 156.05 16.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 111.003 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.27 124.04 34.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.717 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.32 135.84 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.11 0.481 . . . . 0.0 110.864 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.401 ' O ' HD12 ' A' ' 59' ' ' ILE . 36.5 m-80 -98.51 -178.75 4.11 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.13 -36.88 85.64 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.37 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.04 -29.2 68.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.067 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 17.7 m-20 -73.75 -29.81 62.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.077 0.151 . . . . 0.0 110.866 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -61.99 -50.71 78.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 171.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.759 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -66.07 -29.26 69.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.623 176.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.539 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -69.58 -41.03 76.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.989 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.695 HG23 ' HG2' ' A' ' 46' ' ' MET . 85.2 m -58.61 -46.92 86.0 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.941 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 60' ' ' SER . 66.6 mt -52.83 -55.38 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.682 0.614 . . . . 0.0 110.854 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.59 -29.41 66.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.434 -174.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.66 -54.82 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 66' ' ' LEU . 30.2 mt -62.54 -30.81 71.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.343 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -46.2 83.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.69 60.1 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.819 HG21 ' HB3' ' A' ' 45' ' ' SER . 82.2 p -79.91 -24.13 41.31 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.821 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.07 78.56 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.067 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -82.74 -36.33 25.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.102 0.477 . . . . 0.0 110.383 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -129.72 164.36 24.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.516 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.528 ' HG2' ' HD3' ' A' ' 89' ' ' LYS . 0.7 OUTLIER -77.72 -50.99 11.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.447 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -133.49 144.05 49.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.392 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.28 120.68 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -114.26 118.43 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.801 174.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.451 HG22 HG13 ' A' ' 86' ' ' VAL . 51.3 t -112.42 123.08 67.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.017 0.437 . . . . 0.0 109.934 173.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.75 159.03 43.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -96.06 141.85 28.96 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.075 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -136.65 93.66 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.96 -109.31 2.79 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.143 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 11.88 20.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.74 141.78 35.49 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.419 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.1 111.28 23.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.02 111.63 23.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.51 -174.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.451 HG13 HG22 ' A' ' 77' ' ' VAL . 5.0 t -114.1 103.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.459 0.647 . . . . 0.0 109.905 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.578 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.83 127.13 44.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 150.41 30.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.528 ' HD3' ' HG2' ' A' ' 73' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.176 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 19.1 Cg_endo . . . . . 0 N--CA 1.461 -0.394 0 N-CA-C 111.007 -0.42 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.884 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 17.1 m -84.47 125.51 32.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.339 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.523 HD11 ' HB2' ' A' ' 125' ' ' LEU . 11.2 mt -66.08 116.58 5.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.7 -38.43 10.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.927 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.54 138.66 26.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.41 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.717 HG21 HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -106.03 122.12 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -118.87 134.59 55.06 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.243 -173.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 24.0 m-85 -116.65 135.38 53.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -170.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.4 m -139.87 110.92 6.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.291 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.44 47.1 0.26 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.857 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -83.16 77.44 9.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.136 0.493 . . . . 0.0 110.553 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.35 -37.48 19.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.918 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.8 m -141.6 -58.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.886 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -75.05 126.01 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -74.31 159.75 32.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.432 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -34.68 78.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.554 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.0 -38.33 90.68 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.9 mtp -70.98 -39.14 72.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -37.76 88.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.38 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 31.1 mttt -60.75 -44.01 97.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 110.937 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 13.8 tt0 -77.66 -27.68 50.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.338 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -66.86 -43.52 83.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.223 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -66.38 -34.0 76.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.802 174.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -63.36 -38.14 90.0 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -18.32 61.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.436 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.8 m -91.48 -13.87 31.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.546 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.37 -14.63 50.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.9 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.09 103.57 14.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.199 0.523 . . . . 0.0 110.242 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.521 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.04 174.92 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.747 -176.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 94' ' ' ILE . 45.5 t -68.77 125.16 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.425 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.67 -28.22 16.4 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.786 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.521 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -86.02 163.88 17.69 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 122.683 0.393 . . . . 0.0 110.413 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.41 156.2 19.69 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.675 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -113.79 138.75 49.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.018 0.437 . . . . 0.0 111.126 -176.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.51 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 12.7 t0 -100.1 115.04 28.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.573 0.701 . . . . 0.0 110.529 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.458 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -72.31 -16.22 61.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.44 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.1 p -85.64 -24.0 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.082 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.51 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 20.3 p -90.75 2.76 55.73 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.603 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.1 mm -56.98 -37.54 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.398 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.19 99.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.815 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 -39.2 78.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.142 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.2 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.227 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -59.29 -45.55 90.98 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.024 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -37.16 86.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.49 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.59 -34.12 72.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.629 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 167' ' ' LEU . 5.0 mt -69.91 -35.95 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.55 0.175 . . . . 0.0 111.352 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -64.04 -36.71 84.88 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 110.116 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.59 -37.13 79.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.016 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -45.0 94.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.396 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -39.1 92.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.012 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -29.44 66.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.199 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.4 m -70.35 -27.09 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.467 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.1 t -73.94 -88.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.467 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.23 18.79 25.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.104 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt 65.9 44.66 2.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.492 0.717 . . . . 0.0 110.321 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -78.55 113.72 16.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.775 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.46 99.98 11.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.483 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.39 147.5 44.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.338 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.01 136.01 39.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.6 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.2 m -97.76 132.21 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.406 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 115.41 16.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.365 169.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.42 111.18 22.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.83 123.34 57.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.516 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.71 114.61 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 110.17 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.53 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 6.9 m -113.62 119.35 41.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.12 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.5 Cg_endo -86.23 139.55 6.15 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.255 2.637 . . . . 0.0 112.615 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 0.3 OUTLIER -114.88 142.03 27.77 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 36.3 Cg_exo -59.08 93.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 114.348 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.492 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.3 OUTLIER 176.3 -92.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.603 1.161 . . . . 0.0 108.391 175.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.492 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 13.4 p-10 -165.3 28.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 109.137 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.884 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -123.02 164.2 19.02 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.64 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.675 HG11 HD22 ' A' ' 125' ' ' LEU . 9.4 p -137.3 147.74 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.395 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.28 123.07 48.67 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.426 ' HB3' HG23 ' A' ' 97' ' ' ILE . 28.1 tp -102.24 114.35 28.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.581 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -110.21 131.09 55.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.884 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.524 HD11 HD13 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -109.03 112.89 25.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.56 -176.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.848 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.57 117.64 34.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.303 0.573 . . . . 0.0 110.33 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 -177.148 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -111.14 153.86 25.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.67 113.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.29 121.42 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.438 0.637 . . . . 0.0 110.791 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -84.37 -26.13 28.62 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.154 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.443 ' HB3' HG23 ' A' ' 83' ' ' THR . 27.0 t0 -158.44 154.01 26.15 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.509 HD12 HD21 ' A' ' 43' ' ' LEU . 86.9 mt -125.59 128.09 72.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.375 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.94 133.24 55.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.309 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.454 ' HD2' HG12 ' A' ' 39' ' ' VAL . 10.5 m-85 -118.47 135.15 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -113.6 -58.49 2.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 -164.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.373 0 CA-C-O 120.349 0.118 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.454 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.9 m -62.1 -29.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 O-C-N 123.647 0.592 . . . . 0.0 112.361 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.65 -40.47 85.75 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.687 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -74.48 -36.22 63.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.34 0.591 . . . . 0.0 110.357 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.58 87.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.91 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 29' ' ' ILE . 4.0 mt -58.74 -33.9 70.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.922 0.489 . . . . 0.0 112.207 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 41' ' ' ALA . 53.4 mt -74.15 -15.14 61.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.008 0.432 . . . . 0.0 111.335 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.01 -20.92 20.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.245 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.688 ' HG2' HG23 ' A' ' 62' ' ' THR . 91.0 mtp -81.75 146.04 55.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.259 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.59 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 6.1 Cg_exo -80.25 9.09 3.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.011 2.474 . . . . 0.0 112.458 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 154.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 16.6 mtm105 -130.63 173.73 10.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 111.275 -174.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 p -67.64 124.58 23.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.416 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -10.36 57.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.864 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -93.7 156.57 16.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 0.0 110.208 178.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.09 130.39 35.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.67 127.16 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.169 0.509 . . . . 0.0 110.912 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.446 ' O ' HD12 ' A' ' 59' ' ' ILE . 49.3 m-80 -97.31 179.38 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.399 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -30.83 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.241 0.543 . . . . 0.0 109.65 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.58 -33.42 75.87 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.495 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.96 -31.04 61.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.6 -50.76 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.72 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -69.64 -29.99 67.6 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.637 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 1.2 m-80 -72.22 -36.71 69.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.618 177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 46' ' ' MET . 74.5 m -60.48 -44.16 96.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.233 0.333 . . . . 0.0 110.273 171.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 60' ' ' SER . 32.1 mt -54.34 -53.02 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 123.351 0.407 . . . . 0.0 110.618 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 64' ' ' ARG . 1.2 tpt180 -65.72 -38.22 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 69' ' ' THR . . . -66.45 -48.14 70.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.442 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 86.4 mt -67.52 -29.92 69.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.15 99.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 110.081 172.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.12 -13.46 61.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.677 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 65' ' ' ALA . 30.2 p -78.93 -24.74 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.902 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.6 73.05 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.607 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -73.47 -44.13 58.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 109.99 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.442 ' HE1' ' HB3' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -124.03 154.83 39.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.692 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.724 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 5.3 mm-40 -72.1 -51.27 22.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.622 0.576 . . . . 0.0 111.956 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -129.61 146.42 51.41 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.77 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 88' ' ' VAL . 38.4 t -127.86 120.64 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.19 116.9 27.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.418 ' HB ' HG23 ' A' ' 59' ' ' ILE . 60.0 t -104.81 130.78 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.49 158.61 39.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -117.99 129.52 55.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.421 0.629 . . . . 0.0 110.404 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.2 95.86 4.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.695 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.34 -109.9 3.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.507 -174.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.31 14.38 19.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.372 0.606 . . . . 0.0 109.933 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -106.83 139.69 40.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -106.08 114.13 28.09 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.001 177.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -106.87 123.43 48.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 110.518 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -118.66 118.38 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.34 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -109.62 132.8 53.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 75' ' ' VAL . 4.5 m -125.56 162.46 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.218 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 tptp . . . . . 0 C--N 1.321 -0.638 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.516 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 68.3 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 CA-C-O 121.201 0.417 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 45.3 m -124.87 133.31 53.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.616 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 125' ' ' LEU . 30.0 mt -68.61 117.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.2 -26.75 16.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.68 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.27 138.54 18.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.173 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.501 HG13 HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -109.23 121.38 62.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.853 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.3 OUTLIER -113.14 133.46 55.02 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.412 -175.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.696 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.2 m-85 -112.11 135.07 53.23 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.838 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.68 118.07 8.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.223 -173.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.07 18.34 56.03 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.334 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.545 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -85.15 93.39 8.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.589 . . . . 0.0 110.843 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.732 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -85.52 -46.09 11.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.251 -179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.2 -77.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.062 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.63 125.64 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -71.01 157.82 37.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.592 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -36.55 76.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.952 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.575 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 4.3 t0 -62.5 -38.47 90.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.481 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtt -73.34 -35.67 66.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -32.89 74.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.593 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.696 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -56.7 -44.84 81.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 176.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -28.3 53.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.388 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.66 -43.17 90.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.4 mm? -67.72 -35.83 79.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.781 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.85 -35.51 80.86 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.52 -23.09 58.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.874 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -17.82 31.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 0.0 110.199 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.05 -14.15 31.37 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.13 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.62 102.54 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.4 0.619 . . . . 0.0 110.604 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.74 176.45 9.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.128 -175.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 97' ' ' ILE . 70.7 t -67.29 127.42 28.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.374 0.607 . . . . 0.0 110.556 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.48 -10.28 62.96 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.925 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -111.45 166.09 11.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.724 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 1.4 m -75.72 162.34 28.3 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.266 177.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -132.18 145.15 51.16 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.512 0.196 . . . . 0.0 110.891 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -109.72 122.05 46.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.621 0.724 . . . . 0.0 111.319 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.444 ' HA ' HG12 ' A' ' 130' ' ' ILE . 6.9 mtp180 -73.02 -15.7 61.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.211 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.5 p -90.09 -17.25 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.1 m -84.32 -13.64 51.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.279 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 153' ' ' ALA . 6.5 mm -54.16 -40.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.065 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.71 99.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.012 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.424 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 0.6 OUTLIER -71.93 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 178.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 130' ' ' ILE . 52.0 mt -62.22 -46.76 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.942 0.401 . . . . 0.0 110.12 174.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.93 -49.83 74.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.309 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -65.3 -33.3 75.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.587 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 135' ' ' LYS . . . -68.09 -41.79 86.12 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.309 -0.472 . . . . 0.0 111.987 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.28 -33.0 72.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.404 0.145 . . . . 0.0 111.278 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -36.72 80.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.063 0.458 . . . . 0.0 110.683 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.13 -44.84 78.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.324 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -38.27 90.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.415 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.545 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -60.39 -43.53 96.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.209 0.528 . . . . 0.0 110.766 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -29.38 65.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.648 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.8 m -66.13 -28.16 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.738 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 4.3 t -78.28 -96.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 110.312 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -103.95 19.84 42.7 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.266 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.7 56.67 1.51 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -87.28 96.47 10.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.987 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.67 101.68 5.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.749 173.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.59 156.3 43.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.376 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.12 113.69 25.66 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.3 p -106.71 127.14 62.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.959 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.97 117.81 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.054 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -93.99 110.16 21.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.56 126.63 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.79 -173.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.05 112.33 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.191 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.5 m -104.82 117.57 58.48 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.855 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.04 141.26 20.83 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.258 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -115.79 154.81 48.16 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.478 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 22.2 Cg_exo -66.5 76.96 0.36 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.549 2.833 . . . . 0.0 113.523 -176.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.51 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -167.39 -115.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 15.6 p-10 -144.11 27.35 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.099 0.952 . . . . 0.0 108.512 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.458 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 11.9 mmt180 -122.59 155.1 37.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.641 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.409 HG21 HD22 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -134.18 157.59 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.6 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -109.93 122.95 48.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.317 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.0 tp -106.6 116.41 31.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.853 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 12.4 tttt -119.22 132.77 55.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.06 110.58 22.56 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.216 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 15.2 t -99.78 116.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.656 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.66 118.28 36.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.974 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.661 178.688 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' HZ ' HD12 ' A' ' 84' ' ' LEU . 6.5 p90 -107.49 153.27 23.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.876 -0.662 . . . . 0.0 110.219 -175.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.46 112.39 17.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.92 125.39 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.01 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -41.3 10.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.722 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HB3' HG23 ' A' ' 83' ' ' THR . 38.7 t70 -147.89 148.55 30.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.598 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -116.51 124.59 72.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.39 127.55 47.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -101.92 115.8 31.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HG3' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -94.09 65.14 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.803 0.811 . . . . 0.0 110.733 -176.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.856 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.519 176.515 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m -58.91 -30.99 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 123.779 0.674 . . . . 0.0 112.205 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.94 -35.08 61.64 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.354 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -76.25 -36.11 58.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.001 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.78 88.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.855 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -32.33 61.48 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.091 0.957 . . . . 0.0 113.088 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 41' ' ' ALA . 51.1 mt -70.98 -15.78 62.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -8.39 23.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.546 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.7 mtp -94.55 137.19 22.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.188 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.57 34.39 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.991 2.461 . . . . 0.0 112.255 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HB ' HG11 ' A' ' 54' ' ' VAL . 1.5 p -155.39 146.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.24 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' H ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -133.37 176.68 8.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.3 p -67.11 121.2 15.08 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.84 0.352 . . . . 0.0 110.17 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.44 47.99 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.456 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.6 t0 -82.84 156.48 23.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.619 0.247 . . . . 0.0 110.987 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -112.78 112.03 23.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.18 178.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.653 HG11 ' HB ' ' A' ' 48' ' ' VAL . 2.6 m -126.24 132.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.184 0.516 . . . . 0.0 112.343 -171.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' O ' HD12 ' A' ' 59' ' ' ILE . 10.2 m-20 -86.14 -177.27 6.23 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.067 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -61.16 -35.42 77.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.984 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -62.93 -37.44 87.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.203 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.757 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 1.3 m-20 -75.85 -29.04 58.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.585 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.78 -47.4 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 171.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.686 ' HA ' HD12 ' A' ' 63' ' ' ILE . 3.7 m -68.76 -30.05 68.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.389 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.757 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 8.9 m-20 -63.75 -45.32 90.38 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 109.825 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.7 m -58.48 -43.88 89.13 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.095 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' A' ' 60' ' ' SER . 65.2 mt -55.81 -50.9 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 123.39 0.431 . . . . 0.0 110.872 176.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -66.28 -36.03 81.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.89 -45.33 74.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.795 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HB2' HG11 ' A' ' 75' ' ' VAL . 83.9 mt -71.01 -29.03 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -39.5 92.66 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.231 0.539 . . . . 0.0 110.538 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.88 -9.48 58.4 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.406 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.0 p -76.68 -20.16 56.94 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -170.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.47 21.27 75.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.943 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -105.01 -89.28 0.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.07 135.1 34.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.418 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.771 ' HB3' ' HB2' ' A' ' 124' ' ' SER . 0.1 OUTLIER -77.63 -30.01 52.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.8 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 11.8 t70 -123.42 135.43 54.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.667 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 88' ' ' VAL . 64.2 t -132.51 118.46 35.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.567 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -120.37 120.61 36.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.389 0.614 . . . . 0.0 110.051 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.441 HG22 HG13 ' A' ' 86' ' ' VAL . 70.1 t -105.19 123.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.29 137.7 51.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -88.0 110.12 20.35 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.49 95.22 5.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.55 -120.89 20.85 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -104.42 12.94 32.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.255 0.55 . . . . 0.0 109.963 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.89 141.71 35.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.791 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.533 HD12 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.02 110.87 22.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.429 HD11 ' HG3' ' A' ' 32' ' ' GLU . 13.6 tp -100.08 112.42 24.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.199 -175.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.441 HG13 HG22 ' A' ' 77' ' ' VAL . 6.1 t -116.16 105.79 19.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.425 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.93 131.44 42.28 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 75' ' ' VAL . 3.5 m -125.73 149.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.936 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HB2' HG22 ' A' ' 163' ' ' VAL . 56.8 Cg_endo . . . . . 0 CA--C 1.534 0.489 0 N-CA-C 114.065 0.756 . . . . 0.0 114.065 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 17.9 m -91.29 135.81 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 125' ' ' LEU . 34.7 mt -65.58 118.31 7.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.63 -37.04 8.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.312 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.39 144.03 32.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.474 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -119.39 123.52 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.62 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -103.71 131.27 51.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.516 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' HB3' HD21 ' A' ' 102' ' ' ASN . 20.3 m-85 -109.96 134.92 51.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.161 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.9 123.8 12.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.87 13.19 47.53 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.773 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -94.59 77.93 3.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.997 -178.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -40.77 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.336 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.9 m -75.97 -61.6 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.266 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.2 140.13 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 4.0 mmtm -70.46 151.95 44.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 111.224 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.5 -35.53 79.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.459 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -69.89 -34.74 73.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.68 177.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.493 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -65.65 -39.44 91.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 173.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -32.97 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.369 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -61.53 -41.74 97.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 176.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.99 -30.06 55.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -66.62 -40.61 88.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.473 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.474 ' CD2' HG21 ' A' ' 97' ' ' ILE . 2.3 mp -69.72 -36.88 76.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.723 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.601 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 1.5 mt-10 -63.34 -37.39 87.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.445 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 m -93.5 -14.53 26.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.024 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.49 -22.09 22.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.924 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.45 104.43 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.355 0.598 . . . . 0.0 111.156 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.601 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.85 173.76 11.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.694 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.78 123.8 23.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.665 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.74 -6.26 58.71 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.888 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.4 158.42 17.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.939 0.399 . . . . 0.0 110.452 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.771 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -80.32 144.08 33.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.478 176.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.591 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.23 144.59 25.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.782 0.325 . . . . 0.0 111.585 -172.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.49 106.0 16.3 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.331 0.586 . . . . 0.0 109.729 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -17.65 62.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.482 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.8 p -83.83 -23.25 31.46 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.425 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 p -98.41 2.28 47.7 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.338 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 130' ' ' ILE . 6.1 mm -58.04 -40.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.844 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.66 83.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.689 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.17 -31.72 68.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.345 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.61 -44.85 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.718 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 138' ' ' GLU . 94.4 mt-10 -59.36 -47.65 84.62 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.651 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -35.68 81.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.147 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.29 -38.04 81.16 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.289 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 137' ' ' LEU . 1.2 mm? -66.58 -39.91 88.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.368 . . . . 0.0 111.282 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 134' ' ' GLU . 84.0 mt-10 -56.14 -43.88 78.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.136 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -31.94 67.21 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -34.62 78.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.163 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.478 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -71.16 -36.0 71.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.752 177.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -71.25 -30.56 66.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.41 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -30.27 63.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 145' ' ' GLY . 1.4 p -79.65 -73.27 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.437 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.494 ' H ' HG13 ' A' ' 144' ' ' VAL . . . -113.73 17.72 20.3 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.964 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 61.11 44.5 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 110.559 -173.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.448 ' CE2' ' HA3' ' A' ' 145' ' ' GLY . 66.4 m-85 -88.83 136.14 33.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.243 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.81 128.96 41.92 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.06 143.79 48.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.783 0.325 . . . . 0.0 110.647 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.97 113.68 27.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.68 131.23 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.158 0.504 . . . . 0.0 111.753 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -128.49 117.29 21.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.961 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.55 112.02 24.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 0.0 110.69 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.82 118.5 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.653 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.63 114.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.7 m -116.11 120.76 34.78 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.596 ' HA ' HG12 ' A' ' 163' ' ' VAL . 74.4 Cg_endo -75.28 147.87 33.5 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.778 2.319 . . . . 0.0 113.155 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 1.3 pp -117.1 160.48 37.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 158' ' ' LEU . 52.6 Cg_endo -76.11 73.92 4.76 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.712 2.275 . . . . 0.0 114.105 -171.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.4 OUTLIER -166.73 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.648 173.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.421 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 2.5 t30 -136.43 25.39 3.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 12.1 mmt180 -131.05 161.03 32.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -171.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -132.74 155.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.085 175.031 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.17 125.52 54.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.151 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.0 tp -108.39 131.51 54.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.59 0.233 . . . . 0.0 110.538 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.62 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 37.8 tttt -122.6 133.55 54.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 0.0 111.261 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.91 109.69 21.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.76 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.64 119.36 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.495 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -109.21 117.8 35.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.807 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 C--N 1.318 -0.786 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.162 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.548 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 43.9 p90 -105.95 148.9 27.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.72 113.36 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 p -73.98 133.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.443 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -88.08 -42.92 12.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.56 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -147.21 144.92 29.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.726 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.492 HD12 HD21 ' A' ' 43' ' ' LEU . 63.6 mt -106.86 120.51 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.46 127.45 54.43 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.071 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.782 ' HD2' HG12 ' A' ' 39' ' ' VAL . 78.6 m-85 -107.77 130.5 54.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG3' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -109.36 -42.66 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -172.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.19 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.198 -174.559 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.782 HG12 ' HD2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -51.76 -38.75 22.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.659 -177.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -73.02 -40.75 50.58 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.683 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.25 78.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.37 72.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.673 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 29' ' ' ILE . 2.9 mt -57.64 -31.08 65.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.5 mt -62.79 -26.76 68.88 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 111.58 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.14 -13.53 43.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.893 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.4 mtp -90.26 138.48 27.18 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.481 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.47 16.0 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.882 2.388 . . . . 0.0 113.257 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 52' ' ' ASP . 1.2 p -153.73 147.02 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.406 ' HG2' HD22 ' A' ' 43' ' ' LEU . 57.0 mtt85 -123.28 177.7 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.922 0.489 . . . . 0.0 110.458 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 p -65.6 126.5 28.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.411 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.77 -6.66 35.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.452 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.6 t0 -96.28 158.47 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.459 . . . . 0.0 110.651 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 133.02 34.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.442 HG13 HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -125.97 128.98 72.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 112.007 -173.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 87.7 m-20 -97.67 -179.63 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.008 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.42 -32.62 74.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 109.838 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 7.5 tp10 -61.29 -37.77 84.37 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.434 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.37 -32.21 62.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.292 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -63.54 -46.13 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.046 0.451 . . . . 0.0 109.951 173.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -73.64 -26.88 60.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.254 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -70.76 -45.61 64.47 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.417 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.3 p -64.51 -38.58 91.51 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.031 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -55.35 -54.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.486 0.491 . . . . 0.0 110.42 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -70.78 -30.31 66.75 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.27 -46.95 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.661 0.267 . . . . 0.0 110.567 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' HG23 ' A' ' 69' ' ' THR . 75.4 mt -71.66 -29.63 64.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -39.25 91.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.558 . . . . 0.0 110.48 173.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.41 -12.35 61.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.117 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 66' ' ' LEU . 21.9 p -78.17 -24.47 47.23 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.978 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.42 7.73 83.01 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.454 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -83.41 -20.61 33.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 165.97 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.725 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 3.4 tm-20 -83.91 -50.49 8.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -136.65 137.72 40.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.817 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.79 120.51 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.74 0.305 . . . . 0.0 110.427 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -118.26 118.96 33.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.044 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.5 t -107.9 123.46 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.802 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.99 158.34 41.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -111.39 141.1 45.37 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.642 178.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -126.92 95.8 4.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.85 -109.68 3.02 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 14.28 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.292 0.567 . . . . 0.0 110.048 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.678 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.46 111.86 24.5 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.45 HD11 ' HG3' ' A' ' 32' ' ' GLU . 16.6 tp -101.73 116.74 33.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.4 t -107.69 110.16 30.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.362 0.601 . . . . 0.0 110.491 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 27.3 mt-30 -106.16 134.37 49.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.45 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.22 155.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.377 0.608 . . . . 0.0 110.995 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.877 -179.062 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 46.0 Cg_endo . . . . . 0 C--O 1.235 0.344 0 CA-C-O 121.86 0.692 . . . . 0.0 113.396 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 80.6 m -97.92 144.48 27.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.742 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 125' ' ' LEU . 35.8 mt -69.59 117.98 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.59 -35.18 8.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.883 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -149.14 143.56 26.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.432 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.529 HG21 ' CD1' ' A' ' 114' ' ' LEU . 3.1 mt -117.11 124.04 72.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 172.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.558 ' HB ' ' HD3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -106.16 136.03 46.59 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 -176.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -114.85 135.29 54.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.9 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.465 ' OG ' ' HD2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -142.69 128.35 19.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.739 178.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.68 15.02 62.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.728 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -105.23 63.13 0.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -88.1 -21.87 24.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -51.63 23.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.088 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t -109.38 141.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.89 145.98 53.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.859 0.361 . . . . 0.0 111.577 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.853 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -60.28 -35.59 75.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.76 177.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.1 -45.36 75.46 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.967 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -43.23 77.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.451 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.853 HD12 ' HA ' ' A' ' 107' ' ' ASP . 4.2 mt -64.64 -33.28 75.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -44.72 96.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.971 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.471 ' HB3' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -78.67 -27.95 45.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.896 -178.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.5 -38.63 90.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.057 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.529 ' CD1' HG21 ' A' ' 97' ' ' ILE . 17.2 mt -66.4 -36.04 81.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.641 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -63.93 -39.45 94.19 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.772 178.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.96 -16.48 60.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.48 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -88.7 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.381 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.81 -25.05 9.79 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.256 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.51 104.2 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.877 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.641 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -132.13 168.19 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.792 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -72.07 129.03 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.461 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.63 -6.3 74.08 Favored Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.835 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.98 145.2 40.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.725 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -66.33 143.13 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.328 178.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.551 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.76 146.33 23.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.156 0.503 . . . . 0.0 111.981 -170.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -107.45 96.35 6.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.152 171.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.431 ' HD3' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -71.89 -14.28 61.9 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.472 -178.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.431 HG23 ' HD3' ' A' ' 127' ' ' ARG . 34.2 p -90.53 -28.19 18.67 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.786 0.803 . . . . 0.0 108.897 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 m -95.13 6.4 49.15 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.51 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 130' ' ' ILE . 2.8 mm -58.35 -35.26 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.006 176.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.31 -35.91 78.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.686 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.22 -38.94 89.13 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.0 -42.64 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.347 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.9 -48.47 79.78 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.0 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -34.82 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.01 -36.96 91.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.523 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.49 -32.65 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 110.988 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -66.78 -43.05 85.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.614 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -31.43 70.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.771 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.1 t80 -60.34 -46.51 89.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.624 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.79 -36.46 83.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.824 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.37 -34.41 77.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.87 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.8 m -71.59 -30.08 65.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 140' ' ' PHE . 19.3 t -78.76 -86.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.786 0.326 . . . . 0.0 111.294 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.68 18.14 24.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.934 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.6 mttp 60.49 47.2 8.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.548 0.689 . . . . 0.0 109.667 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -74.8 123.47 25.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.731 -175.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.64 131.87 35.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.706 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -153.33 143.65 22.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.255 0.55 . . . . 0.0 110.975 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.23 114.06 24.73 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 170.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.29 134.48 45.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.546 0.689 . . . . 0.0 112.108 -167.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -130.48 116.54 18.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.244 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.66 111.53 23.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.18 0.514 . . . . 0.0 109.963 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.21 121.7 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.35 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.93 128.0 52.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.7 m -120.0 121.27 29.72 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.433 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 1.1 Cg_endo -85.72 147.0 9.48 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.407 2.738 . . . . 0.0 113.325 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.657 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -105.07 159.99 27.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.927 172.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.47 65.64 2.21 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.432 2.754 . . . . 0.0 114.121 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.54 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -164.83 -113.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 9.6 p-10 -144.72 53.12 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.565 0.698 . . . . 0.0 110.735 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.657 ' HB2' HD11 ' A' ' 158' ' ' LEU . 1.6 mpp_? -143.12 159.91 41.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.456 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -132.33 153.03 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.377 178.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.81 124.96 53.03 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 43.3 tp -104.58 117.45 34.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.555 -172.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.558 ' HD3' ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -104.53 131.52 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.325 0.584 . . . . 0.0 110.809 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.556 HD12 ' HE2' ' A' ' 169' ' ' PHE . 1.2 mm? -106.39 109.74 21.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.288 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.39 111.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.34 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.556 ' HE2' HD12 ' A' ' 167' ' ' LEU . 6.0 m-85 -104.98 118.28 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 19.8 mm-40 . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -110.41 154.58 23.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.501 . . . . 0.0 110.715 -174.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.17 117.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.426 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.37 122.33 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.51 0.672 . . . . 0.0 110.667 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -95.6 -22.77 17.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.158 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HB3' HG23 ' A' ' 83' ' ' THR . 8.0 t70 -152.41 139.06 18.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.969 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 mt -118.46 123.36 71.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.989 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.472 ' HB3' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -121.21 133.2 55.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.188 -177.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -104.95 136.9 43.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.037 0.446 . . . . 0.0 110.802 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 1.7 mt-10 -119.32 70.39 0.84 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.329 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.957 -179.613 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -32.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.707 0.63 . . . . 0.0 112.618 -174.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.29 -37.17 63.25 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.227 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.49 66.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.167 0.508 . . . . 0.0 110.428 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.73 72.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 46' ' ' MET . 0.7 OUTLIER -55.88 -32.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.664 0.786 . . . . 0.0 112.811 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.06 -14.14 61.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -7.98 38.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.5 ' HB3' HG22 ' A' ' 62' ' ' THR . 1.8 mtm -94.01 133.61 27.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HG3' ' HB3' ' A' ' 61' ' ' ASN . 30.6 Cg_endo -64.91 -28.56 58.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.849 2.366 . . . . 0.0 112.653 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.21 149.58 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.158 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.0 177.87 7.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.591 -174.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.4 p -68.22 121.08 15.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.539 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.54 -6.58 52.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.142 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.74 157.05 16.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.932 0.396 . . . . 0.0 110.887 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.06 136.9 32.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.163 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.55 130.23 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.284 0.564 . . . . 0.0 111.244 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -97.77 -177.07 3.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.964 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -63.91 -27.37 69.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.04 -30.98 65.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.564 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 36.1 m-20 -75.94 -28.83 58.12 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.275 0.23 . . . . 0.0 111.08 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -47.47 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 171.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.419 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.0 m -70.14 -27.63 64.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.708 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.2 m-20 -68.91 -45.26 71.33 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.5 HG22 ' HB3' ' A' ' 46' ' ' MET . 0.9 OUTLIER -63.32 -40.12 96.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.719 175.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 60' ' ' SER . 56.7 mt -55.21 -55.38 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 123.61 0.569 . . . . 0.0 111.128 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -69.26 -31.01 69.26 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 69' ' ' THR . . . -69.01 -50.38 49.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.44 0.162 . . . . 0.0 110.746 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 75' ' ' VAL . 50.8 mt -68.34 -30.44 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.049 0.452 . . . . 0.0 110.313 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.12 -12.52 61.75 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.122 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 65' ' ' ALA . 22.3 p -78.89 -22.54 45.78 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.137 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 19.2 76.71 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.351 -0.452 . . . . 0.0 113.138 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -89.76 -28.7 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.606 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 162.34 28.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.816 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -84.73 -37.93 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -140.5 144.6 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 66' ' ' LEU . 48.3 t -128.63 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 119.53 33.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.361 177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 86' ' ' VAL . 84.1 t -106.11 124.29 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.044 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.0 146.13 47.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -107.76 132.7 53.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.77 95.2 3.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.043 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.95 2.48 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.035 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -106.24 2.1 26.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.006 0.522 . . . . 0.0 110.901 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.492 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -106.66 132.91 52.11 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.75 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.0 113.09 26.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.814 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 30' ' ' HIS . 3.5 tp -102.86 112.24 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.406 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.509 HG13 HG22 ' A' ' 77' ' ' VAL . 15.2 t -110.08 106.22 20.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.546 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 6.6 mt-30 -92.91 136.18 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.49 142.87 41.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.126 0.489 . . . . 0.0 110.243 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.915 -175.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.462 -0.368 0 CA-C-O 121.552 0.563 . . . . 0.0 113.482 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 5.1 m -97.69 133.51 42.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.2 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.5 mt -71.95 117.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.56 -33.17 11.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.036 0.446 . . . . 0.0 110.555 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -147.26 143.08 27.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.446 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.699 HG21 HD22 ' A' ' 114' ' ' LEU . 1.3 mt -115.65 123.0 70.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.605 ' HB ' ' HE3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -122.42 132.86 54.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.243 0.545 . . . . 0.0 110.773 -175.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.515 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 21.3 m-85 -111.23 135.25 52.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.376 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.73 120.25 18.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.37 29.73 9.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.116 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 1.1 p30 -107.98 63.93 0.62 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.562 0.696 . . . . 0.0 110.566 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -85.16 -17.34 37.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.091 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -93.04 -52.03 4.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 31.7 t -108.03 128.92 63.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 11.1 mmmt -69.95 149.4 47.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -170.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -35.13 69.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.729 173.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.78 -43.94 90.56 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.0 mtp -69.1 -41.2 77.76 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.45 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -36.72 80.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.861 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -46.17 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.135 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -28.73 55.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.172 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.29 -46.87 86.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.261 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.699 HD22 HG21 ' A' ' 97' ' ' ILE . 1.9 mp -66.25 -40.63 90.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.014 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.695 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 7.6 mt-10 -60.32 -42.42 95.57 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.402 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.13 -22.15 60.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.703 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -87.93 -16.86 32.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.73 -24.97 6.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.805 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.99 104.7 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.185 0.517 . . . . 0.0 111.641 -174.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.695 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.66 176.47 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.553 178.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 94' ' ' ILE . 44.7 t -68.34 125.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.251 0.548 . . . . 0.0 111.593 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.82 61.93 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.127 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.28 155.26 21.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 110.699 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.21 133.82 42.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.507 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -92.22 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.281 0.562 . . . . 0.0 111.061 -173.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -110.01 102.48 11.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.858 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.406 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -71.16 -15.75 62.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.74 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -84.13 -18.37 37.02 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.549 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.51 -0.75 45.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 130' ' ' ILE . 4.9 mm -59.33 -35.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.499 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.58 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.559 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.21 -28.55 60.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.804 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.29 -43.36 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.957 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.63 -42.01 99.34 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.61 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -41.75 98.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.157 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.62 93.05 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.635 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.595 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 18.2 mt -74.09 -32.43 63.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.586 0.231 . . . . 0.0 111.112 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.01 -40.91 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.207 175.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.51 -39.87 88.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.552 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -43.18 99.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -41.66 91.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.362 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -32.31 66.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.5 m -71.35 -32.25 68.31 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.619 HG13 ' H ' ' A' ' 145' ' ' GLY . 1.9 p -76.0 -77.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.647 -175.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.619 ' H ' HG13 ' A' ' 144' ' ' VAL . . . -114.21 17.49 19.29 Favored Glycine 0 N--CA 1.454 -0.107 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.768 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 55.71 58.63 4.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.569 0.699 . . . . 0.0 110.816 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -92.86 111.54 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.5 98.7 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -107.63 145.27 33.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.048 0.451 . . . . 0.0 111.579 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.29 114.14 26.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 171.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.92 124.58 57.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.15 0.5 . . . . 0.0 111.469 -171.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -130.9 117.02 18.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.492 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.86 112.47 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.427 0.632 . . . . 0.0 110.117 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.26 119.71 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.077 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -99.6 112.14 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 m -104.23 117.42 59.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.533 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 163' ' ' VAL . 88.5 Cg_endo -80.31 137.46 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.2 2.6 . . . . 0.0 113.406 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 1.2 pp -104.82 143.67 27.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 169.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 22.2 Cg_exo -65.28 80.91 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.704 2.936 . . . . 0.0 115.018 -168.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -169.32 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.786 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -163.03 22.64 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.441 0.639 . . . . 0.0 109.944 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.498 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -128.23 155.8 43.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 -174.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 157' ' ' PRO . 3.7 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.683 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.25 131.74 55.33 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.435 ' HB3' HG23 ' A' ' 97' ' ' ILE . 21.9 tp -99.55 114.15 26.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.831 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.605 ' HE3' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.524 0.678 . . . . 0.0 111.138 -177.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.515 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -110.43 109.54 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.129 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.15 111.76 31.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.115 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.595 ' HZ ' HD13 ' A' ' 137' ' ' LEU . 15.2 m-30 -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.766 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.482 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HZ ' ' HB2' ' A' ' 79' ' ' ARG . 48.3 p90 -112.55 154.39 26.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.967 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.2 t -77.44 113.52 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -76.17 124.1 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.469 0.652 . . . . 0.0 109.952 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -88.95 -36.66 15.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.642 -176.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -144.31 143.46 31.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.154 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 85.2 mt -104.62 121.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -111.32 126.38 54.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -106.15 115.61 30.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.477 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 tt0 -102.68 68.4 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.405 0.622 . . . . 0.0 110.056 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.905 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.589 177.871 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.453 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -60.83 -29.13 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.27 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.93 -35.72 57.91 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.265 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -75.81 -34.61 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.351 0.596 . . . . 0.0 110.27 177.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.09 73.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.592 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mt -60.08 -31.73 70.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.211 0.604 . . . . 0.0 112.073 172.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 41' ' ' ALA . 90.4 mt -69.24 -21.74 63.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.21 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 m -88.28 -19.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.036 0.446 . . . . 0.0 110.285 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.521 ' HG2' HG23 ' A' ' 62' ' ' THR . 68.0 mtp -82.65 138.68 43.94 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.853 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 10.8 Cg_exo -73.5 -14.88 24.94 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.931 2.421 . . . . 0.0 112.586 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.506 HG11 HG12 ' A' ' 54' ' ' VAL . 29.3 m -114.93 167.77 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.117 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 4.9 mmt85 -129.12 174.24 9.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.918 0.389 . . . . 0.0 110.456 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.1 p -67.96 122.88 19.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.994 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -5.35 44.29 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.059 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -76.14 155.15 34.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -92.84 113.01 25.17 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.506 HG12 HG11 ' A' ' 48' ' ' VAL . 5.7 m -116.75 127.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.586 -165.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.42 ' O ' HD12 ' A' ' 59' ' ' ILE . 16.2 m-80 -98.85 -178.09 3.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.312 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -28.98 70.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 10.9 tt0 -64.05 -44.27 92.97 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.006 175.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.01 -34.83 75.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.227 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -62.18 -50.96 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 123.153 0.283 . . . . 0.0 110.286 175.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.622 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.1 m -67.89 -35.27 78.2 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.436 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 6.9 t-20 -63.79 -45.37 90.03 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.449 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.521 HG23 ' HG2' ' A' ' 46' ' ' MET . 90.5 m -59.01 -42.58 90.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.416 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 60' ' ' SER . 71.2 mt -55.55 -56.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 123.318 0.386 . . . . 0.0 111.223 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 -70.29 -28.46 65.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.05 -52.72 61.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.06 -31.79 72.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.672 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -33.8 76.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.792 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.68 -12.77 61.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.541 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 p -78.73 -24.95 44.59 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.763 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.48 65.43 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.82 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.04 4.68 15.78 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.18 0.49 . . . . 0.0 111.007 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.9 163.91 26.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 166.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -87.15 -46.01 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 110.192 177.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 33.9 t70 -129.54 136.82 50.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.423 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.9 117.99 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 119.51 32.83 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 174.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.653 HG22 HG13 ' A' ' 86' ' ' VAL . 54.9 t -111.78 121.08 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.05 136.99 42.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -93.43 136.39 33.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.986 0.422 . . . . 0.0 110.029 178.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -126.61 95.38 4.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.99 -109.52 2.84 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.373 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.425 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 15.0 p-10 -106.21 10.96 31.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.164 0.507 . . . . 0.0 111.001 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.87 141.34 46.81 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.624 -177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -103.74 114.85 29.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 176.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tp -107.54 112.81 25.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.48 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.653 HG13 HG22 ' A' ' 77' ' ' VAL . 7.3 t -112.79 111.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.291 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.477 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 5.3 mt-30 -104.74 128.72 52.93 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 m -125.4 141.8 44.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.661 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 44.6 tttt . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.732 -172.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 2.9 Cg_exo . . . . . 0 N--CA 1.464 -0.214 0 N-CA-C 113.891 0.689 . . . . 0.0 113.891 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 50.3 m -89.39 136.21 33.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.53 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 125' ' ' LEU . 35.7 mt -62.46 117.48 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.54 -27.79 13.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.827 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.4 149.87 22.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 114' ' ' LEU . 3.7 mt -123.79 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.86 148.06 52.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.881 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.616 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 25.6 m-85 -120.43 153.63 36.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.104 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.58 143.75 23.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.759 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.63 73.41 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.32 -0.467 . . . . 0.0 114.199 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.5 OUTLIER -101.42 81.51 2.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.393 0.616 . . . . 0.0 110.532 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -86.14 -34.68 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.931 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -56.38 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.993 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -92.62 159.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.987 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' A' ' 106' ' ' LYS . 2.4 mmmm -88.23 145.52 25.84 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.259 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.616 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 15.6 p-10 -66.74 -34.71 78.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.761 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.606 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 16.6 t70 -58.92 -38.35 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.089 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -42.77 68.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.405 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.19 -32.48 68.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.02 0.528 . . . . 0.0 111.959 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.606 ' HD3' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -58.63 -47.96 82.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.226 178.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.9 -28.58 49.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -36.46 83.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.551 HD12 HG21 ' A' ' 97' ' ' ILE . 11.6 mt -74.19 -38.92 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.723 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -61.99 -31.89 72.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.409 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.71 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.605 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -16.72 34.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.875 0.369 . . . . 0.0 110.267 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.86 -21.76 8.87 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.47 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.68 108.12 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.282 0.563 . . . . 0.0 111.303 -176.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.723 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.28 172.15 13.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' A' ' 94' ' ' ILE . 48.4 t -71.62 127.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.062 0.458 . . . . 0.0 110.503 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.53 -20.96 48.25 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.059 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -82.51 163.8 21.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.257 0.551 . . . . 0.0 110.628 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 73' ' ' GLU . 63.3 m -85.21 151.17 24.29 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.535 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -104.8 143.83 32.59 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.695 0.76 . . . . 0.0 111.607 -172.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.588 ' HB3' HG22 ' A' ' 129' ' ' THR . 9.7 t0 -104.65 98.09 7.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.397 176.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.572 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.85 -15.59 62.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.648 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.0 p -83.32 -17.88 40.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.085 0.469 . . . . 0.0 110.363 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 126' ' ' ASP . 0.8 OUTLIER -103.11 6.72 38.69 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 176.07 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.572 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.6 mm -61.45 -39.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.36 78.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.188 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -33.12 70.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.066 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 mt -68.55 -47.19 78.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.112 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.59 -41.73 98.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.966 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -37.12 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.026 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.09 -37.8 87.63 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.529 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 44.4 mt -74.45 -32.0 62.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.675 0.274 . . . . 0.0 111.066 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -37.65 75.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 110.039 175.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.97 -33.22 75.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.559 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.476 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.6 t80 -64.78 -45.42 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.525 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 2.1 m-85 -63.02 -37.1 85.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.2 t80 -68.13 -35.59 78.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.254 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.03 -31.24 69.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.688 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 140' ' ' PHE . 7.9 t -74.57 -91.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.77 0.319 . . . . 0.0 110.338 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.92 18.39 24.16 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.094 -177.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.767 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 58.92 50.32 8.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.357 0.598 . . . . 0.0 110.045 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -80.19 119.64 23.23 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.403 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.94 99.11 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.82 43.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.439 0.637 . . . . 0.0 111.382 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.71 113.06 24.98 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.8 p -108.16 127.44 64.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.439 0.638 . . . . 0.0 110.519 -174.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.91 116.84 20.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.542 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.94 110.58 22.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.17 124.91 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.906 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.58 113.97 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.318 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.0 m -104.41 115.27 63.19 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.799 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.65 127.42 9.57 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.919 2.412 . . . . 0.0 112.618 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -105.79 150.9 39.71 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 171.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.49 79.74 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.463 2.776 . . . . 0.0 113.967 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.432 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -171.21 -104.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.583 0.753 . . . . 0.0 109.348 177.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 16.5 p-10 -157.5 34.92 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HB2' HD11 ' A' ' 158' ' ' LEU . 1.5 mmt85 -133.78 155.3 50.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.877 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -127.6 151.52 34.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.812 177.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.63 118.88 37.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.86 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.1 tp -96.82 121.05 38.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.44 132.49 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.433 0.635 . . . . 0.0 111.044 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.609 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.0 mm? -105.61 111.48 24.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.834 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 21.6 t -99.54 120.41 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -116.06 118.94 34.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.47 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.959 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -97.39 152.5 18.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.3 t -85.66 122.65 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.67 124.28 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.588 0.709 . . . . 0.0 110.689 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -80.31 -26.93 38.57 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.387 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -162.51 149.45 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.453 HD12 HD21 ' A' ' 43' ' ' LEU . 58.7 mt -112.99 121.54 65.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.9 t-160 -116.77 127.22 54.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' HD2' HG12 ' A' ' 39' ' ' VAL . 19.5 m-85 -106.68 136.72 46.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -131.32 167.7 18.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.63 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.348 -177.587 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 120.547 0.213 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.567 HG12 ' HD2' ' A' ' 31' ' ' PHE . 2.7 m -66.48 -27.57 40.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.914 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.69 -36.97 61.8 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.134 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -76.47 -34.42 58.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.547 0.689 . . . . 0.0 110.157 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.57 68.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.997 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.684 HD22 ' HD2' ' A' ' 49' ' ' ARG . 5.1 mt -57.14 -31.29 65.21 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.356 0.662 . . . . 0.0 112.532 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 41' ' ' ALA . 67.1 mt -66.48 -22.31 66.19 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.565 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.57 -8.3 26.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.562 ' HG2' HG23 ' A' ' 62' ' ' THR . 30.9 mtp -83.54 143.25 43.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.204 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.74 -3.56 13.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.512 2.142 . . . . 0.0 113.334 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -139.58 163.79 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.684 ' HD2' HD22 ' A' ' 43' ' ' LEU . 9.6 mmm180 -120.31 176.06 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.936 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 p -66.94 132.92 48.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.61 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.37 -5.7 77.83 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.638 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 156.64 18.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.881 0.372 . . . . 0.0 111.081 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 125.1 30.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.322 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 HG11 ' A' ' 48' ' ' VAL . 20.9 m -123.14 137.22 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.705 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -97.49 178.54 5.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.026 0.441 . . . . 0.0 110.804 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -27.17 63.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.53 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -29.44 64.67 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.36 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 42.3 m-20 -73.91 -29.2 61.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.524 175.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.87 -49.34 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.719 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -64.75 -36.36 84.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 176.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -64.06 -42.33 97.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 178.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.562 HG23 ' HG2' ' A' ' 46' ' ' MET . 54.0 m -60.04 -42.55 94.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 60' ' ' SER . 55.3 mt -55.62 -49.3 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.53 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -36.43 82.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.027 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.11 66.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.623 HD22 ' HE1' ' A' ' 72' ' ' PHE . 89.9 mt -71.08 -28.31 64.24 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.224 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -45.23 66.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.63 -15.79 59.73 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 66' ' ' LEU . 9.7 t -80.78 -24.29 38.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.35 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.5 1.65 90.17 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 164.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -85.12 -6.33 59.3 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.945 0.872 . . . . 0.0 111.698 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.623 ' HE1' HD22 ' A' ' 66' ' ' LEU . 14.2 m-85 -124.43 159.14 31.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -91.75 -36.95 13.28 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.887 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 26.7 t0 -137.73 140.97 41.0 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 66' ' ' LEU . 49.1 t -128.17 119.84 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.892 0.377 . . . . 0.0 110.5 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.7 118.13 30.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.877 173.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.578 HG22 HG13 ' A' ' 86' ' ' VAL . 61.4 t -106.95 122.34 60.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.81 137.97 37.12 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.8 137.15 36.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.407 0.622 . . . . 0.0 110.82 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -113.99 95.31 5.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.74 -109.37 2.87 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.483 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.29 11.02 21.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.239 0.542 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.86 139.57 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.724 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -104.8 114.89 29.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.487 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 20.6 tp -109.23 115.11 29.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.233 0.54 . . . . 0.0 110.453 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.578 HG13 HG22 ' A' ' 77' ' ' VAL . 19.0 t -106.25 108.24 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.351 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.505 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 73.5 mt-30 -97.06 126.38 42.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.41 150.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.85 0.834 . . . . 0.0 111.159 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.463 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 16.4 tttm . . . . . 0 C--N 1.308 -1.199 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.149 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.502 ' HB2' HG13 ' A' ' 163' ' ' VAL . 9.6 Cg_endo . . . . . 0 N--CA 1.449 -1.107 0 CA-C-O 121.104 0.376 . . . . 0.0 111.344 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.9 m -96.36 147.72 23.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.194 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.649 HG13 ' HB2' ' A' ' 125' ' ' LEU . 42.4 mt -58.12 118.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 162' ' ' ARG . . . -105.82 -38.24 6.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.183 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.97 27.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.487 HG12 HD21 ' A' ' 165' ' ' LEU . 1.2 mt -114.83 123.69 70.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 168.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.88 135.4 54.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -176.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.1 m-85 -111.45 135.47 51.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -141.93 112.11 6.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.877 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.695 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 178.96 -60.12 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.911 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.467 ' HB2' ' OH ' ' A' ' 141' ' ' TYR . 0.7 OUTLIER -153.6 148.41 26.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.122 0.487 . . . . 0.0 111.957 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -86.52 -13.01 47.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.903 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.586 ' HB3' HG11 ' A' ' 144' ' ' VAL . 54.0 m -58.35 -50.85 72.18 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.706 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p -87.31 137.68 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.547 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -78.63 143.33 36.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.234 -174.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -67.68 -33.95 75.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.106 177.058 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -30.79 71.84 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.568 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 106' ' ' LYS . 29.6 mtp -73.03 -46.07 54.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.413 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.55 HD22 HD22 ' A' ' 137' ' ' LEU . 4.5 mt -63.22 -31.87 73.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -59.31 -43.4 92.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 111.019 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.97 -28.81 58.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.364 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.63 -43.98 91.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.245 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.421 HD22 HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -65.34 -36.82 85.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.917 175.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -31.42 72.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.56 61.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.547 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.0 m -84.66 -16.83 40.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 110.178 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 106.07 1.28 38.83 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.269 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -103.01 117.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.183 0.516 . . . . 0.0 110.863 -177.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.69 170.5 15.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.222 -177.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.8 t -71.73 126.3 31.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.982 0.42 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.84 -5.91 79.42 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.943 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.9 OUTLIER -106.47 154.59 20.62 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.508 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 1.5 m -57.12 139.34 52.75 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.537 0.523 . . . . 0.0 111.524 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.649 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.92 145.33 25.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.322 0.582 . . . . 0.0 111.183 -175.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.534 ' HA ' ' NH1' ' A' ' 127' ' ' ARG . 26.2 t0 -117.77 111.58 19.28 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.716 0.77 . . . . 0.0 111.243 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.534 ' NH1' ' HA ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -71.2 -15.23 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.051 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.4 p -89.72 -15.43 32.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.741 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -92.73 2.49 56.71 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.929 175.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 130' ' ' ILE . 7.1 mm -59.8 -41.32 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.924 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.39 86.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.816 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.33 -41.63 96.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.115 0.483 . . . . 0.0 109.732 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 10.7 mt -63.55 -45.99 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.479 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -60.37 -49.45 77.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 2.9 tptp -61.95 -40.28 94.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.27 65.84 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.843 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.55 HD22 HD22 ' A' ' 110' ' ' LEU . 12.7 mt -74.01 -32.64 63.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.632 0.253 . . . . 0.0 110.985 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.744 ' HG3' HG12 ' A' ' 151' ' ' VAL . 52.9 mt-10 -67.04 -37.47 84.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 174.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -31.29 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.456 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -66.41 -36.93 84.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.467 ' OH ' ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -62.64 -35.72 80.52 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 177.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -69.35 -34.52 74.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.651 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.29 66.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 104' ' ' SER . 12.4 t -74.87 -86.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.76 18.77 24.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.576 -176.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.6 56.8 3.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.685 0.755 . . . . 0.0 110.063 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -86.18 149.84 24.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.298 -174.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 89.21 3.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.665 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.12 156.52 46.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 0.0 112.036 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 m -117.61 139.98 50.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.843 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.744 HG12 ' HG3' ' A' ' 138' ' ' GLU . 6.6 p -114.4 139.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.134 0.492 . . . . 0.0 110.682 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 127.69 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.228 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.64 116.92 29.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.46 0.648 . . . . 0.0 111.387 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.28 112.33 30.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.904 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.95 111.43 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 120.971 0.415 . . . . 0.0 110.042 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.517 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 22.2 m -118.96 125.15 27.85 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.036 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.1 Cg_exo -82.38 145.62 13.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.191 2.594 . . . . 0.0 112.563 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.3 OUTLIER -105.82 158.88 31.38 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.88 62.77 4.88 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.355 2.703 . . . . 0.0 113.483 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.64 ' HB2' HD12 ' A' ' 158' ' ' LEU . 8.6 mmt180 -146.84 -93.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 -168.69 32.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 174.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.462 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -136.87 166.61 23.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.083 -177.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.528 HG21 HD22 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -128.99 148.03 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.117 0.484 . . . . 0.0 111.163 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -112.07 122.18 47.04 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.487 HD21 HG12 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -119.14 132.58 56.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.713 0.768 . . . . 0.0 111.363 -176.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -120.91 133.34 55.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.975 -176.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.5 mm? -103.56 110.32 22.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.747 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.1 116.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.695 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 75.7 m-85 -97.87 118.56 34.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.538 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -109.43 153.95 23.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.89 117.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.909 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.22 115.69 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -41.53 23.58 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.134 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.699 ' HB3' HG23 ' A' ' 83' ' ' THR . 25.0 t70 -144.11 143.77 31.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.043 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.5 mt -105.31 121.84 57.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.93 128.59 45.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.271 0.557 . . . . 0.0 111.125 -175.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -105.33 137.84 42.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.638 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.46 -42.91 2.96 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.311 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.071 -176.443 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.681 0 CA-C-O 120.447 0.165 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -61.31 -32.48 53.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.463 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.97 -37.61 83.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.9 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.19 63.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.082 0.468 . . . . 0.0 110.738 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.88 -40.05 55.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.479 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.1 -29.92 70.04 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.289 0.635 . . . . 0.0 112.159 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 84.5 mt -62.45 -24.97 67.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.515 ' HB2' HD23 ' A' ' 66' ' ' LEU . 1.5 m -96.82 -7.82 32.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.48 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 33.9 mtp -87.39 131.6 43.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.026 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 13.1 Cg_exo -70.82 -25.43 23.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.914 2.409 . . . . 0.0 112.667 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 m -112.9 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.24 0.543 . . . . 0.0 111.418 -176.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -118.21 -179.87 3.9 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.487 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.9 p -67.47 121.43 15.79 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.847 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -6.11 47.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.5 m-20 -86.0 153.72 21.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.545 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.27 139.01 33.04 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 127.24 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.869 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.54 -177.36 3.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.108 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.513 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -68.07 -36.3 79.61 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.54 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 22.6 m-20 -74.14 -29.81 61.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.787 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -48.38 88.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -70.42 -32.49 70.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.562 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 2.0 m-20 -62.06 -49.76 74.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 110.476 177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 46' ' ' MET . 44.4 m -61.46 -44.34 97.27 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.48 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CD1' HG22 ' A' ' 77' ' ' VAL . 2.4 mt -59.22 -48.2 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 123.39 0.431 . . . . 0.0 110.844 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -33.54 74.14 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.21 -51.59 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.585 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 45' ' ' SER . 79.8 mt -67.61 -30.08 69.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.28 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -41.77 94.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 110.608 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.75 -13.51 62.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.92 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 65' ' ' ALA . 26.4 p -79.37 -25.0 42.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.594 0.235 . . . . 0.0 111.184 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.72 26.97 71.39 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.415 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -95.64 -20.05 19.25 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.117 0.484 . . . . 0.0 110.207 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.67 154.85 45.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 36.3 mt-10 -80.43 -43.66 20.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 111.6 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 12.6 t70 -132.91 136.34 46.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 66' ' ' LEU . 25.9 t -124.98 117.88 51.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.507 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 76' ' ' ARG . 2.4 tpp85 -121.12 122.37 39.87 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.962 172.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 63' ' ' ILE . 27.1 m -96.64 137.54 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -128.34 154.15 46.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -107.57 115.16 29.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.786 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.79 95.62 5.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 -110.45 3.37 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.212 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -106.74 8.32 30.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.225 0.536 . . . . 0.0 110.743 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.699 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -111.08 141.52 44.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.546 -173.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.96 115.55 30.81 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.02 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.32 112.43 24.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.123 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -102.4 109.87 27.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.502 0.668 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -103.95 126.42 51.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.599 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.18 158.3 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.908 0.385 . . . . 0.0 111.262 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.5 tptp . . . . . 0 C--O 1.239 0.547 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 72.6 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 N-CA-C 113.919 0.699 . . . . 0.0 113.919 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.1 m -99.54 138.12 37.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.6 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 20.7 mt -61.62 117.61 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.04 -22.92 13.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.117 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 138.66 13.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.891 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.433 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.2 mt -118.0 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.431 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -117.68 132.27 56.51 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.75 -175.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.64 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 22.2 m-85 -105.84 151.06 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.95 139.71 20.77 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.6 18.5 56.64 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.33 56.99 4.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.455 0.702 . . . . 0.0 110.807 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -86.57 -34.81 19.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 m -84.97 -51.06 6.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.64 137.3 44.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.69 147.86 50.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.619 -174.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.64 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -64.39 -33.09 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.855 176.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -38.01 74.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.024 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -44.08 55.24 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 106' ' ' LYS . 31.1 mt -61.21 -32.49 72.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.101 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.407 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 7.8 mttt -60.47 -46.21 90.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 111.227 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 5.3 tp60 -77.89 -28.24 49.82 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.609 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.094 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.433 ' CD2' HG21 ' A' ' 97' ' ' ILE . 2.3 mp -68.07 -40.57 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.619 174.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.607 ' HG2' ' HB2' ' A' ' 120' ' ' ARG . 1.9 mt-10 -60.46 -42.35 96.0 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.86 -16.0 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.677 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.5 m -91.98 -13.27 31.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.49 -22.03 13.86 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.998 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 94' ' ' ILE . 41.0 t -92.35 104.04 15.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.092 0.472 . . . . 0.0 110.079 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.607 ' HB2' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.0 170.16 16.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.241 -178.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.54 131.47 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.35 0.595 . . . . 0.0 111.283 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.17 -6.63 81.06 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.709 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.58 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -100.15 166.88 10.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.0 111.519 -174.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -61.99 148.08 44.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.433 173.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -112.3 135.08 53.42 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.716 0.769 . . . . 0.0 110.979 -177.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' HG22 ' A' ' 129' ' ' THR . 23.7 t0 -106.17 97.31 7.14 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 172.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.616 ' HD3' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.58 -15.24 62.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.758 -176.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.616 HG23 ' HD3' ' A' ' 127' ' ' ARG . 12.5 p -89.74 -23.62 21.75 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.698 0.285 . . . . 0.0 110.96 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 126' ' ' ASP . 0.5 OUTLIER -87.99 -1.29 57.9 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.406 0.622 . . . . 0.0 110.517 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.703 HG23 ' HB3' ' A' ' 153' ' ' ALA . 5.6 mm -57.51 -43.36 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.215 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.721 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.28 -36.53 84.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.149 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.3 mt -65.18 -45.23 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.353 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -61.12 -47.7 85.05 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 17.2 mmtm -67.09 -34.58 77.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.646 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.94 -39.98 84.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.024 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.587 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 37.0 mt -69.66 -32.54 71.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.633 0.254 . . . . 0.0 111.032 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -63.09 -41.46 99.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.24 -43.48 94.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.688 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.403 ' O ' HG23 ' A' ' 144' ' ' VAL . 14.6 m-85 -65.29 -38.55 90.56 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.228 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -35.47 80.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.947 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -30.4 67.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.206 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -28.44 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 140' ' ' PHE . 12.2 t -72.47 -83.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.233 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.53 18.62 22.59 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.584 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt 63.11 45.58 5.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.368 0.667 . . . . 0.0 110.184 -174.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -80.57 119.62 23.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.092 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.71 73.02 6.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.44 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 143.9 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.39 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.5 m -97.94 115.66 28.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 13.2 t -107.07 122.35 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.563 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 119.57 24.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.388 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.703 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -95.9 111.97 23.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.258 0.552 . . . . 0.0 110.246 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.58 118.82 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.811 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.09 116.75 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.331 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.474 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.1 m -120.77 122.13 28.63 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.791 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.3 Cg_endo -88.11 142.69 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.68 2.92 . . . . 0.0 113.003 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -120.56 159.39 48.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.033 178.056 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.06 -7.69 12.28 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 123.726 2.951 . . . . 0.0 115.0 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.51 12.42 8.57 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 122.488 -0.132 . . . . 0.0 111.193 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 1.3 m-20 62.22 42.35 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.0 0.905 . . . . 0.0 110.603 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HB2' HD11 ' A' ' 158' ' ' LEU . 14.5 mmt85 -131.02 163.57 27.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.381 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.547 HG21 HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -127.43 146.49 33.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.23 0.538 . . . . 0.0 110.537 176.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.08 123.41 49.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.494 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.1 tp -107.22 119.71 40.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.115 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.431 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -115.4 131.27 56.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.376 0.607 . . . . 0.0 110.58 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.6 mm? -104.3 109.93 21.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.462 -176.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.9 t -96.41 111.41 26.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.587 ' HZ ' HD13 ' A' ' 137' ' ' LEU . 48.6 m-85 -108.78 135.2 50.39 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.318 -0.801 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.326 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -107.9 152.76 23.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.686 -0.257 . . . . 0.0 110.428 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.57 113.3 23.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.26 118.42 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 111.256 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -76.69 -46.77 24.31 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 178.363 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.84 146.66 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.427 ' HB ' HD11 ' A' ' 43' ' ' LEU . 62.4 mt -105.39 119.99 55.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -109.65 127.55 54.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.89 137.48 41.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.012 0.434 . . . . 0.0 110.476 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.39 -30.58 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.468 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.796 -176.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.11 -37.54 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.71 -40.23 90.11 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.95 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -71.8 -34.84 69.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.909 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -32.46 70.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.31 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' A' ' 29' ' ' ILE . 4.8 mp -68.94 -30.99 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 41' ' ' ALA . 53.0 mt -68.96 -23.38 64.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.411 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -80.61 -20.96 42.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.422 177.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.547 ' HB3' HG22 ' A' ' 62' ' ' THR . 24.7 mtt -82.53 139.39 44.32 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.95 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 31.4 Cg_exo -63.36 -36.2 57.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.656 2.237 . . . . 0.0 112.328 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.86 150.12 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.389 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 14.6 mmm-85 -127.82 178.09 6.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 0.0 111.067 -175.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -64.65 122.58 17.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.95 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.39 -10.1 42.45 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.83 -174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 5.2 m-20 -89.32 152.77 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.531 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.91 127.7 36.49 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.74 131.15 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.421 0.629 . . . . 0.0 112.491 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -93.13 173.17 7.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.38 174.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.96 -31.6 71.96 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -61.21 -36.97 81.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.893 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 37.8 m-20 -75.05 -29.21 60.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.08 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -45.31 95.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -32.18 73.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.921 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.598 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.4 m-80 -69.63 -43.55 72.45 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.203 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 46' ' ' MET . 1.3 p -63.29 -43.15 98.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.032 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mt -54.21 -49.63 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 123.519 0.512 . . . . 0.0 110.45 174.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -46.59 89.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.416 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 45' ' ' SER . . . -60.8 -48.45 81.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.467 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 75' ' ' VAL . 54.1 mt -69.89 -29.51 66.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -34.36 77.51 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 110.287 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.16 61.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.421 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.8 p -77.61 -25.64 49.98 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.222 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.57 -5.85 20.35 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 116.143 -0.48 . . . . 0.0 114.114 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.63 -23.87 22.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.167 0.483 . . . . 0.0 111.228 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.562 ' CD1' HG21 ' A' ' 88' ' ' VAL . 6.0 m-85 -101.47 157.19 16.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.62 ' HG2' ' HD2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -86.78 -41.66 13.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.151 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.724 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 8.4 t70 -145.88 139.19 26.12 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 66' ' ' LEU . 22.6 t -116.73 120.77 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -174.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.84 118.53 31.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.751 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.6 126.48 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.011 0.434 . . . . 0.0 110.014 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -126.36 159.08 34.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 129.86 50.63 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.806 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.0 96.63 6.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.815 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.2 -109.85 3.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.616 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -111.44 15.9 21.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.394 0.616 . . . . 0.0 110.375 177.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.06 141.41 38.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.085 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.84 119.15 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -112.23 116.99 31.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.98 0.419 . . . . 0.0 110.17 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -106.72 111.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.253 0.549 . . . . 0.0 110.72 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.13 136.24 41.3 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.562 HG21 ' CD1' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -130.78 155.82 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.126 0.489 . . . . 0.0 110.326 -173.349 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.724 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.2 -175.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 3.5 Cg_exo . . . . . 0 N--CA 1.456 -0.714 0 CA-C-O 121.683 0.618 . . . . 0.0 112.559 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -104.34 136.83 43.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.336 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 125' ' ' LEU . 31.0 mt -64.83 118.25 6.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.15 -27.84 14.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.82 139.85 15.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.041 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.17 122.88 65.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 167.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.493 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -116.27 131.94 56.8 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.388 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.607 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -113.43 134.12 54.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.824 -175.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.3 125.75 16.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.66 -2.34 57.19 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.363 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.488 HD21 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -86.36 82.15 8.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.187 0.518 . . . . 0.0 110.709 -177.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.88 -35.77 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.043 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -70.32 -64.91 0.8 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.126 0.488 . . . . 0.0 110.626 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.65 130.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -69.41 158.38 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 0.0 112.087 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -61.47 -34.6 75.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.723 173.133 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -43.1 96.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.983 176.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 mmm -74.45 -35.35 63.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.753 0.311 . . . . 0.0 111.131 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -31.65 72.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.549 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.607 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.93 -43.42 86.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 110.763 176.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -78.29 -28.6 47.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.115 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -66.39 -42.64 87.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.19 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -68.08 -38.45 82.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.53 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -40.16 88.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.097 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.92 -19.38 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.915 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 m -89.23 -12.86 39.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 102.62 -11.86 56.5 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.629 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.3 t -100.5 101.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.519 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 26.8 ptt180 -142.93 175.32 9.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -176.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 94' ' ' ILE . 14.6 p -68.89 135.09 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.216 176.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.33 18.02 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.37 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -84.91 160.5 20.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 110.994 177.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.98 150.58 27.57 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 170.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.634 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -119.02 130.72 55.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -174.052 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.584 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 20.0 t0 -90.13 112.87 24.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.629 0.728 . . . . 0.0 109.893 172.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -15.69 62.25 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.079 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.3 p -83.45 -25.36 31.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.338 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.584 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -89.34 -1.1 57.94 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.952 177.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.559 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.4 mm -56.72 -41.53 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.481 ' HA ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.08 -38.36 90.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.86 -31.22 68.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.583 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.7 mt -67.03 -43.62 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.54 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 131' ' ' ALA . 49.1 mt-10 -62.44 -44.4 96.5 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.591 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.34 93.57 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.748 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.37 -37.49 92.82 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.931 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 mt -68.27 -39.58 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.501 0.191 . . . . 0.0 111.368 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.4 -39.26 88.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.282 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.743 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -60.96 -45.06 96.29 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 147' ' ' TYR . 1.2 m-85 -61.78 -41.42 97.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.181 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -70.75 -34.37 71.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.096 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.2 m -66.51 -28.56 68.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.8 t -80.13 -88.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.975 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.25 18.06 26.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.5 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 1.0 OUTLIER 59.99 44.67 13.07 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.283 0.633 . . . . 0.0 110.697 -174.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HB3' ' A' ' 141' ' ' TYR . 69.3 m-85 -73.58 102.96 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.91 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.32 84.28 6.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 111.676 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -117.81 141.56 48.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 m -100.05 122.42 42.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.749 0.309 . . . . 0.0 110.459 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.2 p -105.47 133.12 50.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.384 0.612 . . . . 0.0 111.657 -174.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -129.23 122.53 29.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.514 173.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -93.8 112.06 23.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.113 0.482 . . . . 0.0 110.762 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.19 116.88 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.471 HG13 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -105.39 118.31 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.433 178.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.5 m -124.12 117.48 26.96 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.629 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 46.7 Cg_endo -69.51 143.83 53.34 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.611 2.207 . . . . 0.0 112.614 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.64 160.35 26.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.79 71.05 0.24 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.616 2.878 . . . . 0.0 114.322 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -164.51 -117.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 18.7 p-10 -138.63 36.79 2.22 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -133.71 157.83 44.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 -172.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -128.18 148.17 32.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.244 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -109.32 126.66 53.62 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.471 HD13 HG13 ' A' ' 155' ' ' VAL . 58.3 tp -113.25 114.35 26.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.934 0.397 . . . . 0.0 110.66 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.493 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 1.3 ttpt -113.28 131.69 55.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 0.0 110.693 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.2 mm? -98.83 110.18 22.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.142 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.483 HG22 ' HE2' ' A' ' 166' ' ' LYS . 25.4 t -94.52 111.08 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -103.26 129.29 50.18 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -106.93 153.56 22.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.202 -0.499 . . . . 0.0 110.072 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.523 HG13 ' HE2' ' A' ' 27' ' ' LYS . 2.1 p -80.6 124.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 110.103 175.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.55 127.75 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.558 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' HG13 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -97.57 -39.44 9.12 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.546 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.611 ' HB3' HG23 ' A' ' 83' ' ' THR . 34.7 t70 -143.8 142.06 30.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.3 mt -109.14 122.07 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -122.75 128.09 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.963 -179.03 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -102.16 138.1 39.56 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.005 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 5.3 mm-40 -119.6 67.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.064 0.935 . . . . 0.0 109.982 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.745 ' HA3' HG22 ' A' ' 88' ' ' VAL . . . . . . . . 0 N--CA 1.443 -0.86 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.745 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.271 0 N-CA-C 110.618 -0.141 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -54.37 -36.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -172.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.96 -35.66 57.83 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.556 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.69 -35.57 60.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -31.25 68.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.384 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.46 -31.05 65.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 112.608 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt -70.41 -23.07 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 111.282 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.98 -17.23 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.278 0.561 . . . . 0.0 110.143 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.665 ' HG2' HG23 ' A' ' 62' ' ' THR . 92.4 mtp -82.81 137.9 43.73 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.823 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HG3' ' HB3' ' A' ' 61' ' ' ASN . 39.6 Cg_endo -69.0 -22.58 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.32 2.013 . . . . 0.0 112.701 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.702 HG11 HG13 ' A' ' 54' ' ' VAL . 2.0 t -125.5 149.77 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.262 0.554 . . . . 0.0 110.811 -175.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 177.9 5.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.673 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -66.16 120.27 12.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.57 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.28 -5.51 38.61 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.214 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' CB ' HG13 ' A' ' 48' ' ' VAL . 1.1 m-20 -98.52 155.78 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.79 140.66 29.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.56 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.702 HG13 HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -125.98 129.16 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.637 0.256 . . . . 0.0 111.652 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.467 ' O ' HD12 ' A' ' 59' ' ' ILE . 1.3 t-20 -95.11 -178.55 4.51 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.25 -30.38 69.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.226 0.536 . . . . 0.0 110.033 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -35.69 81.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.507 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.574 ' HB3' HG12 ' A' ' 54' ' ' VAL . 3.8 m-20 -76.63 -29.6 56.52 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -61.1 -48.14 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 171.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -66.79 -33.48 75.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.55 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.481 ' HB3' ' HG3' ' A' ' 47' ' ' PRO . 4.3 t-20 -63.25 -48.03 79.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.634 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.665 HG23 ' HG2' ' A' ' 46' ' ' MET . 25.5 m -58.9 -46.36 88.07 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.331 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 77' ' ' VAL . 24.4 mt -55.26 -49.46 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.862 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -68.26 -40.42 81.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.204 -175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.0 -53.15 60.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.76 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.722 ' HB3' HG21 ' A' ' 75' ' ' VAL . 6.3 mp -66.5 -30.59 70.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.699 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.407 0.622 . . . . 0.0 110.797 174.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.46 -13.17 61.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.756 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 p -78.63 -25.32 45.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.34 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.94 -7.35 59.73 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.886 176.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.236 0.541 . . . . 0.0 110.572 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 150.31 49.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.938 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.58 -45.14 60.6 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.369 0.418 . . . . 0.0 111.303 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 7.5 t70 -139.43 146.68 40.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 66' ' ' LEU . 70.7 t -126.16 122.72 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.675 0.274 . . . . 0.0 110.304 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.44 118.57 32.1 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.784 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.5 HG22 HG13 ' A' ' 86' ' ' VAL . 43.6 t -103.83 123.19 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.113 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.17 159.06 37.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.65 144.53 43.27 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.277 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -139.23 97.5 3.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.054 171.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 -111.07 3.66 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -112.99 18.82 17.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.298 0.571 . . . . 0.0 109.97 174.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.611 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -107.52 134.54 50.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.029 -177.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 84' ' ' LEU . 1.6 mt -102.65 118.54 37.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.708 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.2 tp -106.09 112.38 25.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.027 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.5 HG13 HG22 ' A' ' 77' ' ' VAL . 3.2 t -110.22 104.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.306 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.49 148.65 23.52 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.745 HG22 ' HA3' ' A' ' 33' ' ' GLY . 15.5 m -125.89 152.32 32.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.092 0.472 . . . . 0.0 110.662 -178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.287 0.453 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 m -97.67 134.74 40.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.456 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 125' ' ' LEU . 32.4 mt -61.96 120.29 7.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.1 -31.17 11.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.593 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.01 138.82 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.191 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -117.75 123.42 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.74 131.55 53.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.662 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.604 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 17.5 m-85 -109.21 134.84 51.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.356 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.11 113.94 11.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.447 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 115.36 13.09 9.19 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.665 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.48 68.54 4.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.731 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -85.39 -31.33 22.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.56 26.35 10.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 111.446 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.8 p -167.89 155.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -83.94 145.67 28.44 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.664 0.745 . . . . 0.0 111.272 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -35.62 80.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.468 175.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -41.74 89.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.248 174.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.74 -42.2 70.83 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.409 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -39.67 84.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.935 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -42.86 99.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.514 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.579 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 1.6 tm0? -77.71 -27.96 50.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.116 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.93 -43.47 95.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.954 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 HG21 ' A' ' 97' ' ' ILE . 3.0 mp -68.49 -41.09 80.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.435 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -57.24 -45.76 83.62 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.791 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.01 -21.82 59.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.733 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -83.62 -17.16 42.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 110.297 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.58 -19.85 8.98 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.271 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.86 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 111.051 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.49 ' HA ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -141.56 175.11 9.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.674 -178.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 94' ' ' ILE . 50.9 t -67.81 123.59 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.077 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.02 29.67 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.31 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.27 160.14 17.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.118 0.485 . . . . 0.0 111.901 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 m -84.75 127.43 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 170.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.48 143.18 27.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.656 -171.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -91.76 113.26 25.48 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.864 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.04 -27.7 62.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.375 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 p -79.24 -22.67 44.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.29 0.88 51.46 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.862 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 125' ' ' LEU . 5.0 mm -55.0 -45.14 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.654 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.42 91.0 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.246 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.96 -34.69 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.496 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 130' ' ' ILE . 61.4 mt -64.87 -48.58 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.748 176.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 130' ' ' ILE . 19.7 mt-10 -59.39 -50.02 75.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.08 0.467 . . . . 0.0 111.358 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -33.17 74.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.6 -37.16 89.2 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.152 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.9 -32.02 68.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.653 0.263 . . . . 0.0 111.12 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.615 ' HG3' HG23 ' A' ' 151' ' ' VAL . 58.5 mt-10 -64.08 -41.44 97.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.095 0.474 . . . . 0.0 110.269 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.82 -39.45 90.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.557 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 144' ' ' VAL . 2.5 t80 -58.8 -45.52 89.68 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.035 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -41.7 87.83 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.406 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.404 ' HE1' ' HG ' ' A' ' 148' ' ' SER . 1.9 t80 -71.25 -29.68 65.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.621 178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.4 m -70.04 -28.56 65.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 140' ' ' PHE . 21.4 t -72.81 -87.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.974 0.416 . . . . 0.0 110.737 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.22 19.52 22.41 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.395 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 62.19 0.96 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.615 0.722 . . . . 0.0 111.105 -174.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -105.63 121.08 43.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.969 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.404 ' HG ' ' HE1' ' A' ' 142' ' ' TYR . 1.0 OUTLIER -94.86 93.6 7.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 110.669 176.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -117.43 153.17 33.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.58 ' HB2' ' HG3' ' A' ' 170' ' ' GLN . 6.8 m -99.65 132.65 44.85 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.615 HG23 ' HG3' ' A' ' 138' ' ' GLU . 21.6 t -110.58 129.34 65.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 110.302 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 168' ' ' VAL . 0.2 OUTLIER -123.06 117.02 24.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.435 176.144 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -95.27 111.12 23.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.158 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.5 113.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.11 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.15 116.97 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.497 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 66.9 m -122.98 124.0 26.65 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.861 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.7 Cg_exo -77.41 141.96 20.63 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.101 2.534 . . . . 0.0 111.768 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.79 156.42 36.61 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.97 76.86 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.134 2.556 . . . . 0.0 113.548 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.494 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -164.53 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.494 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 2.3 t30 -170.14 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.786 0.803 . . . . 0.0 109.124 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -127.08 161.25 28.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.086 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.45 144.6 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.244 176.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.85 130.96 55.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.92 130.37 55.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.097 0.475 . . . . 0.0 111.179 -176.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 130.69 52.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.016 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.2 mm? -106.92 111.63 24.22 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.412 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 152' ' ' LYS . 25.8 t -95.03 111.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.855 -176.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.401 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 81.8 m-85 -103.92 117.5 34.47 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 150' ' ' SER . 1.8 mt-30 . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -101.51 153.22 19.9 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -87.02 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.6 127.87 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.618 0.723 . . . . 0.0 110.633 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -94.49 -41.1 9.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.397 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.18 137.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.633 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.98 121.53 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 7.0 t60 -113.39 127.69 56.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.549 ' HD2' HG12 ' A' ' 39' ' ' VAL . 29.4 m-85 -102.84 134.3 46.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.754 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -133.91 77.53 1.72 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.246 0.546 . . . . 0.0 111.101 -173.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.863 178.693 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.549 HG12 ' HD2' ' A' ' 31' ' ' PHE . 2.3 m -61.67 -32.3 53.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.076 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.35 -37.24 70.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.97 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.27 -36.28 63.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.44 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.26 -39.22 78.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.069 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HA ' ' SD ' ' A' ' 46' ' ' MET . 1.4 mt -59.79 -31.57 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.435 0.694 . . . . 0.0 112.318 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.61 -16.42 61.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.757 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.8 OUTLIER -93.88 -7.87 41.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 175.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.516 ' HG2' HG23 ' A' ' 62' ' ' THR . 70.7 mtp -90.25 147.2 36.34 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.71 -18.51 22.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 112.192 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.459 HG11 HG12 ' A' ' 54' ' ' VAL . 4.3 m -116.71 165.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.972 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -132.38 174.36 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 p -67.45 121.82 16.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.298 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.97 -4.73 49.55 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.313 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -87.31 155.1 20.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 0.0 111.047 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.54 133.42 35.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.845 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.459 HG12 HG11 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -130.8 128.04 62.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.071 0.462 . . . . 0.0 111.363 -175.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.61 179.74 5.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.062 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -30.31 70.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.361 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 17.9 tp10 -66.18 -34.3 77.73 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.36 0.413 . . . . 0.0 110.758 174.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.8 -32.52 69.63 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.37 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -62.68 -49.5 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 123.241 0.338 . . . . 0.0 110.319 173.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -35.03 77.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.58 0.229 . . . . 0.0 111.401 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -66.05 -39.92 90.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.486 177.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.516 HG23 ' HG2' ' A' ' 46' ' ' MET . 68.4 m -59.02 -45.81 89.77 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.032 172.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.416 HG13 HG13 ' A' ' 77' ' ' VAL . 1.2 mt -54.96 -48.44 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 123.445 0.466 . . . . 0.0 110.425 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -67.08 -35.57 80.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.218 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 69' ' ' THR . . . -68.35 -54.89 14.26 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.239 0.337 . . . . 0.0 110.507 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.78 HD22 ' HE2' ' A' ' 72' ' ' PHE . 37.4 mt -58.72 -29.71 66.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -52.67 33.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.969 0.414 . . . . 0.0 110.821 172.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.37 61.33 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.757 HG21 ' HB3' ' A' ' 45' ' ' SER . 30.0 p -79.49 -6.62 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.678 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.87 75.06 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.478 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -83.07 -59.27 2.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.517 . . . . 0.0 111.604 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.78 ' HE2' HD22 ' A' ' 66' ' ' LEU . 2.4 m-85 -124.82 169.96 11.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.524 0.202 . . . . 0.0 111.292 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 1.9 tm-20 -79.01 -42.54 26.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.09 0.471 . . . . 0.0 110.846 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 30.6 t70 -137.89 141.04 40.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.75 119.02 55.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.077 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -120.98 117.29 26.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.943 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.709 ' HB ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -109.41 129.99 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.634 0.73 . . . . 0.0 109.695 172.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.14 156.83 34.24 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -129.16 126.16 38.63 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.513 0.673 . . . . 0.0 111.202 -176.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -115.46 97.12 5.98 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.851 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.06 -109.08 2.71 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.234 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.48 10.42 23.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.708 0.289 . . . . 0.0 110.778 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.33 132.52 50.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.83 116.77 31.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 0.8 OUTLIER -109.96 117.1 32.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.709 HG22 ' HB ' ' A' ' 77' ' ' VAL . 4.8 t -111.22 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.257 0.551 . . . . 0.0 110.989 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.754 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 64.4 mt-30 -93.55 137.93 32.33 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.95 152.24 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 -175.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.554 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.824 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 17.2 Cg_exo . . . . . 0 CA--C 1.529 0.245 0 CA-C-O 121.58 0.575 . . . . 0.0 113.277 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 7.2 m -105.31 139.16 40.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.913 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.635 HD11 ' HB2' ' A' ' 125' ' ' LEU . 50.0 mt -62.88 118.16 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.73 -42.5 11.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.1 39.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 176.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 165' ' ' LEU . 0.7 OUTLIER -115.84 122.39 69.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.63 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -117.11 141.11 48.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.682 -175.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.667 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 26.1 m-85 -121.73 134.96 54.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.154 -172.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.0 114.39 11.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.841 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.554 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 119.91 36.58 0.82 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.052 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 99' ' ' PHE . 8.9 m120 -95.06 83.85 4.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.346 0.594 . . . . 0.0 110.149 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.06 -45.34 10.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.413 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.18 -41.61 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -173.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.495 HG12 ' HE2' ' A' ' 141' ' ' TYR . 14.0 p -117.53 148.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.68 145.33 53.96 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.667 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 18.2 p-10 -66.42 -32.07 73.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.551 170.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -43.72 76.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.073 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.71 65.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -58.44 -32.03 68.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.11 176.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.505 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 3.9 mtpp -56.95 -44.44 82.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.435 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.48 -28.37 52.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.43 -40.57 93.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.664 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 97' ' ' ILE . 1.4 mm? -66.86 -38.85 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.747 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.779 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 2.0 mt-10 -63.91 -39.5 94.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.168 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.2 -17.14 60.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.597 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.6 m -87.0 -16.44 35.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.305 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.85 -21.55 22.84 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.935 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.59 HG21 HD11 ' A' ' 133' ' ' ILE . 1.3 t -102.8 101.13 11.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.779 ' HB3' ' HA ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -142.64 175.25 9.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -167.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.441 HG23 HG13 ' A' ' 97' ' ' ILE . 16.2 t -63.46 129.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.47 175.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.47 -6.34 71.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.548 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.78 138.1 51.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 12.5 m -65.75 138.96 58.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.635 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -91.21 143.42 26.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.638 0.732 . . . . 0.0 112.894 -163.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.545 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 6.8 t0 -97.08 105.23 17.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.452 170.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.701 ' H ' ' HD2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -70.41 -14.17 62.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.632 -177.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.1 p -81.29 -24.53 37.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.653 0.263 . . . . 0.0 110.82 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.545 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -92.58 3.39 55.63 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 111.131 179.019 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 153' ' ' ALA . 6.4 mm -59.46 -40.78 82.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.55 -34.95 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.472 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.1 -34.36 77.46 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.309 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 130' ' ' ILE . 21.2 mt -64.8 -49.09 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.43 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.35 -45.78 92.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.414 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -40.61 89.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.316 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.33 88.77 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.759 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.528 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 13.8 mt -67.65 -35.72 79.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.639 0.257 . . . . 0.0 111.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.29 -30.48 66.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.859 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.41 -34.24 76.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.455 ' O ' HG23 ' A' ' 144' ' ' VAL . 22.2 m-85 -75.22 -39.83 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.346 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.495 ' HE2' HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -61.24 -39.85 91.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.158 0.504 . . . . 0.0 110.867 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -30.07 69.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.536 177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.4 m -73.11 -28.34 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 140' ' ' PHE . 16.0 t -73.66 -87.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.448 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.94 19.3 23.29 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.597 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.6 mttp 66.59 51.44 1.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.447 0.699 . . . . 0.0 110.852 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -90.39 139.08 31.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.581 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.37 88.85 2.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.043 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.28 163.91 12.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.958 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.2 112.52 24.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 3.4 p -118.25 126.91 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.401 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 127.18 38.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.726 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -91.16 111.12 22.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.274 0.559 . . . . 0.0 110.258 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.61 123.25 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.25 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.5 HG12 ' HB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -98.72 127.03 51.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.147 0.498 . . . . 0.0 110.208 177.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -104.74 120.34 50.56 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.153 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.35 135.18 18.14 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 122.821 2.347 . . . . 0.0 112.984 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 0.7 OUTLIER -135.11 151.46 75.32 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.071 175.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 4.1 Cg_exo -76.98 66.53 7.68 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.53 2.82 . . . . 0.0 113.499 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -148.6 16.07 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.169 173.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 37.9 t30 58.0 43.41 21.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.275 -168.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HD3' ' HB ' ' A' ' 93' ' ' THR . 74.9 mmt-85 -135.89 157.81 45.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.35 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.5 ' HB ' HG12 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -132.7 145.6 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.019 173.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.65 121.73 45.88 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 97' ' ' ILE . 37.9 tp -95.59 120.36 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.312 -174.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.63 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.71 131.78 55.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.649 0.738 . . . . 0.0 111.223 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.575 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.9 mm? -102.29 110.63 22.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.255 -176.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.7 t -96.67 110.71 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.554 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 8.0 m-85 -105.88 118.83 37.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.296 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.886 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -107.65 151.46 25.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.911 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.8 t -81.8 119.02 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.315 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 t -70.52 124.63 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.01 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -44.32 12.33 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.779 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 145.97 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.839 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -109.82 122.73 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -119.6 147.75 44.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.966 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.478 ' HD2' HG12 ' A' ' 39' ' ' VAL . 46.0 m-85 -124.43 130.97 53.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 0.0 110.991 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 1.4 tm-20 -123.22 69.89 1.02 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.482 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.512 178.47 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 120.543 0.211 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.478 HG12 ' HD2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -51.96 -40.03 27.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 124.069 0.856 . . . . 0.0 112.751 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.43 90.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.199 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -72.53 -33.56 66.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.21 -33.63 59.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.689 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 mp -61.85 -31.31 71.56 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.174 0.59 . . . . 0.0 111.713 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 41' ' ' ALA . 45.9 mt -67.28 -23.96 65.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.388 . . . . 0.0 111.652 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.516 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -89.79 -8.55 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.221 0.534 . . . . 0.0 110.209 177.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.49 ' HG2' HG23 ' A' ' 62' ' ' THR . 85.2 mtp -88.14 143.03 32.3 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.01 -16.18 40.49 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 122.359 2.039 . . . . 0.0 113.209 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 54' ' ' VAL . 2.5 m -129.02 169.46 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.058 0.456 . . . . 0.0 111.642 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -127.88 177.2 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.691 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -66.4 125.11 24.64 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.53 -7.08 39.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.452 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.4 156.33 19.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 0.0 111.176 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.12 134.02 36.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.119 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 48' ' ' VAL . 3.1 m -131.67 129.51 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 111.892 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.42 ' O ' HD12 ' A' ' 59' ' ' ILE . 4.6 m-20 -82.1 173.62 11.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.397 170.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.74 -26.27 65.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.346 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.48 -32.45 72.46 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.774 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -76.79 -28.7 55.74 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 122.302 0.241 . . . . 0.0 111.363 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.66 -45.04 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.79 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.2 m -67.62 -31.2 71.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.32 175.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.774 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.6 m-20 -66.15 -41.38 90.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.284 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.49 HG23 ' HG2' ' A' ' 46' ' ' MET . 56.3 m -58.37 -46.65 85.92 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.017 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 60' ' ' SER . 65.0 mt -54.04 -50.9 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.545 0.528 . . . . 0.0 110.644 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -39.86 95.87 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.587 0.755 . . . . 0.0 111.747 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.67 -52.55 36.58 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.882 -176.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 45' ' ' SER . 41.1 mt -64.48 -30.61 71.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.429 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.2 -40.39 82.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.674 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 -12.9 61.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.803 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 65' ' ' ALA . 34.6 p -78.14 -23.01 47.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.576 0.227 . . . . 0.0 110.708 -177.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.39 23.18 76.53 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.198 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -87.92 -28.76 21.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.15 . . . . 0.0 111.229 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.44 161.46 35.76 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.253 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 124' ' ' SER . 0.0 OUTLIER -79.84 -38.91 31.83 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.174 0.296 . . . . 0.0 111.185 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.843 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 7.9 t70 -139.16 137.76 36.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 66' ' ' LEU . 75.2 t -117.89 119.56 61.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.992 0.425 . . . . 0.0 109.902 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 118.67 32.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.174 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 67.2 t -114.82 128.99 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp -128.68 155.7 44.61 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -118.18 126.73 52.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.322 0.582 . . . . 0.0 109.803 174.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -125.63 97.08 5.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.772 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 -108.83 2.61 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.92 7.81 15.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.401 . . . . 0.0 110.407 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.91 129.21 53.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.215 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.49 115.89 31.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.4 tp -108.05 121.38 44.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 -175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' A' ' 31' ' ' PHE . 21.9 t -112.84 113.19 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.626 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.701 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 33.9 mt-30 -99.82 138.51 36.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.9 148.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.098 0.475 . . . . 0.0 110.679 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.843 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.828 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.86 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.557 ' HB2' HG22 ' A' ' 163' ' ' VAL . 16.7 Cg_exo . . . . . 0 CA--C 1.531 0.361 0 N-CA-C 114.468 0.911 . . . . 0.0 114.468 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -88.12 140.17 29.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.493 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 125' ' ' LEU . 33.9 mt -65.19 118.24 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.45 -40.75 14.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.06 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.54 146.55 25.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.777 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -107.53 128.78 62.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.92 133.02 54.85 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.632 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 22.6 m-85 -113.52 135.49 53.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -136.91 127.37 26.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.412 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.61 46.38 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.29 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.87 79.99 1.26 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -33.45 21.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.553 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -46.94 76.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.725 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.5 t -118.29 141.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -69.71 151.48 45.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 111.483 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -35.26 79.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.172 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -28.87 65.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.724 0.297 . . . . 0.0 111.153 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.6 mtp -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -34.73 78.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.963 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.632 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 2.4 mttt -59.42 -43.12 93.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.915 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.66 -28.76 56.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.622 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.39 -45.0 85.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.299 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.482 HD12 HG23 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -65.93 -37.16 85.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.21 176.006 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.445 ' HG2' ' CG ' ' A' ' 120' ' ' ARG . 67.0 mt-10 -59.38 -46.58 88.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.26 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.81 61.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -85.04 -16.99 38.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.315 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.98 -19.85 15.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.408 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.482 HG23 HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -96.0 106.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.316 0.579 . . . . 0.0 110.811 -176.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.445 ' CG ' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -119.0 163.29 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.136 -173.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.1 t -69.35 123.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 109.963 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.56 -7.27 80.02 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.061 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 161.58 13.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -74.89 149.54 39.46 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.789 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -103.04 146.76 27.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.969 0.414 . . . . 0.0 111.716 -173.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -116.25 101.49 8.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.648 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.496 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.46 -20.14 62.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.233 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -27.09 65.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.548 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -0.01 43.06 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.805 177.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.9 mm -59.31 -37.87 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.451 0.301 . . . . 0.0 111.69 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.38 86.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.913 0.387 . . . . 0.0 111.3 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -30.07 64.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.26 -42.51 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.272 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -64.38 -40.57 96.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -68.46 -38.06 80.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.626 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.68 -37.5 92.49 Favored Glycine 0 C--O 1.227 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.852 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.487 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 11.1 mt -73.01 -34.3 66.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.682 0.277 . . . . 0.0 111.202 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -38.84 87.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.153 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.41 -37.53 71.51 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.597 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 144' ' ' VAL . 11.1 t80 -61.47 -41.96 98.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.809 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.453 ' HD1' ' O ' ' A' ' 147' ' ' TYR . 1.2 m-85 -62.21 -37.58 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.847 177.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 56.9 t80 -70.41 -35.44 73.44 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.335 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.8 m -67.69 -31.81 72.02 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 140' ' ' PHE . 11.0 t -74.63 -91.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.806 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.43 18.58 22.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.412 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 7.8 mtmt 60.01 57.42 3.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.441 0.639 . . . . 0.0 110.205 -173.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.453 ' O ' ' HD1' ' A' ' 141' ' ' TYR . 51.2 m-85 -96.64 34.89 1.58 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.701 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.13 102.71 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.97 152.51 45.58 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.617 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 m -96.77 126.63 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 110.373 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.4 p -106.48 134.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.43 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -108.81 117.04 33.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.012 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.21 110.45 21.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.318 0.58 . . . . 0.0 110.1 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.69 117.0 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.386 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.67 112.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.185 0.516 . . . . 0.0 110.047 175.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 8.1 m -104.7 121.65 46.2 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 6.2 Cg_exo -79.9 143.78 16.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.109 2.539 . . . . 0.0 112.126 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -129.92 156.76 78.55 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.939 174.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.85 70.85 3.49 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.489 2.793 . . . . 0.0 113.266 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 158' ' ' LEU . 6.0 ttm180 -163.35 15.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.36 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.9 t30 55.59 42.27 29.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.199 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -129.95 157.99 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.815 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.789 HG21 HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.74 152.37 36.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.114 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.87 118.71 37.46 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.8 tp -99.17 112.18 24.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.128 -175.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HG2' HG22 ' A' ' 168' ' ' VAL . 8.2 ttmt -111.63 132.68 54.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.483 0.658 . . . . 0.0 111.145 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.511 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.5 mm? -108.63 109.41 20.6 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.408 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 166' ' ' LYS . 1.5 t -107.19 113.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.807 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 3.2 m-85 -98.34 118.91 36.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.117 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.627 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.097 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p90 -150.47 152.23 33.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.878 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -85.86 118.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.1 119.04 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.354 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.65 -34.61 19.74 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.442 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.481 ' HB3' HG23 ' A' ' 83' ' ' THR . 20.8 t70 -158.57 145.6 17.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.196 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.645 HD13 HD21 ' A' ' 43' ' ' LEU . 4.6 mt -109.28 120.65 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -116.5 127.11 54.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.767 -178.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.41 136.52 40.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.406 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.2 58.22 0.69 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.955 0.883 . . . . 0.0 109.647 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.052 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.611 179.823 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.528 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -51.22 -43.23 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.83 -35.54 50.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.75 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.45 -29.2 64.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.215 0.531 . . . . 0.0 111.031 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.71 -34.65 60.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.409 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.772 HD22 ' HG2' ' A' ' 49' ' ' ARG . 2.3 mt -56.98 -30.26 63.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.384 0.673 . . . . 0.0 112.79 170.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.57 -29.31 69.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 111.445 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.745 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -91.33 -8.82 47.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.014 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.542 ' HG3' ' HA ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -86.28 132.55 42.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 6.7 Cg_exo -74.23 -8.61 21.1 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.784 2.323 . . . . 0.0 112.749 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.424 HG11 ' CG1' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -139.93 151.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.939 0.4 . . . . 0.0 110.418 -175.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.772 ' HG2' HD22 ' A' ' 43' ' ' LEU . 81.5 mtt-85 -131.57 179.41 6.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.576 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.4 p -63.08 123.43 18.56 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.256 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.44 -6.83 39.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.8 m-20 -87.61 148.87 24.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.816 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -101.15 124.51 46.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.342 178.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.424 ' CG1' HG11 ' A' ' 48' ' ' VAL . 2.1 m -142.02 145.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -170.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -100.47 -177.76 3.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.38 -26.44 66.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.786 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.83 -31.64 68.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.642 0.258 . . . . 0.0 110.572 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.38 -29.38 59.83 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.202 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -44.84 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.72 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -68.28 -34.01 75.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.435 177.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -66.58 -40.87 89.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.006 0.431 . . . . 0.0 110.387 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.9 m -58.59 -43.8 89.65 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.154 172.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 60' ' ' SER . 74.6 mt -55.97 -47.15 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.743 176.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmm-85 -62.76 -42.53 99.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 69' ' ' THR . . . -59.63 -53.39 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 45' ' ' SER . 16.4 mt -63.6 -32.66 74.19 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.657 0.598 . . . . 0.0 111.624 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -39.66 91.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.0 110.888 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.67 60.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.222 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 45' ' ' SER . 42.3 p -79.78 -24.93 41.14 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -172.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.75 20.73 79.84 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.752 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -88.83 -26.34 21.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.292 0.568 . . . . 0.0 110.142 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.16 156.54 43.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.364 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.527 ' OE1' ' HE2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.64 -44.24 24.33 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.29 0.369 . . . . 0.0 111.275 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 31.5 t70 -130.73 139.28 50.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.285 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 66' ' ' LEU . 25.2 t -123.51 120.16 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.238 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.49 117.29 29.96 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.473 HG22 HG13 ' A' ' 86' ' ' VAL . 84.4 t -113.87 122.66 68.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.3 137.84 46.16 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.439 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 6.5 ptm180 -95.31 140.56 30.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.356 0.598 . . . . 0.0 110.387 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -130.62 96.94 4.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.43 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.68 -109.08 2.72 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.166 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -108.2 1.7 22.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 0.0 110.759 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.71 137.41 41.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 -173.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.71 115.54 30.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.24 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.6 tp -102.52 119.25 38.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.473 HG13 HG22 ' A' ' 77' ' ' VAL . 17.7 t -117.88 108.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.759 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.92 136.49 44.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.06 153.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.262 0.553 . . . . 0.0 111.073 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.819 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 20.0 Cg_exo . . . . . 0 C--O 1.232 0.197 0 CA-C-O 121.499 0.541 . . . . 0.0 112.917 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 66.9 m -127.75 133.35 49.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.319 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 125' ' ' LEU . 56.9 mt -69.13 118.86 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.09 -34.67 12.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.565 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 138.3 24.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 121' ' ' VAL . 4.7 mt -110.75 123.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 131.74 56.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.064 0.459 . . . . 0.0 110.898 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.657 ' HE2' HD13 ' A' ' 167' ' ' LEU . 21.2 m-85 -110.13 135.75 50.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.989 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.98 122.72 11.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.18 -14.5 64.39 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.535 174.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.29 78.11 3.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 110.829 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -85.84 -19.35 30.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -78.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.526 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.49 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 54.4 t -84.21 139.17 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -69.92 152.19 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.053 0.454 . . . . 0.0 111.644 -172.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.26 76.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.546 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -38.01 89.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mtp -73.05 -39.33 66.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.359 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.485 HD21 ' HE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -63.64 -32.74 74.31 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.417 177.375 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.439 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 10.3 mttt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.076 0.465 . . . . 0.0 110.954 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -28.76 55.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.622 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -67.84 -38.5 83.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.5 mm? -67.9 -38.46 83.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.467 175.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.47 -33.66 76.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.088 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.38 -16.11 60.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.079 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 m -91.83 -16.55 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.193 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 107.93 -25.65 19.95 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.921 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.19 107.89 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.155 0.503 . . . . 0.0 111.451 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.468 ' HA ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -140.94 175.49 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.548 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 97' ' ' ILE . 27.3 t -67.33 126.32 26.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 110.074 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.29 -6.77 66.18 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.34 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 160.4 14.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.234 0.54 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.91 117.97 23.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.802 174.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.835 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.89 137.42 33.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.093 0.473 . . . . 0.0 112.074 -172.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -101.9 105.98 16.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.878 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.446 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.02 -15.72 62.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.403 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.8 p -87.18 -20.45 26.96 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.56 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.3 p -98.69 6.83 46.73 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.927 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.6 mm -55.94 -37.58 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.05 85.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.18 -36.22 79.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 110.068 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.0 mt -66.33 -42.99 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.443 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.18 -45.0 96.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -34.15 77.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.325 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.53 -42.16 89.06 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.777 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.9 -38.62 91.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.452 ' HG3' HG12 ' A' ' 151' ' ' VAL . 13.8 mt-10 -69.62 -34.54 74.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.254 0.346 . . . . 0.0 111.067 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.52 -41.83 75.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.435 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 144' ' ' VAL . 5.4 m-85 -67.49 -37.18 82.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.49 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.95 -41.18 91.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.163 0.506 . . . . 0.0 110.476 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -30.35 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.51 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.8 m -72.35 -28.58 63.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.856 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 140' ' ' PHE . 31.4 t -77.54 -82.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.767 0.317 . . . . 0.0 111.092 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.5 19.46 21.85 Favored Glycine 0 N--CA 1.454 -0.101 0 C-N-CA 121.358 -0.449 . . . . 0.0 112.833 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm 66.05 34.35 7.0 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.341 0.656 . . . . 0.0 110.485 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -76.63 126.27 30.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.219 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.62 59.12 0.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.242 0.544 . . . . 0.0 110.565 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.95 148.21 22.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.642 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 m -97.86 118.82 35.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.942 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.7 p -98.8 137.35 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 116.95 19.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.077 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.49 111.53 23.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.424 0.631 . . . . 0.0 109.949 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.99 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.391 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.67 109.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.483 0.658 . . . . 0.0 110.219 175.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.6 m -104.67 113.47 64.93 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.811 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.37 128.13 8.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.085 2.523 . . . . 0.0 113.004 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -109.46 143.59 28.09 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 16.5 Cg_exo -67.69 79.52 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.83 3.02 . . . . 0.0 114.008 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -157.44 -75.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 6.3 t30 177.79 13.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.802 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.587 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 26.4 mmt-85 -117.92 157.7 26.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.414 -170.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.835 HG11 HD22 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -127.93 152.61 36.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.319 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -108.3 118.89 37.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.4 tp -106.58 110.7 22.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.07 0.462 . . . . 0.0 110.339 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -112.55 132.53 55.07 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.258 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.657 HD13 ' HE2' ' A' ' 99' ' ' PHE . 1.5 mp -114.31 112.09 22.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.696 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.55 112.99 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.596 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.51 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 2.4 m-85 -99.6 118.68 36.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 . . . . . 0 C--N 1.322 -0.613 0 CA-C-O 120.82 0.343 . . . . 0.0 110.867 -178.853 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.606 ' HZ ' HD12 ' A' ' 84' ' ' LEU . 2.7 p90 -93.8 153.38 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.631 0.253 . . . . 0.0 110.51 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.36 117.78 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.245 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.16 137.91 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.233 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 -37.75 5.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.27 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -143.86 138.55 28.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.481 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.664 HG21 ' HE1' ' A' ' 46' ' ' MET . 86.7 mt -103.87 120.72 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 127.95 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.407 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -103.8 122.33 44.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.366 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.774 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 4.3 mt-10 -98.68 54.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.913 0.863 . . . . 0.0 109.907 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.851 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.32 177.925 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.149 0 CA-C-O 119.975 -0.059 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -58.88 -31.61 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.56 81.23 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.872 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.19 -35.94 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.136 0.493 . . . . 0.0 110.696 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.42 83.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.442 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.626 HD22 ' HD2' ' A' ' 49' ' ' ARG . 2.6 mt -57.8 -32.76 67.87 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.58 -21.15 61.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.612 0.244 . . . . 0.0 111.352 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -93.45 -21.98 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.018 0.437 . . . . 0.0 110.369 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.664 ' HE1' HG21 ' A' ' 29' ' ' ILE . 77.0 mtm -82.65 135.73 45.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.39 -2.75 12.77 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.56 2.173 . . . . 0.0 112.444 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.78 147.56 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HD2' HD22 ' A' ' 43' ' ' LEU . 4.1 mmm180 -129.6 175.13 9.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.936 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.6 p -68.06 120.99 15.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.69 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.18 -5.27 52.56 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.424 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -80.02 155.89 27.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 0.0 111.594 -177.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -106.24 126.04 51.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.229 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 58' ' ' ASP . 0.3 OUTLIER -133.03 133.45 58.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 112.134 -168.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.449 ' O ' HD12 ' A' ' 59' ' ' ILE . 2.7 m120 -98.77 -177.27 3.6 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.094 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.32 -32.75 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.568 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.7 -43.09 89.94 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.549 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' A' ' 54' ' ' VAL . 31.1 m-20 -75.09 -27.99 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.246 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.915 HD11 ' HD3' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -59.78 -52.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 172.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -71.47 -26.29 62.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.259 178.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.439 ' HA ' ' HD2' ' A' ' 64' ' ' ARG . 1.8 t-20 -63.98 -47.14 81.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -60.78 -45.66 93.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 174.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 60' ' ' SER . 67.1 mt -53.72 -55.5 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 123.544 0.528 . . . . 0.0 110.886 177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.91 -30.47 67.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.08 -175.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.32 -48.22 68.22 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.558 0.218 . . . . 0.0 110.592 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB2' HG11 ' A' ' 75' ' ' VAL . 84.0 mt -69.27 -30.41 68.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -40.51 94.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 110.774 175.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.57 -13.43 62.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.601 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.3 p -79.03 -24.92 43.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.547 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.475 ' HA3' ' HG3' ' A' ' 123' ' ' GLU . . . 80.83 -10.25 47.64 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.317 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -67.07 -31.72 72.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.4 144.46 46.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.848 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -73.4 -37.25 66.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.054 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -139.49 136.51 34.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 66' ' ' LEU . 39.3 t -127.59 118.15 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.085 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.09 55.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.659 HG22 HG13 ' A' ' 86' ' ' VAL . 68.1 t -125.52 118.38 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 77' ' ' VAL . 2.2 mm? -133.14 159.14 41.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -172.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.915 ' HD3' HD11 ' A' ' 59' ' ' ILE . 15.5 mtm180 -113.49 147.59 37.6 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.655 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -135.27 96.83 3.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.736 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.8 -109.25 2.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.512 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 24' ' ' PHE . 3.8 m-20 -112.85 14.22 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.227 0.537 . . . . 0.0 109.923 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.45 136.82 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.257 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.606 HD12 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.34 112.13 24.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 tp -106.4 112.46 25.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.624 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 77' ' ' VAL . 8.3 t -114.51 117.12 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.774 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.0 mt-30 -106.97 124.94 50.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.99 145.01 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.196 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.175 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 124' ' ' SER . 18.9 Cg_endo . . . . . 0 N--CA 1.459 -0.55 0 N-CA-C 113.939 0.707 . . . . 0.0 113.939 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.754 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 94.0 m -111.93 124.8 53.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.421 176.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 125' ' ' LEU . 19.0 mt -67.54 118.8 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.01 6.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.239 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.05 144.33 27.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.401 . . . . 0.0 110.856 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -106.9 123.87 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 171.304 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.99 141.35 49.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.381 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.547 ' HE1' ' HB2' ' A' ' 111' ' ' LYS . 24.1 m-85 -117.59 152.33 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 112.018 -172.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.79 111.91 3.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.46 55.09 0.28 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.257 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.534 HD21 HD22 ' A' ' 110' ' ' LEU . 33.1 m120 -126.24 41.52 3.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.224 -0.488 . . . . 0.0 112.044 -172.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -86.03 -16.03 39.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.526 177.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 141' ' ' TYR . 75.6 m -105.21 -45.19 4.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.639 0.257 . . . . 0.0 111.108 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.0 t -120.62 147.65 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.44 147.45 50.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.188 0.518 . . . . 0.0 111.939 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.74 -35.2 78.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.446 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -35.09 79.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.121 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -41.65 77.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.215 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.534 HD22 HD21 ' A' ' 102' ' ' ASN . 0.3 OUTLIER -62.87 -40.62 98.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.235 175.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.547 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -64.96 -43.27 93.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.224 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.11 -27.42 60.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -66.57 -43.65 84.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.417 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -61.63 -43.24 99.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.652 173.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.817 ' HG2' ' HG3' ' A' ' 120' ' ' ARG . 91.9 mt-10 -59.9 -42.95 94.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.511 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.75 -18.68 60.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.858 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 m -87.4 -17.18 32.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.632 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.75 -21.22 8.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.282 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.14 103.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.372 0.606 . . . . 0.0 110.147 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.817 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 12.2 ttp-105 -130.98 161.88 30.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.346 -172.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.419 ' HA ' HG22 ' A' ' 94' ' ' ILE . 24.2 t -69.9 124.43 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.956 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.68 -21.67 44.89 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.594 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.475 ' HG3' ' HA3' ' A' ' 70' ' ' GLY . 1.0 OUTLIER -95.79 166.22 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 110.758 -178.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -83.13 142.65 31.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.425 -176.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -116.22 138.64 51.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.451 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 25.6 t0 -94.8 121.07 36.01 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.195 0.998 . . . . 0.0 111.486 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -21.85 61.27 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.661 -1.608 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.9 p -89.6 -10.68 45.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.905 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 1.1 p -104.33 7.32 35.71 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.001 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.518 HD11 HD11 ' A' ' 125' ' ' LEU . 5.5 mm -55.31 -43.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.644 0.59 . . . . 0.0 111.854 -177.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 135' ' ' LYS . . . -62.48 -42.71 99.68 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.492 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.46 -29.02 66.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.888 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.25 -42.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.762 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.91 -46.76 89.38 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 50.6 mmtt -67.88 -36.39 80.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -40.23 84.79 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.374 -0.441 . . . . 0.0 112.608 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.531 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 10.0 mt -69.62 -31.97 70.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.881 ' HG3' HG23 ' A' ' 151' ' ' VAL . 6.2 mt-10 -64.62 -41.37 96.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.418 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -68.56 -34.06 75.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.543 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.463 ' HE1' HD12 ' A' ' 110' ' ' LEU . 28.0 t80 -60.76 -44.28 96.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.536 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.512 ' CE1' ' HB2' ' A' ' 104' ' ' SER . 0.2 OUTLIER -62.7 -38.95 92.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 177.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.55 -29.93 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.999 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 m -70.55 -30.33 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 140' ' ' PHE . 19.4 t -73.9 -82.28 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 110.853 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.69 18.67 22.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.029 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 63.73 40.82 7.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 110.271 -173.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -81.55 120.99 25.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.627 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 101.01 9.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -114.84 156.42 24.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.16 120.7 36.95 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.881 HG23 ' HG3' ' A' ' 138' ' ' GLU . 49.0 t -102.57 124.28 56.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 0.0 111.812 -172.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.85 115.82 26.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.87 111.12 23.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.65 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.66 112.97 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.033 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 117.65 49.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 109.369 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.6 m -104.67 116.89 60.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.944 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 163' ' ' VAL . 91.4 Cg_endo -86.84 136.73 4.42 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.096 2.531 . . . . 0.0 113.113 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.702 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -126.03 150.2 68.61 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 171.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 22.1 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.471 2.781 . . . . 0.0 114.108 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -113.67 26.37 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.208 -0.308 . . . . 0.0 110.81 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.5 t30 74.88 5.35 4.36 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 0.0 111.52 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.754 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 9.8 mmt-85 -113.56 160.29 18.69 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 111.176 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 157' ' ' PRO . 0.7 OUTLIER -136.73 145.26 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.486 175.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.23 131.02 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.67 117.44 33.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.773 0.321 . . . . 0.0 111.188 -173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 131.63 56.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 0.0 109.816 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.89 111.72 23.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.305 -175.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.4 t -94.94 111.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.785 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.531 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 8.7 m-85 -114.18 142.02 46.78 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.231 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 . . . . . 0 C--N 1.317 -0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 167.187 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.554 0.693 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 55' ' ' ASN . 23.9 mp0 -127.19 177.14 6.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.617 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.01 48.16 10.3 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -173.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -110.32 154.21 23.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.09 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.41 115.75 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.355 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.38 142.45 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.486 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -38.31 7.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.398 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -143.32 146.91 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.9 mt -111.23 130.49 64.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.8 156.44 34.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.678 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 5.9 m-85 -128.53 119.66 25.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.41 73.9 2.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.738 0.78 . . . . 0.0 110.599 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 156.24 -20.62 0.48 Allowed Glycine 0 C--N 1.314 -0.691 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.023 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 5.4 mt -85.11 129.04 34.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.32 -0.44 . . . . 0.0 111.08 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.93 -35.09 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.362 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -79.9 -55.52 4.91 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 120.917 0.389 . . . . 0.0 110.048 175.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.408 ' HB ' HD13 ' A' ' 34' ' ' LEU . 4.1 t -78.68 128.2 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.04 158.27 16.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.048 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.479 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.4 m -57.05 -29.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.65 71.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.949 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 -33.94 57.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 110.381 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.62 -31.45 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.66 -32.02 64.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.799 0.839 . . . . 0.0 112.788 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.1 -23.7 65.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.838 0.351 . . . . 0.0 111.633 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.525 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -90.34 -7.49 53.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 178.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 56.7 mtp -100.39 132.64 22.19 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.9 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 23.1 Cg_exo -66.33 -19.99 55.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.886 2.391 . . . . 0.0 112.665 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -104.06 155.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.404 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.528 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.3 176.21 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -68.91 121.52 16.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.983 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.98 -6.33 51.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.139 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 2.9 m-20 -81.16 156.49 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 111.263 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.03 125.98 35.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.27 128.43 72.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 111.907 -173.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 22' ' ' GLU . 14.4 m-80 -98.42 -178.27 3.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.082 175.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.19 -26.77 65.0 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.62 -37.12 86.13 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.548 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.68 -30.96 64.69 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.433 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.84 -46.86 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 123.303 0.377 . . . . 0.0 110.264 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.52 69.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.141 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 2.0 t-20 -68.22 -43.4 78.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.999 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 p -64.2 -40.78 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.774 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.47 HG13 HG23 ' A' ' 77' ' ' VAL . 39.7 mt -55.87 -52.7 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 123.427 0.455 . . . . 0.0 110.997 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.7 -29.64 67.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.56 -52.54 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.703 0.287 . . . . 0.0 110.414 176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 45' ' ' SER . 66.9 mt -66.22 -27.28 67.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.872 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -38.54 76.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.973 -0.454 . . . . 0.0 110.236 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.82 -14.79 59.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.538 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 65' ' ' ALA . 69.0 p -79.71 -25.03 41.28 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.03 88.13 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.459 -0.791 . . . . 0.0 114.601 166.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.12 -29.18 38.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.578 0.689 . . . . 0.0 111.042 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.583 ' HE2' HD21 ' A' ' 34' ' ' LEU . 1.5 m-85 -107.1 152.98 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 6.7 mm-40 -86.67 -26.93 24.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.342 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 6.8 t70 -148.75 146.89 28.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 66' ' ' LEU . 62.1 t -129.89 119.8 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.112 0.257 . . . . 0.0 110.701 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.97 118.79 31.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.55 0.214 . . . . 0.0 110.928 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.47 HG23 HG13 ' A' ' 63' ' ' ILE . 27.5 t -107.91 123.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.89 157.85 44.79 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -102.7 148.21 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.398 0.618 . . . . 0.0 111.657 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -139.55 97.43 3.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.657 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.79 -118.47 8.3 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 15.83 24.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 110.003 174.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.71 128.58 52.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -102.33 115.69 31.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -113.79 129.53 56.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.681 0.753 . . . . 0.0 110.87 -175.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG13 HG22 ' A' ' 77' ' ' VAL . 13.1 t -113.98 105.78 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.413 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -90.91 133.92 34.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.86 154.89 33.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.038 0.447 . . . . 0.0 110.956 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.641 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 4.3 tptt -99.71 147.92 24.91 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.757 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.751 ' HG3' ' HD2' ' A' ' 92' ' ' PRO . 1.9 tp10 -40.04 131.99 1.91 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 125.831 1.957 . . . . 0.0 113.241 -174.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.586 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -58.63 -51.49 81.43 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.771 -176.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.751 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 31.6 Cg_exo -62.05 140.91 86.82 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 121.712 1.608 . . . . 0.0 113.648 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.589 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 29.3 m -96.12 146.48 24.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.877 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.451 HG13 ' HB2' ' A' ' 125' ' ' LEU . 6.0 mt -63.05 117.77 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.08 -48.62 3.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.41 137.52 34.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.138 0.494 . . . . 0.0 111.323 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.782 HG21 HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -111.63 121.75 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.09 52.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.756 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.595 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 23.1 m-85 -114.92 138.05 51.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.409 -173.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.557 ' OG ' ' HE3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -138.79 112.16 8.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.418 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.726 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 112.56 22.32 5.81 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.371 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.16 69.52 7.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.229 0.537 . . . . 0.0 110.383 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -85.16 -26.77 26.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.357 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.6 m -112.28 -60.77 1.82 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.082 0.467 . . . . 0.0 111.197 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -89.28 141.52 14.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.512 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 146.49 52.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.709 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.16 -35.29 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -64.13 -35.61 81.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.1 mtp -67.16 -45.17 77.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.267 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.709 HD12 ' HA ' ' A' ' 107' ' ' ASP . 10.0 mt -62.72 -33.34 74.91 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.451 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -60.61 -48.9 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.303 0.377 . . . . 0.0 111.296 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -27.98 52.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.285 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -63.66 -44.28 94.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.281 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.782 HD22 HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -63.88 -42.85 97.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 175.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' A' ' 120' ' ' ARG . 8.6 mt-10 -61.25 -40.87 95.68 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.392 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.27 60.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.5 m -92.56 -16.36 25.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.235 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.32 -48.05 0.8 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.162 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 t -82.26 103.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.488 0.661 . . . . 0.0 109.685 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' HA ' ' HG2' ' A' ' 115' ' ' GLU . 2.2 ttp85 -128.6 149.49 50.61 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -174.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.03 123.61 21.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.155 0.502 . . . . 0.0 110.795 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.79 70.05 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.713 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -102.95 156.13 17.88 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -177.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.745 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -56.55 133.62 53.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.858 0.463 . . . . 0.0 111.216 174.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.91 145.36 24.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.326 0.584 . . . . 0.0 111.626 -176.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.556 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 12.8 t0 -117.44 121.64 41.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.049 173.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -17.47 61.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.912 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 p -88.64 -21.69 23.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.734 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 6.1 p -85.57 -7.68 58.72 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.405 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 153' ' ' ALA . 9.2 mm -57.45 -46.38 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.116 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.82 -34.55 78.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.75 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.07 -35.19 77.79 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.288 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.2 mt -67.13 -43.61 88.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.208 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -57.28 -49.81 74.91 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.13 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -68.12 -35.48 78.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.477 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.32 -41.63 77.79 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.734 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.444 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 49.3 mt -71.94 -32.64 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.675 ' HG3' HG23 ' A' ' 151' ' ' VAL . 18.0 mt-10 -63.6 -42.49 98.24 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.308 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.13 -37.94 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.916 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.2 m-85 -62.82 -42.62 99.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.386 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -40.59 95.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.11 -30.65 68.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.322 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.1 m -73.91 -27.63 61.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.366 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 140' ' ' PHE . 24.4 t -74.94 -85.09 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.87 19.3 23.43 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.32 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 49.9 1.76 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.394 0.677 . . . . 0.0 110.394 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -89.24 125.17 34.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.96 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.04 97.41 7.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.274 0.559 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -122.59 149.08 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.537 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.45 131.17 45.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.675 HG23 ' HG3' ' A' ' 138' ' ' GLU . 28.8 t -111.85 126.73 69.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.943 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 122.69 28.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.033 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.695 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -98.37 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.238 0.542 . . . . 0.0 110.902 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 28.0 t -98.27 120.61 47.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.349 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.61 118.57 46.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.619 . . . . 0.0 110.925 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.1 m -112.99 119.15 43.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.86 137.59 15.99 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.767 2.311 . . . . 0.0 112.709 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -121.55 148.96 51.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.578 175.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 8.5 Cg_exo -73.33 58.59 3.7 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.712 2.941 . . . . 0.0 113.911 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.578 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -144.86 18.07 1.62 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 60.43 40.15 17.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.526 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.589 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -141.77 167.13 22.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.711 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -127.68 143.33 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 110.965 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -110.8 118.76 37.02 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.487 ' HG ' HG23 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -116.62 132.57 56.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.884 0.85 . . . . 0.0 111.371 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.557 ' HE3' ' OG ' ' A' ' 100' ' ' SER . 5.3 tttt -115.35 133.3 56.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.964 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.595 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.0 mm? -102.56 111.31 23.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.241 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.7 113.92 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.664 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.726 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 38.6 m-85 -105.07 118.09 35.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.452 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.74 115.66 24.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.0 106.61 15.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.982 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.09 67.3 1.26 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.596 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.8 m -96.46 -22.65 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.246 0.546 . . . . 0.0 109.76 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.425 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.318 0.58 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -132.04 161.58 32.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.293 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.69 44.93 4.41 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.666 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 26.4 p90 -104.52 153.03 21.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.88 116.65 29.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.91 113.82 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.63 0.729 . . . . 0.0 110.489 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 7.2 mmtm -79.17 -32.44 44.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.967 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HB3' HG23 ' A' ' 83' ' ' THR . 24.0 t0 -149.32 139.91 22.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.079 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.3 mt -112.1 122.49 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.15 140.71 50.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' CD1' HD21 ' A' ' 34' ' ' LEU . 48.6 m-85 -114.71 148.61 38.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.497 -173.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -142.86 75.62 1.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.07 -44.97 0.13 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.36 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -71.01 134.81 47.43 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.008 0.432 . . . . 0.0 111.716 -176.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.42 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 1.0 OUTLIER -110.41 -28.72 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 178.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.07 -37.67 7.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.958 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.65 121.25 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.889 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.61 156.54 19.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.917 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -59.12 -35.8 59.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.27 -40.07 87.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.801 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.21 69.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.223 0.535 . . . . 0.0 110.49 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.05 -40.74 71.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HA ' ' SD ' ' A' ' 46' ' ' MET . 4.1 mp -62.91 -32.19 73.42 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.536 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 49.0 mt -69.32 -22.85 63.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.334 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -85.44 -18.0 34.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.662 ' HG2' HG23 ' A' ' 62' ' ' THR . 42.0 mtp -82.4 148.44 59.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.839 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.52 12.51 2.85 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.779 2.32 . . . . 0.0 113.126 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.11 166.43 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.722 ' HD2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -131.89 176.94 7.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.137 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -66.4 126.78 29.88 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.689 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.44 -4.46 54.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.657 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.722 ' HB2' ' HD2' ' A' ' 49' ' ' ARG . 2.6 t0 -92.32 156.81 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.412 . . . . 0.0 111.359 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 m -88.34 134.09 33.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.884 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.13 128.91 65.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 111.411 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -98.57 -178.31 3.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.263 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -37.07 79.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.284 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.81 -37.88 80.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.157 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -74.29 -30.45 62.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -50.43 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 173.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -67.62 -32.71 73.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.59 0.233 . . . . 0.0 111.213 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.55 -41.65 88.32 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.684 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.662 HG23 ' HG2' ' A' ' 46' ' ' MET . 91.2 m -60.37 -43.51 96.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 172.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 60' ' ' SER . 59.7 mt -56.07 -54.54 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 123.274 0.359 . . . . 0.0 111.122 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -69.33 -29.62 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.6 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HB2' HG11 ' A' ' 75' ' ' VAL . 80.3 mt -71.19 -30.09 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.814 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.85 -33.84 75.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.373 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.89 -13.27 61.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.196 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.5 p -78.94 -24.43 43.99 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.758 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.02 10.16 84.03 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.291 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -91.41 -25.51 19.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.941 0.4 . . . . 0.0 110.876 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.7 148.43 42.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.343 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -91.8 -14.06 30.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.158 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 9.3 t70 -154.65 138.31 16.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 66' ' ' LEU . 49.0 t -126.34 118.79 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.4 118.16 31.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.373 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.62 122.18 61.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mt -131.14 140.1 49.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.666 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -99.79 140.03 34.59 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.536 0.684 . . . . 0.0 110.293 -178.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.65 95.08 4.31 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.54 -109.58 2.97 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.484 ' HB2' ' HG2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -112.67 13.69 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 175.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.476 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -103.48 135.12 45.67 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.449 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -103.48 111.63 24.16 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.059 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 tp -104.28 119.63 39.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.868 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -117.05 113.75 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.325 0.583 . . . . 0.0 111.265 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -102.24 140.62 36.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.38 157.31 34.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 120.978 0.418 . . . . 0.0 110.438 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.1 OUTLIER -100.24 138.66 37.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.416 -177.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.637 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -65.15 161.58 18.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.506 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -44.06 71.75 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 47.7 Cg_exo -58.61 139.79 92.16 Favored 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.611 1.541 . . . . 0.0 113.382 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 4.3 m -110.42 140.22 44.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.897 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 121' ' ' VAL . 13.7 mt -59.09 119.05 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 109.832 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.45 -32.12 9.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.501 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.11 138.38 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.701 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.426 HG21 ' CD1' ' A' ' 114' ' ' LEU . 1.5 mt -118.75 132.16 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.04 139.19 52.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.652 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.524 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.6 m-85 -112.68 139.33 48.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.58 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.69 123.02 17.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.132 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.62 17.61 25.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.839 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.492 ' ND2' ' HB3' ' A' ' 99' ' ' PHE . 44.1 m-80 -96.94 77.24 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 111.033 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.26 -40.43 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.654 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -76.52 -57.88 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.353 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.57 143.95 10.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -71.02 145.95 49.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 0.0 112.091 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -39.89 84.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.098 171.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.13 -45.32 87.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.84 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -41.23 79.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -32.95 74.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.891 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -47.84 84.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 111.334 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -77.95 -27.12 49.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -63.88 -38.43 91.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.397 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.426 ' CD1' HG21 ' A' ' 97' ' ' ILE . 14.2 mt -68.14 -43.09 79.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.533 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -58.93 -43.53 91.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.194 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.3 61.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.629 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.4 m -91.17 -14.66 30.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 110.559 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.75 -26.55 7.55 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.971 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -89.16 104.0 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.187 0.517 . . . . 0.0 110.88 -176.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 3.6 ptp85 -140.59 172.42 12.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.501 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.554 ' HA ' HG22 ' A' ' 94' ' ' ILE . 50.9 t -69.97 128.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.35 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.12 61.78 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.337 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -120.85 146.31 46.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 35.2 t -65.69 151.73 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 111.227 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -93.53 145.21 24.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.596 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 130' ' ' ILE . 5.3 t70 -104.62 99.01 8.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.296 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.503 ' HA ' ' CG1' ' A' ' 130' ' ' ILE . 1.1 mtp180 -72.2 -18.31 61.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.912 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -75.02 -31.59 61.4 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.33 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 p -95.39 -2.85 48.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.159 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CG1' ' HA ' ' A' ' 127' ' ' ARG . 2.8 mm -55.59 -37.71 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.51 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -75.36 -27.13 59.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.872 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 19.1 mt -66.29 -50.02 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.927 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HG2' HG12 ' A' ' 151' ' ' VAL . 88.0 mt-10 -58.24 -49.09 78.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.638 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -40.32 93.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.573 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -34.86 65.08 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.197 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 137' ' ' LEU . 1.7 mm? -70.5 -40.26 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.927 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -58.77 -40.37 83.75 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.688 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.16 -38.78 91.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.824 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.41 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 2.1 m-30 -65.62 -38.07 88.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.505 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.69 -34.64 78.31 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 110.804 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.3 t80 -70.58 -30.75 67.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.96 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.27 -28.03 65.94 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.8 t -75.24 -88.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 110.574 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.464 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -112.68 18.61 22.25 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.716 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 20.7 mtmt 60.05 49.13 7.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 110.075 -173.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.248 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.22 97.12 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.335 1.022 . . . . 0.0 111.732 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.76 156.21 17.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.052 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 113.37 25.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.406 HG12 ' HG2' ' A' ' 134' ' ' GLU . 93.1 t -103.26 126.72 57.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -172.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -125.38 117.61 24.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.334 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.12 111.24 22.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.028 0.442 . . . . 0.0 110.092 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.1 t -94.08 123.27 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.245 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.4 m -109.89 117.62 55.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.6 m -109.55 117.42 52.75 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.121 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.68 142.49 16.14 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.667 2.245 . . . . 0.0 112.655 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -122.12 155.09 61.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 171.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.83 56.81 6.21 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.149 2.566 . . . . 0.0 113.76 -173.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.549 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -134.85 -89.53 0.35 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -167.75 36.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.666 ' HB2' HD11 ' A' ' 158' ' ' LEU . 10.9 mmt85 -131.42 162.2 30.73 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.442 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -135.2 148.01 28.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.858 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.27 127.45 53.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.82 122.16 46.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -120.48 132.7 55.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 110.559 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.524 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -102.07 110.79 22.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.201 -177.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.57 122.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.592 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.436 ' HE2' ' HB3' ' A' ' 167' ' ' LEU . 23.7 m-85 -113.69 118.31 33.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.421 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.85 115.98 31.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.914 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -80.98 120.6 24.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.931 0.396 . . . . 0.0 110.573 -178.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 102.25 106.97 3.04 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.86 -33.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.146 0.498 . . . . 0.0 109.769 -168.445 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.663 0.268 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.19 129.41 56.52 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.04 47.8 4.04 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -110.12 151.57 27.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.23 117.95 29.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.32 107.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.535 0.683 . . . . 0.0 110.228 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -20.53 31.6 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.578 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.754 ' HB3' HG23 ' A' ' 83' ' ' THR . 20.5 t70 -156.83 137.98 13.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.913 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.4 121.29 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.13 126.48 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.99 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' HD2' HG12 ' A' ' 39' ' ' VAL . 80.2 m-85 -104.24 122.23 44.95 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.661 ' HG3' HD11 ' A' ' 85' ' ' LEU . 1.4 mm-40 -117.97 -8.81 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.853 -172.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.812 ' HA3' ' H ' ' A' ' 88' ' ' VAL . . . -103.62 -10.8 34.64 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.985 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.589 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -125.54 136.0 52.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.95 0.405 . . . . 0.0 111.257 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -116.68 -36.98 3.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.142 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -77.97 -42.26 33.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.138 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.589 ' HB ' HD13 ' A' ' 34' ' ' LEU . 9.5 t -69.11 141.36 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.16 157.26 16.49 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.8 m -54.3 -43.51 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 O-C-N 123.981 0.801 . . . . 0.0 112.222 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.32 -38.0 46.73 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.688 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -67.7 -37.72 82.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.18 -35.93 64.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.88 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -58.92 -31.12 68.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.315 0.646 . . . . 0.0 112.54 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 41' ' ' ALA . 69.0 mt -69.29 -19.47 63.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.701 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.516 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -92.73 -8.37 44.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.785 ' HG2' HG23 ' A' ' 62' ' ' THR . 87.8 mtp -90.16 141.61 27.93 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.602 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 26.3 Cg_exo -64.31 -37.04 42.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.773 2.315 . . . . 0.0 112.768 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -121.96 155.47 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.39 -177.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -113.51 170.79 7.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.098 0.475 . . . . 0.0 110.983 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -67.24 138.72 57.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.2 177.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 -14.47 48.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.8 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.28 156.94 18.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 110.211 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.8 135.05 38.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.908 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.433 HG12 HG21 ' A' ' 48' ' ' VAL . 6.0 m -128.66 129.39 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.178 0.513 . . . . 0.0 110.889 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.19 -177.56 3.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.386 0.613 . . . . 0.0 110.645 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -65.37 -29.83 70.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.339 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.77 62.83 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.664 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 43.0 m-20 -74.13 -29.56 61.88 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.13 -49.26 84.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -66.86 -35.94 81.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.602 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -62.39 -45.13 94.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.426 177.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.785 HG23 ' HG2' ' A' ' 46' ' ' MET . 63.1 m -58.24 -47.06 84.71 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.267 174.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 77' ' ' VAL . 7.9 mt -56.92 -50.43 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.441 0.463 . . . . 0.0 111.142 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -69.81 -34.04 73.16 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.89 -46.7 70.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 45' ' ' SER . 60.7 mt -67.87 -30.9 70.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.914 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.56 99.23 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.11 -12.08 61.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.194 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 65' ' ' ALA . 32.7 p -78.42 -24.71 46.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.478 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.83 16.22 76.25 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.877 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -88.22 -32.48 18.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.303 0.573 . . . . 0.0 109.888 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.2 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 6.4 mm-40 -93.25 -27.1 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 14.8 t70 -141.78 137.07 31.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 88' ' ' VAL . 38.1 t -124.91 117.1 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.43 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.6 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.507 HG22 HD11 ' A' ' 63' ' ' ILE . 16.0 m -104.67 144.11 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 110.405 174.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.11 155.99 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -116.07 127.14 54.63 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.291 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.86 95.27 4.76 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.99 -110.47 3.51 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.839 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.78 10.07 30.88 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.754 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -103.65 128.78 50.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.8 -176.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.06 113.2 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 0.0 110.328 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.661 HD11 ' HG3' ' A' ' 32' ' ' GLU . 3.1 tp -93.9 112.66 24.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.216 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.56 106.85 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.301 0.572 . . . . 0.0 110.477 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -105.6 123.81 48.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.379 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.812 ' H ' ' HA3' ' A' ' 33' ' ' GLY . 4.2 m -124.51 147.47 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.445 0.641 . . . . 0.0 110.891 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.1 ttpt -100.37 142.81 31.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.135 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 125' ' ' LEU . 3.2 mm-40 76.04 171.09 0.25 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 124.511 1.132 . . . . 0.0 112.143 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.642 ' H ' ' HD2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -159.79 -52.11 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.246 -170.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.642 ' HD2' ' H ' ' A' ' 91' ' ' ARG . 55.0 Cg_endo -69.57 141.99 47.53 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.462 1.441 . . . . 0.0 113.015 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.504 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 86.6 m -94.6 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.842 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 125' ' ' LEU . 12.9 mt -73.21 118.73 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HB2' ' HG2' ' A' ' 162' ' ' ARG . . . -97.44 -42.81 7.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.12 147.17 33.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.482 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -117.96 123.58 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 172.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.963 -175.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.727 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 21.6 m-85 -114.27 133.88 55.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.792 0.329 . . . . 0.0 110.791 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.9 m -126.39 144.39 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.801 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.76 -79.97 0.26 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 47.07 49.97 14.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.752 0.821 . . . . 0.0 112.611 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 171' ' ' GLU . 59.8 mmtt -76.17 -42.64 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 m -130.54 -25.73 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.76 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 13.6 t -111.4 132.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 155.46 39.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.378 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.27 77.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.291 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.156 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -45.44 73.65 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -32.61 71.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.074 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.727 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 9.9 mttt -58.14 -48.79 79.15 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.425 0.453 . . . . 0.0 111.584 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.81 48.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.735 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.3 -38.12 88.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.662 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.9 mm? -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 2.8 mt-10 -65.58 -37.83 87.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.417 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.72 -16.39 61.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.233 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.3 m -88.21 -16.02 34.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.965 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.06 -32.38 5.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.326 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 125' ' ' LEU . 0.3 OUTLIER -90.73 113.0 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -174.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.569 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -141.06 176.72 8.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.642 -178.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 94' ' ' ILE . 53.1 t -67.43 127.2 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.912 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.48 -27.81 18.82 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.553 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.97 162.41 19.41 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.534 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -79.03 164.86 24.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -112.04 143.63 42.72 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.057 -177.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.444 ' HB3' ' HB ' ' A' ' 129' ' ' THR . 43.9 t0 -107.86 105.7 15.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.571 0.7 . . . . 0.0 110.097 174.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.468 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.3 -14.1 62.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.763 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.8 p -89.54 -23.47 22.01 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.071 0.939 . . . . 0.0 108.745 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 126' ' ' ASP . 5.3 m -87.89 -13.57 41.63 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.715 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.3 mm -53.69 -39.95 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.097 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.54 94.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.2 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.492 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 130' ' ' ILE . 15.6 mt -63.09 -44.39 99.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.923 174.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.75 -44.66 96.48 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.726 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -41.32 93.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.634 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.42 -38.41 69.98 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.704 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.16 -33.06 71.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 111.492 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.29 -34.2 75.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.507 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.83 -32.46 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.519 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -62.51 -39.37 93.31 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.676 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.434 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -64.5 -34.53 78.44 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.099 0.476 . . . . 0.0 110.872 177.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -69.49 -30.79 68.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.156 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.6 m -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.797 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 9.5 t -76.18 -85.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.627 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.8 19.96 22.82 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.674 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mttp 66.7 42.21 2.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.429 0.692 . . . . 0.0 110.569 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -87.26 139.44 30.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.442 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -115.16 74.47 0.88 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.238 0.542 . . . . 0.0 110.127 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.4 142.04 28.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.369 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.688 ' H ' ' HB2' ' A' ' 170' ' ' GLN . 0.9 OUTLIER -99.41 126.42 45.3 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 11.4 p -113.4 138.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.176 0.512 . . . . 0.0 111.388 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.89 125.21 39.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.658 175.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.616 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.258 0.551 . . . . 0.0 110.919 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.57 128.77 56.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.329 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.74 123.36 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.433 0.635 . . . . 0.0 111.204 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 m -107.01 120.19 48.82 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.579 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 9.6 Cg_endo -89.64 130.4 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.408 2.739 . . . . 0.0 112.952 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -113.47 152.95 45.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 22.47 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.04 2.493 . . . . 0.0 113.876 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -115.72 19.98 14.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.992 0.425 . . . . 0.0 110.144 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 t30 67.51 26.62 8.14 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.999 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.531 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -129.75 167.03 18.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.288 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.497 HG21 HD22 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -133.21 153.53 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.0 0.429 . . . . 0.0 111.139 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -108.92 118.82 37.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.494 HD11 ' HB1' ' A' ' 153' ' ' ALA . 59.4 tp -101.18 113.47 26.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.352 -175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -105.15 131.34 52.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 111.01 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.7 108.58 19.48 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.632 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 2.8 t -101.28 111.74 31.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.885 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -99.53 146.61 26.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.688 ' HB2' ' H ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -74.46 144.15 44.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.886 178.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.59 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 2.1 tt0 -57.98 -27.36 63.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.964 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 121.12 116.03 2.44 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.378 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.476 ' HB ' ' H ' ' A' ' 174' ' ' SER . 0.0 OUTLIER -89.19 -136.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.519 0.199 . . . . 0.0 111.142 -177.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.476 ' H ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 111.499 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.934 0.397 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -145.66 157.13 43.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.631 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.56 58.78 3.21 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' HE1' HD11 ' A' ' 59' ' ' ILE . 10.9 p90 -95.49 153.39 17.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.395 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.17 118.98 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -69.88 122.46 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -49.59 7.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.122 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.07 140.99 29.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.247 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.527 HG21 ' HE1' ' A' ' 46' ' ' MET . 7.1 mt -104.85 121.17 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 172.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 127.74 53.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.988 0.423 . . . . 0.0 110.121 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 34' ' ' LEU . 75.7 m-85 -102.79 125.84 49.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.024 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.01 68.92 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.348 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.34 -41.33 0.13 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.562 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.9 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.4 OUTLIER -93.08 162.48 14.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.738 0.304 . . . . 0.0 110.884 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -156.42 -58.21 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.458 -176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -39.23 90.8 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.468 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -77.8 121.27 30.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 164.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.62 157.16 28.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 31' ' ' PHE . 5.6 m -53.63 -40.25 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.118 0.886 . . . . 0.0 112.604 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.12 -33.45 57.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.489 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.25 -35.25 63.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.54 74.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.507 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.51 -32.35 57.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.032 0.933 . . . . 0.0 112.879 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.7 mt -69.45 -14.04 62.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.499 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -100.06 -7.45 24.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.744 176.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.527 ' HE1' HG21 ' A' ' 29' ' ' ILE . 14.4 mtm -102.24 136.34 19.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.394 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.37 12.67 2.78 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.7 2.267 . . . . 0.0 113.296 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.73 HG12 HG11 ' A' ' 54' ' ' VAL . 32.0 m -119.08 149.12 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 49' ' ' ARG . 6.0 mmm-85 -131.85 166.22 22.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.504 0.668 . . . . 0.0 111.598 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 p -68.12 121.28 15.82 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.611 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.26 62.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.222 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.19 150.78 25.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.082 0.468 . . . . 0.0 111.224 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 116.35 32.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.73 HG11 HG12 ' A' ' 48' ' ' VAL . 14.7 m -133.2 156.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.081 0.467 . . . . 0.0 112.001 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 11.6 m-80 -99.3 179.16 4.67 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.312 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.84 -32.83 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.191 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.67 -31.73 72.9 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 12.2 m-20 -75.2 -33.72 61.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.075 177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 55' ' ' ASN . 1.3 mp -63.14 -46.63 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 171.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.76 ' HA ' HD12 ' A' ' 63' ' ' ILE . 19.0 m -65.35 -31.86 73.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.303 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -70.01 -38.87 76.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.407 178.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 m -58.29 -46.67 85.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 171.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 60' ' ' SER . 68.8 mt -55.33 -55.0 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.385 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -29.55 68.19 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.7 -45.71 74.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.485 0.183 . . . . 0.0 110.614 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 45' ' ' SER . 93.7 mt -69.39 -30.89 68.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.58 -35.01 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.74 -12.75 61.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.445 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.5 p -78.87 -25.1 43.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.497 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.5 8.04 83.53 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.609 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -82.99 -48.77 10.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.997 0.427 . . . . 0.0 110.829 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.85 150.16 20.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -53.75 17.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -135.49 140.7 45.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -121.47 118.65 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.404 ' HG2' HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -120.07 118.79 31.51 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.021 175.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 HG13 ' A' ' 86' ' ' VAL . 98.3 t -118.06 122.74 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.404 HD11 ' HG2' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -133.25 158.6 42.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 150.84 31.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.999 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -125.49 95.03 4.31 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.33 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.11 -108.44 2.35 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.276 -171.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -104.36 5.54 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.643 0.377 . . . . 0.0 111.323 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.97 133.11 49.48 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.401 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 111.75 24.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.233 0.539 . . . . 0.0 110.127 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.0 tp -100.58 112.95 25.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.038 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.41 HG13 HG22 ' A' ' 77' ' ' VAL . 36.7 t -106.86 105.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.483 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -105.42 126.52 52.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.25 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG21 HD23 ' A' ' 34' ' ' LEU . 2.7 m -125.55 144.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.253 0.549 . . . . 0.0 109.867 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.73 125.86 44.18 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.33 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 43.55 88.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 125.086 1.491 . . . . 0.0 113.732 176.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.9 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -80.93 -26.06 0.42 Allowed Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 13.9 Cg_exo -71.05 140.93 38.86 Favored 'Trans proline' 0 C--N 1.377 2.066 0 CA-C-N 122.391 1.89 . . . . 0.0 113.234 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -96.66 134.25 40.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.426 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 125' ' ' LEU . 25.7 mt -65.06 118.63 7.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.6 -34.88 14.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -157.93 154.36 27.72 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 110.448 174.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 114' ' ' LEU . 1.1 mt -112.67 122.96 67.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.127 172.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.511 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -103.38 130.74 50.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.049 -178.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.659 ' HB3' HD21 ' A' ' 102' ' ' ASN . 19.9 m-30 -112.96 134.77 54.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.862 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -142.35 137.17 30.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.435 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.26 76.98 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.636 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.659 HD21 ' HB3' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -89.97 72.35 7.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.644 0.735 . . . . 0.0 110.648 -177.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 12.9 mmmt -86.41 -19.91 28.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.865 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -53.0 6.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.92 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.2 t -107.45 141.4 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -68.98 158.11 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 112.608 -171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.29 95.38 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.243 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.48 -34.76 72.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.721 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.4 82.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.176 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -32.87 74.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.818 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -59.64 -44.8 93.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.372 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.529 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 4.1 tm0? -77.72 -28.53 50.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.36 -45.74 91.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.046 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.485 ' CD1' HG21 ' A' ' 97' ' ' ILE . 18.0 mt -67.95 -36.59 80.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.831 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -59.88 -46.14 90.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.137 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -15.97 61.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.542 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.4 m -90.94 -12.11 37.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.749 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.03 -20.8 19.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.631 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.4 102.41 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.303 0.573 . . . . 0.0 110.762 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.24 173.56 11.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.543 -178.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HA ' HG22 ' A' ' 94' ' ' ILE . 65.4 t -69.36 125.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 110.651 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.11 -5.62 61.38 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 4.3 mm-40 -107.14 160.3 15.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.34 138.79 40.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.754 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.67 145.99 24.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.752 -175.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -115.83 103.76 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.649 0.737 . . . . 0.0 110.425 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.566 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -71.47 -15.3 62.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.562 178.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p -84.11 -20.66 32.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.095 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 p -100.64 3.26 42.37 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.23 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.9 mm -57.5 -41.52 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.768 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.9 -38.01 87.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 111.51 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -33.84 73.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.677 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.92 -44.11 88.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.908 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 92.3 mt-10 -57.28 -51.3 69.91 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.488 175.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -61.95 -34.2 75.68 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.756 0.66 . . . . 0.0 111.758 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.62 86.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.932 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.42 HD22 ' HZ ' ' A' ' 169' ' ' PHE . 9.9 mt -73.87 -36.61 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 134' ' ' GLU . 1.9 pt-20 -72.55 -28.86 63.09 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.4 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.22 -40.84 64.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.269 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.538 ' O ' HG23 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -61.9 -44.3 97.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.13 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.05 90.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.496 0.498 . . . . 0.0 111.278 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -67.08 -33.98 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.188 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.5 m -72.23 -28.75 63.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.899 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 140' ' ' PHE . 41.2 t -78.55 -82.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.998 0.427 . . . . 0.0 110.913 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.558 ' O ' ' HG2' ' A' ' 146' ' ' LYS . . . -112.7 20.9 19.74 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-O 118.88 -0.955 . . . . 0.0 113.21 -172.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER 70.02 16.72 7.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.759 1.224 . . . . 0.0 111.064 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -60.42 118.0 5.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.285 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.22 94.66 9.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.595 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.69 143.23 50.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.762 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.56 120.66 39.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.53 124.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -129.39 120.31 25.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.301 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.644 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -98.31 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.201 0.524 . . . . 0.0 110.181 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.33 123.56 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.167 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 t -98.61 113.36 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.038 0.447 . . . . 0.0 110.19 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.0 m -106.0 123.54 38.82 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.12 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -88.23 146.11 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.892 2.394 . . . . 0.0 113.138 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -135.26 157.63 76.32 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.6 51.22 3.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.966 2.444 . . . . 0.0 113.932 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.47 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.33 17.02 2.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.97 176.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 41.7 t30 60.43 37.47 19.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.261 1.029 . . . . 0.0 109.933 -173.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.511 ' HB2' HD11 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -131.08 161.39 32.16 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.527 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.754 HG21 HD22 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -133.4 147.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.64 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -108.92 119.05 38.41 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.2 tp -99.18 115.78 29.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.212 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.511 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -105.56 132.29 51.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.423 0.63 . . . . 0.0 111.194 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 1.8 mm? -108.84 109.93 21.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.163 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 t -101.34 114.19 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.268 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.42 ' HZ ' HD22 ' A' ' 137' ' ' LEU . 43.6 m-85 -105.51 118.32 36.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.246 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.2 140.18 36.42 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -77.99 -9.4 59.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.769 0.318 . . . . 0.0 110.848 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -169.32 -142.15 3.45 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 t 59.8 68.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.303 0.573 . . . . 0.0 110.836 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.536 0.43 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.946 178.139 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -70.53 140.31 51.79 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.37 47.52 2.78 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -171.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -113.33 154.12 27.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.099 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.13 116.66 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.622 ' HB ' ' HA ' ' A' ' 50' ' ' THR . 0.5 OUTLIER -65.22 114.29 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 121.359 0.6 . . . . 0.0 111.285 -177.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 2.1 mttm -76.99 -39.97 48.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.812 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -156.89 142.26 17.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.217 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.586 HD12 HD21 ' A' ' 43' ' ' LEU . 91.9 mt -104.26 121.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.565 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -115.71 127.56 55.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.516 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.56 ' HE2' ' HE1' ' A' ' 46' ' ' MET . 0.7 OUTLIER -106.18 146.23 30.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.16 0.505 . . . . 0.0 111.163 -176.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -133.41 156.62 47.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.484 178.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.74 -2.99 57.58 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.716 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 34' ' ' LEU . 6.2 mt -73.25 155.92 39.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.151 0.5 . . . . 0.0 112.071 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -157.28 -52.48 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.657 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -82.91 -56.63 3.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.874 -178.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.414 ' O ' HD13 ' A' ' 34' ' ' LEU . 3.4 t -76.98 143.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.582 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.07 157.81 16.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.84 -33.52 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.92 -36.95 60.92 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.255 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.742 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -73.2 -34.05 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.0 110.168 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.09 73.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.843 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 29' ' ' ILE . 3.8 mt -60.93 -32.72 72.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.074 0.55 . . . . 0.0 111.811 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 41' ' ' ALA . 17.6 mt -71.85 -20.39 61.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.98 0.419 . . . . 0.0 111.249 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.524 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -91.73 -10.96 38.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.894 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.56 ' HE1' ' HE2' ' A' ' 31' ' ' PHE . 53.8 mtm -94.78 135.83 23.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.69 -17.6 29.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.642 2.228 . . . . 0.0 112.725 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 149.56 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.718 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -120.91 176.27 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.896 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.622 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -67.48 136.07 54.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.01 -8.72 59.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.529 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.16 156.23 17.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.93 125.12 34.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.525 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.22 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.308 0.575 . . . . 0.0 111.563 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.81 -177.78 3.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -25.67 64.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.811 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -65.71 -35.8 81.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.396 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.647 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 53.0 m-20 -74.6 -28.9 61.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.908 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.97 -47.0 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 172.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -30.3 68.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.5 m-20 -67.36 -46.53 73.07 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.778 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 p -62.88 -38.86 92.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.006 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.6 mt -55.81 -54.12 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 123.427 0.454 . . . . 0.0 110.626 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 64' ' ' ARG . 9.6 ptm85 -70.23 -31.19 68.48 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.9 70.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.538 0.208 . . . . 0.0 110.713 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 45' ' ' SER . 58.9 mt -69.94 -30.79 68.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.731 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -37.87 88.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 110.647 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.1 -13.42 61.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 45' ' ' SER . 19.0 p -79.26 -24.79 42.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.629 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.12 -1.76 73.54 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.432 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -76.34 -47.1 24.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.403 0.621 . . . . 0.0 109.887 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.6 136.3 54.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.29 -18.27 25.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.54 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 24.6 t70 -122.74 134.47 54.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.4 t -132.7 118.46 34.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.61 116.82 27.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.731 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.9 t -103.9 122.51 56.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -125.69 148.78 48.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.71 136.91 53.03 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.501 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.22 95.99 4.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.364 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.75 -111.68 4.32 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 40.3 m-20 -106.16 7.01 31.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.976 0.417 . . . . 0.0 110.486 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.47 133.61 48.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.421 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 111.8 24.62 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 3.6 tp -104.32 116.43 32.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.056 0.455 . . . . 0.0 110.752 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.5 110.99 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 6.3 mt-30 -96.65 127.75 42.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.18 162.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 0.0 111.554 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -117.78 106.52 13.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.244 176.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.14 27.29 3.85 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.979 0.895 . . . . 0.0 109.489 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.16 -64.03 0.25 Allowed Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.579 -170.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 5.7 Cg_endo -89.43 140.82 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.756 1.637 . . . . 0.0 112.241 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 59.8 m -125.19 137.79 54.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 125' ' ' LEU . 21.7 mt -74.94 120.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.12 -38.59 10.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.063 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.52 143.0 25.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.485 HG21 HD22 ' A' ' 114' ' ' LEU . 2.4 mt -123.13 128.07 74.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 141.56 47.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.47 177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.466 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.9 m-85 -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.619 0.247 . . . . 0.0 111.021 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.0 140.42 42.12 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 169' ' ' PHE . . . 85.39 16.22 64.8 Favored Glycine 0 C--N 1.328 0.113 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.695 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 1.7 p30 -79.47 69.92 5.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.54 0.686 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -83.13 -47.62 11.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.184 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -27.96 24.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 2.2 t -126.66 141.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -68.84 156.72 37.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.139 0.495 . . . . 0.0 111.619 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -33.95 77.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 171.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.853 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -60.99 -39.42 89.57 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 175.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.9 mtp -73.33 -39.04 65.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.218 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -62.8 -32.62 73.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.242 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' A' ' 108' ' ' ASP . 7.6 mtmm -57.14 -48.52 78.47 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.591 0.557 . . . . 0.0 111.138 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.1 45.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.415 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -37.63 88.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.485 HD22 HG21 ' A' ' 97' ' ' ILE . 1.1 mp -72.31 -38.38 68.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.921 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 16.4 mt-10 -62.67 -39.45 93.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.901 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.48 -15.66 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.125 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.631 ' HB2' HG12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -95.0 -16.14 22.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 175.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.16 -37.01 2.37 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.608 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.66 111.53 22.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.267 0.555 . . . . 0.0 111.715 -171.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.03 171.17 14.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.223 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.25 127.82 31.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.233 0.54 . . . . 0.0 110.598 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.65 53.26 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.497 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.576 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 1.1 tp10 -89.02 156.72 18.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 122.71 0.404 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.99 134.48 43.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.728 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -114.89 142.85 46.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.227 -177.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.542 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 33.6 t0 -117.58 133.48 55.91 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 110.054 164.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.408 ' CD ' ' H ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -71.29 -16.04 62.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.714 178.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 p -82.47 -26.59 32.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.461 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -86.52 -11.48 51.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.428 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 130' ' ' ILE . 5.9 mm -55.15 -40.13 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.732 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.68 91.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.11 -35.21 76.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.13 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.631 HG12 ' HB2' ' A' ' 117' ' ' SER . 3.2 mt -67.41 -40.2 84.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.213 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -61.1 -40.92 95.57 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.45 96.97 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.869 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.33 -37.23 92.65 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.528 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.667 HD22 ' HZ ' ' A' ' 169' ' ' PHE . 8.2 mt -66.83 -36.81 83.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.752 0.31 . . . . 0.0 110.943 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.2 -39.56 86.37 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.67 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -67.01 -43.35 83.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.07 -44.1 97.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.641 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -38.35 87.08 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.962 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -28.98 65.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m -70.94 -27.58 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.409 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 4.1 t -75.2 -83.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 111.187 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.409 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.85 19.77 22.93 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.525 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.87 44.26 13.96 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.734 0.778 . . . . 0.0 110.504 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -80.03 118.66 21.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.935 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 m -89.51 86.36 6.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.003 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.11 144.53 25.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.022 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.3 113.44 25.39 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.9 m -101.16 133.0 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.384 0.611 . . . . 0.0 111.519 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 116.69 18.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.574 172.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.6 110.8 22.77 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.386 0.612 . . . . 0.0 109.909 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.65 113.47 36.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.108 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.18 110.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.775 0.798 . . . . 0.0 109.205 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 7.3 m -112.41 116.46 48.54 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.842 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.502 ' HA ' HG12 ' A' ' 163' ' ' VAL . 59.0 Cg_endo -71.79 135.65 26.21 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.624 2.216 . . . . 0.0 112.429 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 162' ' ' ARG . 0.6 OUTLIER -100.54 159.03 30.78 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.261 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.33 80.07 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.18 2.586 . . . . 0.0 113.306 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 1.0 OUTLIER -174.51 -112.31 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.712 0.805 . . . . 0.0 109.188 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 3.0 t-20 -146.15 9.62 1.12 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.968 0.89 . . . . 0.0 109.842 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.538 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 1.1 mpt_? -117.92 167.36 11.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.868 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 125' ' ' LEU . 18.5 m -130.95 159.76 42.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 111.466 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.43 119.13 38.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.444 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.7 tp -108.19 125.95 52.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.459 ' HB3' ' HE2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -123.43 132.27 53.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 111.132 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 2.7 mm? -108.52 110.87 22.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.011 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.18 112.3 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.331 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.667 ' HZ ' HD22 ' A' ' 137' ' ' LEU . 11.4 m-30 -109.65 127.86 54.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.323 0.582 . . . . 0.0 111.398 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -98.63 135.28 40.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -82.71 15.39 2.65 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.013 0.435 . . . . 0.0 111.668 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.81 14.7 78.17 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.878 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.4 m 39.1 39.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.488 1.515 . . . . 0.0 113.465 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.233 0.221 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.31 178.421 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 69.22 153.93 0.11 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.099 0.96 . . . . 0.0 112.793 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.27 50.06 10.98 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.456 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -104.99 153.18 21.79 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.8 t -87.06 113.84 25.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -72.07 125.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.6 0.714 . . . . 0.0 110.346 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -91.4 -29.66 16.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.974 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.45 137.12 14.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.056 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.4 mt -109.64 121.38 62.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -119.88 127.86 53.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.174 0.511 . . . . 0.0 109.851 -178.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.68 ' HD2' HG12 ' A' ' 39' ' ' VAL . 58.7 m-85 -101.34 149.22 24.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.066 -175.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -137.73 167.4 21.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.402 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.15 -44.47 3.34 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.27 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.5 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -74.92 159.48 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.626 -177.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -113.52 -65.37 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.877 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -0.82 50.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.801 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 t -84.02 126.47 40.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.73 157.16 16.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.682 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.68 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.6 m -56.67 -41.85 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 123.857 0.723 . . . . 0.0 112.151 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -74.27 -34.16 55.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.573 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.75 -34.43 64.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.135 0.493 . . . . 0.0 110.953 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.32 -33.81 59.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.834 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.84 -31.04 58.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 112.695 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 78.4 mt -66.56 -18.95 65.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.77 -8.45 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.695 0.284 . . . . 0.0 110.823 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.474 ' SD ' ' HZ ' ' A' ' 31' ' ' PHE . 36.7 mtp -93.23 136.6 24.25 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.613 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 3.0 Cg_exo -78.41 6.56 4.69 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.069 2.513 . . . . 0.0 112.597 174.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.8 156.64 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 20.2 mtp85 -132.47 176.6 8.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.423 0.63 . . . . 0.0 112.114 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.9 p -67.84 120.49 14.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.883 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.31 44.94 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.095 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.4 OUTLIER -77.72 156.27 30.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.147 0.499 . . . . 0.0 111.573 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.67 117.01 30.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.16 129.07 73.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.243 0.544 . . . . 0.0 112.283 -168.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -100.14 -175.96 3.09 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.72 172.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.46 -26.21 68.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.966 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.33 -34.02 70.17 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.52 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -74.33 -29.7 61.71 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.427 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.27 -44.85 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.478 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 p -71.0 -29.62 65.63 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 110.568 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.9 -45.73 73.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 p -63.74 -39.49 94.4 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.673 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 28.9 mt -56.04 -50.68 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 123.364 0.415 . . . . 0.0 110.326 174.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 mtt85 -65.04 -36.63 84.96 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.545 0.528 . . . . 0.0 111.985 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.67 -48.76 71.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.068 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.471 HD22 ' HE1' ' A' ' 72' ' ' PHE . 29.3 mt -70.71 -30.78 67.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.46 -36.25 78.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 110.724 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.05 -13.59 61.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.208 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 65' ' ' ALA . 19.0 p -78.77 -25.06 44.37 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.435 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.38 21.04 72.07 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.639 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -85.56 -23.89 27.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.7 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HE1' HD22 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -127.12 176.76 7.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.575 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 3.6 mm-40 -97.16 -23.42 16.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.664 0.268 . . . . 0.0 111.521 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.784 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 3.6 t70 -155.67 145.0 20.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.5 119.07 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -121.01 124.96 46.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.306 0.574 . . . . 0.0 110.997 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.5 t -101.3 123.35 54.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.07 158.01 39.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 145.78 47.62 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.386 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -128.03 96.09 4.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.7 -110.14 3.31 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.54 13.77 23.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.38 132.18 50.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.802 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 111.58 24.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.035 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 4.2 tp -105.11 112.75 25.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.407 ' HB ' ' CD1' ' A' ' 31' ' ' PHE . 18.3 t -108.58 106.75 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 54.1 mt-30 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.08 159.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.835 0.35 . . . . 0.0 110.381 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 3.3 tptm -102.86 151.66 22.18 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.501 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' CD ' ' HE ' ' A' ' 127' ' ' ARG . 0.5 OUTLIER -25.94 128.3 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 O-C-N 125.957 2.036 . . . . 0.0 114.778 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.6 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 51.4 mtp85 -61.71 -49.91 84.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.476 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 91' ' ' ARG . 16.8 Cg_exo -69.49 140.51 43.86 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 121.505 1.47 . . . . 0.0 112.347 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.7 m -102.58 139.77 37.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.161 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.4 mt -62.15 118.86 5.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.01 -25.41 11.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.14 0.495 . . . . 0.0 110.554 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -147.96 138.56 23.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.655 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.89 120.51 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.689 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 2.3 m -118.85 143.12 47.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.985 0.421 . . . . 0.0 111.006 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.808 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -121.75 135.93 54.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.497 -172.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.3 m -147.24 119.78 8.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.66 -7.96 39.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.791 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -81.11 83.88 6.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 110.937 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -85.92 -29.52 23.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.841 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -66.35 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.518 -175.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.497 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 15.1 t -90.47 142.52 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -69.74 146.48 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.07 0.462 . . . . 0.0 111.814 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.549 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 4.5 p30 -63.86 -33.01 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.206 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.58 -40.02 95.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.5 mtp -67.96 -40.32 83.23 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.381 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.03 -36.07 82.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.841 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.808 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 15.6 mttt -58.92 -46.1 88.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.816 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 3.0 tp60 -76.66 -27.98 55.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.288 -177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.36 -49.95 71.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.69 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.44 -34.96 79.1 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.977 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -60.46 -42.47 96.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.437 178.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.03 -15.56 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.686 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.9 m -88.08 -16.58 33.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.51 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 113.35 -15.21 22.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.112 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.46 103.73 15.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.241 0.543 . . . . 0.0 110.162 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 115' ' ' GLU . 12.3 mtm180 -134.34 172.15 13.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.203 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.87 123.64 28.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 110.206 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.25 71.2 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.004 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 159.77 15.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 120.895 0.378 . . . . 0.0 110.81 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -66.33 142.93 57.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.925 170.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.565 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.48 148.23 22.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.087 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.72 98.1 6.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.459 0.647 . . . . 0.0 110.516 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.518 ' HE ' ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -70.49 -14.83 62.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.56 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 p -85.08 -23.02 28.7 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.299 -0.251 . . . . 0.0 111.172 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 p -100.24 5.53 44.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.466 HG12 ' HA ' ' A' ' 127' ' ' ARG . 7.0 mm -57.64 -42.78 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.427 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . . . -64.86 -38.09 89.81 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.803 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 -27.46 63.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.779 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.2 mt -67.45 -44.99 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 131' ' ' ALA . 35.5 mt-10 -61.37 -47.77 84.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.241 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.51 82.2 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.959 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.02 -30.43 63.25 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.891 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.5 mt -76.11 -32.61 59.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.689 0.244 . . . . 0.0 110.741 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.595 ' HG3' HG23 ' A' ' 151' ' ' VAL . 6.5 mt-10 -64.98 -39.52 93.6 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 173.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -66.47 -43.56 85.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.599 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -62.37 -33.4 74.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.17 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.497 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -71.34 -44.41 65.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.139 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -30.22 66.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -173.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -28.85 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.469 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.58 -84.77 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.48 19.62 23.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.98 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? 62.56 52.55 2.88 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.446 0.641 . . . . 0.0 109.65 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -88.8 105.41 17.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.048 -173.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.791 ' HB2' HG21 ' A' ' 173' ' ' VAL . 0.5 OUTLIER -91.08 121.57 32.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.308 175.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.49 162.69 40.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.06 114.47 27.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.595 HG23 ' HG3' ' A' ' 138' ' ' GLU . 23.3 t -96.67 123.1 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.036 0.446 . . . . 0.0 110.812 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -124.71 117.7 24.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.78 111.62 23.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.37 133.05 61.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.03 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.26 123.04 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.274 0.559 . . . . 0.0 110.43 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.3 m -104.37 119.83 52.66 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.158 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 131.05 11.6 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 112.583 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -123.1 155.67 64.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.96 56.26 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.831 2.354 . . . . 0.0 113.879 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.501 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -144.32 19.37 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 177.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 38.5 t30 60.21 38.55 20.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 122.185 0.993 . . . . 0.0 109.247 -173.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.454 ' HB2' HD11 ' A' ' 158' ' ' LEU . 7.3 mmt180 -130.28 160.62 33.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.143 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -130.74 148.64 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.986 178.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.25 122.26 46.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.91 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.3 tp -96.13 110.39 22.67 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.689 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -113.22 132.06 55.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.792 0.806 . . . . 0.0 111.426 -175.428 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -107.78 110.69 22.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.445 -176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.93 111.05 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.448 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.93 117.43 34.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -111.19 116.23 30.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.373 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.39 153.45 35.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.835 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 144.31 48.67 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.994 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.791 HG21 ' HB2' ' A' ' 148' ' ' SER . 0.3 OUTLIER -127.88 161.87 35.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.915 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 60.68 93.79 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.152 0.977 . . . . 0.0 110.03 -173.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.95 41.39 4.08 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -166.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -110.4 153.11 25.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.973 -0.613 . . . . 0.0 109.972 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -79.68 113.32 18.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.79 125.49 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.49 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -85.54 -31.5 22.68 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.671 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB3' HG23 ' A' ' 83' ' ' THR . 29.5 t70 -157.63 147.01 19.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.245 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.8 mt -109.9 120.14 60.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.77 127.03 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.941 -176.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.678 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 1.8 m-85 -105.11 120.13 40.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -177.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.578 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 52.8 mm-40 -103.64 66.18 0.85 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.665 0.745 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.18 -75.37 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.945 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.678 ' HG ' ' HB3' ' A' ' 31' ' ' PHE . 38.2 mt 50.56 71.48 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.482 0.713 . . . . 0.0 112.659 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.665 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -91.31 91.47 8.18 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.723 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' A' ' 36' ' ' ARG . 3.8 mmt85 75.12 -21.89 0.28 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.683 1.193 . . . . 0.0 112.942 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 t -97.73 120.19 46.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.32 158.1 30.35 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.528 0.517 . . . . 0.0 111.6 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -51.86 -40.49 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.16 -41.77 94.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.145 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.14 68.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.826 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.3 81.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.85 -31.61 72.84 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.932 0.493 . . . . 0.0 111.186 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.4 mt -74.55 -13.21 60.64 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.819 ' HB3' HG21 ' A' ' 69' ' ' THR . 1.2 m -96.01 -8.19 34.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.15 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.695 ' HG2' HG23 ' A' ' 62' ' ' THR . 62.9 mtp -91.5 148.96 38.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.419 175.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 7.2 Cg_exo -75.0 -10.85 21.39 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.671 2.247 . . . . 0.0 112.212 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.4 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.175 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -133.76 177.96 7.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.2 p -66.27 131.29 45.78 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.221 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.68 -7.4 65.49 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.51 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -97.7 156.05 16.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 111.003 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.27 124.04 34.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.717 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.32 135.84 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.11 0.481 . . . . 0.0 110.864 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.401 ' O ' HD12 ' A' ' 59' ' ' ILE . 36.5 m-80 -98.51 -178.75 4.11 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.13 -36.88 85.64 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.37 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.04 -29.2 68.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.067 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 17.7 m-20 -73.75 -29.81 62.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.077 0.151 . . . . 0.0 110.866 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -61.99 -50.71 78.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 171.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.759 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -66.07 -29.26 69.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.623 176.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.539 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -69.58 -41.03 76.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.989 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.695 HG23 ' HG2' ' A' ' 46' ' ' MET . 85.2 m -58.61 -46.92 86.0 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.941 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 60' ' ' SER . 66.6 mt -52.83 -55.38 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.682 0.614 . . . . 0.0 110.854 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.59 -29.41 66.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.434 -174.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.66 -54.82 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 66' ' ' LEU . 30.2 mt -62.54 -30.81 71.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.343 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -46.2 83.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.69 60.1 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.819 HG21 ' HB3' ' A' ' 45' ' ' SER . 82.2 p -79.91 -24.13 41.31 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.821 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.07 78.56 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.067 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -82.74 -36.33 25.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.102 0.477 . . . . 0.0 110.383 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -129.72 164.36 24.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.516 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.745 ' HB2' ' HB3' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -77.72 -50.99 11.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.447 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -133.49 144.05 49.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.392 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.28 120.68 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -114.26 118.43 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.801 174.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.451 HG22 HG13 ' A' ' 86' ' ' VAL . 51.3 t -112.42 123.08 67.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.017 0.437 . . . . 0.0 109.934 173.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.75 159.03 43.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -96.06 141.85 28.96 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.075 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -136.65 93.66 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.96 -109.31 2.79 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.143 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 11.88 20.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.74 141.78 35.49 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.419 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.1 111.28 23.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.02 111.63 23.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.51 -174.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.451 HG13 HG22 ' A' ' 77' ' ' VAL . 5.0 t -114.1 103.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.459 0.647 . . . . 0.0 109.905 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.578 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.83 127.13 44.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 150.41 30.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.528 ' HD3' ' HG2' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -99.39 139.0 35.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.176 -172.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.665 ' HA ' ' HG2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -54.18 141.06 30.44 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.633 173.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.745 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -128.61 69.46 79.47 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.403 178.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 19.1 Cg_endo -60.76 138.86 82.19 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.78 1.653 . . . . 0.0 111.007 172.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.884 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 17.1 m -84.47 125.51 32.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.339 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.523 HD11 ' HB2' ' A' ' 125' ' ' LEU . 11.2 mt -66.08 116.58 5.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.7 -38.43 10.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.927 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.54 138.66 26.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.41 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.717 HG21 HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -106.03 122.12 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 166.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -118.87 134.59 55.06 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.243 -173.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 24.0 m-85 -116.65 135.38 53.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -170.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.4 m -139.87 110.92 6.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.291 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.44 47.1 0.26 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.857 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -83.16 77.44 9.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.136 0.493 . . . . 0.0 110.553 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.35 -37.48 19.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.918 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.8 m -141.6 -58.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.886 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -75.05 126.01 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -74.31 159.75 32.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.432 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -34.68 78.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.554 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.0 -38.33 90.68 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.9 mtp -70.98 -39.14 72.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -37.76 88.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.38 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 31.1 mttt -60.75 -44.01 97.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 110.937 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 13.8 tt0 -77.66 -27.68 50.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.338 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -66.86 -43.52 83.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.223 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -66.38 -34.0 76.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.802 174.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -63.36 -38.14 90.0 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -18.32 61.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.436 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.8 m -91.48 -13.87 31.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.546 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.37 -14.63 50.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.9 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.09 103.57 14.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.199 0.523 . . . . 0.0 110.242 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.521 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -142.04 174.92 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.747 -176.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 94' ' ' ILE . 45.5 t -68.77 125.16 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.425 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.67 -28.22 16.4 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.786 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.521 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -86.02 163.88 17.69 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 122.683 0.393 . . . . 0.0 110.413 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.403 ' CB ' ' HB2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -87.41 156.2 19.69 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.675 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -113.79 138.75 49.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.018 0.437 . . . . 0.0 111.126 -176.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.51 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 12.7 t0 -100.1 115.04 28.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.573 0.701 . . . . 0.0 110.529 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.458 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -72.31 -16.22 61.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.44 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.1 p -85.64 -24.0 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.082 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.51 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 20.3 p -90.75 2.76 55.73 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.603 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.1 mm -56.98 -37.54 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.398 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.19 99.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.815 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 -39.2 78.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.142 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.2 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.227 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -59.29 -45.55 90.98 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.024 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -37.16 86.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.49 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.59 -34.12 72.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.629 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 167' ' ' LEU . 5.0 mt -69.91 -35.95 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.55 0.175 . . . . 0.0 111.352 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -64.04 -36.71 84.88 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 110.116 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.59 -37.13 79.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.016 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -45.0 94.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.396 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -39.1 92.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.012 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -29.44 66.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.199 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.4 m -70.35 -27.09 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.467 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 2.1 t -73.94 -88.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.467 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.23 18.79 25.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.104 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt 65.9 44.66 2.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.492 0.717 . . . . 0.0 110.321 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -78.55 113.72 16.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.775 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.46 99.98 11.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.483 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.39 147.5 44.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.338 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.01 136.01 39.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.6 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.2 m -97.76 132.21 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.406 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 115.41 16.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.365 169.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.42 111.18 22.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.83 123.34 57.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.516 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.71 114.61 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 110.17 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.53 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 6.9 m -113.62 119.35 41.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.12 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.5 Cg_endo -86.23 139.55 6.15 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.255 2.637 . . . . 0.0 112.615 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 0.3 OUTLIER -114.88 142.03 27.77 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 36.3 Cg_exo -59.08 93.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 114.348 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.492 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.3 OUTLIER 176.3 -92.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.603 1.161 . . . . 0.0 108.391 175.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.492 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 13.4 p-10 -165.3 28.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 109.137 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.884 ' HG3' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -123.02 164.2 19.02 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.64 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.675 HG11 HD22 ' A' ' 125' ' ' LEU . 9.4 p -137.3 147.74 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.395 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.28 123.07 48.67 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.426 ' HB3' HG23 ' A' ' 97' ' ' ILE . 28.1 tp -102.24 114.35 28.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.581 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -110.21 131.09 55.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.884 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.524 HD11 HD13 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -109.03 112.89 25.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.56 -176.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.848 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.57 117.64 34.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.303 0.573 . . . . 0.0 110.33 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -98.38 140.82 32.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.53 48.46 0.94 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.057 0.456 . . . . 0.0 109.884 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.47 -70.21 1.35 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.683 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.46 145.03 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.711 0.291 . . . . 0.0 110.901 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.324 -0.532 0 CA-C-O 120.928 0.394 . . . . 0.0 111.488 -177.814 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.136 0.493 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.09 154.16 35.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.76 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.09 43.33 26.74 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -111.14 153.86 25.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.67 113.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -70.29 121.42 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.438 0.637 . . . . 0.0 110.791 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -84.37 -26.13 28.62 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.154 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' HB3' HG23 ' A' ' 83' ' ' THR . 27.0 t0 -158.44 154.01 26.15 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.509 HD12 HD21 ' A' ' 43' ' ' LEU . 86.9 mt -125.59 128.09 72.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.375 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.94 133.24 55.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.309 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.454 ' HD2' HG12 ' A' ' 39' ' ' VAL . 10.5 m-85 -118.47 135.15 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -113.6 -58.49 2.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.28 -4.95 90.37 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 -164.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.26 156.49 35.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.804 0.811 . . . . 0.0 112.525 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -135.35 122.29 21.25 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.375 -1.284 . . . . 0.0 107.627 174.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER 83.17 -28.23 0.1 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.877 1.271 . . . . 0.0 111.176 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 t -79.54 122.82 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.981 0.42 . . . . 0.0 110.172 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.99 157.35 15.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.099 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.454 HG12 ' HD2' ' A' ' 31' ' ' PHE . 1.9 m -62.1 -29.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 O-C-N 123.647 0.592 . . . . 0.0 112.361 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.65 -40.47 85.75 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.687 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -74.48 -36.22 63.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.34 0.591 . . . . 0.0 110.357 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.58 87.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.91 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 29' ' ' ILE . 4.0 mt -58.74 -33.9 70.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.922 0.489 . . . . 0.0 112.207 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 41' ' ' ALA . 53.4 mt -74.15 -15.14 61.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.008 0.432 . . . . 0.0 111.335 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.01 -20.92 20.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.245 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.688 ' HG2' HG23 ' A' ' 62' ' ' THR . 91.0 mtp -81.75 146.04 55.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.259 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.59 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 6.1 Cg_exo -80.25 9.09 3.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.011 2.474 . . . . 0.0 112.458 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 154.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 16.6 mtm105 -130.63 173.73 10.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 111.275 -174.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 p -67.64 124.58 23.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.416 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -10.36 57.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.864 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -93.7 156.57 16.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 0.0 110.208 178.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.09 130.39 35.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.67 127.16 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.169 0.509 . . . . 0.0 110.912 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.446 ' O ' HD12 ' A' ' 59' ' ' ILE . 49.3 m-80 -97.31 179.38 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.399 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -30.83 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.241 0.543 . . . . 0.0 109.65 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.58 -33.42 75.87 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.495 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.96 -31.04 61.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.6 -50.76 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.72 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -69.64 -29.99 67.6 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.637 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 1.2 m-80 -72.22 -36.71 69.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.618 177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 46' ' ' MET . 74.5 m -60.48 -44.16 96.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.233 0.333 . . . . 0.0 110.273 171.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 60' ' ' SER . 32.1 mt -54.34 -53.02 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 123.351 0.407 . . . . 0.0 110.618 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 64' ' ' ARG . 1.2 tpt180 -65.72 -38.22 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 69' ' ' THR . . . -66.45 -48.14 70.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.442 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 86.4 mt -67.52 -29.92 69.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -41.15 99.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 110.081 172.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.12 -13.46 61.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.677 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 65' ' ' ALA . 30.2 p -78.93 -24.74 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.902 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.6 73.05 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.607 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -73.47 -44.13 58.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 109.99 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.442 ' HE1' ' HB3' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -124.03 154.83 39.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.692 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.724 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 5.3 mm-40 -72.1 -51.27 22.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.622 0.576 . . . . 0.0 111.956 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -129.61 146.42 51.41 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.77 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 88' ' ' VAL . 38.4 t -127.86 120.64 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.19 116.9 27.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.418 ' HB ' HG23 ' A' ' 59' ' ' ILE . 60.0 t -104.81 130.78 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.49 158.61 39.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -117.99 129.52 55.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.421 0.629 . . . . 0.0 110.404 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.2 95.86 4.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.695 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.34 -109.9 3.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.507 -174.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.31 14.38 19.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.372 0.606 . . . . 0.0 109.933 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -106.83 139.69 40.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -106.08 114.13 28.09 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.001 177.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -106.87 123.43 48.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 110.518 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -118.66 118.38 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.34 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -109.62 132.8 53.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 75' ' ' VAL . 4.5 m -125.56 162.46 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.218 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -98.37 110.52 23.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 0.3 OUTLIER -157.83 163.01 38.43 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.815 -173.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 43.6 mtp85 117.2 -57.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 126.476 2.36 . . . . 0.0 111.961 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 68.3 Cg_endo -73.41 139.41 28.75 Favored 'Trans proline' 0 C--N 1.362 1.265 0 CA-C-N 120.605 1.252 . . . . 0.0 112.308 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 45.3 m -124.87 133.31 53.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.616 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 125' ' ' LEU . 30.0 mt -68.61 117.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.2 -26.75 16.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.68 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.27 138.54 18.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.173 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.501 HG13 HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -109.23 121.38 62.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.853 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.3 OUTLIER -113.14 133.46 55.02 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.412 -175.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.696 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.2 m-85 -112.11 135.07 53.23 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.838 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.68 118.07 8.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.223 -173.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.07 18.34 56.03 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.334 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.545 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -85.15 93.39 8.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.589 . . . . 0.0 110.843 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.732 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -85.52 -46.09 11.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.251 -179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.2 -77.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.062 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.63 125.64 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -71.01 157.82 37.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.592 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -36.55 76.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.952 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.575 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 4.3 t0 -62.5 -38.47 90.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.481 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtt -73.34 -35.67 66.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -32.89 74.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.593 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.696 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -56.7 -44.84 81.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 176.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -28.3 53.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.388 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.66 -43.17 90.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.4 mm? -67.72 -35.83 79.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.781 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.85 -35.51 80.86 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.52 -23.09 58.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.874 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -17.82 31.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 0.0 110.199 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.05 -14.15 31.37 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.13 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.62 102.54 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.4 0.619 . . . . 0.0 110.604 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.74 176.45 9.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.128 -175.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 97' ' ' ILE . 70.7 t -67.29 127.42 28.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.374 0.607 . . . . 0.0 110.556 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.48 -10.28 62.96 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.925 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -111.45 166.09 11.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.724 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 1.4 m -75.72 162.34 28.3 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.266 177.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -132.18 145.15 51.16 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.512 0.196 . . . . 0.0 110.891 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -109.72 122.05 46.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.621 0.724 . . . . 0.0 111.319 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.444 ' HA ' HG12 ' A' ' 130' ' ' ILE . 6.9 mtp180 -73.02 -15.7 61.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.211 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.5 p -90.09 -17.25 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.1 m -84.32 -13.64 51.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.279 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 153' ' ' ALA . 6.5 mm -54.16 -40.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.065 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.71 99.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.012 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.424 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 0.6 OUTLIER -71.93 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 178.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 130' ' ' ILE . 52.0 mt -62.22 -46.76 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.942 0.401 . . . . 0.0 110.12 174.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.93 -49.83 74.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.309 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -65.3 -33.3 75.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.587 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 135' ' ' LYS . . . -68.09 -41.79 86.12 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.309 -0.472 . . . . 0.0 111.987 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.28 -33.0 72.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.404 0.145 . . . . 0.0 111.278 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -36.72 80.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.063 0.458 . . . . 0.0 110.683 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.13 -44.84 78.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.324 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -38.27 90.43 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.415 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.545 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -60.39 -43.53 96.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.209 0.528 . . . . 0.0 110.766 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -29.38 65.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.648 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.8 m -66.13 -28.16 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.738 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 145' ' ' GLY . 4.3 t -78.28 -96.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 110.312 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -103.95 19.84 42.7 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.266 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.7 56.67 1.51 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -87.28 96.47 10.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.987 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.67 101.68 5.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.749 173.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.59 156.3 43.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.376 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.12 113.69 25.66 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.3 p -106.71 127.14 62.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.959 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.97 117.81 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.054 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -93.99 110.16 21.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.56 126.63 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.79 -173.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.05 112.33 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.191 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.5 m -104.82 117.57 58.48 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.855 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.04 141.26 20.83 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.258 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -115.79 154.81 48.16 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.478 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 22.2 Cg_exo -66.5 76.96 0.36 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.549 2.833 . . . . 0.0 113.523 -176.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.51 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -167.39 -115.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 15.6 p-10 -144.11 27.35 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.099 0.952 . . . . 0.0 108.512 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.458 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 11.9 mmt180 -122.59 155.1 37.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.641 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.409 HG21 HD22 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -134.18 157.59 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.6 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -109.93 122.95 48.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.317 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.0 tp -106.6 116.41 31.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.853 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 12.4 tttt -119.22 132.77 55.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.06 110.58 22.56 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.216 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 15.2 t -99.78 116.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.656 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.66 118.28 36.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.974 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -74.05 144.2 45.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.661 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.62 -44.67 26.9 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -172.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 154.79 -29.15 0.67 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.968 -1.111 . . . . 0.0 113.135 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 37.6 t 69.47 -78.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.691 0.796 . . . . 0.0 111.267 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.158 0.504 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -83.33 152.07 25.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.44 47.29 8.21 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -171.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' HZ ' HD12 ' A' ' 84' ' ' LEU . 6.5 p90 -107.49 153.27 23.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.876 -0.662 . . . . 0.0 110.219 -175.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.46 112.39 17.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.92 125.39 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.01 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -41.3 10.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.722 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HB3' HG23 ' A' ' 83' ' ' THR . 38.7 t70 -147.89 148.55 30.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.598 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -116.51 124.59 72.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.39 127.55 47.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.666 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 3.6 m-85 -101.92 115.8 31.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HG3' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -94.09 65.14 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.803 0.811 . . . . 0.0 110.733 -176.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.84 -87.49 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.519 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.666 ' HG ' ' HB3' ' A' ' 31' ' ' PHE . 18.6 mt 54.33 -165.47 0.09 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.898 0.879 . . . . 0.0 113.292 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.482 ' OE1' ' HD3' ' A' ' 92' ' ' PRO . 0.8 OUTLIER -175.13 -101.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.947 176.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -98.14 -1.59 41.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.012 0.434 . . . . 0.0 110.603 176.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.462 HG22 ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -90.21 132.55 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.41 175.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.16 157.44 15.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.472 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m -58.91 -30.99 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 123.779 0.674 . . . . 0.0 112.205 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.94 -35.08 61.64 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.354 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -76.25 -36.11 58.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.001 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.78 88.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.855 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -32.33 61.48 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.091 0.957 . . . . 0.0 113.088 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 41' ' ' ALA . 51.1 mt -70.98 -15.78 62.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -8.39 23.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.546 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.7 mtp -94.55 137.19 22.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.188 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.57 34.39 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.991 2.461 . . . . 0.0 112.255 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HB ' HG11 ' A' ' 54' ' ' VAL . 1.5 p -155.39 146.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.24 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' H ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -133.37 176.68 8.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.3 p -67.11 121.2 15.08 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.84 0.352 . . . . 0.0 110.17 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.44 47.99 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.456 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.6 t0 -82.84 156.48 23.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.619 0.247 . . . . 0.0 110.987 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -112.78 112.03 23.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.18 178.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.653 HG11 ' HB ' ' A' ' 48' ' ' VAL . 2.6 m -126.24 132.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.184 0.516 . . . . 0.0 112.343 -171.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.405 ' O ' HD12 ' A' ' 59' ' ' ILE . 10.2 m-20 -86.14 -177.27 6.23 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.067 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -61.16 -35.42 77.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.984 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -62.93 -37.44 87.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.203 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.757 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 1.3 m-20 -75.85 -29.04 58.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.585 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.78 -47.4 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 171.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.686 ' HA ' HD12 ' A' ' 63' ' ' ILE . 3.7 m -68.76 -30.05 68.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.389 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.757 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 8.9 m-20 -63.75 -45.32 90.38 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 109.825 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.7 m -58.48 -43.88 89.13 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.095 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' A' ' 60' ' ' SER . 65.2 mt -55.81 -50.9 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 123.39 0.431 . . . . 0.0 110.872 176.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -66.28 -36.03 81.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.89 -45.33 74.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.795 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HB2' HG11 ' A' ' 75' ' ' VAL . 83.9 mt -71.01 -29.03 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -39.5 92.66 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.231 0.539 . . . . 0.0 110.538 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.88 -9.48 58.4 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.406 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.0 p -76.68 -20.16 56.94 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -170.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.47 21.27 75.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.943 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -105.01 -89.28 0.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.07 135.1 34.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.418 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.771 ' HB3' ' HB2' ' A' ' 124' ' ' SER . 0.1 OUTLIER -77.63 -30.01 52.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.8 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 11.8 t70 -123.42 135.43 54.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.667 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 88' ' ' VAL . 64.2 t -132.51 118.46 35.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.567 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -120.37 120.61 36.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.389 0.614 . . . . 0.0 110.051 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.441 HG22 HG13 ' A' ' 86' ' ' VAL . 70.1 t -105.19 123.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.29 137.7 51.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -88.0 110.12 20.35 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.49 95.22 5.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.55 -120.89 20.85 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -104.42 12.94 32.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.255 0.55 . . . . 0.0 109.963 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.89 141.71 35.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.791 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.533 HD12 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.02 110.87 22.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD11 ' HG3' ' A' ' 32' ' ' GLU . 13.6 tp -100.08 112.42 24.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.199 -175.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.441 HG13 HG22 ' A' ' 77' ' ' VAL . 6.1 t -116.16 105.79 19.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.425 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.93 131.44 42.28 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 75' ' ' VAL . 3.5 m -125.73 149.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.95 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -114.89 124.11 50.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.936 -176.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 47.7 90.6 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.722 1.264 . . . . 0.0 113.85 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.479 ' HD2' ' OD1' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -71.73 -34.38 3.05 Favored Pre-proline 0 CA--C 1.561 1.37 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 177.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HD3' ' OE1' ' A' ' 35' ' ' GLN . 56.8 Cg_endo -70.06 141.89 45.16 Favored 'Trans proline' 0 C--N 1.372 1.794 0 CA-C-N 121.747 1.66 . . . . 0.0 114.065 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 17.9 m -91.29 135.81 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 125' ' ' LEU . 34.7 mt -65.58 118.31 7.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.63 -37.04 8.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.312 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.39 144.03 32.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.474 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -119.39 123.52 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.62 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -103.71 131.27 51.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.516 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' HB3' HD21 ' A' ' 102' ' ' ASN . 20.3 m-85 -109.96 134.92 51.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.161 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.9 123.8 12.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.87 13.19 47.53 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.773 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.0 OUTLIER -94.59 77.93 3.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.997 -178.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -40.77 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.336 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.9 m -75.97 -61.6 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.266 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.2 140.13 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 4.0 mmtm -70.46 151.95 44.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 111.224 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.5 -35.53 79.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.459 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -69.89 -34.74 73.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.68 177.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.493 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -65.65 -39.44 91.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 173.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -32.97 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.369 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -61.53 -41.74 97.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 176.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.99 -30.06 55.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -66.62 -40.61 88.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.473 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.474 ' CD2' HG21 ' A' ' 97' ' ' ILE . 2.3 mp -69.72 -36.88 76.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.723 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.601 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 1.5 mt-10 -63.34 -37.39 87.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.445 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 m -93.5 -14.53 26.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.024 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.49 -22.09 22.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.924 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.45 104.43 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.355 0.598 . . . . 0.0 111.156 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.601 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.85 173.76 11.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.694 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.78 123.8 23.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.665 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.74 -6.26 58.71 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.888 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.4 158.42 17.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.939 0.399 . . . . 0.0 110.452 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.771 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -80.32 144.08 33.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.478 176.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.591 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.23 144.59 25.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.782 0.325 . . . . 0.0 111.585 -172.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.49 106.0 16.3 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.331 0.586 . . . . 0.0 109.729 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -17.65 62.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.482 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.8 p -83.83 -23.25 31.46 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.425 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 p -98.41 2.28 47.7 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.338 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 130' ' ' ILE . 6.1 mm -58.04 -40.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.844 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.66 83.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.689 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.17 -31.72 68.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.345 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.61 -44.85 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.718 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 138' ' ' GLU . 94.4 mt-10 -59.36 -47.65 84.62 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.651 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -35.68 81.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.147 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.29 -38.04 81.16 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.289 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 137' ' ' LEU . 1.2 mm? -66.58 -39.91 88.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.368 . . . . 0.0 111.282 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 134' ' ' GLU . 84.0 mt-10 -56.14 -43.88 78.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.136 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -31.94 67.21 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -34.62 78.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.163 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.478 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -71.16 -36.0 71.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.752 177.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -71.25 -30.56 66.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.41 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -30.27 63.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 145' ' ' GLY . 1.4 p -79.65 -73.27 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.437 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.494 ' H ' HG13 ' A' ' 144' ' ' VAL . . . -113.73 17.72 20.3 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.964 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 61.11 44.5 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 110.559 -173.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.448 ' CE2' ' HA3' ' A' ' 145' ' ' GLY . 66.4 m-85 -88.83 136.14 33.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.243 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.81 128.96 41.92 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.06 143.79 48.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.783 0.325 . . . . 0.0 110.647 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.97 113.68 27.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.68 131.23 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.158 0.504 . . . . 0.0 111.753 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -128.49 117.29 21.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.961 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.55 112.02 24.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 0.0 110.69 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.82 118.5 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.653 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.63 114.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.202 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.7 m -116.11 120.76 34.78 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.596 ' HA ' HG12 ' A' ' 163' ' ' VAL . 74.4 Cg_endo -75.28 147.87 33.5 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.778 2.319 . . . . 0.0 113.155 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 1.3 pp -117.1 160.48 37.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 158' ' ' LEU . 52.6 Cg_endo -76.11 73.92 4.76 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.712 2.275 . . . . 0.0 114.105 -171.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.4 OUTLIER -166.73 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.648 173.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.479 ' OD1' ' HD2' ' A' ' 91' ' ' ARG . 2.5 t30 -136.43 25.39 3.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 12.1 mmt180 -131.05 161.03 32.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -171.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -132.74 155.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.085 175.031 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.17 125.52 54.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.151 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.0 tp -108.39 131.51 54.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.59 0.233 . . . . 0.0 110.538 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.62 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 37.8 tttt -122.6 133.55 54.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 0.0 111.261 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.91 109.69 21.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.76 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.64 119.36 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.495 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -109.21 117.8 35.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.807 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -89.85 129.22 36.25 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.84 42.13 0.9 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -169.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.75 -14.81 34.69 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 114.07 172.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.82 -40.6 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.679 1.192 . . . . 0.0 112.644 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.233 0.192 0 CA-C-N 117.825 0.284 . . . . 0.0 111.19 178.559 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.19 154.54 22.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.139 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.34 46.0 3.13 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.59 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' CE1' ' HD2' ' A' ' 79' ' ' ARG . 43.9 p90 -105.95 148.9 27.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.72 113.36 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 p -73.98 133.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.443 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -88.08 -42.92 12.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.56 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -147.21 144.92 29.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.726 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.492 HD12 HD21 ' A' ' 43' ' ' LEU . 63.6 mt -106.86 120.51 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.46 127.45 54.43 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.071 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.782 ' HD2' HG12 ' A' ' 39' ' ' VAL . 78.6 m-85 -107.77 130.5 54.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG3' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -109.36 -42.66 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -172.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.54 -33.34 43.5 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.198 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.604 HD21 ' HD1' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -96.05 121.62 38.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.877 0.37 . . . . 0.0 110.513 -177.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -107.2 -47.38 3.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.609 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -35.83 73.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.688 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 34' ' ' LEU . 3.6 t -78.44 125.6 38.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.18 157.95 16.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.782 HG12 ' HD2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -51.76 -38.75 22.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.659 -177.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -73.02 -40.75 50.58 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.683 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.25 78.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.37 72.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.673 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 29' ' ' ILE . 2.9 mt -57.64 -31.08 65.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 95.5 mt -62.79 -26.76 68.88 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 111.58 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.14 -13.53 43.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.893 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.4 mtp -90.26 138.48 27.18 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.481 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.47 16.0 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.882 2.388 . . . . 0.0 113.257 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 52' ' ' ASP . 1.2 p -153.73 147.02 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.406 ' HG2' HD22 ' A' ' 43' ' ' LEU . 57.0 mtt85 -123.28 177.7 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.922 0.489 . . . . 0.0 110.458 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 p -65.6 126.5 28.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.411 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.77 -6.66 35.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.452 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.6 t0 -96.28 158.47 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.459 . . . . 0.0 110.651 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 133.02 34.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.442 HG13 HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -125.97 128.98 72.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 112.007 -173.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 87.7 m-20 -97.67 -179.63 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.008 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -65.42 -32.62 74.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 109.838 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 7.5 tp10 -61.29 -37.77 84.37 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.434 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.37 -32.21 62.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.292 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -63.54 -46.13 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.046 0.451 . . . . 0.0 109.951 173.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -73.64 -26.88 60.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.254 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -70.76 -45.61 64.47 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.417 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.3 p -64.51 -38.58 91.51 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.031 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -55.35 -54.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.486 0.491 . . . . 0.0 110.42 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -70.78 -30.31 66.75 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.27 -46.95 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.661 0.267 . . . . 0.0 110.567 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' HG23 ' A' ' 69' ' ' THR . 75.4 mt -71.66 -29.63 64.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -39.25 91.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.558 . . . . 0.0 110.48 173.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.41 -12.35 61.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.117 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 66' ' ' LEU . 21.9 p -78.17 -24.47 47.23 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.978 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.42 7.73 83.01 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.454 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -83.41 -20.61 33.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 165.97 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.725 ' HG2' ' HB2' ' A' ' 124' ' ' SER . 3.4 tm-20 -83.91 -50.49 8.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -136.65 137.72 40.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.817 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.79 120.51 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.74 0.305 . . . . 0.0 110.427 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -118.26 118.96 33.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.044 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.5 t -107.9 123.46 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.802 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.99 158.34 41.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -111.39 141.1 45.37 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.642 178.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -126.92 95.8 4.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.85 -109.68 3.02 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 14.28 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.292 0.567 . . . . 0.0 110.048 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.678 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.46 111.86 24.5 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.45 HD11 ' HG3' ' A' ' 32' ' ' GLU . 16.6 tp -101.73 116.74 33.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.4 t -107.69 110.16 30.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.362 0.601 . . . . 0.0 110.491 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 27.3 mt-30 -106.16 134.37 49.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.45 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.22 155.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.377 0.608 . . . . 0.0 110.995 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -100.69 133.12 45.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.877 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER 61.97 -167.83 0.2 Allowed 'General case' 0 C--O 1.236 0.375 0 O-C-N 124.266 0.979 . . . . 0.0 113.165 176.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.528 ' H ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -174.54 -45.11 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.328 -175.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 46.0 Cg_endo -69.65 140.68 43.69 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 121.161 1.241 . . . . 0.0 113.396 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 162' ' ' ARG . 80.6 m -97.92 144.48 27.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.742 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 125' ' ' LEU . 35.8 mt -69.59 117.98 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.59 -35.18 8.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.883 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -149.14 143.56 26.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.432 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.529 HG21 ' CD1' ' A' ' 114' ' ' LEU . 3.1 mt -117.11 124.04 72.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 172.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.558 ' HB ' ' HD3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -106.16 136.03 46.59 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 -176.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -114.85 135.29 54.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.9 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.465 ' OG ' ' HD2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -142.69 128.35 19.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.739 178.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.68 15.02 62.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.728 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -105.23 63.13 0.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.069 0.462 . . . . 0.0 111.245 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -88.1 -21.87 24.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -51.63 23.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.088 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t -109.38 141.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.89 145.98 53.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.859 0.361 . . . . 0.0 111.577 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.853 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -60.28 -35.59 75.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.76 177.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.1 -45.36 75.46 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.967 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -43.23 77.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.451 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.853 HD12 ' HA ' ' A' ' 107' ' ' ASP . 4.2 mt -64.64 -33.28 75.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -44.72 96.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.971 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.471 ' HB3' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -78.67 -27.95 45.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.896 -178.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.5 -38.63 90.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.057 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.529 ' CD1' HG21 ' A' ' 97' ' ' ILE . 17.2 mt -66.4 -36.04 81.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.641 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -63.93 -39.45 94.19 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.772 178.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.96 -16.48 60.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.48 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -88.7 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.381 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.81 -25.05 9.79 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.256 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.51 104.2 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.877 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.641 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -132.13 168.19 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.792 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -72.07 129.03 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.461 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.63 -6.3 74.08 Favored Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.835 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.98 145.2 40.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.725 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -66.33 143.13 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.328 178.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.551 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.76 146.33 23.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.156 0.503 . . . . 0.0 111.981 -170.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -107.45 96.35 6.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.152 171.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.431 ' HD3' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -71.89 -14.28 61.9 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.472 -178.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.431 HG23 ' HD3' ' A' ' 127' ' ' ARG . 34.2 p -90.53 -28.19 18.67 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.786 0.803 . . . . 0.0 108.897 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 m -95.13 6.4 49.15 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.51 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 130' ' ' ILE . 2.8 mm -58.35 -35.26 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.006 176.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.31 -35.91 78.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.686 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.22 -38.94 89.13 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.0 -42.64 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.347 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.9 -48.47 79.78 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.0 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -34.82 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.01 -36.96 91.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.523 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.49 -32.65 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 110.988 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -66.78 -43.05 85.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.614 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -31.43 70.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.771 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.1 t80 -60.34 -46.51 89.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.624 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.79 -36.46 83.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.824 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.37 -34.41 77.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.87 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.8 m -71.59 -30.08 65.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 140' ' ' PHE . 19.3 t -78.76 -86.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.786 0.326 . . . . 0.0 111.294 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.68 18.14 24.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.934 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.6 mttp 60.49 47.2 8.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.548 0.689 . . . . 0.0 109.667 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -74.8 123.47 25.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.731 -175.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.728 ' HB2' ' HA2' ' A' ' 172' ' ' GLY . 0.9 OUTLIER -81.64 131.87 35.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.706 177.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -153.33 143.65 22.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.255 0.55 . . . . 0.0 110.975 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.23 114.06 24.73 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 170.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.29 134.48 45.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.546 0.689 . . . . 0.0 112.108 -167.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -130.48 116.54 18.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.244 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.66 111.53 23.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.18 0.514 . . . . 0.0 109.963 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.21 121.7 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.35 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.93 128.0 52.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.7 m -120.0 121.27 29.72 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.433 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 1.1 Cg_endo -85.72 147.0 9.48 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.407 2.738 . . . . 0.0 113.325 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.657 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -105.07 159.99 27.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.927 172.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.47 65.64 2.21 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.432 2.754 . . . . 0.0 114.121 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.54 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -164.83 -113.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 9.6 p-10 -144.72 53.12 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.565 0.698 . . . . 0.0 110.735 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.657 ' HB2' HD11 ' A' ' 158' ' ' LEU . 1.6 mpp_? -143.12 159.91 41.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.456 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -132.33 153.03 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.377 178.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.81 124.96 53.03 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 43.3 tp -104.58 117.45 34.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.555 -172.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.558 ' HD3' ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -104.53 131.52 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.325 0.584 . . . . 0.0 110.809 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.556 HD12 ' HE2' ' A' ' 169' ' ' PHE . 1.2 mm? -106.39 109.74 21.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.288 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.39 111.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.34 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.556 ' HE2' HD12 ' A' ' 167' ' ' LEU . 6.0 m-85 -104.98 118.28 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 19.8 mm-40 -89.63 121.13 31.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -72.2 112.36 8.22 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.653 0.595 . . . . 0.0 110.908 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.728 ' HA2' ' HB2' ' A' ' 148' ' ' SER . . . 92.67 -136.67 13.3 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.644 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.6 t 60.8 -90.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.834 0.854 . . . . 0.0 111.662 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.346 0.594 . . . . 0.0 112.47 -172.591 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.347 0.594 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -140.58 146.9 38.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.789 . . . . 0.0 108.948 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.66 49.02 39.28 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -170.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -110.41 154.58 23.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.501 . . . . 0.0 110.715 -174.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.17 117.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.426 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.37 122.33 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.51 0.672 . . . . 0.0 110.667 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -95.6 -22.77 17.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.158 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HB3' HG23 ' A' ' 83' ' ' THR . 8.0 t70 -152.41 139.06 18.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.969 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 mt -118.46 123.36 71.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.989 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.472 ' HB3' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -121.21 133.2 55.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.188 -177.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -104.95 136.9 43.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.037 0.446 . . . . 0.0 110.802 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 1.7 mt-10 -119.32 70.39 0.84 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.92 -16.9 0.22 Allowed Glycine 0 C--N 1.32 -0.329 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.957 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 34' ' ' LEU . 7.1 mt -59.59 125.2 22.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.634 0.254 . . . . 0.0 111.03 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.76 29.73 1.52 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.365 -175.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.43 -51.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.225 0.536 . . . . 0.0 109.634 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HB ' HD22 ' A' ' 34' ' ' LEU . 3.5 t -79.56 141.22 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.398 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.67 157.91 16.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.692 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -32.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.707 0.63 . . . . 0.0 112.618 -174.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.29 -37.17 63.25 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.227 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.49 66.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.167 0.508 . . . . 0.0 110.428 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.73 72.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 46' ' ' MET . 0.7 OUTLIER -55.88 -32.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.664 0.786 . . . . 0.0 112.811 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.06 -14.14 61.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -7.98 38.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.799 0.333 . . . . 0.0 110.569 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.5 ' HB3' HG22 ' A' ' 62' ' ' THR . 1.8 mtm -94.01 133.61 27.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HG3' ' HB3' ' A' ' 61' ' ' ASN . 30.6 Cg_endo -64.91 -28.56 58.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.849 2.366 . . . . 0.0 112.653 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.21 149.58 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.158 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.0 177.87 7.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.591 -174.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.4 p -68.22 121.08 15.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.539 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.54 -6.58 52.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.142 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.74 157.05 16.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.932 0.396 . . . . 0.0 110.887 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.06 136.9 32.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.163 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.55 130.23 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.284 0.564 . . . . 0.0 111.244 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -97.77 -177.07 3.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.964 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -63.91 -27.37 69.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.04 -30.98 65.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.564 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 36.1 m-20 -75.94 -28.83 58.12 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.275 0.23 . . . . 0.0 111.08 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -47.47 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 171.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.419 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.0 m -70.14 -27.63 64.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.708 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.2 m-20 -68.91 -45.26 71.33 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.5 HG22 ' HB3' ' A' ' 46' ' ' MET . 0.9 OUTLIER -63.32 -40.12 96.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.719 175.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 60' ' ' SER . 56.7 mt -55.21 -55.38 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 123.61 0.569 . . . . 0.0 111.128 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -69.26 -31.01 69.26 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 69' ' ' THR . . . -69.01 -50.38 49.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.44 0.162 . . . . 0.0 110.746 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 75' ' ' VAL . 50.8 mt -68.34 -30.44 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.049 0.452 . . . . 0.0 110.313 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.12 -12.52 61.75 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.122 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 65' ' ' ALA . 22.3 p -78.89 -22.54 45.78 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.137 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 19.2 76.71 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.351 -0.452 . . . . 0.0 113.138 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -89.76 -28.7 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.606 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 162.34 28.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.816 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -84.73 -37.93 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -140.5 144.6 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 66' ' ' LEU . 48.3 t -128.63 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 119.53 33.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.361 177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 86' ' ' VAL . 84.1 t -106.11 124.29 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.044 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.0 146.13 47.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -107.76 132.7 53.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.77 95.2 3.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.043 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.95 2.48 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.035 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -106.24 2.1 26.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.006 0.522 . . . . 0.0 110.901 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.492 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -106.66 132.91 52.11 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.75 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.0 113.09 26.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.814 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 30' ' ' HIS . 3.5 tp -102.86 112.24 24.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.406 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.509 HG13 HG22 ' A' ' 77' ' ' VAL . 15.2 t -110.08 106.22 20.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.546 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 6.6 mt-30 -92.91 136.18 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.49 142.87 41.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.126 0.489 . . . . 0.0 110.243 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.686 ' HD3' ' HG2' ' A' ' 90' ' ' GLU . 0.3 OUTLIER -100.26 143.32 30.6 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.915 -175.041 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.686 ' HG2' ' HD3' ' A' ' 89' ' ' LYS . 3.1 mm-40 73.19 -174.03 0.15 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 124.846 1.342 . . . . 0.0 112.261 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.543 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 6.0 ttt180 -171.34 -56.38 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.258 -170.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 91' ' ' ARG . 1.9 Cg_endo -81.29 141.7 12.93 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.815 1.676 . . . . 0.0 113.482 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 5.1 m -97.69 133.51 42.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.2 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 28.5 mt -71.95 117.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.56 -33.17 11.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.036 0.446 . . . . 0.0 110.555 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -147.26 143.08 27.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.446 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.699 HG21 HD22 ' A' ' 114' ' ' LEU . 1.3 mt -115.65 123.0 70.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.605 ' HB ' ' HE3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -122.42 132.86 54.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.243 0.545 . . . . 0.0 110.773 -175.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.515 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 21.3 m-85 -111.23 135.25 52.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.376 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.73 120.25 18.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.37 29.73 9.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.116 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 1.1 p30 -107.98 63.93 0.62 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.562 0.696 . . . . 0.0 110.566 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -85.16 -17.34 37.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.091 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -93.04 -52.03 4.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 102' ' ' ASN . 31.7 t -108.03 128.92 63.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 11.1 mmmt -69.95 149.4 47.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -170.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -35.13 69.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.729 173.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.78 -43.94 90.56 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.0 mtp -69.1 -41.2 77.76 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.45 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -36.72 80.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.861 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -46.17 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.135 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -28.73 55.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.172 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.29 -46.87 86.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.261 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.699 HD22 HG21 ' A' ' 97' ' ' ILE . 1.9 mp -66.25 -40.63 90.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.014 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.695 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 7.6 mt-10 -60.32 -42.42 95.57 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.402 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.13 -22.15 60.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.703 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -87.93 -16.86 32.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.73 -24.97 6.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.805 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.99 104.7 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.185 0.517 . . . . 0.0 111.641 -174.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.695 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.66 176.47 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.553 178.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 94' ' ' ILE . 44.7 t -68.34 125.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.251 0.548 . . . . 0.0 111.593 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.82 61.93 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.127 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.28 155.26 21.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 110.699 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.21 133.82 42.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.507 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -92.22 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.281 0.562 . . . . 0.0 111.061 -173.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -110.01 102.48 11.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.858 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.406 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -71.16 -15.75 62.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.74 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -84.13 -18.37 37.02 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.549 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.51 -0.75 45.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 130' ' ' ILE . 4.9 mm -59.33 -35.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.499 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.58 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.559 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.21 -28.55 60.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.804 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.29 -43.36 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.957 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.63 -42.01 99.34 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.61 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -41.75 98.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.157 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.62 93.05 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.635 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.595 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 18.2 mt -74.09 -32.43 63.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.586 0.231 . . . . 0.0 111.112 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.01 -40.91 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.207 175.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.51 -39.87 88.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.552 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -43.18 99.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -41.66 91.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.362 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -32.31 66.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.5 m -71.35 -32.25 68.31 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.619 HG13 ' H ' ' A' ' 145' ' ' GLY . 1.9 p -76.0 -77.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.647 -175.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.619 ' H ' HG13 ' A' ' 144' ' ' VAL . . . -114.21 17.49 19.29 Favored Glycine 0 N--CA 1.454 -0.107 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.768 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 55.71 58.63 4.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.569 0.699 . . . . 0.0 110.816 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -92.86 111.54 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.5 98.7 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 170' ' ' GLN . . . -107.63 145.27 33.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.048 0.451 . . . . 0.0 111.579 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.29 114.14 26.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 171.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.92 124.58 57.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.15 0.5 . . . . 0.0 111.469 -171.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -130.9 117.02 18.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.492 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.86 112.47 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.427 0.632 . . . . 0.0 110.117 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.26 119.71 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.077 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -99.6 112.14 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 m -104.23 117.42 59.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.533 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 163' ' ' VAL . 88.5 Cg_endo -80.31 137.46 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.2 2.6 . . . . 0.0 113.406 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 1.2 pp -104.82 143.67 27.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 169.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 22.2 Cg_exo -65.28 80.91 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.704 2.936 . . . . 0.0 115.018 -168.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -169.32 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.786 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -163.03 22.64 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.441 0.639 . . . . 0.0 109.944 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.498 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -128.23 155.8 43.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 -174.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 157' ' ' PRO . 3.7 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.683 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.25 131.74 55.33 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.435 ' HB3' HG23 ' A' ' 97' ' ' ILE . 21.9 tp -99.55 114.15 26.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.831 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.605 ' HE3' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.524 0.678 . . . . 0.0 111.138 -177.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.515 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.3 mm? -110.43 109.54 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.129 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.15 111.76 31.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.115 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.595 ' HZ ' HD13 ' A' ' 137' ' ' LEU . 15.2 m-30 -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.766 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -105.33 114.42 28.59 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.15 102.53 15.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.066 0.46 . . . . 0.0 111.909 -170.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 173' ' ' VAL . . . 81.83 -84.03 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.519 175.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 172' ' ' GLY . 1.9 m 62.15 -51.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.203 1.801 . . . . 0.0 113.815 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.455 -0.203 0 CA-C-N 118.514 0.597 . . . . 0.0 111.32 -178.612 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.79 0.329 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.31 171.83 7.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.126 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.26 46.72 7.36 Favored Glycine 0 CA--C 1.506 -0.482 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HZ ' ' HB2' ' A' ' 79' ' ' ARG . 48.3 p90 -112.55 154.39 26.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.967 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.2 t -77.44 113.52 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -76.17 124.1 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.469 0.652 . . . . 0.0 109.952 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -88.95 -36.66 15.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.642 -176.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -144.31 143.46 31.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.154 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 85.2 mt -104.62 121.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -111.32 126.38 54.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -106.15 115.61 30.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.477 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 tt0 -102.68 68.4 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.405 0.622 . . . . 0.0 110.056 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.62 -109.82 0.34 Allowed Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.589 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.684 ' H ' HG23 ' A' ' 88' ' ' VAL . 94.2 mt 56.62 -156.86 0.28 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.495 0.718 . . . . 0.0 112.033 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.43 ' H ' ' HB3' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -169.98 -82.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.712 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 35' ' ' GLN . 7.4 ttm-85 -118.76 11.54 12.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.406 0.622 . . . . 0.0 109.983 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.84 124.2 47.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.699 173.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.12 157.66 19.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.716 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -60.83 -29.13 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.27 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.93 -35.72 57.91 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.265 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -75.81 -34.61 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.351 0.596 . . . . 0.0 110.27 177.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.09 73.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.592 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mt -60.08 -31.73 70.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.211 0.604 . . . . 0.0 112.073 172.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 41' ' ' ALA . 90.4 mt -69.24 -21.74 63.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.21 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 m -88.28 -19.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.036 0.446 . . . . 0.0 110.285 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.521 ' HG2' HG23 ' A' ' 62' ' ' THR . 68.0 mtp -82.65 138.68 43.94 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.853 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 10.8 Cg_exo -73.5 -14.88 24.94 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.931 2.421 . . . . 0.0 112.586 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.506 HG11 HG12 ' A' ' 54' ' ' VAL . 29.3 m -114.93 167.77 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.117 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 4.9 mmt85 -129.12 174.24 9.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.918 0.389 . . . . 0.0 110.456 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.1 p -67.96 122.88 19.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.994 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -5.35 44.29 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.059 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -76.14 155.15 34.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -92.84 113.01 25.17 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.506 HG12 HG11 ' A' ' 48' ' ' VAL . 5.7 m -116.75 127.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.586 -165.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.42 ' O ' HD12 ' A' ' 59' ' ' ILE . 16.2 m-80 -98.85 -178.09 3.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.312 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -28.98 70.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 10.9 tt0 -64.05 -44.27 92.97 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.006 175.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.01 -34.83 75.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.227 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -62.18 -50.96 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 123.153 0.283 . . . . 0.0 110.286 175.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.622 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.1 m -67.89 -35.27 78.2 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.436 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 6.9 t-20 -63.79 -45.37 90.03 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.449 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.521 HG23 ' HG2' ' A' ' 46' ' ' MET . 90.5 m -59.01 -42.58 90.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.416 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 60' ' ' SER . 71.2 mt -55.55 -56.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 123.318 0.386 . . . . 0.0 111.223 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 -70.29 -28.46 65.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.05 -52.72 61.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.06 -31.79 72.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.672 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -33.8 76.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.792 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.68 -12.77 61.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.541 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 p -78.73 -24.95 44.59 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.763 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.48 65.43 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.82 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.04 4.68 15.78 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.18 0.49 . . . . 0.0 111.007 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.9 163.91 26.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 166.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 124' ' ' SER . 0.0 OUTLIER -87.15 -46.01 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 110.192 177.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 33.9 t70 -129.54 136.82 50.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.423 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.9 117.99 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 119.51 32.83 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 174.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.653 HG22 HG13 ' A' ' 86' ' ' VAL . 54.9 t -111.78 121.08 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.05 136.99 42.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -93.43 136.39 33.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.986 0.422 . . . . 0.0 110.029 178.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -126.61 95.38 4.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.99 -109.52 2.84 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.373 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.425 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 15.0 p-10 -106.21 10.96 31.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.164 0.507 . . . . 0.0 111.001 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.87 141.34 46.81 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.624 -177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -103.74 114.85 29.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 176.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tp -107.54 112.81 25.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.48 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.653 HG13 HG22 ' A' ' 77' ' ' VAL . 7.3 t -112.79 111.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.291 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.477 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 5.3 mt-30 -104.74 128.72 52.93 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.684 HG23 ' H ' ' A' ' 34' ' ' LEU . 1.8 m -125.4 141.8 44.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.661 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 44.6 tttt -100.67 112.88 25.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.732 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.27 174.59 0.26 Allowed 'General case' 0 CA--C 1.549 0.926 0 O-C-N 124.542 1.151 . . . . 0.0 112.051 172.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.491 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -143.34 -60.19 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -175.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 2.9 Cg_exo -76.08 139.1 21.24 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 121.523 1.482 . . . . 0.0 113.891 -174.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 50.3 m -89.39 136.21 33.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.53 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 125' ' ' LEU . 35.7 mt -62.46 117.48 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.54 -27.79 13.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.827 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.4 149.87 22.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 114' ' ' LEU . 3.7 mt -123.79 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.86 148.06 52.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.881 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.616 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 25.6 m-85 -120.43 153.63 36.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.104 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.58 143.75 23.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.759 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.63 73.41 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.32 -0.467 . . . . 0.0 114.199 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HA ' ' OH ' ' A' ' 141' ' ' TYR . 0.5 OUTLIER -101.42 81.51 2.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.393 0.616 . . . . 0.0 110.532 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -86.14 -34.68 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.931 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -56.38 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.993 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -92.62 159.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.987 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' A' ' 106' ' ' LYS . 2.4 mmmm -88.23 145.52 25.84 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.259 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.616 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 15.6 p-10 -66.74 -34.71 78.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.761 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.606 ' HA ' ' HD3' ' A' ' 111' ' ' LYS . 16.6 t70 -58.92 -38.35 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.089 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -42.77 68.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.405 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.19 -32.48 68.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.02 0.528 . . . . 0.0 111.959 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.606 ' HD3' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -58.63 -47.96 82.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.226 178.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.9 -28.58 49.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -36.46 83.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.551 HD12 HG21 ' A' ' 97' ' ' ILE . 11.6 mt -74.19 -38.92 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.723 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -61.99 -31.89 72.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.409 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.71 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.605 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -16.72 34.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.875 0.369 . . . . 0.0 110.267 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.86 -21.76 8.87 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.47 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.68 108.12 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.282 0.563 . . . . 0.0 111.303 -176.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.723 ' HB3' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -140.28 172.15 13.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' A' ' 94' ' ' ILE . 48.4 t -71.62 127.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.062 0.458 . . . . 0.0 110.503 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.53 -20.96 48.25 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.059 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -82.51 163.8 21.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.257 0.551 . . . . 0.0 110.628 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 73' ' ' GLU . 63.3 m -85.21 151.17 24.29 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.535 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -104.8 143.83 32.59 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.695 0.76 . . . . 0.0 111.607 -172.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.588 ' HB3' HG22 ' A' ' 129' ' ' THR . 9.7 t0 -104.65 98.09 7.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.397 176.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.572 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.85 -15.59 62.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.648 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.0 p -83.32 -17.88 40.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.085 0.469 . . . . 0.0 110.363 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 126' ' ' ASP . 0.8 OUTLIER -103.11 6.72 38.69 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 176.07 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.572 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.6 mm -61.45 -39.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.36 78.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.188 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -33.12 70.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.066 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 mt -68.55 -47.19 78.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.112 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.59 -41.73 98.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.966 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -37.12 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.026 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.09 -37.8 87.63 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.529 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 44.4 mt -74.45 -32.0 62.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.675 0.274 . . . . 0.0 111.066 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -37.65 75.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 110.039 175.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.97 -33.22 75.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.559 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.476 ' O ' HG23 ' A' ' 144' ' ' VAL . 1.6 t80 -64.78 -45.42 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.525 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' A' ' 102' ' ' ASN . 2.1 m-85 -63.02 -37.1 85.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 2.2 t80 -68.13 -35.59 78.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.254 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.0 m -69.03 -31.24 69.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.688 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 140' ' ' PHE . 7.9 t -74.57 -91.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.77 0.319 . . . . 0.0 110.338 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.92 18.39 24.16 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.094 -177.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.767 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 58.92 50.32 8.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.357 0.598 . . . . 0.0 110.045 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -80.19 119.64 23.23 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.403 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.94 99.11 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.82 43.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.439 0.637 . . . . 0.0 111.382 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.71 113.06 24.98 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 2.8 p -108.16 127.44 64.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.439 0.638 . . . . 0.0 110.519 -174.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.91 116.84 20.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.542 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.94 110.58 22.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.17 124.91 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.906 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.58 113.97 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.318 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.0 m -104.41 115.27 63.19 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.799 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.65 127.42 9.57 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.919 2.412 . . . . 0.0 112.618 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -105.79 150.9 39.71 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 171.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.49 79.74 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.463 2.776 . . . . 0.0 113.967 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.432 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -171.21 -104.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.583 0.753 . . . . 0.0 109.348 177.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 16.5 p-10 -157.5 34.92 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HB2' HD11 ' A' ' 158' ' ' LEU . 1.5 mmt85 -133.78 155.3 50.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.877 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -127.6 151.52 34.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.812 177.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.63 118.88 37.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.86 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.1 tp -96.82 121.05 38.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.44 132.49 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.433 0.635 . . . . 0.0 111.044 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.609 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.0 mm? -105.61 111.48 24.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.834 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 21.6 t -99.54 120.41 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -116.06 118.94 34.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.75 120.3 29.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.47 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.54 134.45 54.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.667 0.27 . . . . 0.0 110.446 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 140.87 -78.67 0.29 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.533 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.808 HG13 ' H ' ' A' ' 174' ' ' SER . 10.2 p 41.19 -103.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 125.164 1.386 . . . . 0.0 112.865 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.808 ' H ' HG13 ' A' ' 173' ' ' VAL . 60.3 m . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 119.096 0.862 . . . . 0.0 110.99 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -96.8 21.83 9.02 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.07 77.37 1.93 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -97.39 152.5 18.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.3 t -85.66 122.65 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.67 124.28 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.588 0.709 . . . . 0.0 110.689 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -80.31 -26.93 38.57 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.387 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -162.51 149.45 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.453 HD12 HD21 ' A' ' 43' ' ' LEU . 58.7 mt -112.99 121.54 65.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.9 t-160 -116.77 127.22 54.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.644 ' HB3' HD21 ' A' ' 34' ' ' LEU . 19.5 m-85 -106.68 136.72 46.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -131.32 167.7 18.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.63 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.95 -33.19 2.89 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.348 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.644 HD21 ' HB3' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -84.07 150.21 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -101.16 -63.76 1.11 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.776 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -109.66 31.62 5.67 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 111.772 -174.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' HB ' HD22 ' A' ' 34' ' ' LEU . 3.7 t -108.72 112.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.66 156.15 27.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.125 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.567 HG12 ' HD2' ' A' ' 31' ' ' PHE . 2.7 m -66.48 -27.57 40.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.914 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.69 -36.97 61.8 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.134 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -76.47 -34.42 58.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.547 0.689 . . . . 0.0 110.157 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.57 68.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.997 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.684 HD22 ' HD2' ' A' ' 49' ' ' ARG . 5.1 mt -57.14 -31.29 65.21 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.356 0.662 . . . . 0.0 112.532 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 41' ' ' ALA . 67.1 mt -66.48 -22.31 66.19 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.565 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.57 -8.3 26.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.562 ' HG2' HG23 ' A' ' 62' ' ' THR . 30.9 mtp -83.54 143.25 43.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.204 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.74 -3.56 13.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.512 2.142 . . . . 0.0 113.334 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -139.58 163.79 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.684 ' HD2' HD22 ' A' ' 43' ' ' LEU . 9.6 mmm180 -120.31 176.06 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.936 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 p -66.94 132.92 48.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.61 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.37 -5.7 77.83 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.638 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 156.64 18.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.881 0.372 . . . . 0.0 111.081 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 125.1 30.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.322 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 HG11 ' A' ' 48' ' ' VAL . 20.9 m -123.14 137.22 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.705 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -97.49 178.54 5.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.026 0.441 . . . . 0.0 110.804 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -27.17 63.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.53 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -29.44 64.67 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.36 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 42.3 m-20 -73.91 -29.2 61.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.524 175.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.87 -49.34 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.719 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -64.75 -36.36 84.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 176.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -64.06 -42.33 97.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 178.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.562 HG23 ' HG2' ' A' ' 46' ' ' MET . 54.0 m -60.04 -42.55 94.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 60' ' ' SER . 55.3 mt -55.62 -49.3 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.53 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -36.43 82.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.027 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.11 66.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.623 HD22 ' HE1' ' A' ' 72' ' ' PHE . 89.9 mt -71.08 -28.31 64.24 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.224 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -45.23 66.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.63 -15.79 59.73 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 66' ' ' LEU . 9.7 t -80.78 -24.29 38.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.35 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.5 1.65 90.17 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 164.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -85.12 -6.33 59.3 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.945 0.872 . . . . 0.0 111.698 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.623 ' HE1' HD22 ' A' ' 66' ' ' LEU . 14.2 m-85 -124.43 159.14 31.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HG2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -91.75 -36.95 13.28 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.887 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 26.7 t0 -137.73 140.97 41.0 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 66' ' ' LEU . 49.1 t -128.17 119.84 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.892 0.377 . . . . 0.0 110.5 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.7 118.13 30.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.877 173.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.578 HG22 HG13 ' A' ' 86' ' ' VAL . 61.4 t -106.95 122.34 60.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.81 137.97 37.12 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.8 137.15 36.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.407 0.622 . . . . 0.0 110.82 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -113.99 95.31 5.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.74 -109.37 2.87 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.483 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.29 11.02 21.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.239 0.542 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.86 139.57 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.724 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -104.8 114.89 29.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.487 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 20.6 tp -109.23 115.11 29.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.233 0.54 . . . . 0.0 110.453 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.578 HG13 HG22 ' A' ' 77' ' ' VAL . 19.0 t -106.25 108.24 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.351 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.505 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 73.5 mt-30 -97.06 126.38 42.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.41 150.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.85 0.834 . . . . 0.0 111.159 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.463 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 16.4 tttm -108.38 130.76 55.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.149 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.541 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 2.4 tp10 73.33 151.12 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.475 1.109 . . . . 0.0 111.956 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.67 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 5.8 tpt180 -155.22 -53.87 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.703 175.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 91' ' ' ARG . 9.6 Cg_endo -90.63 137.24 2.34 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.246 1.298 . . . . 0.0 111.344 171.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.9 m -96.36 147.72 23.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.194 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.649 HG13 ' HB2' ' A' ' 125' ' ' LEU . 42.4 mt -58.12 118.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 162' ' ' ARG . . . -105.82 -38.24 6.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.183 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.97 27.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.487 HG12 HD21 ' A' ' 165' ' ' LEU . 1.2 mt -114.83 123.69 70.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 168.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.88 135.4 54.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -176.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 22.1 m-85 -111.45 135.47 51.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.6 m -141.93 112.11 6.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.877 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.695 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 178.96 -60.12 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.911 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.467 ' HB2' ' OH ' ' A' ' 141' ' ' TYR . 0.7 OUTLIER -153.6 148.41 26.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.122 0.487 . . . . 0.0 111.957 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -86.52 -13.01 47.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.903 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.586 ' HB3' HG11 ' A' ' 144' ' ' VAL . 54.0 m -58.35 -50.85 72.18 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.706 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p -87.31 137.68 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -78.63 143.33 36.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.234 -174.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.445 ' HA ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -67.68 -33.95 75.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.106 177.058 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -30.79 71.84 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.568 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 106' ' ' LYS . 29.6 mtp -73.03 -46.07 54.0 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.413 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.55 HD22 HD22 ' A' ' 137' ' ' LEU . 4.5 mt -63.22 -31.87 73.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -59.31 -43.4 92.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 111.019 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.97 -28.81 58.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.364 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.63 -43.98 91.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.245 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.421 HD22 HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -65.34 -36.82 85.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.917 175.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -31.42 72.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.56 61.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.547 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.0 m -84.66 -16.83 40.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 110.178 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 106.07 1.28 38.83 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.269 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -103.01 117.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.183 0.516 . . . . 0.0 110.863 -177.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.69 170.5 15.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.222 -177.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.8 t -71.73 126.3 31.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.982 0.42 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.84 -5.91 79.42 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.943 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 124' ' ' SER . 0.9 OUTLIER -106.47 154.59 20.62 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.508 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 1.5 m -57.12 139.34 52.75 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.537 0.523 . . . . 0.0 111.524 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.649 ' HB2' HG13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.92 145.33 25.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.322 0.582 . . . . 0.0 111.183 -175.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.534 ' HA ' ' NH1' ' A' ' 127' ' ' ARG . 26.2 t0 -117.77 111.58 19.28 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.716 0.77 . . . . 0.0 111.243 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.534 ' NH1' ' HA ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -71.2 -15.23 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.051 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.4 p -89.72 -15.43 32.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.741 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -92.73 2.49 56.71 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.929 175.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 130' ' ' ILE . 7.1 mm -59.8 -41.32 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.924 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.39 86.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.816 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.33 -41.63 96.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.115 0.483 . . . . 0.0 109.732 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 10.7 mt -63.55 -45.99 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.479 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -60.37 -49.45 77.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 2.9 tptp -61.95 -40.28 94.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.27 65.84 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.843 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.55 HD22 HD22 ' A' ' 110' ' ' LEU . 12.7 mt -74.01 -32.64 63.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.632 0.253 . . . . 0.0 110.985 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.744 ' HG3' HG12 ' A' ' 151' ' ' VAL . 52.9 mt-10 -67.04 -37.47 84.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 174.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -31.29 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.456 ' HD2' ' HA ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -66.41 -36.93 84.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.467 ' OH ' ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -62.64 -35.72 80.52 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 177.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -69.35 -34.52 74.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.651 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.29 66.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 104' ' ' SER . 12.4 t -74.87 -86.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 144' ' ' VAL . . . -111.76 18.77 24.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.576 -176.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.6 56.8 3.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.685 0.755 . . . . 0.0 110.063 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -86.18 149.84 24.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.298 -174.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 89.21 3.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.665 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.12 156.52 46.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 0.0 112.036 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 m -117.61 139.98 50.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.843 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.744 HG12 ' HG3' ' A' ' 138' ' ' GLU . 6.6 p -114.4 139.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.134 0.492 . . . . 0.0 110.682 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 127.69 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.228 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.64 116.92 29.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.46 0.648 . . . . 0.0 111.387 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.28 112.33 30.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.904 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.95 111.43 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 120.971 0.415 . . . . 0.0 110.042 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.517 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 22.2 m -118.96 125.15 27.85 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.036 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.1 Cg_exo -82.38 145.62 13.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.191 2.594 . . . . 0.0 112.563 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.3 OUTLIER -105.82 158.88 31.38 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.88 62.77 4.88 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.355 2.703 . . . . 0.0 113.483 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.64 ' HB2' HD12 ' A' ' 158' ' ' LEU . 8.6 mmt180 -146.84 -93.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 24.4 t30 -168.69 32.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 174.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.462 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -136.87 166.61 23.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.083 -177.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.528 HG21 HD22 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -128.99 148.03 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.117 0.484 . . . . 0.0 111.163 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -112.07 122.18 47.04 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.487 HD21 HG12 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -119.14 132.58 56.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.713 0.768 . . . . 0.0 111.363 -176.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -120.91 133.34 55.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.975 -176.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.5 mm? -103.56 110.32 22.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.747 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.1 116.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.695 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 75.7 m-85 -97.87 118.56 34.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.13 115.59 25.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.538 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.68 89.41 2.8 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.378 0.608 . . . . 0.0 110.464 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 170.99 -169.75 42.7 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 41.0 t 69.62 153.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.068 0.547 . . . . 0.0 110.955 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.23 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 120.946 0.403 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.47 165.78 22.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.696 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.59 43.57 6.09 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -109.43 153.95 23.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.89 117.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.909 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.22 115.69 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -41.53 23.58 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.134 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.699 ' HB3' HG23 ' A' ' 83' ' ' THR . 25.0 t70 -144.11 143.77 31.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.043 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.5 mt -105.31 121.84 57.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.93 128.59 45.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.271 0.557 . . . . 0.0 111.125 -175.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.456 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 41.3 m-85 -105.33 137.84 42.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.638 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.46 -42.91 2.96 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.64 4.45 85.74 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.071 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.496 HD13 ' HB ' ' A' ' 37' ' ' VAL . 4.5 mt -69.39 132.53 46.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.904 0.383 . . . . 0.0 111.471 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -82.27 -84.9 0.11 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.473 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -126.67 27.2 6.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 111.096 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' A' ' 34' ' ' LEU . 3.0 t -85.97 132.61 31.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.95 154.97 21.1 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -61.31 -32.48 53.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.463 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -68.97 -37.61 83.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.9 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.19 63.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.082 0.468 . . . . 0.0 110.738 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.88 -40.05 55.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.479 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.1 -29.92 70.04 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.289 0.635 . . . . 0.0 112.159 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 40' ' ' GLY . 84.5 mt -62.45 -24.97 67.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.515 ' HB2' HD23 ' A' ' 66' ' ' LEU . 1.5 m -96.82 -7.82 32.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.48 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 33.9 mtp -87.39 131.6 43.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.026 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 13.1 Cg_exo -70.82 -25.43 23.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.914 2.409 . . . . 0.0 112.667 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 m -112.9 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.24 0.543 . . . . 0.0 111.418 -176.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -118.21 -179.87 3.9 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.487 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.9 p -67.47 121.43 15.79 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.847 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -6.11 47.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.5 m-20 -86.0 153.72 21.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.545 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.27 139.01 33.04 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 127.24 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.869 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.54 -177.36 3.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.108 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.513 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -68.07 -36.3 79.61 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.54 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 22.6 m-20 -74.14 -29.81 61.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.787 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -48.38 88.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -70.42 -32.49 70.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.562 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 2.0 m-20 -62.06 -49.76 74.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 110.476 177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 46' ' ' MET . 44.4 m -61.46 -44.34 97.27 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.48 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CD1' HG22 ' A' ' 77' ' ' VAL . 2.4 mt -59.22 -48.2 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 123.39 0.431 . . . . 0.0 110.844 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -33.54 74.14 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 69' ' ' THR . . . -65.21 -51.59 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.585 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 45' ' ' SER . 79.8 mt -67.61 -30.08 69.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.28 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -41.77 94.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 110.608 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.75 -13.51 62.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.92 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 65' ' ' ALA . 26.4 p -79.37 -25.0 42.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.594 0.235 . . . . 0.0 111.184 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.72 26.97 71.39 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.415 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -95.64 -20.05 19.25 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.117 0.484 . . . . 0.0 110.207 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.67 154.85 45.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 124' ' ' SER . 36.3 mt-10 -80.43 -43.66 20.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 111.6 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 12.6 t70 -132.91 136.34 46.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 66' ' ' LEU . 25.9 t -124.98 117.88 51.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.507 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 76' ' ' ARG . 2.4 tpp85 -121.12 122.37 39.87 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.962 172.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 63' ' ' ILE . 27.1 m -96.64 137.54 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -128.34 154.15 46.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -107.57 115.16 29.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.786 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.79 95.62 5.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 -110.45 3.37 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.212 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -106.74 8.32 30.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.225 0.536 . . . . 0.0 110.743 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.699 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -111.08 141.52 44.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.546 -173.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.96 115.55 30.81 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.02 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.32 112.43 24.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.123 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -102.4 109.87 27.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.502 0.668 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -103.95 126.42 51.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.599 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.18 158.3 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.908 0.385 . . . . 0.0 111.262 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 10.5 tptp -100.74 121.0 40.93 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -177.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' HB3' ' H ' ' A' ' 91' ' ' ARG . 0.6 OUTLIER 50.7 -118.61 1.25 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.816 1.322 . . . . 0.0 112.666 173.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.508 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -168.08 -55.8 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.698 -172.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 72.6 Cg_endo -84.96 138.59 6.91 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 120.863 1.042 . . . . 0.0 113.919 -169.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.1 m -99.54 138.12 37.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.6 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 125' ' ' LEU . 20.7 mt -61.62 117.61 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.04 -22.92 13.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.117 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 138.66 13.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.891 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.433 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.2 mt -118.0 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.431 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -117.68 132.27 56.51 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.75 -175.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.64 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 22.2 m-85 -105.84 151.06 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.95 139.71 20.77 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.6 18.5 56.64 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.33 56.99 4.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.455 0.702 . . . . 0.0 110.807 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -86.57 -34.81 19.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 m -84.97 -51.06 6.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.64 137.3 44.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.69 147.86 50.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.619 -174.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.64 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -64.39 -33.09 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.855 176.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -38.01 74.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.024 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -44.08 55.24 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 106' ' ' LYS . 31.1 mt -61.21 -32.49 72.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.101 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.407 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 7.8 mttt -60.47 -46.21 90.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 111.227 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 5.3 tp60 -77.89 -28.24 49.82 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.609 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.094 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.433 ' CD2' HG21 ' A' ' 97' ' ' ILE . 2.3 mp -68.07 -40.57 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.619 174.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.607 ' HG2' ' HB2' ' A' ' 120' ' ' ARG . 1.9 mt-10 -60.46 -42.35 96.0 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.86 -16.0 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.677 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.5 m -91.98 -13.27 31.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.49 -22.03 13.86 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.998 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 94' ' ' ILE . 41.0 t -92.35 104.04 15.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.092 0.472 . . . . 0.0 110.079 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.607 ' HB2' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -142.0 170.16 16.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.241 -178.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.54 131.47 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.35 0.595 . . . . 0.0 111.283 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.17 -6.63 81.06 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.709 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.58 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -100.15 166.88 10.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.0 111.519 -174.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -61.99 148.08 44.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.433 173.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -112.3 135.08 53.42 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.716 0.769 . . . . 0.0 110.979 -177.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' HG22 ' A' ' 129' ' ' THR . 23.7 t0 -106.17 97.31 7.14 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 172.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.616 ' HD3' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.58 -15.24 62.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.758 -176.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.616 HG23 ' HD3' ' A' ' 127' ' ' ARG . 12.5 p -89.74 -23.62 21.75 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.698 0.285 . . . . 0.0 110.96 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 126' ' ' ASP . 0.5 OUTLIER -87.99 -1.29 57.9 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.406 0.622 . . . . 0.0 110.517 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.703 HG23 ' HB3' ' A' ' 153' ' ' ALA . 5.6 mm -57.51 -43.36 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.215 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.721 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.28 -36.53 84.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.149 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.3 mt -65.18 -45.23 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.353 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -61.12 -47.7 85.05 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 17.2 mmtm -67.09 -34.58 77.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.646 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.94 -39.98 84.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.024 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.587 HD13 ' HZ ' ' A' ' 169' ' ' PHE . 37.0 mt -69.66 -32.54 71.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.633 0.254 . . . . 0.0 111.032 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -63.09 -41.46 99.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.24 -43.48 94.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.688 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.403 ' O ' HG23 ' A' ' 144' ' ' VAL . 14.6 m-85 -65.29 -38.55 90.56 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.228 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -35.47 80.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.947 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -30.4 67.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.206 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -28.44 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 140' ' ' PHE . 12.2 t -72.47 -83.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.233 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.53 18.62 22.59 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.584 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt 63.11 45.58 5.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.368 0.667 . . . . 0.0 110.184 -174.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -80.57 119.62 23.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.092 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.456 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -90.71 73.02 6.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.44 176.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 143.9 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.39 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.5 m -97.94 115.66 28.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 13.2 t -107.07 122.35 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.563 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 119.57 24.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.388 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.703 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -95.9 111.97 23.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.258 0.552 . . . . 0.0 110.246 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.58 118.82 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.811 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.09 116.75 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.331 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.474 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 17.1 m -120.77 122.13 28.63 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.791 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.3 Cg_endo -88.11 142.69 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.68 2.92 . . . . 0.0 113.003 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -120.56 159.39 48.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.033 178.056 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.06 -7.69 12.28 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 123.726 2.951 . . . . 0.0 115.0 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.51 12.42 8.57 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 122.488 -0.132 . . . . 0.0 111.193 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 1.3 m-20 62.22 42.35 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.0 0.905 . . . . 0.0 110.603 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HB2' HD11 ' A' ' 158' ' ' LEU . 14.5 mmt85 -131.02 163.57 27.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.381 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.547 HG21 HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -127.43 146.49 33.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.23 0.538 . . . . 0.0 110.537 176.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.08 123.41 49.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.494 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.1 tp -107.22 119.71 40.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.115 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.431 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -115.4 131.27 56.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.376 0.607 . . . . 0.0 110.58 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.6 mm? -104.3 109.93 21.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.462 -176.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.9 t -96.41 111.41 26.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.587 ' HZ ' HD13 ' A' ' 137' ' ' LEU . 48.6 m-85 -108.78 135.2 50.39 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.436 ' HB3' HG23 ' A' ' 173' ' ' VAL . 1.6 mp0 -112.89 111.93 23.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -96.03 23.4 6.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.763 0.792 . . . . 0.0 110.799 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -133.45 20.09 4.2 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.464 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 148' ' ' SER . 11.2 t -98.59 123.37 51.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.422 0 O-C-N 124.103 0.877 . . . . 0.0 110.514 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 120.765 0.317 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.51 143.13 39.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.518 176.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.44 47.27 80.43 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -107.9 152.76 23.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.686 -0.257 . . . . 0.0 110.428 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.57 113.3 23.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.26 118.42 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 111.256 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -76.69 -46.77 24.31 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 178.363 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.84 146.66 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.427 ' HB ' HD11 ' A' ' 43' ' ' LEU . 62.4 mt -105.39 119.99 55.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -109.65 127.55 54.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.89 137.48 41.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.012 0.434 . . . . 0.0 110.476 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.39 -30.58 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.468 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.99 -73.81 1.19 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.796 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 37' ' ' VAL . 32.6 mt 61.88 -164.68 0.24 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.443 0.697 . . . . 0.0 112.126 -176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.469 HE21 ' HB2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -165.47 -89.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.744 -177.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.02 11.2 6.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.445 0.64 . . . . 0.0 109.838 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.494 ' O ' HD22 ' A' ' 34' ' ' LEU . 42.3 t -108.42 140.66 26.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.311 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.54 158.11 18.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.11 -37.54 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.71 -40.23 90.11 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.95 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -71.8 -34.84 69.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.909 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -32.46 70.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.31 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' A' ' 29' ' ' ILE . 4.8 mp -68.94 -30.99 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 41' ' ' ALA . 53.0 mt -68.96 -23.38 64.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.411 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -80.61 -20.96 42.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.422 177.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.547 ' HB3' HG22 ' A' ' 62' ' ' THR . 24.7 mtt -82.53 139.39 44.32 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.95 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 31.4 Cg_exo -63.36 -36.2 57.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.656 2.237 . . . . 0.0 112.328 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.86 150.12 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.389 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 14.6 mmm-85 -127.82 178.09 6.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 0.0 111.067 -175.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -64.65 122.58 17.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.95 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.39 -10.1 42.45 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.83 -174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 5.2 m-20 -89.32 152.77 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.531 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.91 127.7 36.49 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.74 131.15 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.421 0.629 . . . . 0.0 112.491 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -93.13 173.17 7.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.38 174.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.96 -31.6 71.96 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -61.21 -36.97 81.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.893 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 37.8 m-20 -75.05 -29.21 60.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.08 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -45.31 95.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -32.18 73.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.921 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.598 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.4 m-80 -69.63 -43.55 72.45 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.203 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 46' ' ' MET . 1.3 p -63.29 -43.15 98.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.032 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mt -54.21 -49.63 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 123.519 0.512 . . . . 0.0 110.45 174.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -46.59 89.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.416 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 45' ' ' SER . . . -60.8 -48.45 81.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.467 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 75' ' ' VAL . 54.1 mt -69.89 -29.51 66.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -34.36 77.51 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 110.287 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.16 61.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.421 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.8 p -77.61 -25.64 49.98 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.222 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.57 -5.85 20.35 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 116.143 -0.48 . . . . 0.0 114.114 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.63 -23.87 22.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.167 0.483 . . . . 0.0 111.228 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.562 ' CD1' HG21 ' A' ' 88' ' ' VAL . 6.0 m-85 -101.47 157.19 16.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.62 ' HG2' ' HD2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -86.78 -41.66 13.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.151 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.724 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 8.4 t70 -145.88 139.19 26.12 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 66' ' ' LEU . 22.6 t -116.73 120.77 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -174.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.84 118.53 31.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.751 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.6 126.48 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.011 0.434 . . . . 0.0 110.014 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -126.36 159.08 34.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 129.86 50.63 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.806 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.0 96.63 6.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.815 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.2 -109.85 3.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.616 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -111.44 15.9 21.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.394 0.616 . . . . 0.0 110.375 177.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.06 141.41 38.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.085 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.84 119.15 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -112.23 116.99 31.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.98 0.419 . . . . 0.0 110.17 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -106.72 111.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.253 0.549 . . . . 0.0 110.72 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.13 136.24 41.3 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG21 ' CD1' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -130.78 155.82 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.126 0.489 . . . . 0.0 110.326 -173.349 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.724 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -98.6 140.45 32.81 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.2 -175.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 79.35 -154.09 0.02 OUTLIER 'General case' 0 C--O 1.238 0.475 0 O-C-N 125.974 2.047 . . . . 0.0 111.407 -176.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.427 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 0.6 OUTLIER 159.62 -46.93 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 124.773 1.229 . . . . 0.0 109.555 -164.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 3.5 Cg_exo -79.31 140.42 15.4 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.266 1.311 . . . . 0.0 112.559 172.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -104.34 136.83 43.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.336 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 125' ' ' LEU . 31.0 mt -64.83 118.25 6.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.15 -27.84 14.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.82 139.85 15.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.041 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.17 122.88 65.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 167.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.493 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -116.27 131.94 56.8 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.388 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.607 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 23.0 m-85 -113.43 134.12 54.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.824 -175.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.3 125.75 16.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.66 -2.34 57.19 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.363 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.488 HD21 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -86.36 82.15 8.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.187 0.518 . . . . 0.0 110.709 -177.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 171' ' ' GLU . 0.2 OUTLIER -85.88 -35.77 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.043 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -70.32 -64.91 0.8 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.126 0.488 . . . . 0.0 110.626 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.65 130.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -69.41 158.38 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 0.0 112.087 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -61.47 -34.6 75.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.723 173.133 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -43.1 96.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.983 176.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 mmm -74.45 -35.35 63.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.753 0.311 . . . . 0.0 111.131 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -31.65 72.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.549 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.607 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.93 -43.42 86.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 110.763 176.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -78.29 -28.6 47.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.115 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -66.39 -42.64 87.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.19 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -68.08 -38.45 82.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.53 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -40.16 88.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.097 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.92 -19.38 61.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.915 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 m -89.23 -12.86 39.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 102.62 -11.86 56.5 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.629 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.3 t -100.5 101.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.519 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 26.8 ptt180 -142.93 175.32 9.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -176.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 94' ' ' ILE . 14.6 p -68.89 135.09 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.216 176.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.33 18.02 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.37 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -84.91 160.5 20.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 110.994 177.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.98 150.58 27.57 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 170.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.634 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -119.02 130.72 55.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -174.052 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.584 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 20.0 t0 -90.13 112.87 24.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.629 0.728 . . . . 0.0 109.893 172.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -15.69 62.25 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.079 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.3 p -83.45 -25.36 31.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.338 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.584 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -89.34 -1.1 57.94 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.952 177.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.559 HG23 ' HB3' ' A' ' 153' ' ' ALA . 4.4 mm -56.72 -41.53 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.481 ' HA ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.08 -38.36 90.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.86 -31.22 68.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.583 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.7 mt -67.03 -43.62 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.54 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 131' ' ' ALA . 49.1 mt-10 -62.44 -44.4 96.5 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.591 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.34 93.57 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.748 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.37 -37.49 92.82 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.931 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 mt -68.27 -39.58 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.501 0.191 . . . . 0.0 111.368 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.4 -39.26 88.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.282 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.743 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -60.96 -45.06 96.29 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 147' ' ' TYR . 1.2 m-85 -61.78 -41.42 97.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.181 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -70.75 -34.37 71.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.096 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.2 m -66.51 -28.56 68.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.8 t -80.13 -88.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.975 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.25 18.06 26.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.5 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 1.0 OUTLIER 59.99 44.67 13.07 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.283 0.633 . . . . 0.0 110.697 -174.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HB3' ' A' ' 141' ' ' TYR . 69.3 m-85 -73.58 102.96 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.91 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.32 84.28 6.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 111.676 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -117.81 141.56 48.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 m -100.05 122.42 42.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.749 0.309 . . . . 0.0 110.459 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.2 p -105.47 133.12 50.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.384 0.612 . . . . 0.0 111.657 -174.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -129.23 122.53 29.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.514 173.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -93.8 112.06 23.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.113 0.482 . . . . 0.0 110.762 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.19 116.88 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.471 HG13 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -105.39 118.31 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.433 178.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.5 m -124.12 117.48 26.96 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.629 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 46.7 Cg_endo -69.51 143.83 53.34 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.611 2.207 . . . . 0.0 112.614 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.64 160.35 26.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.79 71.05 0.24 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.616 2.878 . . . . 0.0 114.322 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -164.51 -117.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 18.7 p-10 -138.63 36.79 2.22 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -133.71 157.83 44.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 -172.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -128.18 148.17 32.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.244 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -109.32 126.66 53.62 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.471 HD13 HG13 ' A' ' 155' ' ' VAL . 58.3 tp -113.25 114.35 26.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.934 0.397 . . . . 0.0 110.66 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.493 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 1.3 ttpt -113.28 131.69 55.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 0.0 110.693 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.2 mm? -98.83 110.18 22.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.142 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.483 HG22 ' HE2' ' A' ' 166' ' ' LYS . 25.4 t -94.52 111.08 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -103.26 129.29 50.18 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.4 113.61 11.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.502 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -105.0 72.33 1.0 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.283 -176.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 155.86 81.89 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.846 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 1.3 p -123.7 169.57 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.134 0.493 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -128.72 124.69 36.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.0 44.95 12.51 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -171.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -106.93 153.56 22.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.202 -0.499 . . . . 0.0 110.072 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.523 HG13 ' HE2' ' A' ' 27' ' ' LYS . 2.1 p -80.6 124.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 110.103 175.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.55 127.75 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.558 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' HG13 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -97.57 -39.44 9.12 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.546 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.611 ' HB3' HG23 ' A' ' 83' ' ' THR . 34.7 t70 -143.8 142.06 30.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.3 mt -109.14 122.07 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -122.75 128.09 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.963 -179.03 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . 2.4 m-85 -102.16 138.1 39.56 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.005 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 5.3 mm-40 -119.6 67.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.064 0.935 . . . . 0.0 109.982 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.745 ' HA3' HG22 ' A' ' 88' ' ' VAL . . . 172.0 -83.0 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.745 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' A' ' 31' ' ' PHE . 49.5 mt 65.23 120.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.075 0.941 . . . . 0.0 113.361 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.432 ' HG3' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -131.49 91.05 2.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.238 176.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.73 -35.15 0.23 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.384 1.074 . . . . 0.0 112.585 173.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.38 113.11 24.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.32 158.08 35.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.618 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -54.37 -36.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -172.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.96 -35.66 57.83 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.556 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.69 -35.57 60.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.89 -31.25 68.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.384 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.46 -31.05 65.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 112.608 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt -70.41 -23.07 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 111.282 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.98 -17.23 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.278 0.561 . . . . 0.0 110.143 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.665 ' HG2' HG23 ' A' ' 62' ' ' THR . 92.4 mtp -82.81 137.9 43.73 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.823 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HG3' ' HB3' ' A' ' 61' ' ' ASN . 39.6 Cg_endo -69.0 -22.58 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.32 2.013 . . . . 0.0 112.701 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.702 HG11 HG13 ' A' ' 54' ' ' VAL . 2.0 t -125.5 149.77 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.262 0.554 . . . . 0.0 110.811 -175.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 177.9 5.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.673 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -66.16 120.27 12.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.57 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.28 -5.51 38.61 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.214 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' CB ' HG13 ' A' ' 48' ' ' VAL . 1.1 m-20 -98.52 155.78 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.79 140.66 29.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.56 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.702 HG13 HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -125.98 129.16 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.637 0.256 . . . . 0.0 111.652 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.467 ' O ' HD12 ' A' ' 59' ' ' ILE . 1.3 t-20 -95.11 -178.55 4.51 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.25 -30.38 69.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.226 0.536 . . . . 0.0 110.033 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -35.69 81.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.507 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.574 ' HB3' HG12 ' A' ' 54' ' ' VAL . 3.8 m-20 -76.63 -29.6 56.52 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -61.1 -48.14 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 171.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -66.79 -33.48 75.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.55 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.481 ' HB3' ' HG3' ' A' ' 47' ' ' PRO . 4.3 t-20 -63.25 -48.03 79.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.634 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.665 HG23 ' HG2' ' A' ' 46' ' ' MET . 25.5 m -58.9 -46.36 88.07 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.331 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 77' ' ' VAL . 24.4 mt -55.26 -49.46 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.862 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -68.26 -40.42 81.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.204 -175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.0 -53.15 60.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.76 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.722 ' HB3' HG21 ' A' ' 75' ' ' VAL . 6.3 mp -66.5 -30.59 70.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.699 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.407 0.622 . . . . 0.0 110.797 174.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.46 -13.17 61.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.756 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 p -78.63 -25.32 45.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.34 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.94 -7.35 59.73 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.886 176.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.236 0.541 . . . . 0.0 110.572 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 150.31 49.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.938 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.58 -45.14 60.6 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.369 0.418 . . . . 0.0 111.303 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 7.5 t70 -139.43 146.68 40.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 66' ' ' LEU . 70.7 t -126.16 122.72 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.675 0.274 . . . . 0.0 110.304 -176.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.44 118.57 32.1 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.784 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.5 HG22 HG13 ' A' ' 86' ' ' VAL . 43.6 t -103.83 123.19 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.113 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.17 159.06 37.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.65 144.53 43.27 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.277 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -139.23 97.5 3.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.054 171.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 -111.07 3.66 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -112.99 18.82 17.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.298 0.571 . . . . 0.0 109.97 174.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.611 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -107.52 134.54 50.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.029 -177.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 84' ' ' LEU . 1.6 mt -102.65 118.54 37.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.708 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.2 tp -106.09 112.38 25.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.027 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.5 HG13 HG22 ' A' ' 77' ' ' VAL . 3.2 t -110.22 104.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.306 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 3.3 mt-30 -98.49 148.65 23.52 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.745 HG22 ' HA3' ' A' ' 33' ' ' GLY . 15.5 m -125.89 152.32 32.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.092 0.472 . . . . 0.0 110.662 -178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.895 ' HD3' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.19 139.43 36.88 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.71 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.895 ' HG2' ' HD3' ' A' ' 89' ' ' LYS . 25.1 mm-40 66.17 -169.59 0.2 Allowed 'General case' 0 C--O 1.236 0.344 0 O-C-N 124.407 1.067 . . . . 0.0 112.006 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.432 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -174.4 -54.91 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.307 -168.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.18 142.03 26.84 Favored 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 121.642 1.561 . . . . 0.0 112.827 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 m -97.67 134.74 40.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.456 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 125' ' ' LEU . 32.4 mt -61.96 120.29 7.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.1 -31.17 11.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.593 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.01 138.82 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.191 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -117.75 123.42 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.74 131.55 53.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.662 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.604 ' HD2' ' HB2' ' A' ' 167' ' ' LEU . 17.5 m-85 -109.21 134.84 51.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.356 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.11 113.94 11.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.447 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 115.36 13.09 9.19 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.665 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.48 68.54 4.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.731 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -85.39 -31.33 22.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.56 26.35 10.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 111.446 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.8 p -167.89 155.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -83.94 145.67 28.44 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.664 0.745 . . . . 0.0 111.272 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -35.62 80.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.468 175.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -41.74 89.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.248 174.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.74 -42.2 70.83 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.409 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -39.67 84.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.935 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -42.86 99.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.514 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.579 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 1.6 tm0? -77.71 -27.96 50.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.116 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.93 -43.47 95.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.954 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 HG21 ' A' ' 97' ' ' ILE . 3.0 mp -68.49 -41.09 80.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.435 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -57.24 -45.76 83.62 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.791 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.01 -21.82 59.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.733 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -83.62 -17.16 42.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 110.297 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.58 -19.85 8.98 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.271 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.86 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 111.051 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.49 ' HA ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -141.56 175.11 9.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.674 -178.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 94' ' ' ILE . 50.9 t -67.81 123.59 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.077 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.02 29.67 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.31 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.27 160.14 17.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.118 0.485 . . . . 0.0 111.901 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 m -84.75 127.43 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 170.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.48 143.18 27.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.656 -171.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -91.76 113.26 25.48 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.864 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.04 -27.7 62.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.375 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 p -79.24 -22.67 44.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.29 0.88 51.46 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.862 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 125' ' ' LEU . 5.0 mm -55.0 -45.14 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.654 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.42 91.0 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.246 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.96 -34.69 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.496 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 130' ' ' ILE . 61.4 mt -64.87 -48.58 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.748 176.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 130' ' ' ILE . 19.7 mt-10 -59.39 -50.02 75.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.08 0.467 . . . . 0.0 111.358 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -33.17 74.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.6 -37.16 89.2 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.152 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.9 -32.02 68.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.653 0.263 . . . . 0.0 111.12 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.615 ' HG3' HG23 ' A' ' 151' ' ' VAL . 58.5 mt-10 -64.08 -41.44 97.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.095 0.474 . . . . 0.0 110.269 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.82 -39.45 90.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.557 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 144' ' ' VAL . 2.5 t80 -58.8 -45.52 89.68 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.035 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -41.7 87.83 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.406 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' HE1' ' HG ' ' A' ' 148' ' ' SER . 1.9 t80 -71.25 -29.68 65.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.621 178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.4 m -70.04 -28.56 65.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 140' ' ' PHE . 21.4 t -72.81 -87.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.974 0.416 . . . . 0.0 110.737 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.22 19.52 22.41 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.395 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 62.19 0.96 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.615 0.722 . . . . 0.0 111.105 -174.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -105.63 121.08 43.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.969 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.404 ' HG ' ' HE1' ' A' ' 142' ' ' TYR . 1.0 OUTLIER -94.86 93.6 7.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 110.669 176.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -117.43 153.17 33.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.58 ' HB2' ' HG3' ' A' ' 170' ' ' GLN . 6.8 m -99.65 132.65 44.85 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.615 HG23 ' HG3' ' A' ' 138' ' ' GLU . 21.6 t -110.58 129.34 65.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 110.302 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 168' ' ' VAL . 0.2 OUTLIER -123.06 117.02 24.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.435 176.144 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -95.27 111.12 23.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.158 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.5 113.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.11 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.15 116.97 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.497 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 66.9 m -122.98 124.0 26.65 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.861 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 2.7 Cg_exo -77.41 141.96 20.63 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.101 2.534 . . . . 0.0 111.768 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.79 156.42 36.61 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.97 76.86 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.134 2.556 . . . . 0.0 113.548 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.494 ' HB3' ' H ' ' A' ' 161' ' ' ASN . 0.0 OUTLIER -164.53 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.494 ' H ' ' HB3' ' A' ' 160' ' ' ARG . 2.3 t30 -170.14 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.786 0.803 . . . . 0.0 109.124 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -127.08 161.25 28.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.086 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.45 144.6 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.244 176.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.85 130.96 55.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.92 130.37 55.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.097 0.475 . . . . 0.0 111.179 -176.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 130.69 52.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.016 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.2 mm? -106.92 111.63 24.22 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.412 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 152' ' ' LYS . 25.8 t -95.03 111.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.855 -176.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.401 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 81.8 m-85 -103.92 117.5 34.47 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 150' ' ' SER . 1.8 mt-30 -78.15 114.99 17.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.09 103.93 12.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.321 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 94.14 56.46 1.38 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.147 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.1 t -81.81 -65.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.13 178.602 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -125.94 131.48 52.28 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.027 0.442 . . . . 0.0 110.215 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.52 42.1 10.6 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.646 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -101.51 153.22 19.9 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -87.02 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.6 127.87 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.618 0.723 . . . . 0.0 110.633 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -94.49 -41.1 9.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.397 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.18 137.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.633 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.98 121.53 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 7.0 t60 -113.39 127.69 56.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.549 ' HD2' HG12 ' A' ' 39' ' ' VAL . 29.4 m-85 -102.84 134.3 46.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.754 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -133.91 77.53 1.72 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.246 0.546 . . . . 0.0 111.101 -173.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.54 -28.63 0.18 Allowed Glycine 0 C--N 1.316 -0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.863 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -88.49 146.75 25.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.535 0.683 . . . . 0.0 111.787 178.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -142.31 142.27 32.5 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 170.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 78.62 -32.06 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.631 1.207 . . . . 0.0 110.506 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.418 ' O ' HD13 ' A' ' 34' ' ' LEU . 10.9 t -82.75 118.72 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 169.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.34 156.2 19.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.549 HG12 ' HD2' ' A' ' 31' ' ' PHE . 2.3 m -61.67 -32.3 53.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.076 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.35 -37.24 70.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.97 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.27 -36.28 63.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.44 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.26 -39.22 78.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.069 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HA ' ' SD ' ' A' ' 46' ' ' MET . 1.4 mt -59.79 -31.57 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.435 0.694 . . . . 0.0 112.318 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.61 -16.42 61.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.757 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.8 OUTLIER -93.88 -7.87 41.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 175.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.516 ' HG2' HG23 ' A' ' 62' ' ' THR . 70.7 mtp -90.25 147.2 36.34 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.71 -18.51 22.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 112.192 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.459 HG11 HG12 ' A' ' 54' ' ' VAL . 4.3 m -116.71 165.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.972 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -132.38 174.36 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 p -67.45 121.82 16.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.298 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.97 -4.73 49.55 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.313 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -87.31 155.1 20.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 0.0 111.047 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.54 133.42 35.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.845 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.459 HG12 HG11 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -130.8 128.04 62.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.071 0.462 . . . . 0.0 111.363 -175.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.61 179.74 5.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.062 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -30.31 70.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.361 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 17.9 tp10 -66.18 -34.3 77.73 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.36 0.413 . . . . 0.0 110.758 174.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.8 -32.52 69.63 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.37 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -62.68 -49.5 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 123.241 0.338 . . . . 0.0 110.319 173.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -35.03 77.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.58 0.229 . . . . 0.0 111.401 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -66.05 -39.92 90.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.486 177.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.516 HG23 ' HG2' ' A' ' 46' ' ' MET . 68.4 m -59.02 -45.81 89.77 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.032 172.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.416 HG13 HG13 ' A' ' 77' ' ' VAL . 1.2 mt -54.96 -48.44 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 123.445 0.466 . . . . 0.0 110.425 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -67.08 -35.57 80.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.218 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 69' ' ' THR . . . -68.35 -54.89 14.26 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.239 0.337 . . . . 0.0 110.507 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.78 HD22 ' HE2' ' A' ' 72' ' ' PHE . 37.4 mt -58.72 -29.71 66.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -52.67 33.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.969 0.414 . . . . 0.0 110.821 172.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.37 61.33 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.757 HG21 ' HB3' ' A' ' 45' ' ' SER . 30.0 p -79.49 -6.62 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.678 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.87 75.06 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.478 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -83.07 -59.27 2.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.517 . . . . 0.0 111.604 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.78 ' HE2' HD22 ' A' ' 66' ' ' LEU . 2.4 m-85 -124.82 169.96 11.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.524 0.202 . . . . 0.0 111.292 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 89' ' ' LYS . 1.9 tm-20 -79.01 -42.54 26.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.09 0.471 . . . . 0.0 110.846 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 30.6 t70 -137.89 141.04 40.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.75 119.02 55.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.077 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -120.98 117.29 26.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.943 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.709 ' HB ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -109.41 129.99 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.634 0.73 . . . . 0.0 109.695 172.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.14 156.83 34.24 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -129.16 126.16 38.63 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.513 0.673 . . . . 0.0 111.202 -176.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -115.46 97.12 5.98 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.851 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.06 -109.08 2.71 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.234 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.48 10.42 23.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.708 0.289 . . . . 0.0 110.778 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.33 132.52 50.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.83 116.77 31.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 0.8 OUTLIER -109.96 117.1 32.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.709 HG22 ' HB ' ' A' ' 77' ' ' VAL . 4.8 t -111.22 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.257 0.551 . . . . 0.0 110.989 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.754 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 64.4 mt-30 -93.55 137.93 32.33 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.95 152.24 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 -175.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -98.71 150.16 22.09 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.824 -178.23 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.51 144.13 6.09 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 124.752 1.282 . . . . 0.0 113.788 -167.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.463 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 4.6 mtm180 -71.32 -51.91 9.49 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.776 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 17.2 Cg_exo -68.1 139.92 48.05 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.55 1.5 . . . . 0.0 113.277 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 7.2 m -105.31 139.16 40.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.913 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.635 HD11 ' HB2' ' A' ' 125' ' ' LEU . 50.0 mt -62.88 118.16 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.73 -42.5 11.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.1 39.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 176.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 165' ' ' LEU . 0.7 OUTLIER -115.84 122.39 69.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.63 ' HB ' ' HG2' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -117.11 141.11 48.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.682 -175.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.667 ' HD1' ' HB2' ' A' ' 107' ' ' ASP . 26.1 m-85 -121.73 134.96 54.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.154 -172.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.0 114.39 11.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.841 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.554 ' HA3' ' HB2' ' A' ' 169' ' ' PHE . . . 119.91 36.58 0.82 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.052 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 99' ' ' PHE . 8.9 m120 -95.06 83.85 4.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.346 0.594 . . . . 0.0 110.149 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.06 -45.34 10.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.413 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.18 -41.61 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -173.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.495 HG12 ' HE2' ' A' ' 141' ' ' TYR . 14.0 p -117.53 148.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.68 145.33 53.96 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.667 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 18.2 p-10 -66.42 -32.07 73.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.551 170.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -43.72 76.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.073 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.71 65.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -58.44 -32.03 68.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.11 176.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.505 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 3.9 mtpp -56.95 -44.44 82.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.435 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.48 -28.37 52.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.43 -40.57 93.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.664 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 97' ' ' ILE . 1.4 mm? -66.86 -38.85 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.747 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.779 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 2.0 mt-10 -63.91 -39.5 94.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.168 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.2 -17.14 60.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.597 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.6 m -87.0 -16.44 35.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.305 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 110.85 -21.55 22.84 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.935 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.59 HG21 HD11 ' A' ' 133' ' ' ILE . 1.3 t -102.8 101.13 11.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.779 ' HB3' ' HA ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -142.64 175.25 9.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -167.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.441 HG23 HG13 ' A' ' 97' ' ' ILE . 16.2 t -63.46 129.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.47 175.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.47 -6.34 71.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.548 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.78 138.1 51.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 12.5 m -65.75 138.96 58.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.635 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -91.21 143.42 26.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.638 0.732 . . . . 0.0 112.894 -163.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.545 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 6.8 t0 -97.08 105.23 17.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.452 170.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.701 ' H ' ' HD2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -70.41 -14.17 62.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.632 -177.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.1 p -81.29 -24.53 37.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.653 0.263 . . . . 0.0 110.82 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.545 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -92.58 3.39 55.63 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 111.131 179.019 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 153' ' ' ALA . 6.4 mm -59.46 -40.78 82.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.55 -34.95 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.472 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.1 -34.36 77.46 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.309 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 130' ' ' ILE . 21.2 mt -64.8 -49.09 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.43 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.35 -45.78 92.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.414 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -40.61 89.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.316 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.33 88.77 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.759 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.528 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 13.8 mt -67.65 -35.72 79.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.639 0.257 . . . . 0.0 111.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.29 -30.48 66.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.859 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.41 -34.24 76.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.455 ' O ' HG23 ' A' ' 144' ' ' VAL . 22.2 m-85 -75.22 -39.83 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.346 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.495 ' HE2' HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -61.24 -39.85 91.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.158 0.504 . . . . 0.0 110.867 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -30.07 69.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.536 177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.4 m -73.11 -28.34 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 140' ' ' PHE . 16.0 t -73.66 -87.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.448 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.94 19.3 23.29 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.597 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.6 mttp 66.59 51.44 1.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.447 0.699 . . . . 0.0 110.852 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -90.39 139.08 31.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.581 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.37 88.85 2.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.043 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.28 163.91 12.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.958 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.2 112.52 24.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 168' ' ' VAL . 3.4 p -118.25 126.91 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.401 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 127.18 38.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.726 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -91.16 111.12 22.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.274 0.559 . . . . 0.0 110.258 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.61 123.25 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.25 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.5 HG12 ' HB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -98.72 127.03 51.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.147 0.498 . . . . 0.0 110.208 177.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -104.74 120.34 50.56 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.153 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.35 135.18 18.14 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 122.821 2.347 . . . . 0.0 112.984 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 0.7 OUTLIER -135.11 151.46 75.32 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.071 175.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 158' ' ' LEU . 4.1 Cg_exo -76.98 66.53 7.68 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.53 2.82 . . . . 0.0 113.499 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -148.6 16.07 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.169 173.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 37.9 t30 58.0 43.41 21.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.275 -168.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HD3' ' HB ' ' A' ' 93' ' ' THR . 74.9 mmt-85 -135.89 157.81 45.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.35 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.5 ' HB ' HG12 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -132.7 145.6 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.019 173.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.65 121.73 45.88 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 97' ' ' ILE . 37.9 tp -95.59 120.36 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.312 -174.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.63 ' HG2' ' HB ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.71 131.78 55.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.649 0.738 . . . . 0.0 111.223 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.575 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 3.9 mm? -102.29 110.63 22.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.255 -176.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.7 t -96.67 110.71 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.554 ' HB2' ' HA3' ' A' ' 101' ' ' GLY . 8.0 m-85 -105.88 118.83 37.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.296 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.72 115.23 15.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -82.32 87.45 6.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.356 0.598 . . . . 0.0 110.658 -176.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 134.42 -131.64 6.01 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.385 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.5 t 69.04 -74.18 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.598 0.759 . . . . 0.0 110.597 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.349 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.548 0.213 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -81.5 152.74 27.17 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.938 0.399 . . . . 0.0 110.351 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.13 46.64 4.08 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -172.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -107.65 151.46 25.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.911 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.8 t -81.8 119.02 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.315 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 t -70.52 124.63 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.01 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -44.32 12.33 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.779 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 145.97 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.839 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -109.82 122.73 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -119.6 147.75 44.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.966 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.5 ' CD1' HD21 ' A' ' 34' ' ' LEU . 46.0 m-85 -124.43 130.97 53.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 0.0 110.991 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 1.4 tm-20 -123.22 69.89 1.02 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.482 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.11 -44.54 0.13 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.512 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD21 ' CD1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -91.41 133.62 35.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.763 0.316 . . . . 0.0 111.149 -178.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.56 -36.12 2.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.869 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -44.21 83.75 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.158 175.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.2 t -81.74 130.34 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.76 156.97 17.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.543 0.211 . . . . 0.0 111.078 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.478 HG12 ' HD2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -51.96 -40.03 27.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 124.069 0.856 . . . . 0.0 112.751 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.43 90.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.199 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HA ' HD12 ' A' ' 44' ' ' LEU . . . -72.53 -33.56 66.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.21 -33.63 59.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.689 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 mp -61.85 -31.31 71.56 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.174 0.59 . . . . 0.0 111.713 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 41' ' ' ALA . 45.9 mt -67.28 -23.96 65.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.388 . . . . 0.0 111.652 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.516 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -89.79 -8.55 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.221 0.534 . . . . 0.0 110.209 177.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.49 ' HG2' HG23 ' A' ' 62' ' ' THR . 85.2 mtp -88.14 143.03 32.3 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.01 -16.18 40.49 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 122.359 2.039 . . . . 0.0 113.209 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 54' ' ' VAL . 2.5 m -129.02 169.46 20.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.058 0.456 . . . . 0.0 111.642 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -127.88 177.2 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.691 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -66.4 125.11 24.64 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.53 -7.08 39.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.452 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.4 156.33 19.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 0.0 111.176 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.12 134.02 36.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.119 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 48' ' ' VAL . 3.1 m -131.67 129.51 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 111.892 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.42 ' O ' HD12 ' A' ' 59' ' ' ILE . 4.6 m-20 -82.1 173.62 11.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.397 170.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.74 -26.27 65.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.346 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.48 -32.45 72.46 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.774 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -76.79 -28.7 55.74 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 122.302 0.241 . . . . 0.0 111.363 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -61.66 -45.04 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.79 ' HA ' HD12 ' A' ' 63' ' ' ILE . 2.2 m -67.62 -31.2 71.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.32 175.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.774 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 1.6 m-20 -66.15 -41.38 90.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.284 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.49 HG23 ' HG2' ' A' ' 46' ' ' MET . 56.3 m -58.37 -46.65 85.92 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.017 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 60' ' ' SER . 65.0 mt -54.04 -50.9 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.545 0.528 . . . . 0.0 110.644 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -39.86 95.87 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.587 0.755 . . . . 0.0 111.747 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 69' ' ' THR . . . -67.67 -52.55 36.58 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.882 -176.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 45' ' ' SER . 41.1 mt -64.48 -30.61 71.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.429 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.2 -40.39 82.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.674 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 -12.9 61.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.803 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 65' ' ' ALA . 34.6 p -78.14 -23.01 47.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.576 0.227 . . . . 0.0 110.708 -177.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.39 23.18 76.53 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.198 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -87.92 -28.76 21.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.15 . . . . 0.0 111.229 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -136.44 161.46 35.76 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.253 -177.026 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -79.84 -38.91 31.83 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.174 0.296 . . . . 0.0 111.185 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.843 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 7.9 t70 -139.16 137.76 36.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 66' ' ' LEU . 75.2 t -117.89 119.56 61.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.992 0.425 . . . . 0.0 109.902 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 118.67 32.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.174 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 67.2 t -114.82 128.99 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp -128.68 155.7 44.61 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -118.18 126.73 52.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.322 0.582 . . . . 0.0 109.803 174.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -125.63 97.08 5.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.772 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 -108.83 2.61 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.92 7.81 15.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.401 . . . . 0.0 110.407 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.91 129.21 53.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.215 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.49 115.89 31.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.4 tp -108.05 121.38 44.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 -175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' A' ' 31' ' ' PHE . 21.9 t -112.84 113.19 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.626 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.701 ' HG2' ' HB3' ' A' ' 32' ' ' GLU . 33.9 mt-30 -99.82 138.51 36.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.9 148.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.098 0.475 . . . . 0.0 110.679 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.843 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -100.17 150.84 22.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.86 -178.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -6.22 101.91 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 126.422 2.326 . . . . 0.0 114.274 178.353 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.644 ' HA ' ' HA ' ' A' ' 72' ' ' PHE . 31.3 mtp-105 -64.87 -55.1 30.19 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -170.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.557 ' HB2' HG22 ' A' ' 163' ' ' VAL . 16.7 Cg_exo -68.52 142.28 53.31 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.025 1.817 . . . . 0.0 114.468 -170.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -88.12 140.17 29.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.493 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 125' ' ' LEU . 33.9 mt -65.19 118.24 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.45 -40.75 14.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.06 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.54 146.55 25.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.777 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -107.53 128.78 62.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.92 133.02 54.85 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.632 ' HE1' ' HG3' ' A' ' 111' ' ' LYS . 22.6 m-85 -113.52 135.49 53.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 m -136.91 127.37 26.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.412 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.61 46.38 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.29 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.87 79.99 1.26 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -33.45 21.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.553 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -46.94 76.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.725 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.5 t -118.29 141.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -69.71 151.48 45.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 111.483 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -35.26 79.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.172 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -28.87 65.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.724 0.297 . . . . 0.0 111.153 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.6 mtp -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -34.73 78.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.963 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.632 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 2.4 mttt -59.42 -43.12 93.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.915 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.66 -28.76 56.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.622 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.39 -45.0 85.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.299 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.482 HD12 HG23 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -65.93 -37.16 85.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.21 176.006 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.445 ' HG2' ' CG ' ' A' ' 120' ' ' ARG . 67.0 mt-10 -59.38 -46.58 88.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.26 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.81 61.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -85.04 -16.99 38.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.315 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.98 -19.85 15.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.408 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.482 HG23 HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -96.0 106.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.316 0.579 . . . . 0.0 110.811 -176.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.445 ' CG ' ' HG2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -119.0 163.29 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.136 -173.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.1 t -69.35 123.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 109.963 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.56 -7.27 80.02 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.061 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 161.58 13.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -74.89 149.54 39.46 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.789 HD22 HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -103.04 146.76 27.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.969 0.414 . . . . 0.0 111.716 -173.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.535 ' HA ' ' HG3' ' A' ' 90' ' ' GLU . 34.6 t0 -116.25 101.49 8.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.648 174.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.496 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -71.46 -20.14 62.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.233 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -27.09 65.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.548 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -0.01 43.06 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.805 177.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.9 mm -59.31 -37.87 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.451 0.301 . . . . 0.0 111.69 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.38 86.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.913 0.387 . . . . 0.0 111.3 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -30.07 64.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.26 -42.51 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.272 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -64.38 -40.57 96.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -68.46 -38.06 80.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.626 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.68 -37.5 92.49 Favored Glycine 0 C--O 1.227 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.852 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.487 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 11.1 mt -73.01 -34.3 66.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.682 0.277 . . . . 0.0 111.202 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -38.84 87.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.153 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.41 -37.53 71.51 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.597 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 144' ' ' VAL . 11.1 t80 -61.47 -41.96 98.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.809 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.453 ' HD1' ' O ' ' A' ' 147' ' ' TYR . 1.2 m-85 -62.21 -37.58 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.847 177.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 146' ' ' LYS . 56.9 t80 -70.41 -35.44 73.44 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.335 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.8 m -67.69 -31.81 72.02 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 140' ' ' PHE . 11.0 t -74.63 -91.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.806 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.43 18.58 22.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.412 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 142' ' ' TYR . 7.8 mtmt 60.01 57.42 3.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.441 0.639 . . . . 0.0 110.205 -173.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.453 ' O ' ' HD1' ' A' ' 141' ' ' TYR . 51.2 m-85 -96.64 34.89 1.58 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.701 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.13 102.71 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.97 152.51 45.58 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.617 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 m -96.77 126.63 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 110.373 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.4 p -106.48 134.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.43 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -108.81 117.04 33.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.012 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.21 110.45 21.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.318 0.58 . . . . 0.0 110.1 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.69 117.0 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.386 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.67 112.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.185 0.516 . . . . 0.0 110.047 175.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 8.1 m -104.7 121.65 46.2 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 6.2 Cg_exo -79.9 143.78 16.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.109 2.539 . . . . 0.0 112.126 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -129.92 156.76 78.55 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.939 174.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.85 70.85 3.49 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.489 2.793 . . . . 0.0 113.266 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 158' ' ' LEU . 6.0 ttm180 -163.35 15.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.36 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.9 t30 55.59 42.27 29.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.199 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -129.95 157.99 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.815 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.789 HG21 HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.74 152.37 36.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.114 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.87 118.71 37.46 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.8 tp -99.17 112.18 24.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.128 -175.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HG2' HG22 ' A' ' 168' ' ' VAL . 8.2 ttmt -111.63 132.68 54.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.483 0.658 . . . . 0.0 111.145 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.511 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.5 mm? -108.63 109.41 20.6 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.408 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 166' ' ' LYS . 1.5 t -107.19 113.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.807 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 3.2 m-85 -98.34 118.91 36.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.117 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.4 114.68 19.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.627 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -80.49 99.99 8.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.538 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 99.63 98.9 2.21 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.701 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.485 HG13 ' H ' ' A' ' 174' ' ' SER . 2.2 p -138.69 -62.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.383 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 173' ' ' VAL . 1.7 m . . . . . 0 C--N 1.327 -0.413 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.917 ' HA ' ' HB ' ' A' ' 53' ' ' THR . 1.8 mm-40 57.33 62.3 2.22 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 124.289 0.993 . . . . 0.0 112.578 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.84 -53.17 0.98 Allowed Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.323 171.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p90 -150.47 152.23 33.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.878 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -85.86 118.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.1 119.04 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.354 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.65 -34.61 19.74 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.442 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.481 ' HB3' HG23 ' A' ' 83' ' ' THR . 20.8 t70 -158.57 145.6 17.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.196 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.645 HD13 HD21 ' A' ' 43' ' ' LEU . 4.6 mt -109.28 120.65 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -116.5 127.11 54.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.767 -178.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.41 136.52 40.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.406 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.2 58.22 0.69 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.955 0.883 . . . . 0.0 109.647 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.95 -121.57 0.93 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.611 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD22 ' HB ' ' A' ' 37' ' ' VAL . 20.3 mt 62.18 138.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.27 1.028 . . . . 0.0 113.755 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.33 -56.64 0.32 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.008 -0.432 . . . . 0.0 110.658 174.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -36.78 65.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.132 0.491 . . . . 0.0 110.334 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -101.7 141.59 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.721 -179.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.35 159.53 15.07 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.99 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -51.22 -43.23 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.83 -35.54 50.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.75 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.45 -29.2 64.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.215 0.531 . . . . 0.0 111.031 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.71 -34.65 60.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.409 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.772 HD22 ' HG2' ' A' ' 49' ' ' ARG . 2.3 mt -56.98 -30.26 63.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.384 0.673 . . . . 0.0 112.79 170.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.57 -29.31 69.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 111.445 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.745 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -91.33 -8.82 47.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.014 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.542 ' HG3' ' HA ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -86.28 132.55 42.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 46' ' ' MET . 6.7 Cg_exo -74.23 -8.61 21.1 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.784 2.323 . . . . 0.0 112.749 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.424 HG11 ' CG1' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -139.93 151.91 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.939 0.4 . . . . 0.0 110.418 -175.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.772 ' HG2' HD22 ' A' ' 43' ' ' LEU . 81.5 mtt-85 -131.57 179.41 6.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.576 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.4 p -63.08 123.43 18.56 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.256 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.44 -6.83 39.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 7.8 m-20 -87.61 148.87 24.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.816 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.917 ' HB ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -101.15 124.51 46.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.342 178.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.424 ' CG1' HG11 ' A' ' 48' ' ' VAL . 2.1 m -142.02 145.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -170.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -100.47 -177.76 3.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.38 -26.44 66.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.786 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.83 -31.64 68.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.642 0.258 . . . . 0.0 110.572 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.38 -29.38 59.83 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.202 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -44.84 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.72 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -68.28 -34.01 75.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.435 177.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -66.58 -40.87 89.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.006 0.431 . . . . 0.0 110.387 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.9 m -58.59 -43.8 89.65 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.154 172.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 60' ' ' SER . 74.6 mt -55.97 -47.15 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.743 176.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmm-85 -62.76 -42.53 99.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 69' ' ' THR . . . -59.63 -53.39 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 45' ' ' SER . 16.4 mt -63.6 -32.66 74.19 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.657 0.598 . . . . 0.0 111.624 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -39.66 91.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.0 110.888 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.67 60.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.222 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 45' ' ' SER . 42.3 p -79.78 -24.93 41.14 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -172.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.75 20.73 79.84 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.752 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -88.83 -26.34 21.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.292 0.568 . . . . 0.0 110.142 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.16 156.54 43.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.364 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.527 ' OE1' ' HE2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.64 -44.24 24.33 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.29 0.369 . . . . 0.0 111.275 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 31.5 t70 -130.73 139.28 50.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.285 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 66' ' ' LEU . 25.2 t -123.51 120.16 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.238 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.49 117.29 29.96 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.473 HG22 HG13 ' A' ' 86' ' ' VAL . 84.4 t -113.87 122.66 68.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.3 137.84 46.16 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.439 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 6.5 ptm180 -95.31 140.56 30.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.356 0.598 . . . . 0.0 110.387 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -130.62 96.94 4.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.43 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.68 -109.08 2.72 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.166 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -108.2 1.7 22.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 0.0 110.759 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.71 137.41 41.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 -173.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.71 115.54 30.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.24 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' HIS . 10.6 tp -102.52 119.25 38.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.473 HG13 HG22 ' A' ' 77' ' ' VAL . 17.7 t -117.88 108.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.759 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.92 136.49 44.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.06 153.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.262 0.553 . . . . 0.0 111.073 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -98.91 122.27 41.94 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -147.98 167.08 25.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.74 -168.049 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.8 OUTLIER 110.59 -63.7 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 126.525 1.93 . . . . 0.0 113.243 172.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 161' ' ' ASN . 20.0 Cg_exo -66.16 139.61 56.12 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 121.414 1.409 . . . . 0.0 112.917 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 66.9 m -127.75 133.35 49.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.319 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 125' ' ' LEU . 56.9 mt -69.13 118.86 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.09 -34.67 12.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.565 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 138.3 24.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 121' ' ' VAL . 4.7 mt -110.75 123.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 131.74 56.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.064 0.459 . . . . 0.0 110.898 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.657 ' HE2' HD13 ' A' ' 167' ' ' LEU . 21.2 m-85 -110.13 135.75 50.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.989 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.98 122.72 11.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.18 -14.5 64.39 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.535 174.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.29 78.11 3.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 110.829 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -85.84 -19.35 30.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -78.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.526 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.49 ' HB ' ' CE2' ' A' ' 141' ' ' TYR . 54.4 t -84.21 139.17 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -69.92 152.19 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.053 0.454 . . . . 0.0 111.644 -172.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.26 76.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.546 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -38.01 89.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mtp -73.05 -39.33 66.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.359 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.485 HD21 ' HE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -63.64 -32.74 74.31 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.417 177.375 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.439 ' HG3' ' HE1' ' A' ' 99' ' ' PHE . 10.3 mttt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.076 0.465 . . . . 0.0 110.954 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -28.76 55.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.622 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -67.84 -38.5 83.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.5 mm? -67.9 -38.46 83.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.467 175.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.47 -33.66 76.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.088 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.38 -16.11 60.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.079 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 m -91.83 -16.55 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.193 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 107.93 -25.65 19.95 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.921 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.19 107.89 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.155 0.503 . . . . 0.0 111.451 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.468 ' HA ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -140.94 175.49 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.548 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 97' ' ' ILE . 27.3 t -67.33 126.32 26.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 110.074 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.29 -6.77 66.18 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.34 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 160.4 14.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.234 0.54 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.91 117.97 23.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.802 174.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.835 HD22 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -93.89 137.42 33.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.093 0.473 . . . . 0.0 112.074 -172.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -101.9 105.98 16.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.878 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.446 ' HA ' HG12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.02 -15.72 62.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.403 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.8 p -87.18 -20.45 26.96 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.56 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.3 p -98.69 6.83 46.73 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.927 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 127' ' ' ARG . 4.6 mm -55.94 -37.58 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.05 85.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.18 -36.22 79.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 110.068 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.0 mt -66.33 -42.99 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.443 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.18 -45.0 96.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -34.15 77.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.325 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.53 -42.16 89.06 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.777 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.9 -38.62 91.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.452 ' HG3' HG12 ' A' ' 151' ' ' VAL . 13.8 mt-10 -69.62 -34.54 74.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.254 0.346 . . . . 0.0 111.067 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.52 -41.83 75.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.435 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 144' ' ' VAL . 5.4 m-85 -67.49 -37.18 82.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.49 ' CE2' ' HB ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.95 -41.18 91.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.163 0.506 . . . . 0.0 110.476 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -30.35 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.51 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.8 m -72.35 -28.58 63.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.856 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 140' ' ' PHE . 31.4 t -77.54 -82.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.767 0.317 . . . . 0.0 111.092 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.5 19.46 21.85 Favored Glycine 0 N--CA 1.454 -0.101 0 C-N-CA 121.358 -0.449 . . . . 0.0 112.833 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm 66.05 34.35 7.0 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.341 0.656 . . . . 0.0 110.485 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -76.63 126.27 30.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.219 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.62 59.12 0.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.242 0.544 . . . . 0.0 110.565 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.95 148.21 22.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.642 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.4 m -97.86 118.82 35.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.942 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 169' ' ' PHE . 7.7 p -98.8 137.35 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 116.95 19.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.077 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.49 111.53 23.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.424 0.631 . . . . 0.0 109.949 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.99 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.391 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.67 109.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.483 0.658 . . . . 0.0 110.219 175.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.6 m -104.67 113.47 64.93 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.811 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.37 128.13 8.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.085 2.523 . . . . 0.0 113.004 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -109.46 143.59 28.09 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 16.5 Cg_exo -67.69 79.52 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.83 3.02 . . . . 0.0 114.008 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -157.44 -75.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 6.3 t30 177.79 13.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.802 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.587 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 26.4 mmt-85 -117.92 157.7 26.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.414 -170.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.835 HG11 HD22 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -127.93 152.61 36.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.319 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -108.3 118.89 37.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.4 tp -106.58 110.7 22.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.07 0.462 . . . . 0.0 110.339 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -112.55 132.53 55.07 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.258 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.657 HD13 ' HE2' ' A' ' 99' ' ' PHE . 1.5 mp -114.31 112.09 22.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.696 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.55 112.99 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.596 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.51 ' CE1' ' HB ' ' A' ' 151' ' ' VAL . 2.4 m-85 -99.6 118.68 36.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.93 113.53 20.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.82 0.343 . . . . 0.0 110.867 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.38 61.51 1.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.668 0.747 . . . . 0.0 109.515 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.94 50.48 0.72 Allowed Glycine 0 CA--C 1.504 -0.595 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.895 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.511 ' HB ' ' H ' ' A' ' 174' ' ' SER . 0.1 OUTLIER -125.97 -145.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.892 -174.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.511 ' H ' ' HB ' ' A' ' 173' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.378 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.29 118.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.693 1.246 . . . . 0.0 111.602 177.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.09 44.83 64.79 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.487 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.606 ' HZ ' HD12 ' A' ' 84' ' ' LEU . 2.7 p90 -93.8 153.38 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.631 0.253 . . . . 0.0 110.51 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.36 117.78 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.245 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.16 137.91 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.233 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 -37.75 5.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.27 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -143.86 138.55 28.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.481 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.664 HG21 ' HE1' ' A' ' 46' ' ' MET . 86.7 mt -103.87 120.72 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 127.95 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.407 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -103.8 122.33 44.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.366 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.774 ' HB2' ' HG2' ' A' ' 87' ' ' GLN . 4.3 mt-10 -98.68 54.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.913 0.863 . . . . 0.0 109.907 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.87 -100.77 0.14 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.32 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' H ' HG23 ' A' ' 88' ' ' VAL . 7.1 mt 45.64 84.77 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.079 0.952 . . . . 0.0 112.946 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.543 ' HB2' ' HB2' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -96.95 -29.33 13.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.654 -176.265 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -118.16 -42.51 2.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.47 ' HB ' HD22 ' A' ' 34' ' ' LEU . 46.8 t -87.62 144.53 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.725 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.58 157.96 16.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.991 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -58.88 -31.61 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.56 81.23 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.872 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.19 -35.94 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.136 0.493 . . . . 0.0 110.696 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.42 83.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.442 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.626 HD22 ' HD2' ' A' ' 49' ' ' ARG . 2.6 mt -57.8 -32.76 67.87 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.58 -21.15 61.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.612 0.244 . . . . 0.0 111.352 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -93.45 -21.98 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.018 0.437 . . . . 0.0 110.369 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.664 ' HE1' HG21 ' A' ' 29' ' ' ILE . 77.0 mtm -82.65 135.73 45.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.39 -2.75 12.77 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.56 2.173 . . . . 0.0 112.444 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.78 147.56 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HD2' HD22 ' A' ' 43' ' ' LEU . 4.1 mmm180 -129.6 175.13 9.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.936 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.6 p -68.06 120.99 15.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.69 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.18 -5.27 52.56 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.424 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -80.02 155.89 27.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 0.0 111.594 -177.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -106.24 126.04 51.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.229 176.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 58' ' ' ASP . 0.3 OUTLIER -133.03 133.45 58.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 112.134 -168.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.449 ' O ' HD12 ' A' ' 59' ' ' ILE . 2.7 m120 -98.77 -177.27 3.6 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.094 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.32 -32.75 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.568 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.7 -43.09 89.94 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.549 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' A' ' 54' ' ' VAL . 31.1 m-20 -75.09 -27.99 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.246 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.915 HD11 ' HD3' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -59.78 -52.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 172.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -71.47 -26.29 62.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.259 178.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.439 ' HA ' ' HD2' ' A' ' 64' ' ' ARG . 1.8 t-20 -63.98 -47.14 81.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -60.78 -45.66 93.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 174.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 60' ' ' SER . 67.1 mt -53.72 -55.5 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 123.544 0.528 . . . . 0.0 110.886 177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -69.91 -30.47 67.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.08 -175.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.32 -48.22 68.22 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.558 0.218 . . . . 0.0 110.592 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB2' HG11 ' A' ' 75' ' ' VAL . 84.0 mt -69.27 -30.41 68.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -40.51 94.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 110.774 175.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.57 -13.43 62.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.601 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.3 p -79.03 -24.92 43.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.547 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.475 ' HA3' ' HG3' ' A' ' 123' ' ' GLU . . . 80.83 -10.25 47.64 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.317 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -67.07 -31.72 72.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.4 144.46 46.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.848 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -73.4 -37.25 66.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.054 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -139.49 136.51 34.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 66' ' ' LEU . 39.3 t -127.59 118.15 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.085 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.09 55.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.659 HG22 HG13 ' A' ' 86' ' ' VAL . 68.1 t -125.52 118.38 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 77' ' ' VAL . 2.2 mm? -133.14 159.14 41.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -172.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.915 ' HD3' HD11 ' A' ' 59' ' ' ILE . 15.5 mtm180 -113.49 147.59 37.6 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.655 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -135.27 96.83 3.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.736 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.8 -109.25 2.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.512 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 24' ' ' PHE . 3.8 m-20 -112.85 14.22 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.227 0.537 . . . . 0.0 109.923 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.45 136.82 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.257 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.606 HD12 ' HZ ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -102.34 112.13 24.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 tp -106.4 112.46 25.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.624 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 77' ' ' VAL . 8.3 t -114.51 117.12 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.774 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.0 mt-30 -106.97 124.94 50.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 34' ' ' LEU . 2.0 m -125.99 145.01 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.196 -174.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.16 111.7 24.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.175 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 35' ' ' GLN . 3.6 mt-10 -119.6 95.48 4.8 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.078 -0.388 . . . . 0.0 110.438 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.73 -69.71 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.86 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 124' ' ' SER . 18.9 Cg_endo -88.29 141.08 4.83 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.641 1.561 . . . . 0.0 113.939 -167.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.754 ' HB ' ' HD2' ' A' ' 162' ' ' ARG . 94.0 m -111.93 124.8 53.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.421 176.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 125' ' ' LEU . 19.0 mt -67.54 118.8 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.01 6.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.239 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.05 144.33 27.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.401 . . . . 0.0 110.856 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -106.9 123.87 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 171.304 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.99 141.35 49.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.381 -176.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.547 ' HE1' ' HB2' ' A' ' 111' ' ' LYS . 24.1 m-85 -117.59 152.33 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 112.018 -172.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.79 111.91 3.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.556 ' HA2' ' HG2' ' A' ' 171' ' ' GLU . . . 118.46 55.09 0.28 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.257 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.534 HD21 HD22 ' A' ' 110' ' ' LEU . 33.1 m120 -126.24 41.52 3.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.224 -0.488 . . . . 0.0 112.044 -172.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -86.03 -16.03 39.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.526 177.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 141' ' ' TYR . 75.6 m -105.21 -45.19 4.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.639 0.257 . . . . 0.0 111.108 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.0 t -120.62 147.65 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.44 147.45 50.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.188 0.518 . . . . 0.0 111.939 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.74 -35.2 78.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.446 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -35.09 79.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.121 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -41.65 77.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.215 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.534 HD22 HD21 ' A' ' 102' ' ' ASN . 0.3 OUTLIER -62.87 -40.62 98.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.235 175.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.547 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -64.96 -43.27 93.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.224 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.11 -27.42 60.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -66.57 -43.65 84.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.417 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -61.63 -43.24 99.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.652 173.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.817 ' HG2' ' HG3' ' A' ' 120' ' ' ARG . 91.9 mt-10 -59.9 -42.95 94.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.511 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.75 -18.68 60.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.858 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 m -87.4 -17.18 32.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.632 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.75 -21.22 8.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.282 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.14 103.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.372 0.606 . . . . 0.0 110.147 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.817 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 12.2 ttp-105 -130.98 161.88 30.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.346 -172.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.419 ' HA ' HG22 ' A' ' 94' ' ' ILE . 24.2 t -69.9 124.43 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.956 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.68 -21.67 44.89 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.594 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.475 ' HG3' ' HA3' ' A' ' 70' ' ' GLY . 1.0 OUTLIER -95.79 166.22 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 110.758 -178.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -83.13 142.65 31.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.425 -176.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -116.22 138.64 51.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.451 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 25.6 t0 -94.8 121.07 36.01 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.195 0.998 . . . . 0.0 111.486 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -21.85 61.27 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.661 -1.608 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.9 p -89.6 -10.68 45.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.905 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 126' ' ' ASP . 1.1 p -104.33 7.32 35.71 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.001 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.518 HD11 HD11 ' A' ' 125' ' ' LEU . 5.5 mm -55.31 -43.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.644 0.59 . . . . 0.0 111.854 -177.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 135' ' ' LYS . . . -62.48 -42.71 99.68 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.492 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.46 -29.02 66.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.888 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.25 -42.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.762 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.91 -46.76 89.38 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 50.6 mmtt -67.88 -36.39 80.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -40.23 84.79 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.374 -0.441 . . . . 0.0 112.608 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.531 ' HB3' ' HZ ' ' A' ' 169' ' ' PHE . 10.0 mt -69.62 -31.97 70.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.881 ' HG3' HG23 ' A' ' 151' ' ' VAL . 6.2 mt-10 -64.62 -41.37 96.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.418 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -68.56 -34.06 75.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.543 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.463 ' HE1' HD12 ' A' ' 110' ' ' LEU . 28.0 t80 -60.76 -44.28 96.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.536 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.512 ' CE1' ' HB2' ' A' ' 104' ' ' SER . 0.2 OUTLIER -62.7 -38.95 92.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 177.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.55 -29.93 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.999 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 m -70.55 -30.33 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 140' ' ' PHE . 19.4 t -73.9 -82.28 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 110.853 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.69 18.67 22.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.029 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 63.73 40.82 7.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 110.271 -173.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -81.55 120.99 25.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.627 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 101.01 9.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 138' ' ' GLU . . . -114.84 156.42 24.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.16 120.7 36.95 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.881 HG23 ' HG3' ' A' ' 138' ' ' GLU . 49.0 t -102.57 124.28 56.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 0.0 111.812 -172.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.85 115.82 26.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.87 111.12 23.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.65 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.66 112.97 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.033 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 117.65 49.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 109.369 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.6 m -104.67 116.89 60.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.944 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 163' ' ' VAL . 91.4 Cg_endo -86.84 136.73 4.42 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.096 2.531 . . . . 0.0 113.113 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.702 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.3 OUTLIER -126.03 150.2 68.61 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 171.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 22.1 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.471 2.781 . . . . 0.0 114.108 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -113.67 26.37 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.208 -0.308 . . . . 0.0 110.81 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.5 t30 74.88 5.35 4.36 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 0.0 111.52 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.754 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 9.8 mmt-85 -113.56 160.29 18.69 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 111.176 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 157' ' ' PRO . 0.7 OUTLIER -136.73 145.26 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.486 175.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.23 131.02 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.67 117.44 33.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.773 0.321 . . . . 0.0 111.188 -173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 131.63 56.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 0.0 109.816 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 99' ' ' PHE . 4.4 mm? -108.89 111.72 23.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.305 -175.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.4 t -94.94 111.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.785 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.531 ' HZ ' ' HB3' ' A' ' 137' ' ' LEU . 8.7 m-85 -114.18 142.02 46.78 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.231 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -82.18 125.06 30.47 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 167.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.556 ' HG2' ' HA2' ' A' ' 101' ' ' GLY . 1.3 mt-10 -81.61 32.2 0.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -170.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.43 129.96 5.43 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.473 ' HB ' ' H ' ' A' ' 174' ' ' SER . 0.0 OUTLIER -81.08 -136.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.587 0.232 . . . . 0.0 110.395 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.473 ' H ' ' HB ' ' A' ' 173' ' ' VAL . 2.5 m . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.129 0.49 . . . . 0.0 109.732 176.42 . . . . . . . . 1 1 . 1 stop_ save_